#dbSNP_hg38_chr	dbSNP_hg38_position	Top SNP	P-value	LocusName	RA 1(Reported Allele 1)	nonref_allele	nonref_effect	OR_nonref	nearest_gene_symb	Study type	Study Design	Pubmed PMID	Population_map	Cohort_simple3	Sample size	Analysis group	Phenotype	Phenotype-derived	most_severe_consequence
chr1	6434683	rs12074379	0.00726	ESPN	T	T	NR	NA	ESPN	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AD	AD	intron_variant
chr1	6434683	rs12074379	8.51E-40	NR	T	T	NR	NA	ESPN	SNP-based	eQTL	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	ESPN (ILMN_1806710) expression	Expression	intron_variant
chr1	8708071	rs112053331	0.0009	RERE	NR	NR	NR	NA	RERE	SNP-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr1	8708071	rs112053331	0.08392	NA	NR	NR	NR	NA	RERE	Gene-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr1	11487007	rs2379135	0.0156	PTCHD2	NR	NR	NR	NA	DISP3	SNP-based	Endophenotype	22245343	Caucasian	ADNI	757	All	MRI	Imaging	intron_variant
chr1	11796321	rs1801133	0.832	MTHFR	A	A	0.98	0.98	MTHFR	SNP-based	Disease risk	20534741	Caucasian	"ADC, UM"	1610	All	AD	AD	missense_variant
chr1	14031929	rs7527934	0.00000587	PRDM2	G	G	0.87	0.87	KAZN	SNP-based	Disease risk	20460622	Caucasian	"ADGC, CHARGE, EADI"	24035	All	AD	AD	intergenic_region
chr1	14031929	rs7527934	0.00035	PRDM2	G	G	0.86	0.86	KAZN	SNP-based	Disease risk	20460622	Caucasian	"ADGC, CHARGE"	16675	All	AD	AD	intergenic_region
chr1	14031929	rs7527934	NR	PRDM2	G	G	0.97	0.97	KAZN	SNP-based	Disease risk	20460622	Caucasian	"ADGC, CHARGE, EADI, GERAD"	34363	All	AD	AD	intergenic_region
chr1	16013965	rs1763601	1.55E-60	CLCNKA	NR	NR	1.22	3.38719	HSPB7	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	CLCNKA expression in Cerebellar	Expression	upstream_gene_variant
chr1	16013965	rs1763601	1.67E-46	CLCNKA	NR	NR	1.02	2.77319	HSPB7	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	CLCNKA expression in Temporal cortex	Expression	upstream_gene_variant
chr1	16013965	rs1763601	3.66E-25	CLCNKA	NR	NR	1.14	3.12677	HSPB7	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	CLCNKA expression in Cerebellar	Expression	upstream_gene_variant
chr1	16013965	rs1763601	4.69E-31	CLCNKA	NR	NR	1.3	3.6693	HSPB7	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	CLCNKA expression in Cerebellar	Expression	upstream_gene_variant
chr1	17283250	rs16824888	0.00398	PADI4	A	A	NR	NA	PADI3	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	10870	HTN-P group	AD	AD	3_prime_UTR_variant
chr1	17283250	rs16824888	0.0112	PADI4	A	A	NR	NA	PADI3	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	3_prime_UTR_variant
chr1	17283250	rs16824888	6.28E-87	NR	A	A	NR	NA	PADI3	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	10870	HTN-P group	PADI4 (ILMN_1807529) expression	Expression	3_prime_UTR_variant
chr1	18875425	rs6695033	0.00000324	ALDH4A1	G	G	2.71	NA	RP13-279N23.2	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	missense_variant
chr1	32614460	rs180743675	0.016	RBBP4	A	A	0.44	1.55271	ZBTB8OS	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr1	32614460	rs180743675	0.328	RBBP4	A	A	0.98	2.66446	ZBTB8OS	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly	Episodic Memory Performance	Cognitive	intron_variant
chr1	32614460	rs180743675	0.472	RBBP4	A	A	-0.09	0.913931	ZBTB8OS	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with non-APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr1	32642799	rs9660296	0.04	RBBP4	T	T	0.15	1.16183	ZBTB8OS	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with non-APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr1	32642799	rs9660296	0.089	RBBP4	T	T	1.7	5.47395	ZBTB8OS	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly	Episodic Memory Performance	Cognitive	intron_variant
chr1	32642799	rs9660296	0.779	RBBP4	T	T	0.05	1.05127	ZBTB8OS	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr1	32678295	rs659867	0.053	RBBP4	C	C	1.94	6.95875	RBBP4	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly	Episodic Memory Performance	Cognitive	intron_variant
chr1	32678295	rs659867	0.088	RBBP4	C	C	0.17	1.1853	RBBP4	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with non-APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr1	32678295	rs659867	0.202	RBBP4	C	C	0	1	RBBP4	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr1	39858994	rs61779841	0.000544	TRIT1	A	A	NR	NA	TRIT1	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr1	39858994	rs61779841	0.000737	TRIT1	A	A	NR	NA	TRIT1	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	High-density lipoprotein (HDL)	Non-ADRD	intron_variant
chr1	39858994	rs61779841	0.812	TRIT1	A	A	1	1	TRIT1	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr1	46721583	rs7519866	0.0000097	KIAA0494	G	G	0.71	0.71	EFCAB14	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	2024	All	LOAD	AD	upstream_gene_variant
chr1	46721583	rs7519866	0.04	KIAA0494	G	G	1.15	1.15	EFCAB14	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	1870	All	LOAD	AD	upstream_gene_variant
chr1	46721583	rs7519866	0.67	KIAA0494	G	G	0.9	0.9	EFCAB14	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	3894	All	LOAD	AD	upstream_gene_variant
chr1	48181452	rs11205449	0.386	SLC5A9	NR	NR	NR	NA	SLC5A9	SNP-based	Endophenotype	20452100	Caucasian	ADGC	311	Non-Demented autopsy subjects	High Braak vs Low Braak	Neuropathology	intron_variant
chr1	49465077	rs1415985	0.0000123	NR	NR	NR	NR	NA	AGBL4	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	intron_variant
chr1	49719403	rs11205641	0.00000841	NR	NR	NR	NR	NA	AGBL4	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	intron_variant
chr1	49824429	rs4926831	0.0000123	NR	NR	NR	NR	NA	AGBL4	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	intron_variant
chr1	49977917	rs9659092	0.00000454	NR	NR	NR	NR	NA	AGBL4	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	intron_variant
chr1	50094148	rs11583200	0.0000183	NR	NR	NR	NR	NA	ELAVL4	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	intron_variant
chr1	53502546	rs185031519	0.0000792	GLIS1	NR	NR	0.06	1.06184	GLIS1	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	1509	Female subjects	CSF Ab1-42	Fluid biomarker	downstream_gene_variant
chr1	53502546	rs185031519	0.000106	GLIS1	NR	NR	0.06	1.06184	GLIS1	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	1527	Male subjects	CSF Ab1-42	Fluid biomarker	downstream_gene_variant
chr1	53502546	rs185031519	0.0192	GLIS1	G	G	0.28	1.32313	GLIS1	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	1530	All	AD Progression (based on CDR Score)	Cognitive	downstream_gene_variant
chr1	53502546	rs185031519	0.0343	GLIS1	G	G	1.11	3.03436	GLIS1	SNP-based	Disease risk	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	74046	All	AD risk	AD	downstream_gene_variant
chr1	53502546	rs185031519	0.472	GLIS1	G	G	0.01	1.01005	GLIS1	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	3146	All	CSF T-tau	Fluid biomarker	downstream_gene_variant
chr1	53502546	rs185031519	0.594	GLIS1	G	G	0.01	1.01005	GLIS1	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	3146	All	CSF P-tau181p	Fluid biomarker	downstream_gene_variant
chr1	53502546	rs185031519	0.615	GLIS1	G	G	0.03	1.03045	GLIS1	SNP-based	Age at onset (AAO) / Survival	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	39855	AD subjects	Age at onset	Other	downstream_gene_variant
chr1	53502546	rs185031519	2.08E-08	GLIS1	G	G	0.059	1.06078	GLIS1	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	3146	All	CSF Ab1-42	Fluid biomarker	downstream_gene_variant
chr1	53502546	rs185031519	2.08E-08	GLIS1	NR	NR	0.06	1.06184	GLIS1	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	3036	All	CSF Ab1-42	Fluid biomarker	downstream_gene_variant
chr1	54011258	rs72664117	0.00000203	LDLRAD1	A	A	0.67	0.67	LDLRAD1	SNP-based	Disease risk	25663231	Caucasian	ADGC	1629	All	PD	ADRD	intron_variant
chr1	54021452	rs6696554	0.00000458	NR	A	A	0.68	0.68	LDLRAD1	SNP-based	Disease risk	25663231	Caucasian	ADGC	1629	All	PD	ADRD	upstream_gene_variant
chr1	54021923	rs35719463	0.00000292	NR	G	G	0.68	0.68	LDLRAD1	SNP-based	Disease risk	25663231	Caucasian	ADGC	1629	All	PD	ADRD	upstream_gene_variant
chr1	54022577	rs35109297	0.00000161	NR	A	A	0.67	0.67	TMEM59	SNP-based	Disease risk	25663231	Caucasian	ADGC	1629	All	PD	ADRD	upstream_gene_variant
chr1	54023275	rs6703501	0.000000311	NR	T	T	0.65	0.65	TMEM59	SNP-based	Disease risk	25663231	Caucasian	ADGC	1629	All	PD	ADRD	downstream_gene_variant
chr1	54026129	rs10888830	0.00000571	TMEM59	T	T	0.68	0.68	TMEM59	SNP-based	Disease risk	25663231	Caucasian	ADGC	1629	All	PD	ADRD	downstream_gene_variant
chr1	54031367	rs1547467	0.000000184	TMEM59	T	T	0.65	0.65	TMEM59	SNP-based	Disease risk	25663231	Caucasian	ADGC	1629	All	PD	ADRD	upstream_gene_variant
chr1	54073027	rs7537946	0.000000105	TCEANC2	A	A	0.64	0.64	TCEANC2	SNP-based	Disease risk	25663231	Caucasian	ADGC	1629	All	PD	ADRD	intron_variant
chr1	54086202	rs7516791	0.00000115	TCEANC2	G	G	0.67	0.67	TCEANC2	SNP-based	Disease risk	25663231	Caucasian	ADGC	1629	All	PD	ADRD	intron_variant
chr1	54087534	rs9651202	0.00000115	TCEANC2	T	T	0.67	0.67	TCEANC2	SNP-based	Disease risk	25663231	Caucasian	ADGC	1629	All	PD	ADRD	intron_variant
chr1	54092428	rs4926619	9.09E-08	TCEANC2	T	T	0.64	0.64	TCEANC2	SNP-based	Disease risk	25663231	Caucasian	ADGC	1629	All	PD	ADRD	intron_variant
chr1	54096243	rs7555099	0.00000116	TCEANC2	C	C	0.67	0.67	TCEANC2	SNP-based	Disease risk	25663231	Caucasian	ADGC	1629	All	PD	ADRD	intron_variant
chr1	54097483	rs6588502	0.00000161	TCEANC2	A	A	0.67	0.67	TCEANC2	SNP-based	Disease risk	25663231	Caucasian	ADGC	1629	All	PD	ADRD	3_prime_UTR_variant
chr1	54102815	rs4492560	8.49E-08	TCEANC2	G	G	0.64	0.64	TCEANC2	SNP-based	Disease risk	25663231	Caucasian	ADGC	1629	All	PD	ADRD	intron_variant
chr1	54106570	rs10788972	6.18E-08	TCEANC2	C	C	0.64	0.64	TCEANC2	SNP-based	Disease risk	25663231	Caucasian	ADGC	1629	All	PD	ADRD	intron_variant
chr1	54108937	rs12044517	9.75E-08	TCEANC2	G	G	0.64	0.64	TCEANC2	SNP-based	Disease risk	25663231	Caucasian	ADGC	1629	All	PD	ADRD	intron_variant
chr1	54110966	rs11206283	0.00000198	TCEANC2	G	G	0.67	0.67	TCEANC2	SNP-based	Disease risk	25663231	Caucasian	ADGC	1629	All	PD	ADRD	intron_variant
chr1	54289418	rs6697414	0.0000216	SSBP3	NR	NR	NR	NA	SSBP3	SNP-based	Disease risk	20061627	Caucasian	ADGC	699	All	LOAD	AD	intron_variant
chr1	54873006	rs7551288	0.028	NR	NR	NR	295	NA	DHCR24	SNP-based	Endophenotype	21901424	Caucasian	ADNI	103	All	PiB uptake in Left medial frontal gyrus (BA9)	Imaging	intron_variant
chr1	54873006	rs7551288	0.038	NR	NR	NR	271	NA	DHCR24	SNP-based	Endophenotype	21901424	Caucasian	ADNI	103	All	PiB uptake in Left middle frontal gyrus (BA6)	Imaging	intron_variant
chr1	54873006	rs7551288	0.157	NR	NR	NR	166	NA	DHCR24	SNP-based	Endophenotype	21901424	Caucasian	ADNI	103	All	PiB uptake in Right middle frontal gyrus (BA9)	Imaging	intron_variant
chr1	54873006	rs7551288	0.197	NR	NR	NR	150	NA	DHCR24	SNP-based	Endophenotype	21901424	Caucasian	ADNI	103	All	PiB uptake in Left inferior frontal gyrus (BA47)	Imaging	intron_variant
chr1	54873006	rs7551288	0.232	NR	NR	NR	4.4	NA	DHCR24	SNP-based	Endophenotype	21901424	Caucasian	ADNI	103	All	PiB uptake in Right middle frontal gyrus (BA9)	Imaging	intron_variant
chr1	54873006	rs7551288	0.333	NR	NR	NR	113	NA	DHCR24	SNP-based	Endophenotype	21901424	Caucasian	ADNI	103	All	PiB uptake in Right superior frontal gyrus (BA8)	Imaging	intron_variant
chr1	54873006	rs7551288	0.412	NR	NR	NR	98	NA	DHCR24	SNP-based	Endophenotype	21901424	Caucasian	ADNI	103	All	PiB uptake in Right precentral gyrus (BA44)	Imaging	intron_variant
chr1	54873006	rs7551288	0.447	NR	NR	NR	92	NA	DHCR24	SNP-based	Endophenotype	21901424	Caucasian	ADNI	103	All	PiB uptake in Left superior frontal gyrus (BA9)	Imaging	intron_variant
chr1	54873006	rs7551288	0.507	NR	NR	NR	4.08	NA	DHCR24	SNP-based	Endophenotype	21901424	Caucasian	ADNI	103	All	PiB uptake in Right sub-gyral (BA6)	Imaging	intron_variant
chr1	54873006	rs7551288	0.562	NR	NR	NR	75	NA	DHCR24	SNP-based	Endophenotype	21901424	Caucasian	ADNI	103	All	PiB uptake in Left inferior frontal gyrus (BA45)	Imaging	intron_variant
chr1	54873006	rs7551288	0.569	NR	NR	NR	74	NA	DHCR24	SNP-based	Endophenotype	21901424	Caucasian	ADNI	103	All	PiB uptake in Right inferior frontal gyrus (BA47)	Imaging	intron_variant
chr1	54873006	rs7551288	0.576	NR	NR	NR	73	NA	DHCR24	SNP-based	Endophenotype	21901424	Caucasian	ADNI	103	All	PiB uptake in Left precentral gyrus (BA4)	Imaging	intron_variant
chr1	54873006	rs7551288	0.614	NR	NR	NR	68	NA	DHCR24	SNP-based	Endophenotype	21901424	Caucasian	ADNI	103	All	PiB uptake in Left precentral gyrus (BA9)	Imaging	intron_variant
chr1	54873006	rs7551288	0.637	NR	NR	NR	65	NA	DHCR24	SNP-based	Endophenotype	21901424	Caucasian	ADNI	103	All	PiB uptake in Right sub-gyral (BA6)	Imaging	intron_variant
chr1	54873006	rs7551288	0.663	NR	NR	NR	3.93	NA	DHCR24	SNP-based	Endophenotype	21901424	Caucasian	ADNI	103	All	PiB uptake in Left precentral gyrus (BA4)	Imaging	intron_variant
chr1	54873006	rs7551288	0.708	NR	NR	NR	56	NA	DHCR24	SNP-based	Endophenotype	21901424	Caucasian	ADNI	103	All	PiB uptake in Left medial frontal gyrus (BA8)	Imaging	intron_variant
chr1	54873006	rs7551288	0.717	NR	NR	NR	3.88	NA	DHCR24	SNP-based	Endophenotype	21901424	Caucasian	ADNI	103	All	PiB uptake in Left middle frontal gyrus (BA6)	Imaging	intron_variant
chr1	54873006	rs7551288	0.725	NR	NR	NR	3.88	NA	DHCR24	SNP-based	Endophenotype	21901424	Caucasian	ADNI	103	All	PiB uptake in Left inferior frontal gyrus (BA45)	Imaging	intron_variant
chr1	54873006	rs7551288	0.763	NR	NR	NR	3.84	NA	DHCR24	SNP-based	Endophenotype	21901424	Caucasian	ADNI	103	All	PiB uptake in Left inferior frontal gyrus (BA47)	Imaging	intron_variant
chr1	54873006	rs7551288	0.766	NR	NR	NR	3.83	NA	DHCR24	SNP-based	Endophenotype	21901424	Caucasian	ADNI	103	All	PiB uptake in Left precentral gyrus (BA9)	Imaging	intron_variant
chr1	54873006	rs7551288	0.801	NR	NR	NR	3.8	NA	DHCR24	SNP-based	Endophenotype	21901424	Caucasian	ADNI	103	All	PiB uptake in Left medial frontal gyrus (BA9)	Imaging	intron_variant
chr1	54873006	rs7551288	0.857	NR	NR	NR	3.73	NA	DHCR24	SNP-based	Endophenotype	21901424	Caucasian	ADNI	103	All	PiB uptake in Right precentral gyrus (BA44)	Imaging	intron_variant
chr1	54873006	rs7551288	0.942	NR	NR	NR	3.59	NA	DHCR24	SNP-based	Endophenotype	21901424	Caucasian	ADNI	103	All	PiB uptake in Right inferior frontal gyrus (BA47)	Imaging	intron_variant
chr1	54873006	rs7551288	0.951	NR	NR	NR	3.57	NA	DHCR24	SNP-based	Endophenotype	21901424	Caucasian	ADNI	103	All	PiB uptake in Right superior frontal gyrus (BA8)	Imaging	intron_variant
chr1	54873006	rs7551288	0.968	NR	NR	NR	3.52	NA	DHCR24	SNP-based	Endophenotype	21901424	Caucasian	ADNI	103	All	PiB uptake in Left superior frontal gyrus (BA9)	Imaging	intron_variant
chr1	54873006	rs7551288	0.984	NR	NR	NR	3.44	NA	DHCR24	SNP-based	Endophenotype	21901424	Caucasian	ADNI	103	All	PiB uptake in Left medial frontal gyrus (BA8)	Imaging	intron_variant
chr1	55166109	rs1759499	0.00105	USP24	G	G	NR	NA	USP24	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr1	55166109	rs1759499	1.57E-09	USP24	G	G	NR	NA	USP24	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Low-density lipoprotein (LDL)	Non-ADRD	intron_variant
chr1	56385014	rs11206801	6.37E-08	NR	A	A	NR	NA	AC119674.2	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF Ab1-42	Fluid biomarker	intergenic_region
chr1	56386595	rs4431886	6.37E-08	NR	C	C	NR	NA	AC119674.2	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF Ab1-42	Fluid biomarker	intergenic_region
chr1	57273491	rs74834332	0.000000043	DAB1	A	A	0.79	2.2034	DAB1	SNP-based	Endophenotype	29274321	Caucasian	ADNI	305	Normal controls	Logic memory delayed (LMdT) recall test	Cognitive	intron_variant
chr1	57634035	rs1539053	0.0000071	DAB1	NR	NR	0.88	0.88	DAB1	SNP-based	Disease risk	19734902	Caucasian	Cohorts from Europe and USA	11789	All	AD	AD	intron_variant
chr1	66330543	rs910694	0.2	PDE4B	NR	NR	1.07	1.07	PDE4B	SNP-based	Cross phenotype 	22005930	Caucasian	"ADGC, GERAD, Cohort from UK"	6958	AD+P and control subjects	AD+Psychosis	ADRD	intron_variant
chr1	66330543	rs910694	0.3	PDE4B	NR	NR	1.08	1.08	PDE4B	SNP-based	Cross phenotype 	22005930	Caucasian	"ADGC, GERAD"	2034	AD+P and AD-P subjects	AD+Psychosis	ADRD	intron_variant
chr1	71819228	rs522395	0.00011	NEGR1	NR	NR	NR	NA	NEGR1	SNP-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr1	71819228	rs522395	0.10689	NA	NR	NR	NR	NA	NEGR1	Gene-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr1	72346757	rs2815752	0.093	NR	A	A	0.01	1.01005	NEGR1	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	intergenic_region
chr1	72346757	rs2815752	0.253	NR	A	A	0.96	0.96	NEGR1	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	intergenic_region
chr1	72346757	rs2815752	0.767	NR	A	A	0.99	0.99	NEGR1	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	intergenic_region
chr1	72346757	rs2815752	0.902	NR	A	A	0.997	0.997	NEGR1	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	intergenic_region
chr1	73886165	rs6701710	0.0071	CUGBP2	NR	NR	NR	NA	LRRIQ3	SNP-based	Disease risk	21379329	Caucasian	ADGC	3786	All	LOAD	AD	downstream_gene_variant
chr1	73886165	rs6701710	0.0237	CUGBP2	NR	NR	NR	NA	LRRIQ3	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	downstream_gene_variant
chr1	73886165	rs6701710	0.0263	CUGBP2	NR	NR	NR	NA	LRRIQ3	SNP-based	Disease risk	21379329	Caucasian	ADGC	3839	All	LOAD	AD	downstream_gene_variant
chr1	73886165	rs6701710	0.0278	CUGBP2	NR	NR	NR	NA	LRRIQ3	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	downstream_gene_variant
chr1	73886165	rs6701710	0.0379	CUGBP2	NR	NR	NR	NA	LRRIQ3	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	downstream_gene_variant
chr1	73886165	rs6701710	0.0475	CUGBP2	NR	NR	NR	NA	LRRIQ3	SNP-based	Disease risk	21379329	Caucasian	ADGC	1642	APOE-e4/e3	LOAD	AD	downstream_gene_variant
chr1	73886165	rs6701710	0.0581	CUGBP2	NR	NR	NR	NA	LRRIQ3	SNP-based	Disease risk	21379329	Caucasian	ADGC	2167	APOE-e4+	LOAD	AD	downstream_gene_variant
chr1	73886165	rs6701710	0.0805	CUGBP2	NR	NR	NR	NA	LRRIQ3	SNP-based	Disease risk	21379329	Caucasian	ADGC	3461	Northwestern European ancestry	LOAD	AD	downstream_gene_variant
chr1	73886165	rs6701710	0.123	CUGBP2	NR	NR	NR	NA	LRRIQ3	SNP-based	Disease risk	21379329	Caucasian	ADGC	3722	All	LOAD	AD	downstream_gene_variant
chr1	73886165	rs6701710	0.146	CUGBP2	NR	NR	NR	NA	LRRIQ3	SNP-based	Disease risk	21379329	Caucasian	ADGC	3839	All	LOAD	AD	downstream_gene_variant
chr1	73886165	rs6701710	0.444	CUGBP2	NR	NR	NR	NA	LRRIQ3	SNP-based	Disease risk	21379329	Caucasian	ADGC	250	APOE-e3/e2+e2/e2	LOAD	AD	downstream_gene_variant
chr1	73886165	rs6701710	0.501	CUGBP2	NR	NR	NR	NA	LRRIQ3	SNP-based	Disease risk	21379329	Caucasian	ADGC	1672	APOE-e4-	LOAD	AD	downstream_gene_variant
chr1	73886165	rs6701710	0.681	CUGBP2	NR	NR	NR	NA	LRRIQ3	SNP-based	Disease risk	21379329	Caucasian	ADGC	1422	APOE-e3/e3	LOAD	AD	downstream_gene_variant
chr1	73886165	rs6701710	0.789	CUGBP2	NR	NR	NR	NA	LRRIQ3	SNP-based	Disease risk	21379329	Caucasian	ADGC	408	APOE-e4/e4	LOAD	AD	downstream_gene_variant
chr1	74525960	rs1514175	0.169	NR	A	A	0.004	1.00401	FPGT-TNNI3K	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	intron_variant
chr1	74525960	rs1514175	0.426	NR	A	A	1.03	1.03	FPGT-TNNI3K	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	intron_variant
chr1	74525960	rs1514175	0.432	NR	A	A	0.983	0.983	FPGT-TNNI3K	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	intron_variant
chr1	74525960	rs1514175	0.588	NR	A	A	0.981	0.981	FPGT-TNNI3K	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	intron_variant
chr1	83789052	rs7539409	0.00000123	TTLL7	NR	NR	NR	NA	TTLL7	SNP-based	Disease risk	20061627	Caucasian	ADGC	699	All	LOAD	AD	intron_variant
chr1	83849071	rs10747407	0.0000301	TTLL7	NR	NR	NR	NA	TTLL7	SNP-based	Disease risk	20061627	Caucasian	ADGC	699	All	LOAD	AD	intron_variant
chr1	89100413	rs12725861	0.000945	GBP2	NR	NR	NR	NA	GBP2	SNP-based	Disease risk	19118814	Caucasian	"CAP, Reiman et al.(2007)"	NR	All	LOAD	AD	downstream_gene_variant
chr1	89100413	rs12725861	0.0085	GBP2	NR	NR	NR	NA	GBP2	SNP-based	Disease risk	19118814	Caucasian	CAP	458	All	LOAD	AD	downstream_gene_variant
chr1	89100413	rs12725861	0.016	GBP2	NR	NR	NR	NA	GBP2	SNP-based	Disease risk	19118814	Caucasian	Reiman et al.(2007)	NR	All	LOAD	AD	downstream_gene_variant
chr1	89118386	rs6428503	0.000665	GBP2	NR	NR	NR	NA	GBP2	SNP-based	Disease risk	19118814	Caucasian	"CAP, Reiman et al.(2007)"	NR	All	LOAD	AD	intron_variant
chr1	89118386	rs6428503	0.00854	GBP2	NR	NR	NR	NA	GBP2	SNP-based	Disease risk	19118814	Caucasian	Reiman et al.(2007)	NR	All	LOAD	AD	intron_variant
chr1	89118386	rs6428503	0.0117	GBP2	NR	NR	NR	NA	GBP2	SNP-based	Disease risk	19118814	Caucasian	CAP	458	All	LOAD	AD	intron_variant
chr1	89122697	rs10922573	0.000833	GBP2	NR	NR	NR	NA	GBP2	SNP-based	Disease risk	19118814	Caucasian	"CAP, Reiman et al.(2007)"	NR	All	LOAD	AD	intron_variant
chr1	89122697	rs10922573	0.00854	GBP2	NR	NR	NR	NA	GBP2	SNP-based	Disease risk	19118814	Caucasian	Reiman et al.(2007)	NR	All	LOAD	AD	intron_variant
chr1	89122697	rs10922573	0.0148	GBP2	NR	NR	NR	NA	GBP2	SNP-based	Disease risk	19118814	Caucasian	CAP	458	All	LOAD	AD	intron_variant
chr1	90074206	rs2813746	0.00000172	ZNF326	A	A	148.1	20845521757762694238396486799702335272885473816774277910530883584	ZNF326	SNP-based	Endophenotype	20197096	Caucasian	ADNI	698	All	Hippocampal Volume	Imaging	intergenic_region
chr1	90074206	rs2813746	0.0000105	NR	A	A	148.1	20845521757762694238396486799702335272885473816774277910530883584	ZNF326	SNP-based	Endophenotype	20197096	Caucasian	ADNI	698	All	Hippocampal Volume	Imaging	intergenic_region
chr1	93055535	rs520885	0.00000504	MTF2	NR	NR	NR	NA	MTF2	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	818	All	Plasma Clusterin	Fluid biomarker	intergenic_region
chr1	96479241	rs1555543	0.452	NR	C	C	0.97	0.97	PTBP2	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	intergenic_region
chr1	96479241	rs1555543	0.535	NR	C	C	1.01	1.01	PTBP2	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	intergenic_region
chr1	109594056	rs2301229	0.000492	GNAI3	T	T	NR	NA	GNAI3	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AD	AD	3_prime_UTR_variant
chr1	109594056	rs2301229	1.45E-211	NR	T	T	NR	NA	GNAI3	SNP-based	eQTL	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	GNAI3 (ILMN_1696003) expression	Expression	3_prime_UTR_variant
chr1	109931820	rs7537752	0.00209	CSF1	NR	NR	NR	NA	CSF1	SNP-based	Disease risk	19118814	Caucasian	"CAP, Reiman et al.(2007)"	NR	All	LOAD	AD	downstream_gene_variant
chr1	109931820	rs7537752	0.0327	CSF1	NR	NR	NR	NA	CSF1	SNP-based	Disease risk	19118814	Caucasian	CAP	458	All	LOAD	AD	downstream_gene_variant
chr1	109931820	rs7537752	0.0378	CSF1	NR	NR	NR	NA	CSF1	SNP-based	Disease risk	19118814	Caucasian	Reiman et al.(2007)	NR	All	LOAD	AD	downstream_gene_variant
chr1	113380753	rs7533701	0.00000246	MAGI3	NR	NR	0.358	1.43047	MAGI3	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	673	All	CSF Clusterin	Fluid biomarker	intergenic_region
chr1	113380753	rs7533701	0.000337	MAGI3	NR	NR	0.357	1.42904	MAGI3	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	403	Subjects with APOE-e4-	CSF Clusterin	Fluid biomarker	intergenic_region
chr1	113380753	rs7533701	0.0109	MAGI3	NR	NR	0.307	1.35934	MAGI3	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	270	Subjects with APOE-e4+	CSF Clusterin	Fluid biomarker	intergenic_region
chr1	113419409	rs7552954	0.0041	MAGI3	NR	NR	NR	NA	MAGI3	SNP-based	Endophenotype	22245343	Caucasian	ADNI	757	All	MRI	Imaging	intron_variant
chr1	113510496	rs17507884	0.00000127	MAGI3	NR	NR	0.466	1.59361	MAGI3	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	673	All	CSF Clusterin	Fluid biomarker	intron_variant
chr1	113510496	rs17507884	0.000272	MAGI3	NR	NR	0.476	1.60962	MAGI3	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	403	Subjects with APOE-e4-	CSF Clusterin	Fluid biomarker	intron_variant
chr1	113510496	rs17507884	0.00145	MAGI3	NR	NR	0.452	1.57145	MAGI3	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	270	Subjects with APOE-e4+	CSF Clusterin	Fluid biomarker	intron_variant
chr1	113969461	rs11102709	0.0000425	HIPK1	NR	NR	2.96	2.96	HIPK1	SNP-based	Disease risk	21098978	Arab	Cohort from Israeli	266	All	AD	AD	intron_variant
chr1	113973708	rs10108	0.0000416	HIPK1	NR	NR	0.34	0.34	HIPK1	SNP-based	Disease risk	21098978	Arab	Cohort from Israeli	266	All	AD	AD	3_prime_UTR_variant
chr1	149951049	rs6587723	0.000326	OTUD7B	C	C	NR	NA	OTUD7B	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr1	149951049	rs6587723	0.0015	OTUD7B	C	C	NR	NA	OTUD7B	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Total cholesterol (TC)	Non-ADRD	intron_variant
chr1	151764400	rs1568485	0.00042	OAZ3	NR	NR	NR	NA	OAZ3	SNP-based	Cross phenotype 	28780673	Caucasian	GAME-ON	33832	All	Breast Cancer	Non-ADRD	5_prime_UTR_premature_start_codon_gain_variant
chr1	151764400	rs1568485	0.00097	OAZ3	NR	NR	NR	NA	OAZ3	SNP-based	Cross phenotype 	28780673	Caucasian	IGAP	54162	All	AD	AD	5_prime_UTR_premature_start_codon_gain_variant
chr1	151764400	rs1568485	0.0057	OAZ3	NR	NR	NR	NA	OAZ3	SNP-based	Cross phenotype 	28780673	Caucasian	"GAME-ON, IGAP"	116992	All	AD + Breast cancer + Lung Cancer	Non-ADRD	5_prime_UTR_premature_start_codon_gain_variant
chr1	151764400	rs1568485	0.37	OAZ3	NR	NR	NR	NA	OAZ3	SNP-based	Cross phenotype 	28780673	Caucasian	GAME-ON	28998	All	Lung Cancer	Non-ADRD	5_prime_UTR_premature_start_codon_gain_variant
chr1	153796924	rs9426935	0.00000525	LOC343052	NR	NR	-96.63	1.08174e-42	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	153796924	rs9426935	0.00012	LOC343052	C	C	-117.61	8.36808e-52	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	153796924	rs9426935	0.0074	LOC343052	C	C	NR	NA	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	153796924	rs9426935	0.0089	LOC343052	C	C	-77.11	3.24752e-34	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	153804190	rs4341393	0.00000525	LOC343052	NR	NR	-96.63	1.08174e-42	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	downstream_gene_variant
chr1	153804190	rs4341393	0.00012	LOC343052	C	C	-117.6	8.45218e-52	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	downstream_gene_variant
chr1	153804190	rs4341393	0.0074	LOC343052	C	C	NR	NA	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	downstream_gene_variant
chr1	153804190	rs4341393	0.0089	LOC343052	C	C	-77.11	3.24752e-34	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	downstream_gene_variant
chr1	153805372	rs1139620	0.00000495	GATAD2B	NR	NR	-96.93	8.01375e-43	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	3_prime_UTR_variant
chr1	153805372	rs1139620	0.00012	GATAD2B	C	C	-117.6	8.45218e-52	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	3_prime_UTR_variant
chr1	153805372	rs1139620	0.0071	GATAD2B	C	C	NR	NA	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	3_prime_UTR_variant
chr1	153805372	rs1139620	0.0085	GATAD2B	C	C	-77.66	1.87366e-34	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	3_prime_UTR_variant
chr1	153806936	rs1127091	0.00000476	GATAD2B	NR	NR	-97.12	6.62704e-43	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	3_prime_UTR_variant
chr1	153806936	rs1127091	0.00012	GATAD2B	A	A	-117.6	8.45218e-52	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	3_prime_UTR_variant
chr1	153806936	rs1127091	0.0069	GATAD2B	A	A	NR	NA	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	3_prime_UTR_variant
chr1	153806936	rs1127091	0.0082	GATAD2B	A	A	-78.02	1.30721e-34	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	3_prime_UTR_variant
chr1	153807822	rs9426938	0.00000392	GATAD2B	NR	NR	-98.03	2.66755e-43	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	3_prime_UTR_variant
chr1	153807822	rs9426938	0.00012	GATAD2B	C	C	-117.55	8.88554e-52	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	3_prime_UTR_variant
chr1	153807822	rs9426938	0.0059	GATAD2B	C	C	NR	NA	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	3_prime_UTR_variant
chr1	153807822	rs9426938	0.0069	GATAD2B	C	C	-79.79	2.22661e-35	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	3_prime_UTR_variant
chr1	153820482	rs9427232	0.00000318	GATAD2B	NR	NR	-98.95	1.06307e-43	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	153820482	rs9427232	0.00012	GATAD2B	A	A	117.41	978397017756068824174117462529579564512863200477184	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	153820482	rs9427232	0.0049	GATAD2B	G	G	NR	NA	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	153820482	rs9427232	0.0057	GATAD2B	G	G	-81.71	3.26436e-36	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	153876520	rs7414227	0.00000278	GATAD2B	NR	NR	-99.5	6.13337e-44	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	153876520	rs7414227	0.00016	GATAD2B	G	G	-115.46	7.18388e-51	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	153876520	rs7414227	0.0037	GATAD2B	G	G	NR	NA	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	153876520	rs7414227	0.0042	GATAD2B	G	G	-84.58	1.85086e-37	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	153881560	rs7522030	0.00000306	GATAD2B	NR	NR	-99.72	4.92214e-44	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	153881560	rs7522030	0.00019	GATAD2B	C	C	-114.64	1.6311e-50	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	153881560	rs7522030	0.0034	GATAD2B	C	C	NR	NA	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	153881560	rs7522030	0.004	GATAD2B	C	C	-85.67	6.22288e-38	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	153904499	rs11264573	0.00000317	GATAD2B	NR	NR	-98.93	1.08454e-43	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	153904499	rs11264573	0.0002	GATAD2B	A	A	-113.67	4.30275e-50	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	153904499	rs11264573	0.0036	GATAD2B	A	A	NR	NA	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	153904499	rs11264573	0.004	GATAD2B	A	A	-85.1	1.10037e-37	GATAD2B	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	153941294	rs2252508	0.00000539	DENND4B	NR	NR	-97.78	3.4252e-43	DENND4B	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	splice_region_variant&intron_variant
chr1	153941294	rs2252508	0.0002	DENND4B	G	G	-113.85	3.59396e-50	DENND4B	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	splice_region_variant&intron_variant
chr1	153941294	rs2252508	0.0049	DENND4B	G	G	NR	NA	DENND4B	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	splice_region_variant&intron_variant
chr1	153941294	rs2252508	0.0065	DENND4B	G	G	-82.13	2.14484e-36	DENND4B	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	splice_region_variant&intron_variant
chr1	153966654	rs11264736	0.00000376	SLC39A1	NR	NR	-98.69	1.37872e-43	SLC39A1	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	153966654	rs11264736	0.0001	SLC39A1	T	T	-119.65	1.08809e-52	SLC39A1	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	153966654	rs11264736	0.0051	SLC39A1	T	T	NR	NA	SLC39A1	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	153966654	rs11264736	0.0074	SLC39A1	T	T	-79.29	3.67105e-35	SLC39A1	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	154438943	rs4845622	0.0000643	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Amyloid deposition strata	CSF IL6R 	Fluid biomarker	intron_variant
chr1	154438943	rs4845622	0.00293	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR = 0	CSF IL6R 	Fluid biomarker	intron_variant
chr1	154438943	rs4845622	0.0555	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	Plasma IL6R 	Fluid biomarker	intron_variant
chr1	154438943	rs4845622	0.597	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR > 0	CSF IL6R 	Fluid biomarker	intron_variant
chr1	154438943	rs4845622	0.82	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr1	154438943	rs4845622	0.88	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF Ab1-42	Fluid biomarker	intron_variant
chr1	154438943	rs4845622	0.89	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF T-tau	Fluid biomarker	intron_variant
chr1	154438943	rs4845622	0.93	IL6R	NR	NR	-0.001	0.999	IL6R	SNP-based	Disease risk	25340798	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr1	154438943	rs4845622	1.36E-62	IL6R	C	C	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF IL6R 	Fluid biomarker	intron_variant
chr1	154438943	rs4845622	2.28E-36	IL6R	C	C	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	ADNI	308	All	CSF IL6R 	Fluid biomarker	intron_variant
chr1	154438943	rs4845622	3.29E-09	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	No amyloid deposition strata	CSF IL6R 	Fluid biomarker	intron_variant
chr1	154438943	rs4845622	4.44E-28	IL6R	C	C	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	Knight-ADRC	266	All	CSF IL6R 	Fluid biomarker	intron_variant
chr1	154447611	rs61812598	0.000528	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Amyloid deposition strata	CSF IL6R 	Fluid biomarker	intron_variant
chr1	154447611	rs61812598	0.0157	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR > 0	CSF IL6R 	Fluid biomarker	intron_variant
chr1	154447611	rs61812598	0.0601	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR = 0	CSF IL6R 	Fluid biomarker	intron_variant
chr1	154447611	rs61812598	0.538	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	No amyloid deposition strata	CSF IL6R 	Fluid biomarker	intron_variant
chr1	154447611	rs61812598	0.65	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF T-tau	Fluid biomarker	intron_variant
chr1	154447611	rs61812598	0.7	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF Ab1-42	Fluid biomarker	intron_variant
chr1	154447611	rs61812598	0.72	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr1	154447611	rs61812598	0.76	IL6R	NR	NR	-0.005	0.995012	IL6R	SNP-based	Disease risk	25340798	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr1	154447611	rs61812598	1.45E-27	IL6R	G	G	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	Knight-ADRC	266	All	CSF IL6R 	Fluid biomarker	intron_variant
chr1	154447611	rs61812598	2.61E-37	IL6R	G	G	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	ADNI	308	All	CSF IL6R 	Fluid biomarker	intron_variant
chr1	154447611	rs61812598	2.67E-09	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	Plasma IL6R 	Fluid biomarker	intron_variant
chr1	154447611	rs61812598	5.91E-63	IL6R	G	G	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF IL6R 	Fluid biomarker	intron_variant
chr1	154453788	rs4129267	0.000000464	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	Plasma IL6R 	Fluid biomarker	intron_variant
chr1	154453788	rs4129267	0.000169	IL6R	NR	NR	4.86	129.024	IL6R	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	IMAS	59	All	Plasma IL-6r 	Fluid biomarker	intron_variant
chr1	154453788	rs4129267	0.012	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR > 0	CSF IL6R 	Fluid biomarker	intron_variant
chr1	154453788	rs4129267	0.0173	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Amyloid deposition strata	CSF IL6R 	Fluid biomarker	intron_variant
chr1	154453788	rs4129267	0.097	IL6R	NR	NR	0.001	1.001	IL6R	SNP-based	Disease risk	25340798	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr1	154453788	rs4129267	0.283	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	No amyloid deposition strata	CSF IL6R 	Fluid biomarker	intron_variant
chr1	154453788	rs4129267	0.54	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF T-tau	Fluid biomarker	intron_variant
chr1	154453788	rs4129267	0.63	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF Ab1-42	Fluid biomarker	intron_variant
chr1	154453788	rs4129267	0.64	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr1	154453788	rs4129267	0.959	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR = 0	CSF IL6R 	Fluid biomarker	intron_variant
chr1	154453788	rs4129267	1.11E-26	IL6R	G	G	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	Knight-ADRC	266	All	CSF IL6R 	Fluid biomarker	intron_variant
chr1	154453788	rs4129267	1.30E-37	IL6R	G	G	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	ADNI	308	All	CSF IL6R 	Fluid biomarker	intron_variant
chr1	154453788	rs4129267	1.56E-58	IL6R	NR	NR	0.12	1.1275	IL6R	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	ADNI	521	All	Plasma IL-6r 	Fluid biomarker	intron_variant
chr1	154453788	rs4129267	2.70E-62	IL6R	G	G	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF IL6R 	Fluid biomarker	intron_variant
chr1	154454494	rs2228145	0.000000464	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	Plasma IL6R 	Fluid biomarker	missense_variant
chr1	154454494	rs2228145	0.012	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR > 0	CSF IL6R 	Fluid biomarker	missense_variant
chr1	154454494	rs2228145	0.0173	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Amyloid deposition strata	CSF IL6R 	Fluid biomarker	missense_variant
chr1	154454494	rs2228145	0.283	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	No amyloid deposition strata	CSF IL6R 	Fluid biomarker	missense_variant
chr1	154454494	rs2228145	0.6	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF T-tau	Fluid biomarker	missense_variant
chr1	154454494	rs2228145	0.62	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF Ab1-42	Fluid biomarker	missense_variant
chr1	154454494	rs2228145	0.69	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF P-tau181p	Fluid biomarker	missense_variant
chr1	154454494	rs2228145	0.85	IL6R	NR	NR	0.003	1.003	IL6R	SNP-based	Disease risk	25340798	Caucasian	IGAP	54162	All	AD	AD	missense_variant
chr1	154454494	rs2228145	0.959	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR = 0	CSF IL6R 	Fluid biomarker	missense_variant
chr1	154454494	rs2228145	1.11E-26	IL6R	C	C	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	Knight-ADRC	266	All	CSF IL6R 	Fluid biomarker	missense_variant
chr1	154454494	rs2228145	1.30E-37	IL6R	C	C	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	ADNI	308	All	CSF IL6R 	Fluid biomarker	missense_variant
chr1	154454494	rs2228145	2.70E-62	IL6R	C	C	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF IL6R 	Fluid biomarker	missense_variant
chr1	154465420	rs2229238	0.00000022	IL6R	G	G	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	Knight-ADRC	266	All	CSF IL6R 	Fluid biomarker	3_prime_UTR_variant
chr1	154465420	rs2229238	0.000000238	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR > 0	CSF IL6R 	Fluid biomarker	3_prime_UTR_variant
chr1	154465420	rs2229238	0.000000657	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Amyloid deposition strata	CSF IL6R 	Fluid biomarker	3_prime_UTR_variant
chr1	154465420	rs2229238	0.17	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF Ab1-42	Fluid biomarker	3_prime_UTR_variant
chr1	154465420	rs2229238	0.55	IL6R	NR	NR	0.012	1.01207	IL6R	SNP-based	Disease risk	25340798	Caucasian	IGAP	54162	All	AD	AD	3_prime_UTR_variant
chr1	154465420	rs2229238	0.67	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF T-tau	Fluid biomarker	3_prime_UTR_variant
chr1	154465420	rs2229238	0.83	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF P-tau181p	Fluid biomarker	3_prime_UTR_variant
chr1	154465420	rs2229238	1.46E-11	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	Plasma IL6R 	Fluid biomarker	3_prime_UTR_variant
chr1	154465420	rs2229238	1.51E-09	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR = 0	CSF IL6R 	Fluid biomarker	3_prime_UTR_variant
chr1	154465420	rs2229238	2.04E-08	IL6R	NR	NR	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	No amyloid deposition strata	CSF IL6R 	Fluid biomarker	3_prime_UTR_variant
chr1	154465420	rs2229238	2.07E-08	IL6R	G	G	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	ADNI	308	All	CSF IL6R 	Fluid biomarker	3_prime_UTR_variant
chr1	154465420	rs2229238	2.29E-14	IL6R	G	G	NR	NA	IL6R	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF IL6R 	Fluid biomarker	3_prime_UTR_variant
chr1	154544102	rs3811448	0.000000109	IL6R	NR	NR	NR	NA	TDRD10	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR > 0	CSF IL6R 	Fluid biomarker	missense_variant
chr1	154544102	rs3811448	0.00000049	IL6R	G	G	NR	NA	TDRD10	SNP-based	Endophenotype	25340798	Caucasian	ADNI	308	All	CSF IL6R 	Fluid biomarker	missense_variant
chr1	154544102	rs3811448	0.000000952	IL6R	NR	NR	NR	NA	TDRD10	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Amyloid deposition strata	CSF IL6R 	Fluid biomarker	missense_variant
chr1	154544102	rs3811448	0.04	IL6R	NR	NR	NR	NA	TDRD10	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF Ab1-42	Fluid biomarker	missense_variant
chr1	154544102	rs3811448	0.11	IL6R	NR	NR	0.031	1.03149	TDRD10	SNP-based	Disease risk	25340798	Caucasian	IGAP	54162	All	AD	AD	missense_variant
chr1	154544102	rs3811448	0.29	IL6R	NR	NR	NR	NA	TDRD10	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF T-tau	Fluid biomarker	missense_variant
chr1	154544102	rs3811448	0.86	IL6R	NR	NR	NR	NA	TDRD10	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF P-tau181p	Fluid biomarker	missense_variant
chr1	154544102	rs3811448	2.13E-10	IL6R	NR	NR	NR	NA	TDRD10	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR = 0	CSF IL6R 	Fluid biomarker	missense_variant
chr1	154544102	rs3811448	2.36E-09	IL6R	NR	NR	NR	NA	TDRD10	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	No amyloid deposition strata	CSF IL6R 	Fluid biomarker	missense_variant
chr1	154544102	rs3811448	3.36E-15	IL6R	G	G	NR	NA	TDRD10	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF IL6R 	Fluid biomarker	missense_variant
chr1	154544102	rs3811448	7.91E-12	IL6R	NR	NR	NR	NA	TDRD10	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	Plasma IL6R 	Fluid biomarker	missense_variant
chr1	154544102	rs3811448	8.24E-10	IL6R	G	G	NR	NA	TDRD10	SNP-based	Endophenotype	25340798	Caucasian	Knight-ADRC	266	All	CSF IL6R 	Fluid biomarker	missense_variant
chr1	154572175	rs4845378	0.827	CHRNB2	T	T	1.03	1.03	CHRNB2	SNP-based	Disease risk	20534741	Caucasian	"ADC, UM"	1610	All	AD	AD	intron_variant
chr1	156136394	rs505058	0.0002	LMNA	NR	NR	1.35	1.35	LMNA	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	3870	All	LOAD	AD	missense_variant
chr1	156136394	rs505058	0.0119	LMNA	NR	NR	NR	NA	LMNA	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	776	All	LOAD	AD	missense_variant
chr1	156136394	rs505058	0.15	LMNA	NR	NR	NR	NA	LMNA	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	720	All	LOAD	AD	missense_variant
chr1	156136394	rs505058	0.171	LMNA	NR	NR	NR	NA	LMNA	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	658	All	LOAD	AD	missense_variant
chr1	156136394	rs505058	0.261	LMNA	NR	NR	NR	NA	LMNA	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	1146	All	LOAD	AD	missense_variant
chr1	156136394	rs505058	0.357	LMNA	NR	NR	NR	NA	LMNA	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	570	All	LOAD	AD	missense_variant
chr1	157834858	rs2765501	0.00000152	CD5L	NR	NR	0.05	1.05127	CD5L	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	ADNI	521	All	Plasma CD5L	Fluid biomarker	intron_variant
chr1	157834858	rs2765501	0.00646	CD5L	NR	NR	597.09	20553803470443539105282101568546374858340805974892353132193811913663431698611270693866050850066172540698028203589628320987068877929320657766222153268721210450392762498436793789453621437358839204650563436406573770522814344684927698528467609593684624516990369792	CD5L	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	IMAS	59	All	Plasma CD5L	Fluid biomarker	intron_variant
chr1	159093183	rs76576833	0.00748	AIM2	T	T	NR	NA	AIM2	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	intron_variant
chr1	159093183	rs76576833	1.82E-17	NR	T	T	NR	NA	AIM2	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AIM2 (ILMN_1681301) expression	Expression	intron_variant
chr1	161185602	rs4575098	0.000157	ADAMTS4	A	A	NR	NA	ADAMTS4	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ"	79145	All	AD	AD	3_prime_UTR_variant
chr1	161185602	rs4575098	2.05E-10	ADAMTS4	A	A	6.36	NA	ADAMTS4	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ, UKBB"	455258	All	AD + AD-by-proxy	AD	3_prime_UTR_variant
chr1	161185602	rs4575098	6.88E-08	ADAMTS4	A	A	NR	NA	ADAMTS4	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	3_prime_UTR_variant
chr1	165476293	rs10737511	0.00000939	LOC400794	NR	NR	93.97	64662495984625947923257794161178295926784	RXRG	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	downstream_gene_variant
chr1	165476293	rs10737511	0.0000347	LOC400794	C	C	120.34	18323057827582513744613169212539009273450782301093888	RXRG	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	downstream_gene_variant
chr1	165476293	rs10737511	0.00062	LOC400794	C	C	NR	NA	RXRG	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	downstream_gene_variant
chr1	165476293	rs10737511	0.039	LOC400794	C	C	63.95	5931057271816606608158359552	RXRG	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	downstream_gene_variant
chr1	165478920	rs10918196	0.00000931	LOC400794	NR	NR	93.94	62751430416378524043519520305202258247680	RXRG	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	165478920	rs10918196	0.0000345	LOC400794	C	C	120.25	16746013958155684171462401814751122754011261342580736	RXRG	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	165478920	rs10918196	0.00061	LOC400794	C	C	NR	NA	RXRG	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	165478920	rs10918196	0.039	LOC400794	C	C	63.93	5813614469141004057866928128	RXRG	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	168633624	rs10489216	0.000000844	"DPT, XCL1"	G	G	0.28	NA	XCL1	SNP-based	Disease risk	21379329	Caucasian	ADGC	250	APOE-e3e2+e2e2	LOAD	AD	intergenic_region
chr1	171100818	rs12076145	0.00000444	FM03	NR	NR	-94.94	5.86249e-42	FMO3	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	171100818	rs12076145	0.0000149	FM03	G	G	-121.68	1.42905e-53	FMO3	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	171100818	rs12076145	0.00018	FM03	G	G	NR	NA	FMO3	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	171100818	rs12076145	0.038	FM03	G	G	-63.33	3.13423e-28	FMO3	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	171102742	rs10911192	0.00000445	FM03	NR	NR	-94.89	6.16306e-42	FMO3	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	171102742	rs10911192	0.000015	FM03	C	C	-121.62	1.51742e-53	FMO3	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	171102742	rs10911192	0.00018	FM03	C	C	NR	NA	FMO3	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	171102742	rs10911192	0.038	FM03	C	C	-63.3	3.22968e-28	FMO3	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	171108057	rs1920149	0.00000418	FM03	NR	NR	-94.95	5.80415e-42	FMO3	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	171108057	rs1920149	0.0000151	FM03	A	A	-121.46	1.78071e-53	FMO3	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	171108057	rs1920149	0.00018	FM03	A	A	NR	NA	FMO3	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	171108057	rs1920149	0.036	FM03	A	A	-63.78	1.99847e-28	FMO3	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	171109428	rs1736556	0.000000133	FM03	NR	NR	-109.34	3.26769e-48	FMO3	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	171109428	rs1736556	0.000000404	FM03	C	C	-144.41	1.92103e-63	FMO3	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	171109428	rs1736556	0.0000134	FM03	C	C	NR	NA	FMO3	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	171109428	rs1736556	0.021	FM03	C	C	-69.92	4.30655e-31	FMO3	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	171111344	rs2075992	0.000000128	FM03	NR	NR	-109.5	2.78454e-48	FMO3	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	171111344	rs2075992	0.000000408	FM03	C	C	-144.37	1.99943e-63	FMO3	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	171111344	rs2075992	0.0000134	FM03	C	C	NR	NA	FMO3	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	171111344	rs2075992	0.02	FM03	C	C	-70.34	2.82961e-31	FMO3	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	171122735	rs1795240	0.000000346	FM03	A	A	-143.48	4.86887e-63	FMO3	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	downstream_gene_variant
chr1	171122735	rs1795240	0.00000749	FM03	A	A	NR	NA	FMO3	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	downstream_gene_variant
chr1	171122735	rs1795240	0.011	FM03	A	A	-76.57	5.57278e-34	FMO3	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	downstream_gene_variant
chr1	171122735	rs1795240	4.79E-08	FM03	NR	NR	-112.27	1.74485e-49	FMO3	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	downstream_gene_variant
chr1	171128422	rs4916390	0.00000389	FM06P	NR	NR	-95.04	5.3046e-42	FMO3	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	intergenic_region
chr1	171128422	rs4916390	0.0000272	FM06P	T	T	-117.48	9.52981e-52	FMO3	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intergenic_region
chr1	171128422	rs4916390	0.00024	FM06P	T	T	NR	NA	FMO3	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intergenic_region
chr1	171128422	rs4916390	0.024	FM06P	T	T	-68.66	1.51824e-30	FMO3	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	intergenic_region
chr1	171147265	rs1795243	0.000000712	FM06P	C	C	-141.44	3.74445e-62	FMO3	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	171147265	rs1795243	0.0000137	FM06P	C	C	NR	NA	FMO3	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	171147265	rs1795243	0.011	FM06P	C	C	-76.81	4.3837e-34	FMO3	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	171147265	rs1795243	8.76E-08	FM06P	NR	NR	-110.96	6.46672e-49	FMO3	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	171149882	rs1795244	0.000000129	FM06P	C	C	-151.07	2.46112e-66	FMO3	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	171149882	rs1795244	0.00000157	FM06P	C	C	NR	NA	FMO3	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	171149882	rs1795244	0.031	FM06P	T	T	-66.01	2.14892e-29	FMO3	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	171149882	rs1795244	9.77E-08	FM06P	NR	NR	-111.33	4.46679e-49	FMO3	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	171150061	rs1736567	0.000000129	FM06P	C	C	-151.1	2.38838e-66	FMO3	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	171150061	rs1736567	0.00000158	FM06P	C	C	NR	NA	FMO3	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	171150061	rs1736567	0.031	FM06P	G	G	-66.02	2.12754e-29	FMO3	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	171150061	rs1736567	9.81E-08	FM06P	NR	NR	-111.34	4.42234e-49	FMO3	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	intron_variant
chr1	177920345	rs543874	0.373	NR	G	G	0.003	1.003	SEC16B	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	downstream_gene_variant
chr1	177920345	rs543874	0.458	NR	G	G	0.979	0.979	SEC16B	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	downstream_gene_variant
chr1	177920345	rs543874	0.746	NR	G	G	1.01	1.01	SEC16B	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	downstream_gene_variant
chr1	177920345	rs543874	0.883	NR	G	G	1.01	1.01	SEC16B	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	downstream_gene_variant
chr1	178552781	rs17361286	0.000012	"C1orf49, RALGPS2"	NA	NA	NA	NA	TEX35	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	"Cognitive function (Memory - Learning (or working memory), Memory - Delayed recall, Memory - Recognition, Executive Function - Stroop Color Word test, Executive Function - Part B of the Trail making test (TMTB), Executive Function - Block test, Verbal Fluency - Semantic fluency, Verbal Fluency - Phonological fluency)"	Cognitive	downstream_gene_variant
chr1	178552781	rs17361286	0.0003	"C1orf49, RALGPS2"	NA	NA	NA	NA	TEX35	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Part B of the Trail making test (TMTB)	Cognitive	downstream_gene_variant
chr1	178552781	rs17361286	0.44	"C1orf49, RALGPS2"	NA	NA	NA	NA	TEX35	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Stroop Color Word test	Cognitive	downstream_gene_variant
chr1	178552781	rs17361286	0.51	"C1orf49, RALGPS2"	NA	NA	NA	NA	TEX35	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Block test	Cognitive	downstream_gene_variant
chr1	178552781	rs17361286	0.56	"C1orf49, RALGPS2"	NA	NA	NA	NA	TEX35	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Delayed recall	Cognitive	downstream_gene_variant
chr1	178552781	rs17361286	0.64	"C1orf49, RALGPS2"	NA	NA	NA	NA	TEX35	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Verbal Fluency - Phonological fluency	Cognitive	downstream_gene_variant
chr1	178552781	rs17361286	0.68	"C1orf49, RALGPS2"	NA	NA	NA	NA	TEX35	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Learning (or working memory)	Cognitive	downstream_gene_variant
chr1	178552781	rs17361286	0.91	"C1orf49, RALGPS2"	NA	NA	NA	NA	TEX35	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Recognition	Cognitive	downstream_gene_variant
chr1	178552781	rs17361286	0.96	"C1orf49, RALGPS2"	NA	NA	NA	NA	TEX35	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Verbal Fluency - Semantic fluency	Cognitive	downstream_gene_variant
chr1	178575868	rs2493864	0.000017	"C1orf49, RALGPS2"	NA	NA	NA	NA	TEX35	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	"Cognitive function (Memory - Learning (or working memory), Memory - Delayed recall, Memory - Recognition, Executive Function - Stroop Color Word test, Executive Function - Part B of the Trail making test (TMTB), Executive Function - Block test, Verbal Fluency - Semantic fluency, Verbal Fluency - Phonological fluency)"	Cognitive	intergenic_region
chr1	178575868	rs2493864	0.0003	"C1orf49, RALGPS2"	NA	NA	NA	NA	TEX35	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Part B of the Trail making test (TMTB)	Cognitive	intergenic_region
chr1	178575868	rs2493864	0.46	"C1orf49, RALGPS2"	NA	NA	NA	NA	TEX35	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Stroop Color Word test	Cognitive	intergenic_region
chr1	178575868	rs2493864	0.49	"C1orf49, RALGPS2"	NA	NA	NA	NA	TEX35	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Block test	Cognitive	intergenic_region
chr1	178575868	rs2493864	0.62	"C1orf49, RALGPS2"	NA	NA	NA	NA	TEX35	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Verbal Fluency - Phonological fluency	Cognitive	intergenic_region
chr1	178575868	rs2493864	0.63	"C1orf49, RALGPS2"	NA	NA	NA	NA	TEX35	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Delayed recall	Cognitive	intergenic_region
chr1	178575868	rs2493864	0.76	"C1orf49, RALGPS2"	NA	NA	NA	NA	TEX35	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Learning (or working memory)	Cognitive	intergenic_region
chr1	178575868	rs2493864	0.96	"C1orf49, RALGPS2"	NA	NA	NA	NA	TEX35	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Recognition	Cognitive	intergenic_region
chr1	178575868	rs2493864	0.99	"C1orf49, RALGPS2"	NA	NA	NA	NA	TEX35	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Verbal Fluency - Semantic fluency	Cognitive	intergenic_region
chr1	180993146	rs1411478	0.0085	STX6	NR	NR	0.04	1.04081	STX6	SNP-based	eQTL	22685416	Caucasian	MAYO	202	AD	STX6 (ILMN_2157951) expression in Temporal cortex	Expression	intron_variant
chr1	180993146	rs1411478	0.0117	STX6	NR	NR	0.03	1.03045	STX6	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	STX6 (ILMN_2157951) expression in Temporal cortex	Expression	intron_variant
chr1	180993146	rs1411478	0.012	MR1	NR	NR	0.08	1.08329	STX6	SNP-based	eQTL	22685416	Caucasian	MAYO	202	AD	MR1 (ILMN_2167416) expression in Temporal cortex	Expression	intron_variant
chr1	180993146	rs1411478	0.0427	MR1	NR	NR	0.05	1.05127	STX6	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	MR1 (ILMN_2167416) expression in Cerebellar	Expression	intron_variant
chr1	180993146	rs1411478	0.0448	MR1	NR	NR	0.09	1.09417	STX6	SNP-based	eQTL	22685416	Caucasian	MAYO	98	PSP	MR1 (ILMN_2167416) expression in Cerebellar	Expression	intron_variant
chr1	180993146	rs1411478	0.132	STX6	NR	NR	-0.03	0.970446	STX6	SNP-based	eQTL	22685416	Caucasian	MAYO	98	PSP	STX6 (ILMN_2157951) expression in Cerebellar	Expression	intron_variant
chr1	180993146	rs1411478	0.212	IER5	NR	NR	-0.04	0.960789	STX6	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	IER5 (ILMN_1721833) expression in Cerebellar	Expression	intron_variant
chr1	180993146	rs1411478	0.224	MR1	NR	NR	0.03	1.03045	STX6	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	MR1 (ILMN_2167416) expression in Temporal cortex	Expression	intron_variant
chr1	180993146	rs1411478	0.256	IER5	NR	NR	-0.07	0.932394	STX6	SNP-based	eQTL	22685416	Caucasian	MAYO	98	PSP	IER5 (ILMN_1721833) expression in Cerebellar	Expression	intron_variant
chr1	180993146	rs1411478	0.476	IER5	NR	NR	0.02	1.0202	STX6	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	IER5 (ILMN_1721833) expression in Temporal cortex	Expression	intron_variant
chr1	180993146	rs1411478	0.573	IER5	NR	NR	0.03	1.03045	STX6	SNP-based	eQTL	22685416	Caucasian	MAYO	107	PSP	IER5 (ILMN_1721833) expression in Temporal cortex	Expression	intron_variant
chr1	180993146	rs1411478	0.602	MR1	NR	NR	0.02	1.0202	STX6	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	MR1 (ILMN_2167416) expression in Cerebellar	Expression	intron_variant
chr1	180993146	rs1411478	0.641	STX6	NR	NR	-0.01	0.99005	STX6	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	STX6 (ILMN_2157951) expression in Cerebellar	Expression	intron_variant
chr1	180993146	rs1411478	0.89	STX6	NR	NR	0	1	STX6	SNP-based	eQTL	22685416	Caucasian	MAYO	107	PSP	STX6 (ILMN_2157951) expression in Temporal cortex	Expression	intron_variant
chr1	180993146	rs1411478	0.897	STX6	NR	NR	0	1	STX6	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	STX6 (ILMN_2157951) expression in Cerebellar	Expression	intron_variant
chr1	180993146	rs1411478	0.966	MR1	NR	NR	0	1	STX6	SNP-based	eQTL	22685416	Caucasian	MAYO	107	PSP	MR1 (ILMN_2167416) expression in Temporal cortex	Expression	intron_variant
chr1	180993146	rs1411478	0.995	IER5	NR	NR	0	1	STX6	SNP-based	eQTL	22685416	Caucasian	MAYO	202	AD	IER5 (ILMN_1721833) expression in Temporal cortex	Expression	intron_variant
chr1	180993146	rs1411478	3.50E-11	STX6	NA	NA	0.79	0.79	STX6	SNP-based	Disease Risk	22685416	Caucasian	"Cohorts from Europe, USA"	8851	All	Progressive Supranuclear Palsy (PSP)	ADRD	intron_variant
chr1	182469951	rs2584820	0.0001	RGSL2	NA	NA	NA	NA	RGSL1	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Stroop Color Word test	Cognitive	intron_variant
chr1	182469951	rs2584820	0.03	RGSL2	NA	NA	NA	NA	RGSL1	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Verbal Fluency - Phonological fluency	Cognitive	intron_variant
chr1	182469951	rs2584820	0.07	RGSL2	NA	NA	NA	NA	RGSL1	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Verbal Fluency - Semantic fluency	Cognitive	intron_variant
chr1	182469951	rs2584820	0.19	RGSL2	NA	NA	NA	NA	RGSL1	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Delayed recall	Cognitive	intron_variant
chr1	182469951	rs2584820	0.2	RGSL2	NA	NA	NA	NA	RGSL1	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Learning (or working memory)	Cognitive	intron_variant
chr1	182469951	rs2584820	0.76	RGSL2	NA	NA	NA	NA	RGSL1	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Recognition	Cognitive	intron_variant
chr1	182469951	rs2584820	0.89	RGSL2	NA	NA	NA	NA	RGSL1	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Part B of the Trail making test (TMTB)	Cognitive	intron_variant
chr1	182469951	rs2584820	0.98	RGSL2	NA	NA	NA	NA	RGSL1	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Block test	Cognitive	intron_variant
chr1	182469951	rs2584820	5.90E-09	RGSL2	NA	NA	NA	NA	RGSL1	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	"Cognitive function (Memory - Learning (or working memory), Memory - Delayed recall, Memory - Recognition, Executive Function - Stroop Color Word test, Executive Function - Part B of the Trail making test (TMTB), Executive Function - Block test, Verbal Fluency - Semantic fluency, Verbal Fluency - Phonological fluency)"	Cognitive	intron_variant
chr1	185453472	rs10911736	0.000000769	NR	A	A	NR	NA	IVNS1ABP	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF Ab1-42	Fluid biomarker	intergenic_region
chr1	193614932	rs6668266	0.00000578	"CDC73, EEF1AL12"	NR	NR	NR	NA	CDC73	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr1	193627126	rs1887726	0.00000623	"CDC73, EEF1AL12"	NR	NR	NR	NA	CDC73	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr1	193656103	rs6678275	0.342	NR	C	C	0.948	0.948	CDC73	SNP-based	Disease risk	24495969	Caucasian	Cohort from Spain	4372	All	AD	AD	intergenic_region
chr1	193665521	rs7550917	0.00000429	"CDC73, EEF1AL12"	NR	NR	NR	NA	CDC73	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr1	194388206	rs4428865	0.000000653	LOC102723336	NR	NR	NR	NA	CDC73	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	818	All	Plasma Clusterin	Fluid biomarker	intergenic_region
chr1	196717788	rs6677604	0.0000075	CFH	NR	NR	-1360.29	0	CFH	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	IMAS	59	All	Plasma CompFactH (CFH gene) 	Fluid biomarker	intron_variant
chr1	196717788	rs6677604	9.29E-112	CFH	NR	NR	-1567	0	CFH	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	ADNI	521	All	Plasma CompFactH (CFH gene) 	Fluid biomarker	intron_variant
chr1	196871142	rs7517126	0.000601	CFHR1	NR	NR	-1212.74	0	CFHR4	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	IMAS	59	All	Plasma CompFactH (CFHR1 gene) 	Fluid biomarker	intron_variant
chr1	196871142	rs7517126	1.46E-60	CFHR1	NR	NR	-1487.46	0	CFHR4	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	ADNI	521	All	Plasma CompFactH (CFHR1 gene) 	Fluid biomarker	intron_variant
chr1	203186952	rs10399931	1.76E-14	CHI3L1	T	T	-0.58	0.559898	CHI3L1	SNP-based	Cross phenotype 	27832767	Caucasian	Knight-ADRC	379	All	CSF YKL-40	Fluid biomarker	upstream_gene_variant
chr1	203703739	rs145963279	0.092	ATP2B4	NR	NR	NR	NA	ATP2B4	SNP-based	Disease risk	25172201	African American	ADGC	816	All	AD	AD	missense_variant
chr1	206836565	rs2243170	0.000000662	IL19	A	A	1.65	NA	IL19	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	intron_variant
chr1	207151436	rs78363635	0.0000546	C4BPA	C	C	NR	NA	C4BPA	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Low-density lipoprotein (LDL)	Non-ADRD	upstream_gene_variant
chr1	207151436	rs78363635	0.00083	C4BPA	C	C	NR	NA	C4BPA	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	upstream_gene_variant
chr1	207151436	rs78363635	0.00622	C4BPA	C	C	1.09	1.09	C4BPA	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	upstream_gene_variant
chr1	207151436	rs78363635	0.0103	C4BPA	C	C	1.08	1.08	C4BPA	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	upstream_gene_variant
chr1	207151436	rs78363635	0.205	C4BPA	C	C	1	1	C4BPA	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	upstream_gene_variant
chr1	207151436	rs78363635	0.742	C4BPA	C	C	0.96	0.96	C4BPA	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	upstream_gene_variant
chr1	207505962	rs4844600	0.000000422	CR1	NR	NR	1.17	1.17	CR1	SNP-based	Disease risk	30448613	Caucasian	ADGC	15330	All	AD	AD	synonymous_variant
chr1	207512441	rs4266886	0.002	CR1	NR	NR	-0.09	NA	CR1	SNP-based	Age at onset (AAO) / Survival	28323831	Caucasian	ADGC	15795	All	Age of AD onset	Other	intron_variant
chr1	207518704	rs6656401	0.00000018	CR1	NR	NR	1.27	1.27	CR1	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	7349	All	AD	AD	intron_variant
chr1	207518704	rs6656401	0.00000018	CR1	NR	NR	1.38	1.38	CR1	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	4129	APOE-e4 carrier	AD	AD	intron_variant
chr1	207518704	rs6656401	0.00000037	CR1	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1 (2377395) expression  in intra-locular white matter (WHMT)	Expression	intron_variant
chr1	207518704	rs6656401	0.00000065	CR1	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1 (t2377332) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr1	207518704	rs6656401	0.000000849	CR1	NR	NR	1.17	1.17	CR1	SNP-based	Disease risk	30448613	Caucasian	ADGC	15330	All	AD	AD	intron_variant
chr1	207518704	rs6656401	0.000027	CR1	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1 (t2377332) expression in hippocampus (HIPP)	Expression	intron_variant
chr1	207518704	rs6656401	0.00063	CR1L	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1L (2377445) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr1	207518704	rs6656401	0.00082	CR1	NR	NR	1.16	1.16	CR1	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	7078	All	AD	AD	intron_variant
chr1	207518704	rs6656401	0.0025	CR1	NR	NR	1.38	1.38	CR1	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	1262	All	AD	AD	intron_variant
chr1	207518704	rs6656401	0.0037	CR1	NR	NR	1.13	1.13	CR1	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	9541	APOE-e4 non-carrier	AD	AD	intron_variant
chr1	207518704	rs6656401	0.0038	CR2	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR2 (2377285) expression in substantia nigra (SNIG)	Expression	intron_variant
chr1	207518704	rs6656401	0.004	CR1	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1 (t2377332) expression in temporal cortex (TCTX)	Expression	intron_variant
chr1	207518704	rs6656401	0.0068	CR1L	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1L (2377428) expression in thalamus (THAL)	Expression	intron_variant
chr1	207518704	rs6656401	0.008	CR1	A	A	1.28	1.28	CR1	SNP-based	Disease risk	20534741	Caucasian	"ADC, UM"	1610	All	AD	AD	intron_variant
chr1	207518704	rs6656401	0.00902	CR1	A	A	1.38	1.38	CR1	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	2024	All	LOAD	AD	intron_variant
chr1	207518704	rs6656401	0.01	CR1	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1 (2377395) expression  in hippocampus (HIPP)	Expression	intron_variant
chr1	207518704	rs6656401	0.01	CR1	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1 (t2377332)  expression in frontal cortex (FCTX)	Expression	intron_variant
chr1	207518704	rs6656401	0.01	CR1	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1 (t2377332) expression in thalamus (THAL)	Expression	intron_variant
chr1	207518704	rs6656401	0.018	"CR1,CR2"	NR	NR	-0.01	0.99005	CR1	SNP-based	Endophenotype	30805717	Caucasian	MAGIC	51750	All	Fasting Insulin	Fluid biomarker	intron_variant
chr1	207518704	rs6656401	0.026	CR1	NR	NR	1.23	1.23	CR1	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	1535	All	AD	AD	intron_variant
chr1	207518704	rs6656401	0.03	CR1	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1 (2377395) expression  in frontal cortex (FCTX)	Expression	intron_variant
chr1	207518704	rs6656401	0.04	CR1	A	A	1.16	1.16	CR1	SNP-based	Endophenotype	25188341	Caucasian	ADGC	4914	All	Clinico-pathologic AD dementia (No neuropathologist documentation)	Neuropathology	intron_variant
chr1	207518704	rs6656401	0.05	CR1	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1 (t2377332) expression in putamen (PUTM)	Expression	intron_variant
chr1	207518704	rs6656401	0.056	CR1	NR	NR	1.24	1.24	CR1	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	1566	All	AD	AD	intron_variant
chr1	207518704	rs6656401	0.07	CR1	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1 (t2377332) expression in occipital cortex (OCTX)	Expression	intron_variant
chr1	207518704	rs6656401	0.09	CR1	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1 (t2377332) expression in medulla (MEDU)	Expression	intron_variant
chr1	207518704	rs6656401	0.09	CR1L	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1L (2377445) expression in temporal cortex (TCTX)	Expression	intron_variant
chr1	207518704	rs6656401	0.11	CR1	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1 (2377395) expression  in temporal cortex (TCTX)	Expression	intron_variant
chr1	207518704	rs6656401	0.11	CR2	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR2 (2377285) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr1	207518704	rs6656401	0.11	CR2	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR2 (2377285) expression in occipital cortex (OCTX)	Expression	intron_variant
chr1	207518704	rs6656401	0.13	CR1	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1 (2377395) expression  in putamen (PUTM)	Expression	intron_variant
chr1	207518704	rs6656401	0.13	CR1L	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1L (2377428) expression in medulla (MEDU)	Expression	intron_variant
chr1	207518704	rs6656401	0.14	CR1L	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1L (2377445) expression in substantia nigra (SNIG)	Expression	intron_variant
chr1	207518704	rs6656401	0.15	CR1	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1 (t2377332) expression in substantia nigra (SNIG)	Expression	intron_variant
chr1	207518704	rs6656401	0.21	CR1	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1 (2377395) expression  in occipital cortex (OCTX)	Expression	intron_variant
chr1	207518704	rs6656401	0.227	CR1	A	A	0.79	0.79	CR1	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr1	207518704	rs6656401	0.27	CR1L	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1L (2377428) expression in hippocampus (HIPP)	Expression	intron_variant
chr1	207518704	rs6656401	0.28	CR1L	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1L (2377445) expression in occipital cortex (OCTX)	Expression	intron_variant
chr1	207518704	rs6656401	0.31	CR1	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1 (t2377332) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr1	207518704	rs6656401	0.31	CR1L	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1L (2377445)  expression in frontal cortex (FCTX)	Expression	intron_variant
chr1	207518704	rs6656401	0.36	CR1L	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1L (2377428)  expression in frontal cortex (FCTX)	Expression	intron_variant
chr1	207518704	rs6656401	0.375	CR1	A	A	1.24	1.24	CR1	SNP-based	Disease risk	23565137	Asian	Cohort from Korea	1468	All	LOAD	AD	intron_variant
chr1	207518704	rs6656401	0.38	CR1L	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1L (2377445) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr1	207518704	rs6656401	0.39	CR2	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR2 (2377285) expression in temporal cortex (TCTX)	Expression	intron_variant
chr1	207518704	rs6656401	0.42	CR1L	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1L (2377428) expression in putamen (PUTM)	Expression	intron_variant
chr1	207518704	rs6656401	0.47	CR1L	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1L (2377445) expression in thalamus (THAL)	Expression	intron_variant
chr1	207518704	rs6656401	0.53	CR1	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1 (2377395) expression  in medulla (MEDU)	Expression	intron_variant
chr1	207518704	rs6656401	0.54	CR1L	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1L (2377428) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr1	207518704	rs6656401	0.58	CR1	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1 (2377395) expression  in cerebellar cortex (CRBL)	Expression	intron_variant
chr1	207518704	rs6656401	0.63	CR2	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR2 (2377285) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr1	207518704	rs6656401	0.66	CR1L	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1L (2377428) expression in occipital cortex (OCTX)	Expression	intron_variant
chr1	207518704	rs6656401	0.68	CR2	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR2 (2377285) expression in thalamus (THAL)	Expression	intron_variant
chr1	207518704	rs6656401	0.69	CR2	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR2 (2377285)  expression in frontal cortex (FCTX)	Expression	intron_variant
chr1	207518704	rs6656401	0.69	CR2	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR2 (2377285) expression in medulla (MEDU)	Expression	intron_variant
chr1	207518704	rs6656401	0.7	CR1L	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1L (2377428) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr1	207518704	rs6656401	0.71	CR1L	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1L (2377445) expression in medulla (MEDU)	Expression	intron_variant
chr1	207518704	rs6656401	0.72	CR1L	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1L (2377445) expression in putamen (PUTM)	Expression	intron_variant
chr1	207518704	rs6656401	0.73	CR2	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR2 (2377285) expression in hippocampus (HIPP)	Expression	intron_variant
chr1	207518704	rs6656401	0.77	CR2	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR2 (2377285) expression in putamen (PUTM)	Expression	intron_variant
chr1	207518704	rs6656401	0.8	CR1L	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1L (2377428) expression in substantia nigra (SNIG)	Expression	intron_variant
chr1	207518704	rs6656401	0.84	CR1	NR	NR	1.03	1.03	CR1	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	2715	All	AD	AD	intron_variant
chr1	207518704	rs6656401	0.88	CR1	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1 (2377395) expression  in thalamus (THAL)	Expression	intron_variant
chr1	207518704	rs6656401	0.91	CR1	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1 (2377395) expression  in substantia nigra (SNIG)	Expression	intron_variant
chr1	207518704	rs6656401	0.93	CR1L	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1L (2377445) expression in hippocampus (HIPP)	Expression	intron_variant
chr1	207518704	rs6656401	0.97	CR1L	NR	NR	NR	NA	CR1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CR1L (2377428) expression in temporal cortex (TCTX)	Expression	intron_variant
chr1	207518704	rs6656401	0.98	CR1	A	A	1	1	CR1	SNP-based	Endophenotype	25188341	Caucasian	ADGC	3702	All	Clinico-pathologic AD dementia (with neuropathologist documentation)	Neuropathology	intron_variant
chr1	207518704	rs6656401	1.39E-17	CR1	A	A	NR	NA	CR1	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ"	79145	All	AD	AD	intron_variant
chr1	207518704	rs6656401	3.50E-09	CR1	NR	NR	1.21	1.21	CR1	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	14431	All	AD	AD	intron_variant
chr1	207518704	rs6656401	5.70E-24	CR1	A	A	1.18	1.18	CR1	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD, Cohorts from Europe and USA"	74046	All	LOAD	AD	intron_variant
chr1	207518704	rs6656401	7.70E-15	CR1	A	A	1.17	1.17	CR1	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD"	54162	All	LOAD	AD	intron_variant
chr1	207518704	rs6656401	7.73E-15	"CR1,CR2"	NR	NR	0.16	1.17351	CR1	SNP-based	Endophenotype	30805717	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr1	207518704	rs6656401	7.90E-11	CR1	A	A	1.21	1.21	CR1	SNP-based	Disease risk	24162737	Caucasian	Cohorts from Europe and USA	19884	All	LOAD	AD	intron_variant
chr1	207518704	rs6656401	NR	CR1	A	A	1.46	1.46	CR1	SNP-based	Disease risk	27849641	Caucasian	ADGC	589	All	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr1	207518704	rs6656401	NR	ZCWPW1	A	A	1.44	1.44	CR1	SNP-based	Disease risk	27849641	Caucasian	ADGC	297	APOE-e4 non-carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr1	207518704	rs6656401	NR	ZCWPW1	A	A	1.56	1.56	CR1	SNP-based	Disease risk	27849641	Caucasian	ADGC	292	APOE-e4 carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr1	207577223	rs679515	0.000016	CR1	T	T	1.13	1.13	CR1	SNP-based	Disease risk	25778476	Caucasian	"ADGC, IGAP"	36569	APOE-e4- subjects	AD	AD	intron_variant
chr1	207577223	rs679515	3.60E-09	CR1	T	T	1.22	1.22	CR1	SNP-based	Disease risk	25778476	Caucasian	"ADGC, IGAP"	21345	APOE-e4+ subjects	AD	AD	intron_variant
chr1	207577223	rs679515	8.85E-10	CR1	A	A	NR	NA	CR1	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	intron_variant
chr1	207611623	rs3818361	0.000000085	CR1	NR	NR	1.28	1.28	CR1	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	7342	All	AD	AD	intron_variant
chr1	207611623	rs3818361	0.000000089	CR1	NR	NR	1.19	1.19	CR1	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	14153	All	AD	AD	intron_variant
chr1	207611623	rs3818361	0.00000029	CR1	NR	NR	1.34	1.34	CR1	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	4728	APOE-e4 carrier	AD	AD	intron_variant
chr1	207611623	rs3818361	0.0000092	CR1	NR	NR	1.17	1.17	CR1	SNP-based	Disease risk	19734902	Caucasian	Cohorts from Europe and USA	11789	All	AD	AD	intron_variant
chr1	207611623	rs3818361	0.000061	CR1	A	A	1.14	1.14	CR1	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	intron_variant
chr1	207611623	rs3818361	0.0002	CR1	A	A	1.15	1.15	CR1	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	intron_variant
chr1	207611623	rs3818361	0.000671	CR1	NR	NR	1.38	1.38	CR1	SNP-based	Endophenotype	26993346	Caucasian	Cohort from Europe	10840	All	PCA (posterior cortical atrophy)	Imaging	intron_variant
chr1	207611623	rs3818361	0.001	CR1	A	A	1.22	1.22	CR1	SNP-based	Disease risk	21390209	Caucasian	"ADNI, GenADA, Pfizer"	3595	All	AD	AD	intron_variant
chr1	207611623	rs3818361	0.0014	CR1	NR	NR	1.13	1.13	CR1	SNP-based	Disease risk	21460840	Caucasian	GERAD	9799	All	AD	AD	intron_variant
chr1	207611623	rs3818361	0.0064	CR1	NR	NR	1.12	1.12	CR1	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	9328	APOE-e4 non-carrier	AD	AD	intron_variant
chr1	207611623	rs3818361	0.0071	CUGBP2	NR	NR	NR	NA	CR1	SNP-based	Disease risk	21379329	Caucasian	ADGC	3786	All	LOAD	AD	intron_variant
chr1	207611623	rs3818361	0.012	CR1	NR	NR	1.14	1.14	CR1	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4+ carrier	AD	AD	intron_variant
chr1	207611623	rs3818361	0.016	CR1	NR	NR	1.11	1.11	CR1	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	6811	All	AD	AD	intron_variant
chr1	207611623	rs3818361	0.017	CR1	NR	NR	1.1	1.1	CR1	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4- carrier	AD	AD	intron_variant
chr1	207611623	rs3818361	0.019	CR1	A	A	1.23	1.23	CR1	SNP-based	Disease risk	21390209	Caucasian	GenADA	1574	All	AD	AD	intron_variant
chr1	207611623	rs3818361	0.0237	CUGBP2	NR	NR	NR	NA	CR1	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	intron_variant
chr1	207611623	rs3818361	0.026	CR1	NR	NR	1.26	1.26	CR1	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	1224	All	AD	AD	intron_variant
chr1	207611623	rs3818361	0.027	CR1	NR	NR	1.12	1.12	CR1	SNP-based	Disease risk	30979435	Caucasian	ADGC	6554	Age >=80 y	AD	AD	intron_variant
chr1	207611623	rs3818361	0.0273	CUGBP2	NR	NR	NR	NA	CR1	SNP-based	Disease risk	21379329	Caucasian	ADGC	3839	All	LOAD	AD	intron_variant
chr1	207611623	rs3818361	0.0278	CUGBP2	NR	NR	NR	NA	CR1	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	intron_variant
chr1	207611623	rs3818361	0.034	CR1	A	A	1.44	1.44	CR1	SNP-based	Disease risk	21390209	Caucasian	ADNI	496	All	AD	AD	intron_variant
chr1	207611623	rs3818361	0.0379	CUGBP2	NR	NR	NR	NA	CR1	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	intron_variant
chr1	207611623	rs3818361	0.038	CR1	NR	NR	1.21	1.21	CR1	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	1524	All	AD	AD	intron_variant
chr1	207611623	rs3818361	0.0509	CUGBP2	NR	NR	NR	NA	CR1	SNP-based	Disease risk	21379329	Caucasian	ADGC	1642	APOE-e4/e3	LOAD	AD	intron_variant
chr1	207611623	rs3818361	0.0619	CUGBP2	NR	NR	NR	NA	CR1	SNP-based	Disease risk	21379329	Caucasian	ADGC	2167	APOE-e4+	LOAD	AD	intron_variant
chr1	207611623	rs3818361	0.0832	CUGBP2	NR	NR	NR	NA	CR1	SNP-based	Disease risk	21379329	Caucasian	ADGC	3461	Northwestern European ancestry	LOAD	AD	intron_variant
chr1	207611623	rs3818361	0.126	CUGBP2	NR	NR	NR	NA	CR1	SNP-based	Disease risk	21379329	Caucasian	ADGC	3722	All	LOAD	AD	intron_variant
chr1	207611623	rs3818361	0.136	CR1	A	A	1.14	1.14	CR1	SNP-based	Disease risk	21390209	Caucasian	ADGC	1525	All	AD	AD	intron_variant
chr1	207611623	rs3818361	0.15	CUGBP2	NR	NR	NR	NA	CR1	SNP-based	Disease risk	21379329	Caucasian	ADGC	3839	All	LOAD	AD	intron_variant
chr1	207611623	rs3818361	0.254	CR1	A	A	0.94	0.94	CR1	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	2024	All	LOAD	AD	intron_variant
chr1	207611623	rs3818361	0.408	CR1	A	A	0.92	0.92	CR1	SNP-based	Disease risk	23565137	Asian	Cohort from Korea	1468	All	LOAD	AD	intron_variant
chr1	207611623	rs3818361	0.444	CUGBP2	NR	NR	NR	NA	CR1	SNP-based	Disease risk	21379329	Caucasian	ADGC	250	APOE-e3/e2+e2/e2	LOAD	AD	intron_variant
chr1	207611623	rs3818361	0.466	CR1	A	A	0.94	0.94	CR1	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr1	207611623	rs3818361	0.501	CUGBP2	NR	NR	NR	NA	CR1	SNP-based	Disease risk	21379329	Caucasian	ADGC	1672	APOE-e4-	LOAD	AD	intron_variant
chr1	207611623	rs3818361	0.603	CR1	NR	NR	NR	NA	CR1	SNP-based	Endophenotype	21390209	Caucasian	"ADNI, leadC"	597	AD subjects	AD Progression	Cognitive	intron_variant
chr1	207611623	rs3818361	0.68	CR1	NR	NR	1.05	1.05	CR1	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	1408	All	AD	AD	intron_variant
chr1	207611623	rs3818361	0.681	CUGBP2	NR	NR	NR	NA	CR1	SNP-based	Disease risk	21379329	Caucasian	ADGC	1422	APOE-e3/e3	LOAD	AD	intron_variant
chr1	207611623	rs3818361	0.72	CR1	NR	NR	1.03	1.03	CR1	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	2655	All	AD	AD	intron_variant
chr1	207611623	rs3818361	0.789	CUGBP2	NR	NR	NR	NA	CR1	SNP-based	Disease risk	21379329	Caucasian	ADGC	408	APOE-e4/e4	LOAD	AD	intron_variant
chr1	207611623	rs3818361	3.20E-12	CR1	NR	NR	1.21	1.21	CR1	SNP-based	Disease risk	21460840	Caucasian	"ADC, EADI, GERAD"	20373	All	AD	AD	intron_variant
chr1	207611623	rs3818361	3.70E-14	CR1	NR	NR	1.18	1.18	CR1	SNP-based	Disease risk	21460840	Caucasian	"ADGC, CHARGE, EADI, GERAD"	59716	All	AD	AD	intron_variant
chr1	207611623	rs3818361	5.41E-09	CR1	NR	NR	1.21	1.21	CR1	SNP-based	Disease risk	30979435	Caucasian	ADGC	14867	Age 60-79 y	AD	AD	intron_variant
chr1	207612944	rs6701713	0.0000087	CR1	NR	NR	1.17	1.17	CR1	SNP-based	Disease risk	19734902	Caucasian	Cohorts from Europe and USA	11789	All	AD	AD	intron_variant
chr1	207612944	rs6701713	0.000088	CR1	A	A	1.14	1.14	CR1	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	intron_variant
chr1	207612944	rs6701713	0.0002	CR1	A	A	1.15	1.15	CR1	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	intron_variant
chr1	207612944	rs6701713	0.000717	CR1	A	A	-0.41	0.66365	CR1	SNP-based	Age at onset (AAO) / Survival	25199842	Caucasian	ADGC	9162	LOAD subjects	Age of AD onset	Other	intron_variant
chr1	207612944	rs6701713	0.00358	CR1	A	A	1.13	1.13	CR1	SNP-based	Disease risk	21460841	Caucasian	ADGC	7096	All	LOAD	AD	intron_variant
chr1	207612944	rs6701713	0.00402	CR1	A	A	1.13	1.13	CR1	SNP-based	Disease risk	21460841	Caucasian	ADGC	7096	All	LOAD	AD	intron_variant
chr1	207612944	rs6701713	0.00488	CR1	A	A	-0.41	0.66365	CR1	SNP-based	Age at onset (AAO) / Survival	25199842	Caucasian	ADGC	9162	LOAD subjects	Age of AD onset	Other	intron_variant
chr1	207612944	rs6701713	0.011	CR1	NR	NR	1.14	1.14	CR1	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4+ carrier	AD	AD	intron_variant
chr1	207612944	rs6701713	0.021	CR1	NR	NR	1.1	1.1	CR1	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4- carrier	AD	AD	intron_variant
chr1	207612944	rs6701713	0.029	NR	A	A	0.08	1.08329	CR1	SNP-based	Endophenotype	23836404	Caucasian	ADGC	725	All	Neuritic Plaque Pathologic Burden	Neuropathology	intron_variant
chr1	207612944	rs6701713	1.45E-08	CR1	A	A	1.18	1.18	CR1	SNP-based	Disease risk	21460841	Caucasian	ADGC	15675	All	LOAD	AD	intron_variant
chr1	207612944	rs6701713	3.47E-09	CR1	A	A	1.19	1.19	CR1	SNP-based	Disease risk	21460841	Caucasian	ADGC	15675	All	LOAD	AD	intron_variant
chr1	207612944	rs6701713	4.62E-10	CR1	A	A	1.16	1.16	CR1	SNP-based	Disease risk	21460841	Caucasian	ADGC	22771	All	LOAD	AD	intron_variant
chr1	207612944	rs6701713	5.21E-11	CR1	A	A	1.17	1.17	CR1	SNP-based	Disease risk	21460841	Caucasian	ADGC	22771	All	LOAD	AD	intron_variant
chr1	207613483	rs2093760	1.10E-18	CR1	A	A	8.82	NA	CR1	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ, UKBB"	455258	All	AD + AD-by-proxy	AD	intron_variant
chr1	207621975	rs2296160	4.24E-08	CR1	NR	NR	1.18	1.18	CR1	SNP-based	Disease risk	30448613	Caucasian	ADGC	15330	All	AD	AD	missense_variant&splice_region_variant
chr1	207622720	rs61822977	0.00158	CR1	NR	NR	-0.08	NA	CR1	SNP-based	Age at onset (AAO) / Survival	28323831	Caucasian	ADGC	15795	All	Age of AD onset	Other	intron_variant
chr1	207629207	rs4844610	3.60E-24	CR1	A	A	1.17	1.17	CR1	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	82771	All	Clinically diagnosed LOAD	AD	intron_variant
chr1	207629207	rs4844610	3.80E-10	CR1	A	A	1.2	1.2	CR1	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	18845	All	Clinically diagnosed LOAD	AD	intron_variant
chr1	207629207	rs4844610	8.20E-16	CR1	A	A	1.16	1.16	CR1	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	63926	All	Clinically diagnosed LOAD	AD	intron_variant
chr1	207630796	rs1408077	0.0000083	CR1	NR	NR	1.17	1.17	CR1	SNP-based	Disease risk	19734902	Caucasian	Cohorts from Europe and USA	11789	All	AD	AD	intron_variant
chr1	207630796	rs1408077	0.0001	CR1	A	A	1.14	1.14	CR1	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	intron_variant
chr1	207630796	rs1408077	0.0002	CR1	A	A	1.16	1.16	CR1	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	intron_variant
chr1	207630796	rs1408077	0.0099	CR1	NR	NR	1.15	1.15	CR1	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4+ carrier	AD	AD	intron_variant
chr1	207630796	rs1408077	0.0168	CUGBP2	NR	NR	NR	NA	CR1	SNP-based	Disease risk	21379329	Caucasian	ADGC	3786	All	LOAD	AD	intron_variant
chr1	207630796	rs1408077	0.0184	CUGBP2	NR	NR	NR	NA	CR1	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	intron_variant
chr1	207630796	rs1408077	0.02	CR1	NR	NR	1.27	1.27	CR1	SNP-based	Disease risk	20558387	Caucasian	ADNI	740	All	AD + MCI	AD	intron_variant
chr1	207630796	rs1408077	0.0288	CUGBP2	NR	NR	NR	NA	CR1	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	intron_variant
chr1	207630796	rs1408077	0.03	CR1	NR	NR	-0.067	0.935195	CR1	SNP-based	Endophenotype	20558387	Caucasian	ADNI	740	All	Entorhinal cortex thickness	Imaging	intron_variant
chr1	207630796	rs1408077	0.0317	CUGBP2	NR	NR	NR	NA	CR1	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	intron_variant
chr1	207630796	rs1408077	0.036	CR1	NR	NR	1.06	1.06	CR1	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4- carrier	AD	AD	intron_variant
chr1	207630796	rs1408077	0.0478	CUGBP2	NR	NR	NR	NA	CR1	SNP-based	Disease risk	21379329	Caucasian	ADGC	3839	All	LOAD	AD	intron_variant
chr1	207630796	rs1408077	0.0739	CUGBP2	NR	NR	NR	NA	CR1	SNP-based	Disease risk	21379329	Caucasian	ADGC	1642	APOE-e4/e3	LOAD	AD	intron_variant
chr1	207630796	rs1408077	0.113	CUGBP2	NR	NR	NR	NA	CR1	SNP-based	Disease risk	21379329	Caucasian	ADGC	2167	APOE-e4+	LOAD	AD	intron_variant
chr1	207630796	rs1408077	0.12	CR1	NR	NR	-0.031	0.969476	CR1	SNP-based	Endophenotype	20558387	Caucasian	ADNI	740	All	Temporal pole cortex thickness	Imaging	intron_variant
chr1	207630796	rs1408077	0.12	CUGBP2	NR	NR	NR	NA	CR1	SNP-based	Disease risk	21379329	Caucasian	ADGC	3722	All	LOAD	AD	intron_variant
chr1	207630796	rs1408077	0.129	CUGBP2	NR	NR	NR	NA	CR1	SNP-based	Disease risk	21379329	Caucasian	ADGC	3461	Northwestern European ancestry	LOAD	AD	intron_variant
chr1	207630796	rs1408077	0.154	CUGBP2	NR	NR	NR	NA	CR1	SNP-based	Disease risk	21379329	Caucasian	ADGC	3839	All	LOAD	AD	intron_variant
chr1	207630796	rs1408077	0.21	CR1	NR	NR	-0.017	0.983144	CR1	SNP-based	Endophenotype	20558387	Caucasian	ADNI	740	All	Amygdala volume	Imaging	intron_variant
chr1	207630796	rs1408077	0.32	CR1	NR	NR	-0.037	0.963676	CR1	SNP-based	Endophenotype	20558387	Caucasian	ADNI	740	All	Hippocampal volume	Imaging	intron_variant
chr1	207630796	rs1408077	0.42	CUGBP2	NR	NR	NR	NA	CR1	SNP-based	Disease risk	21379329	Caucasian	ADGC	1672	APOE-e4-	LOAD	AD	intron_variant
chr1	207630796	rs1408077	0.45	CR1	NR	NR	0.028	1.0284	CR1	SNP-based	Endophenotype	20558387	Caucasian	ADNI	740	All	White matter lesion volume	Imaging	intron_variant
chr1	207630796	rs1408077	0.474	CUGBP2	NR	NR	NR	NA	CR1	SNP-based	Disease risk	21379329	Caucasian	ADGC	250	APOE-e3/e2+e2/e2	LOAD	AD	intron_variant
chr1	207630796	rs1408077	0.558	CUGBP2	NR	NR	NR	NA	CR1	SNP-based	Disease risk	21379329	Caucasian	ADGC	1422	APOE-e3/e3	LOAD	AD	intron_variant
chr1	207630796	rs1408077	0.867	CUGBP2	NR	NR	NR	NA	CR1	SNP-based	Disease risk	21379329	Caucasian	ADGC	408	APOE-e4/e4	LOAD	AD	intron_variant
chr1	207630796	rs1408077	0.98	CR1	NR	NR	0	1	CR1	SNP-based	Endophenotype	20558387	Caucasian	ADNI	740	All	Parahippocampal gyrus cortex thickness	Imaging	intron_variant
chr1	213944747	rs340849	0.00000752	NR	A	A	0.59	0.59	PROX1	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr1	213972363	rs340883	0.000047	"LOC643330, PROX1"	NR	NR	NR	NA	PROX1	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr1	213974903	rs1431985	0.00042	AK092251	A	A	NR	NA	PROX1	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Total triglycerides (TG)	Non-ADRD	intron_variant
chr1	213974903	rs1431985	0.000663	AK092251	A	A	NR	NA	PROX1	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr1	213974903	rs1431985	0.0024	AK092251	A	A	1.04	1.04	PROX1	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intron_variant
chr1	213974903	rs1431985	0.00484	AK092251	A	A	1.04	1.04	PROX1	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intron_variant
chr1	213974903	rs1431985	0.655	AK092251	A	A	0.98	0.98	PROX1	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intron_variant
chr1	213974903	rs1431985	0.804	AK092251	A	A	1	1	PROX1	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr1	213990332	rs340835	0.0000011	PROX1	NR	NR	NR	NA	PROX1	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr1	218532171	rs4846486	0.00000233	NR	A	A	NR	NA	TGFB2	SNP-based	Disease risk	21390209	Caucasian	"ADNI, GenADA, Pfizer"	3595	All	AD	AD	intergenic_region
chr1	219415461	rs2791559	0.0000397	NR	NR	NR	2.82	2.82	ZC3H11B	SNP-based	Disease risk	21098978	Arab	Cohort from Israeli	266	All	AD	AD	upstream_gene_variant
chr1	226568270	rs7525939	0.00000529	NR	NR	NR	NR	NA	STUM	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr1	226568270	rs7525939	0.000141	NR	NR	NR	0.58	0.58	STUM	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr1	226568270	rs7525939	0.000462	NR	NR	NR	NR	NA	STUM	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intron_variant
chr1	226568270	rs7525939	0.0093	NR	NR	NR	0.6	0.6	STUM	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intron_variant
chr1	226568270	rs7525939	0.013	NR	NR	NR	NR	NA	STUM	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intron_variant
chr1	226568270	rs7525939	0.16364	NR	NR	NR	NR	NA	STUM	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intron_variant
chr1	226568270	rs7525939	0.254	NR	NR	NR	0.59	0.59	STUM	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intron_variant
chr1	226568270	rs7525939	0.487	NR	NR	NR	NR	NA	STUM	SNP-based	Disease risk	21059989	Caucasian	ADGC	1390	Unrelated individuals	LOAD	AD	intron_variant
chr1	226568270	rs7525939	0.67635	NR	NR	NR	NR	NA	STUM	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intron_variant
chr1	230710231	rs4762	4.74E-18	AGT	NR	NR	0.68	1.97388	AGT	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	ADNI	521	All	Plasma Angiotensinogen	Fluid biomarker	missense_variant
chr1	231708601	rs12044355	0.0000092	DISC1	NR	NR	NR	NA	TSNAX-DISC1	SNP-based	Disease risk	19118814	Caucasian	"CAP, Reiman et al.(2007)"	NR	All	LOAD	AD	intron_variant
chr1	231708601	rs12044355	0.000039	DISC1	NR	NR	NR	NA	TSNAX-DISC1	SNP-based	Disease risk	19118814	Caucasian	CAP	458	All	LOAD	AD	intron_variant
chr1	231708601	rs12044355	0.00822	DISC1	NR	NR	NR	NA	TSNAX-DISC1	SNP-based	Disease risk	19118814	Caucasian	Reiman et al.(2007)	NR	All	LOAD	AD	intron_variant
chr1	238308776	rs9659297	0.0000136	Q0VG70_HUMAN	NR	NR	NR	NA	MTRNR2L11	SNP-based	Disease risk	20061627	Caucasian	ADGC	699	All	LOAD	AD	intergenic_region
chr1	238358337	rs11583706	0.0000236	Q0VG70	NR	NR	NR	NA	MTRNR2L11	SNP-based	Disease risk	20061627	Caucasian	ADGC	699	All	LOAD	AD	intergenic_region
chr10	520439	rs11252926	0.00000808	DIP2C	NR	NR	0.72	0.72	DIP2C	SNP-based	Disease risk	22005930	Caucasian	"ADGC, GERAD"	2034	AD+P and AD-P subjects	AD+Psychosis	ADRD	intron_variant
chr10	3113045	rs6602024	0.208	NR	A	A	0.93	0.93	PFKP	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	intron_variant
chr10	3113045	rs6602024	0.218	NR	A	A	0.01	1.01005	PFKP	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	intron_variant
chr10	3113045	rs6602024	0.23	NR	A	A	0.958	0.958	PFKP	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	intron_variant
chr10	3113045	rs6602024	0.993	NR	A	A	0.999	0.999	PFKP	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	intron_variant
chr10	8925559	rs1273007	0.00000308	LOC338591	T	T	0.68	0.68	GATA3	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	2024	All	LOAD	AD	intergenic_region
chr10	8925559	rs1273007	0.00022	LOC338591	T	T	0.81	0.81	GATA3	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	3894	All	LOAD	AD	intergenic_region
chr10	8925559	rs1273007	0.47	LOC338591	T	T	0.95	0.95	GATA3	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	1870	All	LOAD	AD	intergenic_region
chr10	11008014	rs201119	1.52E-08	"CUGBP2, PITRM1"	A	A	4.02	NA	CELF2	SNP-based	Disease risk	21379329	Caucasian	ADGC	408	APOE-e4e4	LOAD	AD	intron_variant
chr10	11670966	rs12784561	0.0000851	CR595071	A	A	0.92	0.92	USP6NL	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intergenic_region
chr10	11670966	rs12784561	0.000131	CR595071	A	A	0.92	0.92	USP6NL	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intergenic_region
chr10	11670966	rs12784561	0.00038	CR595071	A	A	NR	NA	USP6NL	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr10	11670966	rs12784561	0.00143	CR595071	A	A	NR	NA	USP6NL	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Low-density lipoprotein (LDL)	Non-ADRD	intergenic_region
chr10	11670966	rs12784561	0.182	CR595071	A	A	1	1	USP6NL	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intergenic_region
chr10	11670966	rs12784561	0.35	CR595071	A	A	0.93	0.93	USP6NL	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intergenic_region
chr10	11675398	rs11257238	0.0000056	"ECHDC3, LOC439951"	NR	NR	NR	NA	USP6NL	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	upstream_gene_variant
chr10	11675398	rs11257238	0.0000584	ECHDC3	C	C	NR	NA	USP6NL	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	upstream_gene_variant
chr10	11675398	rs11257238	1.26E-08	ECHDC3	C	C	5.69	NA	USP6NL	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ, UKBB"	455258	All	AD + AD-by-proxy	AD	upstream_gene_variant
chr10	11678309	rs7920721	0.00000003	"ECHDC3, USP6NL"	G	G	1.08	1.08	ECHDC3	SNP-based	Disease risk	28183528	Multi-ethnic	"ADGC, IGAP"	59556	All	AD	AD	upstream_gene_variant
chr10	11678309	rs7920721	0.00000019	ECHDC3	G	G	1.08	1.08	ECHDC3	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	63926	All	Clinically diagnosed LOAD	AD	upstream_gene_variant
chr10	11678309	rs7920721	0.000000289	ECHDC3	G	G	1.07	1.07	ECHDC3	SNP-based	Disease risk	25862742	Caucasian	IGAP	74046	All	AD	AD	upstream_gene_variant
chr10	11678309	rs7920721	0.000002	"ECHDC3, USP6NL"	G	G	1.09	1.09	ECHDC3	SNP-based	Disease risk	28183528	Multi-ethnic	ADGC	33269	All	AD	AD	upstream_gene_variant
chr10	11678309	rs7920721	0.00126	CR595071	NR	NR	-0.07	NA	ECHDC3	SNP-based	Age at onset (AAO) / Survival	28323831	Caucasian	ADGC	15795	All	Age of AD onset	Other	upstream_gene_variant
chr10	11678309	rs7920721	0.0015	ECHDC3	G	G	1.11	1.11	ECHDC3	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	11666	All	Clinically diagnosed LOAD	AD	upstream_gene_variant
chr10	11678309	rs7920721	0.0026	"ECHDC3, USP6NL"	G	G	1.07	1.07	ECHDC3	SNP-based	Disease risk	28183528	Caucasian	IGAP	26287	All	AD	AD	upstream_gene_variant
chr10	11678309	rs7920721	0.0032	ECHDC3	G	G	1.07	1.07	ECHDC3	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	18845	All	Clinically diagnosed LOAD	AD	upstream_gene_variant
chr10	11678309	rs7920721	0.08	ECHDC3	G	G	1.12	1.12	ECHDC3	SNP-based	Disease risk	25862742	Caucasian	DemGene	2015	All	AD	AD	upstream_gene_variant
chr10	11678309	rs7920721	0.12	ECHDC3	G	G	1.05	1.05	ECHDC3	SNP-based	Disease risk	25862742	Caucasian	deCODE	67817	All	AD	AD	upstream_gene_variant
chr10	11678309	rs7920721	0.278	ECHDC3	G	G	1.049	1.049	ECHDC3	SNP-based	Disease risk	24495969	Caucasian	Cohort from Spain	4372	All	AD	AD	upstream_gene_variant
chr10	11678309	rs7920721	1.80E-11	ECHDC3	G	G	1.08	1.08	ECHDC3	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	94437	All	Clinically diagnosed LOAD	AD	upstream_gene_variant
chr10	11678309	rs7920721	2.30E-09	ECHDC3	G	G	1.08	1.08	ECHDC3	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	82771	All	Clinically diagnosed LOAD	AD	upstream_gene_variant
chr10	11678309	rs7920721	3.38E-08	ECHDC3	G	G	1.07	1.07	ECHDC3	SNP-based	Disease risk	25862742	Caucasian	"deCODE, DemGene, IGAP"	143878	All	AD	AD	upstream_gene_variant
chr10	11679120	rs11257242	2.38E-08	ECHDC3	C	C	NR	NA	ECHDC3	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ"	79145	All	AD	AD	upstream_gene_variant
chr10	12933450	rs10906257	0.000439	CCDC3	G	G	NR	NA	CCDC3	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr10	12933450	rs10906257	0.000472	CCDC3	G	G	NR	NA	CCDC3	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Total cholesterol (TC)	Non-ADRD	intron_variant
chr10	12933450	rs10906257	0.00537	CCDC3	G	G	1.06	1.06	CCDC3	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intron_variant
chr10	12933450	rs10906257	0.0058	CCDC3	G	G	1.06	1.06	CCDC3	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intron_variant
chr10	12933450	rs10906257	0.775	CCDC3	G	G	1.02	1.02	CCDC3	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intron_variant
chr10	13768427	rs72769570	0.00000809	FRMD4A	A	A	NR	NA	FRMD4A	SNP-based	Disease risk	24770881	Caucasian	ADGC	2239	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	intron_variant
chr10	16257952	rs10508503	0.675	NR	C	C	0.983	0.983	PTER	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	intergenic_region
chr10	16257952	rs10508503	0.693	NR	C	C	1.051	1.051	PTER	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	intergenic_region
chr10	16514711	rs7909832	1.45E-27	PTER	NR	NR	-0.7	0.496585	C1QL3	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	PTER expression in Cerebellar	Expression	splice_region_variant&intron_variant
chr10	16514711	rs7909832	2.86E-29	PTER	NR	NR	-0.81	0.444858	C1QL3	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	PTER expression in Cerebellar	Expression	splice_region_variant&intron_variant
chr10	16514711	rs7909832	3.32E-81	PTER	NR	NR	-1	0.367879	C1QL3	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	PTER expression in Temporal cortex	Expression	splice_region_variant&intron_variant
chr10	16514711	rs7909832	7.54E-63	PTER	NR	NR	-0.75	0.472367	C1QL3	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	PTER expression in Cerebellar	Expression	splice_region_variant&intron_variant
chr10	17026252	rs12146414	0.0000137	CUBN	G	G	NR	NA	CUBN	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr10	17026252	rs12146414	0.00086	CUBN	G	G	NR	NA	CUBN	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intron_variant
chr10	17026252	rs12146414	0.0067	CUBN	G	G	NR	NA	CUBN	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr10	18713958	rs11015839	0.000000645	ARL5B	A	A	NR	NA	ARL5B	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF Ab1-42	Fluid biomarker	intergenic_region
chr10	18713958	rs11015839	0.000000787	NR	A	A	-0.12	0.88692	ARL5B	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF Ab1-42	Fluid biomarker	intergenic_region
chr10	18716110	rs11015860	0.000000645	NR	G	G	NR	NA	ARL5B	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF Ab1-42	Fluid biomarker	intergenic_region
chr10	18716110	rs11015860	0.000000787	NR	G	G	-0.12	0.88692	ARL5B	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF Ab1-42	Fluid biomarker	intergenic_region
chr10	18729013	rs11015939	0.000000925	NR	A	A	-0.12	0.88692	ARL5B	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF Ab1-42	Fluid biomarker	intergenic_region
chr10	18746022	rs10763625	0.000000978	NR	T	T	-0.12	0.88692	ARL5B	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF Ab1-42	Fluid biomarker	upstream_gene_variant
chr10	18773327	rs2493624	0.000000614	NR	G	G	NR	NA	ARL5B	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF Ab1-42	Fluid biomarker	intergenic_region
chr10	18785532	rs2495832	0.000000925	NR	G	G	-0.12	0.88692	ARL5B	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF Ab1-42	Fluid biomarker	intergenic_region
chr10	18871100	rs16917919	0.00000767	NR	G	G	147.6	12643448063789860574301947840595377367444276876034483163334967296	MALRD1	SNP-based	Endophenotype	20197096	Caucasian	ADNI	698	All	Hippocampal Volume	Imaging	intergenic_region
chr10	18871100	rs16917919	0.0000868	NR	G	G	147.6	12643448063789860574301947840595377367444276876034483163334967296	MALRD1	SNP-based	Endophenotype	20197096	Caucasian	ADNI	698	All	Hippocampal Volume	Imaging	intergenic_region
chr10	20101712	rs2358839	0.0229	PLXDC2	NR	NR	NR	NA	PLXDC2	SNP-based	Endophenotype	22245343	Caucasian	ADNI	757	All	MRI	Imaging	intron_variant
chr10	22857501	rs145301439	0.000157	ARMC3	A	A	NR	NA	ARMC3	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	High-density lipoprotein (HDL)	Non-ADRD	intergenic_region
chr10	22857501	rs145301439	0.000242	ARMC3	A	A	NR	NA	ARMC3	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr10	22857501	rs145301439	0.127	ARMC3	A	A	1	1	ARMC3	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intergenic_region
chr10	26509293	rs77131199	0.0000036	NR	A	A	1.48	4.39295	APBB1IP	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	363	AD subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr10	26509293	rs77131199	0.017	NR	A	A	0.37	1.44773	APBB1IP	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	878	AD subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr10	26509293	rs77131199	0.95	NR	A	A	0.01	1.01005	APBB1IP	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	515	AD subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr10	28216015	rs11006923	0.00000899	MPP7	NR	NR	0.63	0.63	MPP7	SNP-based	Disease risk	22005930	Caucasian	"ADGC, GERAD, Cohort from UK"	7693	AD+P and control subjects	AD+Psychosis	ADRD	intron_variant
chr10	29807699	rs2986971	0.00000012	NR	G	G	NR	NA	SVIL	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	MCI	CSF Ab1-42	Fluid biomarker	intergenic_region
chr10	29807699	rs2986971	0.000000888	NR	G	G	0.08	1.08329	SVIL	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	MCI	CSF Ab1-42	Fluid biomarker	intergenic_region
chr10	42845657	rs2142991	0.00000032	BMS1	NA	NA	1.3	1.3	BMS1	SNP-based	Disease Risk	22685416	Caucasian	"Cohorts from Europe, USA"	8851	All	Progressive Supranuclear Palsy (PSP)	ADRD	intergenic_region
chr10	42845657	rs2142991	0.23	BMS1	NR	NR	0.03	1.03045	BMS1	SNP-based	eQTL	22685416	Caucasian	MAYO	107	PSP	BMS1 (ILMN_1772713) expression in Temporal cortex	Expression	intergenic_region
chr10	42845657	rs2142991	0.456	BMS1	NR	NR	-0.01	0.99005	BMS1	SNP-based	eQTL	22685416	Caucasian	MAYO	202	AD	BMS1 (ILMN_1772713) expression in Temporal cortex	Expression	intergenic_region
chr10	42845657	rs2142991	0.726	BMS1	NR	NR	0.01	1.01005	BMS1	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	BMS1 (ILMN_1772713) expression in Cerebellar	Expression	intergenic_region
chr10	42845657	rs2142991	0.802	BMS1	NR	NR	0	1	BMS1	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	BMS1 (ILMN_1772713) expression in Temporal cortex	Expression	intergenic_region
chr10	42845657	rs2142991	0.818	BMS1	NR	NR	-0.01	0.99005	BMS1	SNP-based	eQTL	22685416	Caucasian	MAYO	98	PSP	BMS1 (ILMN_1772713) expression in Cerebellar	Expression	intergenic_region
chr10	42845657	rs2142991	0.936	BMS1	NR	NR	0	1	BMS1	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	BMS1 (ILMN_1772713) expression in Cerebellar	Expression	intergenic_region
chr10	42984275	rs947690	0.00000862	RET	NR	NR	NR	NA	RET	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	upstream_gene_variant
chr10	42987816	rs1547930	0.00000943	RET	NR	NR	NR	NA	RET	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intergenic_region
chr10	42988715	rs3004258	0.00000894	RET	NR	NR	NR	NA	RET	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intergenic_region
chr10	44583495	rs7893928	0.0000231	NR	NR	NR	NR	NA	CXCL12	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	intergenic_region
chr10	51285504	rs1915678	0.0000144	PRKG1	NR	NR	NR	NA	PRKG1	SNP-based	Disease risk	20061627	Caucasian	ADGC	699	All	LOAD	AD	intron_variant
chr10	52058389	rs12268753	2.01E-08	PRKG1	C	C	0.3	1.34986	PRKG1	SNP-based	Endophenotype	29274321	Caucasian	ADNI	305	Normal controls	Logic memory delayed (LMdT) recall test	Cognitive	intron_variant
chr10	57998883	rs11006002	0.00000749	IPMK	NR	NR	0.799	2.22332	IPMK	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	673	All	CSF Clusterin	Fluid biomarker	intergenic_region
chr10	57998883	rs11006002	0.000396	IPMK	NR	NR	0.815	2.25918	IPMK	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	403	Subjects with APOE-e4-	CSF Clusterin	Fluid biomarker	intergenic_region
chr10	57998883	rs11006002	0.01	IPMK	NR	NR	0.753	2.12336	IPMK	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	270	Subjects with APOE-e4+	CSF Clusterin	Fluid biomarker	intergenic_region
chr10	58178575	rs12570088	0.00000573	IPMK	A	A	NR	NA	IPMK	SNP-based	Cross phenotype 	27088644	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr10	58178575	rs12570088	0.0000657	IPMK	A	A	NR	NA	IPMK	SNP-based	Cross phenotype 	27088644	Caucasian	Cohort of Immune-Mediated Diseases	51009	All	Crohn disease	Non-ADRD	intergenic_region
chr10	58388932	rs2306604	0.808	TFAM	G	G	1.02	1.02	TFAM	SNP-based	Disease risk	20534741	Caucasian	"ADC, UM"	1610	All	AD	AD	intron_variant
chr10	60420054	rs10994336	0.025	ANK3	NR	NR	1.26	1.26	ANK3	SNP-based	Cross phenotype 	22005930	Caucasian	"ADGC, GERAD, Cohort from UK"	6958	AD+P and control subjects	AD+Psychosis	ADRD	intron_variant
chr10	60420054	rs10994336	0.071	ANK3	NR	NR	1.36	1.36	ANK3	SNP-based	Cross phenotype 	22005930	Caucasian	"ADGC, GERAD"	2034	AD+P and AD-P subjects	AD+Psychosis	ADRD	intron_variant
chr10	60540625	rs1938526	0.064	ANK3	NR	NR	0.76	0.76	ANK3	SNP-based	Cross phenotype 	22005930	Caucasian	"ADGC, GERAD, Cohort from UK"	6958	AD+P and control subjects	AD+Psychosis	ADRD	intron_variant
chr10	60540625	rs1938526	0.13	ANK3	NR	NR	0.72	0.72	ANK3	SNP-based	Cross phenotype 	22005930	Caucasian	"ADGC, GERAD"	2034	AD+P and AD-P subjects	AD+Psychosis	ADRD	intron_variant
chr10	61824775	rs4948288	0.0036	ARID5B	NR	NR	1.07	1.07	CABCOCO1	SNP-based	Disease risk	21460840	Caucasian	"EADI, GERAD"	20464	All	AD	AD	upstream_gene_variant
chr10	61851595	rs2588969	0.00000069	ARID5B	A	A	0.88	0.88	ARID5B	SNP-based	Disease risk	21460841	Caucasian	ADGC	15675	All	LOAD	AD	intergenic_region
chr10	61851595	rs2588969	0.00000114	ARID5B	A	A	0.88	0.88	ARID5B	SNP-based	Disease risk	21460841	Caucasian	ADGC	15675	All	LOAD	AD	intergenic_region
chr10	61851595	rs2588969	0.000778	ARID5B	A	A	0.93	0.93	ARID5B	SNP-based	Disease risk	21460841	Caucasian	ADGC	22771	All	LOAD	AD	intergenic_region
chr10	61851595	rs2588969	0.00105	ARID5B	A	A	0.93	0.93	ARID5B	SNP-based	Disease risk	21460841	Caucasian	ADGC	22771	All	LOAD	AD	intergenic_region
chr10	61851595	rs2588969	0.018	ARID5B	NR	NR	1.06	1.06	ARID5B	SNP-based	Disease risk	21460841	Caucasian	"CHARGE, EADI, GERAD"	25818	All	LOAD	AD	intergenic_region
chr10	61851595	rs2588969	0.033	ARID5B	NR	NR	1.06	1.06	ARID5B	SNP-based	Disease risk	21460840	Caucasian	"EADI, GERAD"	13448	All	AD	AD	intergenic_region
chr10	61851595	rs2588969	0.189	ARID5B	A	A	1.05	1.05	ARID5B	SNP-based	Disease risk	21460841	Caucasian	ADGC	7096	All	LOAD	AD	intergenic_region
chr10	61851595	rs2588969	0.234	ARID5B	A	A	1.05	1.05	ARID5B	SNP-based	Disease risk	21460841	Caucasian	ADGC	7096	All	LOAD	AD	intergenic_region
chr10	61851595	rs2588969	0.36	ARID5B	NR	NR	0.99	0.99	ARID5B	SNP-based	Disease risk	21460840	Caucasian	"ADGC, GERAD"	NR	All	AD	AD	intergenic_region
chr10	61851595	rs2588969	0.362	ARID5B	NR	NR	0.99	0.99	ARID5B	SNP-based	Disease risk	21460841	Caucasian	"ADGC, CHARGE, EADI, GERAD"	48589	All	LOAD	AD	intergenic_region
chr10	66838712	rs116950805	0.00372	CTNNA3	NR	NR	NR	NA	CTNNA3	SNP-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr10	66838712	rs116950805	0.41658	NA	NR	NR	NR	NA	CTNNA3	Gene-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr10	67796974	rs41299238	0.138	DNAJC12	NR	NR	NR	NA	DNAJC12	SNP-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	3_prime_UTR_variant
chr10	67796974	rs41299238	0.84615	NA	NR	NR	NR	NA	DNAJC12	Gene-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	3_prime_UTR_variant
chr10	67895498	rs10997864	0.0481	SIRT1	NR	NR	NR	NA	SIRT1	SNP-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr10	67895498	rs10997864	0.82118	NA	NR	NR	NR	NA	SIRT1	Gene-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr10	67927049	rs17454621	0.0805	HERC4	NR	NR	NR	NA	HERC4	SNP-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr10	67927049	rs17454621	0.8012	NA	NR	NR	NR	NA	HERC4	Gene-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr10	68140688	rs76451279	0.00867	MYPN	NR	NR	NR	NA	MYPN	SNP-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr10	68140688	rs76451279	0.79321	NA	NR	NR	NR	NA	MYPN	Gene-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr10	68174501	rs3814182	0.073	MYPN	NR	NR	1.34	1.34	MYPN	SNP-based	Cross phenotype 	30010129	Asian	Cohort from Han Chinse	475	All	AD	AD	synonymous_variant
chr10	69778536	rs4746003	0.00000595	RP11-242G20.2	NR	NR	1.3	1.3	COL13A1	SNP-based	Disease risk	22005930	Caucasian	"ADGC, GERAD, Cohort from UK"	7693	AD+P and control subjects	AD+Psychosis	ADRD	upstream_gene_variant
chr10	76886778	rs2116830	0.291	NR	G	G	0.944	0.944	KCNMA1	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	3_prime_UTR_variant
chr10	76886778	rs2116830	0.503	NR	G	G	1.02	1.02	KCNMA1	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	3_prime_UTR_variant
chr10	76977837	rs16934131	0.00334	KCNMA1	NR	NR	NR	NA	KCNMA1	SNP-based	Disease risk	19118814	Caucasian	"CAP, Reiman et al.(2007)"	NR	All	LOAD	AD	intron_variant
chr10	76977837	rs16934131	0.0357	KCNMA1	NR	NR	NR	NA	KCNMA1	SNP-based	Disease risk	19118814	Caucasian	Reiman et al.(2007)	NR	All	LOAD	AD	intron_variant
chr10	76977837	rs16934131	0.0452	KCNMA1	NR	NR	NR	NA	KCNMA1	SNP-based	Disease risk	19118814	Caucasian	CAP	458	All	LOAD	AD	intron_variant
chr10	79182863	rs810517	0.0000002	ZMIZ1	NR	NR	NR	NA	ZMIZ1	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr10	80027909	rs12783314	0.00026	LOC219347	A	A	NR	NA	SFTPD	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	upstream_gene_variant
chr10	80027909	rs12783314	0.00153	LOC219347	A	A	NR	NA	SFTPD	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Low-density lipoprotein (LDL)	Non-ADRD	upstream_gene_variant
chr10	83868459	rs11200713	0.0000364	GHITM	NR	NR	NR	NA	GHITM	SNP-based	Disease risk	20061627	Caucasian	ADGC	699	All	LOAD	AD	intergenic_region
chr10	84032167	rs7908652	0.00000359	"C10orf99, GHITM, PCDH21, LRT1, LRT2, RGR"	NR	NR	NR	NA	GHITM	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intergenic_region
chr10	84032167	rs7908652	0.000092	NR	NR	NR	1.5	1.5	GHITM	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intergenic_region
chr10	84032167	rs7908652	0.000451	"C10orf99, GHITM, PCDH21, LRT1, LRT2, RGR"	NR	NR	NR	NA	GHITM	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intergenic_region
chr10	84032167	rs7908652	0.00253	"C10orf99, GHITM, PCDH21, LRT1, LRT2, RGR"	NR	NR	NR	NA	GHITM	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intergenic_region
chr10	84032167	rs7908652	0.0106	NR	NR	NR	1.74	1.74	GHITM	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intergenic_region
chr10	84032167	rs7908652	0.0265	"C10orf99, GHITM, PCDH21, LRT1, LRT2, RGR"	NR	NR	NR	NA	GHITM	SNP-based	Disease risk	21059989	Caucasian	ADGC	1390	Unrelated individuals	LOAD	AD	intergenic_region
chr10	84032167	rs7908652	0.03457	"GHITM, C10orf99, PCDH21, LRT2, LRT1, RGR"	NR	NR	NR	NA	GHITM	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intergenic_region
chr10	84032167	rs7908652	0.0515	NR	NR	NR	1.38	1.38	GHITM	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intergenic_region
chr10	84032167	rs7908652	0.13064	"GHITM, C10orf99, PCDH21, LRT2, LRT1, RGR"	NR	NR	NR	NA	GHITM	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intergenic_region
chr10	88998030	rs1571011	0.00000032	FAS	NR	NR	0.04	1.04081	FAS	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	ADNI	521	All	Plasma FAS	Fluid biomarker	intron_variant
chr10	89213735	rs13500	0.162	CH25H	A	A	1.18	1.18	LIPA	SNP-based	Disease risk	20534741	Caucasian	"ADC, UM"	1610	All	AD	AD	3_prime_UTR_variant
chr10	89402425	rs41284944	0.0137	IFIT3	T	T	NR	NA	LIPA	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	synonymous_variant
chr10	89402425	rs41284944	1.65E-13	NR	T	T	NR	NA	LIPA	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	IFIT2 (ILMN_1739428) expression	Expression	synonymous_variant
chr10	89402425	rs41284944	4.19E-39	NR	T	T	NR	NA	LIPA	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	IFIT3 (ILMN_2239754) expression	Expression	synonymous_variant
chr10	89981179	rs17129662	0.00003	"MPHOSPH1, HTR7"	NA	NA	NA	NA	KIF20B	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Stroop Color Word test	Cognitive	downstream_gene_variant
chr10	89981179	rs17129662	0.002	"MPHOSPH1, HTR7"	NA	NA	NA	NA	KIF20B	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Verbal Fluency - Phonological fluency	Cognitive	downstream_gene_variant
chr10	89981179	rs17129662	0.00235	"MPHOSPH1, HTR7"	NA	NA	NA	NA	KIF20B	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Part B of the Trail making test (TMTB)	Cognitive	downstream_gene_variant
chr10	89981179	rs17129662	0.1	"MPHOSPH1, HTR7"	NA	NA	NA	NA	KIF20B	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Verbal Fluency - Semantic fluency	Cognitive	downstream_gene_variant
chr10	89981179	rs17129662	0.23	"MPHOSPH1, HTR7"	NA	NA	NA	NA	KIF20B	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Learning (or working memory)	Cognitive	downstream_gene_variant
chr10	89981179	rs17129662	0.48	"MPHOSPH1, HTR7"	NA	NA	NA	NA	KIF20B	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Recognition	Cognitive	downstream_gene_variant
chr10	89981179	rs17129662	0.55	"MPHOSPH1, HTR7"	NA	NA	NA	NA	KIF20B	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Delayed recall	Cognitive	downstream_gene_variant
chr10	89981179	rs17129662	0.84	"MPHOSPH1, HTR7"	NA	NA	NA	NA	KIF20B	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Block test	Cognitive	downstream_gene_variant
chr10	89981179	rs17129662	7.00E-13	"MPHOSPH1, HTR7"	NA	NA	NA	NA	KIF20B	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	"Cognitive function (Memory - Learning (or working memory), Memory - Delayed recall, Memory - Recognition, Executive Function - Stroop Color Word test, Executive Function - Part B of the Trail making test (TMTB), Executive Function - Block test, Verbal Fluency - Semantic fluency, Verbal Fluency - Phonological fluency)"	Cognitive	downstream_gene_variant
chr10	90029031	rs11185978	0.00002	"MPHOSPH1, HTR7"	NA	NA	NA	NA	KIF20B	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Stroop Color Word test	Cognitive	intergenic_region
chr10	90029031	rs11185978	0.001	"MPHOSPH1, HTR7"	NA	NA	NA	NA	KIF20B	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Verbal Fluency - Phonological fluency	Cognitive	intergenic_region
chr10	90029031	rs11185978	0.01	"MPHOSPH1, HTR7"	NA	NA	NA	NA	KIF20B	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Part B of the Trail making test (TMTB)	Cognitive	intergenic_region
chr10	90029031	rs11185978	0.05	"MPHOSPH1, HTR7"	NA	NA	NA	NA	KIF20B	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Verbal Fluency - Semantic fluency	Cognitive	intergenic_region
chr10	90029031	rs11185978	0.36	"MPHOSPH1, HTR7"	NA	NA	NA	NA	KIF20B	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Learning (or working memory)	Cognitive	intergenic_region
chr10	90029031	rs11185978	0.6	"MPHOSPH1, HTR7"	NA	NA	NA	NA	KIF20B	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Delayed recall	Cognitive	intergenic_region
chr10	90029031	rs11185978	0.6	"MPHOSPH1, HTR7"	NA	NA	NA	NA	KIF20B	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Recognition	Cognitive	intergenic_region
chr10	90029031	rs11185978	0.61	"MPHOSPH1, HTR7"	NA	NA	NA	NA	KIF20B	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Block test	Cognitive	intergenic_region
chr10	90029031	rs11185978	8.90E-13	"MPHOSPH1, HTR7"	NA	NA	NA	NA	KIF20B	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	"Cognitive function (Memory - Learning (or working memory), Memory - Delayed recall, Memory - Recognition, Executive Function - Stroop Color Word test, Executive Function - Part B of the Trail making test (TMTB), Executive Function - Block test, Verbal Fluency - Semantic fluency, Verbal Fluency - Phonological fluency)"	Cognitive	intergenic_region
chr10	90058530	rs7071717	0.000005	"MPHOSPH1, HTR7"	NA	NA	NA	NA	KIF20B	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Stroop Color Word test	Cognitive	intergenic_region
chr10	90058530	rs7071717	0.01	"MPHOSPH1, HTR7"	NA	NA	NA	NA	KIF20B	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Part B of the Trail making test (TMTB)	Cognitive	intergenic_region
chr10	90058530	rs7071717	0.01	"MPHOSPH1, HTR7"	NA	NA	NA	NA	KIF20B	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Verbal Fluency - Phonological fluency	Cognitive	intergenic_region
chr10	90058530	rs7071717	0.04	"MPHOSPH1, HTR7"	NA	NA	NA	NA	KIF20B	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Verbal Fluency - Semantic fluency	Cognitive	intergenic_region
chr10	90058530	rs7071717	0.3	"MPHOSPH1, HTR7"	NA	NA	NA	NA	KIF20B	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Learning (or working memory)	Cognitive	intergenic_region
chr10	90058530	rs7071717	0.67	"MPHOSPH1, HTR7"	NA	NA	NA	NA	KIF20B	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Recognition	Cognitive	intergenic_region
chr10	90058530	rs7071717	0.73	"MPHOSPH1, HTR7"	NA	NA	NA	NA	KIF20B	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Delayed recall	Cognitive	intergenic_region
chr10	90058530	rs7071717	0.9	"MPHOSPH1, HTR7"	NA	NA	NA	NA	KIF20B	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Block test	Cognitive	intergenic_region
chr10	90058530	rs7071717	2.90E-12	"MPHOSPH1, HTR7"	NA	NA	NA	NA	KIF20B	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	"Cognitive function (Memory - Learning (or working memory), Memory - Delayed recall, Memory - Recognition, Executive Function - Stroop Color Word test, Executive Function - Part B of the Trail making test (TMTB), Executive Function - Block test, Verbal Fluency - Semantic fluency, Verbal Fluency - Phonological fluency)"	Cognitive	intergenic_region
chr10	91864915	rs2258946	0.00000066	NR	G	G	1.24	3.45561	TNKS2	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	363	AD subjects	CSF Ab1-42	Fluid biomarker	3_prime_UTR_variant
chr10	91864915	rs2258946	0.011	NR	G	G	0.17	1.1853	TNKS2	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	878	AD subjects	CSF Ab1-42	Fluid biomarker	3_prime_UTR_variant
chr10	91864915	rs2258946	0.29	NR	T	T	-0.1	0.904837	TNKS2	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	515	AD subjects	CSF Ab1-42	Fluid biomarker	3_prime_UTR_variant
chr10	92588073	rs6583826	0.00000006	"IDE, KIF11"	NR	NR	NR	NA	KIF11	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intergenic_region
chr10	92677094	rs7911264	4.50E-13	HHEX	NR	NR	NR	NA	HHEX	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intergenic_region
chr10	92732959	rs2497304	8.50E-09	"EXOC6, HHEX"	NR	NR	NR	NA	HHEX	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intergenic_region
chr10	94890571	rs4110517	0.00003	"CYP2C19, CYP2C9"	NA	NA	NA	NA	CYP2C19	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Verbal Fluency - Semantic fluency	Cognitive	intergenic_region
chr10	94890571	rs4110517	0.04	"CYP2C19, CYP2C9"	NA	NA	NA	NA	CYP2C19	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Verbal Fluency - Phonological fluency	Cognitive	intergenic_region
chr10	94890571	rs4110517	0.09	"CYP2C19, CYP2C9"	NA	NA	NA	NA	CYP2C19	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Delayed recall	Cognitive	intergenic_region
chr10	94890571	rs4110517	0.1	"CYP2C19, CYP2C9"	NA	NA	NA	NA	CYP2C19	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Learning (or working memory)	Cognitive	intergenic_region
chr10	94890571	rs4110517	0.18	"CYP2C19, CYP2C9"	NA	NA	NA	NA	CYP2C19	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Stroop Color Word test	Cognitive	intergenic_region
chr10	94890571	rs4110517	0.24	"CYP2C19, CYP2C9"	NA	NA	NA	NA	CYP2C19	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Part B of the Trail making test (TMTB)	Cognitive	intergenic_region
chr10	94890571	rs4110517	0.87	"CYP2C19, CYP2C9"	NA	NA	NA	NA	CYP2C19	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Block test	Cognitive	intergenic_region
chr10	94890571	rs4110517	0.94	"CYP2C19, CYP2C9"	NA	NA	NA	NA	CYP2C19	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Recognition	Cognitive	intergenic_region
chr10	94890571	rs4110517	4.70E-10	"CYP2C19, CYP2C9"	NA	NA	NA	NA	CYP2C19	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	"Cognitive function (Memory - Learning (or working memory), Memory - Delayed recall, Memory - Recognition, Executive Function - Stroop Color Word test, Executive Function - Part B of the Trail making test (TMTB), Executive Function - Block test, Verbal Fluency - Semantic fluency, Verbal Fluency - Phonological fluency)"	Cognitive	intergenic_region
chr10	95595157	rs498055	0.82	LOC439999	C	C	0.98	0.98	ALDH18A1	SNP-based	Disease risk	20534741	Caucasian	"ADC, UM"	1610	All	AD	AD	non_coding_transcript_exon_variant
chr10	99673635	rs911541	0.929	ENTPD7	G	G	0.99	0.99	AL133353.2	SNP-based	Disease risk	20534741	Caucasian	"ADC, UM"	1610	All	AD	AD	intron_variant
chr10	100741814	rs4509693	0.00000629	PAX2	NR	NR	NR	NA	PAX2	SNP-based	Disease risk	20061627	Caucasian	ADGC	699	All	LOAD	AD	intron_variant
chr10	102863821	rs9527	3.42E-62	C10orf32	NR	NR	-0.45	0.637628	BORCS7	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	C10orf32 expression in Temporal cortex	Expression	3_prime_UTR_variant
chr10	103410892	rs11191683	0.021	NR	T	T	0.19	1.20925	PDCD11	SNP-based	Endophenotype	27694991	African American	"CHARGE, ENIGMA"	938	African	Intracranial Volume	Imaging	intron_variant
chr10	103410892	rs11191683	0.075	NR	T	T	0.09	1.09417	PDCD11	SNP-based	Endophenotype	27694991	Asian	"CHARGE, ENIGMA"	955	Asian	Intracranial Volume	Imaging	intron_variant
chr10	103410892	rs11191683	0.174	NR	T	T	0.04	1.04081	PDCD11	SNP-based	Endophenotype	27694991	Caucasian	"CHARGE, ENIGMA"	2363	European	Intracranial Volume	Imaging	intron_variant
chr10	103410892	rs11191683	0.911	NR	T	T	-0.01	0.99005	PDCD11	SNP-based	Endophenotype	27694991	Hispanic	"CHARGE, ENIGMA"	1605	Hispanic	Intracranial Volume	Imaging	intron_variant
chr10	103410892	rs11191683	1.10E-10	NR	T	T	0.06	1.06184	PDCD11	SNP-based	Endophenotype	27694991	Caucasian	"CHARGE, ENIGMA"	26577	European	Intracranial Volume	Imaging	intron_variant
chr10	103458495	rs2986017	0.314	CALHM1	A	A	0.92	0.92	CALHM1	SNP-based	Disease risk	20534741	Caucasian	"ADC, UM"	1610	All	AD	AD	missense_variant
chr10	104845682	rs12249460	0.00345	SORCS3	A	A	0.95	2.58571	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	intron_variant
chr10	104845682	rs12249460	0.00371	SORCS3	A	A	-0.941	0.390237	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	intron_variant
chr10	104845682	rs12249460	0.02	SORCS3	A	A	0.14	1.15027	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	104848677	rs6584629	0.00341	SORCS3	A	A	0.688	1.98973	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	intron_variant
chr10	104848677	rs6584629	0.0036	SORCS3	A	A	-0.682	0.505605	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	intron_variant
chr10	104848677	rs6584629	0.023	SORCS3	A	A	0.1	1.10517	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	104850142	rs10786828	0.00463	SORCS3	NR	NR	NR	NA	SORCS3	SNP-based	Disease risk	19118814	Caucasian	"CAP, Reiman et al.(2007)"	NR	All	LOAD	AD	intron_variant
chr10	104850142	rs10786828	0.035	SORCS3	NR	NR	NR	NA	SORCS3	SNP-based	Disease risk	19118814	Caucasian	Reiman et al.(2007)	NR	All	LOAD	AD	intron_variant
chr10	104850142	rs10786828	0.0455	SORCS3	NR	NR	NR	NA	SORCS3	SNP-based	Disease risk	19118814	Caucasian	CAP	458	All	LOAD	AD	intron_variant
chr10	104853572	rs7894737	0.00435	SORCS3	NR	NR	NR	NA	SORCS3	SNP-based	Disease risk	19118814	Caucasian	"CAP, Reiman et al.(2007)"	NR	All	LOAD	AD	intron_variant
chr10	104853572	rs7894737	0.0469	SORCS3	NR	NR	NR	NA	SORCS3	SNP-based	Disease risk	19118814	Caucasian	CAP	458	All	LOAD	AD	intron_variant
chr10	104853572	rs7894737	0.0474	SORCS3	NR	NR	NR	NA	SORCS3	SNP-based	Disease risk	19118814	Caucasian	Reiman et al.(2007)	NR	All	LOAD	AD	intron_variant
chr10	104855629	rs12259189	0.00295	SORCS3	C	C	-0.694	0.499574	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	intron_variant
chr10	104855629	rs12259189	0.00318	SORCS3	C	C	0.687	1.98774	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	intron_variant
chr10	104855629	rs12259189	0.0336	SORCS3	T	T	0.1	1.10517	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	104856978	rs3976793	0.00287	SORCS3	A	A	0.695	2.00371	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	intron_variant
chr10	104856978	rs3976793	0.00309	SORCS3	A	A	-0.689	0.502078	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	intron_variant
chr10	104856978	rs3976793	0.0343	SORCS3	A	A	0.1	1.10517	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	104860546	rs112898269	0.00344	SORCS3	NR	NR	NR	NA	SORCS3	SNP-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr10	104860546	rs112898269	0.2997	NA	NR	NR	NR	NA	SORCS3	Gene-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr10	104861946	rs12262245	0.00237	SORCS3	C	C	-0.705	0.494109	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	intron_variant
chr10	104861946	rs12262245	0.00258	SORCS3	C	C	0.697	2.00772	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	intron_variant
chr10	104861946	rs12262245	0.0409	SORCS3	C	C	0.0941	1.09867	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	104862251	rs7086583	0.00241	SORCS3	A	A	-0.703	0.495098	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	intron_variant
chr10	104862251	rs7086583	0.00262	SORCS3	A	A	0.696	2.00571	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	intron_variant
chr10	104862251	rs7086583	0.0434	SORCS3	A	A	0.0929	1.09735	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	105047431	rs1670036	0.0164	SORCS3	A	A	0.21	1.23368	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	105230641	rs749304	0.00066	SORCS3	A	A	-0.426	0.653116	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	intron_variant
chr10	105230641	rs749304	0.00071	SORCS3	A	A	0.424	1.52806	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	intron_variant
chr10	105230641	rs749304	0.00133	SORCS3	A	A	-0.235	0.790571	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	intron_variant
chr10	105230641	rs749304	0.00903	SORCS3	A	A	0.159	1.17234	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	intron_variant
chr10	105230641	rs749304	0.0391	SORCS3	A	A	0.0469	1.04802	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	105234012	rs12263804	0.00067	SORCS3	C	C	-0.425	0.65377	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	intron_variant
chr10	105234012	rs12263804	0.00072	SORCS3	C	C	0.423	1.52653	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	intron_variant
chr10	105234012	rs12263804	0.00134	SORCS3	C	C	-0.235	0.790571	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	intron_variant
chr10	105234012	rs12263804	0.00936	SORCS3	C	C	0.158	1.17117	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	intron_variant
chr10	105234012	rs12263804	0.0371	SORCS3	T	T	0.05	1.05127	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	105253494	rs7920533	0.0135	SORCS3	A	A	0.05	1.05127	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	105263632	rs3750261	0.00073	SORCS3	C	C	0.413	1.51135	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	3_prime_UTR_variant
chr10	105263632	rs3750261	0.00076	SORCS3	C	C	-0.412	0.662324	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	3_prime_UTR_variant
chr10	105263632	rs3750261	0.00279	SORCS3	C	C	-0.216	0.805735	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	3_prime_UTR_variant
chr10	105263632	rs3750261	0.0465	SORCS3	T	T	0.05	1.05127	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	3_prime_UTR_variant
chr10	105265270	rs10884126	0.00072	SORCS3	A	A	-0.414	0.661001	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	downstream_gene_variant
chr10	105265270	rs10884126	0.00074	SORCS3	A	A	0.413	1.51135	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	downstream_gene_variant
chr10	105265270	rs10884126	0.00292	SORCS3	A	A	0.215	1.23986	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	downstream_gene_variant
chr10	105265270	rs10884126	0.0463	SORCS3	A	A	0.05	1.05127	SORCS3	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	downstream_gene_variant
chr10	106798187	rs12258738	0.0333	SORCS1	T	T	0.1415	1.152	SORCS1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	106802250	rs12248379	0.00306	SORCS1	T	T	0.08	1.08329	SORCS1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	106803358	rs17121613	0.00733	SORCS1	G	G	-0.2	0.818731	SORCS1	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	intron_variant
chr10	106803358	rs17121613	0.0111	SORCS1	T	T	0.0773	1.08037	SORCS1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	106890416	rs4917491	0.0446	SORCS1	T	T	0.0405	1.04133	SORCS1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	106893409	rs7076579	0.0472	SORCS1	T	T	0.04	1.04081	SORCS1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	106893725	rs7096260	0.0494	SORCS1	A	A	0.0396	1.04039	SORCS1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	106897422	rs12356136	0.0473	SORCS1	T	T	0.04	1.04081	SORCS1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	106898839	rs7895881	0.0467	SORCS1	A	A	0.04	1.04081	SORCS1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	106899290	rs1004921	0.045	SORCS1	A	A	0.04	1.04081	SORCS1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	106936019	rs10884389	0.00982	SORCS1	C	C	-0.39	0.677057	SORCS1	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	intron_variant
chr10	106936019	rs10884389	0.0489	SORCS1	T	T	0.0388	1.03956	SORCS1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	106944789	rs10786997	0.0409	SORCS1	A	A	0.04	1.04081	SORCS1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	106946264	rs11193127	0.0417	SORCS1	A	A	0.0399	1.04071	SORCS1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	106946440	rs11193128	0.0427	SORCS1	T	T	0.04	1.04081	SORCS1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	106949608	rs10884390	0.0417	SORCS1	A	A	0.04	1.04081	SORCS1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	106950134	rs10884391	0.00724	SORCS1	A	A	0.405	1.4993	SORCS1	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	intron_variant
chr10	106950134	rs10884391	0.038	SORCS1	A	A	0.0406	1.04144	SORCS1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	106950369	rs10786998	0.00712	SORCS1	A	A	0.405	1.4993	SORCS1	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	intron_variant
chr10	106950369	rs10786998	0.0374	SORCS1	A	A	0.0408	1.04164	SORCS1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	106952475	rs12245675	0.00942	SORCS1	C	C	-0.392	0.675704	SORCS1	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	intron_variant
chr10	106952475	rs12245675	0.0354	SORCS1	T	T	0.0413	1.04216	SORCS1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	106952640	rs17276802	0.00952	SORCS1	C	C	-0.392	0.675704	SORCS1	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	intron_variant
chr10	106952640	rs17276802	0.0347	SORCS1	T	T	0.0414	1.04227	SORCS1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	106957026	rs2149197	0.0268	SORCS1	C	C	0.04	1.04081	SORCS1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	106958696	rs11193130	0.00922	SORCS1	C	C	0.393	1.48142	SORCS1	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	intron_variant
chr10	106958696	rs11193130	0.0268	SORCS1	T	T	0.04	1.04081	SORCS1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	107102369	rs7907690	0.0498	SORCS1	A	A	1.46	1.46	SORCS1	SNP-based	Disease risk	17998437	Caucasian	Cohorts from Canada	1387	All	AD	AD	intron_variant
chr10	107102369	rs7907690	0.16	SORCS1	A	A	1.11	1.11	SORCS1	SNP-based	Age at onset (AAO) / Survival	17998437	Caucasian	Cohorts from Canada	1387	All	Age of AD onset	Other	intron_variant
chr10	107102983	rs4918282	0.0134	SORCS1	A	A	0.07	1.07251	SORCS1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	107103202	rs10787010	0.0442	SORCS1	A	A	0.061	1.0629	SORCS1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	107130378	rs11193209	0.006	SORCS1	C	C	-0.399	0.670991	SORCS1	SNP-based	Disease risk	23673467	Caucasian	ADGC	30871	All	AD	AD	intron_variant
chr10	107130378	rs11193209	0.0384	SORCS1	T	T	0.1544	1.16696	SORCS1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr10	107154687	rs601883	0.001	SORCS1	C	C	3.41	3.41	SORCS1	SNP-based	Age at onset (AAO) / Survival	17998437	Caucasian	Cohorts from Canada	1374	All	Age of AD onset	Other	intron_variant
chr10	107154687	rs601883	0.07	SORCS1	C	C	3.23	3.23	SORCS1	SNP-based	Disease risk	17998437	Caucasian	Cohorts from Canada	1374	All	AD	AD	intron_variant
chr10	107163360	rs600879	0.712	SORCS1	T	T	1.05	1.05	SORCS1	SNP-based	Disease risk	20534741	Caucasian	"ADC, UM"	1610	All	AD	AD	intron_variant
chr10	107441914	rs1903908	0.951	hCG2039140	A	A	1.01	1.01	SORCS1	SNP-based	Disease risk	20534741	Caucasian	"ADC, UM"	1610	All	AD	AD	intergenic_region
chr10	112986029	rs7079711	0.00000025	TCF7L2	NR	NR	NR	NA	TCF7L2	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr10	112988738	rs4074720	7.80E-37	TCF7L2	NR	NR	NR	NA	TCF7L2	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr10	112992744	rs17747324	0.0323	TCF7L2	NR	NR	-0.04	0.960789	TCF7L2	SNP-based	Endophenotype	30805717	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr10	112992744	rs17747324	7.50E-10	TCF7L2	NR	NR	-0.02	0.980199	TCF7L2	SNP-based	Endophenotype	30805717	Caucasian	MAGIC	58047	All	Fasting Glucose	Fluid biomarker	intron_variant
chr10	113022528	rs11196192	0.00000011	TCF7L2	NR	NR	NR	NA	TCF7L2	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr10	113029318	rs7077039	1.00E-36	TCF7L2	NR	NR	NR	NA	TCF7L2	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr10	113061490	rs11196212	1.90E-10	TCF7L2	NR	NR	NR	NA	TCF7L2	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr10	113101545	rs10885414	0.0000087	TCF7L2	NR	NR	NR	NA	TCF7L2	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr10	113155455	rs290483	0.00016	TCF7L2	NR	NR	NR	NA	TCF7L2	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr10	114271014	rs676768	0.000312	VWA2	NR	NR	NR	NA	VWA2	SNP-based	Disease risk	27899424	Caucasian	IFGC	12928	All	Frontotemporal Dementia	ADRD	intron_variant
chr10	114271014	rs676768	0.000312	VWA2	T	T	0.78	0.78	VWA2	SNP-based	Disease risk	27899424	Caucasian	IFGC	6462	All	Frontotemporal Dementia	ADRD	intron_variant
chr10	114271014	rs676768	0.0024	VWA2	T	T	0.86	0.86	VWA2	SNP-based	Disease risk	27899424	Caucasian	IFGC	12928	All	Frontotemporal Dementia	ADRD	intron_variant
chr10	114271014	rs676768	0.55	VWA2	T	T	0.96	0.96	VWA2	SNP-based	Disease risk	27899424	Caucasian	IFGC	6466	All	Frontotemporal Dementia	ADRD	intron_variant
chr10	119906261	rs2456721	0.00000494	SEC23IP	NR	NR	0.266	1.30474	SEC23IP	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	673	All	CSF Clusterin	Fluid biomarker	intron_variant
chr10	119906261	rs2456721	0.000667	SEC23IP	NR	NR	0.266	1.30474	SEC23IP	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	403	Subjects with APOE-e4-	CSF Clusterin	Fluid biomarker	intron_variant
chr10	119906261	rs2456721	0.0026	SEC23IP	NR	NR	0.265	1.30343	SEC23IP	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	270	Subjects with APOE-e4+	CSF Clusterin	Fluid biomarker	intron_variant
chr10	120539864	rs2182513	2.04E-29	PPAPDC1A	NR	NR	0.87	2.38691	PLPP4	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	PPAPDC1A expression in Cerebellar	Expression	intron_variant
chr10	120539864	rs2182513	4.79E-82	PPAPDC1A	NR	NR	0.84	2.31637	PLPP4	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	PPAPDC1A expression in Cerebellar	Expression	intron_variant
chr10	120539864	rs2182513	5.55E-47	PPAPDC1A	NR	NR	0.82	2.2705	PLPP4	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	PPAPDC1A expression in Cerebellar	Expression	intron_variant
chr10	120539864	rs2182513	NS	PPAPDC1A	NR	NR	0.01	1.01005	PLPP4	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	PPAPDC1A expression in Temporal cortex	Expression	intron_variant
chr10	122360941	rs10510109	0.0000029	"BTBD16, PLEKHA1"	NR	NR	NR	NA	PLEKHA1	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intergenic_region
chr10	122360941	rs10510109	0.0000665	"BTBD16, PLEKHA1"	NR	NR	NR	NA	PLEKHA1	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr10	122407996	rs2421016	0.0000047	PLEKHA1	NR	NR	NR	NA	PLEKHA1	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr10	122407996	rs2421016	0.00151	PLEKHA1	NR	NR	NR	NA	PLEKHA1	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr10	124106508	rs7098392	0.0009	CHST15	A	A	NR	NA	CHST15	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Total cholesterol (TC)	Non-ADRD	intergenic_region
chr10	124106508	rs7098392	0.00137	CHST15	A	A	NR	NA	CHST15	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr10	124418396	rs140350519	0.082	OAT	NR	NR	NR	NA	OAT	SNP-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr10	124418396	rs140350519	0.90909	NA	NR	NR	NR	NA	OAT	Gene-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr10	124484294	rs6597801	0.038	LHPP	NR	NR	2.32	2.32	LHPP	SNP-based	Cross phenotype 	30010129	Asian	Cohort from Han Chinse	475	All	AD	AD	missense_variant
chr10	124493728	rs60015709	0.0136	LHPP	NR	NR	NR	NA	LHPP	SNP-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr10	124493728	rs60015709	0.6014	NA	NR	NR	NR	NA	LHPP	Gene-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr10	124736183	rs11245345	0.0221	FAM53B	NR	NR	NR	NA	AC068896.3	SNP-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr10	124736183	rs11245345	0.22478	NA	NR	NR	NR	NA	AC068896.3	Gene-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr10	124771186	rs11245363	0.0723	METTL10	NR	NR	NR	NA	AC068896.3	SNP-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr10	124771186	rs11245363	0.58042	NA	NR	NR	NR	NA	AC068896.3	Gene-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr10	124813572	rs2277263	0.124	FAM175B	NR	NR	NR	NA	ABRAXAS2	SNP-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr10	124813572	rs2277263	0.82717	NA	NR	NR	NR	NA	ABRAXAS2	Gene-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr10	126145997	rs11244841	0.00339	ADAM12	NR	NR	NR	NA	ADAM12	SNP-based	Disease risk	19118814	Caucasian	"CAP, Reiman et al.(2007)"	NR	All	LOAD	AD	intron_variant
chr10	126145997	rs11244841	0.0438	ADAM12	NR	NR	NR	NA	ADAM12	SNP-based	Disease risk	19118814	Caucasian	CAP	458	All	LOAD	AD	intron_variant
chr10	126145997	rs11244841	0.0455	ADAM12	NR	NR	NR	NA	ADAM12	SNP-based	Disease risk	19118814	Caucasian	Reiman et al.(2007)	NR	All	LOAD	AD	intron_variant
chr10	128643917	rs1575951	0.00000401	LINC01163	NR	NR	NR	NA	MKI67	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	818	All	Plasma Clusterin	Fluid biomarker	intergenic_region
chr10	129852137	rs11016976	0.001	EBF3	NR	NR	1.08	1.08	EBF3	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	3870	All	LOAD	AD	intron_variant
chr10	129852137	rs11016976	0.024	EBF3	NR	NR	NR	NA	EBF3	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	720	All	LOAD	AD	intron_variant
chr10	129852137	rs11016976	0.033	EBF3	NR	NR	NR	NA	EBF3	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	1146	All	LOAD	AD	intron_variant
chr10	129852137	rs11016976	0.05	EBF3	NR	NR	NR	NA	EBF3	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	776	All	LOAD	AD	intron_variant
chr10	129852137	rs11016976	0.294	EBF3	NR	NR	NR	NA	EBF3	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	570	All	LOAD	AD	intron_variant
chr10	129852137	rs11016976	0.966	EBF3	NR	NR	NR	NA	EBF3	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	658	All	LOAD	AD	intron_variant
chr11	924904	rs10794342	0.00000445	AP2A2	C	C	0.82	0.82	AP2A2	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	17480	Plan 1 (males and females)	AD	AD	non_coding_transcript_exon_variant
chr11	986185	rs7396366	0.00000068	AP2A2	C	C	0.94	0.94	AP2A2	SNP-based	Disease risk	25862742	Caucasian	"deCODE, DemGene, IGAP"	143878	All	AD	AD	intron_variant
chr11	986185	rs7396366	0.00000289	AP2A2	C	C	0.93	0.93	AP2A2	SNP-based	Disease risk	25862742	Caucasian	IGAP	74046	All	AD	AD	intron_variant
chr11	986185	rs7396366	0.21	AP2A2	C	C	0.92	0.92	AP2A2	SNP-based	Disease risk	25862742	Caucasian	DemGene	2015	All	AD	AD	intron_variant
chr11	986185	rs7396366	0.22	AP2A2	C	C	0.96	0.96	AP2A2	SNP-based	Disease risk	25862742	Caucasian	deCODE	67817	All	AD	AD	intron_variant
chr11	991530	rs6597951	0.0000294	AP2A2	C	C	NR	NA	AP2A2	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr11	991530	rs6597951	0.000138	AP2A2	C	C	NR	NA	AP2A2	SNP-based	Cross phenotype 	30413934	Caucasian	GIANT	681275	All	Body-mass index (BMI)	Non-ADRD	intron_variant
chr11	991530	rs6597951	0.17	AP2A2	C	C	1	1	AP2A2	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr11	2716675	rs2283202	0.0000093	KCNQ1	NR	NR	NR	NA	KCNQ1	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr11	4685804	rs58655671	0.00000991	OR51E2	NR	NR	NR	NA	OR51E2	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	818	All	Plasma Clusterin	Fluid biomarker	5_prime_UTR_variant
chr11	8308071	rs4363584	0.0000306	NR	NR	NR	0.48	0.48	LMO1	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	282	All women	LOAD	AD	intergenic_region
chr11	8308071	rs4363584	0.000924	NR	NR	NR	0.55	0.55	LMO1	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	282	All women	LOAD	AD	intergenic_region
chr11	8308071	rs4363584	0.0129	NR	NR	NR	0.59	0.59	LMO1	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	282	All women	LOAD	AD	intergenic_region
chr11	8308071	rs4363584	0.205	NR	NR	NR	0.72	0.72	LMO1	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	235	All women	LOAD	AD	intergenic_region
chr11	8583046	rs4929949	0.565	NR	C	C	1.01	1.01	STK33	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	intron_variant
chr11	8583046	rs4929949	0.63	NR	C	C	1.02	1.02	STK33	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	intron_variant
chr11	8583046	rs4929949	0.709	NR	C	C	0.001	1.001	STK33	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	intron_variant
chr11	8583046	rs4929949	0.784	NR	C	C	1.01	1.01	STK33	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	intron_variant
chr11	11841863	rs12418935	0.0000011	NR	A	A	0.62	1.85893	USP47	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	363	AD subjects	CSF P-tau181p	Fluid biomarker	5_prime_UTR_variant
chr11	11841863	rs12418935	0.0021	NR	A	A	0.26	1.29693	USP47	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	878	AD subjects	CSF P-tau181p	Fluid biomarker	5_prime_UTR_variant
chr11	11841863	rs12418935	0.65	NR	A	A	-0.05	0.951229	USP47	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	515	AD subjects	CSF P-tau181p	Fluid biomarker	5_prime_UTR_variant
chr11	18074035	rs7106970	0.000588	SAAL1	C	C	NR	NA	SAAL1	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	intron_variant
chr11	18074035	rs7106970	1.15E-43	NR	C	C	NR	NA	SAAL1	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	SAAL1 (ENSG00000166788) expression	Expression	intron_variant
chr11	18099100	rs11024482	0.00021	SAAL1	C	C	NR	NA	SAAL1	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	intron_variant
chr11	18099100	rs11024482	2.25E-89	NR	C	C	NR	NA	SAAL1	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	SAAL1 (ILMN_1658678) expression	Expression	intron_variant
chr11	26640999	rs4497357	0.00000852	NR	A	A	NR	NA	ANO3	SNP-based	Disease risk	21390209	Caucasian	"ADNI, GenADA, Pfizer"	3595	All	AD	AD	intron_variant
chr11	26673295	rs4551716	0.0000083	NR	C	C	NR	NA	SLC5A12	SNP-based	Disease risk	21390209	Caucasian	"ADNI, GenADA, Pfizer"	3595	All	AD	AD	intron_variant
chr11	27638228	rs11030094	0.021	BDNF	NR	NR	NR	NA	BDNF	SNP-based	Endophenotype	24086677	Caucasian	ADNI	127	Normal controls	1-Year ADAS change	Cognitive	intron_variant
chr11	27638228	rs11030094	0.048	BDNF	NR	NR	NR	NA	BDNF	SNP-based	Endophenotype	24086677	Caucasian	ADNI	127	Normal controls	2-Year Normalized Whole Brain Volume	Imaging	intron_variant
chr11	27638228	rs11030094	0.056	BDNF	NR	NR	NR	NA	BDNF	SNP-based	Endophenotype	24086677	Caucasian	ADNI	127	Normal controls	Baseline Right Normalized hippocampal volume	Imaging	intron_variant
chr11	27638228	rs11030094	0.805	BDNF	NR	NR	1.62	NA	BDNF	SNP-based	Disease risk	24086677	Caucasian	ADNI	329	All	AD	AD	intron_variant
chr11	27645655	rs925946	0.355	BDNF	NR	NR	4.4	NA	BDNF	SNP-based	Disease risk	24086677	Caucasian	ADNI	329	All	AD	AD	intron_variant
chr11	27648561	rs10501087	0.048	BDNF	NR	NR	NR	NA	BDNF	SNP-based	Endophenotype	24086677	Caucasian	ADNI	127	Normal controls	2-Year Right Hippo Atrophy	Imaging	intron_variant
chr11	27648561	rs10501087	0.32	BDNF	NR	NR	2.33	NA	BDNF	SNP-based	Disease risk	24086677	Caucasian	ADNI	329	All	AD	AD	intron_variant
chr11	27649363	rs2203877	0.622	BDNF	NR	NR	0.95	NA	BDNF	SNP-based	Disease risk	24086677	Caucasian	ADNI	329	All	AD	AD	intron_variant
chr11	27658369	rs6265	0.027	BDNF	NR	NR	NR	NA	BDNF	SNP-based	Endophenotype	24086677	Caucasian	ADNI	127	Normal controls	2-Year Right Hippo Atrophy	Imaging	missense_variant
chr11	27658369	rs6265	0.428	BDNF	NR	NR	1.31	NA	BDNF	SNP-based	Disease risk	24086677	Caucasian	ADNI	329	All	AD	AD	missense_variant
chr11	27658369	rs6265	0.433	BDNF	T	T	0.93	0.93	BDNF	SNP-based	Disease risk	20534741	Caucasian	"ADC, UM"	1610	All	AD	AD	missense_variant
chr11	27662970	rs11030104	0.278	BDNF	NR	NR	2.56	NA	BDNF	SNP-based	Disease risk	24086677	Caucasian	ADNI	329	All	AD	AD	intron_variant
chr11	27673917	rs11030108	0.028	BDNF	NR	NR	NR	NA	BDNF	SNP-based	Endophenotype	24086677	Caucasian	ADNI	179	MCI	1-Year ADAS change	Cognitive	intron_variant
chr11	27673917	rs11030108	0.687	BDNF	NR	NR	0.75	NA	BDNF	SNP-based	Disease risk	24086677	Caucasian	ADNI	329	All	AD	AD	intron_variant
chr11	27679818	rs10835211	0.765	BDNF	NR	NR	0.54	NA	BDNF	SNP-based	Disease risk	24086677	Caucasian	ADNI	329	All	AD	AD	intron_variant
chr11	27704439	rs10767664	0.688	NR	A	A	1.02	1.02	BDNF	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	intron_variant
chr11	27704439	rs10767664	0.83	NR	A	A	0	1	BDNF	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	intron_variant
chr11	27704439	rs10767664	0.943	NR	A	A	1	1	BDNF	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	intron_variant
chr11	27710436	rs7934165	0.773	BDNF	NR	NR	1.8	NA	BDNF	SNP-based	Disease risk	24086677	Caucasian	ADNI	329	All	AD	AD	intron_variant
chr11	27723312	rs12273363	0.725	BDNF	NR	NR	0.41	NA	BDNF	SNP-based	Disease risk	24086677	Caucasian	ADNI	329	All	AD	AD	intron_variant
chr11	27724217	rs908867	0.01	BDNF	NR	NR	NR	NA	BDNF	SNP-based	Endophenotype	24086677	Caucasian	ADNI	381	All	2-Year Right Hippo Atrophy	Imaging	intron_variant
chr11	27724217	rs908867	0.025	BDNF	NR	NR	NR	NA	BDNF	SNP-based	Cross phenotype 	24086677	Caucasian	ADNI	75	AD	2-Year Right Hippo Atrophy	Imaging	intron_variant
chr11	27724217	rs908867	0.512	BDNF	NR	NR	0.31	NA	BDNF	SNP-based	Disease risk	24086677	Caucasian	ADNI	329	All	AD	AD	intron_variant
chr11	27728178	rs1491850	0.048	BDNF	NR	NR	NR	NA	BDNF	SNP-based	Cross phenotype 	24086677	Caucasian	ADNI	75	AD	2-Year Left Hippo Atrophy	Imaging	intron_variant
chr11	27728178	rs1491850	0.6	BDNF	NR	NR	0.87	NA	BDNF	SNP-based	Disease risk	24086677	Caucasian	ADNI	329	All	AD	AD	intron_variant
chr11	27736075	rs1157659	0.012	BDNF	NR	NR	NR	NA	BDNF	SNP-based	Endophenotype	24086677	Caucasian	ADNI	179	MCI	Baseline ADAS (total 11 cognitive score)	Cognitive	intron_variant
chr11	27736075	rs1157659	0.025	BDNF	NR	NR	NR	NA	BDNF	SNP-based	Endophenotype	24086677	Caucasian	ADNI	127	Normal controls	2-Year Left Hippo Atrophy	Imaging	intron_variant
chr11	27736075	rs1157659	0.025	BDNF	NR	NR	NR	NA	BDNF	SNP-based	Endophenotype	24086677	Caucasian	ADNI	381	All	Baseline ADAS (total 11 cognitive score)	Cognitive	intron_variant
chr11	27736075	rs1157659	0.341	BDNF	NR	NR	0.5	NA	BDNF	SNP-based	Disease risk	24086677	Caucasian	ADNI	329	All	AD	AD	intron_variant
chr11	31796571	rs113859447	0.222	PAX6	NR	NR	NR	NA	PAX6	SNP-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr11	31796571	rs113859447	0.8971	NA	NR	NR	NR	NA	PAX6	Gene-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr11	45688426	rs1447575	0.000000642	"CHST1, MIR7154"	T	T	0.51	0.51	CHST1	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	intergenic_region
chr11	45689102	rs1447576	0.000000546	"CHST1, MIR7154"	G	G	0.51	0.51	CHST1	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	intergenic_region
chr11	45689480	rs2666895	0.000000448	"CHST1, MIR7154"	G	G	0.5	0.5	CHST1	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	intergenic_region
chr11	45818338	rs12805422	0.000338	"C11orf94, CRY2, MAPK8IP1, PEX16"	NR	NR	0.06	1.06184	SLC35C1	SNP-based	Cross phenotype 	30805717	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr11	45818338	rs12805422	9.55E-13	"C11orf94, CRY2, MAPK8IP1, PEX16"	NR	NR	-0.02	0.980199	SLC35C1	SNP-based	Cross phenotype 	30805717	Caucasian	MAGIC	58047	All	Fasting Glucose	Fluid biomarker	intron_variant
chr11	46890405	rs138878258	0.17	LRP4	NR	NR	NR	NA	LRP4	SNP-based	Disease risk	25172201	African American	ADGC	816	All	AD	AD	missense_variant
chr11	47210487	rs11039131	0.000000701	DDB2	T	T	0.93	0.93	DDB2	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	upstream_gene_variant
chr11	47210487	rs11039131	0.00000518	DDB2	T	T	0.94	0.94	DDB2	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	upstream_gene_variant
chr11	47210487	rs11039131	0.0000408	DDB2	T	T	NR	NA	DDB2	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	upstream_gene_variant
chr11	47210487	rs11039131	0.0000855	DDB2	T	T	NR	NA	DDB2	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Total triglycerides (TG)	Non-ADRD	upstream_gene_variant
chr11	47210487	rs11039131	0.0218	DDB2	T	T	0.88	0.88	DDB2	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	upstream_gene_variant
chr11	47210487	rs11039131	0.0334	DDB2	T	T	1	1	DDB2	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	upstream_gene_variant
chr11	47272248	rs10501320	0.00000298	"ACP2,AGBL2,AMBRA1,ARFGAP2,ARHGAP1,ATG13,C1QTNF4,C11orf49,CELF1,CHRM4,CKAP5,CREB3L1,DDB2,DGKZ,F2,FAM180B,FNBP4,HARBI1,KBTBD4,LRP4,LRP4-AS1,MADD, MDK, MIR3160-1, MIR3160-2, MIR4688, MIR5582, MIR6745, MTCH2, MYBPC3, NDUFS3, NR1H3,NUP160,PACSIN3,PSMC3,PTPMT1,PTPRJ,RAPSN,SLC39A13,SNORD67,SPI1,ZNF408"	NR	NR	0.08	1.08329	MADD	SNP-based	Cross phenotype 	30805717	Caucasian	IGAP	54162	All	AD	AD	5_prime_UTR_variant
chr11	47272248	rs10501320	7.11E-13	"ACP2,AGBL2,AMBRA1,ARFGAP2,ARHGAP1,ATG13,C1QTNF4,C11orf49,CELF1,CHRM4,CKAP5,CREB3L1,DDB2,DGKZ,F2,FAM180B,FNBP4,HARBI1,KBTBD4,LRP4,LRP4-AS1,MADD, MDK, MIR3160-1, MIR3160-2, MIR4688, MIR5582, MIR6745, MTCH2, MYBPC3, NDUFS3, NR1H3,NUP160,PACSIN3,PSMC3,PTPMT1,PTPRJ,RAPSN,SLC39A13,SNORD67,SPI1,ZNF408"	NR	NR	-0.03	0.970446	MADD	SNP-based	Cross phenotype 	30805717	Caucasian	MAGIC	58047	All	Fasting Glucose	Fluid biomarker	5_prime_UTR_variant
chr11	47343648	rs2856650	0.00000407	MYBPC3	NR	NR	NR	NA	MYBPC3	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr11	47349406	rs2071305	0.000000253	MYBPC3	C	C	NR	NA	MYBPC3	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	High-density lipoprotein (HDL)	Non-ADRD	intron_variant
chr11	47349406	rs2071305	0.00000154	MYBPC3	C	C	0.93	0.93	MYBPC3	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intron_variant
chr11	47349406	rs2071305	0.00000301	MYBPC3	C	C	NR	NA	MYBPC3	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr11	47349406	rs2071305	0.00112	MYBPC3	C	C	0.83	0.83	MYBPC3	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intron_variant
chr11	47349406	rs2071305	5.62E-08	MYBPC3	C	C	0.93	0.93	MYBPC3	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intron_variant
chr11	47358789	rs3740688	0.0012	SPI1	G	G	0.93	0.93	SPI1	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	18845	All	Clinically diagnosed LOAD	AD	missense_variant
chr11	47358789	rs3740688	0.00158	SPI1	NR	NR	0.07	NA	SPI1	SNP-based	Age at onset (AAO) / Survival	28323831	Caucasian	ADGC	15795	All	Age of AD onset	Other	missense_variant
chr11	47358789	rs3740688	5.40E-13	SPI1	G	G	0.92	0.92	SPI1	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	82771	All	Clinically diagnosed LOAD	AD	missense_variant
chr11	47358789	rs3740688	9.70E-11	SPI1	G	G	0.91	0.91	SPI1	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	63926	All	Clinically diagnosed LOAD	AD	missense_variant
chr11	47372754	rs896817	0.00000756	SPI1	NR	NR	NR	NA	SPI1	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr11	47389337	rs10838702	0.00000898	"SLC39A13, SPI1"	NR	NR	NR	NA	SPI1	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr11	47398112	rs1534576	0.00000321	SLC39A13	T	T	NR	NA	SLC39A13	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr11	47398112	rs1534576	0.000746	SLC39A13	T	T	1.01	1.01	SLC39A13	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr11	47398112	rs1534576	0.00703	SLC39A13	T	T	1.14	1.14	SLC39A13	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intron_variant
chr11	47398112	rs1534576	1.49E-09	SLC39A13	T	T	1.08	1.08	SLC39A13	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intron_variant
chr11	47398112	rs1534576	2.97E-08	SLC39A13	T	T	1.08	1.08	SLC39A13	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intron_variant
chr11	47398112	rs1534576	6.62E-08	SLC39A13	T	T	NR	NA	SLC39A13	SNP-based	Cross phenotype 	30413934	Caucasian	GIANT	681275	All	Body-mass index (BMI)	Non-ADRD	intron_variant
chr11	47413435	rs2293576	0.24	CELF1	NR	NR	1.03	1.03	SLC39A13	SNP-based	Disease risk	30448613	Caucasian	ADGC	15330	All	AD	AD	synonymous_variant
chr11	47425795	rs10838709	0.0000156	PSMC3	NR	NR	NR	NA	PSMC3	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr11	47518145	rs4752845	0.0537	CELF1	A	A	0.87	NA	CELF1	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	intron_variant
chr11	47536319	rs10838725	0.000000011	CELF1	C	C	1.08	1.08	CELF1	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD, Cohorts from Europe and USA"	74046	All	LOAD	AD	intron_variant
chr11	47536319	rs10838725	0.000000107	CELF1	NR	NR	0.14	1.15027	CELF1	SNP-based	eQTL	30448613	Caucasian	ADNI	763	All	MYBPC3 (11725151_at) expression in blood	Expression	intron_variant
chr11	47536319	rs10838725	0.0000067	CELF1	C	C	1.08	1.08	CELF1	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD"	54162	All	LOAD	AD	intron_variant
chr11	47536319	rs10838725	0.00029	FNBP4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	FNBP4 (3372515) expression in occipital cortex (OCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.00036	FNBP4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	FNBP4 (t3372459) expression in medulla (MEDU)	Expression	intron_variant
chr11	47536319	rs10838725	0.00041	CELF1	C	C	1.09	1.09	CELF1	SNP-based	Disease risk	24162737	Caucasian	Cohorts from Europe and USA	19884	All	LOAD	AD	intron_variant
chr11	47536319	rs10838725	0.00051	FNBP4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	FNBP4 (3372515) expression in hippocampus (HIPP)	Expression	intron_variant
chr11	47536319	rs10838725	0.00091	NUP160	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	NUP160 (3372006) expression in medulla (MEDU)	Expression	intron_variant
chr11	47536319	rs10838725	0.00091	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372006) expression in medulla (MEDU)	Expression	intron_variant
chr11	47536319	rs10838725	0.0011	KBTD4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	KBTD4 (3372337) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr11	47536319	rs10838725	0.0012	CELF1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CELF1 (t3372253) expression in thalamus (THAL)	Expression	intron_variant
chr11	47536319	rs10838725	0.0013	FNBP4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	FNBP4 (3372495) expression in thalamus (THAL)	Expression	intron_variant
chr11	47536319	rs10838725	0.0014	MTCH2	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	MTCH2 (3372370) expression in medulla (MEDU)	Expression	intron_variant
chr11	47536319	rs10838725	0.0023	CELF1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CELF1 (3372283) expression in medulla (MEDU)	Expression	intron_variant
chr11	47536319	rs10838725	0.0025	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372007) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr11	47536319	rs10838725	0.0026	NDUFS3	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	NDUFS3 (3329922) expression in medulla (MEDU)	Expression	intron_variant
chr11	47536319	rs10838725	0.0033	FNBP4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	FNBP4 (3372495) expression in medulla (MEDU)	Expression	intron_variant
chr11	47536319	rs10838725	0.0039	FNBP4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	FNBP4 (t3372459) expression in thalamus (THAL)	Expression	intron_variant
chr11	47536319	rs10838725	0.004	CELF1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CELF1 (t3372253) expression in medulla (MEDU)	Expression	intron_variant
chr11	47536319	rs10838725	0.0059	MADD	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	MADD (3329744) expression in medulla (MEDU)	Expression	intron_variant
chr11	47536319	rs10838725	0.0067	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372037) expression in thalamus (THAL)	Expression	intron_variant
chr11	47536319	rs10838725	0.0072	MTCH2	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	MTCH2 (3372370) expression in thalamus (THAL)	Expression	intron_variant
chr11	47536319	rs10838725	0.0079	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372066) expression in temporal cortex (TCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.0095	MTCH2	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	MTCH2 (3372370) expression in temporal cortex (TCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.01	CELF1	C	C	1.14	1.14	CELF1	SNP-based	Disease risk	26339675	Caribbean Hispanic	"EFIGA, NOMAS, WHICAP "	4514	All	LOAD	AD	intron_variant
chr11	47536319	rs10838725	0.019	CELF1	C	C	1.14	1.14	CELF1	SNP-based	Disease risk	26339675	Caribbean Hispanic	"EFIGA, NOMAS, WHICAP "	4514	All	LOAD	AD	intron_variant
chr11	47536319	rs10838725	0.02	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372037) expression in medulla (MEDU)	Expression	intron_variant
chr11	47536319	rs10838725	0.03	FNBP4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	FNBP4 (3372515) expression in thalamus (THAL)	Expression	intron_variant
chr11	47536319	rs10838725	0.04	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372066) expression in medulla (MEDU)	Expression	intron_variant
chr11	47536319	rs10838725	0.054	CELF1	NR	NR	1.05	1.05	CELF1	SNP-based	Disease risk	30448613	Caucasian	ADGC	15330	All	AD	AD	intron_variant
chr11	47536319	rs10838725	0.06	MTCH2	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	MTCH2 (3372370) expression in hippocampus (HIPP)	Expression	intron_variant
chr11	47536319	rs10838725	0.07	FNBP4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	FNBP4 (3372515) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr11	47536319	rs10838725	0.07	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372007) expression in thalamus (THAL)	Expression	intron_variant
chr11	47536319	rs10838725	0.1	FNBP4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	FNBP4 (3372495) expression in occipital cortex (OCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.1	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372037) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr11	47536319	rs10838725	0.11	NDUFS3	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	NDUFS3 (3329922) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr11	47536319	rs10838725	0.12	CELF1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CELF1 (3372283) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr11	47536319	rs10838725	0.12	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372066) expression in hippocampus (HIPP)	Expression	intron_variant
chr11	47536319	rs10838725	0.13	FNBP4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	FNBP4 (t3372459) expression in occipital cortex (OCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.13	MTCH2	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	MTCH2 (3372370) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr11	47536319	rs10838725	0.13	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372007) expression in temporal cortex (TCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.14	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372007) expression in hippocampus (HIPP)	Expression	intron_variant
chr11	47536319	rs10838725	0.14	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372037) expression in temporal cortex (TCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.15	NDUFS3	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	NDUFS3 (3329922) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr11	47536319	rs10838725	0.16	FNBP4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	FNBP4 (3372495) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr11	47536319	rs10838725	0.16	FNBP4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	FNBP4 (3372515) expression in medulla (MEDU)	Expression	intron_variant
chr11	47536319	rs10838725	0.16	KBTD4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	KBTD4 (3372337) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr11	47536319	rs10838725	0.17	MTCH2	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	MTCH2 (3372370) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr11	47536319	rs10838725	0.19	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372037) expression in occipital cortex (OCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.2	MTCH2	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	MTCH2 (3372370) expression in occipital cortex (OCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.21	NDUFS3	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	NDUFS3 (3329922) expression in thalamus (THAL)	Expression	intron_variant
chr11	47536319	rs10838725	0.22	FNBP4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	FNBP4 (3372515) expression in temporal cortex (TCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.24	FNBP4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	FNBP4 (t3372459) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr11	47536319	rs10838725	0.25	CELF1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CELF1 (3372283) expression in thalamus (THAL)	Expression	intron_variant
chr11	47536319	rs10838725	0.26	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372007) expression in medulla (MEDU)	Expression	intron_variant
chr11	47536319	rs10838725	0.27	NDUFS3	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	NDUFS3 (3329922) expression in occipital cortex (OCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.28	CELF1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CELF1 (t3372253) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr11	47536319	rs10838725	0.29	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372007) expression in substantia nigra (SNIG)	Expression	intron_variant
chr11	47536319	rs10838725	0.31	NUP160	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	NUP160 (3372006) expression in frontal cortex (FCTX) 	Expression	intron_variant
chr11	47536319	rs10838725	0.31	NUP160	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	NUP160 (3372006) expression in thalamus (THAL)	Expression	intron_variant
chr11	47536319	rs10838725	0.31	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372006) expression in frontal cortex (FCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.31	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372006) expression in thalamus (THAL)	Expression	intron_variant
chr11	47536319	rs10838725	0.32	CELF1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CELF1 (3372283) expression in hippocampus (HIPP)	Expression	intron_variant
chr11	47536319	rs10838725	0.32	MTCH2	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	MTCH2 (3372370) expression in putamen (PUTM)	Expression	intron_variant
chr11	47536319	rs10838725	0.34	NDUFS3	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	NDUFS3 (3329922) expression in temporal cortex (TCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.34	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372007) expression in occipital cortex (OCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.36	MADD	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	MADD (3329744) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr11	47536319	rs10838725	0.39	NUP160	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	NUP160 (3372006) expression in occipital cortex (OCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.39	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372006) expression in occipital cortex (OCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.4	FNBP4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	FNBP4 (3372495) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr11	47536319	rs10838725	0.4	MADD	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	MADD (3329744) expression in putamen (PUTM)	Expression	intron_variant
chr11	47536319	rs10838725	0.4	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372037) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr11	47536319	rs10838725	0.41	FNBP4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	FNBP4 (3372495) expression in putamen (PUTM)	Expression	intron_variant
chr11	47536319	rs10838725	0.43	CELF1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CELF1 (3372283)  expression in frontal cortex (FCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.43	FNBP4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	FNBP4 (t3372459) expression in temporal cortex (TCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.46	CELF1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CELF1 (t3372253) expression in temporal cortex (TCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.46	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372007) expression in putamen (PUTM)	Expression	intron_variant
chr11	47536319	rs10838725	0.49	MADD	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	MADD (3329744) expression in temporal cortex (TCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.51	FNBP4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	FNBP4 (3372495) expression in hippocampus (HIPP)	Expression	intron_variant
chr11	47536319	rs10838725	0.52	MADD	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	MADD (3329744) expression in thalamus (THAL)	Expression	intron_variant
chr11	47536319	rs10838725	0.55	vPTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	vPTPMT1 (3372066) expression in thalamus (THAL)	Expression	intron_variant
chr11	47536319	rs10838725	0.56	FNBP4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	FNBP4 (3372515) expression in frontal cortex (FCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.57	CELF1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CELF1 (3372283) expression in occipital cortex (OCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.57	MADD	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	MADD (3329744) expression in frontal cortex (FCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.6	MTCH2	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	MTCH2 (3372370) expression in substantia nigra (SNIG)	Expression	intron_variant
chr11	47536319	rs10838725	0.61	MADD	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	MADD (3329744) expression in occipital cortex (OCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.61	NUP160	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	NUP160 (3372006) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr11	47536319	rs10838725	0.61	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372006) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr11	47536319	rs10838725	0.62	CELF1	C	C	0.97	0.97	CELF1	SNP-based	Endophenotype	25188341	Caucasian	ADGC	4914	All	Clinico-pathologic AD dementia (No neuropathologist documentation)	Neuropathology	intron_variant
chr11	47536319	rs10838725	0.65	NUP160	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	NUP160 (3372006) expression in substantia nigra (SNIG)	Expression	intron_variant
chr11	47536319	rs10838725	0.65	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372006) expression in substantia nigra (SNIG)	Expression	intron_variant
chr11	47536319	rs10838725	0.66	FNBP4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	FNBP4 (3372495) expression in substantia nigra (SNIG)	Expression	intron_variant
chr11	47536319	rs10838725	0.66	FNBP4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	FNBP4 (t3372459) expression in substantia nigra (SNIG)	Expression	intron_variant
chr11	47536319	rs10838725	0.67	FNBP4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	FNBP4 (3372495) expression in temporal cortex (TCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.67	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372037) expression in putamen (PUTM)	Expression	intron_variant
chr11	47536319	rs10838725	0.67	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372066) expression in putamen (PUTM)	Expression	intron_variant
chr11	47536319	rs10838725	0.68	CELF1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CELF1 (t3372253) expression in hippocampus (HIPP)	Expression	intron_variant
chr11	47536319	rs10838725	0.68	NUP160	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	NUP160 (3372006) expression in hippocampus (HIPP)	Expression	intron_variant
chr11	47536319	rs10838725	0.68	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372006) expression in hippocampus (HIPP)	Expression	intron_variant
chr11	47536319	rs10838725	0.7	KBTD4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	KBTD4 (3372337) expression in putamen (PUTM)	Expression	intron_variant
chr11	47536319	rs10838725	0.71	CELF1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CELF1 (t3372253) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr11	47536319	rs10838725	0.72	FNBP4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	FNBP4 (t3372459) expression in putamen (PUTM)	Expression	intron_variant
chr11	47536319	rs10838725	0.72	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372007) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr11	47536319	rs10838725	0.74	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372037) expression in hippocampus (HIPP)	Expression	intron_variant
chr11	47536319	rs10838725	0.75	KBTD4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	KBTD4 (3372337) expression in frontal cortex (FCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.76	KBTD4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	KBTD4 (3372337) expression in medulla (MEDU)	Expression	intron_variant
chr11	47536319	rs10838725	0.76	NDUFS3	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	NDUFS3 (3329922) expression in frontal cortex (FCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.77	FNBP4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	FNBP4 (3372515) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr11	47536319	rs10838725	0.77	NUP160	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	NUP160 (3372006) expression in temporal cortex (TCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.77	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372006) expression in temporal cortex (TCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.78	MTCH2	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	MTCH2 (3372370) expression in frontal cortex (FCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.78	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372037) expression in substantia nigra (SNIG)	Expression	intron_variant
chr11	47536319	rs10838725	0.79	FNBP4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	FNBP4 (3372495) expression in frontal cortex (FCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.8	CELF1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CELF1 (3372283) expression in temporal cortex (TCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.8	CELF1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CELF1 (t3372253) expression in substantia nigra (SNIG)	Expression	intron_variant
chr11	47536319	rs10838725	0.81	CELF1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CELF1 (3372283) expression in substantia nigra (SNIG)	Expression	intron_variant
chr11	47536319	rs10838725	0.82	KBTD4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	KBTD4 (3372337) expression in occipital cortex (OCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.83	CELF1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CELF1 (t3372253)  expression in frontal cortex (FCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.83	FNBP4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	FNBP4 (3372515) expression in substantia nigra (SNIG)	Expression	intron_variant
chr11	47536319	rs10838725	0.84	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372066) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr11	47536319	rs10838725	0.85	CELF1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CELF1 (3372283) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr11	47536319	rs10838725	0.86	CELF1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CELF1 (t3372253) expression in occipital cortex (OCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.86	CELF1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CELF1 (t3372253) expression in putamen (PUTM)	Expression	intron_variant
chr11	47536319	rs10838725	0.86	FNBP4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	FNBP4 (t3372459) expression in hippocampus (HIPP)	Expression	intron_variant
chr11	47536319	rs10838725	0.86	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372037) expression in frontal cortex (FCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.86	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372066) expression in frontal cortex (FCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.88	CELF1	C	C	0.99	0.99	CELF1	SNP-based	Endophenotype	25188341	Caucasian	ADGC	3702	All	Clinico-pathologic AD dementia (with neuropathologist documentation)	Neuropathology	intron_variant
chr11	47536319	rs10838725	0.88	NDUFS3	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	NDUFS3 (3329922) expression in substantia nigra (SNIG)	Expression	intron_variant
chr11	47536319	rs10838725	0.89	CELF1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CELF1 (3372283) expression in putamen (PUTM)	Expression	intron_variant
chr11	47536319	rs10838725	0.9	KBTD4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	KBTD4 (3372337) expression in thalamus (THAL)	Expression	intron_variant
chr11	47536319	rs10838725	0.9	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372066) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr11	47536319	rs10838725	0.91	KBTD4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	KBTD4 (3372337) expression in temporal cortex (TCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.92	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372007) expression in frontal cortex (FCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.93	KBTD4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	KBTD4 (3372337) expression in hippocampus (HIPP)	Expression	intron_variant
chr11	47536319	rs10838725	0.93	NDUFS3	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	NDUFS3 (3329922) expression in putamen (PUTM)	Expression	intron_variant
chr11	47536319	rs10838725	0.93	NUP160	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	NUP160 (3372006) expression in putamen (PUTM)	Expression	intron_variant
chr11	47536319	rs10838725	0.93	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372006) expression in putamen (PUTM)	Expression	intron_variant
chr11	47536319	rs10838725	0.94	FNBP4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	FNBP4 (3372515) expression in putamen (PUTM)	Expression	intron_variant
chr11	47536319	rs10838725	0.95	FNBP4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	FNBP4 (t3372459) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr11	47536319	rs10838725	0.96	FNBP4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	FNBP4 (t3372459) expression in frontal cortex (FCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.96	NDUFS3	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	NDUFS3 (3329922) expression in hippocampus (HIPP)	Expression	intron_variant
chr11	47536319	rs10838725	0.96	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372066) expression in occipital cortex (OCTX)	Expression	intron_variant
chr11	47536319	rs10838725	0.97	MADD	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	MADD (3329744) expression in hippocampus (HIPP)	Expression	intron_variant
chr11	47536319	rs10838725	0.98	CELF1	NR	NR	1.01	1.01	CELF1	SNP-based	Endophenotype	26993346	Caucasian	Cohort from Europe	10840	All	PCA (posterior cortical atrophy)	Imaging	intron_variant
chr11	47536319	rs10838725	0.98	NUP160	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	NUP160 (3372006) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr11	47536319	rs10838725	0.98	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372006) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr11	47536319	rs10838725	0.99	MADD	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	MADD (3329744) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr11	47536319	rs10838725	0.99	MADD	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	MADD (3329744) expression in substantia nigra (SNIG)	Expression	intron_variant
chr11	47536319	rs10838725	1	KBTD4	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	KBTD4 (3372337) expression in substantia nigra (SNIG)	Expression	intron_variant
chr11	47536319	rs10838725	1	PTPMT1	NR	NR	NR	NA	CELF1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PTPMT1 (3372066) expression in substantia nigra (SNIG)	Expression	intron_variant
chr11	47536319	rs10838725	NR	CELF1	C	C	0.99	0.99	CELF1	SNP-based	Disease risk	27849641	Caucasian	ADGC	589	All	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr11	47536319	rs10838725	NR	ZCWPW1	C	C	0.7	0.7	CELF1	SNP-based	Disease risk	27849641	Caucasian	ADGC	292	APOE-e4 carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr11	47536319	rs10838725	NR	ZCWPW1	C	C	1.14	1.14	CELF1	SNP-based	Disease risk	27849641	Caucasian	ADGC	297	APOE-e4 non-carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr11	47544800	rs7928842	0.0000875	CELF1	C	C	NR	NA	CELF1	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr11	47544800	rs7928842	0.825	CELF1	C	C	1	1	CELF1	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr11	47544800	rs7928842	3.19E-24	CELF1	C	C	NR	NA	CELF1	SNP-based	Cross phenotype 	30413934	Caucasian	GIANT	681275	All	Body-mass index (BMI)	Non-ADRD	intron_variant
chr11	47559891	rs11039297	0.0000124	PTPMT1	A	A	NR	NA	CELF1	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr11	47559891	rs11039297	0.0000515	PTPMT1	A	A	NR	NA	CELF1	SNP-based	Cross phenotype 	30413934	Caucasian	"GIANT, UKBB"	180423	All	Waist-to-hip ratio (WHR)	Non-ADRD	intron_variant
chr11	47559891	rs11039297	0.028	PTPMT1	A	A	1	1	CELF1	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr11	47578886	rs2280231	0.0000282	"DKFZp586K0821, NDUFS3"	C	C	NR	NA	NDUFS3	SNP-based	Cross phenotype 	27088644	Caucasian	IGAP	54162	All	AD	AD	5_prime_UTR_variant
chr11	47578886	rs2280231	0.000055	NDUFS3	C	C	NR	NA	NDUFS3	SNP-based	Cross phenotype 	27088644	Caucasian	Cohort of Immune-Mediated Diseases	16559	All	Type 1 diabetes (T1D)	Non-ADRD	5_prime_UTR_variant
chr11	47629441	rs3817334	0.007	NR	T	T	0.943	0.943	MTCH2	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	intron_variant
chr11	47629441	rs3817334	0.141	NR	T	T	0.005	1.00501	MTCH2	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	intron_variant
chr11	47629441	rs3817334	0.142	NR	T	T	1.051	1.051	MTCH2	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	intron_variant
chr11	47629441	rs3817334	0.486	NR	T	T	0.97	0.97	MTCH2	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	intron_variant
chr11	47641380	rs7120548	0.0011	MTCH2	NR	NR	0.075	1.07788	MTCH2	SNP-based	eQTL	26919393	Caucasian	"UM, NACC"	364	All	MTCH2 expression in Brain	Expression	intron_variant
chr11	48311808	rs1483121	0.00258	OR4S1	NR	NR	0.07	1.07251	OR4S1	SNP-based	Cross phenotype 	30805717	Caucasian	IGAP	54162	All	AD	AD	downstream_gene_variant
chr11	48311808	rs1483121	1.66E-09	OR4S1	NR	NR	-0.03	0.970446	OR4S1	SNP-based	Endophenotype	30805717	Caucasian	MAGIC	58047	All	Fasting Glucose	Fluid biomarker	downstream_gene_variant
chr11	49980436	rs11602981	0	NR	C	C	NR	NA	OR4C12	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	FOLH1 (ENSG00000086205) expression	Expression	downstream_gene_variant
chr11	49980436	rs11602981	0.00134	FOLH1	C	C	NR	NA	OR4C12	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	downstream_gene_variant
chr11	57589434	rs2848630	1.51E-59	TIMM10	NR	NR	-0.53	0.588605	SERPING1	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	TIMM10 expression in Cerebellar	Expression	intergenic_region
chr11	57589434	rs2848630	2.07E-30	TIMM10	NR	NR	-0.62	0.537944	SERPING1	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	TIMM10 expression in Cerebellar	Expression	intergenic_region
chr11	57589434	rs2848630	5.23E-23	TIMM10	NR	NR	-0.42	0.657047	SERPING1	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	TIMM10 expression in Cerebellar	Expression	intergenic_region
chr11	57589434	rs2848630	5.48E-65	TIMM10	NR	NR	-0.45	0.637628	SERPING1	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	TIMM10 expression in Temporal cortex	Expression	intergenic_region
chr11	58587146	rs7928565	0.0247	LPXN	C	C	NR	NA	ZFP91	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	7289	Plan 2 (only males)	AD	AD	intron_variant
chr11	58587146	rs7928565	7.17E-86	NR	C	C	NR	NA	ZFP91	SNP-based	eQTL	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	7289	Plan 2 (only males)	LPXN (ILMN_1742789) expression in peripheral blood	Expression	intron_variant
chr11	60064457	rs1286170	0.00000901	MS4A3	NR	NR	NR	NA	MS4A3	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr11	60069624	rs528823	0.00000155	MS4A3	T	T	0.79	0.79	MS4A3	SNP-based	Disease risk	24755620	Caucasian	ADGC	4569	All	AD	AD	synonymous_variant
chr11	60071148	rs474951	0.00000125	MS4A3	G	G	0.79	0.79	MS4A3	SNP-based	Disease risk	24755620	Caucasian	ADGC	4569	All	AD	AD	downstream_gene_variant
chr11	60110494	rs4939311	1.29E-09	"MS4A6A, MS4A2"	NR	NR	NR	NA	MS4A2	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr11	60132633	rs4939312	4.96E-10	"MS4A6A, MS4A2"	NR	NR	NR	NA	MS4A2	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr11	60156035	rs983392	0.00000115	MS4A6A	NR	NR	0.15	1.16183	MS4A6A	SNP-based	eQTL	30448613	Caucasian	ADNI	763	All	MS4A4A (11751570_a_at) expression in blood	Expression	downstream_gene_variant
chr11	60156035	rs983392	0.00000159	MS4A6A	NR	NR	0.179	1.19602	MS4A6A	SNP-based	eQTL	30448613	Caucasian	ADNI	763	All	MS4A4A (11732865_a_at) expression in blood	Expression	downstream_gene_variant
chr11	60156035	rs983392	0.0000045	MS4A6A	G	G	0.9	0.9	MS4A6A	SNP-based	Disease risk	24162737	Caucasian	Cohorts from Europe and USA	19884	All	LOAD	AD	downstream_gene_variant
chr11	60156035	rs983392	0.00013	MS4A4A 	G	G	0.8	0.8	MS4A6A	SNP-based	Endophenotype	25188341	Caucasian	ADGC	4914	All	Clinico-pathologic AD dementia (No neuropathologist documentation)	Neuropathology	downstream_gene_variant
chr11	60156035	rs983392	0.036	MS4A4A 	G	G	0.85	0.85	MS4A6A	SNP-based	Endophenotype	25188341	Caucasian	ADGC	3702	All	Clinico-pathologic AD dementia (with neuropathologist documentation)	Neuropathology	downstream_gene_variant
chr11	60156035	rs983392	0.71	MS4A6A	NR	NR	1.04	1.04	MS4A6A	SNP-based	Endophenotype	26993346	Caucasian	Cohort from Europe	10840	All	PCA (posterior cortical atrophy)	Imaging	downstream_gene_variant
chr11	60156035	rs983392	2.34E-12	MS4A6A	NR	NR	0.082	1.08546	MS4A6A	SNP-based	eQTL	30448613	Caucasian	ADNI	763	All	MS4A6A (11716846_a_at) expression in blood	Expression	downstream_gene_variant
chr11	60156035	rs983392	2.80E-11	MS4A6A	G	G	0.9	0.9	MS4A6A	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD"	54162	All	LOAD	AD	downstream_gene_variant
chr11	60156035	rs983392	6.10E-16	MS4A6A	G	G	0.9	0.9	MS4A6A	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD, Cohorts from Europe and USA"	74046	All	LOAD	AD	downstream_gene_variant
chr11	60156035	rs983392	7.22E-09	MS4A6A	NR	NR	0.86	0.86	MS4A6A	SNP-based	Disease risk	30448613	Caucasian	ADGC	15330	All	AD	AD	downstream_gene_variant
chr11	60156035	rs983392	NR	MS4A4A	A	A	1.29	1.29	MS4A6A	SNP-based	Disease risk	27849641	Caucasian	ADGC	589	All	Symptomatic AD (CDR global score >=0.5)	AD	downstream_gene_variant
chr11	60156035	rs983392	NR	ZCWPW1	A	A	1.19	1.19	MS4A6A	SNP-based	Disease risk	27849641	Caucasian	ADGC	297	APOE-e4 non-carriers	Symptomatic AD (CDR global score >=0.5)	AD	downstream_gene_variant
chr11	60156035	rs983392	NR	ZCWPW1	A	A	1.57	1.57	MS4A6A	SNP-based	Disease risk	27849641	Caucasian	ADGC	292	APOE-e4 carriers	Symptomatic AD (CDR global score >=0.5)	AD	downstream_gene_variant
chr11	60169453	rs7933202	0.000016	MS4A2	C	C	0.9	0.9	MS4A6A	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	18845	All	Clinically diagnosed LOAD	AD	downstream_gene_variant
chr11	60169453	rs7933202	1.90E-19	MS4A2	C	C	0.89	0.89	MS4A6A	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	82771	All	Clinically diagnosed LOAD	AD	downstream_gene_variant
chr11	60169453	rs7933202	2.20E-15	MS4A2	C	C	0.89	0.89	MS4A6A	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	63926	All	Clinically diagnosed LOAD	AD	downstream_gene_variant
chr11	60171834	rs610932	0.000000018	MS4A6A	NR	NR	0.88	0.88	MS4A6A	SNP-based	Disease risk	21460840	Caucasian	"ADC, EADI, GERAD"	20373	All	AD	AD	3_prime_UTR_variant
chr11	60171834	rs610932	0.0000014	MS4A6A	NR	NR	0.87	0.87	MS4A6A	SNP-based	Disease risk	19734902	Caucasian	Cohorts from Europe and USA	11789	All	AD	AD	3_prime_UTR_variant
chr11	60171834	rs610932	0.000021	MS4A6A	NR	NR	0.91	0.91	MS4A6A	SNP-based	Disease risk	21460840	Caucasian	"ADGC, CHARGE, EADI"	29544	All	AD	AD	3_prime_UTR_variant
chr11	60171834	rs610932	0.0016	MS4A6A	NR	NR	0.9	0.9	MS4A6A	SNP-based	Disease risk	21460840	Caucasian	GERAD	9799	All	AD	AD	3_prime_UTR_variant
chr11	60171834	rs610932	0.199	MS4A6A	A	A	0.92	NA	MS4A6A	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	3_prime_UTR_variant
chr11	60171834	rs610932	0.299	MS4A	T	T	0.91	0.91	MS4A6A	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	3_prime_UTR_variant
chr11	60171834	rs610932	0.799	MS4A6A	T	T	0.99	0.99	MS4A6A	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	2024	All	LOAD	AD	3_prime_UTR_variant
chr11	60171834	rs610932	1.20E-16	MS4A6A	NR	NR	0.91	0.91	MS4A6A	SNP-based	Disease risk	21460840	Caucasian	"ADGC, GERAD"	NR	All	AD	AD	3_prime_UTR_variant
chr11	60171834	rs610932	1.80E-14	MS4A6A	NR	NR	0.9	0.9	MS4A6A	SNP-based	Disease risk	21460840	Caucasian	"ADGC, CHARGE, EADI, GERAD"	59716	All	AD	AD	3_prime_UTR_variant
chr11	60175284	rs662196	0.0000052	MS4A6A	NR	NR	0.88	0.88	MS4A6A	SNP-based	Disease risk	19734902	Caucasian	Cohorts from Europe and USA	11789	All	AD	AD	intron_variant
chr11	60175342	rs7935829	1.64E-10	MS4A6A	NR	NR	NR	NA	MS4A6A	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr11	60175342	rs7935829	8.21E-13	MS4A6A	A	A	NR	NA	MS4A6A	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ"	79145	All	AD	AD	intron_variant
chr11	60178272	rs12453	1.34E-09	MS4A6A	NR	NR	0.86	0.86	MS4A6A	SNP-based	Disease risk	30448613	Caucasian	ADGC	15330	All	AD	AD	stop_retained_variant
chr11	60179779	rs583791	0.0000053	MS4A6A	NR	NR	0.88	0.88	MS4A6A	SNP-based	Disease risk	19734902	Caucasian	Cohorts from Europe and USA	11789	All	AD	AD	missense_variant
chr11	60190907	rs2081545	1.55E-15	MS4A6A	A	A	-7.97	NA	MS4A4A	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ, UKBB"	455258	All	AD + AD-by-proxy	AD	intergenic_region
chr11	60192370	rs1834550	0.0000108	MS4A6A	NR	NR	0.89	0.89	MS4A4A	SNP-based	Disease risk	30979435	Caucasian	ADGC	14677	Age 60-79 y	AD	AD	intergenic_region
chr11	60192370	rs1834550	0.000338	MS4A6A	NR	NR	0.86	0.86	MS4A4A	SNP-based	Disease risk	30979435	Caucasian	ADGC	6473	Age >=80 y	AD	AD	intergenic_region
chr11	60197519	rs7116190	0.000126	MS4A6A	NR	NR	0.08	NA	MS4A4A	SNP-based	Age at onset (AAO) / Survival	28323831	Caucasian	ADGC	15795	All	Age of AD onset	Other	downstream_gene_variant
chr11	60201268	rs184909761	0.00000145	MS4A4E	NR	NR	0.86	0.86	MS4A4A	SNP-based	Disease risk	30979435	Caucasian	ADGC	12169	Age 60-79 y	AD	AD	3_prime_UTR_variant
chr11	60201268	rs184909761	0.000553	MS4A4E	NR	NR	0.85	0.85	MS4A4A	SNP-based	Disease risk	30979435	Caucasian	ADGC	5340	Age >=80 y	AD	AD	3_prime_UTR_variant
chr11	60204322	rs670139	0.00001	MS4A6E	NR	NR	1.11	1.11	MS4A4A	SNP-based	Disease risk	21460840	Caucasian	"ADC, EADI, GERAD"	20373	All	AD	AD	intron_variant
chr11	60204322	rs670139	0.0011	MS4A6E	NR	NR	1.11	1.11	MS4A4A	SNP-based	Disease risk	21460840	Caucasian	GERAD	9799	All	AD	AD	intron_variant
chr11	60204322	rs670139	0.0032	MS4A6E	NR	NR	1.06	1.06	MS4A4A	SNP-based	Disease risk	21460840	Caucasian	"ADGC, CHARGE, EADI"	29544	All	AD	AD	intron_variant
chr11	60204322	rs670139	0.77	MS4A4E	NR	NR	0.97	0.97	MS4A4A	SNP-based	Endophenotype	26993346	Caucasian	Cohort from Europe	10840	All	PCA (posterior cortical atrophy)	Imaging	intron_variant
chr11	60204322	rs670139	0.823	MS4A6A	T	T	0.99	0.99	MS4A4A	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	2024	All	LOAD	AD	intron_variant
chr11	60204322	rs670139	1.10E-10	MS4A6E	NR	NR	1.08	1.08	MS4A4A	SNP-based	Disease risk	21460840	Caucasian	"ADGC, GERAD"	NR	All	AD	AD	intron_variant
chr11	60204322	rs670139	1.40E-09	MS4A6E	NR	NR	1.09	1.09	MS4A4A	SNP-based	Disease risk	21460840	Caucasian	"ADGC, CHARGE, EADI, GERAD"	59716	All	AD	AD	intron_variant
chr11	60221957	rs2081547	2.19E-10	MS4A4E	NR	NR	NR	NA	MS4A4A	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr11	60232853	rs668134	0.18	MS4A4E	G	G	0.84	NA	MS4A4A	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	intron_variant
chr11	60234100	rs676309	0.0000063	MS4A4E	NR	NR	1.14	1.14	MS4A4A	SNP-based	Disease risk	19734902	Caucasian	Cohorts from Europe and USA	11789	All	AD	AD	intron_variant
chr11	60254475	rs1582763	0.003	MS4 region	A	A	0.92	0.92	MS4A4A	SNP-based	Disease risk	25778476	Caucasian	"ADGC, IGAP"	21345	APOE-e4+ subjects	AD	AD	intergenic_region
chr11	60254475	rs1582763	2.20E-09	MS4 region	A	A	0.87	0.87	MS4A4A	SNP-based	Disease risk	25778476	Caucasian	"ADGC, IGAP"	36569	APOE-e4- subjects	AD	AD	intergenic_region
chr11	60254475	rs1582763	4.72E-09	MS4A6A	A	A	NR	NA	MS4A4A	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	intergenic_region
chr11	60254847	rs10792258	0.01	MS4A	T	T	0.79	0.79	MS4A4A	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intergenic_region
chr11	60259140	rs4938931	1.54E-10	"MS4A4A, MS4A4E"	NR	NR	NR	NA	MS4A4A	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr11	60260669	rs7108663	0.000217	MS4A6A	C	C	NR	NA	MS4A4A	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	17480	Plan 1 (males and females)	AD	AD	intergenic_region
chr11	60260669	rs7108663	1.41E-48	NR	C	C	NR	NA	MS4A4A	SNP-based	eQTL	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	17480	Plan 1 (males and females)	MS4A6A (ILMN_2359800) expression	Expression	intergenic_region
chr11	60266956	rs4938933	0.00054	MS4A6A	NR	NR	0.92	0.92	MS4A4A	SNP-based	Disease risk	21460841	Caucasian	"CHARGE, EADI, GERAD"	25818	All	LOAD	AD	intergenic_region
chr11	60266956	rs4938933	0.0044	MS4A6A	C	C	0.9	0.9	MS4A4A	SNP-based	Disease risk	21460841	Caucasian	ADGC	7096	All	LOAD	AD	intergenic_region
chr11	60266956	rs4938933	0.00481	MS4A6A	C	C	0.9	0.9	MS4A4A	SNP-based	Disease risk	21460841	Caucasian	ADGC	7096	All	LOAD	AD	intergenic_region
chr11	60266956	rs4938933	0.323	MS4A6A	C	C	1.06	1.06	MS4A4A	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	2024	All	LOAD	AD	intergenic_region
chr11	60266956	rs4938933	0.448	MS4A4A 	C	C	0.09	1.09417	MS4A4A	SNP-based	Age at onset (AAO) / Survival	25199842	Caucasian	ADGC	9162	LOAD subjects	Age of AD onset	Other	intergenic_region
chr11	60266956	rs4938933	0.493	MS4A	C	C	1.06	1.06	MS4A4A	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intergenic_region
chr11	60266956	rs4938933	0.887	MS4A4A 	C	C	0.02	1.0202	MS4A4A	SNP-based	Age at onset (AAO) / Survival	25199842	Caucasian	ADGC	9162	LOAD subjects	Age of AD onset	Other	intergenic_region
chr11	60266956	rs4938933	0.889	NR	C	C	0	1	MS4A4A	SNP-based	Endophenotype	23836404	Caucasian	ADGC	725	All	Neuritic Plaque Pathologic Burden	Neuropathology	intergenic_region
chr11	60266956	rs4938933	1.66E-09	MS4A6A	C	C	0.88	0.88	MS4A4A	SNP-based	Disease risk	21460841	Caucasian	ADGC	22771	All	LOAD	AD	intergenic_region
chr11	60266956	rs4938933	1.73E-09	MS4A6A	C	C	0.88	0.88	MS4A4A	SNP-based	Disease risk	21460841	Caucasian	ADGC	22771	All	LOAD	AD	intergenic_region
chr11	60266956	rs4938933	4.47E-08	MS4A6A	C	C	0.87	0.87	MS4A4A	SNP-based	Disease risk	21460841	Caucasian	ADGC	15675	All	LOAD	AD	intergenic_region
chr11	60266956	rs4938933	5.19E-08	MS4A6A	C	C	0.88	0.88	MS4A4A	SNP-based	Disease risk	21460841	Caucasian	ADGC	15675	All	LOAD	AD	intergenic_region
chr11	60266956	rs4938933	8.20E-12	MS4A6A	NR	NR	0.89	0.89	MS4A4A	SNP-based	Disease risk	21460841	Caucasian	"ADGC, CHARGE, EADI, GERAD"	48589	All	LOAD	AD	intergenic_region
chr11	60292543	rs2044981	0.00000392	MS4A4A	NR	NR	NR	NA	MS4A4A	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr11	60312178	rs10792263	3.21E-11	"MS4A4A, MS4A4E"	NR	NR	NR	NA	MS4A4A	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	downstream_gene_variant
chr11	60332956	rs2868121	0.00000192	MS4A6E	NR	NR	NR	NA	MS4A6E	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	upstream_gene_variant
chr11	60334911	rs2304935	0.000186	MS4A4A	G	G	0.22	1.24608	MS4A6E	SNP-based	eQTL	22722634	Caucasian	MAYO	399	All subjects with Temporal Cortex data	MS4A4A brain expression (probe ILMN_2370336) in Temporal cortex (TCX)	Expression	missense_variant
chr11	60334911	rs2304935	0.0111	MS4A4A	G	G	1.06	1.06	MS4A6E	SNP-based	Disease risk	22722634	Caucasian	ADGC	22771	All	AD	AD	missense_variant
chr11	60334911	rs2304935	0.0365	MS4A4A	G	G	0.09	1.09417	MS4A6E	SNP-based	eQTL	22722634	Caucasian	MAYO	374	All subjects with Cerebellum data	MS4A4A brain expression (probe ILMN_2370336) in Cerebellar tissue (CER)	Expression	missense_variant
chr11	60335034	rs2304933	0.000148	MS4A4A	A	A	0.22	1.24608	MS4A6E	SNP-based	eQTL	22722634	Caucasian	MAYO	399	All subjects with Temporal Cortex data	MS4A4A brain expression (probe ILMN_2370336) in Temporal cortex (TCX)	Expression	missense_variant
chr11	60335034	rs2304933	0.0113	MS4A4A	A	A	1.06	1.06	MS4A6E	SNP-based	Disease risk	22722634	Caucasian	ADGC	22771	All	AD	AD	missense_variant
chr11	60335034	rs2304933	0.0365	MS4A4A	A	A	0.09	1.09417	MS4A6E	SNP-based	eQTL	22722634	Caucasian	MAYO	374	All subjects with Cerebellum data	MS4A4A brain expression (probe ILMN_2370336) in Cerebellar tissue (CER)	Expression	missense_variant
chr11	62566624	rs7124057	1.17E-85	EEF1G	NR	NR	-0.9	0.40657	EEF1G	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	EEF1G expression in Cerebellar	Expression	intron_variant
chr11	62566624	rs7124057	2.78E-44	EEF1G	NR	NR	-1.03	0.357007	EEF1G	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	EEF1G expression in Cerebellar	Expression	intron_variant
chr11	62566624	rs7124057	4.01E-88	EEF1G	NR	NR	-0.7	0.496585	EEF1G	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	EEF1G expression in Temporal cortex	Expression	intron_variant
chr11	62566624	rs7124057	6.83E-36	EEF1G	NR	NR	-0.74	0.477114	EEF1G	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	EEF1G expression in Cerebellar	Expression	intron_variant
chr11	63837705	rs10792421	0.0000216	MARK2	G	G	NR	NA	MARK2	SNP-based	Cross phenotype 	30930738	Caucasian	PGC2-BIP	51710	All	Bipolar disorder (BIP)	ADRD	upstream_gene_variant
chr11	63837705	rs10792421	0.0000668	MARK2	G	G	NR	NA	MARK2	SNP-based	Cross phenotype 	30930738	Caucasian	IGAP	54162	All	AD	AD	upstream_gene_variant
chr11	69200174	rs10896445	0.00031	MYEOV	NR	NR	NR	NA	AP003071.5	SNP-based	Cross phenotype 	28780673	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr11	69200174	rs10896445	0.0032	MYEOV	NR	NR	NR	NA	AP003071.5	SNP-based	Cross phenotype 	28780673	Caucasian	"GAME-ON, IGAP"	116992	All	AD + Breast cancer + Lung Cancer	Non-ADRD	intergenic_region
chr11	69200174	rs10896445	0.0071	MYEOV	NR	NR	NR	NA	AP003071.5	SNP-based	Cross phenotype 	28780673	Caucasian	GAME-ON	33832	All	Breast Cancer	Non-ADRD	intergenic_region
chr11	69200174	rs10896445	0.011	MYEOV	NR	NR	NR	NA	AP003071.5	SNP-based	Cross phenotype 	28780673	Caucasian	GAME-ON	28998	All	Lung Cancer	Non-ADRD	intergenic_region
chr11	72354165	rs74766959	0.00032	CLPB	NR	NR	NR	NA	CLPB	SNP-based	Cross phenotype 	28780673	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr11	72354165	rs74766959	0.0008	CLPB	NR	NR	NR	NA	CLPB	SNP-based	Cross phenotype 	28780673	Caucasian	GAME-ON	28998	All	Lung Cancer	Non-ADRD	intron_variant
chr11	72354165	rs74766959	0.005	CLPB	NR	NR	NR	NA	CLPB	SNP-based	Cross phenotype 	28780673	Caucasian	"GAME-ON, IGAP"	116992	All	AD + Breast cancer + Lung Cancer	Non-ADRD	intron_variant
chr11	72354165	rs74766959	0.17	CLPB	NR	NR	NR	NA	CLPB	SNP-based	Cross phenotype 	28780673	Caucasian	GAME-ON	33832	All	Breast Cancer	Non-ADRD	intron_variant
chr11	74322021	rs3888908	0.00000952	NR	A	A	1.72	1.72	PGM2L1	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr11	76597228	rs11827375	0.0000072	C11orf30	NR	NR	1.23	1.23	EMSY	SNP-based	Disease risk	19734902	Caucasian	Cohorts from Europe and USA	11789	All	AD	AD	intergenic_region
chr11	76723776	rs1893306	0.0000425	GUCY2EP	G	G	NR	NA	LRRC32	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	upstream_gene_variant
chr11	76723776	rs1893306	0.00109	GUCY2EP	G	G	0.95	0.95	LRRC32	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	upstream_gene_variant
chr11	76723776	rs1893306	0.00146	GUCY2EP	G	G	NR	NA	LRRC32	SNP-based	Cross phenotype 	30413934	Caucasian	GIANT	681275	All	Body-mass index (BMI)	Non-ADRD	upstream_gene_variant
chr11	76723776	rs1893306	0.00235	GUCY2EP	G	G	0.96	0.96	LRRC32	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	upstream_gene_variant
chr11	76723776	rs1893306	0.558	GUCY2EP	G	G	1	1	LRRC32	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	upstream_gene_variant
chr11	76723776	rs1893306	0.668	GUCY2EP	G	G	1.02	1.02	LRRC32	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	upstream_gene_variant
chr11	78219453	rs901104	0.000000456	GAP2	C	C	3.24	3.24	GAB2	SNP-based	Disease risk	17553421	Caucasian	"ADGC, Cohort from Europe"	360	APOE-e4+	LOAD	AD	intron_variant
chr11	78219453	rs901104	0.00000199	GAP2	C	C	2.87	2.87	GAB2	SNP-based	Disease risk	17553421	Caucasian	ADGC	644	APOE-e4+	LOAD	AD	intron_variant
chr11	78219453	rs901104	0.0452	GAP2	C	C	2.54	2.54	GAB2	SNP-based	Disease risk	17553421	Caucasian	"ADGC, Cohort from Europe"	140	APOE-e4+	LOAD	AD	intron_variant
chr11	78219453	rs901104	0.147	GAP2	C	C	2.08	2.08	GAB2	SNP-based	Disease risk	17553421	Caucasian	ADGC	144	APOE-e4+	LOAD	AD	intron_variant
chr11	78225120	rs1385600	0.000000502	GAP2	T	T	3.18	3.18	GAB2	SNP-based	Disease risk	17553421	Caucasian	"ADGC, Cohort from Europe"	360	APOE-e4+	LOAD	AD	synonymous_variant
chr11	78225120	rs1385600	0.0132	GAP2	T	T	3	3	GAB2	SNP-based	Disease risk	17553421	Caucasian	"ADGC, Cohort from Europe"	140	APOE-e4+	LOAD	AD	synonymous_variant
chr11	78225120	rs1385600	0.0463	GAP2	T	T	5.56	5.56	GAB2	SNP-based	Disease risk	17553421	Caucasian	ADGC	144	APOE-e4+	LOAD	AD	synonymous_variant
chr11	78225120	rs1385600	2.81E-09	GAP2	T	T	3.65	3.65	GAB2	SNP-based	Disease risk	17553421	Caucasian	ADGC	644	APOE-e4+	LOAD	AD	synonymous_variant
chr11	78230030	rs1007837	0.000000397	GAP2	C	C	3.01	3.01	GAB2	SNP-based	Disease risk	17553421	Caucasian	ADGC	644	APOE-e4+	LOAD	AD	intron_variant
chr11	78230030	rs1007837	0.00000478	GAP2	C	C	3.18	3.18	GAB2	SNP-based	Disease risk	17553421	Caucasian	"ADGC, Cohort from Europe"	360	APOE-e4+	LOAD	AD	intron_variant
chr11	78230030	rs1007837	0.032	GAP2	C	C	2.85	2.85	GAB2	SNP-based	Disease risk	17553421	Caucasian	"ADGC, Cohort from Europe"	140	APOE-e4+	LOAD	AD	intron_variant
chr11	78230030	rs1007837	0.204	GAP2	C	C	1.89	1.89	GAB2	SNP-based	Disease risk	17553421	Caucasian	ADGC	144	APOE-e4+	LOAD	AD	intron_variant
chr11	78254988	rs2510038	0.0000119	GAP2	C	C	2.72	2.72	GAB2	SNP-based	Disease risk	17553421	Caucasian	ADGC	644	APOE-e4+	LOAD	AD	intron_variant
chr11	78254988	rs2510038	0.0000892	GAP2	C	C	2.44	2.44	GAB2	SNP-based	Disease risk	17553421	Caucasian	"ADGC, Cohort from Europe"	360	APOE-e4+	LOAD	AD	intron_variant
chr11	78254988	rs2510038	0.0435	GAP2	C	C	2.53	2.53	GAB2	SNP-based	Disease risk	17553421	Caucasian	"ADGC, Cohort from Europe"	140	APOE-e4+	LOAD	AD	intron_variant
chr11	78254988	rs2510038	0.147	GAP2	C	C	2.08	2.08	GAB2	SNP-based	Disease risk	17553421	Caucasian	ADGC	144	APOE-e4+	LOAD	AD	intron_variant
chr11	78279214	rs4945261	0.000000566	GAP2	G	G	3.21	3.21	GAB2	SNP-based	Disease risk	17553421	Caucasian	"ADGC, Cohort from Europe"	360	APOE-e4+	LOAD	AD	intron_variant
chr11	78279214	rs4945261	0.042	GAP2	G	G	2.54	2.54	GAB2	SNP-based	Disease risk	17553421	Caucasian	"ADGC, Cohort from Europe"	140	APOE-e4+	LOAD	AD	intron_variant
chr11	78279214	rs4945261	0.0463	GAP2	G	G	5.56	5.56	GAB2	SNP-based	Disease risk	17553421	Caucasian	ADGC	144	APOE-e4+	LOAD	AD	intron_variant
chr11	78279214	rs4945261	3.06E-08	GAP2	G	G	3.44	3.44	GAB2	SNP-based	Disease risk	17553421	Caucasian	ADGC	644	APOE-e4+	LOAD	AD	intron_variant
chr11	78281921	rs7101429	0.00000106	GAP2	A	A	2.96	2.96	GAB2	SNP-based	Disease risk	17553421	Caucasian	ADGC	644	APOE-e4+	LOAD	AD	intron_variant
chr11	78281921	rs7101429	0.0000462	GAP2	A	A	2.13	2.13	GAB2	SNP-based	Disease risk	17553421	Caucasian	"ADGC, Cohort from Europe"	360	APOE-e4+	LOAD	AD	intron_variant
chr11	78281921	rs7101429	0.0187	GAP2	A	A	2.84	2.84	GAB2	SNP-based	Disease risk	17553421	Caucasian	"ADGC, Cohort from Europe"	140	APOE-e4+	LOAD	AD	intron_variant
chr11	78281921	rs7101429	0.0499	GAP2	A	A	2.5	2.5	GAB2	SNP-based	Disease risk	17553421	Caucasian	ADGC	144	APOE-e4+	LOAD	AD	intron_variant
chr11	78285357	rs10793294	0.000000159	GAP2	C	C	2.83	2.83	GAB2	SNP-based	Disease risk	17553421	Caucasian	ADGC	644	APOE-e4+	LOAD	AD	intron_variant
chr11	78285357	rs10793294	0.0000298	GAP2	C	C	2.45	2.45	GAB2	SNP-based	Disease risk	17553421	Caucasian	"ADGC, Cohort from Europe"	360	APOE-e4+	LOAD	AD	intron_variant
chr11	78285357	rs10793294	0.0134	GAP2	C	C	2.66	2.66	GAB2	SNP-based	Disease risk	17553421	Caucasian	"ADGC, Cohort from Europe"	140	APOE-e4+	LOAD	AD	intron_variant
chr11	78285357	rs10793294	0.0217	GAP2	C	C	4.45	4.45	GAB2	SNP-based	Disease risk	17553421	Caucasian	ADGC	144	APOE-e4+	LOAD	AD	intron_variant
chr11	78285357	rs10793294	0.025	GAB2	C	C	0.82	0.82	GAB2	SNP-based	Disease risk	20534741	Caucasian	"ADC, UM"	1610	All	AD	AD	intron_variant
chr11	78290202	rs4291702	0.000000588	GAP2	C	C	2.96	2.96	GAB2	SNP-based	Disease risk	17553421	Caucasian	ADGC	644	APOE-e4+	LOAD	AD	intron_variant
chr11	78290202	rs4291702	0.00000373	GAP2	C	C	3.19	3.19	GAB2	SNP-based	Disease risk	17553421	Caucasian	"ADGC, Cohort from Europe"	360	APOE-e4+	LOAD	AD	intron_variant
chr11	78290202	rs4291702	0.0244	GAP2	C	C	2.7	2.7	GAB2	SNP-based	Disease risk	17553421	Caucasian	"ADGC, Cohort from Europe"	140	APOE-e4+	LOAD	AD	intron_variant
chr11	78290202	rs4291702	0.204	GAP2	C	C	1.89	1.89	GAB2	SNP-based	Disease risk	17553421	Caucasian	ADGC	144	APOE-e4+	LOAD	AD	intron_variant
chr11	78334025	rs7115850	0.00000016	GAP2	C	C	3.21	3.21	GAB2	SNP-based	Disease risk	17553421	Caucasian	"ADGC, Cohort from Europe"	360	APOE-e4+	LOAD	AD	intron_variant
chr11	78334025	rs7115850	0.00345	GAP2	C	C	14.93	14.93	GAB2	SNP-based	Disease risk	17553421	Caucasian	ADGC	144	APOE-e4+	LOAD	AD	intron_variant
chr11	78334025	rs7115850	0.0391	GAP2	C	C	2.48	2.48	GAB2	SNP-based	Disease risk	17553421	Caucasian	"ADGC, Cohort from Europe"	140	APOE-e4+	LOAD	AD	intron_variant
chr11	78334025	rs7115850	2.80E-10	GAP2	C	C	3.92	3.92	GAB2	SNP-based	Disease risk	17553421	Caucasian	ADGC	644	APOE-e4+	LOAD	AD	intron_variant
chr11	78380104	rs2373115	0.00000046	GAP2	G	G	3.21	3.21	GAB2	SNP-based	Disease risk	17553421	Caucasian	"ADGC, Cohort from Europe"	360	APOE-e4+	LOAD	AD	intron_variant
chr11	78380104	rs2373115	0.00345	GAP2	G	G	14.93	14.93	GAB2	SNP-based	Disease risk	17553421	Caucasian	ADGC	144	APOE-e4+	LOAD	AD	intron_variant
chr11	78380104	rs2373115	0.0391	GAP2	G	G	2.48	2.48	GAB2	SNP-based	Disease risk	17553421	Caucasian	"ADGC, Cohort from Europe"	140	APOE-e4+	LOAD	AD	intron_variant
chr11	78380104	rs2373115	9.66E-11	GAP2	G	G	4.06	4.06	GAB2	SNP-based	Disease risk	17553421	Caucasian	ADGC	644	APOE-e4+	LOAD	AD	intron_variant
chr11	78493334	rs4474465	0.00000341	NARS2	G	G	1.44	NA	NARS2	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	intron_variant
chr11	80666008	rs17140547	0.00000796	NR	NR	NR	-532.56	5.15384e-232	TENM4	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	intergenic_region
chr11	80666008	rs17140547	0.00014	NR	T	T	-711.52	9.79017e-310	TENM4	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	intergenic_region
chr11	80666008	rs17140547	0.0082	NR	T	T	-409.41	1.56854e-178	TENM4	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intergenic_region
chr11	80666008	rs17140547	0.039	NR	T	T	NR	NA	TENM4	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intergenic_region
chr11	85836460	rs10898417	0.00000117	SYTL2	G	G	0.59	0.59	CCDC83	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	2024	All	LOAD	AD	intergenic_region
chr11	85836460	rs10898417	0.003	SYTL2	G	G	0.82	0.82	CCDC83	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	3894	All	LOAD	AD	intergenic_region
chr11	85836460	rs10898417	0.83	SYTL2	G	G	1.02	1.02	CCDC83	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	1870	All	LOAD	AD	intergenic_region
chr11	85960659	rs618679	0.00000135	PICALM	NR	NR	NR	NA	PICALM	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr11	85966428	rs17817600	0.000014	PICALM	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	22832961	Caucasian	ADGC	8292	All	LOAD	AD	intron_variant
chr11	85966428	rs17817600	0.000367	PICALM	NR	NR	1.41	1.41	PICALM	SNP-based	Disease risk	22832961	Caucasian	ADGC	2229	All	LOAD	AD	intron_variant
chr11	85966428	rs17817600	0.00231	PICALM	NR	NR	1.36	1.36	PICALM	SNP-based	Disease risk	22832961	Caucasian	ADGC	2099	All	LOAD	AD	intron_variant
chr11	85966428	rs17817600	0.0122	PICALM	NR	NR	1.38	1.38	PICALM	SNP-based	Disease risk	22832961	Caucasian	MIRAGE	1262	All	LOAD	AD	intron_variant
chr11	85966428	rs17817600	0.0212	PICALM	NR	NR	1.25	1.25	PICALM	SNP-based	Disease risk	22832961	Caucasian	ADGC	2321	All	LOAD	AD	intron_variant
chr11	85966428	rs17817600	0.848	PICALM	NR	NR	0.94	0.94	PICALM	SNP-based	Disease risk	22832961	Caucasian	ADNI	381	All	LOAD	AD	intron_variant
chr11	85966428	rs17817600	2.17E-08	PICALM	NR	NR	1.33	1.33	PICALM	SNP-based	Disease risk	22832961	Caucasian	ADGC	8292	All	LOAD	AD	intron_variant
chr11	85970540	rs639012	0.000000186	PICALM	NR	NR	0.86	0.86	PICALM	SNP-based	Disease risk	30979435	Caucasian	ADGC	14880	Age 60-79 y	AD	AD	intron_variant
chr11	85970540	rs639012	0.601	PICALM	NR	NR	0.98	0.98	PICALM	SNP-based	Disease risk	30979435	Caucasian	ADGC	6552	Age >=80 y	AD	AD	intron_variant
chr11	85975053	rs532470	0.03	PICALM	NR	NR	1.12	1.12	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4+ carrier	AD	AD	intron_variant
chr11	85975053	rs532470	0.048	PICALM	G	G	1.06	1.06	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	intron_variant
chr11	85975053	rs532470	0.47	PICALM	G	G	1.02	1.02	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	intron_variant
chr11	85975053	rs532470	0.89	PICALM	NR	NR	0.99	0.99	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4- carrier	AD	AD	intron_variant
chr11	85993023	rs12795381	0.0086	PICALM	C	C	0.49	0.49	PICALM	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr11	86014894	rs592297	0.02	PICALM	C	C	0.92	0.92	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	synonymous_variant
chr11	86014894	rs592297	0.12	PICALM	NR	NR	0.9	0.9	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4+ carrier	AD	AD	synonymous_variant
chr11	86014894	rs592297	0.32	PICALM	NR	NR	1.04	1.04	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4- carrier	AD	AD	synonymous_variant
chr11	86014894	rs592297	0.33	PICALM	C	C	0.96	0.96	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	synonymous_variant
chr11	86032331	rs10501605	0.112	PICALM	G	G	0.89	NA	PICALM	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	intron_variant
chr11	86046547	rs677909	0.000033	PICALM	C	C	0.88	0.88	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	intron_variant
chr11	86046547	rs677909	0.0062	PICALM	NR	NR	0.86	0.86	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4+ carrier	AD	AD	intron_variant
chr11	86046547	rs677909	0.056	PICALM	C	C	0.94	0.94	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	intron_variant
chr11	86046547	rs677909	0.8	PICALM	NR	NR	0.99	0.99	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4- carrier	AD	AD	intron_variant
chr11	86046547	rs677909	8.35E-11	PICALM	NR	NR	NR	NA	PICALM	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr11	86065502	rs867611	2.19E-18	SUZ12P1	G	G	-8.75	NA	PICALM	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ, UKBB"	455258	All	AD + AD-by-proxy	AD	intron_variant
chr11	86071625	rs636848	0.27	PICALM	NR	NR	1.07	1.07	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4+ carrier	AD	AD	upstream_gene_variant
chr11	86071625	rs636848	0.44	PICALM	NR	NR	0.96	0.96	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4- carrier	AD	AD	upstream_gene_variant
chr11	86071625	rs636848	0.6	PICALM	G	G	1.02	1.02	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	upstream_gene_variant
chr11	86071625	rs636848	0.98	PICALM	G	G	1	1	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	upstream_gene_variant
chr11	86075245	rs17159904	0.0424	PICALM	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intergenic_region
chr11	86075245	rs17159904	0.0427	PICALM	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intergenic_region
chr11	86075245	rs17159904	0.0495	PICALM	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intergenic_region
chr11	86075245	rs17159904	0.653	PICALM	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intergenic_region
chr11	86076782	rs536841	0.011	PICALM	NR	NR	0.053	1.05443	PICALM	SNP-based	Endophenotype	21116278	Caucasian	"AddNeuroMed, ADNI"	939	All	Entorhinal cortex thickness	Imaging	intergenic_region
chr11	86077309	rs541458	0.000026	PICALM	C	C	0.88	0.88	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	intergenic_region
chr11	86077309	rs541458	0.0053	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	3461	Northwestern European ancestry	LOAD	AD	intergenic_region
chr11	86077309	rs541458	0.0066	PICALM	NR	NR	0.86	0.86	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4+ carrier	AD	AD	intergenic_region
chr11	86077309	rs541458	0.01	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	3839	All	LOAD	AD	intergenic_region
chr11	86077309	rs541458	0.01	PICALM	C	C	0.81	0.81	PICALM	SNP-based	Disease risk	20534741	Caucasian	"ADC, UM"	1610	All	AD	AD	intergenic_region
chr11	86077309	rs541458	0.013	PICALM	NR	NR	0.052	1.05338	PICALM	SNP-based	Endophenotype	21116278	Caucasian	"AddNeuroMed, ADNI"	939	All	Entorhinal cortex thickness	Imaging	intergenic_region
chr11	86077309	rs541458	0.048	PICALM	C	C	0.94	0.94	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	intergenic_region
chr11	86077309	rs541458	0.0628	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	intergenic_region
chr11	86077309	rs541458	0.0752	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	2167	APOE-e4+	LOAD	AD	intergenic_region
chr11	86077309	rs541458	0.19	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	1642	APOE-e4/e3	LOAD	AD	intergenic_region
chr11	86077309	rs541458	0.272	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	250	APOE-e3/e2+e2/e2	LOAD	AD	intergenic_region
chr11	86077309	rs541458	0.283	PICALM	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intergenic_region
chr11	86077309	rs541458	0.363	PICALM	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intergenic_region
chr11	86077309	rs541458	0.407	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	3786	All	LOAD	AD	intergenic_region
chr11	86077309	rs541458	0.447	PICALM	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intergenic_region
chr11	86077309	rs541458	0.515	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	3722	All	LOAD	AD	intergenic_region
chr11	86077309	rs541458	0.54	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	3839	All	LOAD	AD	intergenic_region
chr11	86077309	rs541458	0.573	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	1422	APOE-e3/e3	LOAD	AD	intergenic_region
chr11	86077309	rs541458	0.705	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	intergenic_region
chr11	86077309	rs541458	0.778	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	intergenic_region
chr11	86077309	rs541458	0.794	PICALM	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intergenic_region
chr11	86077309	rs541458	0.81	PICALM	NR	NR	0.99	0.99	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4- carrier	AD	AD	intergenic_region
chr11	86077309	rs541458	0.82	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	408	APOE-e4/e4	LOAD	AD	intergenic_region
chr11	86077309	rs541458	0.842	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	1672	APOE-e4-	LOAD	AD	intergenic_region
chr11	86089237	rs561655	0.000000122	PICALM	G	G	0.88	0.88	PICALM	SNP-based	Disease risk	21460841	Caucasian	ADGC	15675	All	LOAD	AD	upstream_gene_variant
chr11	86089237	rs561655	0.00000046	PICALM	G	G	0.88	0.88	PICALM	SNP-based	Disease risk	21460841	Caucasian	ADGC	15675	All	LOAD	AD	upstream_gene_variant
chr11	86089237	rs561655	0.000034	PICALM	G	G	0.89	0.89	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	upstream_gene_variant
chr11	86089237	rs561655	0.0000369	PICALM	G	G	0.86	0.86	PICALM	SNP-based	Disease risk	21460841	Caucasian	ADGC	7096	All	LOAD	AD	upstream_gene_variant
chr11	86089237	rs561655	0.0000844	PICALM	G	G	0.86	0.86	PICALM	SNP-based	Disease risk	21460841	Caucasian	ADGC	7096	All	LOAD	AD	upstream_gene_variant
chr11	86089237	rs561655	0.0009	PICALM	NR	NR	0.83	0.83	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4+ carrier	AD	AD	upstream_gene_variant
chr11	86089237	rs561655	0.00223	PICALM 	G	G	0.33	1.39097	PICALM	SNP-based	Age at onset (AAO) / Survival	25199842	Caucasian	ADGC	9162	LOAD subjects	Age of AD onset	Other	upstream_gene_variant
chr11	86089237	rs561655	0.0112	PICALM 	G	G	0.32	1.37713	PICALM	SNP-based	Age at onset (AAO) / Survival	25199842	Caucasian	ADGC	9162	LOAD subjects	Age of AD onset	Other	upstream_gene_variant
chr11	86089237	rs561655	0.017	PICALM	G	G	0.92	0.92	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	upstream_gene_variant
chr11	86089237	rs561655	0.117	NR	G	G	-0.05	0.951229	PICALM	SNP-based	Endophenotype	23836404	Caucasian	ADGC	725	All	Neuritic Plaque Pathologic Burden	Neuropathology	upstream_gene_variant
chr11	86089237	rs561655	0.5	PICALM	NR	NR	0.97	0.97	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4- carrier	AD	AD	upstream_gene_variant
chr11	86089237	rs561655	1.02E-10	PICALM	G	G	0.87	0.87	PICALM	SNP-based	Disease risk	21460841	Caucasian	ADGC	22771	All	LOAD	AD	upstream_gene_variant
chr11	86089237	rs561655	7.00E-11	PICALM	G	G	0.87	0.87	PICALM	SNP-based	Disease risk	21460841	Caucasian	ADGC	22771	All	LOAD	AD	upstream_gene_variant
chr11	86100322	rs526904	0.00501	PICALM	NR	NR	-0.2	NA	PICALM	SNP-based	Age at onset (AAO) / Survival	28323831	Caucasian	ADGC	15795	All	Age of AD onset	Other	intergenic_region
chr11	86103988	rs1237999	0.009	PICALM	NR	NR	0.053	1.05443	PICALM	SNP-based	Endophenotype	21116278	Caucasian	"AddNeuroMed, ADNI"	939	All	Entorhinal cortex thickness	Imaging	intergenic_region
chr11	86109035	rs543293	0.000023	PICALM	A	A	0.88	0.88	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	intergenic_region
chr11	86109035	rs543293	0.0000631	PICALM	NR	NR	0.3	NA	PICALM	SNP-based	Age at onset (AAO) / Survival	28323831	Caucasian	ADGC	15795	All	Age of AD onset	Other	intergenic_region
chr11	86109035	rs543293	0.0011	PICALM	NR	NR	0.83	0.83	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4+ carrier	AD	AD	intergenic_region
chr11	86109035	rs543293	0.0086	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	3461	Northwestern European ancestry	LOAD	AD	intergenic_region
chr11	86109035	rs543293	0.009	PICALM	NR	NR	0.054	1.05548	PICALM	SNP-based	Endophenotype	21116278	Caucasian	"AddNeuroMed, ADNI"	939	All	Entorhinal cortex thickness	Imaging	intergenic_region
chr11	86109035	rs543293	0.014	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	2167	APOE-e4+	LOAD	AD	intergenic_region
chr11	86109035	rs543293	0.015	PICALM	A	A	0.92	0.92	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	intergenic_region
chr11	86109035	rs543293	0.0189	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	3839	All	LOAD	AD	intergenic_region
chr11	86109035	rs543293	0.045	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	1642	APOE-e4/e3	LOAD	AD	intergenic_region
chr11	86109035	rs543293	0.171	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	intergenic_region
chr11	86109035	rs543293	0.272	PICALM	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intergenic_region
chr11	86109035	rs543293	0.349	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	3786	All	LOAD	AD	intergenic_region
chr11	86109035	rs543293	0.367	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	408	APOE-e4/e4	LOAD	AD	intergenic_region
chr11	86109035	rs543293	0.406	PICALM	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intergenic_region
chr11	86109035	rs543293	0.517	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	3839	All	LOAD	AD	intergenic_region
chr11	86109035	rs543293	0.543	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	3722	All	LOAD	AD	intergenic_region
chr11	86109035	rs543293	0.599	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	1672	APOE-e4-	LOAD	AD	intergenic_region
chr11	86109035	rs543293	0.641	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	1422	APOE-e3/e3	LOAD	AD	intergenic_region
chr11	86109035	rs543293	0.701	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	intergenic_region
chr11	86109035	rs543293	0.71	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	intergenic_region
chr11	86109035	rs543293	0.722	PICALM	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intergenic_region
chr11	86109035	rs543293	0.932	PICALM	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intergenic_region
chr11	86109035	rs543293	0.967	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	250	APOE-e3/e2+e2/e2	LOAD	AD	intergenic_region
chr11	86109035	rs543293	0.98	PICALM	NR	NR	1	1	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4- carrier	AD	AD	intergenic_region
chr11	86127766	rs10792830	0.0000064	AP003097.1	NR	NR	1.25	1.25	PICALM	SNP-based	Disease risk	22005930	Caucasian	"ADGC, GERAD, Cohort from UK"	7693	AD+P and control subjects	AD+Psychosis	ADRD	intergenic_region
chr11	86139201	rs3844143	0.000779	PICALM	T	T	NR	NA	PICALM	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Low-density lipoprotein (LDL)	Non-ADRD	intergenic_region
chr11	86139201	rs3844143	0.162	PICALM	T	T	0.93	0.93	PICALM	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intergenic_region
chr11	86139201	rs3844143	1.27E-08	"FNTAL1, LOC100130431"	NR	NR	NR	NA	PICALM	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr11	86139201	rs3844143	1.33E-16	PICALM	T	T	0.9	0.9	PICALM	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intergenic_region
chr11	86139201	rs3844143	1.94E-08	PICALM	T	T	NR	NA	PICALM	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr11	86139201	rs3844143	5.31E-11	PICALM	C	C	0.99	0.99	PICALM	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intergenic_region
chr11	86139201	rs3844143	5.31E-11	PICALM	G	G	NR	NA	PICALM	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	intergenic_region
chr11	86139201	rs3844143	6.52E-17	PICALM	T	T	0.9	0.9	PICALM	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intergenic_region
chr11	86142965	rs17148827	0.0089	PICALM	C	C	2.01	2.01	PICALM	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intergenic_region
chr11	86147496	rs7941541	0.0007	PICALM	G	G	0.89	0.89	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	intergenic_region
chr11	86147496	rs7941541	0.019	PICALM	NR	NR	0.049	1.05022	PICALM	SNP-based	Endophenotype	21116278	Caucasian	"AddNeuroMed, ADNI"	939	All	Entorhinal cortex thickness	Imaging	intergenic_region
chr11	86147496	rs7941541	0.0243	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	3461	Northwestern European ancestry	LOAD	AD	intergenic_region
chr11	86147496	rs7941541	0.0338	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	2167	APOE-e4+	LOAD	AD	intergenic_region
chr11	86147496	rs7941541	0.0479	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	3839	All	LOAD	AD	intergenic_region
chr11	86147496	rs7941541	0.0596	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	1642	APOE-e4/e3	LOAD	AD	intergenic_region
chr11	86147496	rs7941541	0.099	PICALM	NR	NR	0.9	0.9	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4+ carrier	AD	AD	intergenic_region
chr11	86147496	rs7941541	0.156	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	intergenic_region
chr11	86147496	rs7941541	0.21	PICALM	G	G	0.95	0.95	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	intergenic_region
chr11	86147496	rs7941541	0.279	PICALM	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intergenic_region
chr11	86147496	rs7941541	0.39	PICALM	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intergenic_region
chr11	86147496	rs7941541	0.448	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	3786	All	LOAD	AD	intergenic_region
chr11	86147496	rs7941541	0.55	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	3839	All	LOAD	AD	intergenic_region
chr11	86147496	rs7941541	0.595	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	intergenic_region
chr11	86147496	rs7941541	0.612	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	intergenic_region
chr11	86147496	rs7941541	0.648	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	3722	All	LOAD	AD	intergenic_region
chr11	86147496	rs7941541	0.684	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	1672	APOE-e4-	LOAD	AD	intergenic_region
chr11	86147496	rs7941541	0.72	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	250	APOE-e3/e2+e2/e2	LOAD	AD	intergenic_region
chr11	86147496	rs7941541	0.73	PICALM	NR	NR	0.98	0.98	PICALM	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4- carrier	AD	AD	intergenic_region
chr11	86147496	rs7941541	0.732	PICALM	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intergenic_region
chr11	86147496	rs7941541	0.795	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	1422	APOE-e3/e3	LOAD	AD	intergenic_region
chr11	86147496	rs7941541	0.805	CUGBP2	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21379329	Caucasian	ADGC	408	APOE-e4/e4	LOAD	AD	intergenic_region
chr11	86147496	rs7941541	0.902	PICALM	NR	NR	NR	NA	PICALM	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intergenic_region
chr11	86148441	rs10898439	2.96E-09	"FNTAL1, LOC100130431"	NR	NR	NR	NA	PICALM	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	upstream_gene_variant
chr11	86156833	rs10792832	0.00013	PICALM 	A	A	0.8	0.8	PICALM	SNP-based	Endophenotype	25188341	Caucasian	ADGC	4914	All	Clinico-pathologic AD dementia (No neuropathologist documentation)	Neuropathology	downstream_gene_variant
chr11	86156833	rs10792832	0.00021	EED	NR	NR	NR	NA	PICALM	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	EED (t3343202) expression in medulla (MEDU)	Expression	downstream_gene_variant
chr11	86156833	rs10792832	0.0017	PICALM 	A	A	0.79	0.79	PICALM	SNP-based	Endophenotype	25188341	Caucasian	ADGC	3702	All	Clinico-pathologic AD dementia (with neuropathologist documentation)	Neuropathology	downstream_gene_variant
chr11	86156833	rs10792832	0.0041	EED	NR	NR	NR	NA	PICALM	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	EED (t3343202) expression in putamen (PUTM)	Expression	downstream_gene_variant
chr11	86156833	rs10792832	0.0044	EED	NR	NR	NR	NA	PICALM	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	EED (t3343202) expression in thalamus (THAL)	Expression	downstream_gene_variant
chr11	86156833	rs10792832	0.12	EED	NR	NR	NR	NA	PICALM	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	EED (t3343202) expression in intra-locular white matter (WHMT)	Expression	downstream_gene_variant
chr11	86156833	rs10792832	0.12	EED	NR	NR	NR	NA	PICALM	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	EED (t3343202) expression in substantia nigra (SNIG)	Expression	downstream_gene_variant
chr11	86156833	rs10792832	0.22	EED	NR	NR	NR	NA	PICALM	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	EED (t3343202) expression in temporal cortex (TCTX)	Expression	downstream_gene_variant
chr11	86156833	rs10792832	0.36	EED	NR	NR	NR	NA	PICALM	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	EED (t3343202) expression in occipital cortex (OCTX)	Expression	downstream_gene_variant
chr11	86156833	rs10792832	0.44	EED	NR	NR	NR	NA	PICALM	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	EED (t3343202) expression in cerebellar cortex (CRBL)	Expression	downstream_gene_variant
chr11	86156833	rs10792832	0.56	EED	NR	NR	NR	NA	PICALM	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	EED (t3343202) expression in hippocampus (HIPP)	Expression	downstream_gene_variant
chr11	86156833	rs10792832	0.98	EED	NR	NR	NR	NA	PICALM	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	EED (t3343202) expression in frontal cortex (FCTX)	Expression	downstream_gene_variant
chr11	86156833	rs10792832	1.10E-11	PICALM	A	A	0.85	0.85	PICALM	SNP-based	Disease risk	24162737	Caucasian	Cohorts from Europe and USA	19884	All	LOAD	AD	downstream_gene_variant
chr11	86156833	rs10792832	1.12E-17	PICALM	G	G	NR	NA	PICALM	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ"	79145	All	AD	AD	downstream_gene_variant
chr11	86156833	rs10792832	6.50E-16	PICALM	A	A	0.88	0.88	PICALM	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD"	54162	All	LOAD	AD	downstream_gene_variant
chr11	86156833	rs10792832	9.30E-26	PICALM	A	A	0.87	0.87	PICALM	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD, Cohorts from Europe and USA"	74046	All	LOAD	AD	downstream_gene_variant
chr11	86156833	rs10792832	NR	PICALM	G	G	1.16	1.16	PICALM	SNP-based	Disease risk	27849641	Caucasian	ADGC	589	All	Symptomatic AD (CDR global score >=0.5)	AD	downstream_gene_variant
chr11	86156833	rs10792832	NR	ZCWPW1	G	G	1.03	1.03	PICALM	SNP-based	Disease risk	27849641	Caucasian	ADGC	292	APOE-e4 carriers	Symptomatic AD (CDR global score >=0.5)	AD	downstream_gene_variant
chr11	86156833	rs10792832	NR	ZCWPW1	G	G	1.15	1.15	PICALM	SNP-based	Disease risk	27849641	Caucasian	ADGC	297	APOE-e4 non-carriers	Symptomatic AD (CDR global score >=0.5)	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.000000019	PICALM	NR	NR	0.85	0.85	EED	SNP-based	Disease risk	19734902	Caucasian	Cohorts from Europe and USA	11789	All	AD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.00000281	PICALM	T	T	0.89	0.89	EED	SNP-based	Disease risk	20460622	Caucasian	"ADGC, CHARGE, EADI"	24035	All	AD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.0000122	PICALM	T	T	0.86	0.86	EED	SNP-based	Disease risk	20460622	Caucasian	"ADGC, CHARGE"	16675	All	AD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.0000171	PICALM	T	T	0.8	0.8	EED	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	2024	All	LOAD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.000039	PICALM	T	T	0.89	0.89	EED	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.0034	PICALM	NR	NR	0.86	0.86	EED	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4+ carrier	AD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.006	PICALM	A	A	0.87	0.87	EED	SNP-based	Disease risk	21390209	Caucasian	"ADNI, GenADA, Pfizer"	3595	All	AD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.007	PICALM	NR	NR	0.84	0.84	EED	SNP-based	Disease risk	20460622	Caucasian	Cohort from Europe	2349	All	AD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.01	PICALM	NR	NR	0.066	1.06823	EED	SNP-based	Endophenotype	20558387	Caucasian	ADNI	740	All	Entorhinal cortex thickness	Imaging	downstream_gene_variant
chr11	86157598	rs3851179	0.014	PICALM	NR	NR	0.9	0.9	EED	SNP-based	Disease risk	19734902	Caucasian	Cohorts from Europe and USA	4363	All	AD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.0152	CUGBP2	NR	NR	NR	NA	EED	SNP-based	Disease risk	21379329	Caucasian	ADGC	3461	Northwestern European ancestry	LOAD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.018	PICALM	A	A	0.84	0.84	EED	SNP-based	Disease risk	21390209	Caucasian	ADGC	1525	All	AD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.0199	PICALM	T	T	0.79	0.79	EED	SNP-based	Disease risk	23565137	Asian	Cohort from Korea	1468	All	LOAD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.021	PICALM	NR	NR	NR	NA	EED	SNP-based	Endophenotype	21390209	Caucasian	"ADNI, leadC"	597	AD subjects	AD Progression	Cognitive	downstream_gene_variant
chr11	86157598	rs3851179	0.026	PICALM	T	T	0.93	0.93	EED	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.034	PICALM	NR	NR	0.043	1.04394	EED	SNP-based	Endophenotype	21116278	Caucasian	"AddNeuroMed, ADNI"	939	All	Entorhinal cortex thickness	Imaging	downstream_gene_variant
chr11	86157598	rs3851179	0.039	CUGBP2	NR	NR	NR	NA	EED	SNP-based	Disease risk	21379329	Caucasian	ADGC	3839	All	LOAD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.04	PICALM	NR	NR	0.061	1.0629	EED	SNP-based	Endophenotype	20558387	Caucasian	ADNI	740	All	Hippocampal volume	Imaging	downstream_gene_variant
chr11	86157598	rs3851179	0.06	PICALM	NR	NR	0.033	1.03355	EED	SNP-based	Endophenotype	20558387	Caucasian	ADNI	740	All	Temporal pole cortex thickness	Imaging	downstream_gene_variant
chr11	86157598	rs3851179	0.0817	PICALM	NR	NR	NR	NA	EED	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.118	CUGBP2	NR	NR	NR	NA	EED	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.118	CUGBP2	NR	NR	NR	NA	EED	SNP-based	Disease risk	21379329	Caucasian	ADGC	2167	APOE-e4+	LOAD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.157	PICALM	T	T	0.85	0.85	EED	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.171	PICALM	A	A	0.9	0.9	EED	SNP-based	Disease risk	21390209	Caucasian	GenADA	1574	All	AD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.199	CUGBP2	NR	NR	NR	NA	EED	SNP-based	Disease risk	21379329	Caucasian	ADGC	1642	APOE-e4/e3	LOAD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.21	PICALM	NR	NR	NR	NA	EED	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.29	PICALM	NR	NR	0.014	1.0141	EED	SNP-based	Endophenotype	20558387	Caucasian	ADNI	740	All	Parahippocampal gyrus cortex thickness	Imaging	downstream_gene_variant
chr11	86157598	rs3851179	0.321	PICALM	NR	NR	NR	NA	EED	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.39	PICALM	NR	NR	0.94	0.94	EED	SNP-based	Endophenotype	26993346	Caucasian	Cohort from Europe	10840	All	PCA (posterior cortical atrophy)	Imaging	downstream_gene_variant
chr11	86157598	rs3851179	0.392	PICALM	A	A	0.89	0.89	EED	SNP-based	Disease risk	21390209	Caucasian	ADNI	496	All	AD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.446	PICALM	NR	NR	NR	NA	EED	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.47	PICALM	NR	NR	0.009	1.00904	EED	SNP-based	Endophenotype	20558387	Caucasian	ADNI	740	All	Amygdala volume	Imaging	downstream_gene_variant
chr11	86157598	rs3851179	0.629	CUGBP2	NR	NR	NR	NA	EED	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.632	CUGBP2	NR	NR	NR	NA	EED	SNP-based	Disease risk	21379329	Caucasian	ADGC	3839	All	LOAD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.653	CUGBP2	NR	NR	NR	NA	EED	SNP-based	Disease risk	21379329	Caucasian	ADGC	1422	APOE-e3/e3	LOAD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.655	CUGBP2	NR	NR	NR	NA	EED	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.677	CUGBP2	NR	NR	NR	NA	EED	SNP-based	Disease risk	21379329	Caucasian	ADGC	250	APOE-e3/e2+e2/e2	LOAD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.695	CUGBP2	NR	NR	NR	NA	EED	SNP-based	Disease risk	21379329	Caucasian	ADGC	3722	All	LOAD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.73	PICALM	NR	NR	0.99	0.99	EED	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4- carrier	AD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.799	CUGBP2	NR	NR	NR	NA	EED	SNP-based	Disease risk	21379329	Caucasian	ADGC	1672	APOE-e4-	LOAD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.851	CUGBP2	NR	NR	NR	NA	EED	SNP-based	Disease risk	21379329	Caucasian	ADGC	3786	All	LOAD	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.87	PICALM	NR	NR	0.99	0.99	EED	SNP-based	Disease risk	20558387	Caucasian	ADNI	740	All	AD + MCI	AD	downstream_gene_variant
chr11	86157598	rs3851179	0.97	PICALM	NR	NR	-0.005	0.995012	EED	SNP-based	Endophenotype	20558387	Caucasian	ADNI	740	All	White matter lesion volume	Imaging	downstream_gene_variant
chr11	86157598	rs3851179	0.976	CUGBP2	NR	NR	NR	NA	EED	SNP-based	Disease risk	21379329	Caucasian	ADGC	408	APOE-e4/e4	LOAD	AD	downstream_gene_variant
chr11	86157598	rs3851179	1.30E-09	PICALM	NR	NR	0.86	0.86	EED	SNP-based	Disease risk	19734902	Caucasian	Cohorts from Europe and USA	19052	All	AD	AD	downstream_gene_variant
chr11	86157598	rs3851179	3.16E-12	PICALM	T	T	0.87	0.87	EED	SNP-based	Disease risk	20460622	Caucasian	"ADGC, CHARGE, EADI, GERAD"	34363	All	AD	AD	downstream_gene_variant
chr11	86157598	rs3851179	5.80E-16	PICALM	T	T	0.89	0.89	EED	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	63926	All	Clinically diagnosed LOAD	AD	downstream_gene_variant
chr11	86157598	rs3851179	6.00E-25	PICALM	T	T	0.88	0.88	EED	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	82771	All	Clinically diagnosed LOAD	AD	downstream_gene_variant
chr11	86157598	rs3851179	6.10E-11	PICALM	T	T	0.85	0.85	EED	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	18845	All	Clinically diagnosed LOAD	AD	downstream_gene_variant
chr11	93036582	rs271057	0.0000068	"MTNR1B, SLC36A4"	NR	NR	NR	NA	MTNR1B	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intergenic_region
chr11	94963977	rs7937776	0.0006	HSPC148	C	C	NR	NA	CWC15	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr11	94963977	rs7937776	0.00067	HSPC148	C	C	NR	NA	CWC15	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intron_variant
chr11	94963977	rs7937776	0.0007	HSPC148	C	C	NR	NA	CWC15	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr11	95804194	rs3017756	0.0113	CEP57	NR	NR	NR	NA	CEP57	SNP-based	Endophenotype	22245343	Caucasian	ADNI	757	All	MRI	Imaging	intron_variant
chr11	97180604	rs1690600	0.00000162	NR	NR	NR	NR	NA	JRKL	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intergenic_region
chr11	97180784	rs1793382	0.00000128	NR	NR	NR	NR	NA	JRKL	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intergenic_region
chr11	98646026	rs3018573	0.00000681	NR	G	G	NR	NA	CNTN5	SNP-based	Disease risk	24770881	Caucasian	ADGC	2239	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	intergenic_region
chr11	99206206	rs10892901	0.0196	CNTN5	NR	NR	NR	NA	CNTN5	SNP-based	Endophenotype	22245343	Caucasian	ADNI	757	All	MRI	Imaging	intron_variant
chr11	99886997	rs10501927	0.000002	CNTN5	NR	NR	1.18	1.18	CNTN5	SNP-based	Disease risk	19734902	Caucasian	Cohorts from Europe and USA	11789	All	AD	AD	intron_variant
chr11	99886997	rs10501927	0.002	CNTN5	NR	NR	0.119	1.12637	CNTN5	SNP-based	Endophenotype	20558387	Caucasian	ADNI	740	All	White matter lesion volume	Imaging	intron_variant
chr11	99886997	rs10501927	0.02	CNTN5	NR	NR	-0.067	0.935195	CNTN5	SNP-based	Endophenotype	20558387	Caucasian	ADNI	740	All	Entorhinal cortex thickness	Imaging	intron_variant
chr11	99886997	rs10501927	0.02	CR1	NR	NR	-0.051	0.950279	CNTN5	SNP-based	Endophenotype	20558387	Caucasian	ADNI	740	All	Temporal pole cortex thickness	Imaging	intron_variant
chr11	99886997	rs10501927	0.03	CNTN5	NR	NR	1.25	1.25	CNTN5	SNP-based	Disease risk	20558387	Caucasian	ADNI	740	All	AD + MCI	AD	intron_variant
chr11	99886997	rs10501927	0.05	CNTN5	NR	NR	-0.04	0.960789	CNTN5	SNP-based	Endophenotype	20558387	Caucasian	ADNI	740	All	Parahippocampal gyrus cortex thickness	Imaging	intron_variant
chr11	99886997	rs10501927	0.17	CNTN5	NR	NR	-0.046	0.955042	CNTN5	SNP-based	Endophenotype	20558387	Caucasian	ADNI	740	All	Hippocampal volume	Imaging	intron_variant
chr11	99886997	rs10501927	0.19	CNTN5	NR	NR	-0.018	0.982161	CNTN5	SNP-based	Endophenotype	20558387	Caucasian	ADNI	740	All	Amygdala volume	Imaging	intron_variant
chr11	102809498	rs603050	0.000000178	MMP3	NR	NR	NR	NA	MMP1	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR = 0	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102809498	rs603050	0.00000439	MMP3	T	T	NR	NA	MMP1	SNP-based	Endophenotype	25340798	Caucasian	ADNI	308	All	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102809498	rs603050	0.0000986	MMP3	T	T	NR	NA	MMP1	SNP-based	Endophenotype	25340798	Caucasian	Knight-ADRC	266	All	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102809498	rs603050	0.000118	MMP3	NR	NR	NR	NA	MMP1	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	No amyloid deposition strata	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102809498	rs603050	0.00369	MMP3	NR	NR	NR	NA	MMP1	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Amyloid deposition strata	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102809498	rs603050	0.00395	MMP3	NR	NR	NR	NA	MMP1	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR > 0	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102809498	rs603050	0.268	MMP3	NR	NR	NR	NA	MMP1	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	Plasma MMP3 	Fluid biomarker	intron_variant
chr11	102809498	rs603050	0.4	MMP3	NR	NR	0.015	1.01511	MMP1	SNP-based	Disease risk	25340798	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr11	102809498	rs603050	0.67	MMP3	NR	NR	NR	NA	MMP1	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF T-tau	Fluid biomarker	intron_variant
chr11	102809498	rs603050	0.75	MMP3	NR	NR	NR	NA	MMP1	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr11	102809498	rs603050	0.9	MMP3	NR	NR	NR	NA	MMP1	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF Ab1-42	Fluid biomarker	intron_variant
chr11	102809498	rs603050	1.84E-09	MMP3	T	T	NR	NA	MMP1	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102820751	rs11225434	0.000032	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	No amyloid deposition strata	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102820751	rs11225434	0.0000612	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR = 0	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102820751	rs11225434	0.0292	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	Plasma MMP3 	Fluid biomarker	intron_variant
chr11	102820751	rs11225434	0.091	MMP3	NR	NR	-0.027	0.973361	MMP3	SNP-based	Disease risk	25340798	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr11	102820751	rs11225434	0.86	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF Ab1-42	Fluid biomarker	intron_variant
chr11	102820751	rs11225434	0.91	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF T-tau	Fluid biomarker	intron_variant
chr11	102820751	rs11225434	0.94	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr11	102820751	rs11225434	1.69E-12	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Amyloid deposition strata	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102820751	rs11225434	4.50E-39	MMP3	C	C	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102820751	rs11225434	4.94E-24	MMP3	C	C	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	ADNI	308	All	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102820751	rs11225434	5.67E-14	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR > 0	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102820751	rs11225434	7.38E-17	MMP3	C	C	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	Knight-ADRC	266	All	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102824377	rs495366	0.000000232	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR = 0	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102824377	rs495366	0.00000184	MMP3	A	A	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	ADNI	308	All	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102824377	rs495366	0.00000773	MMP3	A	A	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	Knight-ADRC	266	All	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102824377	rs495366	0.00025	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR > 0	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102824377	rs495366	0.00607	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Amyloid deposition strata	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102824377	rs495366	0.29	MMP3	NR	NR	0.018	1.01816	MMP3	SNP-based	Disease risk	25340798	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr11	102824377	rs495366	0.466	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	Plasma MMP3 	Fluid biomarker	intron_variant
chr11	102824377	rs495366	0.64	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr11	102824377	rs495366	0.78	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF T-tau	Fluid biomarker	intron_variant
chr11	102824377	rs495366	0.92	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF Ab1-42	Fluid biomarker	intron_variant
chr11	102824377	rs495366	2.25E-09	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	No amyloid deposition strata	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102824377	rs495366	6.19E-11	MMP3	A	A	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102827993	rs7926920	0.000000122	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	No amyloid deposition strata	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102827993	rs7926920	0.000000152	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR = 0	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102827993	rs7926920	0.0489	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	Plasma MMP3 	Fluid biomarker	intron_variant
chr11	102827993	rs7926920	0.053	MMP3	NR	NR	-0.029	0.971416	MMP3	SNP-based	Disease risk	25340798	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr11	102827993	rs7926920	0.74	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr11	102827993	rs7926920	0.76	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF T-tau	Fluid biomarker	intron_variant
chr11	102827993	rs7926920	0.99	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF Ab1-42	Fluid biomarker	intron_variant
chr11	102827993	rs7926920	1.32E-25	MMP3	A	A	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	ADNI	308	All	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102827993	rs7926920	1.57E-18	MMP3	A	A	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	Knight-ADRC	266	All	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102827993	rs7926920	1.90E-13	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Amyloid deposition strata	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102827993	rs7926920	1.95E-14	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR > 0	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102827993	rs7926920	2.56E-42	MMP3	A	A	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102838056	rs650108	0.000000177	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR = 0	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102838056	rs650108	0.000000829	MMP3	A	A	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	ADNI	308	All	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102838056	rs650108	0.0000268	MMP3	A	A	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	Knight-ADRC	266	All	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102838056	rs650108	0.000266	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR > 0	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102838056	rs650108	0.00346	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Amyloid deposition strata	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102838056	rs650108	0.31	MMP3	NR	NR	0.018	1.01816	MMP3	SNP-based	Disease risk	25340798	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr11	102838056	rs650108	0.562	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	Plasma MMP3 	Fluid biomarker	intron_variant
chr11	102838056	rs650108	0.59	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF T-tau	Fluid biomarker	intron_variant
chr11	102838056	rs650108	0.63	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr11	102838056	rs650108	0.95	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF Ab1-42	Fluid biomarker	intron_variant
chr11	102838056	rs650108	1.01E-10	MMP3	A	A	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102838056	rs650108	1.33E-08	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	No amyloid deposition strata	CSF MMP3 	Fluid biomarker	intron_variant
chr11	102842889	rs679620	0.0444	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	Plasma MMP3 	Fluid biomarker	missense_variant
chr11	102842889	rs679620	0.046	MMP3	NR	NR	-0.032	0.968507	MMP3	SNP-based	Disease risk	25340798	Caucasian	IGAP	54162	All	AD	AD	missense_variant
chr11	102842889	rs679620	0.51	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF P-tau181p	Fluid biomarker	missense_variant
chr11	102842889	rs679620	0.68	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF T-tau	Fluid biomarker	missense_variant
chr11	102842889	rs679620	0.96	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF Ab1-42	Fluid biomarker	missense_variant
chr11	102842889	rs679620	1.54E-09	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR = 0	CSF MMP3 	Fluid biomarker	missense_variant
chr11	102842889	rs679620	3.07E-14	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR > 0	CSF MMP3 	Fluid biomarker	missense_variant
chr11	102842889	rs679620	4.93E-44	MMP3	A	A	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF MMP3 	Fluid biomarker	missense_variant
chr11	102842889	rs679620	6.05E-15	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Amyloid deposition strata	CSF MMP3 	Fluid biomarker	missense_variant
chr11	102842889	rs679620	6.36E-26	MMP3	A	A	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	ADNI	308	All	CSF MMP3 	Fluid biomarker	missense_variant
chr11	102842889	rs679620	7.12E-20	MMP3	A	A	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	Knight-ADRC	266	All	CSF MMP3 	Fluid biomarker	missense_variant
chr11	102842889	rs679620	9.95E-08	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	No amyloid deposition strata	CSF MMP3 	Fluid biomarker	missense_variant
chr11	102845590	rs645419	0.039	MMP3	NR	NR	-0.032	0.968507	MMP3	SNP-based	Disease risk	25340798	Caucasian	IGAP	54162	All	AD	AD	upstream_gene_variant
chr11	102845590	rs645419	0.0444	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	Plasma MMP3 	Fluid biomarker	upstream_gene_variant
chr11	102845590	rs645419	0.5	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF P-tau181p	Fluid biomarker	upstream_gene_variant
chr11	102845590	rs645419	0.68	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF T-tau	Fluid biomarker	upstream_gene_variant
chr11	102845590	rs645419	0.96	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF Ab1-42	Fluid biomarker	upstream_gene_variant
chr11	102845590	rs645419	1.02E-09	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR = 0	CSF MMP3 	Fluid biomarker	upstream_gene_variant
chr11	102845590	rs645419	3.07E-14	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR > 0	CSF MMP3 	Fluid biomarker	upstream_gene_variant
chr11	102845590	rs645419	3.26E-44	MMP3	A	A	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF MMP3 	Fluid biomarker	upstream_gene_variant
chr11	102845590	rs645419	4.10E-15	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Amyloid deposition strata	CSF MMP3 	Fluid biomarker	upstream_gene_variant
chr11	102845590	rs645419	4.15E-26	MMP3	A	A	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	ADNI	308	All	CSF MMP3 	Fluid biomarker	upstream_gene_variant
chr11	102845590	rs645419	7.12E-20	MMP3	A	A	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	Knight-ADRC	266	All	CSF MMP3 	Fluid biomarker	upstream_gene_variant
chr11	102845590	rs645419	9.95E-08	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	No amyloid deposition strata	CSF MMP3 	Fluid biomarker	upstream_gene_variant
chr11	102846249	rs573521	0.038	MMP3	NR	NR	-0.032	0.968507	MMP3	SNP-based	Disease risk	25340798	Caucasian	IGAP	54162	All	AD	AD	upstream_gene_variant
chr11	102846249	rs573521	0.0444	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	Plasma MMP3 	Fluid biomarker	upstream_gene_variant
chr11	102846249	rs573521	0.5	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF P-tau181p	Fluid biomarker	upstream_gene_variant
chr11	102846249	rs573521	0.67	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF T-tau	Fluid biomarker	upstream_gene_variant
chr11	102846249	rs573521	0.812	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR = 0	CSF MMP3 	Fluid biomarker	upstream_gene_variant
chr11	102846249	rs573521	0.93	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF Ab1-42	Fluid biomarker	upstream_gene_variant
chr11	102846249	rs573521	2.39E-44	MMP3	A	A	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF MMP3 	Fluid biomarker	upstream_gene_variant
chr11	102846249	rs573521	3.00E-26	MMP3	A	A	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	ADNI	308	All	CSF MMP3 	Fluid biomarker	upstream_gene_variant
chr11	102846249	rs573521	3.07E-14	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR > 0	CSF MMP3 	Fluid biomarker	upstream_gene_variant
chr11	102846249	rs573521	3.40E-15	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Amyloid deposition strata	CSF MMP3 	Fluid biomarker	upstream_gene_variant
chr11	102846249	rs573521	7.12E-20	MMP3	A	A	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	Knight-ADRC	266	All	CSF MMP3 	Fluid biomarker	upstream_gene_variant
chr11	102846249	rs573521	9.95E-08	MMP3	NR	NR	NR	NA	MMP3	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	No amyloid deposition strata	CSF MMP3 	Fluid biomarker	upstream_gene_variant
chr11	102862432	rs12808148	0.00000124	"MMP3, MMP12"	NR	NR	0.81	0.81	MMP12	SNP-based	Disease risk	22832961	Caucasian	ADGC	8292	All	LOAD	AD	downstream_gene_variant
chr11	102862432	rs12808148	0.0000102	"MMP3, MMP12"	NR	NR	NR	NA	MMP12	SNP-based	Disease risk	22832961	Caucasian	ADGC	8292	All	LOAD	AD	downstream_gene_variant
chr11	102862432	rs12808148	0.00138	"MMP3, MMP12"	NR	NR	0.76	0.76	MMP12	SNP-based	Disease risk	22832961	Caucasian	ADGC	2229	All	LOAD	AD	downstream_gene_variant
chr11	102862432	rs12808148	0.015	"MMP3, MMP12"	NR	NR	0.82	0.82	MMP12	SNP-based	Disease risk	22832961	Caucasian	ADGC	2321	All	LOAD	AD	downstream_gene_variant
chr11	102862432	rs12808148	0.0455	"MMP3, MMP12"	NR	NR	0.82	0.82	MMP12	SNP-based	Disease risk	22832961	Caucasian	ADGC	2099	All	LOAD	AD	downstream_gene_variant
chr11	102862432	rs12808148	0.056	"MMP3, MMP12"	NR	NR	0.62	0.62	MMP12	SNP-based	Disease risk	22832961	Caucasian	ADNI	381	All	LOAD	AD	downstream_gene_variant
chr11	102862432	rs12808148	0.139	"MMP3, MMP12"	NR	NR	0.87	0.87	MMP12	SNP-based	Disease risk	22832961	Caucasian	MIRAGE	1262	All	LOAD	AD	downstream_gene_variant
chr11	102900410	rs948399	0.000000178	MMP3	NR	NR	NR	NA	MMP12	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Amyloid deposition strata	CSF MMP3 	Fluid biomarker	downstream_gene_variant
chr11	102900410	rs948399	0.000000542	MMP3	NR	NR	NR	NA	MMP12	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR = 0	CSF MMP3 	Fluid biomarker	downstream_gene_variant
chr11	102900410	rs948399	0.000000961	MMP3	T	T	NR	NA	MMP12	SNP-based	Endophenotype	25340798	Caucasian	ADNI	308	All	CSF MMP3 	Fluid biomarker	downstream_gene_variant
chr11	102900410	rs948399	0.00000893	MMP3	T	T	NR	NA	MMP12	SNP-based	Endophenotype	25340798	Caucasian	Knight-ADRC	266	All	CSF MMP3 	Fluid biomarker	downstream_gene_variant
chr11	102900410	rs948399	0.0000228	MMP3	NR	NR	NR	NA	MMP12	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	No amyloid deposition strata	CSF MMP3 	Fluid biomarker	downstream_gene_variant
chr11	102900410	rs948399	0.0000635	MMP3	NR	NR	NR	NA	MMP12	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR > 0	CSF MMP3 	Fluid biomarker	downstream_gene_variant
chr11	102900410	rs948399	0.0137	MMP3	NR	NR	NR	NA	MMP12	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	Plasma MMP3 	Fluid biomarker	downstream_gene_variant
chr11	102900410	rs948399	0.18	MMP3	NR	NR	NR	NA	MMP12	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF T-tau	Fluid biomarker	downstream_gene_variant
chr11	102900410	rs948399	0.23	MMP3	NR	NR	NR	NA	MMP12	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF P-tau181p	Fluid biomarker	downstream_gene_variant
chr11	102900410	rs948399	0.74	MMP3	NR	NR	0.006	1.00602	MMP12	SNP-based	Disease risk	25340798	Caucasian	IGAP	54162	All	AD	AD	downstream_gene_variant
chr11	102900410	rs948399	0.76	MMP3	NR	NR	NR	NA	MMP12	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF Ab1-42	Fluid biomarker	downstream_gene_variant
chr11	102900410	rs948399	4.29E-11	MMP3	T	T	NR	NA	MMP12	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF MMP3 	Fluid biomarker	downstream_gene_variant
chr11	105974196	rs509512	0.00000737	GRIA4	C	C	0.75	0.75	GRIA4	SNP-based	Disease risk	20885792	Caucasian	"CAP, MSBB, NCRAD"	2035	All	LOAD	AD	intron_variant
chr11	105974196	rs509512	0.133	GRIA4	C	C	0.94	0.94	GRIA4	SNP-based	Disease risk	20885792	Caucasian	"ADGC, CAP, CHARGE"	4355	All	LOAD	AD	intron_variant
chr11	105974196	rs509512	0.439	GRIA4	C	C	1.04	1.04	GRIA4	SNP-based	Disease risk	20885792	Caucasian	"ADGC, CAP, CHARGE"	2979	All	LOAD	AD	intron_variant
chr11	111017760	rs978769	0.0000029	NR	NR	NR	NR	NA	C11orf53	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intergenic_region
chr11	111017760	rs978769	0.000074	NR	NR	NR	0.66	0.66	C11orf53	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intergenic_region
chr11	111017760	rs978769	0.000287	NR	NR	NR	NR	NA	C11orf53	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intergenic_region
chr11	111017760	rs978769	0.00308	NR	NR	NR	NR	NA	C11orf53	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intergenic_region
chr11	111017760	rs978769	0.00681	NR	NR	NR	0.56	0.56	C11orf53	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intergenic_region
chr11	111017760	rs978769	0.0572	NR	NR	NR	NR	NA	C11orf53	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intergenic_region
chr11	111017760	rs978769	0.0605	NR	NR	NR	0.73	0.73	C11orf53	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intergenic_region
chr11	111017760	rs978769	0.25093	NR	NR	NR	NR	NA	C11orf53	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intergenic_region
chr11	111017760	rs978769	0.674	NR	NR	NR	NR	NA	C11orf53	SNP-based	Disease risk	21059989	Caucasian	ADGC	1390	Unrelated individuals	LOAD	AD	intergenic_region
chr11	111017868	rs978770	0.00000149	NR	NR	NR	NR	NA	C11orf53	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intergenic_region
chr11	111017868	rs978770	0.000041	NR	NR	NR	0.65	0.65	C11orf53	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intergenic_region
chr11	111017868	rs978770	0.000223	NR	NR	NR	NR	NA	C11orf53	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intergenic_region
chr11	111017868	rs978770	0.00208	NR	NR	NR	NR	NA	C11orf53	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intergenic_region
chr11	111017868	rs978770	0.00527	NR	NR	NR	0.56	0.56	C11orf53	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intergenic_region
chr11	111017868	rs978770	0.0406	NR	NR	NR	0.72	0.72	C11orf53	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intergenic_region
chr11	111017868	rs978770	0.05678	NR	NR	NR	NR	NA	C11orf53	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intergenic_region
chr11	111017868	rs978770	0.25242	NR	NR	NR	NR	NA	C11orf53	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intergenic_region
chr11	111017868	rs978770	0.683	NR	NR	NR	NR	NA	C11orf53	SNP-based	Disease risk	21059989	Caucasian	ADGC	1390	Unrelated individuals	LOAD	AD	intergenic_region
chr11	111019216	rs11213703	0.00000235	NR	NR	NR	NR	NA	C11orf53	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intergenic_region
chr11	111019216	rs11213703	0.000063	NR	NR	NR	0.66	0.66	C11orf53	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intergenic_region
chr11	111019216	rs11213703	0.000287	NR	NR	NR	NR	NA	C11orf53	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intergenic_region
chr11	111019216	rs11213703	0.00246	NR	NR	NR	NR	NA	C11orf53	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intergenic_region
chr11	111019216	rs11213703	0.00681	NR	NR	NR	0.56	0.56	C11orf53	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intergenic_region
chr11	111019216	rs11213703	0.0534	NR	NR	NR	0.72	0.72	C11orf53	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intergenic_region
chr11	111019216	rs11213703	0.06128	NR	NR	NR	NR	NA	C11orf53	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intergenic_region
chr11	111019216	rs11213703	0.30704	NR	NR	NR	NR	NA	C11orf53	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intergenic_region
chr11	111019216	rs11213703	0.633	NR	NR	NR	NR	NA	C11orf53	SNP-based	Disease risk	21059989	Caucasian	ADGC	1390	Unrelated individuals	LOAD	AD	intergenic_region
chr11	116807007	rs1263167	0.0342	APOA4	NR	NR	-4.36	0.0127784	APOA4	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	IMAS	59	All	Plasma ApoA-IV	Fluid biomarker	intergenic_region
chr11	116807007	rs1263167	6.84E-31	APOA4	NR	NR	-0.15	0.860708	APOA4	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	ADNI	521	All	Plasma ApoA-IV	Fluid biomarker	intergenic_region
chr11	116807697	rs1263170	0.000655	APOA4	T	T	NR	NA	APOA4	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr11	116807697	rs1263170	0.00337	APOA4	T	T	1.05	1.05	APOA4	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intergenic_region
chr11	116807697	rs1263170	0.00422	APOA4	T	T	1.04	1.04	APOA4	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intergenic_region
chr11	116807697	rs1263170	0.442	APOA4	T	T	1	1	APOA4	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intergenic_region
chr11	116807697	rs1263170	0.895	APOA4	T	T	1.01	1.01	APOA4	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intergenic_region
chr11	116807697	rs1263170	4.33E-09	APOA4	T	T	NR	NA	APOA4	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Total triglycerides (TG)	Non-ADRD	intergenic_region
chr11	118559804	rs11552421	1.55E-147	TMEM25	NR	NR	2.67	14.44	IFT46	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	TMEM25 expression in Cerebellar	Expression	missense_variant
chr11	118559804	rs11552421	6.37E-63	TMEM25	NR	NR	2.69	14.7317	IFT46	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	TMEM25 expression in Cerebellar	Expression	missense_variant
chr11	118559804	rs11552421	7.41E-77	TMEM25	NR	NR	2.65	14.154	IFT46	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	TMEM25 expression in Cerebellar	Expression	missense_variant
chr11	121451045	rs4935774	0.809	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121453498	rs17125349	0.236	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121458245	rs661057	0.01	SORL1	C	C	0.94	0.94	SORL1	SNP-based	Disease risk	21220680	Caucasian	"Cohorts from Asia, Europe, and USA"	16753	All	AD	AD	intron_variant
chr11	121458245	rs661057	0.31	SORL1	C	C	0.97	0.97	SORL1	SNP-based	Disease risk	21220680	Caucasian	"Cohorts from Asia, Europe, and USA"	12813	All	AD	AD	intron_variant
chr11	121458245	rs661057	0.61	SORL1	C	C	1.05	1.05	SORL1	SNP-based	Disease risk	21220680	Asian	"Cohorts from Asia, Europe, and USA"	888	All	AD	AD	intron_variant
chr11	121458687	rs610188	0.415	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121467284	rs1784934	0.513	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121469524	rs676160	0.399	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121478402	rs11218304	0.01	SORL1	C	C	1.1	1.1	SORL1	SNP-based	Disease risk	21220680	Caucasian	"Cohorts from Asia, Europe, and USA"	5924	All	AD	AD	intron_variant
chr11	121478402	rs11218304	0.06	SORL1	C	C	1.13	1.13	SORL1	SNP-based	Disease risk	21220680	Caucasian	"Cohorts from Asia, Europe, and USA"	1984	All	AD	AD	intron_variant
chr11	121488556	rs676759	0.648	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121490175	rs560573	0.119	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121490306	rs2298525	0.883	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121491607	rs985421	0.343	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121496917	rs12364988	0.352	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	synonymous_variant
chr11	121497212	rs668387	0.001	SORL1	C	C	1.08	1.08	SORL1	SNP-based	Disease risk	21220680	Caucasian	"Cohorts from Asia, Europe, and USA"	20742	All	AD	AD	intron_variant
chr11	121497212	rs668387	0.01	SORL1	C	C	1.07	1.07	SORL1	SNP-based	Disease risk	21220680	Caucasian	"Cohorts from Asia, Europe, and USA"	16802	All	AD	AD	intron_variant
chr11	121497212	rs668387	0.523	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121497212	rs668387	0.99	SORL1	C	C	0.99	0.99	SORL1	SNP-based	Disease risk	21220680	Asian	"Cohorts from Asia, Europe, and USA"	1753	All	AD	AD	intron_variant
chr11	121498541	rs2101756	0.0192	SORL1	C	C	1.19	1.19	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121500411	rs689021	0.007	SORL1	G	G	1.06	1.06	SORL1	SNP-based	Disease risk	21220680	Caucasian	"Cohorts from Asia, Europe, and USA"	26308	All	AD	AD	intron_variant
chr11	121500411	rs689021	0.03	SORL1	G	G	1.05	1.05	SORL1	SNP-based	Disease risk	21220680	Caucasian	"Cohorts from Asia, Europe, and USA"	22368	All	AD	AD	intron_variant
chr11	121500411	rs689021	0.82	SORL1	G	G	0.99	0.99	SORL1	SNP-based	Disease risk	21220680	Asian	"Cohorts from Asia, Europe, and USA"	1753	All	AD	AD	intron_variant
chr11	121505242	rs4598682	0.0000095	SORL1	G	G	0.75	0.75	SORL1	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	3894	All	LOAD	AD	intron_variant
chr11	121505242	rs4598682	0.0000225	SORL1	G	G	0.68	0.68	SORL1	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	2024	All	LOAD	AD	intron_variant
chr11	121505242	rs4598682	0.0036	SORL1	G	G	0.82	0.82	SORL1	SNP-based	Disease risk	23565137	Multi-ethnic	"ADGC, Cohorts from Japan and Korea "	30559	All	LOAD	AD	intron_variant
chr11	121505242	rs4598682	0.05	SORL1	G	G	0.83	0.83	SORL1	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	1870	All	LOAD	AD	intron_variant
chr11	121505242	rs4598682	0.68	SORL1	G	G	1.04	1.04	SORL1	SNP-based	Disease risk	23565137	Caucasian	ADGC	22771	All	LOAD	AD	intron_variant
chr11	121510256	rs641120	0.002	SORL1	C	C	1.08	1.08	SORL1	SNP-based	Disease risk	21220680	Caucasian	"Cohorts from Asia, Europe, and USA"	15812	All	AD	AD	intron_variant
chr11	121510256	rs641120	0.006	SORL1	C	C	1.08	1.08	SORL1	SNP-based	Disease risk	21220680	Caucasian	"Cohorts from Asia, Europe, and USA"	15411	All	AD	AD	intron_variant
chr11	121510256	rs641120	0.42	SORL1	C	C	0.92	0.92	SORL1	SNP-based	Disease risk	21220680	Asian	"Cohorts from Asia, Europe, and USA"	865	All	AD	AD	intron_variant
chr11	121512162	rs11218313	0.0203	SORL1	C	C	1.55	1.55	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121522517	rs12285364	0.006	SORL1	C	C	0.8	0.8	SORL1	SNP-based	Disease risk	21220680	Caucasian	"Cohorts from Asia, Europe, and USA"	6694	All	AD	AD	intron_variant
chr11	121522517	rs12285364	0.03	SORL1	C	C	0.75	0.75	SORL1	SNP-based	Disease risk	21220680	Caucasian	"Cohorts from Asia, Europe, and USA"	2754	All	AD	AD	intron_variant
chr11	121522517	rs12285364	0.07	SORL1	C	C	0.82	0.82	SORL1	SNP-based	Disease risk	21220680	Asian	"Cohorts from Asia, Europe, and USA"	888	All	AD	AD	intron_variant
chr11	121522517	rs12285364	0.662	SORL1	T	T	1.09	1.09	SORL1	SNP-based	Disease risk	20534741	Caucasian	"ADC, UM"	1610	All	AD	AD	intron_variant
chr11	121533842	rs17125423	0.338	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121538247	rs626885	0.0362	SORL1	T	T	1.19	1.19	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121543767	rs2276346	0.0933	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121544603	rs10502262	0.106	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121552931	rs7946599	0.00000966	SORL1	A	A	0.4545	1.57539	SORL1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr11	121552931	rs7946599	0.00858	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	19118814	Caucasian	"CAP, Reiman et al.(2007)"	NR	All	LOAD	AD	intron_variant
chr11	121552931	rs7946599	0.0483	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	19118814	Caucasian	CAP	458	All	LOAD	AD	intron_variant
chr11	121552931	rs7946599	0.0491	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	19118814	Caucasian	Reiman et al.(2007)	NR	All	LOAD	AD	intron_variant
chr11	121554173	rs2298814	0.00000376	SORL1	A	A	0.4234	1.52715	SORL1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr11	121554173	rs2298814	0.00858	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	19118814	Caucasian	"CAP, Reiman et al.(2007)"	NR	All	LOAD	AD	intron_variant
chr11	121554173	rs2298814	0.0483	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	19118814	Caucasian	CAP	458	All	LOAD	AD	intron_variant
chr11	121554173	rs2298814	0.0491	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	19118814	Caucasian	Reiman et al.(2007)	NR	All	LOAD	AD	intron_variant
chr11	121555333	rs6589885	0.00000257	SORL1	A	A	0.4004	1.49242	SORL1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr11	121555333	rs6589885	0.00858	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	19118814	Caucasian	"CAP, Reiman et al.(2007)"	NR	All	LOAD	AD	intron_variant
chr11	121555333	rs6589885	0.0483	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	19118814	Caucasian	CAP	458	All	LOAD	AD	intron_variant
chr11	121555333	rs6589885	0.0491	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	19118814	Caucasian	Reiman et al.(2007)	NR	All	LOAD	AD	intron_variant
chr11	121556161	rs7131432	0.00000275	SORL1	A	A	0.3804	1.46287	SORL1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr11	121556161	rs7131432	0.0387	SORL1	A	A	1.73	1.73	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121556550	rs1790208	0.348	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121560645	rs11218340	0.608	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121563084	rs720099	0.00000251	SORL1	T	T	0.36	1.43333	SORL1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr11	121563084	rs720099	0.00851	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	19118814	Caucasian	"CAP, Reiman et al.(2007)"	NR	All	LOAD	AD	intron_variant
chr11	121563084	rs720099	0.0483	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	19118814	Caucasian	CAP	458	All	LOAD	AD	intron_variant
chr11	121563084	rs720099	0.0486	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	19118814	Caucasian	Reiman et al.(2007)	NR	All	LOAD	AD	intron_variant
chr11	121563719	rs11218342	0.0000026	SORL1	T	T	0.36	1.43333	SORL1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr11	121563719	rs11218342	0.00851	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	19118814	Caucasian	"CAP, Reiman et al.(2007)"	NR	All	LOAD	AD	intron_variant
chr11	121563719	rs11218342	0.0483	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	19118814	Caucasian	CAP	458	All	LOAD	AD	intron_variant
chr11	121563719	rs11218342	0.0486	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	19118814	Caucasian	Reiman et al.(2007)	NR	All	LOAD	AD	intron_variant
chr11	121563847	rs10892756	0.73	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121564878	rs11218343	0.000000027	SORL1	C	C	0.81	0.81	SORL1	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	63926	All	Clinically diagnosed LOAD	AD	intron_variant
chr11	121564878	rs11218343	0.0000001	SORL1	C	C	0.75	0.75	SORL1	SNP-based	Disease risk	23565137	Caucasian	ADGC	22771	All	LOAD	AD	intron_variant
chr11	121564878	rs11218343	0.00000272	SORL1	T	T	0.35	1.41907	SORL1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr11	121564878	rs11218343	0.00000281	SORL1	C	C	NR	NA	SORL1	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	intron_variant
chr11	121564878	rs11218343	0.000018	SORL1	C	C	0.77	0.77	SORL1	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	18845	All	Clinically diagnosed LOAD	AD	intron_variant
chr11	121564878	rs11218343	0.00004	SORL1	C	C	0.78	0.78	SORL1	SNP-based	Disease risk	24162737	Caucasian	Cohorts from Europe and USA	19884	All	LOAD	AD	intron_variant
chr11	121564878	rs11218343	0.00038	SORL1	C	C	0.83	0.83	SORL1	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	3894	All	LOAD	AD	intron_variant
chr11	121564878	rs11218343	0.00158	SORL1	NR	NR	0.18	NA	SORL1	SNP-based	Age at onset (AAO) / Survival	28323831	Caucasian	ADGC	15795	All	Age of AD onset	Other	intron_variant
chr11	121564878	rs11218343	0.0043	SORL1	C	C	0.68	0.68	SORL1	SNP-based	Endophenotype	25188341	Caucasian	ADGC	4914	All	Clinico-pathologic AD dementia (No neuropathologist documentation)	Neuropathology	intron_variant
chr11	121564878	rs11218343	0.00851	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	19118814	Caucasian	"CAP, Reiman et al.(2007)"	NR	All	LOAD	AD	intron_variant
chr11	121564878	rs11218343	0.0483	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	19118814	Caucasian	CAP	458	All	LOAD	AD	intron_variant
chr11	121564878	rs11218343	0.0486	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	19118814	Caucasian	Reiman et al.(2007)	NR	All	LOAD	AD	intron_variant
chr11	121564878	rs11218343	0.1	SORL1	C	C	0.74	0.74	SORL1	SNP-based	Endophenotype	25188341	Caucasian	ADGC	3702	All	Clinico-pathologic AD dementia (with neuropathologist documentation)	Neuropathology	intron_variant
chr11	121564878	rs11218343	0.233	SORL1	C	C	0.864	0.864	SORL1	SNP-based	Disease risk	24495969	Caucasian	Cohort from Spain	4372	All	AD	AD	intron_variant
chr11	121564878	rs11218343	0.57	SORL1	NR	NR	0.81	0.81	SORL1	SNP-based	Endophenotype	26993346	Caucasian	Cohort from Europe	10840	All	PCA (posterior cortical atrophy)	Imaging	intron_variant
chr11	121564878	rs11218343	0.636	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121564878	rs11218343	0.68	SORL1	C	C	0.96	0.96	SORL1	SNP-based	Disease risk	23565137	Asian	Cohort from Korea	1468	All	LOAD	AD	intron_variant
chr11	121564878	rs11218343	1.09E-11	SORL1	C	C	-6.79	NA	SORL1	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ, UKBB"	455258	All	AD + AD-by-proxy	AD	intron_variant
chr11	121564878	rs11218343	2.20E-09	SORL1	C	C	0.81	0.81	SORL1	SNP-based	Disease risk	23565137	Multi-ethnic	"ADGC, Cohorts from Japan and Korea "	28133	All	LOAD	AD	intron_variant
chr11	121564878	rs11218343	2.90E-12	SORL1	C	C	0.8	0.8	SORL1	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	82771	All	Clinically diagnosed LOAD	AD	intron_variant
chr11	121564878	rs11218343	5.00E-11	SORL1	C	C	0.76	0.76	SORL1	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD"	54162	All	LOAD	AD	intron_variant
chr11	121564878	rs11218343	5.57E-11	SORL1	C	C	NR	NA	SORL1	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ"	79145	All	AD	AD	intron_variant
chr11	121564878	rs11218343	9.70E-15	SORL1	C	C	0.77	0.77	SORL1	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD, Cohorts from Europe and USA"	74046	All	LOAD	AD	intron_variant
chr11	121564878	rs11218343	NR	SORL1	T	T	1.72	1.72	SORL1	SNP-based	Disease risk	27849641	Caucasian	ADGC	589	All	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr11	121564878	rs11218343	NR	ZCWPW1	T	T	1.45	1.45	SORL1	SNP-based	Disease risk	27849641	Caucasian	ADGC	297	APOE-e4 non-carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr11	121564878	rs11218343	NR	ZCWPW1	T	T	2.99	2.99	SORL1	SNP-based	Disease risk	27849641	Caucasian	ADGC	292	APOE-e4 carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr11	121568472	rs11218346	0.466	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121568956	rs1784919	0.00000188	SORL1	T	T	0.3586	1.43132	SORL1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr11	121568956	rs1784919	0.00843	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	19118814	Caucasian	"CAP, Reiman et al.(2007)"	NR	All	LOAD	AD	intron_variant
chr11	121568956	rs1784919	0.0481	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	19118814	Caucasian	Reiman et al.(2007)	NR	All	LOAD	AD	intron_variant
chr11	121568956	rs1784919	0.0483	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	19118814	Caucasian	CAP	458	All	LOAD	AD	intron_variant
chr11	121570811	rs1792124	0.00000183	SORL1	A	A	0.359	1.4319	SORL1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr11	121570811	rs1792124	0.00843	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	19118814	Caucasian	"CAP, Reiman et al.(2007)"	NR	All	LOAD	AD	intron_variant
chr11	121570811	rs1792124	0.0481	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	19118814	Caucasian	Reiman et al.(2007)	NR	All	LOAD	AD	intron_variant
chr11	121570811	rs1792124	0.0483	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	19118814	Caucasian	CAP	458	All	LOAD	AD	intron_variant
chr11	121570811	rs1792124	0.615	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121571480	rs1790213	0.295	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121575231	rs3781834	0.00000073	SORL1	G	G	0.74	0.74	SORL1	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	3894	All	LOAD	AD	intron_variant
chr11	121575231	rs3781834	0.00079	SORL1	G	G	0.78	0.78	SORL1	SNP-based	Disease risk	23565137	Caucasian	ADGC	22771	All	LOAD	AD	intron_variant
chr11	121575231	rs3781834	0.55	SORL1	G	G	0.94	0.94	SORL1	SNP-based	Disease risk	23565137	Asian	Cohort from Korea	1468	All	LOAD	AD	intron_variant
chr11	121575231	rs3781834	9.90E-09	SORL1	G	G	0.78	0.78	SORL1	SNP-based	Disease risk	23565137	Multi-ethnic	"ADGC, Cohorts from Japan and Korea "	28133	All	LOAD	AD	intron_variant
chr11	121575839	rs11218347	0.782	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121577381	rs2070045	0.001	SORL1	G	G	1.27	1.27	SORL1	SNP-based	Disease risk	21220680	Asian	"Cohorts from Asia, Europe, and USA"	1443	All	AD	AD	synonymous_variant
chr11	121577381	rs2070045	0.02	SORL1	G	G	1.08	1.08	SORL1	SNP-based	Disease risk	21220680	Caucasian	"Cohorts from Asia, Europe, and USA"	19206	All	AD	AD	synonymous_variant
chr11	121577381	rs2070045	0.1	SORL1	G	G	1.05	1.05	SORL1	SNP-based	Disease risk	21220680	Caucasian	"Cohorts from Asia, Europe, and USA"	15266	All	AD	AD	synonymous_variant
chr11	121577545	rs3781835	0.000000316	S0RL1	NR	NR	NR	NA	SORL1	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr11	121577545	rs3781835	0.00000314	SORL1	A	A	0.3501	1.41921	SORL1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr11	121577545	rs3781835	0.00624	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	19118814	Caucasian	"CAP, Reiman et al.(2007)"	NR	All	LOAD	AD	intron_variant
chr11	121577545	rs3781835	0.0346	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	19118814	Caucasian	Reiman et al.(2007)	NR	All	LOAD	AD	intron_variant
chr11	121577545	rs3781835	0.0483	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	19118814	Caucasian	CAP	458	All	LOAD	AD	intron_variant
chr11	121581217	rs1699103	0.86	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121581231	rs7116734	0.102	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121581325	rs1792127	0.157	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121581942	rs11218350	0.787	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121582808	rs3781838	0.00000329	SORL1	T	T	0.35	1.41907	SORL1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr11	121582808	rs3781838	0.00406	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	19118814	Caucasian	"CAP, Reiman et al.(2007)"	NR	All	LOAD	AD	intron_variant
chr11	121582808	rs3781838	0.0307	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	19118814	Caucasian	CAP	458	All	LOAD	AD	intron_variant
chr11	121582808	rs3781838	0.0331	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	19118814	Caucasian	Reiman et al.(2007)	NR	All	LOAD	AD	intron_variant
chr11	121586253	rs1699102	0.07	SORL1	C	C	0.78	0.78	SORL1	SNP-based	Disease risk	21220680	Asian	"Cohorts from Asia, Europe, and USA"	865	All	AD	AD	synonymous_variant
chr11	121586253	rs1699102	0.21	SORL1	C	C	1.03	1.03	SORL1	SNP-based	Disease risk	21220680	Caucasian	"Cohorts from Asia, Europe, and USA"	20850	All	AD	AD	synonymous_variant
chr11	121586253	rs1699102	0.54	SORL1	C	C	1.02	1.02	SORL1	SNP-based	Disease risk	21220680	Caucasian	"Cohorts from Asia, Europe, and USA"	16910	All	AD	AD	synonymous_variant
chr11	121589615	rs12272618	0.00000274	SORL1	T	T	0.35	1.41907	SORL1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr11	121590137	rs2276412	0.000000468	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	synonymous_variant
chr11	121590137	rs2276412	0.00000264	SORL1	T	T	0.3531	1.42347	SORL1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	synonymous_variant
chr11	121593379	rs10892759	0.112	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121597547	rs7939826	0.00000269	SORL1	T	T	0.3463	1.41383	SORL1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr11	121602682	rs11218360	0.936	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121602889	rs7128608	0.946	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121603530	rs17125523	0.0000033	SORL1	G	G	0.82	0.82	SORL1	SNP-based	Disease risk	23565137	Multi-ethnic	"ADGC, Cohorts from Japan and Korea "	28133	All	LOAD	AD	intron_variant
chr11	121603530	rs17125523	0.0000055	SORL1	G	G	0.77	0.77	SORL1	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	3894	All	LOAD	AD	intron_variant
chr11	121603530	rs17125523	0.034	SORL1	G	G	0.85	0.85	SORL1	SNP-based	Disease risk	23565137	Caucasian	ADGC	22771	All	LOAD	AD	intron_variant
chr11	121603530	rs17125523	0.72	SORL1	G	G	0.96	0.96	SORL1	SNP-based	Disease risk	23565137	Asian	Cohort from Korea	1468	All	LOAD	AD	intron_variant
chr11	121605213	rs3824968	0.62	SORL1	T	T	0.99	0.99	SORL1	SNP-based	Disease risk	21220680	Caucasian	"Cohorts from Asia, Europe, and USA"	16307	All	AD	AD	synonymous_variant
chr11	121605213	rs3824968	0.62	SORL1	T	T	1.02	1.02	SORL1	SNP-based	Disease risk	21220680	Caucasian	"Cohorts from Asia, Europe, and USA"	20247	All	AD	AD	synonymous_variant
chr11	121605213	rs3824968	<0.001	SORL1	T	T	0.79	0.79	SORL1	SNP-based	Disease risk	21220680	Asian	"Cohorts from Asia, Europe, and USA"	1753	All	AD	AD	synonymous_variant
chr11	121606387	rs1629493	0.266	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121607107	rs3737529	0.0000041	SORL1	T	T	0.77	0.77	SORL1	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	3894	All	LOAD	AD	intron_variant
chr11	121607107	rs3737529	0.0000051	SORL1	T	T	0.82	0.82	SORL1	SNP-based	Disease risk	23565137	Multi-ethnic	"ADGC, Cohorts from Japan and Korea "	28133	All	LOAD	AD	intron_variant
chr11	121607107	rs3737529	0.016	SORL1	T	T	0.83	0.83	SORL1	SNP-based	Disease risk	23565137	Caucasian	ADGC	22771	All	LOAD	AD	intron_variant
chr11	121607107	rs3737529	0.7	SORL1	T	T	1.04	1.04	SORL1	SNP-based	Disease risk	23565137	Asian	Cohort from Korea	1468	All	LOAD	AD	intron_variant
chr11	121607786	rs2282648	0.202	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121608249	rs2282649	0.22	SORL1	C	C	0.96	0.96	SORL1	SNP-based	Disease risk	21220680	Caucasian	"Cohorts from Asia, Europe, and USA"	19195	All	AD	AD	intron_variant
chr11	121608249	rs2282649	0.69	SORL1	C	C	0.99	0.99	SORL1	SNP-based	Disease risk	21220680	Caucasian	"Cohorts from Asia, Europe, and USA"	15255	All	AD	AD	intron_variant
chr11	121608249	rs2282649	0.97	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121608249	rs2282649	<0.001	SORL1	C	C	0.76	0.76	SORL1	SNP-based	Disease risk	21220680	Asian	"Cohorts from Asia, Europe, and USA"	1753	All	AD	AD	intron_variant
chr11	121610698	rs726601	0.19	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121612229	rs1784931	0.138	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121612692	rs1010159	0.02	SORL1	C	C	1.21	1.21	SORL1	SNP-based	Disease risk	21220680	Asian	"Cohorts from Asia, Europe, and USA"	1198	All	AD	AD	intron_variant
chr11	121612692	rs1010159	0.255	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121612692	rs1010159	0.47	SORL1	C	C	0.98	0.98	SORL1	SNP-based	Disease risk	21220680	Caucasian	"Cohorts from Asia, Europe, and USA"	12180	All	AD	AD	intron_variant
chr11	121612692	rs1010159	0.62	SORL1	C	C	1.01	1.01	SORL1	SNP-based	Disease risk	21220680	Caucasian	"Cohorts from Asia, Europe, and USA"	16120	All	AD	AD	intron_variant
chr11	121616105	rs1503413	0.569	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121618707	rs1784933	0.000363	SORL1	A	A	0.22	1.24608	SORL1	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr11	121618707	rs1784933	0.0367	SORL1	A	A	1.34	NA	SORL1	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	intron_variant
chr11	121622292	rs1614735	0.435	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121623318	rs17125558	0.793	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121623380	rs17125561	0.462	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	121627175	rs10892761	0.466	SORL1	NR	NR	NR	NA	SORL1	SNP-based	Disease risk	17975299	Caucasian	"ADGC, Cohorts from Europe and USA"	1086	All	AD	AD	intron_variant
chr11	124736389	rs12807809	0.18	NRGN	NR	NR	0.88	0.88	NRGN	SNP-based	Cross phenotype 	22005930	Caucasian	"ADGC, GERAD"	2034	AD+P and AD-P subjects	AD+Psychosis	ADRD	upstream_gene_variant
chr11	124736389	rs12807809	0.83	NRGN	NR	NR	0.99	0.99	NRGN	SNP-based	Cross phenotype 	22005930	Caucasian	"ADGC, GERAD, Cohort from UK"	6958	AD+P and control subjects	AD+Psychosis	ADRD	upstream_gene_variant
chr11	125323700	rs11601321	0.00000803	PKNOX2	G	G	1.63	NA	PKNOX2	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	intron_variant
chr11	129964624	rs55746218	0.00933	PRDM10	C	C	NR	NA	PRDM10	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	7289	Plan 2 (only males)	AD	AD	intron_variant
chr11	129964624	rs55746218	2.10E-09	NR	C	C	NR	NA	PRDM10	SNP-based	eQTL	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	7289	Plan 2 (only males)	PRDM10 expression in Cerebellar hemisphere	Expression	intron_variant
chr11	130118110	rs12269733	0.000537	ST14	G	G	NR	NA	APLP2	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	intron_variant
chr11	130118110	rs12269733	1.27E-17	NR	G	G	NR	NA	APLP2	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	ST14 (ILMN_1699887) expression	Expression	intron_variant
chr11	130165703	rs34008994	0.000155	ST14	C	C	NR	NA	ST14	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	intron_variant
chr11	130165703	rs34008994	2.79E-08	NR	C	C	NR	NA	ST14	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	ST14 (ENSG00000149418) expression	Expression	intron_variant
chr11	132065380	rs1629316	0.000000008	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	"Cognitive function (Memory - Learning (or working memory), Memory - Delayed recall, Memory - Recognition, Executive Function - Stroop Color Word test, Executive Function - Part B of the Trail making test (TMTB), Executive Function - Block test, Verbal Fluency - Semantic fluency, Verbal Fluency - Phonological fluency)"	Cognitive	intron_variant
chr11	132065380	rs1629316	0.0007	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Part B of the Trail making test (TMTB)	Cognitive	intron_variant
chr11	132065380	rs1629316	0.05	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Verbal Fluency - Phonological fluency	Cognitive	intron_variant
chr11	132065380	rs1629316	0.07	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Learning (or working memory)	Cognitive	intron_variant
chr11	132065380	rs1629316	0.1	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Block test	Cognitive	intron_variant
chr11	132065380	rs1629316	0.21	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Delayed recall	Cognitive	intron_variant
chr11	132065380	rs1629316	0.35	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Verbal Fluency - Semantic fluency	Cognitive	intron_variant
chr11	132065380	rs1629316	0.41	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Recognition	Cognitive	intron_variant
chr11	132065380	rs1629316	0.94	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Stroop Color Word test	Cognitive	intron_variant
chr11	132076884	rs1547897	0.0006	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Part B of the Trail making test (TMTB)	Cognitive	intron_variant
chr11	132076884	rs1547897	0.05	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Verbal Fluency - Phonological fluency	Cognitive	intron_variant
chr11	132076884	rs1547897	0.06	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Learning (or working memory)	Cognitive	intron_variant
chr11	132076884	rs1547897	0.16	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Block test	Cognitive	intron_variant
chr11	132076884	rs1547897	0.16	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Delayed recall	Cognitive	intron_variant
chr11	132076884	rs1547897	0.29	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Verbal Fluency - Semantic fluency	Cognitive	intron_variant
chr11	132076884	rs1547897	0.39	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Recognition	Cognitive	intron_variant
chr11	132076884	rs1547897	1	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Stroop Color Word test	Cognitive	intron_variant
chr11	132076884	rs1547897	4.80E-09	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	"Cognitive function (Memory - Learning (or working memory), Memory - Delayed recall, Memory - Recognition, Executive Function - Stroop Color Word test, Executive Function - Part B of the Trail making test (TMTB), Executive Function - Block test, Verbal Fluency - Semantic fluency, Verbal Fluency - Phonological fluency)"	Cognitive	intron_variant
chr11	132108262	rs11222931	0.0007	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Part B of the Trail making test (TMTB)	Cognitive	intron_variant
chr11	132108262	rs11222931	0.05	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Verbal Fluency - Phonological fluency	Cognitive	intron_variant
chr11	132108262	rs11222931	0.07	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Learning (or working memory)	Cognitive	intron_variant
chr11	132108262	rs11222931	0.15	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Delayed recall	Cognitive	intron_variant
chr11	132108262	rs11222931	0.16	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Block test	Cognitive	intron_variant
chr11	132108262	rs11222931	0.27	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Verbal Fluency - Semantic fluency	Cognitive	intron_variant
chr11	132108262	rs11222931	0.33	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Recognition	Cognitive	intron_variant
chr11	132108262	rs11222931	0.87	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Stroop Color Word test	Cognitive	intron_variant
chr11	132108262	rs11222931	4.50E-09	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	"Cognitive function (Memory - Learning (or working memory), Memory - Delayed recall, Memory - Recognition, Executive Function - Stroop Color Word test, Executive Function - Part B of the Trail making test (TMTB), Executive Function - Block test, Verbal Fluency - Semantic fluency, Verbal Fluency - Phonological fluency)"	Cognitive	intron_variant
chr11	132108367	rs11222932	0.0006	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Part B of the Trail making test (TMTB)	Cognitive	intron_variant
chr11	132108367	rs11222932	0.05	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Verbal Fluency - Phonological fluency	Cognitive	intron_variant
chr11	132108367	rs11222932	0.07	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Learning (or working memory)	Cognitive	intron_variant
chr11	132108367	rs11222932	0.15	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Delayed recall	Cognitive	intron_variant
chr11	132108367	rs11222932	0.18	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Block test	Cognitive	intron_variant
chr11	132108367	rs11222932	0.3	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Verbal Fluency - Semantic fluency	Cognitive	intron_variant
chr11	132108367	rs11222932	0.34	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Recognition	Cognitive	intron_variant
chr11	132108367	rs11222932	0.86	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Stroop Color Word test	Cognitive	intron_variant
chr11	132108367	rs11222932	4.60E-09	HNT	NA	NA	NA	NA	NTM	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	"Cognitive function (Memory - Learning (or working memory), Memory - Delayed recall, Memory - Recognition, Executive Function - Stroop Color Word test, Executive Function - Part B of the Trail making test (TMTB), Executive Function - Block test, Verbal Fluency - Semantic fluency, Verbal Fluency - Phonological fluency)"	Cognitive	intron_variant
chr11	132823315	rs11223225	0.0004	OPCML	NA	NA	NA	NA	OPCML	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Delayed recall	Cognitive	intron_variant
chr11	132823315	rs11223225	0.02	OPCML	NA	NA	NA	NA	OPCML	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Stroop Color Word test	Cognitive	intron_variant
chr11	132823315	rs11223225	0.03	OPCML	NA	NA	NA	NA	OPCML	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Learning (or working memory)	Cognitive	intron_variant
chr11	132823315	rs11223225	0.06	OPCML	NA	NA	NA	NA	OPCML	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Block test	Cognitive	intron_variant
chr11	132823315	rs11223225	0.09	OPCML	NA	NA	NA	NA	OPCML	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Part B of the Trail making test (TMTB)	Cognitive	intron_variant
chr11	132823315	rs11223225	0.26	OPCML	NA	NA	NA	NA	OPCML	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Recognition	Cognitive	intron_variant
chr11	132823315	rs11223225	0.26	OPCML	NA	NA	NA	NA	OPCML	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Verbal Fluency - Phonological fluency	Cognitive	intron_variant
chr11	132823315	rs11223225	0.47	OPCML	NA	NA	NA	NA	OPCML	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Verbal Fluency - Semantic fluency	Cognitive	intron_variant
chr11	132823315	rs11223225	3.20E-11	OPCML	NA	NA	NA	NA	OPCML	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	"Cognitive function (Memory - Learning (or working memory), Memory - Delayed recall, Memory - Recognition, Executive Function - Stroop Color Word test, Executive Function - Part B of the Trail making test (TMTB), Executive Function - Block test, Verbal Fluency - Semantic fluency, Verbal Fluency - Phonological fluency)"	Cognitive	intron_variant
chr12	2236129	rs1006737	0.53	CACNA1C	NR	NR	1.05	1.05	CACNA1C	SNP-based	Cross phenotype 	22005930	Caucasian	"ADGC, GERAD"	2034	AD+P and AD-P subjects	AD+Psychosis	ADRD	intron_variant
chr12	2236129	rs1006737	0.89	CACNA1C	NR	NR	1.01	1.01	CACNA1C	SNP-based	Cross phenotype 	22005930	Caucasian	"ADGC, GERAD, Cohort from UK"	6958	AD+P and control subjects	AD+Psychosis	ADRD	intron_variant
chr12	5658219	rs4930776	0.0000032	ANO2	NR	NR	NR	NA	ANO2	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	818	All	Plasma Clusterin	Fluid biomarker	intron_variant
chr12	11052141	rs2708389	1.24E-106	TAS2R43	NR	NR	1.07	2.91538	PRH1	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	TAS2R43 expression in Cerebellar	Expression	intron_variant
chr12	11052141	rs2708389	2.34E-47	TAS2R43	NR	NR	1.01	2.7456	PRH1	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	TAS2R43 expression in Cerebellar	Expression	intron_variant
chr12	11052141	rs2708389	4.12E-53	TAS2R43	NR	NR	1.13	3.09566	PRH1	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	TAS2R43 expression in Cerebellar	Expression	intron_variant
chr12	13717530	rs74442473	2.53E-08	GRIN2B	G	G	-1.02	0.360595	GRIN2B	SNP-based	Endophenotype	29274321	Caucasian	ADNI	206	Normal controls	CSF Ab1-42	Fluid biomarker	intron_variant
chr12	13763366	rs78210707	0.00000428	GRIN2B	G	G	0.38	0.38	GRIN2B	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	10870	HTN-P group	AD	AD	intron_variant
chr12	13770394	rs11055612	0.00000281	GRIN2B	T	T	-3371.6	0	GRIN2B	SNP-based	Endophenotype	20197096	Caucasian	ADNI	742	All	Temporal Lobe Atrophy	Imaging	intron_variant
chr12	13770394	rs11055612	0.0000159	GRIN2B	T	T	-3371.6	0	GRIN2B	SNP-based	Endophenotype	20197096	Caucasian	ADNI	742	All	Temporal Lobe Atrophy	Imaging	intron_variant
chr12	13777923	rs10845840	0.000000126	GRIN2B	T	T	-3802.2	0	GRIN2B	SNP-based	Endophenotype	20197096	Caucasian	ADNI	742	All	Temporal Lobe Atrophy	Imaging	intron_variant
chr12	13777923	rs10845840	0.000000403	GRIN2B	T	T	-3802.2	0	GRIN2B	SNP-based	Endophenotype	20197096	Caucasian	ADNI	742	All	Temporal Lobe Atrophy	Imaging	intron_variant
chr12	21304500	rs11568563	0.00000007	SLCO1A2	NA	NA	0.68	0.68	SLCO1A2	SNP-based	Disease Risk	22685416	Caucasian	"Cohorts from Europe, USA"	8851	All	Progressive Supranuclear Palsy (PSP)	ADRD	missense_variant
chr12	21304500	rs11568563	0.0000198	SLCO1A2	NR	NR	-0.44	0.644036	SLCO1A2	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	SLCO1A2 (ILMN_2381020) expression in Cerebellar	Expression	missense_variant
chr12	21304500	rs11568563	0.0000389	SLCO1A2	NR	NR	-0.64	0.527292	SLCO1A2	SNP-based	eQTL	22685416	Caucasian	MAYO	107	PSP	SLCO1A2 (ILMN_2381020) expression in Temporal cortex	Expression	missense_variant
chr12	21304500	rs11568563	0.00362	SLCO1A2	NR	NR	-0.37	0.690734	SLCO1A2	SNP-based	eQTL	22685416	Caucasian	MAYO	98	PSP	SLCO1A2 (ILMN_2381020) expression in Cerebellar	Expression	missense_variant
chr12	21304500	rs11568563	0.0436	SLCO1A2	NR	NR	-0.12	0.88692	SLCO1A2	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	SLCO1A2 (ILMN_1656097) expression in Temporal cortex	Expression	missense_variant
chr12	21304500	rs11568563	0.212	SLCO1A2	NR	NR	-0.12	0.88692	SLCO1A2	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	SLCO1A2 (ILMN_1656097) expression in Cerebellar	Expression	missense_variant
chr12	21304500	rs11568563	0.241	SLCO1A2	NR	NR	-0.08	0.923116	SLCO1A2	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	SLCO1A2 (ILMN_1656097) expression in Cerebellar	Expression	missense_variant
chr12	21304500	rs11568563	0.422	SLCO1A2	NR	NR	-0.06	0.941765	SLCO1A2	SNP-based	eQTL	22685416	Caucasian	MAYO	202	AD	SLCO1A2 (ILMN_1656097) expression in Temporal cortex	Expression	missense_variant
chr12	21304500	rs11568563	0.608	SLCO1A2	NR	NR	-0.06	0.941765	SLCO1A2	SNP-based	eQTL	22685416	Caucasian	MAYO	107	PSP	SLCO1A2 (ILMN_1656097) expression in Temporal cortex	Expression	missense_variant
chr12	21304500	rs11568563	0.814	SLCO1A2	NR	NR	-0.03	0.970446	SLCO1A2	SNP-based	eQTL	22685416	Caucasian	MAYO	98	PSP	SLCO1A2 (ILMN_1656097) expression in Cerebellar	Expression	missense_variant
chr12	21304500	rs11568563	1.23E-08	SLCO1A2	NR	NR	-0.72	0.486752	SLCO1A2	SNP-based	eQTL	22685416	Caucasian	MAYO	202	AD	SLCO1A2 (ILMN_2381020) expression in Temporal cortex	Expression	missense_variant
chr12	21304500	rs11568563	2.33E-08	SLCO1A2	NR	NR	-0.4	0.67032	SLCO1A2	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	SLCO1A2 (ILMN_2381020) expression in Cerebellar	Expression	missense_variant
chr12	21304500	rs11568563	9.14E-18	SLCO1A2	NR	NR	-0.73	0.481909	SLCO1A2	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	SLCO1A2 (ILMN_2381020) expression in Temporal cortex	Expression	missense_variant
chr12	21841177	rs704180	NR	ABCC9	A	A	1.13	1.13	ABCC9	SNP-based	Disease risk	25470345	Caucasian	ADGC	612	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	intron_variant
chr12	21841177	rs704180	NR	ABCC9	A	A	1.38	1.38	ABCC9	SNP-based	Disease risk	25470345	Caucasian	ADGC	612	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	intron_variant
chr12	21841177	rs704180	NR	ABCC9	A	A	1.46	1.46	ABCC9	SNP-based	Disease risk	25470345	Caucasian	ADGC	2343	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	intron_variant
chr12	21841177	rs704180	NR	ABCC9	A	A	1.51	1.51	ABCC9	SNP-based	Disease risk	25470345	Caucasian	ADGC	2343	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	intron_variant
chr12	21841177	rs704180	NR	ABCC9	A	A	1.9	1.9	ABCC9	SNP-based	Disease risk	25470345	Caucasian	ADGC	2343	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	intron_variant
chr12	21841177	rs704180	NR	ABCC9	A	A	2	2	ABCC9	SNP-based	Disease risk	25470345	Caucasian	ADGC	612	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	intron_variant
chr12	21846929	rs829080	0.0057	ABCC9	C	C	1.76	1.76	ABCC9	SNP-based	Disease risk	28131462	Caucasian	ADGC	3251	Individual who died at age 60 or older (DOM Model)	Hippocampal sclerosis of aging	ADRD	intron_variant
chr12	21851264	rs7966849	0.000000101	ABCC9	G	G	NR	NA	ABCC9	SNP-based	Disease risk	24770881	Caucasian	ADGC	2239	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	intron_variant
chr12	21851264	rs7966849	0.0000071	ABCC9	A	A	1.84	1.84	ABCC9	SNP-based	Disease risk	28131462	Caucasian	ADGC	3251	Individual who died at age 60 or older (REC Model)	Hippocampal sclerosis of aging	ADRD	intron_variant
chr12	21851264	rs7966849	0.000044	ABCC9	NR	NR	1.46	1.46	ABCC9	SNP-based	Disease risk	28131462	Caucasian	ADGC	3251	Individual who died at age 60 or older (ADD Model)	Hippocampal sclerosis of aging	ADRD	intron_variant
chr12	29768734	rs302318	0.00000197	TMTC1	C	C	0.59	0.59	TMTC1	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr12	31088411	rs10843881	2.48E-52	DDX11	NR	NR	-1.06	0.346456	DDX11	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	DDX11 expression in Cerebellar	Expression	intron_variant
chr12	31088411	rs10843881	3.49E-48	DDX11	NR	NR	-1.06	0.346456	DDX11	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	DDX11 expression in Cerebellar	Expression	intron_variant
chr12	31088411	rs10843881	4.87E-110	DDX11	NR	NR	-1.16	0.313486	DDX11	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	DDX11 expression in Temporal cortex	Expression	intron_variant
chr12	31088411	rs10843881	6.57E-107	DDX11	NR	NR	-1.06	0.346456	DDX11	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	DDX11 expression in Cerebellar	Expression	intron_variant
chr12	38774384	rs10876062	0.0000387	CPNE8	NR	NR	4.28	4.28	CPNE8	SNP-based	Disease risk	21098978	Arab	Cohort from Israeli	266	All	AD	AD	intron_variant
chr12	38821850	rs12424244	0.0000411	CPNE8	NR	NR	0.25	0.25	CPNE8	SNP-based	Disease risk	21098978	Arab	Cohort from Israeli	266	All	AD	AD	intron_variant
chr12	38825216	rs17126713	0.0000399	CPNE8	NR	NR	3.94	3.94	CPNE8	SNP-based	Disease risk	21098978	Arab	Cohort from Israeli	266	All	AD	AD	intron_variant
chr12	38849391	rs9943730	0.000036	CPNE8	NR	NR	0.25	0.25	CPNE8	SNP-based	Disease risk	21098978	Arab	Cohort from Israeli	266	All	AD	AD	intron_variant
chr12	38856882	rs12425783	0.0000342	CPNE8	NR	NR	4.04	4.04	CPNE8	SNP-based	Disease risk	21098978	Arab	Cohort from Israeli	266	All	AD	AD	intron_variant
chr12	38863148	rs12422883	0.0000349	CPNE8	NR	NR	4.03	4.03	CPNE8	SNP-based	Disease risk	21098978	Arab	Cohort from Israeli	266	All	AD	AD	intron_variant
chr12	38864847	rs10876185	0.0000347	CPNE8	NR	NR	0.25	0.25	CPNE8	SNP-based	Disease risk	21098978	Arab	Cohort from Israeli	266	All	AD	AD	intron_variant
chr12	38891156	rs7308580	0.0000149	CPNE8	NR	NR	0.18	0.18	CPNE8	SNP-based	Disease risk	21098978	Arab	Cohort from Israeli	266	All	AD	AD	intron_variant
chr12	38891304	rs7307936	0.0000151	CPNE8	NR	NR	5.6	5.6	CPNE8	SNP-based	Disease risk	21098978	Arab	Cohort from Israeli	266	All	AD	AD	intron_variant
chr12	38903226	rs1516555	0.0000165	CPNE8	NR	NR	5.55	5.55	CPNE8	SNP-based	Disease risk	21098978	Arab	Cohort from Israeli	266	All	AD	AD	intron_variant
chr12	38912965	rs12423647	0.0000301	NR	NR	NR	5.17	5.17	CPNE8	SNP-based	Disease risk	21098978	Arab	Cohort from Israeli	266	All	AD	AD	downstream_gene_variant
chr12	38915912	rs1878224	0.000036	NR	NR	NR	5.08	5.08	CPNE8	SNP-based	Disease risk	21098978	Arab	Cohort from Israeli	266	All	AD	AD	upstream_gene_variant
chr12	39882501	rs75036080	0.00000307	SLC2A13	G	G	0.49	0.49	C12orf40	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	10870	HTN-P group	AD	AD	intron_variant
chr12	40051948	rs10784359	0.000158	SLC2A13	NR	NR	NR	NA	SLC2A13	SNP-based	Disease risk	27899424	Caucasian	IFGC	12928	All	Frontotemporal Dementia	ADRD	intron_variant
chr12	43573874	rs7295246	0.00000027	ADAMTS20	G	G	1.07	1.07	ADAMTS20	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	82771	All	Clinically diagnosed LOAD	AD	upstream_gene_variant
chr12	43573874	rs7295246	0.00000039	ADAMTS20	G	G	1.06	1.06	ADAMTS20	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	94437	All	Clinically diagnosed LOAD	AD	upstream_gene_variant
chr12	43573874	rs7295246	0.325	ADAMST20	G	G	1.044	1.044	ADAMTS20	SNP-based	Disease risk	24495969	Caucasian	Cohort from Spain	4372	All	AD	AD	upstream_gene_variant
chr12	43573874	rs7295246	0.45	ADAMTS20	G	G	1.02	1.02	ADAMTS20	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	11666	All	Clinically diagnosed LOAD	AD	upstream_gene_variant
chr12	47245743	rs11610206	0.00000143	FAM113B	NR	NR	NR	NA	PCED1B	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	intron_variant
chr12	49853685	rs7138803	0.277	NR	A	A	1.041	1.041	BCDIN3D	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	intergenic_region
chr12	49853685	rs7138803	0.436	NR	A	A	0	1	BCDIN3D	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	intergenic_region
chr12	49853685	rs7138803	0.549	NR	A	A	0.987	0.987	BCDIN3D	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	intergenic_region
chr12	49853685	rs7138803	0.999	NR	A	A	1.094	1.094	BCDIN3D	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	intergenic_region
chr12	53130475	rs77451327	0.000906	SOAT2	C	C	NR	NA	SOAT2	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	upstream_gene_variant
chr12	53130475	rs77451327	0.00256	SOAT2	C	C	NR	NA	SOAT2	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Total cholesterol (TC)	Non-ADRD	upstream_gene_variant
chr12	53130475	rs77451327	0.726	SOAT2	C	C	1	1	SOAT2	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	upstream_gene_variant
chr12	53533770	rs784568	0.0073	ATF7	NR	NR	NR	NA	ATF7-NPFF	SNP-based	Endophenotype	22245343	Caucasian	ADNI	757	All	MRI	Imaging	intron_variant
chr12	53664454	rs1971762	2.10E-103	ATP5G2	NR	NR	1.15	3.15819	ATP5MC2	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	ATP5G2 expression in Temporal cortex	Expression	intron_variant
chr12	53664454	rs1971762	2.11E-53	ATP5G2	NR	NR	1.04	2.82922	ATP5MC2	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	ATP5G2 expression in Cerebellar	Expression	intron_variant
chr12	53664454	rs1971762	4.87E-99	ATP5G2	NR	NR	1.01	2.7456	ATP5MC2	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	ATP5G2 expression in Cerebellar	Expression	intron_variant
chr12	53664454	rs1971762	6.73E-39	ATP5G2	NR	NR	0.96	2.6117	ATP5MC2	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	ATP5G2 expression in Cerebellar	Expression	intron_variant
chr12	53669709	rs1800634	0.0006	ATP5G2	NR	NR	NR	NA	ATP5MC2	SNP-based	Endophenotype	22245343	Caucasian	ADNI	757	All	MRI	Imaging	intron_variant
chr12	56007301	rs10876864	8.07E-61	RPS26	NR	NR	0.57	1.76827	IKZF4	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	RPS26 expression in Temporal cortex	Expression	upstream_gene_variant
chr12	56926927	rs840163	0.00000242	SDR9C7	G	G	1.4	NA	SDR9C7	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	intron_variant
chr12	57243810	rs3204635	0.00015	STAC3	NR	NR	NR	NA	STAC3	SNP-based	Cross phenotype 	28780673	Caucasian	GAME-ON	33832	All	Breast Cancer	Non-ADRD	3_prime_UTR_variant
chr12	57243810	rs3204635	0.00086	STAC3	NR	NR	NR	NA	STAC3	SNP-based	Cross phenotype 	28780673	Caucasian	IGAP	54162	All	AD	AD	3_prime_UTR_variant
chr12	57243810	rs3204635	0.0025	STAC3	NR	NR	NR	NA	STAC3	SNP-based	Cross phenotype 	28780673	Caucasian	"GAME-ON, IGAP"	116992	All	AD + Breast cancer + Lung Cancer	Non-ADRD	3_prime_UTR_variant
chr12	57243810	rs3204635	0.41	STAC3	NR	NR	NR	NA	STAC3	SNP-based	Cross phenotype 	28780673	Caucasian	GAME-ON	28998	All	Lung Cancer	Non-ADRD	3_prime_UTR_variant
chr12	65271195	rs10878255	1.16E-59	LEMD3	NR	NR	-0.62	0.537944	MSRB3	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	LEMD3 expression in Cerebellar	Expression	intergenic_region
chr12	65271195	rs10878255	4.09E-30	LEMD3	NR	NR	-0.56	0.571209	MSRB3	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	LEMD3 expression in Cerebellar	Expression	intergenic_region
chr12	65271195	rs10878255	4.65E-66	LEMD3	NR	NR	-0.78	0.458406	MSRB3	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	LEMD3 expression in Temporal cortex	Expression	intergenic_region
chr12	65271195	rs10878255	5.54E-24	LEMD3	NR	NR	-0.68	0.506617	MSRB3	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	LEMD3 expression in Cerebellar	Expression	intergenic_region
chr12	65767191	rs10784496	0.000000309	NR	G	G	NR	NA	HMGA2	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF Ab1-42	Fluid biomarker	intron_variant
chr12	65818538	rs2261181	0.0000001	HMGA2	NR	NR	NR	NA	HMGA2	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr12	66067239	rs35758766	0.00372	TMBIM4	A	A	NR	NA	LLPH	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	10870	HTN-P group	AD	AD	downstream_gene_variant
chr12	66067239	rs35758766	2.16E-61	NR	A	A	NR	NA	LLPH	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	10870	HTN-P group	TMBIM4 (ILMN_1664750) expression	Expression	downstream_gene_variant
chr12	66181338	rs1436849	0.00125	IRAK3	T	T	NR	NA	IRAK3	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	7289	Plan 2 (only males)	AD	AD	intergenic_region
chr12	66181338	rs1436849	6.14E-35	NR	T	T	NR	NA	IRAK3	SNP-based	eQTL	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	7289	Plan 2 (only males)	IRAK3 (ILMN_1913678) expression in peripheral blood	Expression	intergenic_region
chr12	71017781	rs7132840	0.000013	CHR12	NR	NR	NR	NA	PTPRR	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr12	84863448	rs3782369	0.049	SLC6A15	NR	NR	12.25	12.25	SLC6A15	SNP-based	Cross phenotype 	30010129	Asian	Cohort from Han Chinse	475	All	AD	AD	missense_variant
chr12	84870956	rs79265864	0.125	SLC6A15	NR	NR	NR	NA	SLC6A15	SNP-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr12	84870956	rs79265864	0.47453	NA	NR	NR	NR	NA	SLC6A15	Gene-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr12	94930613	rs249153	0.000000438	NR	C	C	1.41	1.41	NDUFA12	SNP-based	Disease risk	24755620	Caucasian	ADGC	4569	All	AD	AD	intron_variant
chr12	94934697	rs249166	0.000000691	NR	T	T	1.4	1.4	NDUFA12	SNP-based	Disease risk	24755620	Caucasian	ADGC	4569	All	AD	AD	intron_variant
chr12	94936497	rs249167	0.000000691	NR	A	A	1.4	1.4	NDUFA12	SNP-based	Disease risk	24755620	Caucasian	ADGC	4569	All	AD	AD	intron_variant
chr12	101293265	rs2290720	0.00000284	UTP20	A	A	-148.1	4.79719e-65	UTP20	SNP-based	Endophenotype	20197096	Caucasian	ADNI	698	All	Hippocampal Volume	Imaging	intron_variant
chr12	101293265	rs2290720	0.0000146	NR	A	A	-148.1	4.79719e-65	UTP20	SNP-based	Endophenotype	20197096	Caucasian	ADNI	698	All	Hippocampal Volume	Imaging	intron_variant
chr12	102529208	rs2195243	0.000000015	NR	C	C	-0.06	0.941765	IGF1	SNP-based	Endophenotype	27694991	Caucasian	"CHARGE, ENIGMA"	26577	European	Intracranial Volume	Imaging	intergenic_region
chr12	102529208	rs2195243	0.101	NR	C	C	-0.09	0.913931	IGF1	SNP-based	Endophenotype	27694991	Hispanic	"CHARGE, ENIGMA"	1605	Hispanic	Intracranial Volume	Imaging	intergenic_region
chr12	102529208	rs2195243	0.132	NR	C	C	-0.04	0.960789	IGF1	SNP-based	Endophenotype	27694991	Caucasian	"CHARGE, ENIGMA"	2363	European	Intracranial Volume	Imaging	intergenic_region
chr12	102529208	rs2195243	0.585	NR	C	C	0.04	1.04081	IGF1	SNP-based	Endophenotype	27694991	African American	"CHARGE, ENIGMA"	938	African	Intracranial Volume	Imaging	intergenic_region
chr12	102529208	rs2195243	0.774	NR	C	C	-0.02	0.980199	IGF1	SNP-based	Endophenotype	27694991	Asian	"CHARGE, ENIGMA"	955	Asian	Intracranial Volume	Imaging	intergenic_region
chr12	108342575	rs7304039	0.00000079	NR	A	A	0.41	1.50682	CMKLR1	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	363	AD subjects	CSF P-tau181p	Fluid biomarker	upstream_gene_variant
chr12	108342575	rs7304039	0.0069	NR	A	A	0.15	1.16183	CMKLR1	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	878	AD subjects	CSF P-tau181p	Fluid biomarker	upstream_gene_variant
chr12	108342575	rs7304039	0.34	NR	A	A	-0.07	0.932394	CMKLR1	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	515	AD subjects	CSF P-tau181p	Fluid biomarker	upstream_gene_variant
chr12	108448599	rs66478310	0.00000486	LOC102723562	NR	NR	NR	NA	FICD	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	818	All	Plasma Clusterin	Fluid biomarker	intron_variant
chr12	112403438	rs7972529	0.000352	RPL6	G	G	NR	NA	RPL6	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	downstream_gene_variant
chr12	112403438	rs7972529	0.000449	RPL6	G	G	NR	NA	RPL6	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Low-density lipoprotein (LDL)	Non-ADRD	downstream_gene_variant
chr12	112996713	rs1635142	0.0000532	OAS2	A	A	NR	NA	OAS2	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr12	112996713	rs1635142	0.00015	OAS2	A	A	0.95	0.95	OAS2	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intron_variant
chr12	112996713	rs1635142	0.000228	OAS2	A	A	NR	NA	OAS2	SNP-based	Cross phenotype 	30413934	Caucasian	"GIANT, UKBB"	180423	All	Waist-to-hip ratio (WHR)	Non-ADRD	intron_variant
chr12	112996713	rs1635142	0.0005	OAS2	A	A	0.95	0.95	OAS2	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intron_variant
chr12	112996713	rs1635142	0.306	OAS2	A	A	1	1	OAS2	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr12	112996713	rs1635142	0.461	OAS2	A	A	1.04	1.04	OAS2	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intron_variant
chr12	114942588	rs10850408	0.000000925	NR	T	T	0.63	0.63	TBX3	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intergenic_region
chr12	115427498	rs10161338	0.0000352	Intergenic (as reported in paper)	C	C	NR	NA	MED13L	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intergenic_region
chr12	115427498	rs10161338	0.0009	NR	C	C	NR	NA	MED13L	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intergenic_region
chr12	115427498	rs10161338	0.00176	NR	C	C	NR	NA	MED13L	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intergenic_region
chr12	116857528	rs17429217	0.00000257	"HRK, RNFT2"	NR	NR	NR	NA	HRK	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	2222	AD subjects	Age at onset	Other	3_prime_UTR_variant
chr12	116857528	rs17429217	0.00000318	"HRK, RNFT2"	NR	NR	NR	NA	HRK	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	2222	AD subjects	Age at onset	Other	3_prime_UTR_variant
chr12	116857528	rs17429217	0.000248	"HRK, RNFT2"	NR	NR	2.84	17.1158	HRK	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	844	AD subjects	Age at onset	Other	3_prime_UTR_variant
chr12	116857528	rs17429217	0.004	"HRK, RNFT2"	NR	NR	2.44	11.473	HRK	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	1190	AD subjects	Age at onset	Other	3_prime_UTR_variant
chr12	116857528	rs17429217	0.503	"HRK, RNFT2"	NR	NR	4.76	116.746	HRK	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADNI	188	AD subjects	Age at onset	Other	3_prime_UTR_variant
chr12	117347106	rs2101238	0.00000956	NOS1	NR	NR	NR	NA	NOS1	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intron_variant
chr12	118455443	rs11613092	0.00000231	NR	A	A	0.41	0.41	SUDS3	SNP-based	Disease risk	26049409	Asian	Cohort from Japan	6944	e4 noncarrier	LOAD	AD	intergenic_region
chr12	118455443	rs11613092	0.00000685	NR	A	A	0.61	0.61	SUDS3	SNP-based	Disease risk	26049409	Asian	Cohort from Japan	13290	e4 noncarrier	LOAD	AD	intergenic_region
chr12	118455443	rs11613092	0.0356	NR	A	A	0.75	0.75	SUDS3	SNP-based	Disease risk	26049409	Asian	Cohort from Japan	6346	e4 noncarrier	LOAD	AD	intergenic_region
chr12	118930022	rs11069178	0.000000165	NR	C	C	NR	NA	SRRM4	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF T-tau	Fluid biomarker	intergenic_region
chr12	118950113	rs1997111	0.000000011	NR	T	T	NR	NA	SRRM4	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF T-tau	Fluid biomarker	intergenic_region
chr12	118950113	rs1997111	0.000000211	NR	T	T	NR	NA	SRRM4	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF T-tau	Fluid biomarker	intergenic_region
chr12	118952720	rs10775009	1.59E-09	SRRM4	T	T	0.51	1.66529	SRRM4	SNP-based	Endophenotype	29274321	Caucasian	ADNI	203	Normal controls	CSF T-tau	Fluid biomarker	intergenic_region
chr12	123034319	rs641760	0.000275	ABCB9	T	T	NR	NA	PITPNM2	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	17480	Plan 1 (males and females)	AD	AD	intron_variant
chr12	123034319	rs641760	9.79E-17	NR	T	T	NR	NA	PITPNM2	SNP-based	eQTL	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	17480	Plan 1 (males and females)	ABCB9 (ILMN_2343047) expression	Expression	intron_variant
chr12	130537465	rs1464108	0.00000819	RIMBP2	NR	NR	1.28	1.28	RIMBP2	SNP-based	Disease risk	22005930	Caucasian	"ADGC, GERAD, Cohort from UK"	7693	AD+P and control subjects	AD+Psychosis	ADRD	intron_variant
chr12	131542412	rs73156187	0.00000447	SFSWAP	G	G	0.7	0.7	SFSWAP	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AD	AD	intergenic_region
chr12	131573284	rs7963314	0.00000272	SFSWAP	G	G	0.7	0.7	SFSWAP	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AD	AD	intergenic_region
chr12	132630826	rs4883627	1.06E-15	POLE	NR	NR	0.22	1.24608	POLE	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	POLE expression in Temporal cortex	Expression	intron_variant
chr13	21325916	rs12583648	0.000000233	"LINC00539, ZDHHC20"	C	C	NR	NA	ZDHHC20	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	20770	All	Brain infarcts (BI)	Imaging	intron_variant
chr13	21325916	rs12583648	0.0000295	"LINC00539, ZDHHC20"	C	C	1.2	1.2	ZDHHC20	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	16690	All	Small sub-cortical brain infarcts (SSBI)	Imaging	intron_variant
chr13	21325916	rs12583648	0.0000408	"LINC00539, ZDHHC20"	NR	NR	1.11	1.11	ZDHHC20	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	27632	All	Brain infarcts (BI)	Imaging	intron_variant
chr13	21325916	rs12583648	0.0000766	"LINC00539, ZDHHC20"	C	C	NR	NA	ZDHHC20	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	16690	All	Small sub-cortical brain infarcts (SSBI)	Imaging	intron_variant
chr13	21325916	rs12583648	0.00895	"LINC00539, ZDHHC20"	NR	NR	1.08	1.08	ZDHHC20	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	23552	All	Small sub-cortical brain infarcts (SSBI)	Imaging	intron_variant
chr13	21325916	rs12583648	0.46	"LINC00539, ZDHHC20"	NR	NR	0.95	0.95	ZDHHC20	SNP-based	Endophenotype	30651383	Caucasian	ADGC	2940	All	Pathologically defined infarcts	Imaging	intron_variant
chr13	21325916	rs12583648	0.53	"LINC00539, ZDHHC20"	NR	NR	1.01	1.01	ZDHHC20	SNP-based	Endophenotype	30651383	Caucasian	"CHARGE, METASTROKE, SiGN"	137560	All	Ischemic stroke (IS)	Imaging	intron_variant
chr13	21325916	rs12583648	0.55	"LINC00539, ZDHHC20"	NR	NR	0.97	0.97	ZDHHC20	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	6862	All	Small sub-cortical brain infarcts (SSBI)	Imaging	intron_variant
chr13	21325916	rs12583648	0.63	"LINC00539, ZDHHC20"	NR	NR	0.98	0.98	ZDHHC20	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	6862	All	Brain infarcts (BI)	Imaging	intron_variant
chr13	21325916	rs12583648	0.86	"LINC00539, ZDHHC20"	NR	NR	1.01	1.01	ZDHHC20	SNP-based	Endophenotype	30651383	Caucasian	"METASTROKE, SiGN, YLSDR"	41039	All	Ischemic stroke due to small vessel disease (IS-SVD)	Imaging	intron_variant
chr13	21325916	rs12583648	5.82E-09	"LINC00539, ZDHHC20"	C	C	1.21	1.21	ZDHHC20	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	20770	All	Brain infarcts (BI)	Imaging	intron_variant
chr13	26150190	rs17511627	0.00000501	NR	C	C	1.75	1.75	RNF6	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr13	27446043	rs4771122	0.403	NR	G	G	0.961	0.961	MTIF3	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	intron_variant
chr13	27446043	rs4771122	0.672	NR	G	G	0.988	0.988	MTIF3	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	intron_variant
chr13	27852622	rs2387100	0.0000382	NR	NR	NR	NR	NA	GSX1	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	intron_variant
chr13	32313252	rs4942417	0.0000021	NR	C	C	0.44	1.55271	ZAR1L	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	363	AD subjects	CSF P-tau181p	Fluid biomarker	null
chr13	32313252	rs4942417	0.0036	NR	C	C	-0.19	0.826959	ZAR1L	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	878	AD subjects	CSF P-tau181p	Fluid biomarker	null
chr13	32313252	rs4942417	0.42	NR	C	C	-0.08	0.923116	ZAR1L	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	515	AD subjects	CSF P-tau181p	Fluid biomarker	null
chr13	32572915	rs718444	0.00116	N4BP2L2	T	T	NR	NA	PDS5B	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	7289	Plan 2 (only males)	AD	AD	intergenic_region
chr13	32572915	rs718444	1.80E-53	NR	T	T	NR	NA	PDS5B	SNP-based	eQTL	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	7289	Plan 2 (only males)	N4BP2L2 (ILMN_1737561) expression in peripheral blood	Expression	intergenic_region
chr13	34080781	rs690705	0.000000634	RFC3	NR	NR	NR	NA	RFC3	SNP-based	Disease risk	20061627	Caucasian	ADGC	699	All	LOAD	AD	downstream_gene_variant
chr13	34376390	rs17798800	0.00000684	NR	A	A	0.38	0.38	RFC3	SNP-based	Endophenotype	23374588	Caucasian	Cohort from Italy	337	Probable AD	"Responder (MMSE increased, remained stable, or the Delta MMSE fell by 1or less) vs Non-responder (worsening of >3 points in Delta MMSE)"	Cognitive	intron_variant
chr13	34376390	rs17798800	0.0000823	NR	A	A	-2.12	0.120032	RFC3	SNP-based	Endophenotype	23374588	Caucasian	Cohort from Italy	337	Probable AD	Delta MMSE (annualized difference between MMSE score at baseline and at follow-up)	Cognitive	intron_variant
chr13	34376390	rs17798800	0.000124	NR	A	A	0.34	0.34	RFC3	SNP-based	Endophenotype	23374588	Caucasian	Cohort from Italy	169	Probable AD	"Responder (MMSE increased, remained stable, or the Delta MMSE fell by 1or less) vs Non-responder (worsening of >3 points in Delta MMSE)"	Cognitive	intron_variant
chr13	34376390	rs17798800	0.00138	NR	A	A	-2.38	0.0925506	RFC3	SNP-based	Endophenotype	23374588	Caucasian	Cohort from Italy	169	Probable AD	Delta MMSE (annualized difference between MMSE score at baseline and at follow-up)	Cognitive	intron_variant
chr13	34376390	rs17798800	0.00878	NR	A	A	0.44	0.44	RFC3	SNP-based	Endophenotype	23374588	Caucasian	Cohort from Italy	168	Probable AD	"Responder (MMSE increased, remained stable, or the Delta MMSE fell by 1or less) vs Non-responder (worsening of >3 points in Delta MMSE)"	Cognitive	intron_variant
chr13	34376390	rs17798800	0.0241	NR	A	A	-1.82	0.162026	RFC3	SNP-based	Endophenotype	23374588	Caucasian	Cohort from Italy	168	Probable AD	Delta MMSE (annualized difference between MMSE score at baseline and at follow-up)	Cognitive	intron_variant
chr13	43591883	rs17460623	0.00000937	ENOX1	C	C	0.49	0.49	ENOX1	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr13	45942333	rs741668	0.00000464	ZC3H13	NR	NR	0.27	1.30996	ZC3H13	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	673	All	CSF Clusterin	Fluid biomarker	intergenic_region
chr13	45942333	rs741668	0.0002	ZC3H13	NR	NR	0.3	1.34986	ZC3H13	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	270	Subjects with APOE-e4+	CSF Clusterin	Fluid biomarker	intergenic_region
chr13	45942333	rs741668	0.00749	ZC3H13	NR	NR	0.23	1.2586	ZC3H13	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	403	Subjects with APOE-e4-	CSF Clusterin	Fluid biomarker	intergenic_region
chr13	49533153	rs1046028	1.44E-79	PHF11	NR	NR	0.38	1.46228	RCBTB1	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	PHF11 expression in Temporal cortex	Expression	3_prime_UTR_variant
chr13	49533153	rs1046028	4.73E-70	PHF11	NR	NR	0.35	1.41907	RCBTB1	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	PHF11 expression in Cerebellar	Expression	3_prime_UTR_variant
chr13	49533153	rs1046028	4.79E-29	PHF11	NR	NR	0.37	1.44773	RCBTB1	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	PHF11 expression in Cerebellar	Expression	3_prime_UTR_variant
chr13	49533153	rs1046028	5.61E-35	PHF11	NR	NR	0.33	1.39097	RCBTB1	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	PHF11 expression in Cerebellar	Expression	3_prime_UTR_variant
chr13	51272469	rs1006064	0.00000502	FAM124A	NR	NR	0.252	1.2866	FAM124A	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	673	All	CSF Clusterin	Fluid biomarker	intron_variant
chr13	51272469	rs1006064	0.000143	FAM124A	NR	NR	0.283	1.32711	FAM124A	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	403	Subjects with APOE-e4-	CSF Clusterin	Fluid biomarker	intron_variant
chr13	51272469	rs1006064	0.00799	FAM124A	NR	NR	0.216	1.2411	FAM124A	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	270	Subjects with APOE-e4+	CSF Clusterin	Fluid biomarker	intron_variant
chr13	52656848	rs4885767	0.00079	SUGT1	NR	NR	NR	NA	SUGT1	SNP-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr13	52656848	rs4885767	0.00197	NA	NR	NR	NR	NA	SUGT1	Gene-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr13	52930540	rs9527039	0.000000564	GLIS1	NR	NR	0.08	1.08329	PCDH8	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	1509	Female subjects	CSF P-tau181p	Fluid biomarker	intergenic_region
chr13	52930540	rs9527039	0.000011	GLIS1	C	C	0.05	1.05127	PCDH8	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	3146	All	CSF T-tau	Fluid biomarker	intergenic_region
chr13	52930540	rs9527039	0.002	GLIS1	NR	NR	0.05	1.05127	PCDH8	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	1527	Male subjects	CSF P-tau181p	Fluid biomarker	intergenic_region
chr13	52930540	rs9527039	0.0424	GLIS1	C	C	0.02	1.0202	PCDH8	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	3146	All	CSF Ab1-42	Fluid biomarker	intergenic_region
chr13	52930540	rs9527039	0.403	GLIS1	C	C	0.02	1.0202	PCDH8	SNP-based	Age at onset (AAO) / Survival	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	39855	AD subjects	Age at onset	Other	intergenic_region
chr13	52930540	rs9527039	0.425	GLIS1	C	C	0.069	1.07144	PCDH8	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	1530	All	AD Progression (based on CDR Score)	Cognitive	intergenic_region
chr13	52930540	rs9527039	0.822	GLIS1	C	C	0.99	2.69123	PCDH8	SNP-based	Disease risk	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	74046	All	AD risk	AD	intergenic_region
chr13	52930540	rs9527039	5.95E-09	GLIS1	C	C	0.061	1.0629	PCDH8	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	3146	All	CSF P-tau181p	Fluid biomarker	intergenic_region
chr13	52930540	rs9527039	5.95E-09	GLIS1	NR	NR	0.06	1.06184	PCDH8	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	3036	All	CSF P-tau181p	Fluid biomarker	intergenic_region
chr13	53039196	rs3803259	0.0326	OLFM4	NR	NR	NR	NA	OLFM4	SNP-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr13	53039196	rs3803259	0.3996	NA	NR	NR	NR	NA	OLFM4	Gene-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr13	59271334	rs80155385	0.00000495	NR	C	C	NR	NA	DIAPH3	SNP-based	Disease risk	24770881	Caucasian	ADGC	2239	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	intergenic_region
chr13	70846292	rs1328032	0.000000193	DACH1	A	A	0.67	0.67	DACH1	SNP-based	Disease risk	27899424	Caucasian	IFGC	6462	All	Frontotemporal Dementia	ADRD	intergenic_region
chr13	70846292	rs1328032	0.0000739	DACH1	A	A	0.8	0.8	DACH1	SNP-based	Disease risk	27899424	Caucasian	IFGC	12928	All	Frontotemporal Dementia	ADRD	intergenic_region
chr13	70846292	rs1328032	0.34	DACH1	A	A	0.94	0.94	DACH1	SNP-based	Disease risk	27899424	Caucasian	IFGC	6466	All	Frontotemporal Dementia	ADRD	intergenic_region
chr13	75984017	rs9544105	0.00000541	NR	NR	NR	NR	NA	LMO7	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	intergenic_region
chr13	76651467	rs9530579	0.985	NR	NR	NR	NR	NA	KCTD12	SNP-based	Endophenotype	20452100	Caucasian	ADGC	311	Non-Demented autopsy subjects	High Braak vs Low Braak	Neuropathology	intergenic_region
chr13	76736658	rs9600764	0.0000998	Intergenic (as reported in paper)	G	G	NR	NA	KCTD12	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intergenic_region
chr13	76736658	rs9600764	0.00019	NR	G	G	NR	NA	KCTD12	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intergenic_region
chr13	76736658	rs9600764	0.0027	NR	G	G	NR	NA	KCTD12	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intergenic_region
chr13	76889101	rs659628	0.0000446	KCTD12	NR	NR	NR	NA	KCTD12	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	upstream_gene_variant
chr13	89362235	rs7995618	0.0000041	LOC160824	NR	NR	NR	NA	SLITRK5	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	818	All	Plasma Clusterin	Fluid biomarker	non_coding_transcript_exon_variant
chr13	89869274	rs7331792	0.000469	BC038529	A	A	NR	NA	GPC5	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Low-density lipoprotein (LDL)	Non-ADRD	intergenic_region
chr13	89869274	rs7331792	0.00125	BC038529	A	A	NR	NA	GPC5	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr13	91176054	rs61023801	0.00000047	NR	G	G	0.52	1.68203	GPC5	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	363	AD subjects	CSF Ab1-42	Fluid biomarker	intergenic_region
chr13	91176054	rs61023801	0.0003	NR	G	G	0.52	1.68203	GPC5	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	878	AD subjects	CSF Ab1-42	Fluid biomarker	intergenic_region
chr13	91177310	rs74922937	0.92	NR	A	A	0.02	1.0202	GPC5	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	515	AD subjects	CSF Ab1-42	Fluid biomarker	intergenic_region
chr13	98479040	rs912330	0.00000379	STK24	T	T	0.54	0.54	STK24	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr13	101393128	rs11617026	0.0000017	NR	NR	NR	NR	NA	NALCN	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intron_variant
chr13	101393128	rs11617026	0.000055	NR	NR	NR	0.21	0.21	NALCN	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intron_variant
chr13	101393128	rs11617026	0.000912	NR	NR	NR	NR	NA	NALCN	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr13	101393128	rs11617026	0.0199	NR	NR	NR	0.54	0.54	NALCN	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr13	101393128	rs11617026	0.29264	NR	NR	NR	NR	NA	NALCN	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intron_variant
chr13	101393128	rs11617026	0.381	NR	NR	NR	NR	NA	NALCN	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intron_variant
chr13	101393128	rs11617026	0.445	NR	NR	NR	NR	NA	NALCN	SNP-based	Disease risk	21059989	Caucasian	ADGC	1390	Unrelated individuals	LOAD	AD	intron_variant
chr13	101393128	rs11617026	0.81524	NR	NR	NR	NR	NA	NALCN	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intron_variant
chr13	101393128	rs11617026	1	NR	NR	NR	0.82	0.82	NALCN	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intron_variant
chr13	103011595	rs16961023	0.000000103	SLC10A2	G	G	0.41	1.50682	SLC10A2	SNP-based	Disease risk	27770636	African American	ADGC	5609	All	LOAD liability score	AD	intergenic_region
chr13	103011595	rs16961023	0.000000801	SLC10A2	G	G	2.77	2.77	SLC10A2	SNP-based	Disease risk	27770636	African American	ADGC	5609	All	LOAD	AD	intergenic_region
chr13	103011595	rs16961023	0.00000792	SLC10A2	G	G	2.68	2.68	SLC10A2	SNP-based	Disease risk	27770636	African American	ADGC	5609	All	LOAD	AD	intergenic_region
chr13	103011595	rs16961023	4.59E-08	SLC10A2	G	G	0.41	1.50682	SLC10A2	SNP-based	Disease risk	27770636	African American	ADGC	5609	All	LOAD liability score	AD	intergenic_region
chr13	106414855	rs2893253	0.000202	EFNB2	NR	NR	NR	NA	EFNB2	SNP-based	Disease risk	27899424	Caucasian	IFGC	12928	All	Frontotemporal Dementia	ADRD	intergenic_region
chr13	109152426	rs9555561	0.00000253	MYO16	C	C	1.25	1.25	MYO16	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	17480	Plan 1 (males and females)	AD	AD	intron_variant
chr13	109155938	rs912322	0.00000129	MYO16	A	A	1.26	1.26	MYO16	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	17480	Plan 1 (males and females)	AD	AD	intron_variant
chr13	112951220	rs61963560	0.000592	BC035340	A	A	NR	NA	MCF2L	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr13	112951220	rs61963560	0.000758	BC035340	A	A	0.94	0.94	MCF2L	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intron_variant
chr13	112951220	rs61963560	0.00194	BC035340	A	A	NR	NA	MCF2L	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Total cholesterol (TC)	Non-ADRD	intron_variant
chr13	112951220	rs61963560	0.00579	BC035340	A	A	0.95	0.95	MCF2L	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intron_variant
chr13	112951220	rs61963560	0.0743	BC035340	A	A	1.13	1.13	MCF2L	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intron_variant
chr13	112951220	rs61963560	0.867	BC035340	A	A	1	1	MCF2L	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr13	113116562	rs488703	0.00000002	F7	NR	NR	-0.1	0.904837	F7	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	ADNI	521	All	Plasma FactorVII	Fluid biomarker	intron_variant
chr13	113116562	rs488703	0.042	F7	NR	NR	-118.18	4.73236e-52	F7	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	IMAS	59	All	Plasma FactorVII	Fluid biomarker	intron_variant
chr13	114070327	rs7981577	0.000137	RASA3	C	C	NR	NA	RASA3	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr13	114070327	rs7981577	0.00228	RASA3	C	C	NR	NA	RASA3	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Total cholesterol (TC)	Non-ADRD	intron_variant
chr13	114070327	rs7981577	0.0956	RASA3	C	C	0.98	0.98	RASA3	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intron_variant
chr13	114070327	rs7981577	0.0976	RASA3	C	C	0.98	0.98	RASA3	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intron_variant
chr13	114070327	rs7981577	0.344	RASA3	C	C	1	1	RASA3	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr13	114070327	rs7981577	0.834	RASA3	C	C	0.99	0.99	RASA3	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intron_variant
chr14	23932540	rs10483284	0.00701	DHRS4L2	T	T	NR	NA	DHRS4	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	intron_variant
chr14	23932540	rs10483284	5.36E-38	NR	T	T	NR	NA	DHRS4	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	DHRS4L2 (ILMN_1761450) expression	Expression	intron_variant
chr14	30045906	rs11847697	0.112	NR	T	T	0.835	0.835	PRKD1	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	intron_variant
chr14	30045906	rs11847697	0.671	NR	T	T	1.03	1.03	PRKD1	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	intron_variant
chr14	32483161	rs4296166	0.00000408	AKAP6	A	A	1.12	1.12	AKAP6	SNP-based	Disease risk	20460622	Caucasian	"ADGC, CHARGE, EADI"	24035	All	AD	AD	intron_variant
chr14	32483161	rs4296166	0.0000836	AKAP6	A	A	1.14	1.14	AKAP6	SNP-based	Disease risk	20460622	Caucasian	"ADGC, CHARGE"	16675	All	AD	AD	intron_variant
chr14	32483161	rs4296166	NR	AKAP6	A	A	0.98	0.98	AKAP6	SNP-based	Disease risk	20460622	Caucasian	"ADGC, CHARGE, EADI, GERAD"	34363	All	AD	AD	intron_variant
chr14	32911892	rs12146962	0.00000725	NR	NR	NR	NR	NA	NPAS3	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	intergenic_region
chr14	33841207	rs10149826	0.00000915	NPAS3	T	T	0.22	1.24608	NPAS3	SNP-based	Endophenotype	23836404	Caucasian	ADGC	651	All	Neuritic plaque (NP)	Neuropathology	intergenic_region
chr14	39349412	rs8018486	0.00000115	"CTAGE5, FBXO33"	G	G	NR	NA	MIA2	SNP-based	Disease risk	24770881	Caucasian	ADGC	2239	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	intron_variant
chr14	52773317	rs73298734	0.00000169	GNPNAT1	NR	NR	1.23	1.23	STYX	SNP-based	Disease risk	30979435	Caucasian	ADGC	14297	Age 60-79 y	AD	AD	3_prime_UTR_variant
chr14	52773317	rs73298734	0.455	GNPNAT1	NR	NR	0.95	0.95	STYX	SNP-based	Disease risk	30979435	Caucasian	ADGC	6311	Age >=80 y	AD	AD	3_prime_UTR_variant
chr14	52886736	rs6572869	0.01	FERMT2	NR	NR	-0.11	NA	FERMT2	SNP-based	Age at onset (AAO) / Survival	28323831	Caucasian	ADGC	15795	All	Age of AD onset	Other	intron_variant
chr14	52890300	rs62003531	0.0006	FERMT2	NR	NR	0.02745	1.02783	FERMT2	SNP-based	Endophenotype	27933404	Caucasian	"ADNI, BIOCARD, Knight-ADRC, Lund University, MAYO, UPENN, UW "	2886	AD subjects	CSF Ab1-42	Fluid biomarker	intron_variant
chr14	52899098	rs11157934	0.348	FERMT2	A	A	1.06	NA	FERMT2	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	intron_variant
chr14	52924962	rs17125924	0.00000066	FERMT2	G	G	1.13	1.13	FERMT2	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	63926	All	Clinically diagnosed LOAD	AD	intron_variant
chr14	52924962	rs17125924	0.0000148	FERMT2	G	G	NR	NA	FERMT2	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr14	52924962	rs17125924	0.0005	FERMT2	G	G	1.15	1.15	FERMT2	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	18845	All	Clinically diagnosed LOAD	AD	intron_variant
chr14	52924962	rs17125924	0.00117	FERMT2	G	G	NR	NA	FERMT2	SNP-based	Cross phenotype 	30413934	Caucasian	GIANT	681275	All	Body-mass index (BMI)	Non-ADRD	intron_variant
chr14	52924962	rs17125924	0.00147	FERMT2	G	G	1.01	1.01	FERMT2	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr14	52924962	rs17125924	0.769	FERMT2	G	G	1.03	1.03	FERMT2	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intron_variant
chr14	52924962	rs17125924	1.40E-09	FERMT2	G	G	1.14	1.14	FERMT2	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	82771	All	Clinically diagnosed LOAD	AD	intron_variant
chr14	52924962	rs17125924	1.55E-08	FERMT2	G	G	1.13	1.13	FERMT2	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intron_variant
chr14	52924962	rs17125924	2.62E-08	FERMT2	G	G	1.13	1.13	FERMT2	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intron_variant
chr14	52933911	rs17125944	0.00001	FERMT2	C	C	1.13	1.13	FERMT2	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD"	54162	All	LOAD	AD	intron_variant
chr14	52933911	rs17125944	0.00016	FERMT2	C	C	1.17	1.17	FERMT2	SNP-based	Disease risk	24162737	Caucasian	Cohorts from Europe and USA	19884	All	LOAD	AD	intron_variant
chr14	52933911	rs17125944	0.0185	FERMT2	C	C	1.238	1.238	FERMT2	SNP-based	Disease risk	24495969	Caucasian	Cohort from Spain	4372	All	AD	AD	intron_variant
chr14	52933911	rs17125944	0.029	FERMT2	C	C	1.22	1.22	FERMT2	SNP-based	Disease risk	26339675	Caribbean Hispanic	"EFIGA, NOMAS, WHICAP "	4514	All	LOAD	AD	intron_variant
chr14	52933911	rs17125944	0.036	FERMT2	C	C	1.22	1.22	FERMT2	SNP-based	Disease risk	26339675	Caribbean Hispanic	"EFIGA, NOMAS, WHICAP "	4514	All	LOAD	AD	intron_variant
chr14	52933911	rs17125944	0.069	FERMT2	C	C	1.27	1.27	FERMT2	SNP-based	Endophenotype	25188341	Caucasian	ADGC	3702	All	Clinico-pathologic AD dementia (with neuropathologist documentation)	Neuropathology	intron_variant
chr14	52933911	rs17125944	0.085	FERMT2	C	C	1.2	1.2	FERMT2	SNP-based	Endophenotype	25188341	Caucasian	ADGC	4914	All	Clinico-pathologic AD dementia (No neuropathologist documentation)	Neuropathology	intron_variant
chr14	52933911	rs17125944	0.73	FERMT2	NR	NR	0.94	0.94	FERMT2	SNP-based	Endophenotype	26993346	Caucasian	Cohort from Europe	10840	All	PCA (posterior cortical atrophy)	Imaging	intron_variant
chr14	52933911	rs17125944	7.90E-09	FERMT2	C	C	1.14	1.14	FERMT2	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD, Cohorts from Europe and USA"	74046	All	LOAD	AD	intron_variant
chr14	52933911	rs17125944	NR	FERMT2	C	C	1.69	1.69	FERMT2	SNP-based	Disease risk	27849641	Caucasian	ADGC	589	All	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr14	52933911	rs17125944	NR	ZCWPW1	C	C	1.41	1.41	FERMT2	SNP-based	Disease risk	27849641	Caucasian	ADGC	297	APOE-e4 non-carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr14	52933911	rs17125944	NR	ZCWPW1	C	C	3.05	3.05	FERMT2	SNP-based	Disease risk	27849641	Caucasian	ADGC	292	APOE-e4 carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr14	57548363	rs187911	0.00000623	SLC35F4	G	G	-0.14	0.869358	SLC35F4	SNP-based	Endophenotype	23836404	Caucasian	ADGC	651	All	Neuritic plaque (NP)	Neuropathology	intergenic_region
chr14	73198145	rs165932	0.121	PSEN1	G	G	0.89	0.89	PSEN1	SNP-based	Disease risk	20534741	Caucasian	"ADC, UM"	1610	All	AD	AD	intron_variant
chr14	73213398	rs3025787	0.003	PSEN1	G	G	0.71	0.71	PSEN1	SNP-based	Age at onset (AAO) / Survival	17998437	Caucasian	Cohorts from Canada	1335	All	Age of AD onset	Other	intron_variant
chr14	73213398	rs3025787	0.04	PSEN1	G	G	0.69	0.69	PSEN1	SNP-based	Disease risk	17998437	Caucasian	Cohorts from Canada	1335	All	AD	AD	intron_variant
chr14	73809286	rs17182607	0	NR	A	A	NR	NA	MIDEAS	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	LOC100506476 (ENSG00000259065) expression	Expression	intergenic_region
chr14	73809286	rs17182607	0.00478	LOC100506476	A	A	NR	NA	MIDEAS	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	intergenic_region
chr14	74606345	rs2043948	0.000000444	LTBP2	T	T	1.27	1.27	LTBP2	SNP-based	Disease risk	20460622	Caucasian	"ADGC, CHARGE, EADI"	24035	All	AD	AD	intron_variant
chr14	74606345	rs2043948	0.000446	LTBP2	T	T	1.13	1.13	LTBP2	SNP-based	Disease risk	20460622	Caucasian	"ADGC, CHARGE, EADI, GERAD"	34363	All	AD	AD	intron_variant
chr14	74606345	rs2043948	0.000696	LTBP2	T	T	1.25	1.25	LTBP2	SNP-based	Disease risk	20460622	Caucasian	"ADGC, CHARGE"	16675	All	AD	AD	intron_variant
chr14	74643734	rs888417	0.00000409	LTBP2	NR	NR	NR	NA	AREL1	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr14	74812336	rs10483861	0.0054	YLPM1	NR	NR	NR	NA	YLPM1	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr14	78308963	rs7155434	0.00000782	KIAA0743	C	C	3643	inf	NRXN3	SNP-based	Endophenotype	20197096	Caucasian	ADNI	742	All	Temporal Lobe Atrophy	Imaging	intron_variant
chr14	78308963	rs7155434	0.00000795	KIAA0743	C	C	3643	inf	NRXN3	SNP-based	Endophenotype	20197096	Caucasian	ADNI	742	All	Temporal Lobe Atrophy	Imaging	intron_variant
chr14	79470621	rs10150332	0.379	NR	C	C	0.963	0.963	NRXN3	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	intron_variant
chr14	79470621	rs10150332	0.476	NR	C	C	1.02	1.02	NRXN3	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	intron_variant
chr14	79470621	rs10150332	0.55	NR	C	C	0.97	0.97	NRXN3	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	intron_variant
chr14	79470621	rs10150332	0.848	NR	C	C	0	1	NRXN3	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	intron_variant
chr14	79775873	rs17764668	0.00000984	NRXN3	NR	NR	NR	NA	NRXN3	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	2222	AD subjects	Age at onset	Other	intron_variant
chr14	79775873	rs17764668	0.0000208	NRXN3	NR	NR	NR	NA	NRXN3	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	2222	AD subjects	Age at onset	Other	intron_variant
chr14	79775873	rs17764668	0.00114	NRXN3	NR	NR	1.15	3.15819	NRXN3	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	844	AD subjects	Age at onset	Other	intron_variant
chr14	79775873	rs17764668	0.00365	NRXN3	NR	NR	1.14	3.12677	NRXN3	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	1190	AD subjects	Age at onset	Other	intron_variant
chr14	79775873	rs17764668	0.437	NRXN3	NR	NR	2.72	15.1803	NRXN3	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADNI	188	AD subjects	Age at onset	Other	intron_variant
chr14	89310401	rs3783863	0.00000453	FOXN3	NR	NR	0.575	1.77713	FOXN3	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	673	All	CSF Clusterin	Fluid biomarker	intron_variant
chr14	89310401	rs3783863	0.0000814	FOXN3	NR	NR	0.608	1.83675	FOXN3	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	403	Subjects with APOE-e4-	CSF Clusterin	Fluid biomarker	intron_variant
chr14	89310401	rs3783863	0.0241	FOXN3	NR	NR	0.496	1.64214	FOXN3	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	270	Subjects with APOE-e4+	CSF Clusterin	Fluid biomarker	intron_variant
chr14	91419362	rs1285850	0.000031	"CCDC88C, SMEK1"	NR	NR	NR	NA	CCDC88C	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr14	91725006	rs3814837	0.00000326	CATSPERB	C	C	0.64	0.64	CATSPERB	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	intron_variant
chr14	92460608	rs10498633	0.000000147	SLC24A4	NR	NR	NR	NA	SLC24A4	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr14	92460608	rs10498633	0.00000015	"RIN3, SLC24A4"	T	T	0.9	0.9	SLC24A4	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD"	54162	All	LOAD	AD	intron_variant
chr14	92460608	rs10498633	0.0078	"RIN3, SLC24A4"	T	T	0.93	0.93	SLC24A4	SNP-based	Disease risk	24162737	Caucasian	Cohorts from Europe and USA	19884	All	LOAD	AD	intron_variant
chr14	92460608	rs10498633	0.043	"RIN3, SLC24A4"	T	T	0.88	0.88	SLC24A4	SNP-based	Disease risk	26339675	Caribbean Hispanic	"EFIGA, NOMAS, WHICAP "	4514	All	LOAD	AD	intron_variant
chr14	92460608	rs10498633	0.045	"RIN3, SLC24A4"	T	T	0.88	0.88	SLC24A4	SNP-based	Disease risk	26339675	Caribbean Hispanic	"EFIGA, NOMAS, WHICAP "	4514	All	LOAD	AD	intron_variant
chr14	92460608	rs10498633	0.14	"RIN3, SLC24A4"	NR	NR	0.86	0.86	SLC24A4	SNP-based	Endophenotype	26993346	Caucasian	Cohort from Europe	10840	All	PCA (posterior cortical atrophy)	Imaging	intron_variant
chr14	92460608	rs10498633	0.142	SLC24A4	T	T	0.922	0.922	SLC24A4	SNP-based	Disease risk	24495969	Caucasian	Cohort from Spain	4372	All	AD	AD	intron_variant
chr14	92460608	rs10498633	0.31	"RIN3, SLC24A4"	T	T	0.93	0.93	SLC24A4	SNP-based	Endophenotype	25188341	Caucasian	ADGC	4914	All	Clinico-pathologic AD dementia (No neuropathologist documentation)	Neuropathology	intron_variant
chr14	92460608	rs10498633	0.72	"RIN3, SLC24A4"	T	T	1.03	1.03	SLC24A4	SNP-based	Endophenotype	25188341	Caucasian	ADGC	3702	All	Clinico-pathologic AD dementia (with neuropathologist documentation)	Neuropathology	intron_variant
chr14	92460608	rs10498633	5.50E-09	"RIN3, SLC24A4"	T	T	0.91	0.91	SLC24A4	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD, Cohorts from Europe and USA"	74046	All	LOAD	AD	intron_variant
chr14	92460608	rs10498633	NR	"RIN3, SLC24A4"	G	G	1.24	1.24	SLC24A4	SNP-based	Disease risk	27849641	Caucasian	ADGC	589	All	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr14	92460608	rs10498633	NR	ZCWPW1	G	G	1.15	1.15	SLC24A4	SNP-based	Disease risk	27849641	Caucasian	ADGC	297	APOE-e4 non-carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr14	92460608	rs10498633	NR	ZCWPW1	G	G	1.5	1.5	SLC24A4	SNP-based	Disease risk	27849641	Caucasian	ADGC	292	APOE-e4 carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr14	92466484	rs12881735	0.00000049	SLC24A4	C	C	0.92	0.92	SLC24A4	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	63926	All	Clinically diagnosed LOAD	AD	intron_variant
chr14	92466484	rs12881735	0.0043	SLC24A4	C	C	0.92	0.92	SLC24A4	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	18845	All	Clinically diagnosed LOAD	AD	intron_variant
chr14	92466484	rs12881735	7.40E-09	SLC24A4	C	C	0.92	0.92	SLC24A4	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	82771	All	Clinically diagnosed LOAD	AD	intron_variant
chr14	92467776	rs12590273	0.000316	SLC24A4	NR	NR	0.1	NA	SLC24A4	SNP-based	Age at onset (AAO) / Survival	28323831	Caucasian	ADGC	15795	All	Age of AD onset	Other	intron_variant
chr14	92472511	rs12590654	0.0000037	SLC24A4	A	A	NR	NA	SLC24A4	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	intron_variant
chr14	92472511	rs12590654	1.65E-10	SLC24A4	A	A	-6.39	NA	SLC24A4	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ, UKBB"	455258	All	AD + AD-by-proxy	AD	intron_variant
chr14	92472511	rs12590654	1.98E-08	SLC24A4	A	A	NR	NA	SLC24A4	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ"	79145	All	AD	AD	intron_variant
chr14	92526992	rs7160605	0.00405	RIN3	C	C	1.35	NA	RIN3	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	intron_variant
chr14	92649779	rs11621843	0.00000519	RIN3	G	G	1.47	1.47	RIN3	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	2024	All	LOAD	AD	intron_variant
chr14	92649779	rs11621843	0.00081	RIN3	G	G	1.21	1.21	RIN3	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	3894	All	LOAD	AD	intron_variant
chr14	92649779	rs11621843	0.72	RIN3	G	G	1.03	1.03	RIN3	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	1870	All	LOAD	AD	intron_variant
chr14	94397299	rs7151526	0.000000744	SERPINA1	NR	NR	-0.06	0.941765	SERPINA1	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	ADNI	521	All	Plasma AAT	Fluid biomarker	intergenic_region
chr14	94689439	rs11622883	0.000094	NR	NR	NR	1.19	1.19	AL049839.2	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	3870	All	LOAD	AD	intergenic_region
chr14	94689439	rs11622883	0.01	NR	NR	NR	NR	NA	AL049839.2	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	720	All	LOAD	AD	intergenic_region
chr14	94689439	rs11622883	0.033	NR	NR	NR	NR	NA	AL049839.2	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	658	All	LOAD	AD	intergenic_region
chr14	94689439	rs11622883	0.091	NR	NR	NR	NR	NA	AL049839.2	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	1146	All	LOAD	AD	intergenic_region
chr14	94689439	rs11622883	0.144	NR	NR	NR	NR	NA	AL049839.2	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	776	All	LOAD	AD	intergenic_region
chr14	94689439	rs11622883	0.339	GWA_14q32.13	A	A	1.07	1.07	AL049839.2	SNP-based	Disease risk	20534741	Caucasian	"ADC, UM"	1610	All	AD	AD	intergenic_region
chr14	94689439	rs11622883	0.979	NR	NR	NR	NR	NA	AL049839.2	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	570	All	LOAD	AD	intergenic_region
chr14	94895934	rs10484049	0.0000302	GSC	NR	NR	NR	NA	GSC	SNP-based	Disease risk	20061627	Caucasian	ADGC	699	All	LOAD	AD	intergenic_region
chr14	99570681	rs2400749	0.00000225	CCDC85C	G	G	0.72	NA	CCDC85C	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	intron_variant
chr14	104919015	rs2819438	6.94E-09	"C14orf79,PLD4"	A	A	-0.8	0.449329	PLD4	SNP-based	Endophenotype	29274321	Caucasian	ADNI	203	Normal controls	CSF T-tau	Fluid biomarker	intergenic_region
chr14	106514189	rs9324088	0.0002	NR	G	G	NR	NA	TMEM121	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr14	106514189	rs9324088	0.0003	Intergenic (as reported in paper)	G	G	NR	NA	TMEM121	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr14	106514189	rs9324088	0.013	NR	G	G	NR	NA	TMEM121	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intron_variant
chr14	106704673	rs7145100	0.1	abParts	NR	NR	0.08	NA	TMEM121	SNP-based	Age at onset (AAO) / Survival	28323831	Caucasian	ADGC	15795	All	Age of AD onset	Other	upstream_gene_variant
chr14	106825769	rs7140253	0.0000318	Intergenic (as reported in paper)	G	G	NR	NA	TMEM121	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	upstream_gene_variant
chr14	106825769	rs7140253	0.00024	NR	G	G	NR	NA	TMEM121	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	upstream_gene_variant
chr14	106825769	rs7140253	0.0007	NR	G	G	NR	NA	TMEM121	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	upstream_gene_variant
chr15	36901080	rs4924109	0.00348	MEIS2	NR	NR	NR	NA	MEIS2	SNP-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr15	36901080	rs4924109	0.0503	NA	NR	NR	NR	NA	MEIS2	Gene-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr15	37949388	rs112187315	0.179	TMCO5A	NR	NR	NR	NA	TMCO5A	SNP-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr15	37949388	rs112187315	0.69431	NA	NR	NR	NR	NA	TMCO5A	Gene-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr15	41993297	rs12232304	0.0000075	PLA2G4E	NR	NR	NR	NA	PLA2G4E	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intron_variant
chr15	50140297	rs10519262	0.00000448	NR	A	A	1.89	1.89	ATP8B4	SNP-based	Age at onset (AAO) / Survival	17998437	Caucasian	Cohorts from Canada	1321	AD subjects	Age of AD onset	Other	intron_variant
chr15	50140297	rs10519262	0.0332	NR	A	A	1.45	1.45	ATP8B4	SNP-based	Age at onset (AAO) / Survival	17998437	Caucasian	MRC	554	AD subjects	Age of AD onset	Other	intron_variant
chr15	50438957	rs3131575	0.0000374	USP8	G	G	0.93	0.93	USP8	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intron_variant
chr15	50438957	rs3131575	0.000213	USP8	G	G	0.94	0.94	USP8	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intron_variant
chr15	50438957	rs3131575	0.000434	USP8	G	G	NR	NA	USP8	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Total cholesterol (TC)	Non-ADRD	intron_variant
chr15	50438957	rs3131575	0.000459	USP8	G	G	NR	NA	USP8	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr15	50438957	rs3131575	0.0379	USP8	G	G	1	1	USP8	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr15	50438957	rs3131575	0.352	USP8	G	G	1.06	1.06	USP8	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intron_variant
chr15	50510070	rs3131609	0.00000039	USP50	C	C	0.93	0.93	USP8	SNP-based	Disease risk	25862742	Caucasian	IGAP	74046	All	AD	AD	intron_variant
chr15	50510070	rs3131609	0.000000721	USP50	C	C	0.93	0.93	USP8	SNP-based	Disease risk	25862742	Caucasian	"deCODE, DemGene, IGAP"	143878	All	AD	AD	intron_variant
chr15	50510070	rs3131609	0.94	USP50	C	C	1	1	USP8	SNP-based	Disease risk	25862742	Caucasian	deCODE	67817	All	AD	AD	intron_variant
chr15	50510070	rs3131609	0.95	USP50	C	C	0.99	0.99	USP8	SNP-based	Disease risk	25862742	Caucasian	DemGene	2015	All	AD	AD	intron_variant
chr15	50716490	rs10467994	0.00000039	SPPL2A	C	C	0.94	0.94	SPPL2A	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	82771	All	Clinically diagnosed LOAD	AD	intron_variant
chr15	50716490	rs10467994	0.00000043	SPPL2A	C	C	0.94	0.94	SPPL2A	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	94437	All	Clinically diagnosed LOAD	AD	intron_variant
chr15	50716490	rs10467994	0.62	SPPL2A	C	C	0.97	0.97	SPPL2A	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	11666	All	Clinically diagnosed LOAD	AD	intron_variant
chr15	50748601	rs8035452	0.031	SPPL2A	C	C	1.102	1.102	SPPL2A	SNP-based	Disease risk	24495969	Caucasian	Cohort from Spain	4372	All	AD	AD	intron_variant
chr15	51223858	rs2899472	0.000000054	CYP19A1	A	A	0.18	1.19722	CYP19A1	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF Ab1-42	Fluid biomarker	intron_variant
chr15	51223858	rs2899472	0.000000111	CYP19A1	A	A	-0.14	0.869358	CYP19A1	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF Ab1-42	Fluid biomarker	intron_variant
chr15	51223858	rs2899472	1.86E-09	CYP19A1	A	A	NR	NA	CYP19A1	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF Ab1-42	Fluid biomarker	intron_variant
chr15	51223858	rs2899472	1.90E-12	CYP19A1	A	A	NR	NA	CYP19A1	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF Ab1-42	Fluid biomarker	intron_variant
chr15	51223858	rs2899472	3.85E-10	CYP19A1	A	A	-0.14	0.869358	CYP19A1	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF Ab1-42	Fluid biomarker	intron_variant
chr15	51223858	rs2899472	4.15E-09	CYP19A1	A	A	0.16	1.17351	CYP19A1	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF Ab1-42	Fluid biomarker	intron_variant
chr15	51387586	rs2446406	0.000000718	GLDN	A	A	0.81	0.81	GLDN	SNP-based	Disease risk	27899424	Caucasian	IFGC	6462	All	Frontotemporal Dementia	ADRD	intron_variant
chr15	51387586	rs2446406	0.0000224	GLDN	A	A	0.87	0.87	GLDN	SNP-based	Disease risk	27899424	Caucasian	IFGC	12928	All	Frontotemporal Dementia	ADRD	intron_variant
chr15	51387586	rs2446406	0.4	GLDN	A	A	0.96	0.96	GLDN	SNP-based	Disease risk	27899424	Caucasian	IFGC	6466	All	Frontotemporal Dementia	ADRD	intron_variant
chr15	58730416	rs442495	0.000000265	ADAM10	C	C	NR	NA	ADAM10	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	intron_variant
chr15	58730416	rs442495	0.000309	ADAM10	C	C	NR	NA	ADAM10	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ"	79145	All	AD	AD	intron_variant
chr15	58730416	rs442495	1.31E-09	ADAM10	C	C	-6.07	NA	ADAM10	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ, UKBB"	455258	All	AD + AD-by-proxy	AD	intron_variant
chr15	58753575	rs593742	0.00000013	ADAM10	G	G	0.93	0.93	ADAM10	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	82771	All	Clinically diagnosed LOAD	AD	upstream_gene_variant
chr15	58753575	rs593742	0.015	ADAM10	G	G	0.91	0.91	ADAM10	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	11666	All	Clinically diagnosed LOAD	AD	upstream_gene_variant
chr15	58753575	rs593742	6.20E-11	NR	A	A	1.06	1.06	ADAM10	SNP-based	Disease risk	29777097	Caucasian	UKBB	623001	All	AD	AD	upstream_gene_variant
chr15	58753575	rs593742	6.80E-09	ADAM10	G	G	0.93	0.93	ADAM10	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	94437	All	Clinically diagnosed LOAD	AD	upstream_gene_variant
chr15	58768943	rs650366	0.000000448	FAM63B	G	G	0.99	0.99	MINDY2	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr15	58768943	rs650366	0.000654	FAM63B	G	G	NR	NA	MINDY2	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr15	58768943	rs650366	0.000686	FAM63B	G	G	NR	NA	MINDY2	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Total cholesterol (TC)	Non-ADRD	intron_variant
chr15	61879280	rs1981916	0.0016	VPS13C	NR	NR	NR	NA	VPS13C	SNP-based	Endophenotype	22245343	Caucasian	ADNI	757	All	MRI	Imaging	intron_variant
chr15	62395140	rs2456930	0.00000015	NR	A	A	3843.9	inf	TLN2	SNP-based	Endophenotype	20197096	Caucasian	ADNI	742	All	Temporal Lobe Atrophy	Imaging	intron_variant
chr15	62395140	rs2456930	0.000000314	NR	A	A	3843.9	inf	TLN2	SNP-based	Endophenotype	20197096	Caucasian	ADNI	742	All	Temporal Lobe Atrophy	Imaging	intron_variant
chr15	63277703	rs117618017	0.000000264	APH1B	T	T	NR	NA	APH1B	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	missense_variant
chr15	63277703	rs117618017	0.022	APH1B	T	T	NR	NA	APH1B	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ"	79145	All	AD	AD	missense_variant
chr15	63277703	rs117618017	3.35E-08	APH1B	T	T	5.52	NA	APH1B	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ, UKBB"	455258	All	AD + AD-by-proxy	AD	missense_variant
chr15	64383114	rs11635527	0.00661	TRIP4	G	G	1.46	NA	PCLAF	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	intron_variant
chr15	64433291	rs74615166	0.000794	TRIP4	NR	NR	-0.23	NA	TRIP4	SNP-based	Age at onset (AAO) / Survival	28323831	Caucasian	ADGC	15795	All	Age of AD onset	Other	intron_variant
chr15	64433291	rs74615166	0.00327	TRIP4	C	C	1.519	1.519	TRIP4	SNP-based	Disease risk	24495969	Caucasian	Cohort from Spain	4372	All	AD	AD	intron_variant
chr15	67794500	rs2241423	0.043	NR	G	G	0.01	1.01005	MAP2K5	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	intron_variant
chr15	67794500	rs2241423	0.295	NR	G	G	0.951	0.951	MAP2K5	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	intron_variant
chr15	67794500	rs2241423	0.367	NR	G	G	0.964	0.964	MAP2K5	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	intron_variant
chr15	67794500	rs2241423	0.855	NR	G	G	0.995	0.995	MAP2K5	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	intron_variant
chr15	78540007	rs56117933	0.00083	PSMA4	NR	NR	NR	NA	PSMA4	SNP-based	Cross phenotype 	28780673	Caucasian	IGAP	54162	All	AD	AD	upstream_gene_variant
chr15	78540007	rs56117933	0.56	PSMA4	NR	NR	NR	NA	PSMA4	SNP-based	Cross phenotype 	28780673	Caucasian	GAME-ON	33832	All	Breast Cancer	Non-ADRD	upstream_gene_variant
chr15	78540007	rs56117933	4.10E-20	PSMA4	NR	NR	NR	NA	PSMA4	SNP-based	Cross phenotype 	28780673	Caucasian	GAME-ON	28998	All	Lung Cancer	Non-ADRD	upstream_gene_variant
chr15	78540007	rs56117933	<2.2E-16	PSMA4	NR	NR	NR	NA	PSMA4	SNP-based	Cross phenotype 	28780673	Caucasian	"GAME-ON, IGAP"	116992	All	AD + Breast cancer + Lung Cancer	Non-ADRD	upstream_gene_variant
chr15	80347061	rs3843702	0.00013	LINC00927	NR	NR	NR	NA	ARNT2	SNP-based	Cross phenotype 	28780673	Caucasian	GAME-ON	28998	All	Lung Cancer	Non-ADRD	intron_variant
chr15	80347061	rs3843702	0.00087	LINC00927	NR	NR	NR	NA	ARNT2	SNP-based	Cross phenotype 	28780673	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr15	80347061	rs3843702	0.0025	LINC00927	NR	NR	NR	NA	ARNT2	SNP-based	Cross phenotype 	28780673	Caucasian	"GAME-ON, IGAP"	116992	All	AD + Breast cancer + Lung Cancer	Non-ADRD	intron_variant
chr15	80347061	rs3843702	0.44	LINC00927	NR	NR	NR	NA	ARNT2	SNP-based	Cross phenotype 	28780673	Caucasian	GAME-ON	33832	All	Breast Cancer	Non-ADRD	intron_variant
chr15	81299298	rs4778636	0.00383	IL16	NR	NR	-74.1	6.58838e-33	IL16	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	IMAS	59	All	Plasma IL-16	Fluid biomarker	splice_region_variant&intron_variant
chr15	81299298	rs4778636	5.08E-19	IL16	NR	NR	-0.16	0.852144	IL16	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	ADNI	521	All	Plasma IL-16	Fluid biomarker	splice_region_variant&intron_variant
chr15	81948683	rs11630802	0.00000488	NR	NR	NR	NR	NA	MEX3B	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	downstream_gene_variant
chr15	81948683	rs11630802	0.000127	NR	NR	NR	0.66	0.66	MEX3B	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	downstream_gene_variant
chr15	81948683	rs11630802	0.000706	NR	NR	NR	NR	NA	MEX3B	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	downstream_gene_variant
chr15	81948683	rs11630802	0.00185	NR	NR	NR	NR	NA	MEX3B	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	downstream_gene_variant
chr15	81948683	rs11630802	0.0156	NR	NR	NR	0.58	0.58	MEX3B	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	downstream_gene_variant
chr15	81948683	rs11630802	0.0383	NR	NR	NR	0.71	0.71	MEX3B	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	downstream_gene_variant
chr15	81948683	rs11630802	NA	NR	NR	NR	NR	NA	MEX3B	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	downstream_gene_variant
chr15	81948683	rs11630802	NA	NR	NR	NR	NR	NA	MEX3B	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	downstream_gene_variant
chr15	84887738	rs3743162	0.00000868	"ALPK3, SLC28A1, ZNF592"	NR	NR	NR	NA	SLC28A1	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	2222	AD subjects	Age at onset	Other	splice_region_variant&intron_variant
chr15	84887738	rs3743162	0.0000999	"ALPK3, SLC28A1, ZNF592"	NR	NR	NR	NA	SLC28A1	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	2222	AD subjects	Age at onset	Other	splice_region_variant&intron_variant
chr15	84887738	rs3743162	0.000602	"ALPK3, SLC28A1, ZNF592"	NR	NR	-1.03	0.357007	SLC28A1	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	844	AD subjects	Age at onset	Other	splice_region_variant&intron_variant
chr15	84887738	rs3743162	0.0057	"ALPK3, SLC28A1, ZNF592"	NR	NR	-0.88	0.414783	SLC28A1	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	1190	AD subjects	Age at onset	Other	splice_region_variant&intron_variant
chr15	84887738	rs3743162	0.496	"ALPK3, SLC28A1, ZNF592"	NR	NR	-1.84	0.158817	SLC28A1	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADNI	188	AD subjects	Age at onset	Other	splice_region_variant&intron_variant
chr15	88857108	rs2882676	0.001	AGC1	NR	NR	1.07	1.07	ACAN	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	3870	All	LOAD	AD	missense_variant
chr15	88857108	rs2882676	0.033	AGC1	NR	NR	NR	NA	ACAN	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	720	All	LOAD	AD	missense_variant
chr15	88857108	rs2882676	0.05	AGC1	NR	NR	NR	NA	ACAN	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	1146	All	LOAD	AD	missense_variant
chr15	88857108	rs2882676	0.076	AGC1	NR	NR	NR	NA	ACAN	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	776	All	LOAD	AD	missense_variant
chr15	88857108	rs2882676	0.358	AGC1	NR	NR	NR	NA	ACAN	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	570	All	LOAD	AD	missense_variant
chr15	88857108	rs2882676	0.375	AGC1	NR	NR	NR	NA	ACAN	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	658	All	LOAD	AD	missense_variant
chr15	90087660	rs9972327	0.00000562	IDH2	NR	NR	0.4	1.49182	IDH2	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	673	All	CSF Clusterin	Fluid biomarker	intron_variant
chr15	90087660	rs9972327	0.0000174	IDH2	NR	NR	0.531	1.70063	IDH2	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	270	Subjects with APOE-e4+	CSF Clusterin	Fluid biomarker	intron_variant
chr15	90087660	rs9972327	0.0147	IDH2	NR	NR	0.299	1.34851	IDH2	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	403	Subjects with APOE-e4-	CSF Clusterin	Fluid biomarker	intron_variant
chr15	91221762	rs74587705	0.000000336	SV2B	T	T	1.85	1.85	SV2B	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	8363	All	Brain infarcts (BI)	Imaging	intron_variant
chr15	91221762	rs74587705	0.00000569	SV2B	T	T	NR	NA	SV2B	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	8363	All	Brain infarcts (BI)	Imaging	intron_variant
chr15	91221762	rs74587705	0.000582	SV2B	NR	NR	1.25	1.25	SV2B	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	15225	All	Brain infarcts (BI)	Imaging	intron_variant
chr15	91221762	rs74587705	0.39	SV2B	NR	NR	1.19	1.19	SV2B	SNP-based	Endophenotype	30651383	Caucasian	ADGC	2940	All	Pathologically defined infarcts	Imaging	intron_variant
chr15	91221762	rs74587705	0.41	SV2B	NR	NR	1.07	1.07	SV2B	SNP-based	Endophenotype	30651383	Caucasian	"METASTROKE, SiGN, YLSDR"	41039	All	Ischemic stroke due to small vessel disease (IS-SVD)	Imaging	intron_variant
chr15	91221762	rs74587705	0.41	SV2B	NR	NR	1.07	1.07	SV2B	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	6862	All	Brain infarcts (BI)	Imaging	intron_variant
chr15	91221762	rs74587705	0.9	SV2B	NR	NR	1.01	1.01	SV2B	SNP-based	Endophenotype	30651383	Caucasian	"CHARGE, METASTROKE, SiGN"	137560	All	Ischemic stroke (IS)	Imaging	intron_variant
chr15	91221762	rs74587705	0.92	SV2B	NR	NR	1.01	1.01	SV2B	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	6862	All	Small sub-cortical brain infarcts (SSBI)	Imaging	intron_variant
chr15	97396008	rs4555132	0.0000308	NR	NR	NR	NR	NA	ARRDC4	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	intron_variant
chr15	98172432	rs1480090	0.0000352	NR	NR	NR	NR	NA	ARRDC4	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	intron_variant
chr15	98174448	rs1383139	0.0000348	NR	NR	NR	NR	NA	ARRDC4	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	intron_variant
chr15	101646763	rs139709573	0.000000059	TM2D3	NR	NR	8.62	8.62	TM2D3	SNP-based	Disease risk	27764101	Caucasian	AGES	2517	All	LOAD	AD	missense_variant
chr15	101646763	rs139709573	0.000000068	TM2D3	NR	NR	NR	NA	TM2D3	SNP-based	Disease risk	27764101	Caucasian	AGES	4336	All	LOAD	AD	missense_variant
chr15	101646763	rs139709573	0.000000084	TM2D3	NR	NR	NR	NA	TM2D3	SNP-based	Disease risk	27764101	Caucasian	AGES	2517	All	LOAD	AD	missense_variant
chr15	101646763	rs139709573	0.003	TM2D3	NR	NR	5.42	5.42	TM2D3	SNP-based	Disease risk	27764101	Caucasian	AGES	1819	All	LOAD	AD	missense_variant
chr15	101646763	rs139709573	0.011	TM2D3	NR	NR	NR	NA	TM2D3	SNP-based	Disease risk	27764101	Caucasian	AGES	1819	All	LOAD	AD	missense_variant
chr15	101646763	rs139709573	6.60E-09	TM2D3	NR	NR	7.45	7.45	TM2D3	SNP-based	Disease risk	27764101	Caucasian	AGES	4336	All	LOAD	AD	missense_variant
chr16	3687374	rs79848897	0.011	CREBBP	C	C	0.08	1.08329	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with non-APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr16	3687374	rs79848897	0.103	CREBBP	C	C	-0.08	0.923116	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr16	3687374	rs79848897	0.151	CREBBP	C	C	0.04	1.04081	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly	Episodic Memory Performance	Cognitive	intron_variant
chr16	3687374	rs79848897	0.966	CREBBP	C	C	0	1	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	11840	Demented subjects	Episodic Memory Performance	Cognitive	intron_variant
chr16	3688077	rs2108430	0.028	CREBBP	T	T	-0.1	0.904837	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr16	3688077	rs2108430	0.063	CREBBP	T	T	0.06	1.06184	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with non-APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr16	3688077	rs2108430	0.595	CREBBP	T	T	0.01	1.01005	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	11840	Demented subjects	Episodic Memory Performance	Cognitive	intron_variant
chr16	3688077	rs2108430	0.751	CREBBP	T	T	0.02	1.0202	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly	Episodic Memory Performance	Cognitive	intron_variant
chr16	3688285	rs72778151	0.019	CREBBP	T	T	0.08	1.08329	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with non-APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr16	3688285	rs72778151	0.114	CREBBP	T	T	-0.1	0.904837	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr16	3688285	rs72778151	0.157	CREBBP	T	T	0.04	1.04081	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly	Episodic Memory Performance	Cognitive	intron_variant
chr16	3688285	rs72778151	0.506	CREBBP	T	T	0.02	1.0202	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	11840	Demented subjects	Episodic Memory Performance	Cognitive	intron_variant
chr16	3692347	rs36099109	0.006	CREBBP	T	T	0.09	1.09417	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with non-APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr16	3692347	rs36099109	0.043	CREBBP	T	T	-0.12	0.88692	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr16	3692347	rs36099109	0.149	CREBBP	T	T	0.04	1.04081	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly	Episodic Memory Performance	Cognitive	intron_variant
chr16	3692347	rs36099109	0.409	CREBBP	T	T	0.02	1.0202	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	11840	Demented subjects	Episodic Memory Performance	Cognitive	intron_variant
chr16	3694911	rs79213162	0.038	CREBBP	C	C	0.07	1.07251	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly	Episodic Memory Performance	Cognitive	intron_variant
chr16	3694911	rs79213162	0.124	CREBBP	C	C	0.06	1.06184	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with non-APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr16	3694911	rs79213162	0.149	CREBBP	C	C	-0.07	0.932394	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	11840	Demented subjects	Episodic Memory Performance	Cognitive	intron_variant
chr16	3694911	rs79213162	0.303	CREBBP	C	C	0.06	1.06184	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr16	3695272	rs75712687	0.021	CREBBP	A	A	0.09	1.09417	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with non-APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr16	3695272	rs75712687	0.106	CREBBP	A	A	-0.1	0.904837	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr16	3695272	rs75712687	0.212	CREBBP	A	A	0.04	1.04081	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly	Episodic Memory Performance	Cognitive	intron_variant
chr16	3695272	rs75712687	0.52	CREBBP	A	A	0.02	1.0202	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	11840	Demented subjects	Episodic Memory Performance	Cognitive	intron_variant
chr16	3695882	rs75987714	0.042	CREBBP	G	G	0.1	1.10517	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with non-APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr16	3695882	rs75987714	0.113	CREBBP	G	G	0.07	1.07251	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly	Episodic Memory Performance	Cognitive	intron_variant
chr16	3695882	rs75987714	0.585	CREBBP	G	G	0.03	1.03045	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	11840	Demented subjects	Episodic Memory Performance	Cognitive	intron_variant
chr16	3695882	rs75987714	0.734	CREBBP	G	G	-0.02	0.980199	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr16	3696240	rs6500550	0.018	CREBBP	T	T	-0.11	0.895834	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr16	3696240	rs6500550	0.068	CREBBP	T	T	0.04	1.04081	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	11840	Demented subjects	Episodic Memory Performance	Cognitive	intron_variant
chr16	3696240	rs6500550	0.121	CREBBP	T	T	0.05	1.05127	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with non-APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr16	3696240	rs6500550	0.931	CREBBP	T	T	0.01	1.01005	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly	Episodic Memory Performance	Cognitive	intron_variant
chr16	3697203	rs1639150	0.044	CREBBP	C	C	0.05	1.05127	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly	Episodic Memory Performance	Cognitive	intron_variant
chr16	3697203	rs1639150	0.046	CREBBP	C	C	0.06	1.06184	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with non-APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr16	3697203	rs1639150	0.729	CREBBP	C	C	0.01	1.01005	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	11840	Demented subjects	Episodic Memory Performance	Cognitive	intron_variant
chr16	3697203	rs1639150	0.876	CREBBP	C	C	0	1	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr16	3698678	rs112455953	0.001	CREBBP	T	T	0.11	1.11628	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with non-APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr16	3698678	rs112455953	0.059	CREBBP	T	T	0.06	1.06184	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly	Episodic Memory Performance	Cognitive	intron_variant
chr16	3698678	rs112455953	0.063	CREBBP	T	T	-0.12	0.88692	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr16	3698678	rs112455953	0.493	CREBBP	T	T	0.02	1.0202	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	11840	Demented subjects	Episodic Memory Performance	Cognitive	intron_variant
chr16	3698760	rs112193373	0.002	CREBBP	A	A	0.11	1.11628	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with non-APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr16	3698760	rs112193373	0.044	CREBBP	A	A	-0.13	0.878095	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr16	3698760	rs112193373	0.107	CREBBP	A	A	0.05	1.05127	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly	Episodic Memory Performance	Cognitive	intron_variant
chr16	3698760	rs112193373	0.493	CREBBP	A	A	0.02	1.0202	TRAP1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	11840	Demented subjects	Episodic Memory Performance	Cognitive	intron_variant
chr16	3723163	rs39733	0.015	CREBBP	T	T	0.12	1.1275	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with APOE-e4 carriers 	Episodic Memory Performance	Cognitive	downstream_gene_variant
chr16	3723163	rs39733	0.081	CREBBP	T	T	0.11	1.11628	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	11840	Demented subjects	Episodic Memory Performance	Cognitive	downstream_gene_variant
chr16	3723163	rs39733	0.16	CREBBP	T	T	0.03	1.03045	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly	Episodic Memory Performance	Cognitive	downstream_gene_variant
chr16	3723163	rs39733	0.848	CREBBP	T	T	0	1	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with non-APOE-e4 carriers 	Episodic Memory Performance	Cognitive	downstream_gene_variant
chr16	3723489	rs7199513	0.019	CREBBP	G	G	0.06	1.06184	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly	Episodic Memory Performance	Cognitive	downstream_gene_variant
chr16	3723489	rs7199513	0.02	CREBBP	G	G	0.01	1.01005	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with APOE-e4 carriers 	Episodic Memory Performance	Cognitive	downstream_gene_variant
chr16	3723489	rs7199513	0.223	CREBBP	G	G	0.04	1.04081	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with non-APOE-e4 carriers 	Episodic Memory Performance	Cognitive	downstream_gene_variant
chr16	3723489	rs7199513	0.369	CREBBP	G	G	0.03	1.03045	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	11840	Demented subjects	Episodic Memory Performance	Cognitive	downstream_gene_variant
chr16	3784315	rs130024	0.038	CREBBP	T	T	0.15	1.16183	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr16	3784315	rs130024	0.141	CREBBP	T	T	0.14	1.15027	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	11840	Demented subjects	Episodic Memory Performance	Cognitive	intron_variant
chr16	3784315	rs130024	0.463	CREBBP	T	T	-0.04	0.960789	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with non-APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr16	3784315	rs130024	0.815	CREBBP	T	T	0	1	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly	Episodic Memory Performance	Cognitive	intron_variant
chr16	3814501	rs7198381	0.001	CREBBP	A	A	0.19	1.20925	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly	Episodic Memory Performance	Cognitive	intron_variant
chr16	3814501	rs7198381	0.03	CREBBP	A	A	0.14	1.15027	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with non-APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr16	3814501	rs7198381	0.072	CREBBP	A	A	0	1	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr16	3840292	rs62039107	0.019	CREBBP	G	G	0.12	1.1275	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr16	3840292	rs62039107	0.244	CREBBP	G	G	0.03	1.03045	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly	Episodic Memory Performance	Cognitive	intron_variant
chr16	3840292	rs62039107	0.782	CREBBP	G	G	0.01	1.01005	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	11840	Demented subjects	Episodic Memory Performance	Cognitive	intron_variant
chr16	3840292	rs62039107	0.95	CREBBP	G	G	0	1	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with non-APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr16	3867530	rs2526690	0.00037	CREBBP	G	G	0.2	1.2214	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly	Episodic Memory Performance	Cognitive	intron_variant
chr16	3867530	rs2526690	0.018	CREBBP	G	G	0	1	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr16	3867530	rs2526690	0.033	CREBBP	G	G	0.13	1.13883	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with non-APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr16	3867530	rs2526690	0.732	CREBBP	G	G	-0.09	0.913931	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	11840	Demented subjects	Episodic Memory Performance	Cognitive	intron_variant
chr16	3888601	rs2386817	0.01	CREBBP	A	A	0.13	1.13883	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly	Episodic Memory Performance	Cognitive	intergenic_region
chr16	3888601	rs2386817	0.046	CREBBP	A	A	0	1	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intergenic_region
chr16	3888601	rs2386817	0.173	CREBBP	A	A	0.07	1.07251	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with non-APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intergenic_region
chr16	3889456	rs58670576	0.018	CREBBP	C	C	0.15	1.16183	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly	Episodic Memory Performance	Cognitive	intergenic_region
chr16	3889456	rs58670576	0.028	CREBBP	C	C	0.15	1.16183	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with non-APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intergenic_region
chr16	3889456	rs58670576	0.428	CREBBP	C	C	0.08	1.08329	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intergenic_region
chr16	3901739	rs72760840	0.006	CREBBP	A	A	0.15	1.16183	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intergenic_region
chr16	3901739	rs72760840	0.119	CREBBP	A	A	0.04	1.04081	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly	Episodic Memory Performance	Cognitive	intergenic_region
chr16	3901739	rs72760840	1	CREBBP	A	A	0.01	1.01005	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with non-APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intergenic_region
chr16	3906073	rs2080248	0.022	CREBBP	G	G	0.13	1.13883	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly	Episodic Memory Performance	Cognitive	intergenic_region
chr16	3906073	rs2080248	0.032	CREBBP	G	G	0	1	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with non-APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intergenic_region
chr16	3906073	rs2080248	0.553	CREBBP	G	G	0	1	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intergenic_region
chr16	3909436	rs73503973	0.015	CREBBP	C	C	0.17	1.1853	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly	Episodic Memory Performance	Cognitive	intergenic_region
chr16	3909436	rs73503973	0.018	CREBBP	C	C	0	1	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with non-APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intergenic_region
chr16	3909436	rs73503973	0.451	CREBBP	C	C	0	1	CREBBP	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intergenic_region
chr16	3921680	rs117150760	0.033	CREBBP	C	C	0.14	1.15027	ADCY9	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with non-APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intergenic_region
chr16	3921680	rs117150760	0.121	CREBBP	C	C	0.09	1.09417	ADCY9	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly	Episodic Memory Performance	Cognitive	intergenic_region
chr16	3921680	rs117150760	0.618	CREBBP	C	C	-0.08	0.923116	ADCY9	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intergenic_region
chr16	10948382	rs8055533	0.0000985	CLEC16A	G	G	NR	NA	CLEC16A	SNP-based	Cross phenotype 	27088644	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr16	10948382	rs8055533	0.00036	CLEC16A	G	G	NR	NA	CLEC16A	SNP-based	Cross phenotype 	27088644	Caucasian	Cohort of Immune-Mediated Diseases	16559	All	Type 1 diabetes (T1D)	Non-ADRD	intron_variant
chr16	12967754	rs7192086	0.26	SHISA9	NR	NR	0.94	0.94	SHISA9	SNP-based	Cross phenotype 	22005930	Caucasian	"ADGC, GERAD, Cohort from UK"	6958	AD+P and control subjects	AD+Psychosis	ADRD	intron_variant
chr16	12967754	rs7192086	0.74	SHISA9	NR	NR	1.03	1.03	SHISA9	SNP-based	Cross phenotype 	22005930	Caucasian	"ADGC, GERAD"	2034	AD+P and AD-P subjects	AD+Psychosis	ADRD	intron_variant
chr16	13221798	rs407146	0.0006	LOC729993	T	T	NR	NA	SHISA9	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intron_variant
chr16	13221798	rs407146	0.0007	LOC729993	T	T	NR	NA	SHISA9	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr16	13221798	rs407146	0.0137	LOC729993	T	T	NR	NA	SHISA9	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr16	14286074	rs246174	0.000591	MKL2	T	T	NR	NA	MRTFB	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Low-density lipoprotein (LDL)	Non-ADRD	intergenic_region
chr16	14286074	rs246174	0.000789	MKL2	T	T	NR	NA	MRTFB	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr16	14286074	rs246174	0.00441	MKL2	T	T	1.04	1.04	MRTFB	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intergenic_region
chr16	14286074	rs246174	0.00823	MKL2	T	T	1.04	1.04	MRTFB	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intergenic_region
chr16	14286074	rs246174	0.704	MKL2	T	T	0.98	0.98	MRTFB	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intergenic_region
chr16	14286074	rs246174	0.88	MKL2	T	T	1	1	MRTFB	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intergenic_region
chr16	19796841	rs7185636	0.000000024	IQCK	C	C	0.92	0.92	IQCK	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	94437	All	Clinically diagnosed LOAD	AD	intron_variant
chr16	19796841	rs7185636	0.000000084	IQCK	C	C	0.92	0.92	IQCK	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	82771	All	Clinically diagnosed LOAD	AD	intron_variant
chr16	19796841	rs7185636	0.11	IQCK	C	C	0.94	0.94	IQCK	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	11666	All	Clinically diagnosed LOAD	AD	intron_variant
chr16	19905573	rs9941245	0.0000258	GPRC5B	G	G	0.93	0.93	GPRC5B	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intergenic_region
chr16	19905573	rs9941245	0.0000942	GPRC5B	G	G	0.94	0.94	GPRC5B	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intergenic_region
chr16	19905573	rs9941245	0.000229	GPRC5B	G	G	NR	NA	GPRC5B	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr16	19905573	rs9941245	0.0904	GPRC5B	G	G	0.9	0.9	GPRC5B	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intergenic_region
chr16	19905573	rs9941245	0.854	GPRC5B	G	G	1	1	GPRC5B	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intergenic_region
chr16	19905573	rs9941245	5.27E-16	GPRC5B	G	G	NR	NA	GPRC5B	SNP-based	Cross phenotype 	30413934	Caucasian	GIANT	681275	All	Body-mass index (BMI)	Non-ADRD	intergenic_region
chr16	19922278	rs12444979	0.001	NR	C	C	1.105	1.105	GPRC5B	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	intergenic_region
chr16	19922278	rs12444979	0.088	NR	C	C	1.116	1.116	GPRC5B	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	intergenic_region
chr16	19922278	rs12444979	0.301	NR	C	C	0.005	1.00501	GPRC5B	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	intergenic_region
chr16	19922278	rs12444979	0.981	NR	C	C	0.999	0.999	GPRC5B	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	intergenic_region
chr16	20353266	rs4293393	2.48E-28	UMOD	NR	NR	-0.15	0.860708	UMOD	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	ADNI	521	All	Plasma THP	Fluid biomarker	intron_variant
chr16	23355101	rs152745	0.286	SCNN1B	NR	NR	NR	NA	SCNN1B	SNP-based	Endophenotype	20452100	Caucasian	ADGC	311	Non-Demented autopsy subjects	High Braak vs Low Braak	Neuropathology	intron_variant
chr16	24496796	rs11649538	0.267	RBBP6	NR	NR	NR	NA	RBBP6	SNP-based	Endophenotype	20452100	Caucasian	ADGC	311	Non-Demented autopsy subjects	High Braak vs Low Braak	Neuropathology	upstream_gene_variant
chr16	28874338	rs7359397	0.026	NR	T	T	0.007	1.00702	SH2B1	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	upstream_gene_variant
chr16	28874338	rs7359397	0.18	NR	T	T	0.942	0.942	SH2B1	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	upstream_gene_variant
chr16	28874338	rs7359397	0.408	NR	T	T	1.03	1.03	SH2B1	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	upstream_gene_variant
chr16	28874338	rs7359397	0.762	NR	T	T	0.993	0.993	SH2B1	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	upstream_gene_variant
chr16	31111250	rs889555	0.000000032	NR	T	T	0.95	0.95	BCKDK	SNP-based	Disease risk	29777097	Caucasian	UKBB	623001	All	AD	AD	intron_variant
chr16	31121779	rs59735493	0.00000372	KAT8	A	A	NR	NA	KAT8	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	intron_variant
chr16	31121779	rs59735493	0.000825	KAT8	A	A	NR	NA	KAT8	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ"	79145	All	AD	AD	intron_variant
chr16	31121779	rs59735493	3.98E-08	KAT8	A	A	-5.49	NA	KAT8	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ, UKBB"	455258	All	AD + AD-by-proxy	AD	intron_variant
chr16	48598567	rs11649236	1.20E-26	N4BP1	NR	NR	-1.48	0.227638	N4BP1	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	N4BP1 expression in Cerebellar	Expression	intron_variant
chr16	48598567	rs11649236	2.53E-63	N4BP1	NR	NR	-1.57	0.208045	N4BP1	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	N4BP1 expression in Cerebellar	Expression	intron_variant
chr16	48598567	rs11649236	5.25E-82	N4BP1	NR	NR	-1.44	0.236928	N4BP1	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	N4BP1 expression in Temporal cortex	Expression	intron_variant
chr16	48598567	rs11649236	8.82E-34	N4BP1	NR	NR	-1.7	0.182684	N4BP1	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	N4BP1 expression in Cerebellar	Expression	intron_variant
chr16	53766842	rs9940128	0.000000011	FTO	NR	NR	NR	NA	FTO	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr16	53769662	rs1558902	0.313	NR	A	A	0.961	0.961	FTO	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	intron_variant
chr16	53769662	rs1558902	0.568	NR	A	A	0	1	FTO	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	intron_variant
chr16	53769662	rs1558902	0.905	NR	A	A	0.996	0.996	FTO	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	intron_variant
chr16	53778702	rs8057044	0.000000027	FTO	NR	NR	NR	NA	FTO	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr16	53796553	rs9930506	2.80E-09	FTO	NR	NR	NR	NA	FTO	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr16	54121830	rs16953089	0.000136	FTO	C	C	NR	NA	FTO	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	3_prime_UTR_variant
chr16	54121830	rs16953089	0.000862	FTO	C	C	NR	NA	FTO	SNP-based	Cross phenotype 	30413934	Caucasian	GIANT	681275	All	Body-mass index (BMI)	Non-ADRD	3_prime_UTR_variant
chr16	54121830	rs16953089	0.000985	FTO	C	C	0.95	0.95	FTO	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	3_prime_UTR_variant
chr16	54121830	rs16953089	0.00463	FTO	C	C	0.96	0.96	FTO	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	3_prime_UTR_variant
chr16	54121830	rs16953089	0.184	FTO	C	C	1.07	1.07	FTO	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	3_prime_UTR_variant
chr16	54121830	rs16953089	0.654	FTO	C	C	1	1	FTO	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	3_prime_UTR_variant
chr16	56464599	rs4784670	0.0764	OGFOD1	NR	NR	NR	NA	OGFOD1	SNP-based	Endophenotype	20452100	Caucasian	ADGC	311	Non-Demented autopsy subjects	High Braak vs Low Braak	Neuropathology	intron_variant
chr16	58107923	rs74019790	0.0005	C16orf80	T	T	NR	NA	CFAP20	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	intergenic_region
chr16	58107923	rs74019790	6.30E-09	NR	T	T	NR	NA	CFAP20	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	C16orf80 (ENSG00000070761) expression	Expression	intergenic_region
chr16	59856794	rs8056650	0.00000147	NR	A	A	-302.5	4.2259e-132	GOT2	SNP-based	Endophenotype	20197096	Caucasian	ADNI	698	All	Hippocampal Volume	Imaging	intron_variant
chr16	59856794	rs8056650	0.0000317	NR	A	A	-302.5	4.2259e-132	GOT2	SNP-based	Endophenotype	20197096	Caucasian	ADNI	698	All	Hippocampal Volume	Imaging	intron_variant
chr16	66110270	rs12595955	0.000469	CDH5	G	G	NR	NA	CDH5	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Low-density lipoprotein (LDL)	Non-ADRD	intergenic_region
chr16	66110270	rs12595955	0.00174	CDH5	G	G	NR	NA	CDH5	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr16	66110270	rs12595955	0.966	CDH5	G	G	1	1	CDH5	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intergenic_region
chr16	70081616	rs998109	0.0000164	PDXDC2	NR	NR	NR	NA	PDPR	SNP-based	Disease risk	20061627	Caucasian	ADGC	699	All	LOAD	AD	upstream_gene_variant
chr16	70660097	rs4985556	0.00000141	IL34	A	A	1.11	1.11	IL34	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	synonymous_variant
chr16	70660097	rs4985556	0.00000206	IL34	A	A	1.1	1.1	IL34	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	synonymous_variant
chr16	70660097	rs4985556	0.000211	IL34	A	A	NR	NA	IL34	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	synonymous_variant
chr16	70660097	rs4985556	0.00041	IL34	A	A	NR	NA	IL34	SNP-based	Cross phenotype 	30413934	Caucasian	DIAGRAM	298939	All	Type 2 diabetes (T2D)	Non-ADRD	synonymous_variant
chr16	70660097	rs4985556	0.00355	IL34	A	A	1.01	1.01	IL34	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	synonymous_variant
chr16	70660097	rs4985556	0.748	IL34	A	A	1.03	1.03	IL34	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	synonymous_variant
chr16	70671071	rs4985557	0.0000287	MTSS1L	T	T	NR	NA	MTSS2	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr16	70671071	rs4985557	0.0000334	MTSS1L	T	T	1.06	1.06	MTSS2	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intron_variant
chr16	70671071	rs4985557	0.0000928	MTSS1L	T	T	1.05	1.05	MTSS2	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intron_variant
chr16	70671071	rs4985557	0.000119	MTSS1L	T	T	NR	NA	MTSS2	SNP-based	Cross phenotype 	30413934	Caucasian	GIANT	681275	All	Body-mass index (BMI)	Non-ADRD	intron_variant
chr16	70671071	rs4985557	0.139	MTSS1L	T	T	1.08	1.08	MTSS2	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intron_variant
chr16	70671071	rs4985557	0.693	MTSS1L	T	T	1	1	MTSS2	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr16	70702849	rs11649476	0.0000135	VAC14	T	T	NR	NA	VAC14	SNP-based	Cross phenotype 	30930738	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr16	70702849	rs11649476	0.0000298	VAC14	T	T	NR	NA	VAC14	SNP-based	Cross phenotype 	30930738	Caucasian	PGC2-BIP	51710	All	Bipolar disorder (BIP)	ADRD	intron_variant
chr16	71398604	rs12373108	0.000000502	"CALB2, ZNF23"	T	T	1.21	1.21	CALB2	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	19025	All	Brain infarcts (BI)	Imaging	intergenic_region
chr16	71398604	rs12373108	0.000014	"CALB2, ZNF23"	T	T	1.23	1.23	CALB2	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	14645	All	Small sub-cortical brain infarcts (SSBI)	Imaging	intergenic_region
chr16	71398604	rs12373108	0.0000153	"CALB2, ZNF23"	T	T	NR	NA	CALB2	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	19025	All	Brain infarcts (BI)	Imaging	intergenic_region
chr16	71398604	rs12373108	0.0000899	"CALB2, ZNF23"	NR	NR	1.12	1.12	CALB2	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	25887	All	Brain infarcts (BI)	Imaging	intergenic_region
chr16	71398604	rs12373108	0.000137	"CALB2, ZNF23"	T	T	NR	NA	CALB2	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	14645	All	Small sub-cortical brain infarcts (SSBI)	Imaging	intergenic_region
chr16	71398604	rs12373108	0.00022	"CALB2, ZNF23"	NR	NR	1.13	1.13	CALB2	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	21507	All	Small sub-cortical brain infarcts (SSBI)	Imaging	intergenic_region
chr16	71398604	rs12373108	0.28	"CALB2, ZNF23"	NR	NR	1.04	1.04	CALB2	SNP-based	Endophenotype	30651383	Caucasian	"METASTROKE, SiGN, YLSDR"	41039	All	Ischemic stroke due to small vessel disease (IS-SVD)	Imaging	intergenic_region
chr16	71398604	rs12373108	0.34	"CALB2, ZNF23"	NR	NR	1.05	1.05	CALB2	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	6862	All	Small sub-cortical brain infarcts (SSBI)	Imaging	intergenic_region
chr16	71398604	rs12373108	0.44	"CALB2, ZNF23"	NR	NR	0.94	0.94	CALB2	SNP-based	Endophenotype	30651383	Caucasian	ADGC	2940	All	Pathologically defined infarcts	Imaging	intergenic_region
chr16	71398604	rs12373108	0.73	"CALB2, ZNF23"	NR	NR	1.01	1.01	CALB2	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	6862	All	Brain infarcts (BI)	Imaging	intergenic_region
chr16	71398604	rs12373108	0.87	"CALB2, ZNF23"	NR	NR	1	1	CALB2	SNP-based	Endophenotype	30651383	Caucasian	"CHARGE, METASTROKE, SiGN"	137560	All	Ischemic stroke (IS)	Imaging	intergenic_region
chr16	72014733	rs8062895	0.000412	DHODH	G	G	NR	NA	DHODH	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Total cholesterol (TC)	Non-ADRD	intron_variant
chr16	72014733	rs8062895	0.00156	DHODH	G	G	NR	NA	DHODH	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr16	72014733	rs8062895	0.181	DHODH	G	G	1	1	DHODH	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr16	73703474	rs7184882	0.000000664	LOC101927998	T	T	0.71	0.71	ZFHX3	SNP-based	Disease risk	27899424	Caucasian	IFGC	6462	All	Frontotemporal Dementia	ADRD	intergenic_region
chr16	73703474	rs7184882	0.00000308	LOC101927998	T	T	0.78	0.78	ZFHX3	SNP-based	Disease risk	27899424	Caucasian	IFGC	12928	All	Frontotemporal Dementia	ADRD	intergenic_region
chr16	73703474	rs7184882	0.08	LOC101927998	T	T	0.89	0.89	ZFHX3	SNP-based	Disease risk	27899424	Caucasian	IFGC	6466	All	Frontotemporal Dementia	ADRD	intergenic_region
chr16	75212521	rs9927309	0.000009	BCAR1	NR	NR	NR	NA	CTRB2	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intergenic_region
chr16	78197597	rs55751884	0.00000919	WWOX	C	C	NR	NA	WWOX	SNP-based	Disease risk	24770881	Caucasian	ADGC	2239	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	intron_variant
chr16	79321960	rs62039712	0.000000037	WWOX	A	A	1.16	1.16	WWOX	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	94437	All	Clinically diagnosed LOAD	AD	intergenic_region
chr16	79321960	rs62039712	0.00000012	WWOX	A	A	1.17	1.17	WWOX	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	63926	All	Clinically diagnosed LOAD	AD	intergenic_region
chr16	79321960	rs62039712	0.13	WWOX	A	A	1.14	1.14	WWOX	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	30511	All	Clinically diagnosed LOAD	AD	intergenic_region
chr16	79648854	rs1424233	0.312	NR	A	A	0.978	0.978	MAF	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	intergenic_region
chr16	79648854	rs1424233	0.669	NR	A	A	0	1	MAF	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	intergenic_region
chr16	79648854	rs1424233	0.764	NR	A	A	0.987	0.987	MAF	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	intergenic_region
chr16	79648854	rs1424233	0.936	NR	A	A	1	1	MAF	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	intergenic_region
chr16	81738931	rs9931998	0.000459	BC040927	A	A	0.94	0.94	PLCG2	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intron_variant
chr16	81738931	rs9931998	0.000523	BC040927	A	A	NR	NA	PLCG2	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr16	81738931	rs9931998	0.00112	BC040927	A	A	0.95	0.95	PLCG2	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intron_variant
chr16	81738931	rs9931998	0.00199	BC040927	A	A	NR	NA	PLCG2	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Low-density lipoprotein (LDL)	Non-ADRD	intron_variant
chr16	81738931	rs9931998	0.589	BC040927	A	A	1.04	1.04	PLCG2	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intron_variant
chr16	81908423	rs72824905	0.0000119	PLCG2	G	G	0.65	0.65	PLCG2	SNP-based	Disease risk	28714976	Caucasian	"ADGC, CHARGE, EADI, GERAD"	33786	All	AD	AD	missense_variant
chr16	81908423	rs72824905	0.000135	PLCG2	G	G	0.7	0.7	PLCG2	SNP-based	Disease risk	28714976	Caucasian	"CHARGE, EADI, GERAD"	35831	All	AD	AD	missense_variant
chr16	81908423	rs72824905	0.0248	PLCG2	G	G	0.69	0.69	PLCG2	SNP-based	Disease risk	28714976	Caucasian	ADGC	15288	All	AD	AD	missense_variant
chr16	81908423	rs72824905	5.38E-10	PLCG2	G	G	0.68	0.68	PLCG2	SNP-based	Disease risk	28714976	Caucasian	"ADGC, CHARGE, EADI, GERAD"	84905	All	AD	AD	missense_variant
chr16	86243835	rs4843359	0.00000581	NR	NR	NR	NR	NA	FOXF1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intron_variant
chr16	86243835	rs4843359	0.000122	NR	NR	NR	2.19	2.19	FOXF1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intron_variant
chr16	86243835	rs4843359	0.000277	NR	NR	NR	NR	NA	FOXF1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr16	86243835	rs4843359	0.00636	NR	NR	NR	1.69	1.69	FOXF1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr16	86243835	rs4843359	0.09346	NR	NR	NR	NR	NA	FOXF1	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intron_variant
chr16	86243835	rs4843359	0.39124	NR	NR	NR	NR	NA	FOXF1	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intron_variant
chr16	86243835	rs4843359	0.78	NR	NR	NR	NR	NA	FOXF1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intron_variant
chr16	86243835	rs4843359	0.887	NR	NR	NR	NR	NA	FOXF1	SNP-based	Disease risk	21059989	Caucasian	ADGC	1390	Unrelated individuals	LOAD	AD	intron_variant
chr16	86243835	rs4843359	1	NR	NR	NR	0.93	0.93	FOXF1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intron_variant
chr16	86340602	rs2581305	0.000000398	LINC00917	NR	NR	0.608	1.83675	FOXF1	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	673	All	CSF Clusterin	Fluid biomarker	intron_variant
chr16	86340602	rs2581305	0.000403	LINC00917	NR	NR	0.577	1.78069	FOXF1	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	403	Subjects with APOE-e4-	CSF Clusterin	Fluid biomarker	intron_variant
chr16	86340602	rs2581305	0.000583	LINC00917	NR	NR	0.615	1.84966	FOXF1	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	270	Subjects with APOE-e4+	CSF Clusterin	Fluid biomarker	intron_variant
chr16	86547585	rs8047645	0.0238	MTHFSD	A	A	NR	NA	MTHFSD	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	intron_variant
chr16	86547585	rs8047645	7.35E-45	NR	A	A	NR	NA	MTHFSD	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	MTHFSD (ILMN_1797046) expression	Expression	intron_variant
chr16	87078024	rs12933233	0.00000764	NR	NR	NR	NR	NA	C16orf95	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	2222	AD subjects	Age at onset	Other	intergenic_region
chr16	87078024	rs12933233	0.0000199	NR	NR	NR	NR	NA	C16orf95	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	2222	AD subjects	Age at onset	Other	intergenic_region
chr16	87078024	rs12933233	0.000563	NR	NR	NR	0.91	2.48432	C16orf95	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	844	AD subjects	Age at onset	Other	intergenic_region
chr16	87078024	rs12933233	0.00846	NR	NR	NR	0.79	2.2034	C16orf95	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	1190	AD subjects	Age at onset	Other	intergenic_region
chr16	87078024	rs12933233	0.135	NR	NR	NR	2.92	18.5413	C16orf95	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADNI	188	AD subjects	Age at onset	Other	intergenic_region
chr17	4863642	rs8070572	0.000000198	MINK1	C	C	1.12	1.12	MINK1	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intron_variant
chr17	4863642	rs8070572	0.00000149	MINK1	C	C	1.11	1.11	MINK1	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intron_variant
chr17	4863642	rs8070572	0.00000492	MINK1	C	C	NR	NA	MINK1	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr17	4863642	rs8070572	0.000624	MINK1	C	C	NR	NA	MINK1	SNP-based	Cross phenotype 	30413934	Caucasian	GIANT	681275	All	Body-mass index (BMI)	Non-ADRD	intron_variant
chr17	4863642	rs8070572	0.00638	MINK1	C	C	1.01	1.01	MINK1	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr17	4863642	rs8070572	0.0305	MINK1	C	C	1.2	1.2	MINK1	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intron_variant
chr17	5081152	rs9916042	4.73E-08	SCIMP	A	A	NR	NA	ZFP3	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	intron_variant
chr17	5233752	rs7225151	0.448	SCIMP	A	A	0.952	0.952	SCIMP	SNP-based	Disease risk	24495969	Caucasian	Cohort from Spain	4372	All	AD	AD	intron_variant
chr17	5235685	rs113260531	0.00000321	SCIMP	A	A	NR	NA	SCIMP	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ"	79145	All	AD	AD	intron_variant
chr17	5235685	rs113260531	9.16E-10	SCIMP	A	A	6.12	NA	SCIMP	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ, UKBB"	455258	All	AD + AD-by-proxy	AD	intron_variant
chr17	7288772	rs222842	0.201	SLC24A4 (to be removed)	G	G	1.09	NA	YBX2	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	3_prime_UTR_variant
chr17	7383007	rs1554948	0.000063	TNK1	NR	NR	1.19	1.19	TNK1	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	3870	All	LOAD	AD	synonymous_variant
chr17	7383007	rs1554948	0.009	TNK1	NR	NR	NR	NA	TNK1	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	720	All	LOAD	AD	synonymous_variant
chr17	7383007	rs1554948	0.021	TNK1	NR	NR	NR	NA	TNK1	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	1146	All	LOAD	AD	synonymous_variant
chr17	7383007	rs1554948	0.054	TNK1	NR	NR	NR	NA	TNK1	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	658	All	LOAD	AD	synonymous_variant
chr17	7383007	rs1554948	0.13	TNK1	NR	NR	NR	NA	TNK1	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	776	All	LOAD	AD	synonymous_variant
chr17	7383007	rs1554948	0.569	TNK1	A	A	0.96	0.96	TNK1	SNP-based	Disease risk	20534741	Caucasian	"ADC, UM"	1610	All	AD	AD	synonymous_variant
chr17	7383007	rs1554948	0.699	TNK1	NR	NR	NR	NA	TNK1	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	570	All	LOAD	AD	synonymous_variant
chr17	10320397	rs2074877	0.00072	MYH13	NR	NR	1.12	1.12	MYH13	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	3870	All	LOAD	AD	missense_variant
chr17	10320397	rs2074877	0.017	MYH13	NR	NR	NR	NA	MYH13	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	776	All	LOAD	AD	missense_variant
chr17	10320397	rs2074877	0.029	MYH13	NR	NR	NR	NA	MYH13	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	720	All	LOAD	AD	missense_variant
chr17	10320397	rs2074877	0.664	MYH13	NR	NR	NR	NA	MYH13	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	570	All	LOAD	AD	missense_variant
chr17	10320397	rs2074877	0.742	MYH13	NR	NR	NR	NA	MYH13	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	1146	All	LOAD	AD	missense_variant
chr17	10320397	rs2074877	0.931	MYH13	NR	NR	NR	NA	MYH13	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	658	All	LOAD	AD	missense_variant
chr17	18758014	rs12603319	0.39	FBXW10	T	T	NR	NA	FBXW10	SNP-based	Disease risk	25687773	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr17	18758014	rs12603319	1.14E-08	FBXW10	T	T	NR	NA	FBXW10	SNP-based	Disease risk	25687773	Caucasian	IPDGC	17352	All	PD	ADRD	intron_variant
chr17	19656155	rs962800	1.14E-72	ALDH3A2	NR	NR	0.44	1.55271	ALDH3A2	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	ALDH3A2 expression in Temporal cortex	Expression	intron_variant
chr17	19656155	rs962800	1.47E-58	ALDH3A2	NR	NR	0.46	1.58407	ALDH3A2	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	ALDH3A2 expression in Cerebellar	Expression	intron_variant
chr17	19656155	rs962800	2.05E-32	ALDH3A2	NR	NR	0.49	1.63232	ALDH3A2	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	ALDH3A2 expression in Cerebellar	Expression	intron_variant
chr17	19656155	rs962800	3.48E-22	ALDH3A2	NR	NR	0.44	1.55271	ALDH3A2	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	ALDH3A2 expression in Cerebellar	Expression	intron_variant
chr17	27757506	rs11653716	0.00014	NOS2A	NR	NR	NR	NA	NOS2	SNP-based	Disease risk	19118814	Caucasian	"CAP, Reiman et al.(2007)"	NR	All	LOAD	AD	intron_variant
chr17	27757506	rs11653716	0.00353	NOS2A	NR	NR	NR	NA	NOS2	SNP-based	Disease risk	19118814	Caucasian	CAP	458	All	LOAD	AD	intron_variant
chr17	27757506	rs11653716	0.00725	NOS2A	NR	NR	NR	NA	NOS2	SNP-based	Disease risk	19118814	Caucasian	Reiman et al.(2007)	NR	All	LOAD	AD	intron_variant
chr17	31378929	rs2525574	1.22E-85	EVI2A	NR	NR	1.67	5.31217	NF1	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	EVI2A expression in Temporal cortex	Expression	stop_lost
chr17	31378929	rs2525574	3.92E-43	EVI2A	NR	NR	1.79	5.98945	NF1	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	EVI2A expression in Cerebellar	Expression	stop_lost
chr17	31378929	rs2525574	6.73E-94	EVI2A	NR	NR	1.81	6.11045	NF1	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	EVI2A expression in Cerebellar	Expression	stop_lost
chr17	31378929	rs2525574	9.05E-43	EVI2A	NR	NR	1.81	6.11045	NF1	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	EVI2A expression in Cerebellar	Expression	stop_lost
chr17	34333130	rs12602195	2.40E-12	CCL8	NR	NR	-0.08	0.923116	CCL8	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	ADNI	521	All	Plasma MCP-2	Fluid biomarker	upstream_gene_variant
chr17	35960396	rs4795104	1.02E-17	CCL16	T	T	NR	NA	CCL16	SNP-based	Cross phenotype 	27357396	Caucasian	"ADNI, Knight-ADRC"	587	All	Plasma CCL16	Fluid biomarker	downstream_gene_variant
chr17	35960396	rs4795104	9.63E-16	CCL16	T	T	NR	NA	CCL16	SNP-based	Cross phenotype 	27357396	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF CCL16  	Fluid biomarker	downstream_gene_variant
chr17	35965995	rs4796144	1.02E-17	CCL16	A	A	NR	NA	CCL16	SNP-based	Cross phenotype 	27357396	Caucasian	"ADNI, Knight-ADRC"	587	All	Plasma CCL16	Fluid biomarker	upstream_gene_variant
chr17	35965995	rs4796144	9.63E-16	CCL16	A	A	NR	NA	CCL16	SNP-based	Cross phenotype 	27357396	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF CCL16  	Fluid biomarker	upstream_gene_variant
chr17	35968241	rs149197550	8.32E-16	CCL16	T	T	NR	NA	CCL16	SNP-based	Cross phenotype 	27357396	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF CCL16  	Fluid biomarker	upstream_gene_variant
chr17	35968241	rs149197550	9.20E-18	CCL16	T	T	NR	NA	CCL16	SNP-based	Cross phenotype 	27357396	Caucasian	"ADNI, Knight-ADRC"	587	All	Plasma CCL16	Fluid biomarker	upstream_gene_variant
chr17	35976276	rs80329614	1.67E-19	CCL16	C	C	NR	NA	CCL16	SNP-based	Cross phenotype 	27357396	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF CCL16  	Fluid biomarker	downstream_gene_variant
chr17	35976276	rs80329614	5.85E-28	CCL16	C	C	NR	NA	CCL16	SNP-based	Cross phenotype 	27357396	Caucasian	"ADNI, Knight-ADRC"	587	All	Plasma CCL16	Fluid biomarker	downstream_gene_variant
chr17	35976735	rs33995560	2.09E-27	CCL16	C	C	NR	NA	CCL16	SNP-based	Cross phenotype 	27357396	Caucasian	"ADNI, Knight-ADRC"	587	All	Plasma CCL16	Fluid biomarker	3_prime_UTR_variant
chr17	35976735	rs33995560	2.94E-19	CCL16	C	C	NR	NA	CCL16	SNP-based	Cross phenotype 	27357396	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF CCL16  	Fluid biomarker	3_prime_UTR_variant
chr17	35977228	rs150951362	1.65E-17	CCL16	A	A	NR	NA	CCL16	SNP-based	Cross phenotype 	27357396	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF CCL16  	Fluid biomarker	3_prime_UTR_variant
chr17	35977228	rs150951362	2.05E-20	CCL16	A	A	NR	NA	CCL16	SNP-based	Cross phenotype 	27357396	Caucasian	"ADNI, Knight-ADRC"	587	All	Plasma CCL16	Fluid biomarker	3_prime_UTR_variant
chr17	35978012	rs7216969	2.09E-27	CCL16	A	A	NR	NA	CCL16	SNP-based	Cross phenotype 	27357396	Caucasian	"ADNI, Knight-ADRC"	587	All	Plasma CCL16	Fluid biomarker	intron_variant
chr17	35978012	rs7216969	2.94E-19	CCL16	A	A	NR	NA	CCL16	SNP-based	Cross phenotype 	27357396	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF CCL16  	Fluid biomarker	intron_variant
chr17	35978035	rs11080368	1.78E-27	CCL16	A	A	NR	NA	CCL16	SNP-based	Cross phenotype 	27357396	Caucasian	"ADNI, Knight-ADRC"	587	All	Plasma CCL16	Fluid biomarker	intron_variant
chr17	35978035	rs11080368	2.32E-19	CCL16	A	A	NR	NA	CCL16	SNP-based	Cross phenotype 	27357396	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF CCL16  	Fluid biomarker	intron_variant
chr17	35978128	rs11080369	0.00101	CCL16	NR	NR	-2.41	0.0898153	CCL16	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	IMAS	59	All	Plasma HCC-4	Fluid biomarker	intron_variant
chr17	35978128	rs11080369	1.78E-27	CCL16	C	C	NR	NA	CCL16	SNP-based	Cross phenotype 	27357396	Caucasian	"ADNI, Knight-ADRC"	587	All	Plasma CCL16	Fluid biomarker	intron_variant
chr17	35978128	rs11080369	2.32E-19	CCL16	C	C	NR	NA	CCL16	SNP-based	Cross phenotype 	27357396	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF CCL16  	Fluid biomarker	intron_variant
chr17	35978128	rs11080369	8.03E-19	CCL16	NR	NR	-0.22	0.802519	CCL16	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	ADNI	521	All	Plasma HCC-4	Fluid biomarker	intron_variant
chr17	35979434	rs75236781	2.96E-17	CCL16	C	C	NR	NA	CCL16	SNP-based	Cross phenotype 	27357396	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF CCL16  	Fluid biomarker	intron_variant
chr17	35979434	rs75236781	3.94E-20	CCL16	C	C	NR	NA	CCL16	SNP-based	Cross phenotype 	27357396	Caucasian	"ADNI, Knight-ADRC"	587	All	Plasma CCL16	Fluid biomarker	intron_variant
chr17	36018624	rs854656	2.61E-13	CCL23	NR	NR	-0.07	0.932394	CCL23	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	ADNI	521	All	Plasma MPIF-1	Fluid biomarker	upstream_gene_variant
chr17	36058726	rs854462	0.0000867	CCL18	NR	NR	61.74	650640829100921095358251008	CCL18	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	IMAS	59	All	Plasma PARC	Fluid biomarker	intergenic_region
chr17	36058726	rs854462	9.15E-24	CCL18	NR	NR	0.15	1.16183	CCL18	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	ADNI	521	All	Plasma PARC	Fluid biomarker	intergenic_region
chr17	36817647	rs8070114	0.00000358	LHX1	A	A	0.68	0.68	LHX1	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	17480	Plan 1 (males and females)	AD	AD	intergenic_region
chr17	36819274	rs1497197	0.00000296	LHX1	A	A	0.67	0.67	LHX1	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	17480	Plan 1 (males and females)	AD	AD	intergenic_region
chr17	37738049	rs4430796	0.0000024	HNF1B	NR	NR	NR	NA	HNF1B	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr17	38784819	rs12952045	0.037	CWC25	T	T	NR	NA	PIP4K2B	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	intron_variant
chr17	38784819	rs12952045	9.63E-44	NR	T	T	NR	NA	PIP4K2B	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	CWC25 (ILMN_1720233) expression	Expression	intron_variant
chr17	40004501	rs8070454	1.06E-81	MED24	NR	NR	-2.16	0.115325	PSMD3	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	MED24 expression in Temporal cortex	Expression	intergenic_region
chr17	40004501	rs8070454	1.56E-74	MED24	NR	NR	-2.03	0.131336	PSMD3	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	MED24 expression in Cerebellar	Expression	intergenic_region
chr17	40004501	rs8070454	3.15E-40	MED24	NR	NR	-2.05	0.128735	PSMD3	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	MED24 expression in Cerebellar	Expression	intergenic_region
chr17	40004501	rs8070454	7.82E-28	MED24	NR	NR	-1.98	0.138069	PSMD3	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	MED24 expression in Cerebellar	Expression	intergenic_region
chr17	40075600	rs939348	0.757	THRA	T	T	0.97	0.97	THRA	SNP-based	Disease risk	20534741	Caucasian	"ADC, UM"	1610	All	AD	AD	intron_variant
chr17	40597298	rs11658260	0.665	SMARCE1	A	A	0.97	0.97	SMARCE1	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	intergenic_region
chr17	44343224	rs72824731	0.0021	GRN	C	C	3.88	3.88	GRN	SNP-based	Disease risk	28131462	Caucasian	ADGC	3251	Individual who died at age 60 or older (REC Model)	Hippocampal sclerosis of aging	ADRD	upstream_gene_variant
chr17	44346188	rs2879096	0.014	GRN	NR	NR	1.38	1.38	GRN	SNP-based	Disease risk	28131462	Caucasian	ADGC	3251	Individual who died at age 60 or older (DOM Model)	Hippocampal sclerosis of aging	ADRD	5_prime_UTR_variant
chr17	44346188	rs2879096	0.032	GRN	T	T	1.25	1.25	GRN	SNP-based	Disease risk	28131462	Caucasian	ADGC	3251	Individual who died at age 60 or older (ADD Model)	Hippocampal sclerosis of aging	ADRD	5_prime_UTR_variant
chr17	44352876	rs5848	0.073	GRN	T	T	1.9	1.9	GRN	SNP-based	Disease risk	24770881	Caucasian	ADGC	176	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	3_prime_UTR_variant
chr17	44352876	rs5848	0.218	GRN	T	T	1.16	1.16	GRN	SNP-based	Disease risk	24770881	Caucasian	ADGC	2239	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	3_prime_UTR_variant
chr17	44352876	rs5848	0.541	GRN	T	T	1.08	1.08	GRN	SNP-based	Disease risk	24770881	Caucasian	ADGC	1636	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	3_prime_UTR_variant
chr17	44352876	rs5848	0.774	GRN	T	T	1.12	1.12	GRN	SNP-based	Disease risk	24770881	Caucasian	ADGC	427	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	3_prime_UTR_variant
chr17	44352876	rs5848	NR	ABCC9	T	T	1.25	1.25	GRN	SNP-based	Disease risk	25470345	Caucasian	ADGC	2343	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	3_prime_UTR_variant
chr17	44352876	rs5848	NR	ABCC9	T	T	1.33	1.33	GRN	SNP-based	Disease risk	25470345	Caucasian	ADGC	2343	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	3_prime_UTR_variant
chr17	44352876	rs5848	NR	ABCC9	T	T	1.35	1.35	GRN	SNP-based	Disease risk	25470345	Caucasian	ADGC	2343	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	3_prime_UTR_variant
chr17	44352876	rs5848	NR	ABCC9	T	T	1.74	1.74	GRN	SNP-based	Disease risk	25470345	Caucasian	ADGC	612	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	3_prime_UTR_variant
chr17	44352876	rs5848	NR	ABCC9	T	T	1.92	1.92	GRN	SNP-based	Disease risk	25470345	Caucasian	ADGC	612	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	3_prime_UTR_variant
chr17	44352876	rs5848	NR	ABCC9	T	T	2.24	2.24	GRN	SNP-based	Disease risk	25470345	Caucasian	ADGC	612	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	3_prime_UTR_variant
chr17	45641777	rs393152	0.000117	CRHR1	A	A	NR	NA	LINC02210-CRHR1	SNP-based	Disease risk	25687773	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr17	45641777	rs393152	2.22E-18	CRHR1	A	A	NR	NA	LINC02210-CRHR1	SNP-based	Disease risk	25687773	Caucasian	IPDGC	17352	All	PD	ADRD	intron_variant
chr17	45641777	rs393152	NR	MAPT	A	A	2.18	2.18	LINC02210-CRHR1	SNP-based	Disease risk	27849641	Caucasian	ADGC	589	All	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr17	45641777	rs393152	NR	ZCWPW1	A	A	1.77	1.77	LINC02210-CRHR1	SNP-based	Disease risk	27849641	Caucasian	ADGC	297	APOE-e4 non-carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr17	45641777	rs393152	NR	ZCWPW1	A	A	3.73	3.73	LINC02210-CRHR1	SNP-based	Disease risk	27849641	Caucasian	ADGC	292	APOE-e4 carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr17	45725823	rs1358071	0.000000027	CRHR1	A	A	NR	NA	LINC02210-CRHR1	SNP-based	eQTL	27899424	Caucasian	UKBEC	101	All	LRRC37A4 expression in Medulla	Expression	intron_variant
chr17	45725823	rs1358071	0.000000491	CRHR1	A	A	1.19	1.19	LINC02210-CRHR1	SNP-based	Disease risk	27899424	Caucasian	IFGC	12928	All	Frontotemporal Dementia	ADRD	intron_variant
chr17	45725823	rs1358071	0.00000061	CRHR1	A	A	NR	NA	LINC02210-CRHR1	SNP-based	eQTL	27899424	Caucasian	UKBEC	101	All	KANSL1 expression in Hippocampus	Expression	intron_variant
chr17	45725823	rs1358071	0.0000022	CRHR1	A	A	NR	NA	LINC02210-CRHR1	SNP-based	eQTL	27899424	Caucasian	UKBEC	101	All	LRRC37A4 expression in Putamen	Expression	intron_variant
chr17	45725823	rs1358071	0.0000029	CRHR1	A	A	NR	NA	LINC02210-CRHR1	SNP-based	eQTL	27899424	Caucasian	UKBEC	101	All	CRHR1 expression in Medulla	Expression	intron_variant
chr17	45725823	rs1358071	0.0000077	CRHR1	A	A	NR	NA	LINC02210-CRHR1	SNP-based	eQTL	27899424	Caucasian	UKBEC	101	All	LRRC37A4 expression in White matter	Expression	intron_variant
chr17	45725823	rs1358071	0.0000496	CRHR1	A	A	1.22	1.22	LINC02210-CRHR1	SNP-based	Disease risk	27899424	Caucasian	IFGC	6462	All	Frontotemporal Dementia	ADRD	intron_variant
chr17	45725823	rs1358071	0.0000496	CRHR1	NR	NR	NR	NA	LINC02210-CRHR1	SNP-based	Disease risk	27899424	Caucasian	IFGC	12928	All	Frontotemporal Dementia	ADRD	intron_variant
chr17	45725823	rs1358071	0.001	CRHR1	A	A	1.16	1.16	LINC02210-CRHR1	SNP-based	Disease risk	27899424	Caucasian	IFGC	6466	All	Frontotemporal Dementia	ADRD	intron_variant
chr17	45725823	rs1358071	1.90E-11	CRHR1	A	A	NR	NA	LINC02210-CRHR1	SNP-based	eQTL	27899424	Caucasian	UKBEC	101	All	LRRC37A4 expression in Occipital cortex	Expression	intron_variant
chr17	45725823	rs1358071	3.10E-12	CRHR1	A	A	NR	NA	LINC02210-CRHR1	SNP-based	eQTL	27899424	Caucasian	UKBEC	101	All	LRRC37A4 expression in Temporal cortex	Expression	intron_variant
chr17	45725823	rs1358071	3.60E-10	CRHR1	A	A	NR	NA	LINC02210-CRHR1	SNP-based	eQTL	27899424	Caucasian	UKBEC	101	All	LRRC37A4 expression in Frontal cortex	Expression	intron_variant
chr17	45725823	rs1358071	4.70E-10	CRHR1	A	A	NR	NA	LINC02210-CRHR1	SNP-based	eQTL	27899424	Caucasian	UKBEC	101	All	LRRC37A4 expression in Hippocampus	Expression	intron_variant
chr17	45725823	rs1358071	5.70E-12	CRHR1	A	A	NR	NA	LINC02210-CRHR1	SNP-based	eQTL	27899424	Caucasian	UKBEC	101	All	LRRC37A4 expression in Thalamus	Expression	intron_variant
chr17	45725823	rs1358071	7.30E-11	CRHR1	A	A	NR	NA	LINC02210-CRHR1	SNP-based	eQTL	27899424	Caucasian	UKBEC	101	All	LRRC37A4 expression in Substantia nigra	Expression	intron_variant
chr17	45725823	rs1358071	7.40E-22	CRHR1	A	A	NR	NA	LINC02210-CRHR1	SNP-based	eQTL	27899424	Caucasian	UKBEC	101	All	LRRC37A4 expression in Cerebellum	Expression	intron_variant
chr17	45900461	rs1864325	0.03	MAPT	T	T	0.81	0.81	MAPT	SNP-based	Age at onset (AAO) / Survival	17998437	Caucasian	Cohorts from Canada	1352	All	Age of AD onset	Other	intron_variant
chr17	45900461	rs1864325	0.22	MAPT	T	T	0.81	0.81	MAPT	SNP-based	Disease risk	17998437	Caucasian	Cohorts from Canada	1352	All	AD	AD	intron_variant
chr17	45908813	rs1467967	0.0000093	MAPT	NR	NR	0.16	1.17351	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	166	All	MAPT(ILMN_1710903) expression in temporal cortex	Expression	intron_variant
chr17	45908813	rs1467967	0.00026	MAPT	NR	NR	0.15	1.16183	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	171	All	MAPT(ILMN_1710903) expression in Cerebellum	Expression	intron_variant
chr17	45908813	rs1467967	0.011	MAPT	NR	NR	0.11	1.11628	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	166	All	MAPT (ILMN_2298727) expressionin temporal cortex 	Expression	intron_variant
chr17	45908813	rs1467967	0.019	MAPT	NR	NR	0.12	1.1275	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	171	All	MAPT (ILMN_2298727) expressionin Cerebellum	Expression	intron_variant
chr17	45908813	rs1467967	0.062	MAPT	G	G	1.05	1.05	MAPT	SNP-based	Disease risk	25324900	Caucasian	ADGC	19351	All	LOAD Risk	AD	intron_variant
chr17	45908813	rs1467967	0.079	MAPT	G	G	1.1	1.1	MAPT	SNP-based	Disease risk	25324900	Caucasian	ADGC	4986	All	LOAD Risk	AD	intron_variant
chr17	45908813	rs1467967	0.102	MAPT	G	G	1.05	1.05	MAPT	SNP-based	Disease risk	25324900	Caucasian	ADGC	14365	All	LOAD Risk	AD	intron_variant
chr17	45908813	rs1467967	0.604	MAPT	NR	NR	-0.01	0.99005	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	171	All	MAPT (ILMN_2310814) expression in Cerebellum	Expression	intron_variant
chr17	45908813	rs1467967	0.859	MAPT	NR	NR	0	1	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	166	All	MAPT (ILMN_2310814) expression in temporal cortex 	Expression	intron_variant
chr17	45942346	rs242557	0.000000011	MAPT	NR	NR	0.18	1.19722	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	MAPT (ILMN_1710903) expression in Temporal cortex	Expression	intron_variant
chr17	45942346	rs242557	0.000000034	MAPT	NR	NR	0.23	1.2586	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	180	All	MAPT(ILMN_1710903) expression in Cerebellum	Expression	intron_variant
chr17	45942346	rs242557	0.00000239	MAPT	NR	NR	0.18	1.19722	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	MAPT (ILMN_1710903) expression in Cerebellar	Expression	intron_variant
chr17	45942346	rs242557	0.000012	MAPT	NR	NR	0.17	1.1853	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	173	All	MAPT(ILMN_1710903) expression in temporal cortex	Expression	intron_variant
chr17	45942346	rs242557	0.00978	MAPT	NR	NR	0.07	1.07251	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	MAPT (ILMN_2298727) expression in Cerebellar	Expression	intron_variant
chr17	45942346	rs242557	0.0166	MAPT	NR	NR	0.09	1.09417	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	98	PSP	MAPT (ILMN_1710903) expression in Cerebellar	Expression	intron_variant
chr17	45942346	rs242557	0.0226	MAPT	NR	NR	0.11	1.11628	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	202	AD	MAPT (ILMN_2298727) expression in Temporal cortex	Expression	intron_variant
chr17	45942346	rs242557	0.05	MAPT	NR	NR	0.1	1.10517	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	180	All	MAPT (ILMN_2298727) expressionin Cerebellum	Expression	intron_variant
chr17	45942346	rs242557	0.0659	STH	NR	NR	-0.03	0.970446	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	STH (ILMN_1665311) expression in Cerebellar	Expression	intron_variant
chr17	45942346	rs242557	0.0856	MAPT	NR	NR	0.08	1.08329	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	MAPT (ILMN_2298727) expression in Cerebellar	Expression	intron_variant
chr17	45942346	rs242557	0.091	MAPT	NR	NR	0.08	1.08329	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	173	All	MAPT (ILMN_2298727) expressionin temporal cortex 	Expression	intron_variant
chr17	45942346	rs242557	0.0913	MAPT	NR	NR	-0.03	0.970446	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	98	PSP	MAPT (ILMN_2310814) expression in Cerebellar	Expression	intron_variant
chr17	45942346	rs242557	0.0933	MAPT	NR	NR	-0.02	0.980199	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	202	AD	MAPT (ILMN_2310814) expression in Temporal cortex	Expression	intron_variant
chr17	45942346	rs242557	0.094	MAPT	NR	NR	0.09	1.09417	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	98	PSP	MAPT (ILMN_2298727) expression in Cerebellar	Expression	intron_variant
chr17	45942346	rs242557	0.109	MAPT	NR	NR	-0.03	0.970446	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	MAPT (ILMN_2310814) expression in Temporal cortex	Expression	intron_variant
chr17	45942346	rs242557	0.15	KIAA1267	NR	NR	0.03	1.03045	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	107	PSP	KIAA1267 (ILMN_2200636) expression in Temporal cortex	Expression	intron_variant
chr17	45942346	rs242557	0.196	MAPT	NR	NR	-0.02	0.980199	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	180	All	MAPT (ILMN_2310814) expression in Cerebellum	Expression	intron_variant
chr17	45942346	rs242557	0.217	MAPT	NR	NR	0.04	1.04081	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	MAPT (ILMN_2298727) expression in Temporal cortex	Expression	intron_variant
chr17	45942346	rs242557	0.223	KIAA1267	NR	NR	-0.02	0.980199	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	KIAA1267 (ILMN_2200636) expression in Cerebellar	Expression	intron_variant
chr17	45942346	rs242557	0.256	KIAA1267	NR	NR	-0.02	0.980199	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	98	PSP	KIAA1267 (ILMN_2200636) expression in Cerebellar	Expression	intron_variant
chr17	45942346	rs242557	0.259	KIAA1267	NR	NR	-0.01	0.99005	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	KIAA1267 (ILMN_2200636) expression in Cerebellar	Expression	intron_variant
chr17	45942346	rs242557	0.291	STH	NR	NR	-0.08	0.923116	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	107	PSP	STH (ILMN_1665311) expression in Temporal cortex	Expression	intron_variant
chr17	45942346	rs242557	0.349	MAPT	NR	NR	-0.05	0.951229	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	107	PSP	MAPT (ILMN_2310814) expression in Temporal cortex	Expression	intron_variant
chr17	45942346	rs242557	0.383	KIAA1267	NR	NR	0.01	1.01005	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	KIAA1267 (ILMN_2200636) expression in Temporal cortex	Expression	intron_variant
chr17	45942346	rs242557	0.426	MAPT	NR	NR	-0.05	0.951229	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	107	PSP	MAPT (ILMN_2298727) expression in Temporal cortex	Expression	intron_variant
chr17	45942346	rs242557	0.428	STH	NR	NR	-0.02	0.980199	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	STH (ILMN_1665311) expression in Temporal cortex	Expression	intron_variant
chr17	45942346	rs242557	0.442	STH	NR	NR	-0.02	0.980199	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	STH (ILMN_1665311) expression in Cerebellar	Expression	intron_variant
chr17	45942346	rs242557	0.488	STH	NR	NR	-0.02	0.980199	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	98	PSP	STH (ILMN_1665311) expression in Cerebellar	Expression	intron_variant
chr17	45942346	rs242557	0.489	STH	NR	NR	0.03	1.03045	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	202	AD	STH (ILMN_1665311) expression in Temporal cortex	Expression	intron_variant
chr17	45942346	rs242557	0.584	MAPT	NR	NR	0.01	1.01005	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	173	All	MAPT (ILMN_2310814) expression in temporal cortex 	Expression	intron_variant
chr17	45942346	rs242557	0.619	MAPT	NR	NR	0.01	1.01005	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	MAPT (ILMN_2310814) expression in Cerebellar	Expression	intron_variant
chr17	45942346	rs242557	0.665	MAPT	NR	NR	-0.03	0.970446	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	107	PSP	MAPT (ILMN_1710903) expression in Temporal cortex	Expression	intron_variant
chr17	45942346	rs242557	0.721	MAPT	A	A	1.01	1.01	MAPT	SNP-based	Disease risk	25324900	Caucasian	ADGC	13407	All	LOAD Risk	AD	intron_variant
chr17	45942346	rs242557	0.808	KIAA1267	NR	NR	0	1	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	202	AD	KIAA1267 (ILMN_2200636) expression in Temporal cortex	Expression	intron_variant
chr17	45942346	rs242557	0.827	MAPT	NR	NR	0	1	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	MAPT (ILMN_2310814) expression in Cerebellar	Expression	intron_variant
chr17	45942346	rs242557	0.974	MAPT	A	A	1	1	MAPT	SNP-based	Disease risk	25324900	Caucasian	ADGC	18342	All	LOAD Risk	AD	intron_variant
chr17	45942346	rs242557	0.988	MAPT	A	A	1	1	MAPT	SNP-based	Disease risk	25324900	Caucasian	ADGC	4935	All	LOAD Risk	AD	intron_variant
chr17	45942346	rs242557	2.70E-71	MAPT	NA	NA	0.51	0.51	MAPT	SNP-based	Disease Risk	22685416	Caucasian	"Cohorts from Europe, USA"	8851	All	Progressive Supranuclear Palsy (PSP)	ADRD	intron_variant
chr17	45942346	rs242557	4.03E-10	MAPT	NR	NR	0.25	1.28403	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	202	AD	MAPT (ILMN_1710903) expression in Temporal cortex	Expression	intron_variant
chr17	45942346	rs242557	8.80E-13	MAPT	NR	NR	0.18	1.19722	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	MAPT (ILMN_1710903) expression in Cerebellar	Expression	intron_variant
chr17	45977067	rs3785883	0.005	MAPT	NR	NR	0.14	1.15027	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	175	All	MAPT(ILMN_1710903) expression in temporal cortex	Expression	5_prime_UTR_variant
chr17	45977067	rs3785883	0.032	MAPT	A	A	1.08	1.08	MAPT	SNP-based	Disease risk	25324900	Caucasian	ADGC	15187	All	LOAD Risk	AD	5_prime_UTR_variant
chr17	45977067	rs3785883	0.034	MAPT	A	A	1.06	1.06	MAPT	SNP-based	Disease risk	25324900	Caucasian	ADGC	20343	All	LOAD Risk	AD	5_prime_UTR_variant
chr17	45977067	rs3785883	0.266	MAPT	NR	NR	-0.07	0.932394	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	181	All	MAPT (ILMN_2298727) expressionin Cerebellum	Expression	5_prime_UTR_variant
chr17	45977067	rs3785883	0.274	MAPT	A	A	1.07	1.07	MAPT	SNP-based	Disease risk	25324900	Caucasian	ADGC	5247	All	LOAD Risk	AD	5_prime_UTR_variant
chr17	45977067	rs3785883	0.548	MAPT	NR	NR	0.03	1.03045	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	181	All	MAPT(ILMN_1710903) expression in Cerebellum	Expression	5_prime_UTR_variant
chr17	45977067	rs3785883	0.621	MAPT	NR	NR	-0.01	0.99005	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	175	All	MAPT (ILMN_2310814) expression in temporal cortex 	Expression	5_prime_UTR_variant
chr17	45977067	rs3785883	0.706	MAPT	NR	NR	0.01	1.01005	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	181	All	MAPT (ILMN_2310814) expression in Cerebellum	Expression	5_prime_UTR_variant
chr17	45977067	rs3785883	0.977	MAPT	NR	NR	0	1	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	175	All	MAPT (ILMN_2298727) expressionin temporal cortex 	Expression	5_prime_UTR_variant
chr17	45979401	rs1981997	1.13E-27	MAPT	NR	NR	-0.44	0.644036	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	MAPT expression in Cerebellar	Expression	intron_variant
chr17	45979401	rs1981997	1.85E-65	MAPT	NR	NR	-0.48	0.618783	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	MAPT expression in Cerebellar	Expression	intron_variant
chr17	45979401	rs1981997	6.48E-41	MAPT	NR	NR	-0.51	0.600496	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	MAPT expression in Temporal cortex	Expression	intron_variant
chr17	45979401	rs1981997	8.38E-32	MAPT	NR	NR	-0.51	0.600496	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	MAPT expression in Cerebellar	Expression	intron_variant
chr17	45998697	rs2471738	0.016	MAPT	NR	NR	0.11	1.11628	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	182	All	MAPT(ILMN_1710903) expression in Cerebellum	Expression	intron_variant
chr17	45998697	rs2471738	0.089	MAPT	NR	NR	0.09	1.09417	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	182	All	MAPT (ILMN_2298727) expressionin Cerebellum	Expression	intron_variant
chr17	45998697	rs2471738	0.101	MAPT	NR	NR	0.07	1.07251	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	176	All	MAPT(ILMN_1710903) expression in temporal cortex	Expression	intron_variant
chr17	45998697	rs2471738	0.109	MAPT	T	T	1.05	1.05	MAPT	SNP-based	Disease risk	25324900	Caucasian	ADGC	19463	All	LOAD Risk	AD	intron_variant
chr17	45998697	rs2471738	0.194	MAPT	T	T	1.05	1.05	MAPT	SNP-based	Disease risk	25324900	Caucasian	ADGC	14181	All	LOAD Risk	AD	intron_variant
chr17	45998697	rs2471738	0.25	MAPT	T	T	1.07	1.07	MAPT	SNP-based	Disease risk	25324900	Caucasian	ADGC	5282	All	LOAD Risk	AD	intron_variant
chr17	45998697	rs2471738	0.386	MAPT	NR	NR	0.02	1.0202	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	176	All	MAPT (ILMN_2310814) expression in temporal cortex 	Expression	intron_variant
chr17	45998697	rs2471738	0.397	MAPT	NR	NR	-0.01	0.99005	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	182	All	MAPT (ILMN_2310814) expression in Cerebellum	Expression	intron_variant
chr17	45998697	rs2471738	0.665	MAPT	NR	NR	0.02	1.0202	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	176	All	MAPT (ILMN_2298727) expressionin temporal cortex 	Expression	intron_variant
chr17	46003698	rs8070723	0.000000336	MAPT	NR	NR	-0.17	0.843665	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	MAPT (ILMN_2298727) expression in Cerebellar	Expression	intron_variant
chr17	46003698	rs8070723	0.000053	MAPT	G	G	0.9	0.9	MAPT	SNP-based	Disease risk	25324900	Caucasian	ADGC	21024	All	LOAD Risk	AD	intron_variant
chr17	46003698	rs8070723	0.0000867	MAPT	NR	NR	-0.21	0.810584	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	202	AD	MAPT (ILMN_2298727) expression in Temporal cortex	Expression	intron_variant
chr17	46003698	rs8070723	0.00013	MAPT	G	G	0.89	0.89	MAPT	SNP-based	Disease risk	25324900	Caucasian	ADGC	15895	All	LOAD Risk	AD	intron_variant
chr17	46003698	rs8070723	0.00049	MAPT	NR	NR	-0.2	0.818731	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	181	All	MAPT (ILMN_2298727) expressionin Cerebellum	Expression	intron_variant
chr17	46003698	rs8070723	0.0007	MAPT	G	G	0.81	0.81	MAPT	SNP-based	Disease risk	25324900	Caucasian	ADGC	5129	All	LOAD Risk	AD	intron_variant
chr17	46003698	rs8070723	0.00084	MAPT	NR	NR	-0.16	0.852144	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	MAPT (ILMN_2298727) expression in Cerebellar	Expression	intron_variant
chr17	46003698	rs8070723	0.000903	MAPT	NR	NR	-0.14	0.869358	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	MAPT (ILMN_2298727) expression in Temporal cortex	Expression	intron_variant
chr17	46003698	rs8070723	0.002	MAPT	NR	NR	-0.16	0.852144	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	174	All	MAPT (ILMN_2298727) expressionin temporal cortex 	Expression	intron_variant
chr17	46003698	rs8070723	0.0179	STH	NR	NR	0.04	1.04081	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	STH (ILMN_1665311) expression in Cerebellar	Expression	intron_variant
chr17	46003698	rs8070723	0.0404	KIAA1267	NR	NR	0.04	1.04081	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	KIAA1267 (ILMN_2200636) expression in Cerebellar	Expression	intron_variant
chr17	46003698	rs8070723	0.0756	STH	NR	NR	0.11	1.11628	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	98	PSP	STH (ILMN_1665311) expression in Cerebellar	Expression	intron_variant
chr17	46003698	rs8070723	0.0905	MAPT	NR	NR	-0.28	0.755784	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	107	PSP	MAPT (ILMN_1710903) expression in Temporal cortex	Expression	intron_variant
chr17	46003698	rs8070723	0.102	KIAA1267	NR	NR	-0.03	0.970446	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	202	AD	KIAA1267 (ILMN_2200636) expression in Temporal cortex	Expression	intron_variant
chr17	46003698	rs8070723	0.103	MAPT	NR	NR	0.02	1.0202	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	202	AD	MAPT (ILMN_2310814) expression in Temporal cortex	Expression	intron_variant
chr17	46003698	rs8070723	0.114	KIAA1267	NR	NR	0.02	1.0202	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	KIAA1267 (ILMN_2200636) expression in Cerebellar	Expression	intron_variant
chr17	46003698	rs8070723	0.17	KIAA1267	NR	NR	-0.02	0.980199	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	KIAA1267 (ILMN_2200636) expression in Temporal cortex	Expression	intron_variant
chr17	46003698	rs8070723	0.186	STH	NR	NR	0.05	1.05127	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	STH (ILMN_1665311) expression in Temporal cortex	Expression	intron_variant
chr17	46003698	rs8070723	0.222	MAPT	NR	NR	0.02	1.0202	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	181	All	MAPT (ILMN_2310814) expression in Cerebellum	Expression	intron_variant
chr17	46003698	rs8070723	0.259	STH	NR	NR	0.19	1.20925	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	107	PSP	STH (ILMN_1665311) expression in Temporal cortex	Expression	intron_variant
chr17	46003698	rs8070723	0.287	KIAA1267	NR	NR	0.05	1.05127	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	98	PSP	KIAA1267 (ILMN_2200636) expression in Cerebellar	Expression	intron_variant
chr17	46003698	rs8070723	0.305	STH	NR	NR	0.03	1.03045	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	STH (ILMN_1665311) expression in Cerebellar	Expression	intron_variant
chr17	46003698	rs8070723	0.365	MAPT	NR	NR	0.02	1.0202	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	MAPT (ILMN_2310814) expression in Temporal cortex	Expression	intron_variant
chr17	46003698	rs8070723	0.512	MAPT	NR	NR	-0.03	0.970446	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	98	PSP	MAPT (ILMN_2310814) expression in Cerebellar	Expression	intron_variant
chr17	46003698	rs8070723	0.577	MAPT	NR	NR	-0.01	0.99005	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	MAPT (ILMN_2310814) expression in Cerebellar	Expression	intron_variant
chr17	46003698	rs8070723	0.58	KIAA1267	NR	NR	-0.03	0.970446	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	107	PSP	KIAA1267 (ILMN_2200636) expression in Temporal cortex	Expression	intron_variant
chr17	46003698	rs8070723	0.591	MAPT	NR	NR	-0.06	0.941765	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	98	PSP	MAPT (ILMN_2298727) expression in Cerebellar	Expression	intron_variant
chr17	46003698	rs8070723	0.615	MAPT	NR	NR	-0.07	0.932394	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	107	PSP	MAPT (ILMN_2298727) expression in Temporal cortex	Expression	intron_variant
chr17	46003698	rs8070723	0.624	STH	NR	NR	-0.02	0.980199	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	202	AD	STH (ILMN_1665311) expression in Temporal cortex	Expression	intron_variant
chr17	46003698	rs8070723	0.666	MAPT	NR	NR	0.01	1.01005	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	174	All	MAPT (ILMN_2310814) expression in temporal cortex 	Expression	intron_variant
chr17	46003698	rs8070723	0.694	MAPT	NR	NR	0.01	1.01005	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	MAPT (ILMN_2310814) expression in Cerebellar	Expression	intron_variant
chr17	46003698	rs8070723	0.752	MAPT	NR	NR	0.04	1.04081	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	107	PSP	MAPT (ILMN_2310814) expression in Temporal cortex	Expression	intron_variant
chr17	46003698	rs8070723	1.38E-08	MAPT	NR	NR	-0.43	0.650509	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	98	PSP	MAPT (ILMN_1710903) expression in Cerebellar	Expression	intron_variant
chr17	46003698	rs8070723	1.49E-31	MAPT	NR	NR	-0.43	0.650509	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	MAPT (ILMN_1710903) expression in Cerebellar	Expression	intron_variant
chr17	46003698	rs8070723	1.50E-118	MAPT	NA	NA	5.11	5.11	MAPT	SNP-based	Disease Risk	22685416	Caucasian	"Cohorts from Europe, USA"	8851	All	Progressive Supranuclear Palsy (PSP)	ADRD	intron_variant
chr17	46003698	rs8070723	2.10E-30	MAPT	NR	NR	-0.44	0.644036	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	174	All	MAPT(ILMN_1710903) expression in temporal cortex	Expression	intron_variant
chr17	46003698	rs8070723	3.12E-37	MAPT	NR	NR	-0.5	0.606531	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	202	AD	MAPT (ILMN_1710903) expression in Temporal cortex	Expression	intron_variant
chr17	46003698	rs8070723	7.02E-69	MAPT	NR	NR	-0.47	0.625002	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	MAPT (ILMN_1710903) expression in Cerebellar	Expression	intron_variant
chr17	46003698	rs8070723	8.61E-44	MAPT	NR	NR	-0.5	0.606531	MAPT	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	MAPT (ILMN_1710903) expression in Temporal cortex	Expression	intron_variant
chr17	46003698	rs8070723	8.90E-31	MAPT	NR	NR	-0.48	0.618783	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	181	All	MAPT(ILMN_1710903) expression in Cerebellum	Expression	intron_variant
chr17	46028029	rs7521	0.000011	MAPT	NR	NR	0.16	1.17351	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	182	All	MAPT(ILMN_1710903) expression in Cerebellum	Expression	3_prime_UTR_variant
chr17	46028029	rs7521	0.00028	MAPT	NR	NR	0.12	1.1275	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	176	All	MAPT(ILMN_1710903) expression in temporal cortex	Expression	3_prime_UTR_variant
chr17	46028029	rs7521	0.048	MAPT	NR	NR	0.08	1.08329	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	176	All	MAPT (ILMN_2298727) expressionin temporal cortex 	Expression	3_prime_UTR_variant
chr17	46028029	rs7521	0.084	MAPT	NR	NR	0.08	1.08329	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	182	All	MAPT (ILMN_2298727) expressionin Cerebellum	Expression	3_prime_UTR_variant
chr17	46028029	rs7521	0.152	MAPT	A	A	1.08	1.08	MAPT	SNP-based	Disease risk	25324900	Caucasian	ADGC	5171	All	LOAD Risk	AD	3_prime_UTR_variant
chr17	46028029	rs7521	0.437	MAPT	A	A	1.02	1.02	MAPT	SNP-based	Disease risk	25324900	Caucasian	ADGC	20827	All	LOAD Risk	AD	3_prime_UTR_variant
chr17	46028029	rs7521	0.529	MAPT	A	A	1.02	1.02	MAPT	SNP-based	Disease risk	25324900	Caucasian	ADGC	15656	All	LOAD Risk	AD	3_prime_UTR_variant
chr17	46028029	rs7521	0.897	MAPT	NR	NR	0	1	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	176	All	MAPT (ILMN_2310814) expression in temporal cortex 	Expression	3_prime_UTR_variant
chr17	46028029	rs7521	0.976	MAPT	NR	NR	0	1	MAPT	SNP-based	eQTL	25324900	Caucasian	MAYO	182	All	MAPT (ILMN_2310814) expression in Cerebellum	Expression	3_prime_UTR_variant
chr17	46275856	rs2732703	0.00000064	"KANSL1, LRRC37A"	G	G	0.73	0.73	ARL17B	SNP-based	Disease risk	25778476	Caucasian	IGAP	34152	APOE-e4- subjects	AD	AD	intron_variant
chr17	46275856	rs2732703	0.001	"KANSL1, LRRC37A"	G	G	0.71	0.71	ARL17B	SNP-based	Disease risk	25778476	Caucasian	ADGC	2417	APOE-e4- subjects	AD	AD	intron_variant
chr17	46275856	rs2732703	5.80E-09	"KANSL1, LRRC37A"	G	G	0.73	0.73	ARL17B	SNP-based	Disease risk	25778476	Caucasian	"ADGC, IGAP"	36569	APOE-e4- subjects	AD	AD	intron_variant
chr17	46278317	rs113986870	0.000000013	KANSL1	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"KANSL1 (44270189 - 44270252, GRCh37) expression in hippocampus (HIPP)"	Expression	intron_variant
chr17	46278317	rs113986870	0.00000016	C17orf69	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"C17orf69 (43716765 - 43716853, GRCh37) in hippocampus (HIPP)"	Expression	intron_variant
chr17	46278317	rs113986870	0.0000026	MAPT	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"MAPT (44051752 - 44051833, GRCh37) expression in temporal cortex (TCTX)"	Expression	intron_variant
chr17	46278317	rs113986870	0.000004	LRRC37A4P	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"LRRC37A4P (43583231- 43583802, GRCh37) expression in hippocampus (HIPP)"	Expression	intron_variant
chr17	46278317	rs113986870	0.0000092	MAPT	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"MAPT (44051752 - 44051833, GRCh37) expression in frontal cortex (FCTX)"	Expression	intron_variant
chr17	46278317	rs113986870	0.000013	C17orf69	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"C17orf69 (43723359 - 43723556, GRCh37) in temporal cortex (TCTX)"	Expression	intron_variant
chr17	46278317	rs113986870	0.00002	C17orf69	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"C17orf69 (43716765 - 43716853, GRCh37) in frontal cortex (FCTX)"	Expression	intron_variant
chr17	46278317	rs113986870	0.000024	LRRC37A4P	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"LRRC37A4P (43583231- 43583802, GRCh37) expression in temporal cortex (TCTX)"	Expression	intron_variant
chr17	46278317	rs113986870	0.000028	KANSL1	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"KANSL1 (44117069 - 44117161, GRCh37) expression in frontal cortex (FCTX)"	Expression	intron_variant
chr17	46278317	rs113986870	0.000062	KANSL1	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"KANSL1 (44117069 - 44117161, GRCh37) expression in temporal cortex (TCTX)"	Expression	intron_variant
chr17	46278317	rs113986870	0.000083	C17orf69	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"C17orf69 (43716765 - 43716853, GRCh37) in temporal cortex (TCTX)"	Expression	intron_variant
chr17	46278317	rs113986870	0.00064	LRRC37A4P	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"LRRC37A4P (43583231- 43583802, GRCh37) expression in frontal cortex (FCTX)"	Expression	intron_variant
chr17	46278317	rs113986870	0.00076	MAPT	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"MAPT (44051752 - 44051833, GRCh37) expression in hippocampus (HIPP)"	Expression	intron_variant
chr17	46278317	rs113986870	0.00098	C17orf69	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"C17orf69 (43723359 - 43723556, GRCh37) in hippocampus (HIPP)"	Expression	intron_variant
chr17	46278317	rs113986870	0.004	C17orf69	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"C17orf69 (43723359 - 43723556, GRCh37) in frontal cortex (FCTX)"	Expression	intron_variant
chr17	46278317	rs113986870	0.008	KANSL1	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"KANSL1 (44117069 - 44117161, GRCh37) expression in hippocampus (HIPP)"	Expression	intron_variant
chr17	46278317	rs113986870	1.10E-13	KANSL1	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"KANSL1 (44249529 - 44249592, GRCh37) expression in hippocampus (HIPP)"	Expression	intron_variant
chr17	46278317	rs113986870	1.20E-11	KANSL1	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"KANSL1 (44249529 - 44249592, GRCh37) expression in temporal cortex (TCTX)"	Expression	intron_variant
chr17	46278317	rs113986870	1.30E-09	KANSL1	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"KANSL1 (44270189 - 44270252, GRCh37) expression in frontal cortex (FCTX)"	Expression	intron_variant
chr17	46278317	rs113986870	1.30E-11	KANSL1	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"KANSL1 (44270189 - 44270252, GRCh37) expression in temporal cortex (TCTX)"	Expression	intron_variant
chr17	46278317	rs113986870	1.40E-15	LRRC37A4P	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"LRRC37A4P (43583231- 43583802, GRCh37) expression in 10 brain regions (cerebellum (CRBL), frontal cortex (FCTX), hippocampus (HIPP), medulla (specifically inferior olivary nucleus)(MEDU), occipital cortex (specifically primary visual cortex) (OCTX), putamen (PUTM), substantia nigra (SNIG), thalamus (THAL), temporal cortex (TCTX), intralobular white matter (WHMT))"	Expression	intron_variant
chr17	46278317	rs113986870	1.40E-24	KANSL1	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"KANSL1 (44248224 - 44248977, GRCh37) expression in 10 brain regions (cerebellum (CRBL), frontal cortex (FCTX), hippocampus (HIPP), medulla (specifically inferior olivary nucleus)(MEDU), occipital cortex (specifically primary visual cortex) (OCTX), putamen (PUTM), substantia nigra (SNIG), thalamus (THAL), temporal cortex (TCTX), intralobular white matter (WHMT))"	Expression	intron_variant
chr17	46278317	rs113986870	1.60E-15	KANSL1	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"KANSL1 (44247654 - 44247852, GRCh37) expression in temporal cortex (TCTX)"	Expression	intron_variant
chr17	46278317	rs113986870	1.70E-20	LRRC37A4P	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"LRRC37A4P (43584264 - 43584884, GRCh37) expression in 10 brain regions (cerebellum (CRBL), frontal cortex (FCTX), hippocampus (HIPP), medulla (specifically inferior olivary nucleus)(MEDU), occipital cortex (specifically primary visual cortex) (OCTX), putamen (PUTM), substantia nigra (SNIG), thalamus (THAL), temporal cortex (TCTX), intralobular white matter (WHMT))"	Expression	intron_variant
chr17	46278317	rs113986870	2.50E-21	KANSL1	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"KANSL1 (44248224 - 44248977, GRCh37) expression in temporal cortex (TCTX)"	Expression	intron_variant
chr17	46278317	rs113986870	2.60E-18	KANSL1	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"KANSL1 (44248224 - 44248977, GRCh37) expression in frontal cortex (FCTX)"	Expression	intron_variant
chr17	46278317	rs113986870	3.00E-11	KANSL1	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"KANSL1 (44249529 - 44249592, GRCh37) expression in frontal cortex (FCTX)"	Expression	intron_variant
chr17	46278317	rs113986870	3.00E-17	KANSL1	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"KANSL1 (44247654 - 44247852, GRCh37) expression in hippocampus (HIPP)"	Expression	intron_variant
chr17	46278317	rs113986870	3.30E-13	C17orf69	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"C17orf69 (43716765 - 43716853, GRCh37) in 10 brain regions (cerebellum (CRBL), frontal cortex (FCTX), hippocampus (HIPP), medulla (specifically inferior olivary nucleus)(MEDU), occipital cortex (specifically primary visual cortex) (OCTX), putamen (PUTM), substantia nigra (SNIG), thalamus (THAL), temporal cortex (TCTX), intralobular white matter (WHMT))"	Expression	intron_variant
chr17	46278317	rs113986870	3.60E-09	LRRC37A4P	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"LRRC37A4P (43584264 - 43584884, GRCh37) expression in temporal cortex (TCTX)"	Expression	intron_variant
chr17	46278317	rs113986870	3.60E-14	MAPT	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"MAPT (44051752 - 44051833, GRCh37) expression in 10 brain regions (cerebellum (CRBL), frontal cortex (FCTX), hippocampus (HIPP), medulla (specifically inferior olivary nucleus)(MEDU), occipital cortex (specifically primary visual cortex) (OCTX), putamen (PUTM), substantia nigra (SNIG), thalamus (THAL), temporal cortex (TCTX), intralobular white matter (WHMT))"	Expression	intron_variant
chr17	46278317	rs113986870	4.00E-23	KANSL1	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"KANSL1 (44247654 - 44247852, GRCh37) expression in 10 brain regions (cerebellum (CRBL), frontal cortex (FCTX), hippocampus (HIPP), medulla (specifically inferior olivary nucleus)(MEDU), occipital cortex (specifically primary visual cortex) (OCTX), putamen (PUTM), substantia nigra (SNIG), thalamus (THAL), temporal cortex (TCTX), intralobular white matter (WHMT))"	Expression	intron_variant
chr17	46278317	rs113986870	4.30E-13	KANSL1	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"KANSL1 (44270189 - 44270252, GRCh37) expression in 10 brain regions (cerebellum (CRBL), frontal cortex (FCTX), hippocampus (HIPP), medulla (specifically inferior olivary nucleus)(MEDU), occipital cortex (specifically primary visual cortex) (OCTX), putamen (PUTM), substantia nigra (SNIG), thalamus (THAL), temporal cortex (TCTX), intralobular white matter (WHMT))"	Expression	intron_variant
chr17	46278317	rs113986870	4.90E-10	C17orf69	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"C17orf69 (43723359 - 43723556, GRCh37) in 10 brain regions (cerebellum (CRBL), frontal cortex (FCTX), hippocampus (HIPP), medulla (specifically inferior olivary nucleus)(MEDU), occipital cortex (specifically primary visual cortex) (OCTX), putamen (PUTM), substantia nigra (SNIG), thalamus (THAL), temporal cortex (TCTX), intralobular white matter (WHMT))"	Expression	intron_variant
chr17	46278317	rs113986870	5.30E-10	LRRC37A4P	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"LRRC37A4P (43584264 - 43584884, GRCh37) expression in hippocampus (HIPP)"	Expression	intron_variant
chr17	46278317	rs113986870	7.70E-16	KANSL1	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"KANSL1 (44249529 - 44249592, GRCh37) expression in 10 brain regions (cerebellum (CRBL), frontal cortex (FCTX), hippocampus (HIPP), medulla (specifically inferior olivary nucleus)(MEDU), occipital cortex (specifically primary visual cortex) (OCTX), putamen (PUTM), substantia nigra (SNIG), thalamus (THAL), temporal cortex (TCTX), intralobular white matter (WHMT))"	Expression	intron_variant
chr17	46278317	rs113986870	7.80E-20	KANSL1	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"KANSL1 (44248224 - 44248977, GRCh37) expression in hippocampus (HIPP)"	Expression	intron_variant
chr17	46278317	rs113986870	8.00E-11	LRRC37A4P	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"LRRC37A4P (43584264 - 43584884, GRCh37) expression in frontal cortex (FCTX)"	Expression	intron_variant
chr17	46278317	rs113986870	8.00E-13	KANSL1	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"KANSL1 (44247654 - 44247852, GRCh37) expression in frontal cortex (FCTX)"	Expression	intron_variant
chr17	46278317	rs113986870	9.80E-14	KANSL1	NR	NR	NR	NA	ARL17B	SNP-based	eQTL	25778476	Caucasian	UKBEC	134	All	"KANSL1 (44117069 - 44117161, GRCh37) expression in 10 brain regions (cerebellum (CRBL), frontal cortex (FCTX), hippocampus (HIPP), medulla (specifically inferior olivary nucleus)(MEDU), occipital cortex (specifically primary visual cortex) (OCTX), putamen (PUTM), substantia nigra (SNIG), thalamus (THAL), temporal cortex (TCTX), intralobular white matter (WHMT))"	Expression	intron_variant
chr17	46722680	rs7224296	0.000065	NSF	NR	NR	NR	NA	NSF	SNP-based	Cross phenotype 	29630712	Caucasian	UKBEC	NR	All	MAPT expression in brain	Expression	intron_variant
chr17	46722680	rs7224296	0.00059	NSF	NR	NR	NR	NA	NSF	SNP-based	Cross phenotype 	29630712	Caucasian	"ALS group, IGAP, FTGC, AFTD, PSP Genetics Consortium, IPDGC"	36052	All	AD	AD	intron_variant
chr17	46722680	rs7224296	3.30E-18	NSF	NR	NR	NR	NA	NSF	SNP-based	Cross phenotype 	29630712	Caucasian	UKBEC	NR	All	KIAA1267 expression in brain	Expression	intron_variant
chr17	46722680	rs7224296	6.90E-11	NSF	NR	NR	NR	NA	NSF	SNP-based	Cross phenotype 	29630712	Caucasian	UKBEC	NR	All	MAPT (exon 3) expression in brain	Expression	intron_variant
chr17	46765770	rs199528	0.000003	WNT3	C	C	NR	NA	WNT3	SNP-based	eQTL	27899424	Caucasian	UKBEC	101	All	LRRC37A2 expression in Temporal cortex	Expression	intron_variant
chr17	46765770	rs199528	0.00000959	WNT3	T	T	0.85	0.85	WNT3	SNP-based	Disease risk	27899424	Caucasian	IFGC	12928	All	Frontotemporal Dementia	ADRD	intron_variant
chr17	46765770	rs199528	0.00001	WNT3	C	C	NR	NA	WNT3	SNP-based	eQTL	27899424	Caucasian	UKBEC	101	All	KANSL1 expression in Hippocampus	Expression	intron_variant
chr17	46765770	rs199528	0.0000409	WNT3	NR	NR	NR	NA	WNT3	SNP-based	Disease risk	27899424	Caucasian	IFGC	12928	All	Frontotemporal Dementia	ADRD	intron_variant
chr17	46765770	rs199528	0.0000409	WNT3	T	T	0.82	0.82	WNT3	SNP-based	Disease risk	27899424	Caucasian	IFGC	6462	All	Frontotemporal Dementia	ADRD	intron_variant
chr17	46765770	rs199528	0.03	WNT3	T	T	0.89	0.89	WNT3	SNP-based	Disease risk	27899424	Caucasian	IFGC	6466	All	Frontotemporal Dementia	ADRD	intron_variant
chr17	46770468	rs199525	0.0013	NR	T	T	0.36	1.43333	WNT3	SNP-based	Endophenotype	27694991	African American	"CHARGE, ENIGMA"	938	African	Intracranial Volume	Imaging	intron_variant
chr17	46770468	rs199525	0.406	NR	T	T	0.26	1.29693	WNT3	SNP-based	Endophenotype	27694991	Asian	"CHARGE, ENIGMA"	955	Asian	Intracranial Volume	Imaging	intron_variant
chr17	46770468	rs199525	0.407	NR	T	T	0.02	1.0202	WNT3	SNP-based	Endophenotype	27694991	Caucasian	"CHARGE, ENIGMA"	2363	European	Intracranial Volume	Imaging	intron_variant
chr17	46770468	rs199525	0.493	NR	T	T	0.04	1.04081	WNT3	SNP-based	Endophenotype	27694991	Hispanic	"CHARGE, ENIGMA"	1605	Hispanic	Intracranial Volume	Imaging	intron_variant
chr17	46770468	rs199525	3.80E-21	NR	T	T	0.1	1.10517	WNT3	SNP-based	Endophenotype	27694991	Caucasian	"CHARGE, ENIGMA"	26577	European	Intracranial Volume	Imaging	intron_variant
chr17	47297628	rs7221196	0.000000157	ITGB3	G	G	NR	NA	ITGB3	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Low-density lipoprotein (LDL)	Non-ADRD	intron_variant
chr17	47297628	rs7221196	0.000178	ITGB3	G	G	NR	NA	ITGB3	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr17	47297628	rs7221196	0.37	ITGB3	G	G	1	1	ITGB3	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr17	49219935	rs616338	0.0000216	ABI3	T	T	1.42	1.42	ABI3	SNP-based	Disease risk	28714976	Caucasian	"ADGC, CHARGE, EADI, GERAD"	33786	All	AD	AD	missense_variant
chr17	49219935	rs616338	0.0000837	ABI3	T	T	1.41	1.41	ABI3	SNP-based	Disease risk	28714976	Caucasian	"CHARGE, EADI, GERAD"	35831	All	AD	AD	missense_variant
chr17	49219935	rs616338	0.0175	ABI3	T	T	1.58	1.58	ABI3	SNP-based	Disease risk	28714976	Caucasian	ADGC	14876	All	AD	AD	missense_variant
chr17	49219935	rs616338	4.56E-10	ABI3	T	T	1.43	1.43	ABI3	SNP-based	Disease risk	28714976	Caucasian	"ADGC, CHARGE, EADI, GERAD"	84493	All	AD	AD	missense_variant
chr17	49255705	rs850520	0.000108	AK097513	A	A	NR	NA	PHOSPHO1	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Total triglycerides (TG)	Non-ADRD	intron_variant
chr17	49255705	rs850520	0.000125	AK097513	A	A	NR	NA	PHOSPHO1	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr17	49255705	rs850520	0.00024	AK097513	A	A	1.01	1.01	PHOSPHO1	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr17	49301409	rs2960171	0.0000872	ZNF652	C	C	NR	NA	ZNF652	SNP-based	Cross phenotype 	30413934	Caucasian	CARDIoGRAMplusC4D	155197	All	Coronary artery disease (CAD)	Non-ADRD	intron_variant
chr17	49301409	rs2960171	0.000098	ZNF652	C	C	1.01	1.01	ZNF652	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr17	49301409	rs2960171	0.000137	ZNF652	C	C	NR	NA	ZNF652	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr17	49373413	rs28394864	0.0000068	ABI3	A	A	NR	NA	ZNF652	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	intron_variant
chr17	49373413	rs28394864	0.0000729	ABI3	A	A	NR	NA	ZNF652	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ"	79145	All	AD	AD	intron_variant
chr17	49373413	rs28394864	1.87E-08	ABI3	A	A	5.62	NA	ZNF652	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ, UKBB"	455258	All	AD + AD-by-proxy	AD	intron_variant
chr17	49420891	rs8073041	2.17E-10	"PHB, LOC101927207"	NR	NR	NR	NA	PHB	SNP-based	Cross phenotype 	27357110	Caucasian	"ADNI, Knight-ADRC"	543	NA	CSF Prolactin	Fluid biomarker	intron_variant
chr17	49420891	rs8073041	7.87E-09	"PHB, LOC101927207"	NR	NR	NR	NA	PHB	SNP-based	Cross phenotype 	27357110	Caucasian	"ADNI, Knight-ADRC"	587	NA	Plasma Prolactin	Fluid biomarker	intron_variant
chr17	49453879	rs79268972	2.55E-08	"PHB, LOC101927207"	NR	NR	NR	NA	PHB	SNP-based	Cross phenotype 	27357110	Caucasian	"ADNI, Knight-ADRC"	587	NA	Plasma Prolactin	Fluid biomarker	intron_variant
chr17	49453879	rs79268972	8.17E-12	"PHB, LOC101927207"	NR	NR	NR	NA	PHB	SNP-based	Cross phenotype 	27357110	Caucasian	"ADNI, Knight-ADRC"	543	NA	CSF Prolactin	Fluid biomarker	intron_variant
chr17	49454994	rs77482998	4.61E-08	TNS3 (to be removed)	NR	NR	NR	NA	PHB	SNP-based	Cross phenotype 	27357110	Caucasian	"ADNI, Knight-ADRC"	587	NA	Plasma Prolactin	Fluid biomarker	intron_variant
chr17	49454994	rs77482998	7.98E-12	TNS3 (to be removed)	NR	NR	NR	NA	PHB	SNP-based	Cross phenotype 	27357110	Caucasian	"ADNI, Knight-ADRC"	543	NA	CSF Prolactin	Fluid biomarker	intron_variant
chr17	58326988	rs2526378	0.000000273	BZRAP1	G	G	0.94	0.94	TSPOAP1	SNP-based	Disease risk	25862742	Caucasian	"deCODE, DemGene, IGAP"	143878	All	AD	AD	intron_variant
chr17	58326988	rs2526378	0.000000834	BZRAP1	G	G	0.94	0.94	TSPOAP1	SNP-based	Disease risk	25862742	Caucasian	IGAP	74046	All	AD	AD	intron_variant
chr17	58326988	rs2526378	0.00000122	BZRAPl	NR	NR	NR	NA	TSPOAP1	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr17	58326988	rs2526378	0.0000126	BZRAP1	NR	NR	0.09	NA	TSPOAP1	SNP-based	Age at onset (AAO) / Survival	28323831	Caucasian	ADGC	15795	All	Age of AD onset	Other	intron_variant
chr17	58326988	rs2526378	0.00092	BZRAP1	G	G	0.8	0.8	TSPOAP1	SNP-based	Disease risk	25862742	Caucasian	DemGene	2015	All	AD	AD	intron_variant
chr17	58326988	rs2526378	0.5	BZRAP1	G	G	0.98	0.98	TSPOAP1	SNP-based	Disease risk	25862742	Caucasian	deCODE	67817	All	AD	AD	intron_variant
chr17	58331728	rs2632516	0.000000044	BZRAP1-AS1	C	C	0.92	0.92	TSPOAP1	SNP-based	Disease risk	28183528	Multi-ethnic	"ADGC, IGAP"	59556	All	AD	AD	intron_variant
chr17	58331728	rs2632516	0.000000053	"MIR142, TSPOAP1-AS1"	C	C	0.94	0.94	TSPOAP1	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	94437	All	Clinically diagnosed LOAD	AD	intron_variant
chr17	58331728	rs2632516	0.00000023	"MIR142, TSPOAP1-AS1"	C	C	0.94	0.94	TSPOAP1	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	82771	All	Clinically diagnosed LOAD	AD	intron_variant
chr17	58331728	rs2632516	0.00000056	BZRAP1-AS1	C	C	0.91	0.91	TSPOAP1	SNP-based	Disease risk	28183528	Multi-ethnic	ADGC	33269	All	AD	AD	intron_variant
chr17	58331728	rs2632516	0.000000966	BZRAP1-AS1	C	C	-4.9	NA	TSPOAP1	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ, UKBB"	455258	All	AD + AD-by-proxy	AD	intron_variant
chr17	58331728	rs2632516	0.005	BZRAP1-AS1	C	C	NR	NA	TSPOAP1	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	intron_variant
chr17	58331728	rs2632516	0.01	BZRAP1-AS1	C	C	0.94	0.94	TSPOAP1	SNP-based	Disease risk	28183528	Caucasian	IGAP	26287	All	AD	AD	intron_variant
chr17	58331728	rs2632516	0.075	"MIR142, TSPOAP1-AS1"	C	C	0.91	0.91	TSPOAP1	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	11666	All	Clinically diagnosed LOAD	AD	intron_variant
chr17	58331728	rs2632516	1.42E-09	BZRAP1-AS1	C	C	NR	NA	TSPOAP1	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ"	79145	All	AD	AD	intron_variant
chr17	61610481	rs2378873	2.03E-08	"BRIP1, NACA2"	T	T	-0.53	0.588605	NACA2	SNP-based	Endophenotype	29274321	Caucasian	ADNI	206	Normal controls	CSF Ab1-42	Fluid biomarker	intergenic_region
chr17	63460787	rs138190086	0.0000075	ACE	A	A	1.29	1.29	CYB561	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	63926	All	Clinically diagnosed LOAD	AD	downstream_gene_variant
chr17	63460787	rs138190086	0.00018	ACE	A	A	1.41	1.41	CYB561	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	18845	All	Clinically diagnosed LOAD	AD	downstream_gene_variant
chr17	63460787	rs138190086	0.21	ACE	A	A	1.17	1.17	CYB561	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	11666	All	Clinically diagnosed LOAD	AD	downstream_gene_variant
chr17	63460787	rs138190086	5.30E-09	ACE	A	A	1.3	1.3	CYB561	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	94437	All	Clinically diagnosed LOAD	AD	downstream_gene_variant
chr17	63460787	rs138190086	7.50E-09	ACE	A	A	1.32	1.32	CYB561	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	82771	All	Clinically diagnosed LOAD	AD	downstream_gene_variant
chr17	63468418	rs6504163	5.40E-09	NR	T	T	1.05	1.05	ACE	SNP-based	Disease risk	29777097	Caucasian	UKBB	623001	All	AD	AD	upstream_gene_variant
chr17	63471115	rs4968782	0.000000046	ACE	G	G	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	ADNI	308	All	CSF ACE 	Fluid biomarker	upstream_gene_variant
chr17	63471115	rs4968782	0.00000793	ACE	NR	NR	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	Plasma ACE 	Fluid biomarker	upstream_gene_variant
chr17	63471115	rs4968782	0.0000159	ACE	G	G	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	Knight-ADRC	266	All	CSF ACE 	Fluid biomarker	upstream_gene_variant
chr17	63471115	rs4968782	0.000154	ACE	NR	NR	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR > 0	CSF ACE 	Fluid biomarker	upstream_gene_variant
chr17	63471115	rs4968782	0.000406	ACE	NR	NR	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Amyloid deposition strata	CSF ACE 	Fluid biomarker	upstream_gene_variant
chr17	63471115	rs4968782	0.0073	ACE	NR	NR	-0.044	0.956954	ACE	SNP-based	Disease risk	25340798	Caucasian	IGAP	54162	All	AD	AD	upstream_gene_variant
chr17	63471115	rs4968782	0.72	ACE	NR	NR	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF Ab1-42	Fluid biomarker	upstream_gene_variant
chr17	63471115	rs4968782	0.83	ACE	NR	NR	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF T-tau	Fluid biomarker	upstream_gene_variant
chr17	63471115	rs4968782	1.61E-08	ACE	NR	NR	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR = 0	CSF ACE 	Fluid biomarker	upstream_gene_variant
chr17	63471115	rs4968782	3.94E-12	ACE	G	G	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF ACE 	Fluid biomarker	upstream_gene_variant
chr17	63471115	rs4968782	8.39E-09	ACE	NR	NR	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	No amyloid deposition strata	CSF ACE 	Fluid biomarker	upstream_gene_variant
chr17	63471587	rs4459609	0.000000162	ACE	C	C	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	ADNI	308	All	CSF ACE 	Fluid biomarker	upstream_gene_variant
chr17	63471587	rs4459609	0.000000225	ACE	NR	NR	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR = 0	CSF ACE 	Fluid biomarker	upstream_gene_variant
chr17	63471587	rs4459609	0.0000097	ACE	NR	NR	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	Plasma ACE 	Fluid biomarker	upstream_gene_variant
chr17	63471587	rs4459609	0.000115	ACE	C	C	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	Knight-ADRC	266	All	CSF ACE 	Fluid biomarker	upstream_gene_variant
chr17	63471587	rs4459609	0.000205	ACE	NR	NR	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR > 0	CSF ACE 	Fluid biomarker	upstream_gene_variant
chr17	63471587	rs4459609	0.00117	ACE	NR	NR	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Amyloid deposition strata	CSF ACE 	Fluid biomarker	upstream_gene_variant
chr17	63471587	rs4459609	0.0066	ACE	NR	NR	-0.044	0.956954	ACE	SNP-based	Disease risk	25340798	Caucasian	IGAP	54162	All	AD	AD	upstream_gene_variant
chr17	63471587	rs4459609	0.37	ACE	NR	NR	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF T-tau	Fluid biomarker	upstream_gene_variant
chr17	63471587	rs4459609	0.55	ACE	NR	NR	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF Ab1-42	Fluid biomarker	upstream_gene_variant
chr17	63471587	rs4459609	0.79	ACE	NR	NR	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF P-tau181p	Fluid biomarker	upstream_gene_variant
chr17	63471587	rs4459609	1.09E-10	ACE	C	C	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF ACE 	Fluid biomarker	upstream_gene_variant
chr17	63471587	rs4459609	5.83E-08	ACE	NR	NR	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	No amyloid deposition strata	CSF ACE 	Fluid biomarker	upstream_gene_variant
chr17	63473168	rs1800764	0.03	ACE	C	C	0.85	0.85	ACE	SNP-based	Disease risk	20534741	Caucasian	"ADC, UM"	1610	All	AD	AD	upstream_gene_variant
chr17	63484948	rs4316	0.000000011	ACE	C	C	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF ACE 	Fluid biomarker	synonymous_variant
chr17	63484948	rs4316	0.0000096	ACE	NR	NR	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	No amyloid deposition strata	CSF ACE 	Fluid biomarker	synonymous_variant
chr17	63484948	rs4316	0.0000198	ACE	NR	NR	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR = 0	CSF ACE 	Fluid biomarker	synonymous_variant
chr17	63484948	rs4316	0.000222	ACE	NR	NR	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR > 0	CSF ACE 	Fluid biomarker	synonymous_variant
chr17	63484948	rs4316	0.000397	ACE	NR	NR	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Amyloid deposition strata	CSF ACE 	Fluid biomarker	synonymous_variant
chr17	63484948	rs4316	0.0038	ACE	NR	NR	-0.045	0.955997	ACE	SNP-based	Disease risk	25340798	Caucasian	IGAP	54162	All	AD	AD	synonymous_variant
chr17	63484948	rs4316	0.0204	ACE	NR	NR	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	Plasma ACE 	Fluid biomarker	synonymous_variant
chr17	63484948	rs4316	0.0247	ACE	C	C	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	Knight-ADRC	266	All	CSF ACE 	Fluid biomarker	synonymous_variant
chr17	63484948	rs4316	0.13	ACE	NR	NR	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF T-tau	Fluid biomarker	synonymous_variant
chr17	63484948	rs4316	0.65	ACE	NR	NR	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF P-tau181p	Fluid biomarker	synonymous_variant
chr17	63484948	rs4316	0.82	ACE	NR	NR	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF Ab1-42	Fluid biomarker	synonymous_variant
chr17	63484948	rs4316	8.67E-09	ACE	C	C	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	ADNI	308	All	CSF ACE 	Fluid biomarker	synonymous_variant
chr17	63488670	rs4343	0.0000216	ACE	NR	NR	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR = 0	CSF ACE 	Fluid biomarker	synonymous_variant
chr17	63488670	rs4343	0.0000286	ACE	NR	NR	-29.23	2.02103e-13	ACE	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	IMAS	59	All	Plasma ACE	Fluid biomarker	synonymous_variant
chr17	63488670	rs4343	0.0000377	ACE	NR	NR	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	Plasma ACE 	Fluid biomarker	synonymous_variant
chr17	63488670	rs4343	0.000051	ACE	NR	NR	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	No amyloid deposition strata	CSF ACE 	Fluid biomarker	synonymous_variant
chr17	63488670	rs4343	0.000562	ACE	NR	NR	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Amyloid deposition strata	CSF ACE 	Fluid biomarker	synonymous_variant
chr17	63488670	rs4343	0.00126	ACE	NR	NR	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR > 0	CSF ACE 	Fluid biomarker	synonymous_variant
chr17	63488670	rs4343	0.0048	ACE	NR	NR	-0.044	0.956954	ACE	SNP-based	Disease risk	25340798	Caucasian	IGAP	54162	All	AD	AD	synonymous_variant
chr17	63488670	rs4343	0.02	ACE	NR	NR	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF T-tau	Fluid biomarker	synonymous_variant
chr17	63488670	rs4343	0.0216	ACE	G	G	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	Knight-ADRC	266	All	CSF ACE 	Fluid biomarker	synonymous_variant
chr17	63488670	rs4343	0.71	ACE	NR	NR	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF Ab1-42	Fluid biomarker	synonymous_variant
chr17	63488670	rs4343	0.85	ACE	NR	NR	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF P-tau181p	Fluid biomarker	synonymous_variant
chr17	63488670	rs4343	3.71E-08	ACE	G	G	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF ACE 	Fluid biomarker	synonymous_variant
chr17	63488670	rs4343	5.20E-28	ACE	NR	NR	-0.1	0.904837	ACE	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	ADNI	521	All	Plasma ACE	Fluid biomarker	synonymous_variant
chr17	63488670	rs4343	6.26E-08	ACE	G	G	NR	NA	ACE	SNP-based	Endophenotype	25340798	Caucasian	ADNI	308	All	CSF ACE 	Fluid biomarker	synonymous_variant
chr17	63492371	rs4351	0.047	ACE	A	A	1.42	1.42	ACE	SNP-based	Disease risk	17998437	Caucasian	Cohorts from Canada	1321	All	AD	AD	intron_variant
chr17	63492371	rs4351	0.45	ACE	A	A	1.14	1.14	ACE	SNP-based	Age at onset (AAO) / Survival	17998437	Caucasian	Cohorts from Canada	1321	All	Age of AD onset	Other	intron_variant
chr17	66036434	rs1443291	0.00000224	NR	NR	NR	0.44	0.44	CEP112	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	282	All women	LOAD	AD	intron_variant
chr17	66036434	rs1443291	0.0000258	CCDC46	NR	NR	0.44	0.44	CEP112	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	235	All women	LOAD	AD	intron_variant
chr17	66036434	rs1443291	0.0041	NR	NR	NR	0.61	0.61	CEP112	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	282	All women	LOAD	AD	intron_variant
chr17	66036434	rs1443291	0.00636	CCDC46	NR	NR	0.59	0.59	CEP112	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	235	All women	LOAD	AD	intron_variant
chr17	66036434	rs1443291	0.0468	NR	NR	NR	0.58	0.58	CEP112	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	235	All women	LOAD	AD	intron_variant
chr17	66036434	rs1443291	0.0571	NR	NR	NR	0.66	0.66	CEP112	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	282	All women	LOAD	AD	intron_variant
chr17	66223079	rs8178841	0.00492	APOH	NR	NR	-54.36	2.46463e-24	APOH	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	IMAS	59	All	Plasma ApoH	Fluid biomarker	intron_variant
chr17	66223079	rs8178841	1.08E-10	APOH	NR	NR	-68.56	1.67792e-30	APOH	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	ADNI	521	All	Plasma ApoH	Fluid biomarker	intron_variant
chr17	66325449	rs8071250	0.000427	PRKCA	C	C	0.96	0.96	PRKCA	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intron_variant
chr17	66325449	rs8071250	0.000596	PRKCA	C	C	0.96	0.96	PRKCA	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intron_variant
chr17	66325449	rs8071250	0.000756	PRKCA	C	C	NR	NA	PRKCA	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr17	66325449	rs8071250	0.00121	PRKCA	C	C	NR	NA	PRKCA	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Low-density lipoprotein (LDL)	Non-ADRD	intron_variant
chr17	66325449	rs8071250	0.0211	PRKCA	C	C	1	1	PRKCA	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr17	66325449	rs8071250	0.883	PRKCA	C	C	0.99	0.99	PRKCA	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intron_variant
chr17	74979653	rs71380849	0.00000091	CDR2L	A	A	1.47	1.47	HID1	SNP-based	Disease risk	25778476	Caucasian	"ADGC, IGAP"	36569	APOE-e4- subjects	AD	AD	downstream_gene_variant
chr17	74979653	rs71380849	0.0000038	CDR2L	A	A	1.45	1.45	HID1	SNP-based	Disease risk	25778476	Caucasian	IGAP	34152	APOE-e4- subjects	AD	AD	downstream_gene_variant
chr17	74979653	rs71380849	0.04	CDR2L	A	A	1.59	1.59	HID1	SNP-based	Disease risk	25778476	Caucasian	ADGC	2417	APOE-e4- subjects	AD	AD	downstream_gene_variant
chr17	75875692	rs3744020	3.52E-11	NR	A	A	0.11	1.11628	TRIM47	SNP-based	Endophenotype	29752348	Caucasian	UKBB	8429	All	White Matter Hyperintensity Volume	Imaging	intron_variant
chr17	77948568	rs16970672	0.00000167	AC015804.1	NR	NR	1.29	1.29	TNRC6C	SNP-based	Disease risk	22005930	Caucasian	"ADGC, GERAD, Cohort from UK"	7693	AD+P and control subjects	AD+Psychosis	ADRD	intergenic_region
chr17	79053619	rs4790069	0.989	C1QTNF1	NR	NR	NR	NA	C1QTNF1	SNP-based	Endophenotype	20452100	Caucasian	ADGC	311	Non-Demented autopsy subjects	High Braak vs Low Braak	Neuropathology	downstream_gene_variant
chr18	1872316	rs1992269	0.000000977	NR	A	A	1.66	1.66	METTL4	SNP-based	Disease risk	26049409	Asian	Cohort from Japan	16983	All	LOAD	AD	intergenic_region
chr18	1872316	rs1992269	0.000216	NR	A	A	1.57	1.57	METTL4	SNP-based	Disease risk	26049409	Asian	Cohort from Japan	8208	All	LOAD	AD	intergenic_region
chr18	1872316	rs1992269	0.00096	NR	A	A	1.8	1.8	METTL4	SNP-based	Disease risk	26049409	Asian	Cohort from Japan	8775	All	LOAD	AD	intergenic_region
chr18	4133739	rs1402627	0.0000442	NR	NR	NR	NR	NA	DLGAP1	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	intron_variant
chr18	5956471	rs3737355	0.0000107	L3MBTL4	NR	NR	NR	NA	L3MBTL4	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr18	6434982	rs76937036	0.000000046	NR	A	A	2.56	12.9358	L3MBTL4	SNP-based	Endophenotype	25188341	Caucasian	ADGC	2886	All	Medial Temporal Sclerosis (MTS)	Neuropathology	downstream_gene_variant
chr18	13890200	rs7230126	0.67	NR	C	C	0.03	1.03045	MC2R	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	515	AD subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr18	23560468	rs1805081	0.157	NR	G	G	0.004	1.00401	NPC1	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	missense_variant
chr18	23560468	rs1805081	0.436	NR	G	G	1.02	1.02	NPC1	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	missense_variant
chr18	23560468	rs1805081	0.832	NR	G	G	1.01	1.01	NPC1	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	missense_variant
chr18	23560468	rs1805081	0.969	NR	G	G	1	1	NPC1	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	missense_variant
chr18	30214382	rs35242772	0.00000131	MIR302F	C	C	1.23	1.23	DSC3	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	17480	Plan 1 (males and females)	AD	AD	intergenic_region
chr18	31488105	rs7239805	0.107	DSG2	A	A	0.9	NA	DSG3	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	intergenic_region
chr18	31508995	rs8093731	0.000000046	DSG2	T	T	0.54	0.54	DSG2	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD"	54162	All	LOAD	AD	intron_variant
chr18	31508995	rs8093731	0.0000111	DSG2	NR	NR	0.706	2.02587	DSG2	SNP-based	eQTL	30448613	Caucasian	NABEC	85	All	NETO1 (ILMN_1783168) expression in frontal cortex	Expression	intron_variant
chr18	31508995	rs8093731	0.0001	DSG2	T	T	0.73	0.73	DSG2	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD, Cohorts from Europe and USA"	74046	All	LOAD	AD	intron_variant
chr18	31508995	rs8093731	0.003	SUZ12P1	T	T	-2.17	NA	DSG2	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ, UKBB"	455258	All	AD + AD-by-proxy	AD	intron_variant
chr18	31508995	rs8093731	0.122	DSG2	T	T	0.728	0.728	DSG2	SNP-based	Disease risk	24495969	Caucasian	Cohort from Spain	4372	All	AD	AD	intron_variant
chr18	31508995	rs8093731	0.766	SUZ12P1	T	T	NR	NA	DSG2	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	intron_variant
chr18	31508995	rs8093731	0.84	DSG2	T	T	0.81	0.81	DSG2	SNP-based	Endophenotype	25188341	Caucasian	ADGC	3702	All	Clinico-pathologic AD dementia (with neuropathologist documentation)	Neuropathology	intron_variant
chr18	31508995	rs8093731	0.9	DSG2	T	T	1.01	1.01	DSG2	SNP-based	Disease risk	24162737	Caucasian	Cohorts from Europe and USA	19884	All	LOAD	AD	intron_variant
chr18	31508995	rs8093731	1.36E-08	DSG2	NR	NR	0.77	2.15977	DSG2	SNP-based	eQTL	30448613	Caucasian	NABEC	85	All	DLGAP1 (ILMN_2380779) expression in frontal cortex	Expression	intron_variant
chr18	31508995	rs8093731	4.63E-08	SUZ12P1	T	T	NR	NA	DSG2	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ"	79145	All	AD	AD	intron_variant
chr18	31508995	rs8093731	NR	DSG2	C	C	0.96	0.96	DSG2	SNP-based	Disease risk	27849641	Caucasian	ADGC	589	All	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr18	31508995	rs8093731	NR	ZCWPW1	C	C	0.94	0.94	DSG2	SNP-based	Disease risk	27849641	Caucasian	ADGC	297	APOE-e4 non-carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr18	32635093	rs1021599	0.000000881	NR	T	T	NR	NA	KLHL14	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF T-tau	Fluid biomarker	intergenic_region
chr18	45388569	rs73431975	0.0000017	SLC14A2	NR	NR	0.573	1.77358	SLC14A2	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	673	All	CSF Clusterin	Fluid biomarker	intron_variant
chr18	45388569	rs73431975	0.000082	SLC14A2	NR	NR	0.584	1.7932	SLC14A2	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	403	Subjects with APOE-e4-	CSF Clusterin	Fluid biomarker	intron_variant
chr18	45388569	rs73431975	0.0191	SLC14A2	NR	NR	0.489	1.63068	SLC14A2	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	270	Subjects with APOE-e4+	CSF Clusterin	Fluid biomarker	intron_variant
chr18	47160932	rs2635049	0.0000912	NR	NR	NR	1.95	1.95	AC012254.2	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	282	All women	LOAD	AD	intron_variant
chr18	47160932	rs2635049	0.000195	NR	NR	NR	1.89	1.89	AC012254.2	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	282	All women	LOAD	AD	intron_variant
chr18	47160932	rs2635049	0.00268	NR	NR	NR	1.92	1.92	AC012254.2	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	282	All women	LOAD	AD	intron_variant
chr18	47160932	rs2635049	0.0188	NR	NR	NR	1.92	1.92	AC012254.2	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	235	All women	LOAD	AD	intron_variant
chr18	49495404	rs17656050	0.00938	RPL17	G	G	NR	NA	RPL17	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	non_coding_transcript_exon_variant
chr18	49495404	rs17656050	3.87E-113	NR	G	G	NR	NA	RPL17	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	RPL17 (ILMN_1655422) expression	Expression	non_coding_transcript_exon_variant
chr18	49605411	rs9954848	0.000458	LIPG	A	A	NR	NA	LIPG	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr18	49605411	rs9954848	0.00109	LIPG	A	A	NR	NA	LIPG	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Total cholesterol (TC)	Non-ADRD	intergenic_region
chr18	49605411	rs9954848	0.00112	LIPG	A	A	0.96	0.96	LIPG	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intergenic_region
chr18	49605411	rs9954848	0.00161	LIPG	A	A	0.96	0.96	LIPG	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intergenic_region
chr18	49605411	rs9954848	0.123	LIPG	A	A	1	1	LIPG	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intergenic_region
chr18	49605411	rs9954848	0.422	LIPG	A	A	0.96	0.96	LIPG	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intergenic_region
chr18	52244453	rs1445093	0.000000775	NR	C	C	NR	NA	DCC	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	MCI	CSF T-tau	Fluid biomarker	intergenic_region
chr18	55487771	rs9960767	0.027	TCF4	NR	NR	0.67	0.67	TCF4	SNP-based	Cross phenotype 	22005930	Caucasian	"ADGC, GERAD"	2034	AD+P and AD-P subjects	AD+Psychosis	ADRD	intron_variant
chr18	55487771	rs9960767	0.5	TCF4	NR	NR	0.93	0.93	TCF4	SNP-based	Cross phenotype 	22005930	Caucasian	"ADGC, GERAD, Cohort from UK"	6958	AD+P and control subjects	AD+Psychosis	ADRD	intron_variant
chr18	58522227	rs76726049	0.000000033	ALPK2	C	C	5.52	NA	ALPK2	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ, UKBB"	455258	All	AD + AD-by-proxy	AD	intron_variant
chr18	58522227	rs76726049	0.000000183	ALPK2	C	C	NR	NA	ALPK2	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	intron_variant
chr18	58522227	rs76726049	0.039	ALPK2	C	C	NR	NA	ALPK2	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ"	79145	All	AD	AD	intron_variant
chr18	58875863	rs12964543	0.000112	ZNF532	A	A	1.24	1.24	ZNF532	SNP-based	Disease risk	27899424	Caucasian	IFGC	6462	All	Frontotemporal Dementia	ADRD	intron_variant
chr18	58875863	rs12964543	0.000112	ZNF532	NR	NR	NR	NA	ZNF532	SNP-based	Disease risk	27899424	Caucasian	IFGC	12928	All	Frontotemporal Dementia	ADRD	intron_variant
chr18	58875863	rs12964543	0.00091	ZNF532	A	A	1.12	1.12	ZNF532	SNP-based	Disease risk	27899424	Caucasian	IFGC	12928	All	Frontotemporal Dementia	ADRD	intron_variant
chr18	58875863	rs12964543	0.24	ZNF532	A	A	1.05	1.05	ZNF532	SNP-based	Disease risk	27899424	Caucasian	IFGC	6466	All	Frontotemporal Dementia	ADRD	intron_variant
chr18	59084822	rs1037757	0.00000829	"LOC390958, Sec11C"	NR	NR	NR	NA	SEC11C	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	2222	AD subjects	Age at onset	Other	non_coding_transcript_exon_variant
chr18	59084822	rs1037757	0.0000136	"LOC390958, Sec11C"	NR	NR	NR	NA	SEC11C	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	2222	AD subjects	Age at onset	Other	non_coding_transcript_exon_variant
chr18	59084822	rs1037757	0.0000293	"LOC390958, Sec11C"	NR	NR	-4.56	0.0104621	SEC11C	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	1190	AD subjects	Age at onset	Other	non_coding_transcript_exon_variant
chr18	59084822	rs1037757	0.0369	"LOC390958, Sec11C"	NR	NR	-2.26	0.10435	SEC11C	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	844	AD subjects	Age at onset	Other	non_coding_transcript_exon_variant
chr18	59084822	rs1037757	0.71	"LOC390958, Sec11C"	NR	NR	-3.45	0.0317456	SEC11C	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADNI	188	AD subjects	Age at onset	Other	non_coding_transcript_exon_variant
chr18	60172536	rs571312	0.27	NR	A	A	1.051	1.051	MC4R	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	intergenic_region
chr18	60172536	rs571312	0.316	NR	A	A	0.975	0.975	MC4R	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	intergenic_region
chr18	60172536	rs571312	0.47	NR	A	A	0.961	0.961	MC4R	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	intergenic_region
chr18	60172536	rs571312	0.924	NR	A	A	0	1	MC4R	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	intergenic_region
chr18	61948797	rs72934313	0.655	RNF152	C	C	1.07	1.07	PIGN	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	intergenic_region
chr18	62566413	rs11152349	0.0000324	ZCCHC2	NR	NR	NR	NA	ZCCHC2	SNP-based	Disease risk	20061627	Caucasian	ADGC	699	All	LOAD	AD	intron_variant
chr18	64058306	rs11152416	0.0000935	NR	NR	NR	2.12	2.12	SERPINB8	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	235	All women	LOAD	AD	intergenic_region
chr18	64058306	rs11152416	0.0154	NR	NR	NR	1.62	1.62	SERPINB8	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	235	All women	LOAD	AD	intergenic_region
chr18	64058306	rs11152416	0.0769	NR	NR	NR	1.49	1.49	SERPINB8	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	282	All women	LOAD	AD	intergenic_region
chr18	64058306	rs11152416	0.107	NR	NR	NR	1.55	1.55	SERPINB8	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	235	All women	LOAD	AD	intergenic_region
chr18	73391387	rs1943816	0.000000108	NR	C	C	NR	NA	NETO1	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF P-tau181p	Fluid biomarker	intergenic_region
chr18	73391387	rs1943816	0.00000015	NR	C	C	NR	NA	NETO1	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF P-tau181p	Fluid biomarker	intergenic_region
chr18	76997395	rs3794851	0.0000034	NR	C	C	1.05	2.85765	MBP	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	363	AD subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr18	76997395	rs3794851	0.0067	NR	C	C	0.36	1.43333	MBP	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	878	AD subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr18	76997395	rs3794851	0.93	NR	C	C	-0.01	0.99005	MBP	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	515	AD subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr18	78743253	rs9945493	0.000000171	NR	NR	NR	NR	NA	SALL3	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intergenic_region
chr18	78743253	rs9945493	0.000005	NR	NR	NR	0.33	0.33	SALL3	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intergenic_region
chr18	78743253	rs9945493	0.00000897	NR	NR	NR	NR	NA	SALL3	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intergenic_region
chr18	78743253	rs9945493	0.000263	NR	NR	NR	0.23	0.23	SALL3	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intergenic_region
chr18	78743253	rs9945493	0.000494	NR	NR	NR	NR	NA	SALL3	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intergenic_region
chr18	78743253	rs9945493	0.0104	NR	NR	NR	0.38	0.38	SALL3	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intergenic_region
chr18	78743253	rs9945493	0.914	NR	NR	NR	NR	NA	SALL3	SNP-based	Disease risk	21059989	Caucasian	ADGC	1390	Unrelated individuals	LOAD	AD	intergenic_region
chr18	78743253	rs9945493	0.94111	NR	NR	NR	NR	NA	SALL3	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intergenic_region
chr18	78743253	rs9945493	NA	NR	NR	NR	NR	NA	SALL3	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intergenic_region
chr18	79621649	rs12961169	0.0000116	GLIS1	NR	NR	0.05	1.05127	CTDP1	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	1527	Male subjects	CSF P-tau181p	Fluid biomarker	intergenic_region
chr18	79621649	rs12961169	0.0000137	GLIS1	T	T	0.04	1.04081	CTDP1	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	3146	All	CSF T-tau	Fluid biomarker	intergenic_region
chr18	79621649	rs12961169	0.0000358	GLIS1	NR	NR	0.05	1.05127	CTDP1	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	1509	Female subjects	CSF P-tau181p	Fluid biomarker	intergenic_region
chr18	79621649	rs12961169	0.0113	GLIS1	T	T	0.016	1.01613	CTDP1	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	3146	All	CSF Ab1-42	Fluid biomarker	intergenic_region
chr18	79621649	rs12961169	0.0934	GLIS1	T	T	0.12	1.1275	CTDP1	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	1530	All	AD Progression (based on CDR Score)	Cognitive	intergenic_region
chr18	79621649	rs12961169	0.193	GLIS1	T	T	1.03	2.80107	CTDP1	SNP-based	Disease risk	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	74046	All	AD risk	AD	intergenic_region
chr18	79621649	rs12961169	0.249	GLIS1	T	T	0.04	1.04081	CTDP1	SNP-based	Age at onset (AAO) / Survival	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	39855	AD subjects	Age at onset	Other	intergenic_region
chr18	79621649	rs12961169	5.12E-10	GLIS1	NR	NR	0.05	1.05127	CTDP1	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	3036	All	CSF P-tau181p	Fluid biomarker	intergenic_region
chr18	79621649	rs12961169	5.12E-10	GLIS1	T	T	0.05	1.05127	CTDP1	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	3146	All	CSF P-tau181p	Fluid biomarker	intergenic_region
chr19	1001778	rs115882880	6.34E-08	GRIN3B	A	A	1.55	1.55	GRIN3B	SNP-based	Disease risk	23571587	African American	ADGC	5896	All	LOAD	AD	intron_variant
chr19	1021628	rs117481827	0.00316	C19orf6	NR	NR	-0.09	NA	TMEM259	SNP-based	Age at onset (AAO) / Survival	28323831	Caucasian	ADGC	15795	All	Age of AD onset	Other	upstream_gene_variant
chr19	1031213	rs7247087	0.000000103	ABCA7	A	A	0.18	1.19722	CNN2	SNP-based	eQTL	22722634	Caucasian	MAYO	374	All subjects with Cerebellum data	ABCA7 (ILMN_1743205) expression in Cerebellar tissue (CER)	Expression	intron_variant
chr19	1031213	rs7247087	0.0000353	ABCA7	A	A	0.14	1.15027	CNN2	SNP-based	eQTL	22722634	Caucasian	MAYO	399	All subjects with Temporal Cortex data	ABCA7 (ILMN_1743205) expression in Temporal cortex (TCX)	Expression	intron_variant
chr19	1031213	rs7247087	NS	ABCA7	A	A	1.03	2.80107	CNN2	SNP-based	Disease risk	22722634	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr19	1039324	rs111278892	7.93E-11	INPPD5	G	G	6.5	NA	CNN2	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ, UKBB"	455258	All	AD + AD-by-proxy	AD	upstream_gene_variant
chr19	1044713	rs3764647	0.0087	ABCA7	G	G	1.32	1.32	ABCA7	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	missense_variant
chr19	1046521	rs3764650	0.00000025	ABCA7	NR	NR	NR	NA	ABCA7	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr19	1046521	rs3764650	0.00000026	ABCA7	NR	NR	1.22	1.22	ABCA7	SNP-based	Disease risk	21460840	Caucasian	"ADC, EADI, GERAD"	20373	All	AD	AD	intron_variant
chr19	1046521	rs3764650	0.00000029	ABCA7	NR	NR	1.22	1.22	ABCA7	SNP-based	Disease risk	21460840	Caucasian	"ADGC, CHARGE, EADI"	29544	All	AD	AD	intron_variant
chr19	1046521	rs3764650	0.000019	ABCA7	NR	NR	1.28	1.28	ABCA7	SNP-based	Disease risk	21460840	Caucasian	GERAD	9799	All	AD	AD	intron_variant
chr19	1046521	rs3764650	0.019	ABCA7	G	G	1.27	1.27	ABCA7	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr19	1046521	rs3764650	0.02	ABCA7	NR	NR	1.39	1.39	ABCA7	SNP-based	Endophenotype	26993346	Caucasian	Cohort from Europe	10840	All	PCA (posterior cortical atrophy)	Imaging	intron_variant
chr19	1046521	rs3764650	0.03	NR	G	G	0.18	1.19722	ABCA7	SNP-based	Endophenotype	23836404	Caucasian	ADGC	725	All	Neuritic Plaque Pathologic Burden	Neuropathology	intron_variant
chr19	1046521	rs3764650	0.0366	ABCA7	G	G	1.13	1.13	ABCA7	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	2024	All	LOAD	AD	intron_variant
chr19	1046521	rs3764650	4.50E-17	ABCA7	NR	NR	1.23	1.23	ABCA7	SNP-based	Disease risk	21460840	Caucasian	"ADGC, CHARGE, EADI, GERAD"	59716	All	AD	AD	intron_variant
chr19	1046521	rs3764650	5.00E-21	ABCA7	NR	NR	1.23	1.23	ABCA7	SNP-based	Disease risk	21460840	Caucasian	"ADGC, GERAD"	NR	All	AD	AD	intron_variant
chr19	1050131	rs7408475	0.0000501	ABCA7	NR	NR	0.18	NA	ABCA7	SNP-based	Age at onset (AAO) / Survival	28323831	Caucasian	ADGC	15795	All	Age of AD onset	Other	intron_variant
chr19	1050421	rs115550680	2.21E-09	ABCA7	G	G	1.79	1.79	ABCA7	SNP-based	Disease risk	23571587	African American	ADGC	5896	All	LOAD	AD	intron_variant
chr19	1053525	rs3752241	2.87E-08	ABCA7	G	G	NR	NA	ABCA7	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	synonymous_variant
chr19	1056493	rs3752246	0.000000047	ABCA7	G	G	1.18	1.18	ABCA7	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	18845	All	Clinically diagnosed LOAD	AD	missense_variant
chr19	1056493	rs3752246	0.000000497	ABCA7	G	G	1.15	1.15	ABCA7	SNP-based	Disease risk	21460841	Caucasian	ADGC	22771	All	LOAD	AD	missense_variant
chr19	1056493	rs3752246	0.000000579	ABCA7	G	G	1.15	1.15	ABCA7	SNP-based	Disease risk	21460841	Caucasian	ADGC	22771	All	LOAD	AD	missense_variant
chr19	1056493	rs3752246	0.0000102	ABCA7	G	G	1.16	1.16	ABCA7	SNP-based	Disease risk	21460841	Caucasian	ADGC	15675	All	LOAD	AD	missense_variant
chr19	1056493	rs3752246	0.0000193	ABCA7	G	G	1.15	1.15	ABCA7	SNP-based	Disease risk	21460841	Caucasian	ADGC	15675	All	LOAD	AD	missense_variant
chr19	1056493	rs3752246	0.0027	ABCA7	NR	NR	1.11	1.11	ABCA7	SNP-based	Disease risk	30448613	Caucasian	ADGC	15330	All	AD	AD	missense_variant
chr19	1056493	rs3752246	0.00907	ABCA7	G	G	1.13	1.13	ABCA7	SNP-based	Disease risk	21460841	Caucasian	ADGC	7096	All	LOAD	AD	missense_variant
chr19	1056493	rs3752246	0.0123	ABCA7	G	G	1.13	1.13	ABCA7	SNP-based	Disease risk	21460841	Caucasian	ADGC	7096	All	LOAD	AD	missense_variant
chr19	1056493	rs3752246	0.242	ABCA7 	G	G	-0.19	0.826959	ABCA7	SNP-based	Age at onset (AAO) / Survival	25199842	Caucasian	ADGC	9162	LOAD subjects	Age of AD onset	Other	missense_variant
chr19	1056493	rs3752246	0.375	ABCA7	G	G	0.82	0.82	ABCA7	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	missense_variant
chr19	1056493	rs3752246	0.7	ABCA7 	G	G	-0.27	0.763379	ABCA7	SNP-based	Age at onset (AAO) / Survival	25199842	Caucasian	ADGC	9162	LOAD subjects	Age of AD onset	Other	missense_variant
chr19	1056493	rs3752246	3.10E-16	ABCA7	G	G	1.15	1.15	ABCA7	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	82771	All	Clinically diagnosed LOAD	AD	missense_variant
chr19	1056493	rs3752246	3.98E-09	ABCA7	NR	NR	-0.25	NA	ABCA7	SNP-based	Age at onset (AAO) / Survival	28323831	Caucasian	ADGC	15795	All	Age of AD onset	Other	missense_variant
chr19	1056493	rs3752246	6.60E-10	ABCA7	G	G	1.13	1.13	ABCA7	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	63926	All	Clinically diagnosed LOAD	AD	missense_variant
chr19	1063444	rs4147929	0.000000099	ABCA7	A	A	1.17	1.17	ABCA7	SNP-based	Disease risk	24162737	Caucasian	Cohorts from Europe and USA	19884	All	LOAD	AD	intron_variant
chr19	1063444	rs4147929	0.00000394	ABCA7	NR	NR	0.259	1.29563	ABCA7	SNP-based	eQTL	30448613	Caucasian	UKBEC	49	All	EID2B (t3862068) expression in frontal cortex	Expression	intron_variant
chr19	1063444	rs4147929	0.0011	POLR2E	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	POLR2E (3844957) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr19	1063444	rs4147929	0.00139	ABCA7	NR	NR	1.12	1.12	ABCA7	SNP-based	Disease risk	30448613	Caucasian	ADGC	15330	All	AD	AD	intron_variant
chr19	1063444	rs4147929	0.0018	POLR2E	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	POLR2E (t3844952) expression in thalamus (THAL)	Expression	intron_variant
chr19	1063444	rs4147929	0.0037	POLR2E	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	POLR2E (t3844952) expression in temporal cortex (TCTX)	Expression	intron_variant
chr19	1063444	rs4147929	0.005	SBNO2	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	SBNO2 (t3844978) expression in substantia nigra (SNIG)	Expression	intron_variant
chr19	1063444	rs4147929	0.0088	POLR2E	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	POLR2E (3844969) expression in putamen (PUTM)	Expression	intron_variant
chr19	1063444	rs4147929	0.01	ABCA7	A	A	1.32	1.32	ABCA7	SNP-based	Endophenotype	25188341	Caucasian	ADGC	3702	All	Clinico-pathologic AD dementia (with neuropathologist documentation)	Neuropathology	intron_variant
chr19	1063444	rs4147929	0.014	ABCA7	A	A	1.24	1.24	ABCA7	SNP-based	Endophenotype	25188341	Caucasian	ADGC	4914	All	Clinico-pathologic AD dementia (No neuropathologist documentation)	Neuropathology	intron_variant
chr19	1063444	rs4147929	0.02	POLR2E	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	POLR2E (3844957) expression in hippocampus (HIPP)	Expression	intron_variant
chr19	1063444	rs4147929	0.05	POLR2E	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	POLR2E (3844957) expression in temporal cortex (TCTX)	Expression	intron_variant
chr19	1063444	rs4147929	0.06	POLR2E	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	POLR2E (t3844952) expression in frontal cortex (FCTX)	Expression	intron_variant
chr19	1063444	rs4147929	0.06	POLR2E	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	POLR2E (t3844952) expression in putamen (PUTM)	Expression	intron_variant
chr19	1063444	rs4147929	0.18	POLR2E	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	POLR2E (3844969) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr19	1063444	rs4147929	0.2	POLR2E	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	POLR2E (3844969) expression in occipital cortex (OCTX)	Expression	intron_variant
chr19	1063444	rs4147929	0.22	POLR2E	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	POLR2E (t3844952) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr19	1063444	rs4147929	0.23	SBNO2	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	SBNO2 (t3844978) expression in medulla (MEDU)	Expression	intron_variant
chr19	1063444	rs4147929	0.26	POLR2E	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	POLR2E (3844969) expression in temporal cortex (TCTX)	Expression	intron_variant
chr19	1063444	rs4147929	0.3	POLR2E	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	POLR2E (3844969) expression in substantia nigra (SNIG)	Expression	intron_variant
chr19	1063444	rs4147929	0.3	SBNO2	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	SBNO2 (t3844978) expression in hippocampus (HIPP)	Expression	intron_variant
chr19	1063444	rs4147929	0.32	POLR2E	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	POLR2E (3844957) expression in thalamus (THAL)	Expression	intron_variant
chr19	1063444	rs4147929	0.42	SBNO2	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	SBNO2 (t3844978) expression in occipital cortex (OCTX)	Expression	intron_variant
chr19	1063444	rs4147929	0.44	POLR2E	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	POLR2E (3844969) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr19	1063444	rs4147929	0.52	POLR2E	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	POLR2E (t3844952) expression in medulla (MEDU)	Expression	intron_variant
chr19	1063444	rs4147929	0.52	POLR2E	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	POLR2E (t3844952) expression in occipital cortex (OCTX)	Expression	intron_variant
chr19	1063444	rs4147929	0.57	POLR2E	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	POLR2E (3844957) expression in substantia nigra (SNIG)	Expression	intron_variant
chr19	1063444	rs4147929	0.61	POLR2E	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	POLR2E (3844957) expression in frontal cortex (FCTX)	Expression	intron_variant
chr19	1063444	rs4147929	0.65	POLR2E	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	POLR2E (3844957) expression in putamen (PUTM)	Expression	intron_variant
chr19	1063444	rs4147929	0.67	POLR2E	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	POLR2E (3844969) expression in medulla (MEDU)	Expression	intron_variant
chr19	1063444	rs4147929	0.68	SBNO2	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	SBNO2 (t3844978) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr19	1063444	rs4147929	0.7	SBNO2	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	SBNO2 (t3844978) expression in putamen (PUTM)	Expression	intron_variant
chr19	1063444	rs4147929	0.71	POLR2E	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	POLR2E (t3844952) expression in hippocampus (HIPP)	Expression	intron_variant
chr19	1063444	rs4147929	0.71	POLR2E	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	POLR2E (t3844952) expression in substantia nigra (SNIG)	Expression	intron_variant
chr19	1063444	rs4147929	0.74	SBNO2	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	SBNO2 (t3844978) expression in frontal cortex (FCTX)	Expression	intron_variant
chr19	1063444	rs4147929	0.76	SBNO2	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	SBNO2 (t3844978) expression in thalamus (THAL)	Expression	intron_variant
chr19	1063444	rs4147929	0.79	POLR2E	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	POLR2E (3844957) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr19	1063444	rs4147929	0.8	SBNO2	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	SBNO2 (t3844978) expression in temporal cortex (TCTX)	Expression	intron_variant
chr19	1063444	rs4147929	0.89	SBNO2	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	SBNO2 (t3844978) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr19	1063444	rs4147929	0.91	POLR2E	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	POLR2E (3844969) expression in frontal cortex (FCTX)	Expression	intron_variant
chr19	1063444	rs4147929	0.91	POLR2E	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	POLR2E (3844969) expression in hippocampus (HIPP)	Expression	intron_variant
chr19	1063444	rs4147929	0.91	POLR2E	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	POLR2E (3844969) expression in thalamus (THAL)	Expression	intron_variant
chr19	1063444	rs4147929	0.91	POLR2E	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	POLR2E (t3844952) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr19	1063444	rs4147929	0.93	POLR2E	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	POLR2E (3844957) expression in occipital cortex (OCTX)	Expression	intron_variant
chr19	1063444	rs4147929	1	POLR2E	NR	NR	NR	NA	ABCA7	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	POLR2E (3844957) expression in medulla (MEDU)	Expression	intron_variant
chr19	1063444	rs4147929	1.10E-15	ABCA7	A	A	1.15	1.15	ABCA7	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD, Cohorts from Europe and USA"	74046	All	LOAD	AD	intron_variant
chr19	1063444	rs4147929	1.70E-09	ABCA7	A	A	1.14	1.14	ABCA7	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD"	54162	All	LOAD	AD	intron_variant
chr19	1063444	rs4147929	8.64E-09	ABCA7	G	G	NR	NA	ABCA7	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ"	79145	All	AD	AD	intron_variant
chr19	1063444	rs4147929	NR	ABCA7	A	A	1.66	1.66	ABCA7	SNP-based	Disease risk	27849641	Caucasian	ADGC	589	All	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr19	1063444	rs4147929	NR	ZCWPW1	A	A	1.25	1.25	ABCA7	SNP-based	Disease risk	27849641	Caucasian	ADGC	292	APOE-e4 carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr19	1063444	rs4147929	NR	ZCWPW1	A	A	1.81	1.81	ABCA7	SNP-based	Disease risk	27849641	Caucasian	ADGC	297	APOE-e4 non-carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr19	1065946	rs2242436	0.0441	ABCA7	A	A	0.84	NA	ARHGAP45	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	5_prime_UTR_premature_start_codon_gain_variant
chr19	1073074	rs2072102	0.00000357	ABCA7	A	A	0.15	1.16183	ARHGAP45	SNP-based	eQTL	22722634	Caucasian	MAYO	374	All subjects with Cerebellum data	ABCA7 (ILMN_1743205) expression in Cerebellar tissue (CER)	Expression	intron_variant
chr19	1073074	rs2072102	0.0000674	ABCA7	A	A	1.11	3.03436	ARHGAP45	SNP-based	Disease risk	22722634	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr19	1073074	rs2072102	0.00112	ABCA7	A	A	0.11	1.11628	ARHGAP45	SNP-based	eQTL	22722634	Caucasian	MAYO	399	All subjects with Temporal Cortex data	ABCA7 (ILMN_1743205) expression in Temporal cortex (TCX)	Expression	intron_variant
chr19	1075980	rs757232	0.00000262	ABCA7	A	A	0.15	1.16183	ARHGAP45	SNP-based	eQTL	22722634	Caucasian	MAYO	374	All subjects with Cerebellum data	ABCA7 (ILMN_1743205) expression in Cerebellar tissue (CER)	Expression	intron_variant
chr19	1075980	rs757232	0.0000625	ABCA7	A	A	1.11	3.03436	ARHGAP45	SNP-based	Disease risk	22722634	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr19	1075980	rs757232	0.00161	ABCA7	A	A	0.1	1.10517	ARHGAP45	SNP-based	eQTL	22722634	Caucasian	MAYO	399	All subjects with Temporal Cortex data	ABCA7 (ILMN_1743205) expression in Temporal cortex (TCX)	Expression	intron_variant
chr19	1082845	rs115553053	3.14E-08	HMHA1	T	T	1.86	1.86	ARHGAP45	SNP-based	Disease risk	23571587	African American	ADGC	5896	All	LOAD	AD	synonymous_variant
chr19	1207239	rs3764640	0.00000788	STK11	NR	NR	0.68	0.68	STK11	SNP-based	Disease risk	22005930	Caucasian	"ADGC, GERAD"	2034	AD+P and AD-P subjects	AD+Psychosis	ADRD	intron_variant
chr19	1400867	rs3786974	0.0264	GAMT	T	T	NR	NA	GAMT	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	intron_variant
chr19	1400867	rs3786974	1.35E-18	NR	T	T	NR	NA	GAMT	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	GAMT (ILMN_1756469) expression	Expression	intron_variant
chr19	1400867	rs3786974	5.93E-09	NR	T	T	NR	NA	GAMT	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	GAMT (ILMN_1794595) expression	Expression	intron_variant
chr19	3405594	rs9749589	0.0025	NR	NR	NR	1.17	1.17	NFIC	SNP-based	Disease risk	28183528	Multi-ethnic	ADGC	33269	All	AD	AD	intron_variant
chr19	3405594	rs9749589	0.0033	NR	NR	NR	1.1	1.1	NFIC	SNP-based	Disease risk	28183528	Multi-ethnic	"ADGC, IGAP"	59556	All	AD	AD	intron_variant
chr19	3405594	rs9749589	0.5	NR	NR	NR	1.04	1.04	NFIC	SNP-based	Disease risk	28183528	Caucasian	IGAP	26287	All	AD	AD	intron_variant
chr19	3647903	rs12984273	0.00271	CACTIN	T	T	NR	NA	PIP5K1C	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	intron_variant
chr19	3647903	rs12984273	1.30E-21	NR	T	T	NR	NA	PIP5K1C	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	CACTIN (ENSG00000105298) expression	Expression	intron_variant
chr19	6614651	rs61111347	0.63	NR	A	A	-0.08	0.923116	CD70	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	515	AD subjects	CSF P-tau181p	Fluid biomarker	intergenic_region
chr19	6636828	rs149933701	0.0000016	NR	C	C	10.68	43477.6	TNFSF14	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	363	AD subjects	CSF P-tau181p	Fluid biomarker	intergenic_region
chr19	6636828	rs149933701	0.008	NR	C	C	0.36	1.43333	TNFSF14	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	878	AD subjects	CSF P-tau181p	Fluid biomarker	intergenic_region
chr19	10284116	rs1799969	0.00000103	ICAM1	NR	NR	-0.08	0.923116	ICAM1	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	ADNI	521	All	Plasma ICAM-1	Fluid biomarker	missense_variant
chr19	17631660	rs4239633	0.00000198	UNC13A	NR	NR	NR	NA	UNC13A	SNP-based	Cross phenotype 	29630712	Caucasian	"ALS group, IGAP, FTGC, AFTD, PSP Genetics Consortium, IPDGC"	36052	All	AD	AD	intron_variant
chr19	17631660	rs4239633	0.001	UNC13A	NR	NR	NR	NA	UNC13A	SNP-based	Cross phenotype 	29630712	Caucasian	UKBEC	NR	All	ELL expression in brain	Expression	intron_variant
chr19	18422832	rs7258465	0.0000326	SSBP4	T	T	NR	NA	SSBP4	SNP-based	Cross phenotype 	27088644	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr19	18422832	rs7258465	0.000126	"DKFZp586K0821, NDUFS3"	T	T	NR	NA	SSBP4	SNP-based	Cross phenotype 	27088644	Caucasian	Cohort of Immune-Mediated Diseases	16559	All	Type 1 diabetes (T1D)	Non-ADRD	intron_variant
chr19	19250926	rs1064395	0.25	NCAN	NR	NR	1.08	1.08	NCAN	SNP-based	Cross phenotype 	22005930	Caucasian	"ADGC, GERAD, Cohort from UK"	6958	AD+P and control subjects	AD+Psychosis	ADRD	3_prime_UTR_variant
chr19	19250926	rs1064395	0.29	NCAN	NR	NR	1.1	1.1	NCAN	SNP-based	Cross phenotype 	22005930	Caucasian	"ADGC, GERAD"	2034	AD+P and AD-P subjects	AD+Psychosis	ADRD	3_prime_UTR_variant
chr19	29245435	rs11083866	0.00000538	LOC400794	NR	NR	114.77	69819653317255026275047162222818561392730781515776	UQCRFS1	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	intergenic_region
chr19	29245435	rs11083866	0.00074	LOC400794	A	A	114.32	44518976491554210011864262016132115227552656654336	UQCRFS1	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intergenic_region
chr19	29245435	rs11083866	0.0016	LOC400794	A	A	NR	NA	UQCRFS1	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intergenic_region
chr19	29245435	rs11083866	0.0023	LOC400794	A	A	115.32	121015124818587235646718167356365894143602696650752	UQCRFS1	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	intergenic_region
chr19	33161450	rs11084710	0.000045	WDR88	NR	NR	2.43	2.43	WDR88	SNP-based	Disease risk	21098978	Arab	Cohort from Israeli	266	All	AD	AD	intron_variant
chr19	33818627	rs29941	0.155	NR	G	G	0.968	0.968	KCTD15	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	downstream_gene_variant
chr19	33818627	rs29941	0.65	NR	G	G	0.983	0.983	KCTD15	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	downstream_gene_variant
chr19	33818627	rs29941	0.731	NR	G	G	0.98	0.98	KCTD15	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	downstream_gene_variant
chr19	33818627	rs29941	0.907	NR	G	G	0	1	KCTD15	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	downstream_gene_variant
chr19	34165501	rs587259	0.0002	LSM14A	T	T	NR	NA	LSM14A	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intergenic_region
chr19	34165501	rs587259	0.00028	LSM14A	T	T	NR	NA	LSM14A	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intergenic_region
chr19	34165501	rs587259	0.0009	LSM14A	T	T	NR	NA	LSM14A	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intergenic_region
chr19	35534023	rs4806173	0.509	GAPDHS	G	G	0.95	0.95	GAPDHS	SNP-based	Disease risk	20534741	Caucasian	"ADC, UM"	1610	All	AD	AD	intron_variant
chr19	35658859	rs4806187	1.02E-35	UPK1A	NR	NR	-0.72	0.486752	COX6B1	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	UPK1A expression in Temporal cortex	Expression	splice_region_variant
chr19	35658859	rs4806187	1.25E-59	UPK1A	NR	NR	-1.04	0.353455	COX6B1	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	UPK1A expression in Cerebellar	Expression	splice_region_variant
chr19	35658859	rs4806187	2.55E-32	UPK1A	NR	NR	-1.05	0.349938	COX6B1	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	UPK1A expression in Cerebellar	Expression	splice_region_variant
chr19	35658859	rs4806187	3.05E-21	UPK1A	NR	NR	-0.99	0.371577	COX6B1	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	UPK1A expression in Cerebellar	Expression	splice_region_variant
chr19	43988990	rs393195	0.0002	ZNF155	G	G	NR	NA	ZNF155	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr19	43988990	rs393195	0.00071	ZNF155	G	G	NR	NA	ZNF155	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intron_variant
chr19	43988990	rs393195	0.0147	ZNF155	G	G	NR	NA	ZNF155	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr19	44095462	rs4459653	0.000008	ZNF224	NR	NR	NR	NA	ZNF224	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	intron_variant
chr19	44096224	rs4802207	0.00000923	ZNF224	NR	NR	NR	NA	ZNF224	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	5_prime_UTR_variant
chr19	44107267	rs4508518	0.00000195	ZNF224	NR	NR	NR	NA	ZNF224	SNP-based	Disease risk	19118814	Caucasian	"CAP, Reiman et al.(2007)"	NR	All	LOAD	AD	missense_variant
chr19	44107267	rs4508518	0.0000437	ZNF224	NR	NR	NR	NA	ZNF224	SNP-based	Disease risk	19118814	Caucasian	Reiman et al.(2007)	NR	All	LOAD	AD	missense_variant
chr19	44107267	rs4508518	0.0263	ZNF224	NR	NR	NR	NA	ZNF224	SNP-based	Disease risk	19118814	Caucasian	CAP	458	All	LOAD	AD	missense_variant
chr19	44108078	rs3746319	0.00000301	ZNF224	NR	NR	NR	NA	ZNF224	SNP-based	Disease risk	19118814	Caucasian	"CAP, Reiman et al.(2007)"	NR	All	LOAD	AD	missense_variant
chr19	44108078	rs3746319	0.0000296	ZNF224	NR	NR	NR	NA	ZNF224	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	missense_variant
chr19	44108078	rs3746319	0.0000605	ZNF224	NR	NR	NR	NA	ZNF224	SNP-based	Disease risk	19118814	Caucasian	CAP	458	All	LOAD	AD	missense_variant
chr19	44108078	rs3746319	0.0233	ZNF224	NR	NR	NR	NA	ZNF224	SNP-based	Disease risk	19118814	Caucasian	Reiman et al.(2007)	NR	All	LOAD	AD	missense_variant
chr19	44109508	rs2061332	0.00000491	ZNF224	NR	NR	NR	NA	ZNF224	SNP-based	Disease risk	19118814	Caucasian	"CAP, Reiman et al.(2007)"	NR	All	LOAD	AD	intron_variant
chr19	44109508	rs2061332	0.0000393	ZNF224	NR	NR	NR	NA	ZNF224	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	intron_variant
chr19	44109508	rs2061332	0.0000619	ZNF224	NR	NR	NR	NA	ZNF224	SNP-based	Disease risk	19118814	Caucasian	CAP	458	All	LOAD	AD	intron_variant
chr19	44109508	rs2061332	0.0379	ZNF224	NR	NR	NR	NA	ZNF224	SNP-based	Disease risk	19118814	Caucasian	Reiman et al.(2007)	NR	All	LOAD	AD	intron_variant
chr19	44110055	rs2061333	0.00000151	ZNF224	NR	NR	NR	NA	ZNF224	SNP-based	Disease risk	19118814	Caucasian	"CAP, Reiman et al.(2007)"	NR	All	LOAD	AD	intron_variant
chr19	44110055	rs2061333	0.0000251	ZNF224	NR	NR	NR	NA	ZNF224	SNP-based	Disease risk	19118814	Caucasian	Reiman et al.(2007)	NR	All	LOAD	AD	intron_variant
chr19	44110055	rs2061333	0.0175	ZNF224	NR	NR	NR	NA	ZNF224	SNP-based	Disease risk	19118814	Caucasian	CAP	458	All	LOAD	AD	intron_variant
chr19	44129800	rs10406335	0.0003	ZNF225	G	G	NR	NA	ZNF225	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr19	44129800	rs10406335	0.0009	ZNF225	G	G	NR	NA	ZNF225	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr19	44129800	rs10406335	0.0039	ZNF225	G	G	NR	NA	ZNF225	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intron_variant
chr19	44547413	rs17714718	1.48E-08	CEACAM22P	NR	NR	NR	NA	CEACAM20	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	non_coding_transcript_exon_variant
chr19	44570931	rs846848	0.00000252	"CEACAM22P, LOC147710"	NR	NR	NR	NA	CEACAM20	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr19	44642803	rs7255066	5.27E-10	PVR	NR	NR	NR	NA	PVR	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr19	44662645	rs714948	2.03E-10	PVR	A	A	1.6	1.6	PVR	SNP-based	Disease risk	24755620	Caucasian	ADGC	4569	All	AD	AD	3_prime_UTR_variant
chr19	44662645	rs714948	6.26E-13	PVR	NR	NR	NR	NA	PVR	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	3_prime_UTR_variant
chr19	44698757	rs12150984	2.12E-09	CEACAM16	NR	NR	NR	NA	CEACAM16	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr19	44722081	rs2965109	0.0027	"BCL3, CEACAM16"	T	T	0.92	0.92	CEACAM16	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	AD	AD	upstream_gene_variant
chr19	44722081	rs2965109	0.0027	CEACAM16/BCL3	T	T	NR	NA	CEACAM16	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	AD	AD	upstream_gene_variant
chr19	44722081	rs2965109	0.04	CEACAM16/BCL3	T	T	NR	NA	CEACAM16	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	AD	AD	upstream_gene_variant
chr19	44722081	rs2965109	0.042	"BCL3, CEACAM16"	T	T	0.94	0.94	CEACAM16	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	AD	AD	upstream_gene_variant
chr19	44724478	rs7254776	0.0036	"BCL3, CEACAM16"	T	T	1.08	1.08	CEACAM16	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	AD	AD	downstream_gene_variant
chr19	44724478	rs7254776	0.0036	CEACAM16/BCL3	T	T	NR	NA	CEACAM16	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	AD	AD	downstream_gene_variant
chr19	44724478	rs7254776	0.12	"BCL3, CEACAM16"	T	T	1.04	1.04	CEACAM16	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	AD	AD	downstream_gene_variant
chr19	44724478	rs7254776	0.12	CEACAM16/BCL3	T	T	NR	NA	CEACAM16	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	AD	AD	downstream_gene_variant
chr19	44728212	rs2927488	0.00000286	NR	A	A	NR	NA	CEACAM16	SNP-based	Disease risk	21390209	Caucasian	"ADNI, GenADA, Pfizer"	3595	All	AD	AD	upstream_gene_variant
chr19	44734556	rs2965101	0.00000209	NR	C	C	NR	NA	BCL3	SNP-based	Disease risk	21390209	Caucasian	"ADNI, GenADA, Pfizer"	3595	All	AD	AD	intergenic_region
chr19	44734556	rs2965101	0.0055	"BCL3, CEACAM16"	T	T	1.07	1.07	BCL3	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	AD	AD	intergenic_region
chr19	44734556	rs2965101	0.0055	CEACAM16/BCL3	T	T	NR	NA	BCL3	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	AD	AD	intergenic_region
chr19	44734556	rs2965101	0.2	"BCL3, CEACAM16"	T	T	1.03	1.03	BCL3	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	AD	AD	intergenic_region
chr19	44734556	rs2965101	0.2	CEACAM16/BCL3	T	T	NR	NA	BCL3	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	AD	AD	intergenic_region
chr19	44738850	rs2927438	0.000000332	NR	A	A	1.35	1.35	BCL3	SNP-based	Disease risk	24755620	Caucasian	ADGC	4569	All	AD	AD	intergenic_region
chr19	44738850	rs2927438	5.69E-29	BCL3	NR	NR	NR	NA	BCL3	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr19	44738916	rs1531517	5.83E-12	"CEACAM16, BCL3"	NR	NR	NR	NA	BCL3	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr19	44744370	rs4803750	0.008	BCL3	NR	NR	-0.02	0.980199	BCL3	SNP-based	Endophenotype	30805717	Caucasian	MAGIC	51750	All	Fasting Insulin	Fluid biomarker	upstream_gene_variant
chr19	44744370	rs4803750	9.04E-13	BCL3	NR	NR	-0.24	0.786628	BCL3	SNP-based	Endophenotype	30805717	Caucasian	IGAP	54162	All	AD	AD	upstream_gene_variant
chr19	44749847	rs8100239	1.50E-22	BCL3	NR	NR	NR	NA	BCL3	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr19	44750911	rs8103315	1.87E-08	BCL3	A	A	1.5	1.5	BCL3	SNP-based	Disease risk	24755620	Caucasian	ADGC	4569	All	AD	AD	intron_variant
chr19	44810458	rs2927477	4.04E-11	BCAM	NR	NR	NR	NA	BCAM	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr19	44823407	rs10405693	2.83E-12	BCAM	T	T	1.49	1.49	BCAM	SNP-based	Disease risk	24755620	Caucasian	ADGC	4569	All	AD	AD	downstream_gene_variant
chr19	44825957	rs10402271	0.000000147	NR	G	G	NR	NA	BCAM	SNP-based	Disease risk	21390209	Caucasian	"ADNI, GenADA, Pfizer"	3595	All	AD	AD	downstream_gene_variant
chr19	44825957	rs10402271	0.000000214	NR	C	C	1.26	1.26	BCAM	SNP-based	Disease risk	20885792	Caucasian	"ADGC, CAP, CHARGE"	4355	All	LOAD	AD	downstream_gene_variant
chr19	44825957	rs10402271	0.000000726	NR	C	C	1.39	1.39	BCAM	SNP-based	Disease risk	20885792	Caucasian	"CAP, MSBB, NCRAD"	2035	All	LOAD	AD	downstream_gene_variant
chr19	44825957	rs10402271	0.000277	NR	C	C	1.23	1.23	BCAM	SNP-based	Disease risk	20885792	Caucasian	"ADGC, CAP, CHARGE"	2979	All	LOAD	AD	downstream_gene_variant
chr19	44825957	rs10402271	1.98E-17	BCAM	G	G	1.46	1.46	BCAM	SNP-based	Disease risk	24755620	Caucasian	ADGC	4569	All	AD	AD	downstream_gene_variant
chr19	44848259	rs41289512	2.70E-194	APOE	G	G	NR	NA	NECTIN2	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ"	79145	All	AD	AD	intron_variant
chr19	44848259	rs41289512	5.79E-276	APOE	G	G	35.5	NA	NECTIN2	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ, UKBB"	455258	All	AD + AD-by-proxy	AD	intron_variant
chr19	44848489	rs1871047	0.000000487	PVRL2	G	G	0.79	0.79	NECTIN2	SNP-based	Disease risk	24755620	Caucasian	ADGC	4569	All	AD	AD	intron_variant
chr19	44848489	rs1871047	2.20E-18	PVRL2	NR	NR	NR	NA	NECTIN2	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr19	44857967	rs440277	0.000000479	PVRL2	A	A	0.76	0.76	NECTIN2	SNP-based	Disease risk	24755620	Caucasian	ADGC	4569	All	AD	AD	intron_variant
chr19	44859410	rs377702	0.000000199	PVRL2	A	A	1.29	1.29	NECTIN2	SNP-based	Disease risk	24755620	Caucasian	ADGC	4569	All	AD	AD	intron_variant
chr19	44875803	rs387976	4.39E-12	PVRL2	NR	NR	NR	NA	NECTIN2	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr19	44876534	rs11667640	1.12E-09	PVRL2	NR	NR	NR	NA	NECTIN2	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr19	44878777	rs6859	0.000000096	PVRL2	A	A	1.41	1.41	NECTIN2	SNP-based	Disease risk	20885792	Caucasian	"ADGC, CAP, CHARGE"	4355	All	LOAD	AD	3_prime_UTR_variant
chr19	44878777	rs6859	0.000000106	PVRL2	A	A	1.41	1.41	NECTIN2	SNP-based	Disease risk	20885792	Caucasian	"CAP, MSBB, NCRAD"	2035	All	LOAD	AD	3_prime_UTR_variant
chr19	44878777	rs6859	0.000000539	PVRL2	A	A	1.58	1.58	NECTIN2	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	3_prime_UTR_variant
chr19	44878777	rs6859	0.0000006	PVRL2	A	A	NR	NA	NECTIN2	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	3_prime_UTR_variant
chr19	44878777	rs6859	0.00000613	PVRL2	A	A	1.7	1.7	NECTIN2	SNP-based	Disease risk	20885792	Caucasian	"ADGC, CAP, CHARGE"	2979	All	LOAD	AD	3_prime_UTR_variant
chr19	44878777	rs6859	0.0000287	PVRL2	A	A	1.4	NA	NECTIN2	SNP-based	Age at onset (AAO) / Survival	29107063	Multi-ethnic	CHARGE	5018	All	Age at onset	Other	3_prime_UTR_variant
chr19	44878777	rs6859	0.0000534	PVRL2	A	A	1.4	1.4	NECTIN2	SNP-based	Disease risk	29107063	Multi-ethnic	CHARGE	5018	All	AD	AD	3_prime_UTR_variant
chr19	44878777	rs6859	0.0087	PVRL2	A	A	1.3	1.3	NECTIN2	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	3_prime_UTR_variant
chr19	44878777	rs6859	0.042	PVRL2	NR	NR	NR	NA	NECTIN2	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	3_prime_UTR_variant
chr19	44878777	rs6859	1.12E-18	PVRL2	A	A	1.7	1.7	NECTIN2	SNP-based	Disease risk	29107063	Multi-ethnic	ADGC	4561	All	AD	AD	3_prime_UTR_variant
chr19	44878777	rs6859	1.48E-10	NR	A	A	NR	NA	NECTIN2	SNP-based	Disease risk	21390209	Caucasian	"ADNI, GenADA, Pfizer"	3595	All	AD	AD	3_prime_UTR_variant
chr19	44878777	rs6859	1.73E-10	PVRL2	A	A	NR	NA	NECTIN2	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	3_prime_UTR_variant
chr19	44878777	rs6859	3.31E-96	PVRL2	NR	NR	NR	NA	NECTIN2	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	3_prime_UTR_variant
chr19	44878777	rs6859	6.09E-14	PVRL2	A	A	NR	NA	NECTIN2	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	3_prime_UTR_variant
chr19	44878777	rs6859	6.90E-41	APOE	NR	NR	1.46	1.46	NECTIN2	SNP-based	Disease risk	19734902	Caucasian	Cohorts from Europe and USA	11789	All	AD	AD	3_prime_UTR_variant
chr19	44878777	rs6859	7.87E-28	PVRL2	A	A	1.7	1.7	NECTIN2	SNP-based	Disease risk	24755620	Caucasian	ADGC	4569	All	AD	AD	3_prime_UTR_variant
chr19	44879804	rs3852861	0.0000599	TOMM40	T	T	0.64	0.64	NECTIN2	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr19	44879804	rs3852861	0.038	TOMM40	T	T	0.78	0.78	NECTIN2	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr19	44879804	rs3852861	5.32E-11	PVRL2	T	T	0.64	0.64	NECTIN2	SNP-based	Disease risk	24755620	Caucasian	ADGC	4569	All	AD	AD	intron_variant
chr19	44882502	rs3745150	0.0036	PVRL2	C	C	1.11	1.11	NECTIN2	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr19	44882502	rs3745150	0.005	PVRL2	C	C	NR	NA	NECTIN2	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr19	44882502	rs3745150	0.42	PVRL2	C	C	1.03	1.03	NECTIN2	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr19	44882502	rs3745150	0.42	PVRL2	C	C	NR	NA	NECTIN2	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr19	44884202	rs12972156	0.00000153	NR	NR	NR	NR	NA	NECTIN2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr19	44884202	rs12972156	0.00000495	PVRL2	NR	NR	NR	NA	NECTIN2	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intron_variant
chr19	44884202	rs12972156	0.0000672	NR	NR	NR	NR	NA	NECTIN2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44884202	rs12972156	0.00837	NR	NR	NR	NR	NA	NECTIN2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr19	44884202	rs12972156	0.00926	NR	NR	NR	NR	NA	NECTIN2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44884202	rs12972156	1.10E-09	NR	NR	NR	NR	NA	NECTIN2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr19	44884202	rs12972156	1.21E-10	NR	NR	NR	NR	NA	NECTIN2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44884202	rs12972156	2.31E-15	PVRL2	NR	NR	NR	NA	NECTIN2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44884202	rs12972156	3.03E-15	PVRL2	NR	NR	NR	NA	NECTIN2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr19	44884202	rs12972156	6.35E-37	PVRL2	NR	NR	NR	NA	NECTIN2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF Ab1-42	Fluid biomarker	intron_variant
chr19	44884339	rs12972970	0.00000104	NR	NR	NR	NR	NA	NECTIN2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr19	44884339	rs12972970	0.00000324	PVRL2	NR	NR	NR	NA	NECTIN2	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intron_variant
chr19	44884339	rs12972970	0.0000996	NR	NR	NR	NR	NA	NECTIN2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44884339	rs12972970	0.00974	NR	NR	NR	NR	NA	NECTIN2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr19	44884339	rs12972970	0.0125	NR	NR	NR	NR	NA	NECTIN2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44884339	rs12972970	1.28E-15	PVRL2	NR	NR	NR	NA	NECTIN2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44884339	rs12972970	3.74E-40	PVRL2	NR	NR	NR	NA	NECTIN2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF Ab1-42	Fluid biomarker	intron_variant
chr19	44884339	rs12972970	5.94E-10	NR	NR	NR	NR	NA	NECTIN2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr19	44884339	rs12972970	7.83E-11	NR	NR	NR	NR	NA	NECTIN2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44884339	rs12972970	8.24E-16	PVRL2	NR	NR	NR	NA	NECTIN2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr19	44884873	rs34342646	0.00000104	NR	NR	NR	NR	NA	NECTIN2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr19	44884873	rs34342646	0.00000302	PVRL2	NR	NR	NR	NA	NECTIN2	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intron_variant
chr19	44884873	rs34342646	0.0000936	NR	NR	NR	NR	NA	NECTIN2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44884873	rs34342646	0.00958	NR	NR	NR	NR	NA	NECTIN2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr19	44884873	rs34342646	0.0125	NR	NR	NR	NR	NA	NECTIN2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44884873	rs34342646	1.17E-15	PVRL2	NR	NR	NR	NA	NECTIN2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44884873	rs34342646	4.17E-40	PVRL2	NR	NR	NR	NA	NECTIN2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF Ab1-42	Fluid biomarker	intron_variant
chr19	44884873	rs34342646	5.54E-16	PVRL2	NR	NR	NR	NA	NECTIN2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr19	44884873	rs34342646	5.87E-10	NR	NR	NR	NR	NA	NECTIN2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr19	44884873	rs34342646	7.99E-11	NR	NR	NR	NR	NA	NECTIN2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44886339	rs7254892	0.0000112	PVRL2	NR	NR	NR	NA	NECTIN2	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr19	44887076	rs283815	0.000000307	PVRL2	A	A	0.7	NA	NECTIN2	SNP-based	Age at onset (AAO) / Survival	29107063	Multi-ethnic	HRS	9424	All	Age at onset	Other	intron_variant
chr19	44887076	rs283815	1.41E-08	PVRL2	G	G	1.5	1.5	NECTIN2	SNP-based	Disease risk	29107063	Multi-ethnic	HRS	9424	All	AD	AD	intron_variant
chr19	44888997	rs6857	0.000000446	PVRL2	T	T	1.37	1.37	NECTIN2	SNP-based	Disease risk	27899424	Caucasian	IFGC	6466	All	Frontotemporal Dementia	ADRD	3_prime_UTR_variant
chr19	44888997	rs6857	0.000000498	PVRL2	T	T	1.5	1.5	NECTIN2	SNP-based	Disease risk	22159054	Caucasian	"ADGC, CHARGE, GenADA"	9773	All	LOAD	AD	3_prime_UTR_variant
chr19	44888997	rs6857	0.000000703	PVRL2	T	T	1.31	1.31	NECTIN2	SNP-based	Disease risk	27899424	Caucasian	IFGC	6462	All	Frontotemporal Dementia	ADRD	3_prime_UTR_variant
chr19	44888997	rs6857	0.000032	PVRL2	T	T	1.23	1.23	NECTIN2	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	AD	AD	3_prime_UTR_variant
chr19	44888997	rs6857	0.0026	PVRL2	T	T	NR	NA	NECTIN2	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	AD	AD	3_prime_UTR_variant
chr19	44888997	rs6857	0.0063	PVRL2	T	T	1.22	1.22	NECTIN2	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	AD	AD	3_prime_UTR_variant
chr19	44888997	rs6857	0.0063	PVRL2	T	T	NR	NA	NECTIN2	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	AD	AD	3_prime_UTR_variant
chr19	44888997	rs6857	1.49E-108	PVRL2	T	T	3.23	3.23	NECTIN2	SNP-based	Disease risk	22159054	Caucasian	"ADGC, CHARGE, GenADA"	9773	All	LOAD	AD	3_prime_UTR_variant
chr19	44888997	rs6857	1.78E-27	APOE	T	T	1.29	3.63279	NECTIN2	SNP-based	Endophenotype	25188341	Caucasian	ADGC	4046	All	Neuritic Plaque	Neuropathology	3_prime_UTR_variant
chr19	44888997	rs6857	2.02E-62	APOE	T	T	1.61	5.00281	NECTIN2	SNP-based	Endophenotype	25188341	Caucasian	ADGC	4914	All	Clinico-pathologic AD dementia (No neuropathologist documentation)	Neuropathology	3_prime_UTR_variant
chr19	44888997	rs6857	2.21E-12	PVRL2	T	T	1.34	1.34	NECTIN2	SNP-based	Disease risk	27899424	Caucasian	IFGC	12928	All	Frontotemporal Dementia	ADRD	3_prime_UTR_variant
chr19	44888997	rs6857	2.92E-21	APOE	T	T	0.67	1.95424	NECTIN2	SNP-based	Endophenotype	25188341	Caucasian	ADGC	2807	All	Cerebral amyloid angiopathy (CAA	Neuropathology	3_prime_UTR_variant
chr19	44888997	rs6857	3.14E-47	APOE	T	T	0.95	2.58571	NECTIN2	SNP-based	Endophenotype	25188341	Caucasian	ADGC	4232	All	"Neuritic Plaque (Ordinal, 4 categories)"	Neuropathology	3_prime_UTR_variant
chr19	44888997	rs6857	3.48E-38	APOE	T	T	1.5	4.48169	NECTIN2	SNP-based	Endophenotype	25188341	Caucasian	ADGC	3702	All	Clinico-pathologic AD dementia (with neuropathologist documentation)	Neuropathology	3_prime_UTR_variant
chr19	44888997	rs6857	4.73E-47	APOE	T	T	0.66	1.93479	NECTIN2	SNP-based	Endophenotype	25188341	Caucasian	ADGC	4707	All	"NFT Braak (Ordinal I, 7 categories)"	Neuropathology	3_prime_UTR_variant
chr19	44888997	rs6857	4.83E-44	APOE	T	T	0.79	2.2034	NECTIN2	SNP-based	Endophenotype	25188341	Caucasian	ADGC	4735	All	"NFT Braak (Ordinal II, 4 categories)"	Neuropathology	3_prime_UTR_variant
chr19	44891079	rs71352238	0.00000158	NR	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr19	44891079	rs71352238	0.00000319	TOMM40	T	T	1.5	NA	TOMM40	SNP-based	Age at onset (AAO) / Survival	29107063	Multi-ethnic	HRS	9424	All	Age at onset	Other	intron_variant
chr19	44891079	rs71352238	0.00000482	TOMM40	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intron_variant
chr19	44891079	rs71352238	0.0000533	NR	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44891079	rs71352238	0.00946	NR	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr19	44891079	rs71352238	0.0137	NR	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44891079	rs71352238	1.13E-11	NR	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44891079	rs71352238	1.78E-16	TOMM40	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr19	44891079	rs71352238	2.04E-10	NR	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr19	44891079	rs71352238	2.46E-16	TOMM40	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44891079	rs71352238	5.68E-39	TOMM40	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF Ab1-42	Fluid biomarker	intron_variant
chr19	44891079	rs71352238	7.54E-08	TOMM40	C	C	1.6	1.6	TOMM40	SNP-based	Disease risk	29107063	Multi-ethnic	HRS	9424	All	AD	AD	intron_variant
chr19	44892009	rs157580	0.00000684	TOMM40	NR	NR	NR	NA	TOMM40	SNP-based	Disease risk	20061627	Caucasian	ADGC	699	All	LOAD	AD	intron_variant
chr19	44892009	rs157580	0.0000153	TOMM40	G	G	0.49	0.49	TOMM40	SNP-based	Disease risk	20885792	Caucasian	"ADGC, CAP, CHARGE"	2979	All	LOAD	AD	intron_variant
chr19	44892009	rs157580	0.0000643	TOMM40	G	G	NR	NA	TOMM40	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr19	44892009	rs157580	0.005	TOMM40	A	A	-0.34	0.71177	TOMM40	SNP-based	Age at onset (AAO) / Survival	22869155	Caucasian	ADGC	22771	All	Age at onset	Other	intron_variant
chr19	44892009	rs157580	0.13	TOMM40	A	A	1.09	1.09	TOMM40	SNP-based	Disease risk	22159054	Caucasian	"ADGC, CHARGE, GenADA"	9773	All	LOAD	AD	intron_variant
chr19	44892009	rs157580	0.16	TOMM40	A	A	1.05	1.05	TOMM40	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	LOAD	AD	intron_variant
chr19	44892009	rs157580	1.22E-09	TOMM40	G	G	0.66	0.66	TOMM40	SNP-based	Disease risk	20885792	Caucasian	"CAP, MSBB, NCRAD"	2035	All	LOAD	AD	intron_variant
chr19	44892009	rs157580	1.50E-23	TOMM40	G	G	0.5	0.5	TOMM40	SNP-based	Disease risk	29107063	Multi-ethnic	ADGC	4561	All	AD	AD	intron_variant
chr19	44892009	rs157580	2.77E-29	TOMM40	A	A	1.7	1.7	TOMM40	SNP-based	Disease risk	22159054	Caucasian	"ADGC, CHARGE, GenADA"	9773	All	LOAD	AD	intron_variant
chr19	44892009	rs157580	2.79E-17	NR	G	G	NR	NA	TOMM40	SNP-based	Disease risk	21390209	Caucasian	"ADNI, GenADA, Pfizer"	3595	All	AD	AD	intron_variant
chr19	44892009	rs157580	3.87E-11	TOMM40	G	G	NR	NA	TOMM40	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr19	44892009	rs157580	7.78E-13	TOMM40	G	G	0.63	0.63	TOMM40	SNP-based	Disease risk	20885792	Caucasian	"ADGC, CAP, CHARGE"	4355	All	LOAD	AD	intron_variant
chr19	44892009	rs157580	8.24E-11	TOMM40	G	G	NR	NA	TOMM40	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intron_variant
chr19	44892009	rs157580	9.60E-35	"PVRL2, TOMM40"	G	G	0.51	0.51	TOMM40	SNP-based	Disease risk	24755620	Caucasian	ADGC	4569	All	AD	AD	intron_variant
chr19	44892009	rs157580	9.60E-54	TOMM40	NR	NR	0.63	0.63	TOMM40	SNP-based	Disease risk	19734902	Caucasian	Cohorts from Europe and USA	11789	All	AD	AD	intron_variant
chr19	44892009	rs157580	<1.00E-06	EPC2	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	21123754	Non-Hispanic Caucasian	ADNI	374	All	CSF Ab1-42	Fluid biomarker	intron_variant
chr19	44892362	rs2075650	0	TOMM40	NR	NR	NR	NA	TOMM40	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr19	44892362	rs2075650	0.000000165	TOMM40	G	G	1.5	1.5	TOMM40	SNP-based	Disease risk	29107063	Multi-ethnic	HRS	9424	All	AD	AD	intron_variant
chr19	44892362	rs2075650	0.000000303	TOMM40	G	G	NR	NA	TOMM40	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF Ab1-42	Fluid biomarker	intron_variant
chr19	44892362	rs2075650	0.000000517	TOMM40	A	A	1.5	NA	TOMM40	SNP-based	Age at onset (AAO) / Survival	29107063	Multi-ethnic	HRS	9424	All	Age at onset	Other	intron_variant
chr19	44892362	rs2075650	0.000000822	NR	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr19	44892362	rs2075650	0.00000125	TOMM40	A	A	0.71	0.71	TOMM40	SNP-based	Disease risk	22159054	Caucasian	"ADGC, CHARGE, GenADA"	9773	All	LOAD	AD	intron_variant
chr19	44892362	rs2075650	0.00000167	TOMM40	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intron_variant
chr19	44892362	rs2075650	0.0000146	TOMM40	A	A	1.7	NA	TOMM40	SNP-based	Age at onset (AAO) / Survival	29107063	Caucasian	CHARGE	3651	All	Age at onset	Other	intron_variant
chr19	44892362	rs2075650	0.000064	TOMM40	A	A	0.84	0.84	TOMM40	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr19	44892362	rs2075650	0.0000882	NR	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44892362	rs2075650	0.0032	TOMM40	NR	NR	NR	NA	TOMM40	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr19	44892362	rs2075650	0.0034	TOMM40	A	A	NR	NA	TOMM40	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr19	44892362	rs2075650	0.01	TOMM40	A	A	0.85	0.85	TOMM40	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr19	44892362	rs2075650	0.01	TOMM40	A	A	NR	NA	TOMM40	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr19	44892362	rs2075650	0.0203	NR	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr19	44892362	rs2075650	0.0224	NR	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44892362	rs2075650	0.16	TOMM40	A	A	0.89	0.89	TOMM40	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	LOAD	AD	intron_variant
chr19	44892362	rs2075650	0.31	TOMM40	A	A	0.15	1.16183	TOMM40	SNP-based	Age at onset (AAO) / Survival	22869155	Caucasian	ADGC	22771	All	Age at onset	Other	intron_variant
chr19	44892362	rs2075650	1.01E-11	NR	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44892362	rs2075650	1.04E-295	APOE	G	G	2.53	2.53	TOMM40	SNP-based	Disease risk	20460622	Caucasian	"ADGC, CHARGE, EADI, GERAD"	34363	All	AD	AD	intron_variant
chr19	44892362	rs2075650	1.18E-15	"APOC1, APOC4, APOE, PVRL2, TOMM40"	A	A	NR	NA	TOMM40	SNP-based	Disease risk	21379329	Caucasian	ADGC	3839	All	LOAD	AD	intron_variant
chr19	44892362	rs2075650	1.22E-11	NR	G	G	-0.049	0.952181	TOMM40	SNP-based	Cognitive	23562540	NR	ROSMAP	1593	All	global cognitive decline	Cognitive	intron_variant
chr19	44892362	rs2075650	1.30E-36	TOMM40	G	G	2.96	2.96	TOMM40	SNP-based	Disease risk	20885792	Caucasian	"CAP, MSBB, NCRAD"	2035	All	LOAD	AD	intron_variant
chr19	44892362	rs2075650	1.70E-94	TOMM40	A	A	0.35	0.35	TOMM40	SNP-based	Disease risk	22159054	Caucasian	"ADGC, CHARGE, GenADA"	9773	All	LOAD	AD	intron_variant
chr19	44892362	rs2075650	1.80E-157	TOMM40	NR	NR	2.53	2.53	TOMM40	SNP-based	Disease risk	19734902	Caucasian	Cohorts from Europe and USA	11789	All	AD	AD	intron_variant
chr19	44892362	rs2075650	1.99E-15	TOMM40	A	A	2.3	NA	TOMM40	SNP-based	Age at onset (AAO) / Survival	29107063	Multi-ethnic	CHARGE	5018	All	Age at onset	Other	intron_variant
chr19	44892362	rs2075650	2.21E-39	TOMM40	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF Ab1-42	Fluid biomarker	intron_variant
chr19	44892362	rs2075650	2.86E-64	TOMM40	G	G	3.6	3.6	TOMM40	SNP-based	Disease risk	29107063	Multi-ethnic	ADGC	4561	All	AD	AD	intron_variant
chr19	44892362	rs2075650	2.95E-81	"APOC1, APOC4, APOE, PVRL2, TOMM40"	A	A	0.35	NA	TOMM40	SNP-based	Disease risk	21379329	Caucasian	ADGC	3839	All	LOAD	AD	intron_variant
chr19	44892362	rs2075650	3.18E-68	APOE	G	G	2.23	2.23	TOMM40	SNP-based	Disease risk	20460622	Caucasian	"ADGC, CHARGE"	16675	All	AD	AD	intron_variant
chr19	44892362	rs2075650	3.21E-73	"APOC1, APOC4, APOE, PVRL2, TOMM40"	A	A	0.35	NA	TOMM40	SNP-based	Disease risk	21379329	Caucasian	ADGC	3446	Northwestern European ancestry	LOAD	AD	intron_variant
chr19	44892362	rs2075650	3.22E-11	TOMM40	NR	NR	NR	NA	TOMM40	SNP-based	Disease risk	20061627	Caucasian	ADGC	699	All	LOAD	AD	intron_variant
chr19	44892362	rs2075650	3.74E-08	"APOC1, APOC4, APOE, PVRL2, TOMM40"	A	A	0.25	NA	TOMM40	SNP-based	Disease risk	21379329	Caucasian	ADGC	214	Ashkenazi Jewish	LOAD	AD	intron_variant
chr19	44892362	rs2075650	3.88E-10	NR	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr19	44892362	rs2075650	4.02E-09	TOMM40	G	G	2.3	2.3	TOMM40	SNP-based	Disease risk	29107063	Caucasian	CHARGE	3651	All	AD	AD	intron_variant
chr19	44892362	rs2075650	4.28E-16	TOMM40	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr19	44892362	rs2075650	4.67E-172	APOE	G	G	2.61	2.61	TOMM40	SNP-based	Disease risk	20460622	Caucasian	"ADGC, CHARGE, EADI"	24035	All	AD	AD	intron_variant
chr19	44892362	rs2075650	4.87E-36	TOMM40	G	G	2.94	2.94	TOMM40	SNP-based	Disease risk	20885792	Caucasian	"ADGC, CAP, CHARGE"	4355	All	LOAD	AD	intron_variant
chr19	44892362	rs2075650	5.81E-16	TOMM40	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44892362	rs2075650	6.22E-184	NR	G	G	0.985	2.67781	TOMM40	SNP-based	Disease risk	23562540	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr19	44892362	rs2075650	6.24E-14	APOE	NR	NR	2.03	2.03	TOMM40	SNP-based	Endophenotype	26993346	Caucasian	Cohort from Europe	10840	All	PCA (posterior cortical atrophy)	Imaging	intron_variant
chr19	44892362	rs2075650	6.24E-14	TOMM40	G	G	5.72	5.72	TOMM40	SNP-based	Disease risk	20885792	Caucasian	"ADGC, CAP, CHARGE"	2979	All	LOAD	AD	intron_variant
chr19	44892362	rs2075650	8.54E-116	"PVRL2, TOMM40"	G	G	4.48	4.48	TOMM40	SNP-based	Disease risk	24755620	Caucasian	ADGC	4569	All	AD	AD	intron_variant
chr19	44892362	rs2075650	9.32E-15	TOMM40	G	G	2.3	2.3	TOMM40	SNP-based	Disease risk	29107063	Multi-ethnic	CHARGE	5018	All	AD	AD	intron_variant
chr19	44892362	rs2075650	9.33E-10	NR	G	G	0.266	1.30474	TOMM40	SNP-based	Neuropathology	23562540	NR	ROSMAP	651	All	tangle counts	Neuropathology	intron_variant
chr19	44892362	rs2075650	<1.00E-06	EPC2	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	21123754	Non-Hispanic Caucasian	ADNI	374	All	CSF Ab1-42	Fluid biomarker	intron_variant
chr19	44892362	rs2075650	<1.00E-06	EPC2	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	21123754	Non-Hispanic Caucasian	ADNI	374	All	CSF P-tau181p/Ab1-42	Fluid biomarker	intron_variant
chr19	44892362	rs2075650	<1.00E-06	EPC2	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	21123754	Non-Hispanic Caucasian	ADNI	374	All	CSF T-tau/Ab1-42	Fluid biomarker	intron_variant
chr19	44892457	rs157581	0.85	APOE	NR	NR	NR	NA	TOMM40	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	2724	All	LOAD	AD	synonymous_variant
chr19	44892457	rs157581	1.30E-46	APOE	NR	NR	NR	NA	TOMM40	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	2724	All	LOAD	AD	synonymous_variant
chr19	44892457	rs157581	1.60E-51	APOE	NR	NR	NR	NA	TOMM40	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	2724	All	LOAD	AD	synonymous_variant
chr19	44892457	rs157581	2.94E-15	TOMM40	NR	NR	NR	NA	TOMM40	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	658	All	LOAD	AD	synonymous_variant
chr19	44892457	rs157581	3.38E-14	TOMM40	NR	NR	NR	NA	TOMM40	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	720	All	LOAD	AD	synonymous_variant
chr19	44892457	rs157581	4.80E-55	APOE	NR	NR	NR	NA	TOMM40	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	2724	All	LOAD	AD	synonymous_variant
chr19	44892457	rs157581	4.82E-24	TOMM40	NR	NR	NR	NA	TOMM40	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	1146	All	LOAD	AD	synonymous_variant
chr19	44892457	rs157581	5.18E-22	TOMM40	NR	NR	NR	NA	TOMM40	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	570	All	LOAD	AD	synonymous_variant
chr19	44892457	rs157581	6.86E-14	TOMM40	NR	NR	NR	NA	TOMM40	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	776	All	LOAD	AD	synonymous_variant
chr19	44892457	rs157581	7.10E-59	APOE	NR	NR	NR	NA	TOMM40	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	2724	All	LOAD	AD	synonymous_variant
chr19	44892457	rs157581	<1.00E-08	TOMM40	NR	NR	2.73	2.73	TOMM40	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	3870	All	LOAD	AD	synonymous_variant
chr19	44892652	rs34404554	0.00000172	NR	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr19	44892652	rs34404554	0.00000544	TOMM40	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intron_variant
chr19	44892652	rs34404554	0.0000291	NR	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44892652	rs34404554	0.0134	NR	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr19	44892652	rs34404554	0.0143	NR	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44892652	rs34404554	1.01E-39	TOMM40	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF Ab1-42	Fluid biomarker	intron_variant
chr19	44892652	rs34404554	1.33E-16	TOMM40	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44892652	rs34404554	1.87E-12	NR	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44892652	rs34404554	3.19E-10	NR	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr19	44892652	rs34404554	3.58E-16	TOMM40	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr19	44892887	rs11556505	0.00000158	NR	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	synonymous_variant
chr19	44892887	rs11556505	0.00000572	TOMM40	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	synonymous_variant
chr19	44892887	rs11556505	0.0000386	NR	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	synonymous_variant
chr19	44892887	rs11556505	0.0155	NR	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	synonymous_variant
chr19	44892887	rs11556505	0.0177	NR	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	synonymous_variant
chr19	44892887	rs11556505	1.06E-39	TOMM40	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF Ab1-42	Fluid biomarker	synonymous_variant
chr19	44892887	rs11556505	1.68E-16	TOMM40	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	synonymous_variant
chr19	44892887	rs11556505	2.83E-12	NR	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	synonymous_variant
chr19	44892887	rs11556505	3.00E-10	NR	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	synonymous_variant
chr19	44892887	rs11556505	3.48E-16	TOMM40	NR	NR	NR	NA	TOMM40	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	synonymous_variant
chr19	44892962	rs157582	0.000000168	TOMM40	C	C	0.7	NA	TOMM40	SNP-based	Age at onset (AAO) / Survival	29107063	Multi-ethnic	HRS	9424	All	Age at onset	Other	intron_variant
chr19	44892962	rs157582	0.00000326	TOMM40	T	T	1.6	1.6	TOMM40	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr19	44892962	rs157582	0.0011	TOMM40	T	T	1.3	1.3	TOMM40	SNP-based	Disease risk	22159054	Caucasian	"ADGC, CHARGE, GenADA"	9773	All	LOAD	AD	intron_variant
chr19	44892962	rs157582	0.222	TOMM40	T	T	1.15	1.15	TOMM40	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr19	44892962	rs157582	2.54E-91	TOMM40	T	T	2.73	2.73	TOMM40	SNP-based	Disease risk	22159054	Caucasian	"ADGC, CHARGE, GenADA"	9773	All	LOAD	AD	intron_variant
chr19	44892962	rs157582	3.32E-09	TOMM40	T	T	1.5	1.5	TOMM40	SNP-based	Disease risk	29107063	Multi-ethnic	HRS	9424	All	AD	AD	intron_variant
chr19	44893416	rs157583	0.0000248	TOMM40	T	T	2.08	2.08	TOMM40	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr19	44893416	rs157583	0.7	TOMM40	T	T	0.92	0.92	TOMM40	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr19	44896639	rs76366838	1.71E-08	TOMM40	G	G	0.4	NA	TOMM40	SNP-based	Age at onset (AAO) / Survival	29107063	Multi-ethnic	HRS	9424	All	Age at onset	Other	intron_variant
chr19	44898409	rs8106922	0.0000454	TOMM40	G	G	0.7	0.7	TOMM40	SNP-based	Disease risk	29107063	Multi-ethnic	CHARGE	5018	All	AD	AD	intron_variant
chr19	44898409	rs8106922	0.0000834	TOMM40	A	A	0.7	NA	TOMM40	SNP-based	Age at onset (AAO) / Survival	29107063	Multi-ethnic	CHARGE	5018	All	Age at onset	Other	intron_variant
chr19	44898409	rs8106922	0.0000973	TOMM40	A	A	1.48	1.48	TOMM40	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr19	44898409	rs8106922	0.108	TOMM40	G	G	0.79	0.79	TOMM40	SNP-based	Disease risk	20885792	Caucasian	"ADGC, CAP, CHARGE"	2979	All	LOAD	AD	intron_variant
chr19	44898409	rs8106922	0.144	TOMM40	A	A	1.18	1.18	TOMM40	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr19	44898409	rs8106922	0.23	TOMM40	A	A	0.15	1.16183	TOMM40	SNP-based	Age at onset (AAO) / Survival	22869155	Caucasian	ADGC	22771	All	Age at onset	Other	intron_variant
chr19	44898409	rs8106922	0.36	TOMM40	A	A	0.97	0.97	TOMM40	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	LOAD	AD	intron_variant
chr19	44898409	rs8106922	0.679	TOMM40	A	A	1.02	1.02	TOMM40	SNP-based	Disease risk	22159054	Caucasian	"ADGC, CHARGE, GenADA"	9773	All	LOAD	AD	intron_variant
chr19	44898409	rs8106922	1.14E-23	TOMM40	G	G	0.5	0.5	TOMM40	SNP-based	Disease risk	29107063	Multi-ethnic	ADGC	4561	All	AD	AD	intron_variant
chr19	44898409	rs8106922	1.17E-25	TOMM40	G	G	0.57	0.57	TOMM40	SNP-based	Disease risk	24755620	Caucasian	ADGC	4569	All	AD	AD	intron_variant
chr19	44898409	rs8106922	1.21E-10	TOMM40	G	G	NR	NA	TOMM40	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intron_variant
chr19	44898409	rs8106922	2.06E-28	TOMM40	A	A	1.66	1.66	TOMM40	SNP-based	Disease risk	22159054	Caucasian	"ADGC, CHARGE, GenADA"	9773	All	LOAD	AD	intron_variant
chr19	44898409	rs8106922	2.94E-12	TOMM40	G	G	0.62	0.62	TOMM40	SNP-based	Disease risk	20885792	Caucasian	"ADGC, CAP, CHARGE"	4355	All	LOAD	AD	intron_variant
chr19	44898409	rs8106922	3.10E-12	TOMM40	G	G	0.62	0.62	TOMM40	SNP-based	Disease risk	20885792	Caucasian	"CAP, MSBB, NCRAD"	2035	All	LOAD	AD	intron_variant
chr19	44898409	rs8106922	3.96E-14	TOMM40	G	G	NR	NA	TOMM40	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr19	44898409	rs8106922	5.40E-39	TOMM40	NR	NR	0.68	0.68	TOMM40	SNP-based	Disease risk	19734902	Caucasian	Cohorts from Europe and USA	11789	All	AD	AD	intron_variant
chr19	44898409	rs8106922	5.89E-09	TOMM40	G	G	NR	NA	TOMM40	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr19	44899959	rs115881343	2.03E-09	TOMM40	C	C	0.5	NA	TOMM40	SNP-based	Age at onset (AAO) / Survival	29107063	Multi-ethnic	HRS	9424	All	Age at onset	Other	intron_variant
chr19	44900155	rs1160985	0.0000492	TOMM40	T	T	0.65	0.65	TOMM40	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr19	44900155	rs1160985	0.326	TOMM40	T	T	0.95	0.95	TOMM40	SNP-based	Disease risk	22159054	Caucasian	"ADGC, CHARGE, GenADA"	9773	All	LOAD	AD	intron_variant
chr19	44900155	rs1160985	0.73	TOMM40	T	T	1.04	1.04	TOMM40	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr19	44900155	rs1160985	2.78E-33	TOMM40	T	T	0.58	0.58	TOMM40	SNP-based	Disease risk	22159054	Caucasian	"ADGC, CHARGE, GenADA"	9773	All	LOAD	AD	intron_variant
chr19	44901322	rs394819	8.40E-11	"APOE, TOMM40"	T	T	1.89	1.89	TOMM40	SNP-based	Disease risk	26339675	Caribbean Hispanic	"EFIGA, NOMAS, WHICAP "	4514	All	LOAD	AD	missense_variant
chr19	44903416	rs10119	0.000000595	TOMM40	A	A	1.8	1.8	TOMM40	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	3_prime_UTR_variant
chr19	44903416	rs10119	0.0051	TOMM40	A	A	1.22	1.22	TOMM40	SNP-based	Disease risk	22159054	Caucasian	"ADGC, CHARGE, GenADA"	9773	All	LOAD	AD	3_prime_UTR_variant
chr19	44903416	rs10119	0.614	TOMM40	A	A	1.07	1.07	TOMM40	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	3_prime_UTR_variant
chr19	44903416	rs10119	8.15E-70	TOMM40	A	A	2.48	2.48	TOMM40	SNP-based	Disease risk	22159054	Caucasian	"ADGC, CHARGE, GenADA"	9773	All	LOAD	AD	3_prime_UTR_variant
chr19	44905579	rs405509	0.000000098	APOE	NR	NR	NR	NA	APOE	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	2724	All	LOAD	AD	upstream_gene_variant
chr19	44905579	rs405509	0.00000131	APOE	T	T	1.5	1.5	APOE	SNP-based	Disease risk	29107063	Multi-ethnic	CHARGE	5018	All	AD	AD	upstream_gene_variant
chr19	44905579	rs405509	0.00000477	APOE	G	G	NR	NA	APOE	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	upstream_gene_variant
chr19	44905579	rs405509	0.00000733	APOE	G	G	NR	NA	APOE	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	upstream_gene_variant
chr19	44905579	rs405509	0.0000116	APOE	T	T	1.4	NA	APOE	SNP-based	Age at onset (AAO) / Survival	29107063	Multi-ethnic	CHARGE	5018	All	Age at onset	Other	upstream_gene_variant
chr19	44905579	rs405509	0.0000125	APOE	NR	NR	NR	NA	APOE	SNP-based	Disease risk	27899424	Caucasian	IFGC	12928	All	Frontotemporal Dementia	ADRD	upstream_gene_variant
chr19	44905579	rs405509	0.0000125	APOE	T	T	1.18	1.18	APOE	SNP-based	Disease risk	27899424	Caucasian	IFGC	6462	All	Frontotemporal Dementia	ADRD	upstream_gene_variant
chr19	44905579	rs405509	0.0000598	APOE	T	T	1.15	1.15	APOE	SNP-based	Disease risk	27899424	Caucasian	IFGC	12928	All	Frontotemporal Dementia	ADRD	upstream_gene_variant
chr19	44905579	rs405509	0.000081	APOE	NR	NR	NR	NA	APOE	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	776	All	LOAD	AD	upstream_gene_variant
chr19	44905579	rs405509	0.0001	APOE	NR	NR	NR	NA	APOE	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	570	All	LOAD	AD	upstream_gene_variant
chr19	44905579	rs405509	0.0003	APOE	NR	NR	NR	NA	APOE	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	658	All	LOAD	AD	upstream_gene_variant
chr19	44905579	rs405509	0.0013	APOE	NR	NR	NR	NA	APOE	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	2724	All	LOAD	AD	upstream_gene_variant
chr19	44905579	rs405509	0.002	APOE	NR	NR	NR	NA	APOE	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	1146	All	LOAD	AD	upstream_gene_variant
chr19	44905579	rs405509	0.00342	APOE	C	C	0.65	0.65	APOE	SNP-based	Disease risk	20885792	Caucasian	"ADGC, CAP, CHARGE"	2979	All	LOAD	AD	upstream_gene_variant
chr19	44905579	rs405509	0.0035	APOE	NR	NR	NR	NA	APOE	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	720	All	LOAD	AD	upstream_gene_variant
chr19	44905579	rs405509	0.43	APOE	T	T	0.97	0.97	APOE	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	LOAD	AD	upstream_gene_variant
chr19	44905579	rs405509	0.62	APOE	T	T	0.07	1.07251	APOE	SNP-based	Age at onset (AAO) / Survival	22869155	Caucasian	ADGC	22771	All	Age at onset	Other	upstream_gene_variant
chr19	44905579	rs405509	0.74	APOE	NR	NR	NR	NA	APOE	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	2724	All	LOAD	AD	upstream_gene_variant
chr19	44905579	rs405509	0.93	APOE	T	T	1	1	APOE	SNP-based	Disease risk	27899424	Caucasian	IFGC	6466	All	Frontotemporal Dementia	ADRD	upstream_gene_variant
chr19	44905579	rs405509	1.47E-13	APOE	C	C	0.62	0.62	APOE	SNP-based	Disease risk	20885792	Caucasian	"CAP, MSBB, NCRAD"	2035	All	LOAD	AD	upstream_gene_variant
chr19	44905579	rs405509	1.50E-20	APOE	T	T	1.7	1.7	APOE	SNP-based	Disease risk	29107063	Multi-ethnic	ADGC	4561	All	AD	AD	upstream_gene_variant
chr19	44905579	rs405509	1.90E-13	APOE	NR	NR	NR	NA	APOE	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	2724	All	LOAD	AD	upstream_gene_variant
chr19	44905579	rs405509	2.08E-09	APOE	G	G	NR	NA	APOE	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	upstream_gene_variant
chr19	44905579	rs405509	2.29E-27	"APOE, TOMM40"	G	G	0.57	0.57	APOE	SNP-based	Disease risk	24755620	Caucasian	ADGC	4569	All	AD	AD	upstream_gene_variant
chr19	44905579	rs405509	4.35E-73	APOE	NR	NR	NR	NA	APOE	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	upstream_gene_variant
chr19	44905579	rs405509	4.40E-12	APOE	NR	NR	NR	NA	APOE	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	2724	All	LOAD	AD	upstream_gene_variant
chr19	44905579	rs405509	4.90E-37	APOE	NR	NR	0.7	0.7	APOE	SNP-based	Disease risk	19734902	Caucasian	Cohorts from Europe and USA	11789	All	AD	AD	upstream_gene_variant
chr19	44905579	rs405509	8.13E-14	APOE	C	C	0.61	0.61	APOE	SNP-based	Disease risk	20885792	Caucasian	"ADGC, CAP, CHARGE"	4355	All	LOAD	AD	upstream_gene_variant
chr19	44905579	rs405509	<1.00E-08	APOE	NR	NR	1.43	1.43	APOE	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	3870	All	LOAD	AD	upstream_gene_variant
chr19	44906745	rs769449	0.000000958	APOE	NR	NR	NR	NA	APOE	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intron_variant
chr19	44906745	rs769449	0.00000639	NR	NR	NR	NR	NA	APOE	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr19	44906745	rs769449	0.0000322	NR	NR	NR	NR	NA	APOE	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44906745	rs769449	0.00907	NR	NR	NR	NR	NA	APOE	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr19	44906745	rs769449	0.0129	NR	NR	NR	NR	NA	APOE	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44906745	rs769449	0.0842	GLIS1	A	A	0.08	1.08329	APOE	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	1530	All	AD Progression (based on CDR Score)	Cognitive	intron_variant
chr19	44906745	rs769449	1.04E-10	NR	NR	NR	NR	NA	APOE	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr19	44906745	rs769449	1.23E-12	NR	NR	NR	NR	NA	APOE	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44906745	rs769449	1.95E-16	APOE	NR	NR	NR	NA	APOE	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr19	44906745	rs769449	2.56E-18	APOE	NR	NR	NR	NA	APOE	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44906745	rs769449	3.00E-12	APOE	A	A	1.9	1.9	APOE	SNP-based	Disease risk	29107063	Multi-ethnic	HRS	9424	All	AD	AD	intron_variant
chr19	44906745	rs769449	3.12E-08	APOE	G	G	1.7	NA	APOE	SNP-based	Age at onset (AAO) / Survival	29107063	Multi-ethnic	HRS	9424	All	Age at onset	Other	intron_variant
chr19	44906745	rs769449	3.29E-53	GLIS1	NR	NR	0.11	1.11628	APOE	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	1527	Male subjects	CSF Ab1-42	Fluid biomarker	intron_variant
chr19	44906745	rs769449	4.05E-29	GLIS1	A	A	0.08	1.08329	APOE	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	3146	All	CSF T-tau	Fluid biomarker	intron_variant
chr19	44906745	rs769449	4.05E-29	GLIS1	NR	NR	0.08	1.08329	APOE	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	3036	All	CSF T-tau	Fluid biomarker	intron_variant
chr19	44906745	rs769449	4.31E-22	GLIS1	NR	NR	0.09	1.09417	APOE	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	1509	Female subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44906745	rs769449	4.41E-12	GLIS1	NR	NR	0.07	1.07251	APOE	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	1527	Male subjects	CSF T-tau	Fluid biomarker	intron_variant
chr19	44906745	rs769449	4.78E-94	GLIS1	A	A	0.101	1.10628	APOE	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	3146	All	CSF Ab1-42	Fluid biomarker	intron_variant
chr19	44906745	rs769449	4.78E-94	GLIS1	NR	NR	0.1	1.10517	APOE	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	3036	All	CSF Ab1-42	Fluid biomarker	intron_variant
chr19	44906745	rs769449	5.30E-33	GLIS1	A	A	0.08	1.08329	APOE	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	3146	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44906745	rs769449	5.30E-33	GLIS1	NR	NR	0.08	1.08329	APOE	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	3036	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44906745	rs769449	5.58E-20	GLIS1	NR	NR	0.09	1.09417	APOE	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	1509	Female subjects	CSF T-tau	Fluid biomarker	intron_variant
chr19	44906745	rs769449	5.83E-14	GLIS1	NR	NR	0.07	1.07251	APOE	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	1527	Male subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr19	44906745	rs769449	6.76E-43	GLIS1	NR	NR	0.09	1.09417	APOE	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	1509	Female subjects	CSF Ab1-42	Fluid biomarker	intron_variant
chr19	44906745	rs769449	6.81E-106	GLIS1	A	A	0.72	2.05443	APOE	SNP-based	Age at onset (AAO) / Survival	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	39855	AD subjects	Age at onset	Other	intron_variant
chr19	44906745	rs769449	9.02E-47	APOE	NR	NR	NR	NA	APOE	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF Ab1-42	Fluid biomarker	intron_variant
chr19	44906745	rs769449	9.86E-523	GLIS1	A	A	3.52	33.7844	APOE	SNP-based	Disease risk	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	74046	All	AD risk	AD	intron_variant
chr19	44907187	rs769450	0.000159	APOE	A	A	0.7	0.7	APOE	SNP-based	Disease risk	29107063	Multi-ethnic	CHARGE	5018	All	AD	AD	intron_variant
chr19	44908684	rs429358	0.00000059	NR	e4	e4	-0.33	0.718924	APOE	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	167	AD subjects	CSF Ab1-42	Fluid biomarker	missense_variant
chr19	44908684	rs429358	0.0000061	NR	e4	e4	-0.51	0.600496	APOE	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	113	AD subjects	CSF Ab1-42	Fluid biomarker	missense_variant
chr19	44908684	rs429358	0.000011	NR	NR	NR	-0.7	0.496585	APOE	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	515	AD subjects	CSF Ab1-42	Fluid biomarker	missense_variant
chr19	44908684	rs429358	0.0000124	NR	NR	NR	4.82	4.82	APOE	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	235	All women	LOAD	AD	missense_variant
chr19	44908684	rs429358	0.0000823	NR	NR	NR	2.91	2.91	APOE	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	282	All women	LOAD	AD	missense_variant
chr19	44908684	rs429358	0.00502	APOE	A	A	0.83	NA	APOE	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	missense_variant
chr19	44908684	rs429358	0.01	NR	e4	e4	-0.39	0.677057	APOE	SNP-based	Endophenotype	25027320	Caucasian	ADNI	83	AD subjects	CSF Ab1-42	Fluid biomarker	missense_variant
chr19	44908684	rs429358	1.10E-12	APOE	C	C	-0.5	0.606531	APOE	SNP-based	Endophenotype	25188341	Caucasian	ADGC	3525	All	"Lewy Body (Ordinal I, 5 categories)"	Neuropathology	missense_variant
chr19	44908684	rs429358	1.2E-881	APOE	C	C	3.32	3.32	APOE	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	63926	All	Clinically diagnosed LOAD	AD	missense_variant
chr19	44908684	rs429358	1.60E-79	APOE	NR	NR	NR	NA	APOE	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	2724	All	LOAD	AD	missense_variant
chr19	44908684	rs429358	1.80E-10	NR	NR	NR	1.08	2.94468	APOE	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	363	AD subjects	CSF Ab1-42	Fluid biomarker	missense_variant
chr19	44908684	rs429358	2.20E-74	APOE	NR	NR	NR	NA	APOE	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	2724	All	LOAD	AD	missense_variant
chr19	44908684	rs429358	2.60E-97	APOE	NR	NR	NR	NA	APOE	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	2724	All	LOAD	AD	missense_variant
chr19	44908684	rs429358	2.83E-11	APOE	C	C	-0.49	0.612626	APOE	SNP-based	Endophenotype	25188341	Caucasian	ADGC	3526	All	Lewy Body 	Neuropathology	missense_variant
chr19	44908684	rs429358	2.90E-79	APOE	NR	NR	NR	NA	APOE	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	2724	All	LOAD	AD	missense_variant
chr19	44908684	rs429358	3.90E-43	APOE	NR	NR	2.39	2.39	APOE	SNP-based	Disease risk	30979435	Caucasian	ADGC	6212	Age >=80 y	AD	AD	missense_variant
chr19	44908684	rs429358	4.30E-17	NR	NR	NR	-0.4	0.67032	APOE	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	878	AD subjects	CSF Ab1-42	Fluid biomarker	missense_variant
chr19	44908684	rs429358	4.30E-17	NR	e4	e4	-0.4	0.67032	APOE	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	878	AD subjects	CSF Ab1-42	Fluid biomarker	missense_variant
chr19	44908684	rs429358	4.50E-35	APOE	NR	NR	NR	NA	APOE	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	2724	All	LOAD	AD	missense_variant
chr19	44908684	rs429358	4.87E-12	APOE	C	C	-0.51	0.600496	APOE	SNP-based	Endophenotype	25188341	Caucasian	ADGC	3526	All	"Lewy Body (Ordinal II, 3 categories)"	Neuropathology	missense_variant
chr19	44908684	rs429358	4.90E-286	APOE	NR	NR	3.93	3.93	APOE	SNP-based	Disease risk	30979435	Caucasian	ADGC	13641	Age 60-79 y	AD	AD	missense_variant
chr19	44908684	rs429358	7.27E-30	APOE	NR	NR	-0.13	0.878095	APOE	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	ADNI	521	All	Plasma APOE	Fluid biomarker	missense_variant
chr19	44908684	rs429358	<1.00E-06	EPC2	NR	NR	NR	NA	APOE	SNP-based	Endophenotype	21123754	Non-Hispanic Caucasian	ADNI	374	All	CSF Ab1-42	Fluid biomarker	missense_variant
chr19	44908684	rs429358	<1.00E-06	EPC2	NR	NR	NR	NA	APOE	SNP-based	Endophenotype	21123754	Non-Hispanic Caucasian	ADNI	374	All	CSF P-tau181p	Fluid biomarker	missense_variant
chr19	44908684	rs429358	<1.00E-06	EPC2	NR	NR	NR	NA	APOE	SNP-based	Endophenotype	21123754	Non-Hispanic Caucasian	ADNI	374	All	CSF P-tau181p/Ab1-42	Fluid biomarker	missense_variant
chr19	44908684	rs429358	<1.00E-06	EPC2	NR	NR	NR	NA	APOE	SNP-based	Endophenotype	21123754	Non-Hispanic Caucasian	ADNI	374	All	CSF T-tau/Ab1-42	Fluid biomarker	missense_variant
chr19	44908822	rs7412	0.0000021	APOE	NR	NR	NR	NA	APOE	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	2724	All	LOAD	AD	missense_variant
chr19	44908822	rs7412	0.00023	APOE	NR	NR	NR	NA	APOE	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	2724	All	LOAD	AD	missense_variant
chr19	44908822	rs7412	0.3	NR	NR	NR	0.52	0.52	APOE	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	282	All women	LOAD	AD	missense_variant
chr19	44908822	rs7412	0.753	NR	NR	NR	0.8	0.8	APOE	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	235	All women	LOAD	AD	missense_variant
chr19	44908822	rs7412	2.60E-13	APOE	NR	NR	NR	NA	APOE	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	2724	All	LOAD	AD	missense_variant
chr19	44908822	rs7412	3.90E-11	APOE	NR	NR	NR	NA	APOE	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	2724	All	LOAD	AD	missense_variant
chr19	44908822	rs7412	4.10E-12	APOE	NR	NR	NR	NA	APOE	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	2724	All	LOAD	AD	missense_variant
chr19	44910319	rs75627662	9.51E-296	APOE	G	G	NR	NA	APOE	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	upstream_gene_variant
chr19	44911194	rs439401	0.000000423	LOC100129500	A	A	0.33	0.33	APOE	SNP-based	Disease risk	20885792	Caucasian	"ADGC, CAP, CHARGE"	2979	All	LOAD	AD	upstream_gene_variant
chr19	44911194	rs439401	0.0000897	APOE	T	T	NR	NA	APOE	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	upstream_gene_variant
chr19	44911194	rs439401	0.11	NR	T	T	0.2	1.2214	APOE	SNP-based	Age at onset (AAO) / Survival	22869155	Caucasian	ADGC	22771	All	Age at onset	Other	upstream_gene_variant
chr19	44911194	rs439401	0.16	NR	T	T	0.95	0.95	APOE	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	LOAD	AD	upstream_gene_variant
chr19	44911194	rs439401	1.76E-09	LOC100129500	A	A	0.66	0.66	APOE	SNP-based	Disease risk	20885792	Caucasian	"CAP, MSBB, NCRAD"	2035	All	LOAD	AD	upstream_gene_variant
chr19	44911194	rs439401	3.80E-12	LOC100129500	A	A	0.63	0.63	APOE	SNP-based	Disease risk	20885792	Caucasian	"ADGC, CAP, CHARGE"	4355	All	LOAD	AD	upstream_gene_variant
chr19	44911194	rs439401	5.17E-17	"APOC1, APOE"	T	T	0.6	0.6	APOE	SNP-based	Disease risk	29107063	Multi-ethnic	ADGC	4561	All	AD	AD	upstream_gene_variant
chr19	44911194	rs439401	7.97E-09	APOE	T	T	NR	NA	APOE	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	upstream_gene_variant
chr19	44911194	rs439401	8.82E-29	"APOC1, APOE"	T	T	0.54	0.54	APOE	SNP-based	Disease risk	24755620	Caucasian	ADGC	4569	All	AD	AD	upstream_gene_variant
chr19	44911194	rs439401	9.15E-11	APOE	T	T	NR	NA	APOE	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	upstream_gene_variant
chr19	44911194	rs439401	<1.00E-06	EPC2	NR	NR	NR	NA	APOE	SNP-based	Endophenotype	21123754	Non-Hispanic Caucasian	ADNI	374	All	CSF Ab1-42	Fluid biomarker	upstream_gene_variant
chr19	44912383	rs445925	0.000302	APOC1	A	A	1.57	1.57	APOC1	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	upstream_gene_variant
chr19	44912383	rs445925	0.00079	APOE/APOC1	A	A	NR	NA	APOC1	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	AD	AD	upstream_gene_variant
chr19	44912383	rs445925	0.25	"APOC1, APOE"	A	A	0.93	0.93	APOC1	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	AD	AD	upstream_gene_variant
chr19	44912383	rs445925	0.443	APOC1	A	A	1.13	1.13	APOC1	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	upstream_gene_variant
chr19	44912383	rs445925	0.47	APOE/APOC1	A	A	NR	NA	APOC1	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	AD	AD	upstream_gene_variant
chr19	44912383	rs445925	4.10E-11	"APOC1, APOE"	A	A	0.74	0.74	APOC1	SNP-based	Disease risk	22869155	Caucasian	ADGC	22771	All	AD	AD	upstream_gene_variant
chr19	44917997	rs12721046	2.39E-14	APOC1	G	G	2.2	NA	APOC1	SNP-based	Age at onset (AAO) / Survival	29107063	Multi-ethnic	CHARGE	5018	All	Age at onset	Other	intron_variant
chr19	44917997	rs12721046	2.93E-09	APOC1	G	G	2	NA	APOC1	SNP-based	Age at onset (AAO) / Survival	29107063	Caucasian	CHARGE	3651	All	Age at onset	Other	intron_variant
chr19	44917997	rs12721046	4.87E-09	APOC1	A	A	2.2	2.2	APOC1	SNP-based	Disease risk	29107063	Caucasian	CHARGE	3651	All	AD	AD	intron_variant
chr19	44919689	rs4420638	0.000000154	APOC1	A	A	0.61	0.61	APOC1	SNP-based	Disease risk	22159054	Caucasian	"ADGC, CHARGE, GenADA"	9773	All	LOAD	AD	downstream_gene_variant
chr19	44919689	rs4420638	0.00000211	"APOC1, APOE, TOMM40"	NR	NR	0.28	0.28	APOC1	SNP-based	Disease risk	22832961	Caucasian	ADNI	381	All	LOAD	AD	downstream_gene_variant
chr19	44919689	rs4420638	0.0000132	"APOC1, APOE, TOMM40"	NR	NR	NR	NA	APOC1	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	2222	AD subjects	Age at onset	Other	downstream_gene_variant
chr19	44919689	rs4420638	0.0247	"APOC1, APOE, TOMM40"	NR	NR	0.7	2.01375	APOC1	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	844	AD subjects	Age at onset	Other	downstream_gene_variant
chr19	44919689	rs4420638	0.983	"APOC1, APOE, TOMM40"	NR	NR	-0.05	0.951229	APOC1	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADNI	188	AD subjects	Age at onset	Other	downstream_gene_variant
chr19	44919689	rs4420638	1.07E-144	APOC1	A	A	0.23	0.23	APOC1	SNP-based	Disease risk	22159054	Caucasian	"ADGC, CHARGE, GenADA"	9773	All	LOAD	AD	downstream_gene_variant
chr19	44919689	rs4420638	1.11E-12	"APOC1, APOE, TOMM40"	NR	NR	NR	NA	APOC1	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	2222	AD subjects	Age at onset	Other	downstream_gene_variant
chr19	44919689	rs4420638	1.49E-17	APOE	G	G	0.35	1.41907	APOC1	SNP-based	Endophenotype	23836404	Caucasian	ADGC	651	All	Neuritic Plaque Pathologic Burden	Neuropathology	downstream_gene_variant
chr19	44919689	rs4420638	1.72E-51	"APOC1, APOE, TOMM40"	NR	NR	0.21	0.21	APOC1	SNP-based	Disease risk	22832961	Caucasian	ADGC	2099	All	LOAD	AD	downstream_gene_variant
chr19	44919689	rs4420638	1.97E-42	"APOC1, APOE, TOMM40"	NR	NR	0.32	0.32	APOC1	SNP-based	Disease risk	22832961	Caucasian	ADGC	2229	All	LOAD	AD	downstream_gene_variant
chr19	44919689	rs4420638	1.99E-11	"APOC1, APOE, TOMM40"	NR	NR	NR	NA	APOC1	SNP-based	Disease risk	22832961	Caucasian	ADGC	8292	All	LOAD	AD	downstream_gene_variant
chr19	44919689	rs4420638	4.14E-14	"APOC1, APOE, TOMM40"	NR	NR	2.2	9.02501	APOC1	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	1190	AD subjects	Age at onset	Other	downstream_gene_variant
chr19	44919689	rs4420638	6.44E-22	"APOC1, APOE, TOMM40"	NR	NR	0.38	0.38	APOC1	SNP-based	Disease risk	22832961	Caucasian	MIRAGE	1262	All	LOAD	AD	downstream_gene_variant
chr19	44919689	rs4420638	7.38E-38	"APOC1, APOE, TOMM40"	NR	NR	0.25	0.25	APOC1	SNP-based	Disease risk	22832961	Caucasian	ADGC	2321	All	LOAD	AD	downstream_gene_variant
chr19	44919689	rs4420638	7.91E-149	"APOC1, APOE, TOMM40"	NR	NR	0.29	0.29	APOC1	SNP-based	Disease risk	22832961	Caucasian	ADGC	8292	All	LOAD	AD	downstream_gene_variant
chr19	44944779	rs1132899	0.000017	APOE	NR	NR	NR	NA	APOC4	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	2724	All	LOAD	AD	missense_variant
chr19	44944779	rs1132899	0.000028	APOE	NR	NR	NR	NA	APOC4	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	2724	All	LOAD	AD	missense_variant
chr19	44944779	rs1132899	0.000076	APOC2	NR	NR	1.19	1.19	APOC4	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	3870	All	LOAD	AD	missense_variant
chr19	44944779	rs1132899	0.00019	APOE	NR	NR	NR	NA	APOC4	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	2724	All	LOAD	AD	missense_variant
chr19	44944779	rs1132899	0.0049	APOE	NR	NR	NR	NA	APOC4	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	2724	All	LOAD	AD	missense_variant
chr19	44944779	rs1132899	0.0075	APOC2	NR	NR	NR	NA	APOC4	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	720	All	LOAD	AD	missense_variant
chr19	44944779	rs1132899	0.013	APOC2	NR	NR	NR	NA	APOC4	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	658	All	LOAD	AD	missense_variant
chr19	44944779	rs1132899	0.056	APOC2	NR	NR	NR	NA	APOC4	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	570	All	LOAD	AD	missense_variant
chr19	44944779	rs1132899	0.13	APOE	NR	NR	NR	NA	APOC4	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	2724	All	LOAD	AD	missense_variant
chr19	44944779	rs1132899	0.137	APOC2	NR	NR	NR	NA	APOC4	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	776	All	LOAD	AD	missense_variant
chr19	44944779	rs1132899	0.975	APOC2	NR	NR	NR	NA	APOC4	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	1146	All	LOAD	AD	missense_variant
chr19	44946027	rs2288911	6.42E-10	APOC2	NR	NR	NR	NA	APOC4-APOC2	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	5_prime_UTR_variant
chr19	44954978	rs41334244	5.01E-09	NR	NR	NR	NR	NA	CLPTM1	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	5_prime_UTR_variant
chr19	44979627	rs7257916	3.53E-08	CLPTM1	NR	NR	NR	NA	CLPTM1	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr19	44984163	rs16979600	4.36E-11	CLPTM1	NR	NR	NR	NA	CLPTM1	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr19	45040529	rs1560725	4.72E-08	SFRS16	NR	NR	NR	NA	CLASRP	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr19	45086337	rs1469704	0.0000126	GEMIN7	NR	NR	NR	NA	GEMIN7	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr19	45187631	rs12460985	3.21E-08	"BL0C1S3, EXOC3L2"	NR	NR	NR	NA	MARK4	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	5_prime_UTR_variant
chr19	45205500	rs2627641	1.26E-13	"BL0C1S3, EXOC3L2"	NR	NR	NR	NA	MARK4	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr19	45205630	rs597668	0.00000216	EXOC3L2	C	C	1.18	1.18	MARK4	SNP-based	Disease risk	20460622	Caucasian	"ADGC, CHARGE, EADI"	24035	All	AD	AD	intron_variant
chr19	45205630	rs597668	0.000591	EXOC3L2	C	C	1.18	1.18	MARK4	SNP-based	Disease risk	20460622	Caucasian	"ADGC, CHARGE"	16675	All	AD	AD	intron_variant
chr19	45205630	rs597668	0.00823	EXOC3L2	C	C	0.88	0.88	MARK4	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	2024	All	LOAD	AD	intron_variant
chr19	45205630	rs597668	0.01	EXOC3L2	NR	NR	1.26	1.26	MARK4	SNP-based	Disease risk	20460622	Caucasian	Cohort from Europe	2349	All	AD	AD	intron_variant
chr19	45205630	rs597668	0.59	"EXOC3L2, BLOC1S3, MARK4"	NR	NR	1.04	1.04	MARK4	SNP-based	Endophenotype	26993346	Caucasian	Cohort from Europe	10840	All	PCA (posterior cortical atrophy)	Imaging	intron_variant
chr19	45205630	rs597668	0.731	EXOC3L2	C	C	0.97	0.97	MARK4	SNP-based	Disease risk	23565137	Asian	Cohort from Korea	1468	All	LOAD	AD	intron_variant
chr19	45205630	rs597668	6.45E-09	EXOC3L2	C	C	1.17	1.17	MARK4	SNP-based	Disease risk	20460622	Caucasian	"ADGC, CHARGE, EADI, GERAD"	34363	All	AD	AD	intron_variant
chr19	45222848	rs10422797	0.00000102	EXOC3L2	C	C	1.82	1.82	MARK4	SNP-based	Disease risk	24755620	Caucasian	ADGC	4569	All	AD	AD	intron_variant
chr19	45224865	rs10410003	0.00000311	EXOC3L2	NR	NR	NR	NA	MARK4	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	synonymous_variant
chr19	45226017	rs346763	0.000000367	EXOC3L2	A	A	1.8	1.8	MARK4	SNP-based	Disease risk	24755620	Caucasian	ADGC	4569	All	AD	AD	intron_variant
chr19	45595627	rs10405576	1.10E-26	GPR4	NR	NR	-1.35	0.25924	OPA3	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	GPR4 expression in Cerebellar	Expression	intron_variant
chr19	45595627	rs10405576	1.39E-58	GPR4	NR	NR	-1.53	0.216536	OPA3	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	GPR4 expression in Temporal cortex	Expression	intron_variant
chr19	45595627	rs10405576	2.16E-28	GPR4	NR	NR	-1.27	0.280832	OPA3	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	GPR4 expression in Cerebellar	Expression	intron_variant
chr19	45595627	rs10405576	2.56E-62	GPR4	NR	NR	-1.32	0.267135	OPA3	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	GPR4 expression in Cerebellar	Expression	intron_variant
chr19	45698914	rs2287019	0.123	NR	C	C	0.923	0.923	QPCTL	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	intron_variant
chr19	45698914	rs2287019	0.243	NR	C	C	0.949	0.949	QPCTL	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	intron_variant
chr19	45698914	rs2287019	0.42	NR	C	C	0	1	QPCTL	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	intron_variant
chr19	45698914	rs2287019	0.949	NR	C	C	0.998	0.998	QPCTL	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	intron_variant
chr19	45738583	rs76320948	0.0000154	AC074212.3	T	T	NR	NA	BHMG1	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ"	79145	All	AD	AD	intron_variant
chr19	45738583	rs76320948	0.000018	AC074212.3	T	T	NR	NA	BHMG1	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	intron_variant
chr19	45738583	rs76320948	4.64E-08	AC074212.3	T	T	5.46	NA	BHMG1	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ, UKBB"	455258	All	AD + AD-by-proxy	AD	intron_variant
chr19	45772798	rs16939	0.0000464	DMPK	NR	NR	NR	NA	DMPK	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr19	45842628	rs16980051	0.00000661	SYMPK	NR	NR	NR	NA	SYMPK	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr19	45842628	rs16980051	0.00000661	SYMPK	T	T	NR	NA	SYMPK	SNP-based	Cross phenotype 	27088644	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr19	45842628	rs16980051	0.000933	SYMPK	T	T	NR	NA	SYMPK	SNP-based	Cross phenotype 	27088644	Caucasian	Cohort of Immune-Mediated Diseases	51009	All	Crohn disease	Non-ADRD	intron_variant
chr19	47065746	rs3810291	0.083	NR	A	A	0.948	0.948	ZC3H4	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	3_prime_UTR_variant
chr19	47065746	rs3810291	0.19	NR	A	A	0.942	0.942	ZC3H4	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	3_prime_UTR_variant
chr19	47065746	rs3810291	0.294	NR	A	A	0	1	ZC3H4	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	3_prime_UTR_variant
chr19	47065746	rs3810291	0.589	NR	A	A	1.02	1.02	ZC3H4	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	3_prime_UTR_variant
chr19	51224706	rs3865444	0.000000051	CD33	A	A	0.91	0.91	CD33	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD"	54162	All	LOAD	AD	upstream_gene_variant
chr19	51224706	rs3865444	0.000000107	CD33	A	A	0.89	0.89	CD33	SNP-based	Disease risk	21460841	Caucasian	ADGC	22771	All	LOAD	AD	upstream_gene_variant
chr19	51224706	rs3865444	0.000000201	CD33	A	A	0.89	0.89	CD33	SNP-based	Disease risk	21460841	Caucasian	ADGC	22771	All	LOAD	AD	upstream_gene_variant
chr19	51224706	rs3865444	0.00000082	CD33	A	A	0.88	0.88	CD33	SNP-based	Disease risk	21460841	Caucasian	ADGC	15675	All	LOAD	AD	upstream_gene_variant
chr19	51224706	rs3865444	0.00000189	CD33	A	A	0.88	0.88	CD33	SNP-based	Disease risk	21460841	Caucasian	ADGC	15675	All	LOAD	AD	upstream_gene_variant
chr19	51224706	rs3865444	0.000003	CD33	A	A	0.94	0.94	CD33	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD, Cohorts from Europe and USA"	74046	All	LOAD	AD	upstream_gene_variant
chr19	51224706	rs3865444	0.0000196	CD33	NR	NR	-0.255	0.774916	CD33	SNP-based	eQTL	30448613	Caucasian	UKBEC	49	All	IER2 (t3822216) expression in temporal cortex	Expression	upstream_gene_variant
chr19	51224706	rs3865444	0.0000497	CD33	A	A	NR	NA	CD33	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	upstream_gene_variant
chr19	51224706	rs3865444	0.00022	CD33	NR	NR	0.89	0.89	CD33	SNP-based	Disease risk	21460840	Caucasian	"EADI, GERAD"	13448	All	AD	AD	upstream_gene_variant
chr19	51224706	rs3865444	0.000449	CD33	NR	NR	0.91	0.91	CD33	SNP-based	Disease risk	30448613	Caucasian	ADGC	15330	All	AD	AD	upstream_gene_variant
chr19	51224706	rs3865444	0.002	CD33	NR	NR	0.92	0.92	CD33	SNP-based	Disease risk	21460841	Caucasian	"CHARGE, EADI, GERAD"	25818	All	LOAD	AD	upstream_gene_variant
chr19	51224706	rs3865444	0.008	CD33	A	A	0.87	0.87	CD33	SNP-based	Disease risk	26339675	Caribbean Hispanic	"EFIGA, NOMAS, WHICAP "	4514	All	LOAD	AD	upstream_gene_variant
chr19	51224706	rs3865444	0.015	CD33	A	A	0.87	0.87	CD33	SNP-based	Disease risk	26339675	Caribbean Hispanic	"EFIGA, NOMAS, WHICAP "	4514	All	LOAD	AD	upstream_gene_variant
chr19	51224706	rs3865444	0.016	CD33 	A	A	0.86	0.86	CD33	SNP-based	Endophenotype	25188341	Caucasian	ADGC	4914	All	Clinico-pathologic AD dementia (No neuropathologist documentation)	Neuropathology	upstream_gene_variant
chr19	51224706	rs3865444	0.0213	CD33	A	A	0.91	0.91	CD33	SNP-based	Disease risk	21460841	Caucasian	ADGC	7096	All	LOAD	AD	upstream_gene_variant
chr19	51224706	rs3865444	0.026	CD33 	A	A	0.84	0.84	CD33	SNP-based	Endophenotype	25188341	Caucasian	ADGC	3702	All	Clinico-pathologic AD dementia (with neuropathologist documentation)	Neuropathology	upstream_gene_variant
chr19	51224706	rs3865444	0.0293	CD33	A	A	0.92	0.92	CD33	SNP-based	Disease risk	21460841	Caucasian	ADGC	7096	All	LOAD	AD	upstream_gene_variant
chr19	51224706	rs3865444	0.174	NR	A	A	-0.04	0.960789	CD33	SNP-based	Endophenotype	23836404	Caucasian	ADGC	725	All	Neuritic Plaque Pathologic Burden	Neuropathology	upstream_gene_variant
chr19	51224706	rs3865444	0.206	CD33	A	A	1.09	NA	CD33	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	upstream_gene_variant
chr19	51224706	rs3865444	0.338	CD33 	A	A	0.13	1.13883	CD33	SNP-based	Age at onset (AAO) / Survival	25199842	Caucasian	ADGC	9162	LOAD subjects	Age of AD onset	Other	upstream_gene_variant
chr19	51224706	rs3865444	0.377	CD33 	A	A	0.1	1.10517	CD33	SNP-based	Age at onset (AAO) / Survival	25199842	Caucasian	ADGC	9162	LOAD subjects	Age of AD onset	Other	upstream_gene_variant
chr19	51224706	rs3865444	0.492	CD33	A	A	1.04	1.04	CD33	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	2024	All	LOAD	AD	upstream_gene_variant
chr19	51224706	rs3865444	0.69	CD33	A	A	0.99	0.99	CD33	SNP-based	Disease risk	24162737	Caucasian	Cohorts from Europe and USA	19884	All	LOAD	AD	upstream_gene_variant
chr19	51224706	rs3865444	0.69	CD33	NR	NR	0.95	0.95	CD33	SNP-based	Endophenotype	26993346	Caucasian	Cohort from Europe	10840	All	PCA (posterior cortical atrophy)	Imaging	upstream_gene_variant
chr19	51224706	rs3865444	0.732	CD33	A	A	0.95	0.95	CD33	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	upstream_gene_variant
chr19	51224706	rs3865444	1.60E-09	CD33	NR	NR	0.91	0.91	CD33	SNP-based	Disease risk	21460840	Caucasian	"ADGC, GERAD"	NR	All	AD	AD	upstream_gene_variant
chr19	51224706	rs3865444	1.60E-09	CD33	NR	NR	0.91	0.91	CD33	SNP-based	Disease risk	21460841	Caucasian	"ADGC, CHARGE, EADI, GERAD"	48589	All	LOAD	AD	upstream_gene_variant
chr19	51224706	rs3865444	4.25E-08	CD33	A	A	NR	NA	CD33	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ"	79145	All	AD	AD	upstream_gene_variant
chr19	51224706	rs3865444	6.34E-09	CD33	A	A	-5.81	NA	CD33	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ, UKBB"	455258	All	AD + AD-by-proxy	AD	upstream_gene_variant
chr19	51224706	rs3865444	NR	CD33	C	C	1.26	1.26	CD33	SNP-based	Disease risk	27849641	Caucasian	ADGC	589	All	Symptomatic AD (CDR global score >=0.5)	AD	upstream_gene_variant
chr19	51224706	rs3865444	NR	ZCWPW1	C	C	1.28	1.28	CD33	SNP-based	Disease risk	27849641	Caucasian	ADGC	292	APOE-e4 carriers	Symptomatic AD (CDR global score >=0.5)	AD	upstream_gene_variant
chr19	51224706	rs3865444	NR	ZCWPW1	C	C	1.44	1.44	CD33	SNP-based	Disease risk	27849641	Caucasian	ADGC	297	APOE-e4 non-carriers	Symptomatic AD (CDR global score >=0.5)	AD	upstream_gene_variant
chr19	51225221	rs12459419	0.000402	CD33	NR	NR	0.91	0.91	CD33	SNP-based	Disease risk	30448613	Caucasian	ADGC	15330	All	AD	AD	missense_variant
chr19	51293865	rs10419982	0.00054	CD33	A	A	1.38	1.38	IGLON5	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intergenic_region
chr19	55051034	rs6509916	0.00000583	RDH13	G	G	1.34	1.34	RDH13	SNP-based	Disease risk	20885792	Caucasian	"CAP, MSBB, NCRAD"	2035	All	LOAD	AD	intron_variant
chr19	55051034	rs6509916	0.0223	RDH13	G	G	0.87	0.87	RDH13	SNP-based	Disease risk	20885792	Caucasian	"ADGC, CAP, CHARGE"	2979	All	LOAD	AD	intron_variant
chr19	55051034	rs6509916	0.0334	RDH13	G	G	1.1	1.1	RDH13	SNP-based	Disease risk	20885792	Caucasian	"ADGC, CAP, CHARGE"	4355	All	LOAD	AD	intron_variant
chr19	56182251	rs3745833	0.00005	GALP	NR	NR	1.2	1.2	GALP	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	3870	All	LOAD	AD	splice_region_variant&synonymous_variant
chr19	56182251	rs3745833	0.008	GALP	NR	NR	NR	NA	GALP	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	776	All	LOAD	AD	splice_region_variant&synonymous_variant
chr19	56182251	rs3745833	0.036	GALP	NR	NR	NR	NA	GALP	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	720	All	LOAD	AD	splice_region_variant&synonymous_variant
chr19	56182251	rs3745833	0.061	GALP	NR	NR	NR	NA	GALP	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	1146	All	LOAD	AD	splice_region_variant&synonymous_variant
chr19	56182251	rs3745833	0.261	GALP	NR	NR	NR	NA	GALP	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	658	All	LOAD	AD	splice_region_variant&synonymous_variant
chr19	56182251	rs3745833	0.512	GALP	NR	NR	NR	NA	GALP	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	570	All	LOAD	AD	splice_region_variant&synonymous_variant
chr19	58262705	rs260462	1.88E-125	ZNF544	NR	NR	-1.3	0.272532	ZNF544	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	ZNF544 expression in Temporal cortex	Expression	missense_variant
chr19	58262705	rs260462	3.19E-48	ZNF544	NR	NR	-1.21	0.298197	ZNF544	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	ZNF544 expression in Cerebellar	Expression	missense_variant
chr19	58262705	rs260462	3.67E-95	ZNF544	NR	NR	-1.16	0.313486	ZNF544	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	ZNF544 expression in Cerebellar	Expression	missense_variant
chr19	58262705	rs260462	7.79E-42	ZNF544	NR	NR	-1.12	0.32628	ZNF544	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	ZNF544 expression in Cerebellar	Expression	missense_variant
chr2	622827	rs2867125	0.343	NR	C	C	0.973	0.973	TMEM18	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	intergenic_region
chr2	622827	rs2867125	0.39	NR	C	C	1.051	1.051	TMEM18	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	intergenic_region
chr2	622827	rs2867125	0.701	NR	C	C	0.982	0.982	TMEM18	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	intergenic_region
chr2	622827	rs2867125	0.93	NR	C	C	0	1	TMEM18	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	intergenic_region
chr2	5329700	rs6734151	0.872	NR	NR	NR	NR	NA	SOX11	SNP-based	Endophenotype	20452100	Caucasian	ADGC	311	Non-Demented autopsy subjects	High Braak vs Low Braak	Neuropathology	intergenic_region
chr2	10338810	rs4669573	0.00000367	"HPCAL1, ODC1"	NR	NR	NR	NA	HPCAL1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intron_variant
chr2	10338810	rs4669573	0.0000526	"HPCAL1, ODC1"	NR	NR	NR	NA	HPCAL1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr2	10338810	rs4669573	0.000085	NR	NR	NR	1.64	1.64	HPCAL1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intron_variant
chr2	10338810	rs4669573	0.00118	NR	NR	NR	1.42	1.42	HPCAL1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr2	10338810	rs4669573	0.00628	"HPCAL1, ODC1"	NR	NR	NR	NA	HPCAL1	SNP-based	Disease risk	21059989	Caucasian	ADGC	1390	Unrelated individuals	LOAD	AD	intron_variant
chr2	10338810	rs4669573	0.2504	"HPCAL1, ODC1"	NR	NR	NR	NA	HPCAL1	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intron_variant
chr2	10338810	rs4669573	0.3831	"HPCAL1, ODC1"	NR	NR	NR	NA	HPCAL1	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intron_variant
chr2	10338810	rs4669573	0.523	"HPCAL1, ODC1"	NR	NR	NR	NA	HPCAL1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intron_variant
chr2	10338810	rs4669573	1	NR	NR	NR	1.11	1.11	HPCAL1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intron_variant
chr2	10345283	rs10197851	0.00000713	NR	NR	NR	NR	NA	HPCAL1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intron_variant
chr2	10345283	rs10197851	0.000102	NR	NR	NR	NR	NA	HPCAL1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr2	10345283	rs10197851	0.00016	NR	NR	NR	0.62	0.62	HPCAL1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intron_variant
chr2	10345283	rs10197851	0.00221	NR	NR	NR	0.71	0.71	HPCAL1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr2	10345283	rs10197851	0.0202	NR	NR	NR	NR	NA	HPCAL1	SNP-based	Disease risk	21059989	Caucasian	ADGC	1390	Unrelated individuals	LOAD	AD	intron_variant
chr2	10345283	rs10197851	0.10894	NR	NR	NR	NR	NA	HPCAL1	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intron_variant
chr2	10345283	rs10197851	0.543	NR	NR	NR	NR	NA	HPCAL1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intron_variant
chr2	10345283	rs10197851	0.7171	NR	NR	NR	NR	NA	HPCAL1	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intron_variant
chr2	10345283	rs10197851	1	NR	NR	NR	0.91	0.91	HPCAL1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intron_variant
chr2	12731066	rs13408093	2.12E-25	TRIB2	NR	NR	NR	NA	TRIB2	SNP-based	Cross phenotype 	27357110	Caucasian	"ADNI, Knight-ADRC"	543	NA	CSF Prolactin	Fluid biomarker	intron_variant
chr2	12731066	rs13408093	6.88E-10	TRIB2	NR	NR	NR	NA	TRIB2	SNP-based	Cross phenotype 	27357110	Caucasian	"ADNI, Knight-ADRC"	587	NA	Plasma Prolactin	Fluid biomarker	intron_variant
chr2	17246318	rs11889338	0.00000894	NR	A	A	1.55	1.55	RAD51AP2	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intergenic_region
chr2	17593765	rs4038131	0.00000059	VSNL1	NR	NR	0.65	0.65	VSNL1	SNP-based	Disease risk	22005930	Caucasian	"ADGC, GERAD, Cohort from UK"	7693	AD+P and control subjects	AD+Psychosis	ADRD	intron_variant
chr2	24935139	rs713586	0.018	NR	C	C	0.905	0.905	DNAJC27	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	intergenic_region
chr2	24935139	rs713586	0.446	NR	C	C	0	1	DNAJC27	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	intergenic_region
chr2	24935139	rs713586	0.46	NR	C	C	0.974	0.974	DNAJC27	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	intergenic_region
chr2	24935139	rs713586	0.784	NR	C	C	1.01	1.01	DNAJC27	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	intergenic_region
chr2	27684606	rs17006206	0.0000023	SLC4A1AP	G	G	2.05	2.05	SLC4A1AP	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr2	34687783	rs11683103	0.00000858	NR	NR	NR	NR	NA	FAM98A	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	intron_variant
chr2	37237087	rs61208496	0.0000573	C20RF56	T	T	NR	NA	NDUFAF7	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr2	37237087	rs61208496	0.000188	C20RF56	T	T	NR	NA	NDUFAF7	SNP-based	Cross phenotype 	30413934	Caucasian	"GIANT, UKBB"	180423	All	Waist-to-hip ratio (WHR)	Non-ADRD	intron_variant
chr2	37237087	rs61208496	0.00804	C20RF56	T	T	1	1	NDUFAF7	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr2	43439852	rs7575024	0.0000026	THADA	NR	NR	NR	NA	THADA	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr2	43459106	rs17030835	0.0000017	THADA	NR	NR	NR	NA	THADA	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr2	43836592	rs72796734	0.0000233	ABCG5	T	T	NR	NA	ABCG5	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Low-density lipoprotein (LDL)	Non-ADRD	intron_variant
chr2	43836592	rs72796734	0.000829	ABCG5	T	T	NR	NA	ABCG5	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr2	43836592	rs72796734	0.0132	ABCG5	T	T	0.93	0.93	ABCG5	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intron_variant
chr2	43836592	rs72796734	0.0326	ABCG5	T	T	0.94	0.94	ABCG5	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intron_variant
chr2	43836592	rs72796734	0.115	ABCG5	T	T	0.84	0.84	ABCG5	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intron_variant
chr2	43836592	rs72796734	0.624	ABCG5	T	T	1	1	ABCG5	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr2	45751503	rs1456585679	0.0011	NR	G	G	-0.18	0.83527		SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	878	AD subjects	CSF Ab1-42	Fluid biomarker	NA
chr2	45775021	rs6753292	0.91	NR	T	T	0.01	1.01005	PRKCE	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	515	AD subjects	CSF Ab1-42	Fluid biomarker	intron_variant
chr2	45797073	rs6720975	0.000029	PRKCE	A	A	1.61	5.00281	PRKCE	SNP-based	Endophenotype	23374588	Caucasian	Cohort from Italy	337	Probable AD	Delta MMSE (annualized difference between MMSE score at baseline and at follow-up)	Cognitive	intron_variant
chr2	45797073	rs6720975	0.000387	PRKCE	A	A	1.76	1.76	PRKCE	SNP-based	Endophenotype	23374588	Caucasian	Cohort from Italy	337	Probable AD	"Responder (MMSE increased, remained stable, or the Delta MMSE fell by 1or less) vs Non-responder (worsening of >3 points in Delta MMSE)"	Cognitive	intron_variant
chr2	45797073	rs6720975	0.000449	PRKCE	A	A	1.81	6.11045	PRKCE	SNP-based	Endophenotype	23374588	Caucasian	Cohort from Italy	169	Probable AD	Delta MMSE (annualized difference between MMSE score at baseline and at follow-up)	Cognitive	intron_variant
chr2	45797073	rs6720975	0.000514	PRKCE	A	A	2.19	2.19	PRKCE	SNP-based	Endophenotype	23374588	Caucasian	Cohort from Italy	169	Probable AD	"Responder (MMSE increased, remained stable, or the Delta MMSE fell by 1or less) vs Non-responder (worsening of >3 points in Delta MMSE)"	Cognitive	intron_variant
chr2	45797073	rs6720975	0.026	PRKCE	A	A	1.33	3.78104	PRKCE	SNP-based	Endophenotype	23374588	Caucasian	Cohort from Italy	168	Probable AD	Delta MMSE (annualized difference between MMSE score at baseline and at follow-up)	Cognitive	intron_variant
chr2	45797073	rs6720975	0.112	PRKCE	A	A	1.43	1.43	PRKCE	SNP-based	Endophenotype	23374588	Caucasian	Cohort from Italy	168	Probable AD	"Responder (MMSE increased, remained stable, or the Delta MMSE fell by 1or less) vs Non-responder (worsening of >3 points in Delta MMSE)"	Cognitive	intron_variant
chr2	46886961	rs6715234	0.00000882	"MCFD2, LOC388948"	NR	NR	NR	NA	MCFD2	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr2	47658337	rs2969775	0.00000211	AC079250.1	NR	NR	0.68	0.68	MSH2	SNP-based	Disease risk	22005930	Caucasian	"ADGC, GERAD"	2034	AD+P and AD-P subjects	AD+Psychosis	ADRD	intergenic_region
chr2	50648741	rs858952	0.00000945	NRXN1	C	C	NR	NA	NRXN1	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr2	50648741	rs858952	0.000222	NRXN1	C	C	NR	NA	NRXN1	SNP-based	Cross phenotype 	30413934	Caucasian	GIANT	681275	All	Body-mass index (BMI)	Non-ADRD	intron_variant
chr2	50648741	rs858952	0.00308	NRXN1	C	C	1.05	1.05	NRXN1	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intron_variant
chr2	50648741	rs858952	0.00769	NRXN1	C	C	1.04	1.04	NRXN1	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intron_variant
chr2	50648741	rs858952	0.234	NRXN1	C	C	1	1	NRXN1	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr2	50648741	rs858952	0.467	NRXN1	C	C	0.96	0.96	NRXN1	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intron_variant
chr2	53040635	rs77597338	0.000011	ASB3	NR	NR	NR	NA	ASB3	SNP-based	Cross phenotype 	28780673	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr2	53040635	rs77597338	0.0044	ASB3	NR	NR	NR	NA	ASB3	SNP-based	Cross phenotype 	28780673	Caucasian	"GAME-ON, IGAP"	116992	All	AD + Breast cancer + Lung Cancer	Non-ADRD	intergenic_region
chr2	53040635	rs77597338	0.0045	ASB3	NR	NR	NR	NA	ASB3	SNP-based	Cross phenotype 	28780673	Caucasian	GAME-ON	28998	All	Lung Cancer	Non-ADRD	intergenic_region
chr2	53040635	rs77597338	0.025	ASB3	NR	NR	NR	NA	ASB3	SNP-based	Cross phenotype 	28780673	Caucasian	GAME-ON	33832	All	Breast Cancer	Non-ADRD	intergenic_region
chr2	55925615	rs146896516	3.91E-12	NR	A	A	0.15	1.16183	EFEMP1	SNP-based	Endophenotype	29752348	Caucasian	UKBB	8429	All	White Matter Hyperintensity Volume	Imaging	upstream_gene_variant
chr2	57912830	rs140500963	0.0135	VRK2	NR	NR	NR	NA	VRK2	SNP-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr2	57912830	rs140500963	0.98402	NA	NR	NR	NR	NA	VRK2	Gene-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr2	59046446	rs72804029	0.0000027	NR	T	T	-0.8	0.449329	FANCL	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	363	AD subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr2	59046446	rs72804029	0.01	NR	T	T	-0.26	0.771052	FANCL	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	878	AD subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr2	59046446	rs72804029	0.73	NR	T	T	0.04	1.04081	FANCL	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	515	AD subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr2	59075742	rs887912	0.074	NR	T	T	1.083	1.083	FANCL	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	intergenic_region
chr2	59075742	rs887912	0.508	NR	T	T	0.984	0.984	FANCL	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	intergenic_region
chr2	59075742	rs887912	0.778	NR	T	T	0.989	0.989	FANCL	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	intergenic_region
chr2	59075742	rs887912	0.791	NR	T	T	0.001	1.001	FANCL	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	intergenic_region
chr2	60375757	rs243034	0.00000131	MIR4432	C	C	1.52	1.52	BCL11A	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	intron_variant
chr2	61149328	rs720201	0.000694	C2orf74	C	C	NR	NA	C2orf74	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	17480	Plan 1 (males and females)	AD	AD	intron_variant
chr2	61149328	rs720201	1.34E-164	NR	C	C	NR	NA	C2orf74	SNP-based	eQTL	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	17480	Plan 1 (males and females)	C2orf74 (ILMN_1754501) expression	Expression	intron_variant
chr2	61177796	rs2600667	0.000175	AHSA2	T	T	NR	NA	USP34	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AD	AD	5_prime_UTR_variant
chr2	61177796	rs2600667	1.53E-22	NR	T	T	NR	NA	USP34	SNP-based	eQTL	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AHSA2 expression in Caudate basal ganglia	Expression	5_prime_UTR_variant
chr2	61177796	rs2600667	2.30E-15	NR	T	T	NR	NA	USP34	SNP-based	eQTL	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AHSA2 expression in Hypothalamus	Expression	5_prime_UTR_variant
chr2	61177796	rs2600667	2.65E-24	NR	T	T	NR	NA	USP34	SNP-based	eQTL	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AHSA2 expression in Nucleus accumbens	Expression	5_prime_UTR_variant
chr2	61177796	rs2600667	5.43E-13	NR	T	T	NR	NA	USP34	SNP-based	eQTL	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AHSA2 expression in Substantia nigra	Expression	5_prime_UTR_variant
chr2	61177796	rs2600667	6.30E-28	NR	T	T	NR	NA	USP34	SNP-based	eQTL	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AHSA2 expression in Cortex	Expression	5_prime_UTR_variant
chr2	61177796	rs2600667	7.23E-22	NR	T	T	NR	NA	USP34	SNP-based	eQTL	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AHSA2 expression in Putamen basal ganglia	Expression	5_prime_UTR_variant
chr2	61177796	rs2600667	9.79E-40	NR	T	T	NR	NA	USP34	SNP-based	eQTL	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AHSA2 expression in Cerebellum	Expression	5_prime_UTR_variant
chr2	64732197	rs12994639	0.0000953	SERTAD2	G	G	NR	NA	SERTAD2	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Total cholesterol (TC)	Non-ADRD	intron_variant
chr2	64732197	rs12994639	0.0016	SERTAD2	G	G	NR	NA	SERTAD2	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr2	64732197	rs12994639	0.234	SERTAD2	G	G	1	1	SERTAD2	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr2	64839177	rs741477	0.0000305	NR	G	G	NR	NA	SERTAD2	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intergenic_region
chr2	64839177	rs741477	0.0000544	Intergenic (as reported in paper)	G	G	NR	NA	SERTAD2	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intergenic_region
chr2	64839177	rs741477	0.00124	NR	G	G	NR	NA	SERTAD2	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intergenic_region
chr2	64855281	rs55819441	0.00014	AK097952	T	T	NR	NA	SERTAD2	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Low-density lipoprotein (LDL)	Non-ADRD	intron_variant
chr2	64855281	rs55819441	0.000956	AK097952	T	T	NR	NA	SERTAD2	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr2	64855281	rs55819441	0.0755	AK097952	T	T	0.96	0.96	SERTAD2	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intron_variant
chr2	64855281	rs55819441	0.101	AK097952	T	T	0.97	0.97	SERTAD2	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intron_variant
chr2	64855281	rs55819441	0.627	AK097952	T	T	1	1	SERTAD2	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr2	64855281	rs55819441	0.635	AK097952	T	T	1.05	1.05	SERTAD2	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intron_variant
chr2	69138666	rs7561207	0.00000408	ANTXR1	A	A	0.47	0.47	ANTXR1	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AD	AD	intron_variant
chr2	73928514	rs7557705	0.00494	DGUOK	T	T	NR	NA	DGUOK	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	intron_variant
chr2	73928514	rs7557705	3.29E-11	NR	T	T	NR	NA	DGUOK	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	DGUOK (ILMN_2242403) expression	Expression	intron_variant
chr2	88218921	rs7589728	0.00000495	THNSL2	NR	NR	NR	NA	THNSL2	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	818	All	Plasma Clusterin	Fluid biomarker	intergenic_region
chr2	88595833	rs7571971	0.0703	RPIA	NR	NR	-0.04	0.960789	EIF2AK3	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	RPIA (ILMN_1714809) expression in Cerebellar	Expression	5_prime_UTR_variant
chr2	88595833	rs7571971	0.0957	RPIA	NR	NR	-0.07	0.932394	EIF2AK3	SNP-based	eQTL	22685416	Caucasian	MAYO	98	PSP	RPIA (ILMN_1714809) expression in Cerebellar	Expression	5_prime_UTR_variant
chr2	88595833	rs7571971	0.519	RPIA	NR	NR	0.03	1.03045	EIF2AK3	SNP-based	eQTL	22685416	Caucasian	MAYO	107	PSP	RPIA (ILMN_1714809) expression in Temporal cortex	Expression	5_prime_UTR_variant
chr2	88595833	rs7571971	0.768	RPIA	NR	NR	0.01	1.01005	EIF2AK3	SNP-based	eQTL	22685416	Caucasian	MAYO	202	AD	RPIA (ILMN_1714809) expression in Temporal cortex	Expression	5_prime_UTR_variant
chr2	88595833	rs7571971	0.921	RPIA	NR	NR	0	1	EIF2AK3	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	RPIA (ILMN_1714809) expression in Temporal cortex	Expression	5_prime_UTR_variant
chr2	88595833	rs7571971	4.20E-13	EIF2AK3	NA	NA	0.75	0.75	EIF2AK3	SNP-based	Disease Risk	22685416	Caucasian	"Cohorts from Europe, USA"	8851	All	Progressive Supranuclear Palsy (PSP)	ADRD	5_prime_UTR_variant
chr2	100933381	rs3754675	0.0000057	NPAS2	C	C	NR	NA	NPAS2	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr2	100933381	rs3754675	0.00003	NPAS2	C	C	NR	NA	NPAS2	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intron_variant
chr2	100933381	rs3754675	0.0144	NPAS2	C	C	NR	NA	NPAS2	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr2	106026098	rs34487851	0.00000002	ECRG4	NR	NR	NR	NA	ECRG4	SNP-based	Pleiotropy 	29458411	Caucasian	ADGC	3598	All	Neuritic plaque (NP)+Neurofibrillary tangles (NFT)	Neuropathology	intergenic_region
chr2	106026098	rs34487851	0.00000077	ECRG4	NR	NR	-0.3	0.740818	ECRG4	SNP-based	Pleiotropy 	29458411	Caucasian	ADGC	3598	All	Neuritic plaque (NP) 	Neuropathology	intergenic_region
chr2	106026098	rs34487851	0.0000025	ECRG4	NR	NR	NR	NA	ECRG4	SNP-based	Pleiotropy 	29458411	Caucasian	ADGC	3598	All	Neuritic plaque (NP)+Cerebral amyloid angiopathy (CAA)	Neuropathology	intergenic_region
chr2	106026098	rs34487851	0.0000045	ECRG4	NR	NR	-0.25	0.778801	ECRG4	SNP-based	Pleiotropy 	29458411	Caucasian	ADGC	3598	All	Neurofibrillary tangles (NFT)	Neuropathology	intergenic_region
chr2	106026098	rs34487851	0.0000058	ECRG4	NR	NR	-0.42	0.657047	ECRG4	SNP-based	Pleiotropy 	29458411	Caucasian	ADGC	3598	All	AD	AD	intergenic_region
chr2	106026098	rs34487851	0.000021	ECRG4	NR	NR	NR	NA	ECRG4	SNP-based	Pleiotropy 	29458411	Caucasian	ADGC	3598	All	Neurofibrillary tangles (NFT)+Cerebral amyloid angiopathy (CAA)	Neuropathology	intergenic_region
chr2	106026098	rs34487851	0.06	ECRG4	NR	NR	-0.14	0.869358	ECRG4	SNP-based	Pleiotropy 	29458411	Caucasian	ADGC	3598	All	Cerebral amyloid angiopathy (CAA)	Neuropathology	intergenic_region
chr2	107062032	rs1357692	0.00000328	NR	NR	NR	NR	NA	ST6GAL2	SNP-based	Disease risk	22832961	Caucasian	ADGC	8292	All	LOAD	AD	intergenic_region
chr2	107062032	rs1357692	0.00000927	NR	NR	NR	0.86	0.86	ST6GAL2	SNP-based	Disease risk	22832961	Caucasian	ADGC	8292	All	LOAD	AD	intergenic_region
chr2	107062032	rs1357692	0.00463	NR	NR	NR	0.82	0.82	ST6GAL2	SNP-based	Disease risk	22832961	Caucasian	ADGC	2229	All	LOAD	AD	intergenic_region
chr2	107062032	rs1357692	0.0167	NR	NR	NR	0.82	0.82	ST6GAL2	SNP-based	Disease risk	22832961	Caucasian	MIRAGE	1262	All	LOAD	AD	intergenic_region
chr2	107062032	rs1357692	0.0482	NR	NR	NR	0.87	0.87	ST6GAL2	SNP-based	Disease risk	22832961	Caucasian	ADGC	2099	All	LOAD	AD	intergenic_region
chr2	107062032	rs1357692	0.0517	NR	NR	NR	0.88	0.88	ST6GAL2	SNP-based	Disease risk	22832961	Caucasian	ADGC	2321	All	LOAD	AD	intergenic_region
chr2	107062032	rs1357692	0.789	NR	NR	NR	1.05	1.05	ST6GAL2	SNP-based	Disease risk	22832961	Caucasian	ADNI	381	All	LOAD	AD	intergenic_region
chr2	112785383	rs1800587	0.44	IL1A	A	A	0.94	0.94	IL1A	SNP-based	Disease risk	20534741	Caucasian	"ADC, UM"	1610	All	AD	AD	upstream_gene_variant
chr2	112832813	rs1143634	0.3	IL1B	A	A	0.91	0.91	IL1B	SNP-based	Disease risk	20534741	Caucasian	"ADC, UM"	1610	All	AD	AD	synonymous_variant
chr2	118078449	rs7566605	0.111	NR	C	C	0.93	0.93	INSIG2	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	intergenic_region
chr2	118078449	rs7566605	0.665	NR	C	C	0.984	0.984	INSIG2	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	intergenic_region
chr2	118078449	rs7566605	0.953	NR	C	C	0	1	INSIG2	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	intergenic_region
chr2	119082508	rs893769	0.000000892	NR	C	C	-0.1	0.904837	C1QL2	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF T-tau	Fluid biomarker	intergenic_region
chr2	119087741	rs17189298	0.00000039	NR	A	A	NR	NA	C1QL2	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF T-tau	Fluid biomarker	intergenic_region
chr2	119087741	rs17189298	0.000000866	NR	A	A	NR	NA	C1QL2	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF T-tau	Fluid biomarker	intergenic_region
chr2	119110132	rs895401	0.00000089	NR	G	G	NR	NA	C1QL2	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF T-tau	Fluid biomarker	intergenic_region
chr2	122368903	rs10496584	0.0000041	NR	NR	NR	158.69	828307003131138266429592803503575878641942669209922682113970101288960	TSN	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	intergenic_region
chr2	122368903	rs10496584	0.00034	NR	G	G	165.94	1166343106910857841078271591364990868937452447467395666572276042085433344	TSN	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intergenic_region
chr2	122368903	rs10496584	0.00099	NR	G	G	NR	NA	TSN	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intergenic_region
chr2	122368903	rs10496584	0.0037	NR	G	G	149.68	101204086996127604347682722573438191404119470668879906903831871488	TSN	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	intergenic_region
chr2	122370213	rs2037892	0.00000479	NR	NR	NR	156.7	113225778192516786193190889471681656767738112808267176411180728057856	TSN	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	intergenic_region
chr2	122370213	rs2037892	0.00034	NR	A	A	165.5	751167440329862310341210496192109330500628623044191034523111509259714560	TSN	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intergenic_region
chr2	122370213	rs2037892	0.00095	NR	A	A	NR	NA	TSN	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intergenic_region
chr2	122370213	rs2037892	0.0043	NR	A	A	145.91	2332963018360591978642695032063321121298145414778130206738612224	TSN	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	intergenic_region
chr2	122379314	rs1919922	0.00000517	NR	NR	NR	155.52	34791874300128778888456403724168097534975308740105889483535205531648	TSN	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	intergenic_region
chr2	122379314	rs1919922	0.00034	NR	T	T	164.79	369307113359779591940024819131190099933135415107379976682050054086721536	TSN	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intergenic_region
chr2	122379314	rs1919922	0.0009	NR	T	T	NR	NA	TSN	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intergenic_region
chr2	122379314	rs1919922	0.0046	NR	T	T	144.16	405408183624573310933534702440465522384679108985781662970281984	TSN	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	intergenic_region
chr2	122383969	rs4848768	0.00000571	NR	NR	NR	154.6	13865224383620054112084047847760197899086552558971444722899747864576	TSN	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	intergenic_region
chr2	122383969	rs4848768	0.00035	NR	G	G	163.94	157847374724851772171017218428284868749599183779615801998914315001790464	TSN	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intergenic_region
chr2	122383969	rs4848768	0.00087	NR	G	G	NR	NA	TSN	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intergenic_region
chr2	122383969	rs4848768	0.0049	NR	G	G	143.1	140456020772087941672936762360645236528707767932809320364769280	TSN	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	intergenic_region
chr2	127038444	rs12476995	0.000475	BIN1	G	G	1.25	NA	BIN1	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	intergenic_region
chr2	127082205	rs10194375	0.000000361	BIN1	NR	NR	NR	NA	BIN1	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr2	127082205	rs10194375	0.0276	BIN1	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intron_variant
chr2	127082205	rs10194375	0.336	BIN1	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr2	127082205	rs10194375	0.389	BIN1	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr2	127082205	rs10194375	0.659	BIN1	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intron_variant
chr2	127083761	rs13426725	0.0416	BIN1	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr2	127083761	rs13426725	0.0715	BIN1	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr2	127083761	rs13426725	0.085	BIN1	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intron_variant
chr2	127083761	rs13426725	0.329	BIN1	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intron_variant
chr2	127084807	rs11691237	0.0098	BIN1	T	T	1.52	1.52	BIN1	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr2	127094445	rs10207628	0.00000146	BIN1	NR	NR	0.71	0.71	BIN1	SNP-based	Disease risk	22005930	Caucasian	"ADGC, GERAD, Cohort from UK"	7693	AD+P and control subjects	AD+Psychosis	ADRD	intron_variant
chr2	127104557	rs6431219	0.34	BIN1	NR	NR	1.04	1.04	BIN1	SNP-based	Disease risk	30979435	Caucasian	ADGC	6341	Age >=80 y	AD	AD	intron_variant
chr2	127104557	rs6431219	6.06E-14	BIN1	NR	NR	1.23	1.23	BIN1	SNP-based	Disease risk	30979435	Caucasian	ADGC	14225	Age 60-79 y	AD	AD	intron_variant
chr2	127110859	rs6743470	7.35E-08	"BIN1, CYP27C1"	NR	NR	NR	NA	BIN1	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	upstream_gene_variant
chr2	127115459	rs4663098	0.0285	BIN1	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intergenic_region
chr2	127115459	rs4663098	0.368	BIN1	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intergenic_region
chr2	127115459	rs4663098	0.646	BIN1	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intergenic_region
chr2	127115459	rs4663098	0.714	BIN1	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intergenic_region
chr2	127130409	rs12989701	0.00000468	NR	A	A	NR	NA	BIN1	SNP-based	Disease risk	21390209	Caucasian	"ADNI, GenADA, Pfizer"	3595	All	AD	AD	intergenic_region
chr2	127130409	rs12989701	0.0000895	BIN1	T	T	2.16	2.16	BIN1	SNP-based	Disease risk	21390209	Caucasian	ADNI	496	All	AD	AD	intergenic_region
chr2	127130409	rs12989701	0.00112	BIN1	T	T	1.17	1.17	BIN1	SNP-based	Disease risk	21390209	Caucasian	Cohort from Europe	Refer to Harold et al(2009)	All	AD	AD	intergenic_region
chr2	127130409	rs12989701	0.00216	BIN1	T	T	1.34	1.34	BIN1	SNP-based	Disease risk	21390209	Caucasian	Genizon	1502	All	AD	AD	intergenic_region
chr2	127130409	rs12989701	0.00372	BIN1	T	T	1.34	1.34	BIN1	SNP-based	Disease risk	21390209	Caucasian	ADGC	1525	All	AD	AD	intergenic_region
chr2	127130409	rs12989701	0.0372	BIN1	T	T	1.25	1.25	BIN1	SNP-based	Disease risk	21390209	Caucasian	Cohort from Europe	Refer to Harold et al(2009)	All	AD	AD	intergenic_region
chr2	127130409	rs12989701	0.0526	BIN1	T	T	1.2	1.2	BIN1	SNP-based	Disease risk	21390209	Caucasian	GenADA	1574	All	AD	AD	intergenic_region
chr2	127130409	rs12989701	0.482	BIN1	T	T	1.08	1.08	BIN1	SNP-based	Disease risk	21390209	Caucasian	Cohort from USA	Refer to Harold et al(2009)	All	AD	AD	intergenic_region
chr2	127130409	rs12989701	0.497	BIN1	NR	NR	NR	NA	BIN1	SNP-based	Endophenotype	21390209	Caucasian	"ADNI, leadC"	597	AD subjects	AD Progression	Cognitive	intergenic_region
chr2	127130409	rs12989701	3.16E-10	BIN1	T	T	1.23	1.23	BIN1	SNP-based	Disease risk	21390209	Caucasian	"ADNI, Cohorts from Europe and USA"	16881	All	AD	AD	intergenic_region
chr2	127130545	rs11685593	0.0098	BIN1	T	T	1.66	1.66	BIN1	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intergenic_region
chr2	127130545	rs11685593	0.0147	BIN1	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intergenic_region
chr2	127130545	rs11685593	0.454	BIN1	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intergenic_region
chr2	127130545	rs11685593	0.501	BIN1	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intergenic_region
chr2	127130545	rs11685593	0.522	BIN1	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intergenic_region
chr2	127132061	rs7561528	0.000003	BIN1	NR	NR	1.16	1.16	BIN1	SNP-based	Disease risk	19734902	Caucasian	Cohorts from Europe and USA	11789	All	AD	AD	intergenic_region
chr2	127132061	rs7561528	0.0000994	BIN1	NR	NR	1.29	1.29	BIN1	SNP-based	Disease risk	22832961	Caucasian	ADGC	2321	All	LOAD	AD	intergenic_region
chr2	127132061	rs7561528	0.000121	BIN1	A	A	1.15	1.15	BIN1	SNP-based	Disease risk	21460841	Caucasian	ADGC	7096	All	LOAD	AD	intergenic_region
chr2	127132061	rs7561528	0.000137	BIN1	A	A	1.15	1.15	BIN1	SNP-based	Disease risk	21460841	Caucasian	ADGC	7096	All	LOAD	AD	intergenic_region
chr2	127132061	rs7561528	0.000296	BIN1	NR	NR	1.27	1.27	BIN1	SNP-based	Disease risk	22832961	Caucasian	ADGC	2229	All	LOAD	AD	intergenic_region
chr2	127132061	rs7561528	0.0003	CUGBP2	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	intergenic_region
chr2	127132061	rs7561528	0.000478	BIN1 	A	A	-0.31	0.733447	BIN1	SNP-based	Age at onset (AAO) / Survival	25199842	Caucasian	ADGC	9162	LOAD subjects	Age of AD onset	Other	intergenic_region
chr2	127132061	rs7561528	0.0008	CUGBP2	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	intergenic_region
chr2	127132061	rs7561528	0.001	CUGBP2	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	intergenic_region
chr2	127132061	rs7561528	0.00107	BIN1	NR	NR	1.26	1.26	BIN1	SNP-based	Disease risk	22832961	Caucasian	ADGC	2099	All	LOAD	AD	intergenic_region
chr2	127132061	rs7561528	0.004	BIN1	NR	NR	-0.121	0.886034	BIN1	SNP-based	Endophenotype	20558387	Caucasian	ADNI	740	All	Entorhinal cortex thickness	Imaging	intergenic_region
chr2	127132061	rs7561528	0.00536	BIN1	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intergenic_region
chr2	127132061	rs7561528	0.009	CUGBP2	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21379329	Caucasian	ADGC	3722	All	LOAD	AD	intergenic_region
chr2	127132061	rs7561528	0.00985	BIN1 	A	A	-0.32	0.726149	BIN1	SNP-based	Age at onset (AAO) / Survival	25199842	Caucasian	ADGC	9162	LOAD subjects	Age of AD onset	Other	intergenic_region
chr2	127132061	rs7561528	0.0182	CUGBP2	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21379329	Caucasian	ADGC	3839	All	LOAD	AD	intergenic_region
chr2	127132061	rs7561528	0.02	BIN1	NR	NR	-0.041	0.959829	BIN1	SNP-based	Endophenotype	20558387	Caucasian	ADNI	740	All	Temporal pole cortex thickness	Imaging	intergenic_region
chr2	127132061	rs7561528	0.0299	CUGBP2	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21379329	Caucasian	ADGC	3839	All	LOAD	AD	intergenic_region
chr2	127132061	rs7561528	0.03	BIN1	NR	NR	1.29	1.29	BIN1	SNP-based	Disease risk	20558387	Caucasian	ADNI	740	All	AD + MCI	AD	intergenic_region
chr2	127132061	rs7561528	0.0377	CUGBP2	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21379329	Caucasian	ADGC	3786	All	LOAD	AD	intergenic_region
chr2	127132061	rs7561528	0.0438	CUGBP2	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21379329	Caucasian	ADGC	1672	APOE-e4-	LOAD	AD	intergenic_region
chr2	127132061	rs7561528	0.06	BIN1	NR	NR	-0.055	0.946485	BIN1	SNP-based	Endophenotype	20558387	Caucasian	ADNI	740	All	Hippocampal volume	Imaging	intergenic_region
chr2	127132061	rs7561528	0.0801	CUGBP2	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21379329	Caucasian	ADGC	3461	Northwestern European ancestry	LOAD	AD	intergenic_region
chr2	127132061	rs7561528	0.0866	BIN1	NR	NR	1.14	1.14	BIN1	SNP-based	Disease risk	22832961	Caucasian	MIRAGE	1262	All	LOAD	AD	intergenic_region
chr2	127132061	rs7561528	0.09	BIN1	NR	NR	-0.02	0.980199	BIN1	SNP-based	Endophenotype	20558387	Caucasian	ADNI	740	All	Amygdala volume	Imaging	intergenic_region
chr2	127132061	rs7561528	0.0905	BIN1	NR	NR	1.34	1.34	BIN1	SNP-based	Disease risk	22832961	Caucasian	ADNI	381	All	LOAD	AD	intergenic_region
chr2	127132061	rs7561528	0.0959	CUGBP2	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21379329	Caucasian	ADGC	1422	APOE-e3/e3	LOAD	AD	intergenic_region
chr2	127132061	rs7561528	0.118	CUGBP2	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21379329	Caucasian	ADGC	1642	APOE-e4/e3	LOAD	AD	intergenic_region
chr2	127132061	rs7561528	0.146	CUGBP2	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21379329	Caucasian	ADGC	250	APOE-e3/e2+e2/e2	LOAD	AD	intergenic_region
chr2	127132061	rs7561528	0.17	CUGBP2	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21379329	Caucasian	ADGC	2167	APOE-e4+	LOAD	AD	intergenic_region
chr2	127132061	rs7561528	0.24	BIN1	NR	NR	-0.019	0.981179	BIN1	SNP-based	Endophenotype	20558387	Caucasian	ADNI	740	All	Parahippocampal gyrus cortex thickness	Imaging	intergenic_region
chr2	127132061	rs7561528	0.327	BIN1	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intergenic_region
chr2	127132061	rs7561528	0.463	BIN1	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intergenic_region
chr2	127132061	rs7561528	0.499	BIN1	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intergenic_region
chr2	127132061	rs7561528	0.5	BIN1	NR	NR	0.017	1.01715	BIN1	SNP-based	Endophenotype	20558387	Caucasian	ADNI	740	All	White matter lesion volume	Imaging	intergenic_region
chr2	127132061	rs7561528	0.697	CUGBP2	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21379329	Caucasian	ADGC	408	APOE-e4/e4	LOAD	AD	intergenic_region
chr2	127132061	rs7561528	0.757	NR	A	A	-0.01	0.99005	BIN1	SNP-based	Endophenotype	23836404	Caucasian	ADGC	725	All	Neuritic Plaque Pathologic Burden	Neuropathology	intergenic_region
chr2	127132061	rs7561528	2.86E-11	BIN1	A	A	1.18	1.18	BIN1	SNP-based	Disease risk	21460841	Caucasian	ADGC	15675	All	LOAD	AD	intergenic_region
chr2	127132061	rs7561528	4.22E-14	BIN1	A	A	1.17	1.17	BIN1	SNP-based	Disease risk	21460841	Caucasian	ADGC	22771	All	LOAD	AD	intergenic_region
chr2	127132061	rs7561528	4.80E-09	BIN1	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	22832961	Caucasian	ADGC	8292	All	LOAD	AD	intergenic_region
chr2	127132061	rs7561528	5.21E-14	BIN1	A	A	1.17	1.17	BIN1	SNP-based	Disease risk	21460841	Caucasian	ADGC	22771	All	LOAD	AD	intergenic_region
chr2	127132061	rs7561528	6.00E-11	BIN1	NR	NR	1.25	1.25	BIN1	SNP-based	Disease risk	22832961	Caucasian	ADGC	8292	All	LOAD	AD	intergenic_region
chr2	127132061	rs7561528	6.54E-18	BIN1	NR	NR	NR	NA	BIN1	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr2	127132061	rs7561528	7.66E-11	BIN1	A	A	1.18	1.18	BIN1	SNP-based	Disease risk	21460841	Caucasian	ADGC	15675	All	LOAD	AD	intergenic_region
chr2	127133851	rs4663105	1.80E-12	BIN1	C	C	1.19	1.19	BIN1	SNP-based	Disease risk	25778476	Caucasian	"ADGC, IGAP"	36569	APOE-e4- subjects	AD	AD	intergenic_region
chr2	127133851	rs4663105	2.50E-09	BIN1	C	C	1.19	1.19	BIN1	SNP-based	Disease risk	25778476	Caucasian	"ADGC, IGAP"	21345	APOE-e4+ subjects	AD	AD	intergenic_region
chr2	127133851	rs4663105	3.38E-44	BIN1	C	C	13.94	NA	BIN1	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ, UKBB"	455258	All	AD + AD-by-proxy	AD	intergenic_region
chr2	127133851	rs4663105	3.58E-29	BIN1	C	C	NR	NA	BIN1	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ"	79145	All	AD	AD	intergenic_region
chr2	127133851	rs4663105	5.46E-26	BIN1	C	C	NR	NA	BIN1	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	intergenic_region
chr2	127135234	rs6733839	0.000000151	BIN1	NR	NR	0.07	1.07251	BIN1	SNP-based	eQTL	30448613	Caucasian	ADNI	763	All	BIN1 (11719631_s_at) expression in blood	Expression	intergenic_region
chr2	127135234	rs6733839	0.00000205	BIN1	NR	NR	0.08	1.08329	BIN1	SNP-based	eQTL	30448613	Caucasian	ADNI	763	All	BIN1 (11746895_a_at) expression in blood	Expression	intergenic_region
chr2	127135234	rs6733839	0.0000034	BIN1 	T	T	1.39	1.39	BIN1	SNP-based	Endophenotype	25188341	Caucasian	ADGC	4914	All	Clinico-pathologic AD dementia (No neuropathologist documentation)	Neuropathology	intergenic_region
chr2	127135234	rs6733839	0.00025	BIN1 	T	T	1.36	1.36	BIN1	SNP-based	Endophenotype	25188341	Caucasian	ADGC	3702	All	Clinico-pathologic AD dementia (with neuropathologist documentation)	Neuropathology	intergenic_region
chr2	127135234	rs6733839	0.000894	BIN1	T	T	NR	NA	BIN1	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	High-density lipoprotein (HDL)	Non-ADRD	intergenic_region
chr2	127135234	rs6733839	0.00805	BIN1	T	T	1.17	1.17	BIN1	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intergenic_region
chr2	127135234	rs6733839	1.44E-45	BIN1	T	T	1.21	1.21	BIN1	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intergenic_region
chr2	127135234	rs6733839	1.70E-26	BIN1	T	T	1.21	1.21	BIN1	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD"	54162	All	LOAD	AD	intergenic_region
chr2	127135234	rs6733839	2.00E-18	BIN1	T	T	1.23	1.23	BIN1	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	18845	All	Clinically diagnosed LOAD	AD	intergenic_region
chr2	127135234	rs6733839	2.10E-44	BIN1	T	T	1.2	1.2	BIN1	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	82771	All	Clinically diagnosed LOAD	AD	intergenic_region
chr2	127135234	rs6733839	3.16E-11	BIN1	NR	NR	-0.15	NA	BIN1	SNP-based	Age at onset (AAO) / Survival	28323831	Caucasian	ADGC	15795	All	Age of AD onset	Other	intergenic_region
chr2	127135234	rs6733839	3.40E-19	BIN1	T	T	1.24	1.24	BIN1	SNP-based	Disease risk	24162737	Caucasian	Cohorts from Europe and USA	19884	All	LOAD	AD	intergenic_region
chr2	127135234	rs6733839	4.00E-28	BIN1	T	T	1.18	1.18	BIN1	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	63926	All	Clinically diagnosed LOAD	AD	intergenic_region
chr2	127135234	rs6733839	6.90E-44	BIN1	T	T	1.22	1.22	BIN1	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD, Cohorts from Europe and USA"	74046	All	LOAD	AD	intergenic_region
chr2	127135234	rs6733839	6.94E-44	BIN1	T	T	1.22	1.22	BIN1	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intergenic_region
chr2	127135234	rs6733839	7.11E-26	BIN1	T	T	NR	NA	BIN1	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr2	127135234	rs6733839	NR	BIN1	T	T	0.96	0.96	BIN1	SNP-based	Disease risk	27849641	Caucasian	ADGC	589	All	Symptomatic AD (CDR global score >=0.5)	AD	intergenic_region
chr2	127135234	rs6733839	NR	ZCWPW1	T	T	1.02	1.02	BIN1	SNP-based	Disease risk	27849641	Caucasian	ADGC	292	APOE-e4 carriers	Symptomatic AD (CDR global score >=0.5)	AD	intergenic_region
chr2	127135234	rs6733839	NR	ZCWPW1	T	T	1.06	1.06	BIN1	SNP-based	Disease risk	27849641	Caucasian	ADGC	297	APOE-e4 non-carriers	Symptomatic AD (CDR global score >=0.5)	AD	intergenic_region
chr2	127137039	rs744373	0.00000102	BIN1	G	G	1.14	1.14	BIN1	SNP-based	Disease risk	20460622	Caucasian	"ADGC, CHARGE, EADI"	24035	All	AD	AD	intergenic_region
chr2	127137039	rs744373	0.0000032	BIN1	NR	NR	1.17	1.17	BIN1	SNP-based	Disease risk	19734902	Caucasian	Cohorts from Europe and USA	11789	All	AD	AD	intergenic_region
chr2	127137039	rs744373	0.000038	BIN1	NR	NR	1.17	1.17	BIN1	SNP-based	Disease risk	21460840	Caucasian	GERAD	9799	All	AD	AD	intergenic_region
chr2	127137039	rs744373	0.0000492	BIN1	G	G	1.37	1.37	BIN1	SNP-based	Disease risk	21390209	Caucasian	GenADA	1574	All	AD	AD	intergenic_region
chr2	127137039	rs744373	0.000139	BIN1	G	G	1.25	1.25	BIN1	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	2024	All	LOAD	AD	intergenic_region
chr2	127137039	rs744373	0.000184	BIN1	G	G	1.16	1.16	BIN1	SNP-based	Disease risk	21390209	Caucasian	Cohort from Europe	Refer to Harold et al(2009)	All	AD	AD	intergenic_region
chr2	127137039	rs744373	0.000493	BIN1	G	G	1.13	1.13	BIN1	SNP-based	Disease risk	20460622	Caucasian	"ADGC, CHARGE"	16675	All	AD	AD	intergenic_region
chr2	127137039	rs744373	0.0007	CUGBP2	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	intergenic_region
chr2	127137039	rs744373	0.0007	CUGBP2	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	intergenic_region
chr2	127137039	rs744373	0.0007	CUGBP2	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	intergenic_region
chr2	127137039	rs744373	0.00145	BIN1	G	G	1.31	1.31	BIN1	SNP-based	Disease risk	21390209	Caucasian	Cohort from Europe	Refer to Harold et al(2009)	All	AD	AD	intergenic_region
chr2	127137039	rs744373	0.02	BIN1	NR	NR	1.17	1.17	BIN1	SNP-based	Disease risk	20460622	Caucasian	Cohort from Europe	2349	All	AD	AD	intergenic_region
chr2	127137039	rs744373	0.0237	CUGBP2	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21379329	Caucasian	ADGC	1642	APOE-e4/e3	LOAD	AD	intergenic_region
chr2	127137039	rs744373	0.0383	CUGBP2	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21379329	Caucasian	ADGC	3722	All	LOAD	AD	intergenic_region
chr2	127137039	rs744373	0.04	BIN1	NR	NR	1.2	1.2	BIN1	SNP-based	Endophenotype	26993346	Caucasian	Cohort from Europe	10840	All	PCA (posterior cortical atrophy)	Imaging	intergenic_region
chr2	127137039	rs744373	0.0565	CUGBP2	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21379329	Caucasian	ADGC	3839	All	LOAD	AD	intergenic_region
chr2	127137039	rs744373	0.0604	BIN1	G	G	1.16	1.16	BIN1	SNP-based	Disease risk	21390209	Caucasian	Genizon	1502	All	AD	AD	intergenic_region
chr2	127137039	rs744373	0.0671	CUGBP2	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21379329	Caucasian	ADGC	3839	All	LOAD	AD	intergenic_region
chr2	127137039	rs744373	0.0687	BIN1	G	G	1.16	1.16	BIN1	SNP-based	Disease risk	21390209	Caucasian	ADGC	1525	All	AD	AD	intergenic_region
chr2	127137039	rs744373	0.0894	CUGBP2	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21379329	Caucasian	ADGC	2167	APOE-e4+	LOAD	AD	intergenic_region
chr2	127137039	rs744373	0.128	CUGBP2	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21379329	Caucasian	ADGC	3461	Northwestern European ancestry	LOAD	AD	intergenic_region
chr2	127137039	rs744373	0.187	CUGBP2	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21379329	Caucasian	ADGC	1672	APOE-e4-	LOAD	AD	intergenic_region
chr2	127137039	rs744373	0.22	BIN1	NR	NR	NR	NA	BIN1	SNP-based	Endophenotype	21390209	Caucasian	"ADNI, leadC"	597	AD subjects	AD Progression	Cognitive	intergenic_region
chr2	127137039	rs744373	0.227	CUGBP2	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21379329	Caucasian	ADGC	3786	All	LOAD	AD	intergenic_region
chr2	127137039	rs744373	0.272	CUGBP2	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21379329	Caucasian	ADGC	1422	APOE-e3/e3	LOAD	AD	intergenic_region
chr2	127137039	rs744373	0.405	BIN1	G	G	1.07	1.07	BIN1	SNP-based	Disease risk	21390209	Caucasian	Cohort from USA	Refer to Harold et al(2009)	All	AD	AD	intergenic_region
chr2	127137039	rs744373	0.515	CUGBP2	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21379329	Caucasian	ADGC	250	APOE-e3/e2+e2/e2	LOAD	AD	intergenic_region
chr2	127137039	rs744373	0.805	BIN1	G	G	0.98	0.98	BIN1	SNP-based	Disease risk	23565137	Asian	Cohort from Korea	1468	All	LOAD	AD	intergenic_region
chr2	127137039	rs744373	0.973	CUGBP2	NR	NR	NR	NA	BIN1	SNP-based	Disease risk	21379329	Caucasian	ADGC	408	APOE-e4/e4	LOAD	AD	intergenic_region
chr2	127137039	rs744373	0.999	BIN1	G	G	1	1	BIN1	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intergenic_region
chr2	127137039	rs744373	1.32E-10	BIN1	G	G	1.19	1.19	BIN1	SNP-based	Disease risk	21390209	Caucasian	"ADNI, Cohorts from Europe and USA"	16881	All	AD	AD	intergenic_region
chr2	127137039	rs744373	1.50E-10	BIN1	NR	NR	1.17	1.17	BIN1	SNP-based	Disease risk	21460840	Caucasian	"ADC, EADI, GERAD"	20373	All	AD	AD	intergenic_region
chr2	127137039	rs744373	1.59E-11	BIN1	G	G	1.15	1.15	BIN1	SNP-based	Disease risk	20460622	Caucasian	"ADGC, CHARGE, EADI, GERAD"	34363	All	AD	AD	intergenic_region
chr2	127137039	rs744373	2.60E-14	BIN1	NR	NR	1.17	1.17	BIN1	SNP-based	Disease risk	21460840	Caucasian	"ADGC, CHARGE, EADI, GERAD"	59716	All	AD	AD	intergenic_region
chr2	127204917	rs7585314	0.003	BIN1	T	T	0.75	0.75	CYP27C1	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr2	127284258	rs4150436	0.00403	ERCC3	C	C	NR	NA	ERCC3	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	intron_variant
chr2	127284258	rs4150436	1.72E-21	NR	C	C	NR	NA	ERCC3	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	ERCC3 (ILMN_1740216) expresssion	Expression	intron_variant
chr2	131824938	rs12470837	0.00000116	LOC647996	NR	NR	0.336	1.39934	CCDC74A	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	673	All	CSF Clusterin	Fluid biomarker	downstream_gene_variant
chr2	131824938	rs12470837	0.00000137	LOC647996	NR	NR	0.468	1.5968	CCDC74A	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	270	Subjects with APOE-e4+	CSF Clusterin	Fluid biomarker	downstream_gene_variant
chr2	131824938	rs12470837	0.00000137	MGC50273	NR	NR	NR	NA	CCDC74A	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	downstream_gene_variant
chr2	131824938	rs12470837	0.0122	LOC647996	NR	NR	0.243	1.27507	CCDC74A	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	403	Subjects with APOE-e4-	CSF Clusterin	Fluid biomarker	downstream_gene_variant
chr2	131825705	rs10928155	0.0000022	MGC50273	NR	NR	NR	NA	CCDC74A	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	downstream_gene_variant
chr2	131827077	rs9711604	0.0000022	MGC50273	NR	NR	NR	NA	CCDC74A	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	downstream_gene_variant
chr2	131827540	rs12469076	0.0000022	MGC50273	NR	NR	NR	NA	CCDC74A	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	downstream_gene_variant
chr2	131828237	rs6709732	0.0000022	MGC50273	NR	NR	NR	NA	CCDC74A	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	downstream_gene_variant
chr2	131828417	rs6709893	0.0000022	MGC50273	NR	NR	NR	NA	CCDC74A	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	downstream_gene_variant
chr2	131828659	rs6740860	0.0000022	MGC50273	NR	NR	NR	NA	CCDC74A	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	downstream_gene_variant
chr2	131829097	rs2314388	0.0000022	MGC50273	NR	NR	NR	NA	CCDC74A	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	downstream_gene_variant
chr2	131829281	rs4558626	0.0000022	MGC50273	NR	NR	NR	NA	CCDC74A	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	downstream_gene_variant
chr2	131831662	rs12473669	0.0000022	MGC50273	NR	NR	NR	NA	CCDC74A	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intron_variant
chr2	133575190	rs7588354	0.00000137	NCKAP5	A	A	0.66	NA	NCKAP5	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	intergenic_region
chr2	142202362	rs2890652	0.421	NR	C	C	0.963	0.963	LRP1B	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	intergenic_region
chr2	142202362	rs2890652	0.85	NR	C	C	1.01	1.01	LRP1B	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	intergenic_region
chr2	142202362	rs2890652	0.876	NR	C	C	0.001	1.001	LRP1B	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	intergenic_region
chr2	142202362	rs2890652	0.994	NR	C	C	1	1	LRP1B	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	intergenic_region
chr2	148800291	rs2121433	<1.00E-06	EPC2	NR	NR	NR	NA	EPC2	SNP-based	Endophenotype	21123754	Non-Hispanic Caucasian	ADNI	374	All	CSF T-tau	Fluid biomarker	intergenic_region
chr2	148801056	rs1374441	<1.00E-06	EPC2	NR	NR	NR	NA	EPC2	SNP-based	Endophenotype	21123754	Non-Hispanic Caucasian	ADNI	374	All	CSF T-tau	Fluid biomarker	intergenic_region
chr2	148810827	rs4499362	<1.00E-06	EPC2	NR	NR	NR	NA	EPC2	SNP-based	Endophenotype	21123754	Non-Hispanic Caucasian	ADNI	374	All	CSF T-tau	Fluid biomarker	intergenic_region
chr2	148810827	rs4499362	<1.00E-06	EPC2	NR	NR	NR	NA	EPC2	SNP-based	Endophenotype	21123754	Non-Hispanic Caucasian	ADNI	374	All	CSF T-tau/Ab1-42	Fluid biomarker	intergenic_region
chr2	148811160	rs10171238	<1.00E-06	EPC2	NR	NR	NR	NA	EPC2	SNP-based	Endophenotype	21123754	Non-Hispanic Caucasian	ADNI	374	All	CSF T-tau	Fluid biomarker	intergenic_region
chr2	148811160	rs10171238	<1.00E-06	EPC2	NR	NR	NR	NA	EPC2	SNP-based	Endophenotype	21123754	Non-Hispanic Caucasian	ADNI	374	All	CSF T-tau/Ab1-42	Fluid biomarker	intergenic_region
chr2	153374900	rs13397414	0.00028	NR	G	G	NR	NA	RPRM	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	downstream_gene_variant
chr2	153374900	rs13397414	0.0003	NR	G	G	NR	NA	RPRM	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	downstream_gene_variant
chr2	153374900	rs13397414	3.44E-09	Intergenic (as reported in paper)	G	G	NR	NA	RPRM	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	downstream_gene_variant
chr2	158121282	rs2074955	0.000000109	UPP2	C	C	NR	NA	UPP2	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF P-tau181p	Fluid biomarker	intron_variant
chr2	158121282	rs2074955	0.000000207	UPP2	C	C	NR	NA	UPP2	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF P-tau181p	Fluid biomarker	intron_variant
chr2	160224330	rs12692585	0.000021	"ITGB6, RBMS1"	NR	NR	NR	NA	ITGB6	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr2	160489936	rs7569522	0.000025	RBMS1	NR	NR	NR	NA	RBMS1	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr2	162782597	rs1032412	0.00019	KCNH7	G	G	NR	NA	KCNH7	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intron_variant
chr2	162782597	rs1032412	0.0024	KCNH7	G	G	NR	NA	KCNH7	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr2	162782597	rs1032412	0.0097	KCNH7	G	G	NR	NA	KCNH7	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr2	165270773	rs2119067	0.0000438	NR	NR	NR	NR	NA	SCN2A	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	intron_variant
chr2	165271418	rs10184275	0.000022	NR	NR	NR	NR	NA	SCN2A	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	intron_variant
chr2	168286525	rs9917256	0.79	STK39	A	A	NR	NA	STK39	SNP-based	Disease risk	25687773	Caucasian	ADGC	22771	All	AD	AD	intergenic_region
chr2	168286525	rs9917256	1.62E-09	STK39	A	A	NR	NA	STK39	SNP-based	Disease risk	25687773	Caucasian	IPDGC	17352	All	PD	ADRD	intergenic_region
chr2	169780132	rs11894266	0.00000069	SSB	NR	NR	0.86	0.86	KLHL23	SNP-based	Disease risk	19734902	Caucasian	Cohorts from Europe and USA	11789	All	AD	AD	downstream_gene_variant
chr2	172040778	rs34737109	0.23	NR	A	A	-0.08	0.923116	METAP1D	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	515	AD subjects	CSF Ab1-42	Fluid biomarker	intron_variant
chr2	184913701	rs1344706	0.54	ZNF804A	NR	NR	0.95	0.95	ZNF804A	SNP-based	Cross phenotype 	22005930	Caucasian	"ADGC, GERAD"	2034	AD+P and AD-P subjects	AD+Psychosis	ADRD	intron_variant
chr2	184913701	rs1344706	0.79	ZNF804A	NR	NR	0.99	0.99	ZNF804A	SNP-based	Cross phenotype 	22005930	Caucasian	"ADGC, GERAD, Cohort from UK"	6958	AD+P and control subjects	AD+Psychosis	ADRD	intron_variant
chr2	192871656	rs1373900	0.0000538	Intergenic (as reported in paper)	T	T	NR	NA	TMEFF2	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intergenic_region
chr2	192871656	rs1373900	0.00037	NR	T	T	NR	NA	TMEFF2	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intergenic_region
chr2	192871656	rs1373900	0.0087	NR	T	T	NR	NA	TMEFF2	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intergenic_region
chr2	201399433	rs13022344	0.001	TRAK2	NR	NR	1.07	1.07	TRAK2	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	3870	All	LOAD	AD	missense_variant
chr2	201399433	rs13022344	0.0051	TRAK2	NR	NR	NR	NA	TRAK2	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	776	All	LOAD	AD	missense_variant
chr2	201399433	rs13022344	0.0077	TRAK2	NR	NR	NR	NA	TRAK2	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	720	All	LOAD	AD	missense_variant
chr2	201399433	rs13022344	0.015	TRAK2	NR	NR	NR	NA	TRAK2	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	1146	All	LOAD	AD	missense_variant
chr2	201399433	rs13022344	0.628	TRAK2	NR	NR	NR	NA	TRAK2	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	658	All	LOAD	AD	missense_variant
chr2	201399433	rs13022344	0.821	TRAK2	NR	NR	NR	NA	TRAK2	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	570	All	LOAD	AD	missense_variant
chr2	204481944	rs12613305	0.00000936	PARD3B	A	A	0.13	1.13883	PARD3B	SNP-based	Endophenotype	23836404	Caucasian	ADGC	651	All	Neuritic plaque (NP)	Neuropathology	intron_variant
chr2	207489233	rs80140096	0.009	CREB1	G	G	0.08	1.08329	CREB1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with non-APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr2	207489233	rs80140096	0.034	CREB1	G	G	0.05	1.05127	CREB1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly	Episodic Memory Performance	Cognitive	intron_variant
chr2	207489233	rs80140096	0.77	CREB1	G	G	-0.02	0.980199	CREB1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr2	207489233	rs80140096	0.904	CREB1	G	G	0	1	CREB1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	11840	Demented subjects	Episodic Memory Performance	Cognitive	intron_variant
chr2	207490606	rs72954151	0.008	CREB1	G	G	0.07	1.07251	CREB1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with non-APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr2	207490606	rs72954151	0.066	CREB1	G	G	0.04	1.04081	CREB1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly	Episodic Memory Performance	Cognitive	intron_variant
chr2	207490606	rs72954151	0.439	CREB1	G	G	-0.04	0.960789	CREB1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr2	207490606	rs72954151	0.671	CREB1	G	G	0.01	1.01005	CREB1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	11840	Demented subjects	Episodic Memory Performance	Cognitive	intron_variant
chr2	207498338	rs2042484	0.046	CREB1	T	T	0.08	1.08329	CREB1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr2	207498338	rs2042484	0.286	CREB1	T	T	-0.02	0.980199	CREB1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with non-APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr2	207498338	rs2042484	0.829	CREB1	T	T	0	1	CREB1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly	Episodic Memory Performance	Cognitive	intron_variant
chr2	207498338	rs2042484	0.856	CREB1	T	T	0	1	CREB1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	11840	Demented subjects	Episodic Memory Performance	Cognitive	intron_variant
chr2	207527491	rs74844716	0.04	CREB1	T	T	0.09	1.09417	CREB1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with non-APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr2	207527491	rs74844716	0.106	CREB1	T	T	0.06	1.06184	CREB1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	11840	Demented subjects	Episodic Memory Performance	Cognitive	intron_variant
chr2	207527491	rs74844716	0.188	CREB1	T	T	0.04	1.04081	CREB1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly	Episodic Memory Performance	Cognitive	intron_variant
chr2	207527491	rs74844716	0.756	CREB1	T	T	-0.03	0.970446	CREB1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr2	207578862	rs55834243	0.046	CREB1	C	C	0.11	1.11628	CREB1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with non-APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr2	207578862	rs55834243	0.155	CREB1	C	C	0.09	1.09417	CREB1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	11840	Demented subjects	Episodic Memory Performance	Cognitive	intron_variant
chr2	207578862	rs55834243	0.256	CREB1	C	C	-0.1	0.904837	CREB1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly with APOE-e4 carriers 	Episodic Memory Performance	Cognitive	intron_variant
chr2	207578862	rs55834243	0.302	CREB1	C	C	0.05	1.05127	CREB1	SNP-based	Endophenotype	25150575	Caucasian	ADGC	2764	Cognitively healthy elderly	Episodic Memory Performance	Cognitive	intron_variant
chr2	215750203	rs6758001	0.00000887	LINC00607	NR	NR	0.64	1.89648	MREG	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	673	All	CSF Clusterin	Fluid biomarker	intron_variant
chr2	215750203	rs6758001	0.0000778	LINC00607	NR	NR	0.77	2.15977	MREG	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	403	Subjects with APOE-e4-	CSF Clusterin	Fluid biomarker	intron_variant
chr2	215750203	rs6758001	0.0171	LINC00607	NR	NR	0.51	1.66529	MREG	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	270	Subjects with APOE-e4+	CSF Clusterin	Fluid biomarker	intron_variant
chr2	226697423	rs7558386	0.000000108	NR	G	G	NR	NA	IRS1	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	MCI	CSF P-tau181p	Fluid biomarker	intergenic_region
chr2	226697423	rs7558386	0.000000527	NR	G	G	0.24	1.27125	IRS1	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	MCI	CSF P-tau181p	Fluid biomarker	intergenic_region
chr2	227199464	rs10498214	0.0812	COL4A3	NR	NR	NR	NA	COL4A3	SNP-based	Endophenotype	20452100	Caucasian	ADGC	311	Non-Demented autopsy subjects	High Braak vs Low Braak	Neuropathology	intron_variant
chr2	227356053	rs7560053	1.40E-67	MFF	NR	NR	0.3	1.34986	MFF	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	MFF expression in Temporal cortex	Expression	intron_variant
chr2	231201938	rs753855	0.00000409	"ARMC9, HTR2B, PSMD1"	NR	NR	NR	NA	ARMC9	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	2222	AD subjects	Age at onset	Other	intron_variant
chr2	231201938	rs753855	0.00000982	"ARMC9, HTR2B, PSMD1"	NR	NR	NR	NA	ARMC9	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	2222	AD subjects	Age at onset	Other	intron_variant
chr2	231201938	rs753855	0.0007	"ARMC9, HTR2B, PSMD1"	NR	NR	0.91	2.48432	ARMC9	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	1190	AD subjects	Age at onset	Other	intron_variant
chr2	231201938	rs753855	0.00475	"ARMC9, HTR2B, PSMD1"	NR	NR	0.69	1.99372	ARMC9	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	844	AD subjects	Age at onset	Other	intron_variant
chr2	231201938	rs753855	0.536	"ARMC9, HTR2B, PSMD1"	NR	NR	1.13	3.09566	ARMC9	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADNI	188	AD subjects	Age at onset	Other	intron_variant
chr2	233117202	rs10933431	0.00000026	INPP5D	G	G	0.9	0.9	INPP5D	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	63926	All	Clinically diagnosed LOAD	AD	intron_variant
chr2	233117202	rs10933431	0.00000167	INPPD5	G	G	NR	NA	INPP5D	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ"	79145	All	AD	AD	intron_variant
chr2	233117202	rs10933431	0.00000251	INPPD5	G	G	NR	NA	INPP5D	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	intron_variant
chr2	233117202	rs10933431	0.0032	INPP5D	G	G	0.92	0.92	INPP5D	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	18845	All	Clinically diagnosed LOAD	AD	intron_variant
chr2	233117202	rs10933431	3.40E-09	INPP5D	G	G	0.91	0.91	INPP5D	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	82771	All	Clinically diagnosed LOAD	AD	intron_variant
chr2	233117202	rs10933431	8.92E-10	INPPD5	G	G	-6.13	NA	INPP5D	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ, UKBB"	455258	All	AD + AD-by-proxy	AD	intron_variant
chr2	233117495	rs7421448	0.0000152	INPP5D	T	T	0.99	0.99	INPP5D	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr2	233117495	rs7421448	0.000223	INPP5D	T	T	0.91	0.91	INPP5D	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intron_variant
chr2	233117495	rs7421448	0.000559	INPP5D	T	T	0.92	0.92	INPP5D	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intron_variant
chr2	233117495	rs7421448	0.000584	INPP5D	T	T	NR	NA	INPP5D	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr2	233117495	rs7421448	0.00145	INPP5D	T	T	NR	NA	INPP5D	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Low-density lipoprotein (LDL)	Non-ADRD	intron_variant
chr2	233117495	rs7421448	0.575	INPP5D	T	T	1.06	1.06	INPP5D	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intron_variant
chr2	233138407	rs10202748	0.0079	INPP5D	NR	NR	-0.06	NA	INPP5D	SNP-based	Age at onset (AAO) / Survival	28323831	Caucasian	ADGC	15795	All	Age of AD onset	Other	intron_variant
chr2	233159830	rs35349669	0.000000032	INPP5D	T	T	1.08	1.08	INPP5D	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD, Cohorts from Europe and USA"	74046	All	LOAD	AD	intron_variant
chr2	233159830	rs35349669	0.000057	INPP5D	T	T	1.1	1.1	INPP5D	SNP-based	Disease risk	24162737	Caucasian	Cohorts from Europe and USA	19884	All	LOAD	AD	intron_variant
chr2	233159830	rs35349669	0.000096	INPP5D	T	T	1.07	1.07	INPP5D	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD"	54162	All	LOAD	AD	intron_variant
chr2	233159830	rs35349669	0.0231	INPP5D	T	T	1.104	1.104	INPP5D	SNP-based	Disease risk	24495969	Caucasian	Cohort from Spain	4372	All	AD	AD	intron_variant
chr2	233159830	rs35349669	0.21	INPP5D	NR	NR	0.89	0.89	INPP5D	SNP-based	Endophenotype	26993346	Caucasian	Cohort from Europe	10840	All	PCA (posterior cortical atrophy)	Imaging	intron_variant
chr2	233159830	rs35349669	0.84	DSG2	T	T	0.98	0.98	INPP5D	SNP-based	Endophenotype	25188341	Caucasian	ADGC	3702	All	Clinico-pathologic AD dementia (with neuropathologist documentation)	Neuropathology	intron_variant
chr2	233159830	rs35349669	0.84	INPP5D	T	T	1.01	1.01	INPP5D	SNP-based	Endophenotype	25188341	Caucasian	ADGC	4914	All	Clinico-pathologic AD dementia (No neuropathologist documentation)	Neuropathology	intron_variant
chr2	233159830	rs35349669	NR	INPP5D	T	T	0.88	0.88	INPP5D	SNP-based	Disease risk	27849641	Caucasian	ADGC	589	All	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr2	233159830	rs35349669	NR	ZCWPW1	T	T	0.75	0.75	INPP5D	SNP-based	Disease risk	27849641	Caucasian	ADGC	297	APOE-e4 non-carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr2	233159830	rs35349669	NR	ZCWPW1	T	T	1.07	1.07	INPP5D	SNP-based	Disease risk	27849641	Caucasian	ADGC	292	APOE-e4 carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr2	233206691	rs3792117	0.000453	INPP5D	A	A	1.55	NA	INPP5D	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	intron_variant
chr2	239166779	rs3791523	0.455	HDAC4	NR	NR	NR	NA	HDAC4	SNP-based	Endophenotype	20452100	Caucasian	ADGC	311	Non-Demented autopsy subjects	High Braak vs Low Braak	Neuropathology	intron_variant
chr2	240285947	rs4417745	0.0000252	OTOS	A	A	1.36	1.36	OTOS	SNP-based	Disease risk	27899424	Caucasian	IFGC	6462	All	Frontotemporal Dementia	ADRD	intergenic_region
chr2	240285947	rs4417745	0.00032	OTOS	A	A	1.22	1.22	OTOS	SNP-based	Disease risk	27899424	Caucasian	IFGC	12928	All	Frontotemporal Dementia	ADRD	intergenic_region
chr2	240285947	rs4417745	0.47	OTOS	A	A	1.06	1.06	OTOS	SNP-based	Disease risk	27899424	Caucasian	IFGC	6466	All	Frontotemporal Dementia	ADRD	intergenic_region
chr20	1154256	rs2300186	0.0000393	PSMF1	NR	NR	0.41	0.41	PSMF1	SNP-based	Disease risk	21098978	Arab	Cohort from Israeli	266	All	AD	AD	intron_variant
chr20	1154769	rs2300185	0.0000451	PSMF1	NR	NR	0.42	0.42	PSMF1	SNP-based	Disease risk	21098978	Arab	Cohort from Israeli	266	All	AD	AD	intron_variant
chr20	1155512	rs6074191	0.0000431	PSMF1	NR	NR	0.41	0.41	PSMF1	SNP-based	Disease risk	21098978	Arab	Cohort from Israeli	266	All	AD	AD	intron_variant
chr20	1156012	rs4813945	0.0000451	PSMF1	NR	NR	0.42	0.42	PSMF1	SNP-based	Disease risk	21098978	Arab	Cohort from Israeli	266	All	AD	AD	intron_variant
chr20	1156560	rs6134051	0.0000455	PSMF1	NR	NR	0.43	0.43	PSMF1	SNP-based	Disease risk	21098978	Arab	Cohort from Israeli	266	All	AD	AD	intron_variant
chr20	1165492	rs2072965	0.0000364	PSMF1	NR	NR	0.41	0.41	PSMF1	SNP-based	Disease risk	21098978	Arab	Cohort from Israeli	266	All	AD	AD	3_prime_UTR_variant
chr20	1168139	rs4813044	0.0000397	PSMF1	NR	NR	0.44	0.44	PSMF1	SNP-based	Disease risk	21098978	Arab	Cohort from Israeli	266	All	AD	AD	3_prime_UTR_variant
chr20	1723468	rs6135782	0.00000618	NR	NR	NR	NR	NA	SIRPG	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	upstream_gene_variant
chr20	1723468	rs6135782	0.000158	NR	NR	NR	0.5	0.5	SIRPG	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	upstream_gene_variant
chr20	1723468	rs6135782	0.00163	NR	NR	NR	NR	NA	SIRPG	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	upstream_gene_variant
chr20	1723468	rs6135782	0.00219	NR	NR	NR	NR	NA	SIRPG	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	upstream_gene_variant
chr20	1723468	rs6135782	0.0335	NR	NR	NR	0.56	0.56	SIRPG	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	upstream_gene_variant
chr20	1723468	rs6135782	0.0498	NR	NR	NR	0.42	0.42	SIRPG	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	upstream_gene_variant
chr20	1723468	rs6135782	0.15025	NR	NR	NR	NR	NA	SIRPG	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	upstream_gene_variant
chr20	1723468	rs6135782	0.61181	NR	NR	NR	NR	NA	SIRPG	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	upstream_gene_variant
chr20	1723468	rs6135782	0.709	NR	NR	NR	NR	NA	SIRPG	SNP-based	Disease risk	21059989	Caucasian	ADGC	1390	Unrelated individuals	LOAD	AD	upstream_gene_variant
chr20	4696446	rs6107516	0.009	PRNP	A	A	0.73	0.73	PRNP	SNP-based	Disease risk	17998437	Caucasian	Cohorts from Canada	1374	All	AD	AD	intron_variant
chr20	4696446	rs6107516	0.19	PRNP	A	A	0.68	0.68	PRNP	SNP-based	Age at onset (AAO) / Survival	17998437	Caucasian	Cohorts from Canada	1374	All	Age of AD onset	Other	intron_variant
chr20	23637790	rs1064039	0.033	CST3	T	T	0.83	0.83	CST3	SNP-based	Disease risk	20534741	Caucasian	"ADC, UM"	1610	All	AD	AD	missense_variant
chr20	23656343	rs2424590	0.00000475	CST3	NR	NR	-0.04	0.960789	CST3	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	ADNI	521	All	Plasma Cystatin-C	Fluid biomarker	non_coding_transcript_exon_variant
chr20	25618924	rs2387976	1.72E-32	NANP	NR	NR	-0.57	0.565525	NANP	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	NANP expression in Cerebellar	Expression	intron_variant
chr20	25618924	rs2387976	4.25E-73	NANP	NR	NR	-0.54	0.582748	NANP	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	NANP expression in Cerebellar	Expression	intron_variant
chr20	25618924	rs2387976	5.29E-84	NANP	NR	NR	-0.65	0.522046	NANP	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	NANP expression in Temporal cortex	Expression	intron_variant
chr20	25618924	rs2387976	6.29E-35	NANP	NR	NR	-0.51	0.600496	NANP	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	NANP expression in Cerebellar	Expression	intron_variant
chr20	31422680	rs6059244	0.0000476	NR	NR	NR	NR	NA	DEFB121	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	intron_variant
chr20	31431051	rs2180566	0.000038	DEFB123	NR	NR	NR	NA	DEFB123	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	upstream_gene_variant
chr20	35038413	rs6087664	5.63E-11	NR	NR	NR	NR	NA	TRPC4AP	SNP-based	Disease risk	18449908	Caucasian	Cohort from USA	70	All	AD	AD	intron_variant
chr20	35050785	rs6088692	5.63E-11	NR	NR	NR	NR	NA	TRPC4AP	SNP-based	Disease risk	18449908	Caucasian	Cohort from USA	70	All	AD	AD	intron_variant
chr20	35056555	rs6120816	6.99E-11	NR	NR	NR	NR	NA	TRPC4AP	SNP-based	Disease risk	18449908	Caucasian	Cohort from USA	70	All	AD	AD	intron_variant
chr20	35057846	rs1885119	5.63E-11	NR	NR	NR	NR	NA	TRPC4AP	SNP-based	Disease risk	18449908	Caucasian	Cohort from USA	70	All	AD	AD	intron_variant
chr20	35119019	rs2065108	3.85E-10	NR	NR	NR	NR	NA	EDEM2	SNP-based	Disease risk	18449908	Caucasian	Cohort from USA	70	All	AD	AD	intron_variant
chr20	35125836	rs6088727	3.85E-10	NR	NR	NR	NR	NA	EDEM2	SNP-based	Disease risk	18449908	Caucasian	Cohort from USA	70	All	AD	AD	intron_variant
chr20	35335763	rs2425062	0.000201	UQCC	G	G	NR	NA	UQCC1	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	7289	Plan 2 (only males)	AD	AD	intron_variant
chr20	35335763	rs2425062	4.58E-13	NR	G	G	NR	NA	UQCC1	SNP-based	eQTL	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	7289	Plan 2 (only males)	UQCC (ILMN_1724734) expression in peripheral blood	Expression	intron_variant
chr20	36232134	rs41293100	0.00309	AAR2	A	A	NR	NA	EPB41L1	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	3_prime_UTR_variant
chr20	36232134	rs41293100	1.31E-35	NR	A	A	NR	NA	EPB41L1	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AAR2 (ILMN_1721225) expression	Expression	3_prime_UTR_variant
chr20	36483848	rs118164920	0.00588	NDRG3	G	G	NR	NA	DLGAP4	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	10870	HTN-P group	AD	AD	intron_variant
chr20	36483848	rs118164920	3.15E-51	NR	G	G	NR	NA	DLGAP4	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	10870	HTN-P group	NDRG3 (ILMN_1738229) expression	Expression	intron_variant
chr20	37771178	rs6013029	0.389	NR	T	T	0.93	0.93	CTNNBL1	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	intron_variant
chr20	37771178	rs6013029	0.4	NR	T	T	1.094	1.094	CTNNBL1	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	intron_variant
chr20	37771178	rs6013029	0.533	NR	T	T	0.969	0.969	CTNNBL1	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	intron_variant
chr20	37771178	rs6013029	0.706	NR	T	T	0	1	CTNNBL1	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	intron_variant
chr20	46113425	rs1569723	9.61E-14	CD40	NR	NR	-0.06	0.941765	CD40	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	ADNI	521	All	Plasma CD40	Fluid biomarker	upstream_gene_variant
chr20	46148656	rs6032678	0.00238	CD40	NR	NR	0.09	1.09417	CD40	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	IMAS	59	All	Plasma CD40	Fluid biomarker	intergenic_region
chr20	56402450	rs2426622	0.00461	CASS4	G	G	0.83	NA	CSTF1	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	intron_variant
chr20	56422512	rs6024870	0.000000035	CASS4	A	A	0.88	0.88	CASS4	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	82771	All	Clinically diagnosed LOAD	AD	intron_variant
chr20	56422512	rs6024870	0.0000011	CASS4	A	A	0.88	0.88	CASS4	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	63926	All	Clinically diagnosed LOAD	AD	intron_variant
chr20	56422512	rs6024870	0.009	CASS4	A	A	0.9	0.9	CASS4	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	18845	All	Clinically diagnosed LOAD	AD	intron_variant
chr20	56423488	rs6014724	0.00000632	CASS4	G	G	NR	NA	CASS4	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	intron_variant
chr20	56423488	rs6014724	6.56E-10	CASS4	G	G	-6.18	NA	CASS4	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ, UKBB"	455258	All	AD + AD-by-proxy	AD	intron_variant
chr20	56423488	rs6014724	8.72E-08	CASS4	G	G	NR	NA	CASS4	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ"	79145	All	AD	AD	intron_variant
chr20	56443204	rs7274581	0.000000025	CASS4	C	C	0.88	0.88	CASS4	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD, Cohorts from Europe and USA"	74046	All	LOAD	AD	intron_variant
chr20	56443204	rs7274581	0.0000016	CASS4	C	C	0.87	0.87	CASS4	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD"	54162	All	LOAD	AD	intron_variant
chr20	56443204	rs7274581	0.0033	CASS4	C	C	0.73	0.73	CASS4	SNP-based	Endophenotype	25188341	Caucasian	ADGC	4914	All	Clinico-pathologic AD dementia (No neuropathologist documentation)	Neuropathology	intron_variant
chr20	56443204	rs7274581	0.0041	CASS4	C	C	0.89	0.89	CASS4	SNP-based	Disease risk	24162737	Caucasian	Cohorts from Europe and USA	19884	All	LOAD	AD	intron_variant
chr20	56443204	rs7274581	0.0079	CASS4	NR	NR	0.1	NA	CASS4	SNP-based	Age at onset (AAO) / Survival	28323831	Caucasian	ADGC	15795	All	Age of AD onset	Other	intron_variant
chr20	56443204	rs7274581	0.011	CASS4	C	C	0.72	0.72	CASS4	SNP-based	Endophenotype	25188341	Caucasian	ADGC	3702	All	Clinico-pathologic AD dementia (with neuropathologist documentation)	Neuropathology	intron_variant
chr20	56443204	rs7274581	0.52	CASS4	NR	NR	1.12	1.12	CASS4	SNP-based	Endophenotype	26993346	Caucasian	Cohort from Europe	10840	All	PCA (posterior cortical atrophy)	Imaging	intron_variant
chr20	56443204	rs7274581	0.815	CASS4	C	C	1.017	1.017	CASS4	SNP-based	Disease risk	24495969	Caucasian	Cohort from Spain	4372	All	AD	AD	intron_variant
chr20	56443204	rs7274581	NR	CASS4	T	T	1.12	1.12	CASS4	SNP-based	Disease risk	27849641	Caucasian	ADGC	589	All	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr20	56443204	rs7274581	NR	ZCWPW1	T	T	1.03	1.03	CASS4	SNP-based	Disease risk	27849641	Caucasian	ADGC	297	APOE-e4 non-carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr20	56443204	rs7274581	NR	ZCWPW1	T	T	1.53	1.53	CASS4	SNP-based	Disease risk	27849641	Caucasian	ADGC	292	APOE-e4 carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr20	57563565	rs8192708	0.000099	PCK1	NR	NR	1.29	1.29	PCK1	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	3870	All	LOAD	AD	missense_variant&splice_region_variant
chr20	57563565	rs8192708	0.0033	PCK1	NR	NR	NR	NA	PCK1	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	776	All	LOAD	AD	missense_variant&splice_region_variant
chr20	57563565	rs8192708	0.026	PCK1	NR	NR	NR	NA	PCK1	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	720	All	LOAD	AD	missense_variant&splice_region_variant
chr20	57563565	rs8192708	0.051	PCK1	NR	NR	NR	NA	PCK1	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	1146	All	LOAD	AD	missense_variant&splice_region_variant
chr20	57563565	rs8192708	0.396	PCK1	NR	NR	NR	NA	PCK1	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	570	All	LOAD	AD	missense_variant&splice_region_variant
chr20	57563565	rs8192708	0.791	PCK1	NR	NR	NR	NA	PCK1	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	658	All	LOAD	AD	missense_variant&splice_region_variant
chr20	60323151	rs6027511	0.00000896	NR	NR	NR	-122.24	8.16286e-54	CDH26	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	intron_variant
chr20	60323151	rs6027511	0.00076	NR	C	C	-121.95	1.09091e-53	CDH26	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr20	60323151	rs6027511	0.00089	NR	C	C	NR	NA	CDH26	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr20	60323151	rs6027511	0.0038	NR	C	C	-122.62	5.58227e-54	CDH26	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	intron_variant
chr20	61371988	rs4925189	0.000000635	CDH4	G	G	0.2	1.2214	CDH4	SNP-based	Endophenotype	20932310	Caucasian	ADNI	172	AD	CSF T-tau	Fluid biomarker	intron_variant
chr21	14356476	rs2403771	0.0000062	NR	NR	NR	NR	NA	HSPA13	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr21	14356476	rs2403771	0.00012	NR	NR	NR	NR	NA	HSPA13	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intron_variant
chr21	14356476	rs2403771	0.000158	NR	NR	NR	0.54	0.54	HSPA13	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr21	14356476	rs2403771	0.00267	NR	NR	NR	0.53	0.53	HSPA13	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intron_variant
chr21	14356476	rs2403771	0.0367	NR	NR	NR	NR	NA	HSPA13	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intron_variant
chr21	14356476	rs2403771	0.126	NR	NR	NR	NR	NA	HSPA13	SNP-based	Disease risk	21059989	Caucasian	ADGC	1390	Unrelated individuals	LOAD	AD	intron_variant
chr21	14356476	rs2403771	0.47516	NR	NR	NR	NR	NA	HSPA13	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intron_variant
chr21	14356476	rs2403771	0.51869	NR	NR	NR	NR	NA	HSPA13	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intron_variant
chr21	14356476	rs2403771	0.534	NR	NR	NR	0.6	0.6	HSPA13	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intron_variant
chr21	19368235	rs2825544	0.000000485	PRSS7	C	C	1.14	1.14	TMPRSS15	SNP-based	Disease risk	20460622	Caucasian	"ADGC, CHARGE, EADI"	24035	All	AD	AD	intergenic_region
chr21	19368235	rs2825544	0.000021	PRSS7	C	C	1.09	1.09	TMPRSS15	SNP-based	Disease risk	20460622	Caucasian	"ADGC, CHARGE, EADI, GERAD"	34363	All	AD	AD	intergenic_region
chr21	19368235	rs2825544	0.000255	PRSS7	C	C	1.13	1.13	TMPRSS15	SNP-based	Disease risk	20460622	Caucasian	"ADGC, CHARGE"	16675	All	AD	AD	intergenic_region
chr21	20983528	rs1022442	0.000000275	NCAM2	A	A	NR	NA	NCAM2	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF Ab1-42	Fluid biomarker	intergenic_region
chr21	25277446	rs76252969	0.00000486	LINC00158	G	G	0.59	0.59	MRPL39	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	17480	Plan 1 (males and females)	AD	AD	intron_variant
chr21	25517756	rs12386284	0.00000455	MIR155HG	T	T	1.37	1.37	MRPL39	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AD	AD	intron_variant
chr21	25547104	rs1783012	0.00000459	MIR155HG	T	T	0.73	0.73	MRPL39	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AD	AD	intergenic_region
chr21	25547257	rs1783013	0.00000465	MIR155HG	T	T	0.73	0.73	MRPL39	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AD	AD	intergenic_region
chr21	25547744	rs926963	0.00000475	MIR155HG	T	T	0.73	0.73	MRPL39	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AD	AD	intergenic_region
chr21	25568503	rs1893650	0.00000394	MIR155HG	T	T	1.32	1.32	MRPL39	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AD	AD	intron_variant
chr21	25569648	rs2226326	0.00000438	MIR155HG	A	A	1.32	1.32	MRPL39	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AD	AD	intron_variant
chr21	25575998	rs2829803	0.00000409	MIR155HG	G	G	1.32	1.32	MRPL39	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AD	AD	downstream_gene_variant
chr21	25583969	rs2298369	0.000000311	LINC00515	C	C	0.75	0.75	MRPL39	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AD	AD	upstream_gene_variant
chr21	25583969	rs2298369	0.000000367	"LINC00515, MRPL39"	C	C	0.8	0.8	MRPL39	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	17480	Plan 1 (males and females)	AD	AD	upstream_gene_variant
chr21	25599076	rs2829823	0.00000406	MRPL39	A	A	1.32	1.32	MRPL39	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AD	AD	intron_variant
chr21	25601939	rs2829832	0.00000468	MRPL39	T	T	1.32	1.32	MRPL39	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AD	AD	intron_variant
chr21	25725147	rs11909995	0.00000441	ATP5J	G	G	0.62	0.62	ATP5PF	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	intron_variant
chr21	25731303	rs2829887	0.00000333	"APP, ATP5J"	T	T	-0.14	0.869358	ATP5PF	SNP-based	Endophenotype	23836404	Caucasian	ADGC	651	All	Neuritic plaque (NP)	Neuropathology	intron_variant
chr21	26101558	rs2154481	0.000618	APP	NR	NR	0.95	0.95	APP	SNP-based	Disease risk	28671113	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr21	26128343	rs2830072	0.02	APP	NR	NR	0.96	0.96	APP	SNP-based	Disease risk	28671113	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr21	26128825	rs2830073	0.00247	APP	NR	NR	0.95	0.95	APP	SNP-based	Disease risk	28671113	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr21	26130406	rs2830077	0.00276	APP	NR	NR	0.95	0.95	APP	SNP-based	Disease risk	28671113	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr21	26135742	rs432766	0.047	APP	NR	NR	0.97	0.97	APP	SNP-based	Disease risk	28671113	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr21	26142055	rs375369	0.015	APP	NR	NR	0.96	0.96	APP	SNP-based	Disease risk	28671113	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr21	26144759	rs467021	0.00306	APP	NR	NR	0.95	0.95	APP	SNP-based	Disease risk	28671113	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr21	26150590	rs12483003	0.00353	APP	NR	NR	0.95	0.95	APP	SNP-based	Disease risk	28671113	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr21	26158949	rs368196	0.00215	APP	NR	NR	0.95	0.95	APP	SNP-based	Disease risk	28671113	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr21	26160704	rs465235	0.00127	APP	NR	NR	0.95	0.95	APP	SNP-based	Disease risk	28671113	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr21	26784537	rs2830500	0.000000026	ADAMTS1	A	A	0.93	0.93	ADAMTS1	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	94437	All	Clinically diagnosed LOAD	AD	intergenic_region
chr21	26784537	rs2830500	0.000000074	ADAMTS1	A	A	0.93	0.93	ADAMTS1	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	82771	All	Clinically diagnosed LOAD	AD	intergenic_region
chr21	26784537	rs2830500	0.13	ADAMTS1	A	A	0.95	0.95	ADAMTS1	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	11666	All	Clinically diagnosed LOAD	AD	intergenic_region
chr21	27324157	rs239713	0.000000496	NR	T	T	NR	NA	ADAMTS5	SNP-based	Endophenotype	20932310	Caucasian	ADNI	172	AD	CSF Ab1-42	Fluid biomarker	intergenic_region
chr21	27903308	rs9305339	0.00000787	LINC00314	NR	NR	0.26	1.29693	ADAMTS5	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	673	All	CSF Clusterin	Fluid biomarker	intergenic_region
chr21	27903308	rs9305339	0.000922	LINC00314	NR	NR	0.3	1.34986	ADAMTS5	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	270	Subjects with APOE-e4+	CSF Clusterin	Fluid biomarker	intergenic_region
chr21	27903308	rs9305339	0.00176	LINC00314	NR	NR	0.25	1.28403	ADAMTS5	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	403	Subjects with APOE-e4-	CSF Clusterin	Fluid biomarker	intergenic_region
chr21	31876391	rs2833546	0.11	HUNK	NR	NR	NR	NA	HUNK	SNP-based	Endophenotype	20452100	Caucasian	ADGC	311	Non-Demented autopsy subjects	High Braak vs Low Braak	Neuropathology	intron_variant
chr21	39209604	rs6517526	1.33E-24	BRWD1	NR	NR	-0.71	0.491644	BRWD1	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	BRWD1 expression in Cerebellar	Expression	intron_variant
chr21	39209604	rs6517526	2.71E-31	BRWD1	NR	NR	-0.88	0.414783	BRWD1	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	BRWD1 expression in Cerebellar	Expression	intron_variant
chr21	39209604	rs6517526	2.80E-61	BRWD1	NR	NR	-0.8	0.449329	BRWD1	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	BRWD1 expression in Cerebellar	Expression	intron_variant
chr21	40135768	rs11700591	0.000000099	NR	C	C	0.72	2.05443	DSCAM	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	363	AD subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr21	40135768	rs11700591	0.00023	NR	C	C	-0.35	0.704688	DSCAM	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	878	AD subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr21	40135768	rs11700591	0.89	NR	C	C	-0.02	0.980199	DSCAM	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	515	AD subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr21	42257956	rs142544282	0.000000008	NR	T	T	-2.11	0.121238	ABCG1	SNP-based	Endophenotype	25188341	Caucasian	ADGC	4046	All	Neuritic Plaque	Neuropathology	intron_variant
chr21	42679905	rs3819902	0.0004	PDE9A	C	C	NR	NA	PDE9A	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr21	42679905	rs3819902	0.00068	PDE9A	C	C	NR	NA	PDE9A	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intron_variant
chr21	42679905	rs3819902	0.0009	PDE9A	C	C	NR	NA	PDE9A	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr21	45264602	rs2838859	1.11E-111	POFUT2	NR	NR	-0.84	0.431711	POFUT2	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	POFUT2 expression in Temporal cortex	Expression	3_prime_UTR_variant
chr21	45264602	rs2838859	1.27E-97	POFUT2	NR	NR	-0.86	0.423162	POFUT2	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	POFUT2 expression in Cerebellar	Expression	3_prime_UTR_variant
chr21	45264602	rs2838859	5.20E-48	POFUT2	NR	NR	-0.89	0.410656	POFUT2	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	POFUT2 expression in Cerebellar	Expression	3_prime_UTR_variant
chr21	45264602	rs2838859	5.28E-43	POFUT2	NR	NR	-0.81	0.444858	POFUT2	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	POFUT2 expression in Cerebellar	Expression	3_prime_UTR_variant
chr22	21619030	rs4821116	0.000402	UBE2L3	T	T	NR	NA	UBE2L3	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr22	21619030	rs4821116	0.00071	UBE2L3	T	T	NR	NA	UBE2L3	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Total cholesterol (TC)	Non-ADRD	intron_variant
chr22	21619030	rs4821116	0.11	UBE2L3	T	T	1	1	UBE2L3	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr22	21628603	rs2298428	0.00009	YDJC	T	T	NR	NA	YDJC	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	missense_variant
chr22	21628603	rs2298428	0.000105	YDJC	C	C	NR	NA	YDJC	SNP-based	Cross phenotype 	27088644	Caucasian	IGAP	54162	All	AD	AD	missense_variant
chr22	21628603	rs2298428	0.000504	YDJC	T	T	0.94	0.94	YDJC	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	missense_variant
chr22	21628603	rs2298428	0.00134	YDJC	T	T	0.95	0.95	YDJC	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	missense_variant
chr22	21628603	rs2298428	0.19	YDJC	T	T	1	1	YDJC	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	missense_variant
chr22	21628603	rs2298428	0.647	YDJC	T	T	1.03	1.03	YDJC	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	missense_variant
chr22	21628603	rs2298428	1.58E-08	YDJC	T	T	NR	NA	YDJC	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	High-density lipoprotein (HDL)	Non-ADRD	missense_variant
chr22	21628603	rs2298428	3.38E-10	YDJC	C	C	NR	NA	YDJC	SNP-based	Cross phenotype 	27088644	Caucasian	Cohort of Immune-Mediated Diseases	51109	All	Crohn disease	Non-ADRD	missense_variant
chr22	27755837	rs2267106	0.0000414	MN1	NR	NR	NR	NA	MN1	SNP-based	Disease risk	20061627	Caucasian	ADGC	699	All	LOAD	AD	intron_variant
chr22	30030080	rs41174	0.000834	MTMR3	T	T	NR	NA	MTMR3	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AD	AD	3_prime_UTR_variant
chr22	30030080	rs41174	3.03E-76	NR	T	T	NR	NA	MTMR3	SNP-based	eQTL	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	MTMR3 (ILMN_1803925) expression	Expression	3_prime_UTR_variant
chr22	30361306	rs737950	1.23E-24	SF3A1	NR	NR	0.42	1.52196	CCDC157	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	SF3A1 expression in Cerebellar	Expression	intron_variant
chr22	30361306	rs737950	1.68E-28	SF3A1	NR	NR	0.45	1.56831	CCDC157	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	SF3A1 expression in Cerebellar	Expression	intron_variant
chr22	30361306	rs737950	2.71E-68	SF3A1	NR	NR	0.46	1.58407	CCDC157	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	SF3A1 expression in Temporal cortex	Expression	intron_variant
chr22	30361306	rs737950	9.11E-61	SF3A1	NR	NR	0.44	1.55271	CCDC157	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	SF3A1 expression in Cerebellar	Expression	intron_variant
chr22	32349929	rs5998432	0.00000087	NR	T	T	NR	NA	RFPL3	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	MCI	CSF T-tau	Fluid biomarker	upstream_gene_variant
chr22	39133424	rs11089928	0.00242	APOBEC3F	A	A	NR	NA	CBX7	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	7289	Plan 2 (only males)	AD	AD	3_prime_UTR_variant
chr22	39133424	rs11089928	7.21E-20	NR	A	A	NR	NA	CBX7	SNP-based	eQTL	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	7289	Plan 2 (only males)	APOBEC3F (ILMN_2296950) expression	Expression	3_prime_UTR_variant
chr22	40820742	rs6002167	0.0000227	ST13	NR	NR	0.67	0.67	SLC25A17	SNP-based	Disease risk	30979435	Caucasian	ADGC	6543	Age >=80 y	AD	AD	upstream_gene_variant
chr22	40820742	rs6002167	0.502	ST13	NR	NR	1.04	1.04	SLC25A17	SNP-based	Disease risk	30979435	Caucasian	ADGC	14844	Age 60-79 y	AD	AD	upstream_gene_variant
chr22	41205381	rs3804097	0.016	L3MBTL2	NR	NR	2.99	2.99	L3MBTL2	SNP-based	Cross phenotype 	30010129	Asian	Cohort from Han Chinse	475	All	AD	AD	missense_variant
chr22	41217299	rs9611520	0.00014	L3MBTL2	NR	NR	NR	NA	L3MBTL2	SNP-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr22	41217299	rs9611520	0.0096	NA	NR	NR	NR	NA	L3MBTL2	Gene-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr22	41822852	rs7364180	<1.00E-06	EPC2	NR	NR	NR	NA	CCDC134	SNP-based	Endophenotype	21123754	Non-Hispanic Caucasian	ADNI	374	All	CSF Ab1-42	Fluid biomarker	intron_variant
chr22	43813408	rs5764317	0.00000222	SULT4A1	NR	NR	NR	NA	EFCAB6	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intron_variant
chr22	43823228	rs138053	0.00000222	SULT4A1	NR	NR	NR	NA	SULT4A1	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	downstream_gene_variant
chr22	43829914	rs138062	0.000000234	SULT4A1	NR	NR	NR	NA	SULT4A1	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intron_variant
chr22	43829993	rs138064	0.00000125	SULT4A1	NR	NR	NR	NA	SULT4A1	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intron_variant
chr22	43833612	rs138069	0.00000125	SULT4A1	NR	NR	NR	NA	SULT4A1	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intron_variant
chr22	43843619	rs138079	0.00000086	SULT4A1	NR	NR	NR	NA	SULT4A1	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intron_variant
chr22	43844805	rs470088	0.00000086	SULT4A1	NR	NR	NR	NA	SULT4A1	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intron_variant
chr22	43846187	rs80637	0.00000086	SULT4A1	NR	NR	NR	NA	SULT4A1	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intron_variant
chr22	43847894	rs138084	0.0000017	SULT4A1	NR	NR	NR	NA	SULT4A1	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intron_variant
chr22	43848422	rs138086	0.00000228	SULT4A1	NR	NR	NR	NA	SULT4A1	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intron_variant
chr22	43848741	rs138087	0.00000086	SULT4A1	NR	NR	NR	NA	SULT4A1	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intron_variant
chr22	43849201	rs80627	0.00000228	SULT4A1	NR	NR	NR	NA	SULT4A1	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intron_variant
chr22	43849299	rs80628	0.00000086	SULT4A1	NR	NR	NR	NA	SULT4A1	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intron_variant
chr22	43854690	rs138097	0.000000168	SULT4A1	NR	NR	NR	NA	SULT4A1	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intron_variant
chr22	43859952	rs138105	0.0000049	SULT4A1	NR	NR	NR	NA	SULT4A1	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intron_variant
chr22	43869595	rs138119	0.00000905	PNPLA5	NR	NR	NR	NA	SULT4A1	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intergenic_region
chr22	43873442	rs138125	0.00000572	PNPLA5	NR	NR	NR	NA	PNPLA5	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intergenic_region
chr22	43876356	rs138127	0.00000239	PNPLA5	NR	NR	NR	NA	PNPLA5	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	downstream_gene_variant
chr22	43878322	rs129655	0.00000138	PNPLA5	NR	NR	NR	NA	PNPLA5	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	downstream_gene_variant
chr22	43880291	rs470093	0.00000164	PNPLA5	NR	NR	NR	NA	PNPLA5	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	3_prime_UTR_variant
chr22	44958251	rs143258763	0.000000019	NR	A	A	-2.41	0.0898153	PHF21B	SNP-based	Endophenotype	25188341	Caucasian	ADGC	4914	All	Clinico-pathologic AD dementia (No neuropathologist documentation)	Neuropathology	intron_variant
chr22	44958251	rs143258763	0.00000002	NR	A	A	-2.41	0.0898153	PHF21B	SNP-based	Endophenotype	25188341	Caucasian	ADGC	3702	All	Clinico-pathologic AD dementia (with neuropathologist documentation)	Neuropathology	intron_variant
chr22	45368994	rs136564	2.11E-53	FAM118A	NR	NR	0.68	1.97388	SMC1B	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	FAM118A expression in Temporal cortex	Expression	intron_variant
chr22	45368994	rs136564	3.74E-75	FAM118A	NR	NR	0.85	2.33965	SMC1B	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	FAM118A expression in Cerebellar	Expression	intron_variant
chr22	45368994	rs136564	7.02E-39	FAM118A	NR	NR	0.82	2.2705	SMC1B	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	FAM118A expression in Cerebellar	Expression	intron_variant
chr22	45368994	rs136564	7.93E-30	FAM118A	NR	NR	0.88	2.4109	SMC1B	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	FAM118A expression in Cerebellar	Expression	intron_variant
chr22	50521672	rs131814	0.0000086	NCAPH2	NR	NR	0.249	1.28274	NCAPH2	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	673	All	CSF Clusterin	Fluid biomarker	intron_variant
chr22	50521672	rs131814	0.000859	NCAPH2	NR	NR	0.247	1.28018	NCAPH2	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	403	Subjects with APOE-e4-	CSF Clusterin	Fluid biomarker	intron_variant
chr22	50521672	rs131814	0.00236	NCAPH2	NR	NR	0.257	1.29305	NCAPH2	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	270	Subjects with APOE-e4+	CSF Clusterin	Fluid biomarker	intron_variant
chr3	7243998	rs2007029	0.00000394	GRM7	NR	NR	NR	NA	GRM7	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	818	All	Plasma Clusterin	Fluid biomarker	intron_variant
chr3	9437458	rs2442825	0.00000779	SETD5	NR	NR	0.237	1.26744	SETD5	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	673	All	CSF Clusterin	Fluid biomarker	intron_variant
chr3	9437458	rs2442825	0.000475	SETD5	NR	NR	0.261	1.29823	SETD5	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	403	Subjects with APOE-e4-	CSF Clusterin	Fluid biomarker	intron_variant
chr3	9437458	rs2442825	0.0103	SETD5	NR	NR	0.191	1.21046	SETD5	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	270	Subjects with APOE-e4+	CSF Clusterin	Fluid biomarker	intron_variant
chr3	10092026	rs9849434	0.00000188	"FANCD2, FANCD2OS"	A	A	0.71	0.71	FANCD2	SNP-based	Disease risk	24755620	Caucasian	ADGC	4569	All	AD	AD	intron_variant
chr3	10093893	rs1552244	0.00000163	"FANCD2, FANCD2OS"	G	G	0.76	0.76	FANCD2	SNP-based	Disease risk	24755620	Caucasian	ADGC	4569	All	AD	AD	intron_variant
chr3	12355456	rs2881654	0.00000017	PPARG	NR	NR	NR	NA	PPARG	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr3	28887369	rs2221154	0.00000258	NR	T	T	0.57	0.57	AC098650.1	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intergenic_region
chr3	32278916	rs7644602	0.0000395	CMTM8	NR	NR	2.46	2.46	CMTM8	SNP-based	Disease risk	21098978	Arab	Cohort from Israeli	266	All	AD	AD	intron_variant
chr3	32280107	rs11708149	0.0000401	CMTM8	NR	NR	2.58	2.58	CMTM8	SNP-based	Disease risk	21098978	Arab	Cohort from Israeli	266	All	AD	AD	intron_variant
chr3	32281483	rs6783478	0.0000397	CMTM8	NR	NR	2.6	2.6	CMTM8	SNP-based	Disease risk	21098978	Arab	Cohort from Israeli	266	All	AD	AD	intron_variant
chr3	35101019	rs11129640	5.57E-08	ARPP-21	NR	NR	0.124	1.13202	ARPP21	SNP-based	Endophenotype	21116278	Caucasian	"AddNeuroMed, ADNI"	939	All	Entorhinal cortex thickness	Imaging	intergenic_region
chr3	37193098	rs7631605	0.00000096	NR	T	T	NR	NA	LRRFIP2	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	MCI	CSF P-tau181p	Fluid biomarker	upstream_gene_variant
chr3	37732734	rs142726080	0.2	ITGA9	NR	NR	NR	NA	ITGA9	SNP-based	Disease risk	25172201	African American	ADGC	816	All	AD	AD	missense_variant
chr3	38126634	rs61095322	0.00736	ACAA1	C	C	NR	NA	ACAA1	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	missense_variant
chr3	38126634	rs61095322	1.27E-23	NR	C	C	NR	NA	ACAA1	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	ACAA1 (ILMN_1738921) expression	Expression	missense_variant
chr3	38126634	rs61095322	2.12E-10	NR	A	A	NR	NA	ACAA1	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	ACAA1 (ENSG00000060971) expression	Expression	missense_variant
chr3	39452367	rs9820623	0.0000169	MOBP	NR	NR	NR	NA	MOBP	SNP-based	Cross phenotype 	29630712	Caucasian	"ALS group, IGAP, FTGC, AFTD, PSP Genetics Consortium, IPDGC"	36052	All	AD	AD	intergenic_region
chr3	39452367	rs9820623	0.0044	MOBP	NR	NR	NR	NA	MOBP	SNP-based	Cross phenotype 	29630712	Caucasian	UKBEC	NR	All	SCN11A expression in brain	Expression	intergenic_region
chr3	39481512	rs1768208	0.000000171	MOBP	NR	NR	0.36	1.43333	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	MOBP (ILMN_2298464) expression in Cerebellar	Expression	intron_variant
chr3	39481512	rs1768208	0.00000157	MOBP	NR	NR	0.33	1.39097	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	MOBP (ILMN_2298464) expression in Temporal cortex	Expression	intron_variant
chr3	39481512	rs1768208	0.0000176	MOBP	NR	NR	0.18	1.19722	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	MOBP (ILMN_2414962) expression in Temporal cortex	Expression	intron_variant
chr3	39481512	rs1768208	0.000117	MOBP	NR	NR	0.24	1.27125	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	MOBP (ILMN_2414962) expression in Cerebellar	Expression	intron_variant
chr3	39481512	rs1768208	0.00037	MOBP	NR	NR	0.33	1.39097	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	MOBP (ILMN_2298464) expression in Cerebellar	Expression	intron_variant
chr3	39481512	rs1768208	0.00123	MOBP	NR	NR	0.31	1.36343	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	202	AD	MOBP (ILMN_2298464) expression in Temporal cortex	Expression	intron_variant
chr3	39481512	rs1768208	0.00303	MOBP	NR	NR	0.11	1.11628	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	MOBP (ILMN_1768947) expression in Temporal cortex	Expression	intron_variant
chr3	39481512	rs1768208	0.00757	MOBP	NR	NR	0.14	1.15027	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	MOBP (ILMN_1768947) expression in Cerebellar	Expression	intron_variant
chr3	39481512	rs1768208	0.00818	MOBP	NR	NR	0.14	1.15027	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	202	AD	MOBP (ILMN_2414962) expression in Temporal cortex	Expression	intron_variant
chr3	39481512	rs1768208	0.0124	MOBP	NR	NR	0.34	1.40495	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	98	PSP	MOBP (ILMN_2298464) expression in Cerebellar	Expression	intron_variant
chr3	39481512	rs1768208	0.0125	MOBP	NR	NR	0.2	1.2214	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	MOBP (ILMN_2414962) expression in Cerebellar	Expression	intron_variant
chr3	39481512	rs1768208	0.0155	MOBP	NR	NR	0.05	1.05127	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	MOBP (ILMN_1750271) expression in Temporal cortex	Expression	intron_variant
chr3	39481512	rs1768208	0.0172	MOBP	NR	NR	0.16	1.17351	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	MOBP (ILMN_1768947) expression in Cerebellar	Expression	intron_variant
chr3	39481512	rs1768208	0.0174	MOBP	NR	NR	0.24	1.27125	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	107	PSP	MOBP (ILMN_2414962) expression in Temporal cortex	Expression	intron_variant
chr3	39481512	rs1768208	0.0183	MOBP	NR	NR	0.2	1.2214	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	107	PSP	MOBP (ILMN_1768947) expression in Temporal cortex	Expression	intron_variant
chr3	39481512	rs1768208	0.0213	MOBP	NR	NR	0.07	1.07251	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	MOBP (ILMN_1750271) expression in Cerebellar	Expression	intron_variant
chr3	39481512	rs1768208	0.0233	MOBP	NR	NR	0.34	1.40495	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	107	PSP	MOBP (ILMN_2298464) expression in Temporal cortex	Expression	intron_variant
chr3	39481512	rs1768208	0.0377	RPSA	NR	NR	-0.06	0.941765	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	98	PSP	RPSA (ILMN_2411723) expression in Cerebellar	Expression	intron_variant
chr3	39481512	rs1768208	0.0429	MOBP	NR	NR	0.05	1.05127	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	202	AD	MOBP (ILMN_1750271) expression in Temporal cortex	Expression	intron_variant
chr3	39481512	rs1768208	0.0692	RPSA	NR	NR	-0.03	0.970446	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	RPSA (ILMN_2411723) expression in Cerebellar	Expression	intron_variant
chr3	39481512	rs1768208	0.0802	MOBP	NR	NR	0.22	1.24608	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	98	PSP	MOBP (ILMN_2414962) expression in Cerebellar	Expression	intron_variant
chr3	39481512	rs1768208	0.0872	RPSA	NR	NR	-0.03	0.970446	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	RPSA (ILMN_2411723) expression in Cerebellar	Expression	intron_variant
chr3	39481512	rs1768208	0.0886	MOBP	NR	NR	0.07	1.07251	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	MOBP (ILMN_1750271) expression in Cerebellar	Expression	intron_variant
chr3	39481512	rs1768208	0.103	MOBP	NR	NR	0.08	1.08329	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	107	PSP	MOBP (ILMN_1750271) expression in Temporal cortex	Expression	intron_variant
chr3	39481512	rs1768208	0.138	MOBP	NR	NR	0.07	1.07251	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	202	AD	MOBP (ILMN_1768947) expression in Temporal cortex	Expression	intron_variant
chr3	39481512	rs1768208	0.147	SLC25A38	NR	NR	0.03	1.03045	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	SLC25A38 (ILMN_1781231) expression in Cerebellar	Expression	intron_variant
chr3	39481512	rs1768208	0.284	BMS1	NR	NR	0.02	1.0202	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	202	AD	SLC25A38 (ILMN_1781231) expression in Temporal cortex	Expression	intron_variant
chr3	39481512	rs1768208	0.284	MOBP	NR	NR	0.06	1.06184	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	98	PSP	MOBP (ILMN_1750271) expression in Cerebellar	Expression	intron_variant
chr3	39481512	rs1768208	0.433	SLC25A38	NR	NR	-0.02	0.980199	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	98	PSP	SLC25A38 (ILMN_1781231) expression in Cerebellar	Expression	intron_variant
chr3	39481512	rs1768208	0.455	MOBP	NR	NR	0.08	1.08329	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	98	PSP	MOBP (ILMN_1768947) expression in Cerebellar	Expression	intron_variant
chr3	39481512	rs1768208	0.729	RPSA	NR	NR	-0.01	0.99005	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	107	PSP	RPSA (ILMN_2411723) expression in Temporal cortex	Expression	intron_variant
chr3	39481512	rs1768208	0.776	SLC25A38	NR	NR	0	1	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	SLC25A38 (ILMN_1781231) expression in Cerebellar	Expression	intron_variant
chr3	39481512	rs1768208	0.902	SLC25A38	NR	NR	0	1	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	SLC25A38 (ILMN_1781231) expression in Temporal cortex	Expression	intron_variant
chr3	39481512	rs1768208	0.941	RPSA	NR	NR	0	1	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	202	AD	RPSA (ILMN_2411723) expression in Temporal cortex	Expression	intron_variant
chr3	39481512	rs1768208	0.966	RPSA	NR	NR	0	1	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	RPSA (ILMN_2411723) expression in Temporal cortex	Expression	intron_variant
chr3	39481512	rs1768208	0.978	SLC25A38	NR	NR	0	1	MOBP	SNP-based	eQTL	22685416	Caucasian	MAYO	107	PSP	SLC25A38 (ILMN_1781231) expression in Temporal cortex	Expression	intron_variant
chr3	39481512	rs1768208	5.30E-17	MOBP	NA	NA	0.73	0.73	MOBP	SNP-based	Disease Risk	22685416	Caucasian	"Cohorts from Europe, USA"	8851	All	Progressive Supranuclear Palsy (PSP)	ADRD	intron_variant
chr3	39708102	rs9832461	0.00000372	NR	G	G	3765.6	inf	MYRIP	SNP-based	Endophenotype	20197096	Caucasian	ADNI	742	All	Temporal Lobe Atrophy	Imaging	intergenic_region
chr3	39708102	rs9832461	0.0000144	NR	G	G	3765.6	inf	MYRIP	SNP-based	Endophenotype	20197096	Caucasian	ADNI	742	All	Temporal Lobe Atrophy	Imaging	intergenic_region
chr3	39730960	rs1527566	0.00000232	NR	C	C	3757.8	inf	MYRIP	SNP-based	Endophenotype	20197096	Caucasian	ADNI	742	All	Temporal Lobe Atrophy	Imaging	intergenic_region
chr3	39730960	rs1527566	0.00000326	NR	C	C	3757.8	inf	MYRIP	SNP-based	Endophenotype	20197096	Caucasian	ADNI	742	All	Temporal Lobe Atrophy	Imaging	intergenic_region
chr3	39755235	rs9878556	0.0000029	NR	T	T	3794.3	inf	MYRIP	SNP-based	Endophenotype	20197096	Caucasian	ADNI	742	All	Temporal Lobe Atrophy	Imaging	intergenic_region
chr3	39755235	rs9878556	0.00000799	NR	T	T	3794.3	inf	MYRIP	SNP-based	Endophenotype	20197096	Caucasian	ADNI	742	All	Temporal Lobe Atrophy	Imaging	intergenic_region
chr3	42530054	rs417387	0.00000279	VIPR1	NR	NR	0.353	1.42333	VIPR1	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	673	All	CSF Clusterin	Fluid biomarker	intron_variant
chr3	42530054	rs417387	0.00034	VIPR1	NR	NR	0.37	1.44773	VIPR1	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	403	Subjects with APOE-e4-	CSF Clusterin	Fluid biomarker	intron_variant
chr3	42530054	rs417387	0.00273	VIPR1	NR	NR	0.342	1.40776	VIPR1	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	270	Subjects with APOE-e4+	CSF Clusterin	Fluid biomarker	intron_variant
chr3	42864624	rs2228467	0.00225	NA	NR	NR	NR	NA	ACKR2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR > 0	CSF CCL2 	Fluid biomarker	missense_variant
chr3	42864624	rs2228467	0.0482	NA	NR	NR	NR	NA	ACKR2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	Plasma CCL2 	Fluid biomarker	missense_variant
chr3	42864624	rs2228467	0.14	NA	NR	NR	NR	NA	ACKR2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF Ab1-42	Fluid biomarker	missense_variant
chr3	42864624	rs2228467	0.51	NA	NR	NR	NR	NA	ACKR2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF T-tau	Fluid biomarker	missense_variant
chr3	42864624	rs2228467	0.52	NA	NR	NR	-0.021	0.979219	ACKR2	SNP-based	Disease risk	25340798	Caucasian	IGAP	54162	All	AD	AD	missense_variant
chr3	42864624	rs2228467	0.8	NA	NR	NR	NR	NA	ACKR2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF P-tau181p	Fluid biomarker	missense_variant
chr3	42864624	rs2228467	1.98E-08	NA	NR	NR	NR	NA	ACKR2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Amyloid deposition strata	CSF CCL2 	Fluid biomarker	missense_variant
chr3	42864624	rs2228467	2.72E-10	NA	NR	NR	NR	NA	ACKR2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	No amyloid deposition strata	CSF CCL2 	Fluid biomarker	missense_variant
chr3	42864624	rs2228467	3.71E-18	CCBP2	G	G	NR	NA	ACKR2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF CCL2 	Fluid biomarker	missense_variant
chr3	42864624	rs2228467	5.36E-16	NA	NR	NR	NR	NA	ACKR2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR = 0	CSF CCL2 	Fluid biomarker	missense_variant
chr3	42864624	rs2228467	6.30E-12	CCBP2	G	G	NR	NA	ACKR2	SNP-based	Endophenotype	25340798	Caucasian	ADNI	308	All	CSF CCL2 	Fluid biomarker	missense_variant
chr3	42864624	rs2228467	7.42E-08	CCBP2	G	G	NR	NA	ACKR2	SNP-based	Endophenotype	25340798	Caucasian	Knight-ADRC	266	All	CSF CCL2 	Fluid biomarker	missense_variant
chr3	44645808	rs1402752	0.00000869	NR	NR	NR	NR	NA	ZNF197	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intron_variant
chr3	44645808	rs1402752	0.000251	NR	NR	NR	2.64	2.64	ZNF197	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intron_variant
chr3	44645808	rs1402752	0.000663	NR	NR	NR	NR	NA	ZNF197	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr3	44645808	rs1402752	0.015	NR	NR	NR	1.48	1.48	ZNF197	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr3	44645808	rs1402752	0.643	NR	NR	NR	NR	NA	ZNF197	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intron_variant
chr3	44645808	rs1402752	0.809	NR	NR	NR	NR	NA	ZNF197	SNP-based	Disease risk	21059989	Caucasian	ADGC	1390	Unrelated individuals	LOAD	AD	intron_variant
chr3	44645808	rs1402752	0.81715	NR	NR	NR	NR	NA	ZNF197	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intron_variant
chr3	44645808	rs1402752	0.88493	NR	NR	NR	NR	NA	ZNF197	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intron_variant
chr3	44645808	rs1402752	1	NR	NR	NR	1.07	1.07	ZNF197	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intron_variant
chr3	46358571	rs3092960	0.000000166	CCR2	G	G	NR	NA	CCR2	SNP-based	Endophenotype	25340798	Caucasian	Knight-ADRC	266	All	CSF CCL4 	Fluid biomarker	synonymous_variant
chr3	46358571	rs3092960	0.00000076	NA	NR	NR	NR	NA	CCR2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR = 0	CSF CCL4 	Fluid biomarker	synonymous_variant
chr3	46358571	rs3092960	0.000002	NA	NR	NR	NR	NA	CCR2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	No amyloid deposition strata	CSF CCL4 	Fluid biomarker	synonymous_variant
chr3	46358571	rs3092960	0.00000404	NA	NR	NR	NR	NA	CCR2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Amyloid deposition strata	CSF CCL4 	Fluid biomarker	synonymous_variant
chr3	46358571	rs3092960	0.0000236	NA	NR	NR	NR	NA	CCR2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	Plasma CCL4 	Fluid biomarker	synonymous_variant
chr3	46358571	rs3092960	0.0000265	NA	NR	NR	NR	NA	CCR2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR > 0	CSF CCL4 	Fluid biomarker	synonymous_variant
chr3	46358571	rs3092960	0.0000504	CCR2	G	G	NR	NA	CCR2	SNP-based	Endophenotype	25340798	Caucasian	ADNI	308	All	CSF CCL4 	Fluid biomarker	synonymous_variant
chr3	46358571	rs3092960	0.6	NA	NR	NR	NR	NA	CCR2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF Ab1-42	Fluid biomarker	synonymous_variant
chr3	46358571	rs3092960	0.679	NA	NR	NR	0.009	1.00904	CCR2	SNP-based	Disease risk	25340798	Caucasian	IGAP	54162	All	AD	AD	synonymous_variant
chr3	46358571	rs3092960	0.89	NA	NR	NR	NR	NA	CCR2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF T-tau	Fluid biomarker	synonymous_variant
chr3	46358571	rs3092960	0.9	NA	NR	NR	NR	NA	CCR2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF P-tau181p	Fluid biomarker	synonymous_variant
chr3	46358571	rs3092960	4.43E-11	CCR2	G	G	NR	NA	CCR2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF CCL4 	Fluid biomarker	synonymous_variant
chr3	46380864	rs11575821	0.000000299	NA	NR	NR	NR	NA	CCR5	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR = 0	CSF CCL4 	Fluid biomarker	intron_variant
chr3	46380864	rs11575821	0.00000299	NA	NR	NR	NR	NA	CCR5	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Amyloid deposition strata	CSF CCL4 	Fluid biomarker	intron_variant
chr3	46380864	rs11575821	0.0000114	NA	NR	NR	NR	NA	CCR5	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR > 0	CSF CCL4 	Fluid biomarker	intron_variant
chr3	46380864	rs11575821	0.000105	NA	NR	NR	NR	NA	CCR5	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	No amyloid deposition strata	CSF CCL4 	Fluid biomarker	intron_variant
chr3	46380864	rs11575821	0.000242	NA	NR	NR	NR	NA	CCR5	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	Plasma CCL4 	Fluid biomarker	intron_variant
chr3	46380864	rs11575821	0.000642	CCR5	G	G	NR	NA	CCR5	SNP-based	Endophenotype	25340798	Caucasian	ADNI	308	All	CSF CCL4 	Fluid biomarker	intron_variant
chr3	46380864	rs11575821	0.46	NA	NR	NR	NR	NA	CCR5	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF Ab1-42	Fluid biomarker	intron_variant
chr3	46380864	rs11575821	0.79	NA	NR	NR	0.006	1.00602	CCR5	SNP-based	Disease risk	25340798	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr3	46380864	rs11575821	0.96	NA	NR	NR	NR	NA	CCR5	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr3	46380864	rs11575821	0.98	NA	NR	NR	NR	NA	CCR5	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF T-tau	Fluid biomarker	intron_variant
chr3	46380864	rs11575821	1.13E-09	CCR5	G	G	NR	NA	CCR5	SNP-based	Endophenotype	25340798	Caucasian	Knight-ADRC	266	All	CSF CCL4 	Fluid biomarker	intron_variant
chr3	46380864	rs11575821	1.22E-11	CCR5	G	G	NR	NA	CCR5	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF CCL4 	Fluid biomarker	intron_variant
chr3	46384227	rs113263161	0.000000027	CCR5	G	G	NR	NA	CCR5	SNP-based	Endophenotype	25340798	Caucasian	Knight-ADRC	266	All	CSF CCL4 	Fluid biomarker	intron_variant
chr3	46384227	rs113263161	0.000000674	NA	NR	NR	NR	NA	CCR5	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	No amyloid deposition strata	CSF CCL4 	Fluid biomarker	intron_variant
chr3	46384227	rs113263161	0.000000785	NA	NR	NR	NR	NA	CCR5	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR = 0	CSF CCL4 	Fluid biomarker	intron_variant
chr3	46384227	rs113263161	0.00000509	NA	NR	NR	NR	NA	CCR5	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR > 0	CSF CCL4 	Fluid biomarker	intron_variant
chr3	46384227	rs113263161	0.0000064	NA	NR	NR	NR	NA	CCR5	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Amyloid deposition strata	CSF CCL4 	Fluid biomarker	intron_variant
chr3	46384227	rs113263161	0.0000786	CCR5	G	G	NR	NA	CCR5	SNP-based	Endophenotype	25340798	Caucasian	ADNI	308	All	CSF CCL4 	Fluid biomarker	intron_variant
chr3	46384227	rs113263161	0.00012	NA	NR	NR	NR	NA	CCR5	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	Plasma CCL4 	Fluid biomarker	intron_variant
chr3	46384227	rs113263161	0.53	NA	NR	NR	NR	NA	CCR5	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF Ab1-42	Fluid biomarker	intron_variant
chr3	46384227	rs113263161	0.74	NA	NR	NR	NR	NA	CCR5	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr3	46384227	rs113263161	0.83	NA	NR	NR	0.005	1.00501	CCR5	SNP-based	Disease risk	25340798	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr3	46384227	rs113263161	0.85	NA	NR	NR	NR	NA	CCR5	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF T-tau	Fluid biomarker	intron_variant
chr3	46384227	rs113263161	1.41E-11	CCR5	G	G	NR	NA	CCR5	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF CCL4 	Fluid biomarker	intron_variant
chr3	46405230	rs11574428	0.000000367	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR = 0	CSF CCL4 	Fluid biomarker	intron_variant
chr3	46405230	rs11574428	0.00000451	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Amyloid deposition strata	CSF CCL4 	Fluid biomarker	intron_variant
chr3	46405230	rs11574428	0.0000154	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR > 0	CSF CCL4 	Fluid biomarker	intron_variant
chr3	46405230	rs11574428	0.000048	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	No amyloid deposition strata	CSF CCL4 	Fluid biomarker	intron_variant
chr3	46405230	rs11574428	0.00012	CCRL2	T	T	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	ADNI	308	All	CSF CCL4 	Fluid biomarker	intron_variant
chr3	46405230	rs11574428	0.000282	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	Plasma CCL4 	Fluid biomarker	intron_variant
chr3	46405230	rs11574428	0.55	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF Ab1-42	Fluid biomarker	intron_variant
chr3	46405230	rs11574428	0.68	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr3	46405230	rs11574428	0.88	NA	NR	NR	0.003	1.003	CCRL2	SNP-based	Disease risk	25340798	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr3	46405230	rs11574428	0.93	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF T-tau	Fluid biomarker	intron_variant
chr3	46405230	rs11574428	1.48E-11	CCRL2	T	T	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF CCL4 	Fluid biomarker	intron_variant
chr3	46405230	rs11574428	1.65E-08	CCRL2	T	T	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	Knight-ADRC	266	All	CSF CCL4 	Fluid biomarker	intron_variant
chr3	46408373	rs6808835	0.000000286	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Amyloid deposition strata	CSF CCL4 	Fluid biomarker	synonymous_variant
chr3	46408373	rs6808835	0.000000307	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	No amyloid deposition strata	CSF CCL4 	Fluid biomarker	synonymous_variant
chr3	46408373	rs6808835	0.00000888	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR > 0	CSF CCL4 	Fluid biomarker	synonymous_variant
chr3	46408373	rs6808835	0.0000297	CCRL2	G	G	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	Knight-ADRC	266	All	CSF CCL4 	Fluid biomarker	synonymous_variant
chr3	46408373	rs6808835	0.000196	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	Plasma CCL4 	Fluid biomarker	synonymous_variant
chr3	46408373	rs6808835	0.47	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF P-tau181p	Fluid biomarker	synonymous_variant
chr3	46408373	rs6808835	0.53	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF T-tau	Fluid biomarker	synonymous_variant
chr3	46408373	rs6808835	0.64	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF Ab1-42	Fluid biomarker	synonymous_variant
chr3	46408373	rs6808835	0.81	NA	NR	NR	0.005	1.00501	CCRL2	SNP-based	Disease risk	25340798	Caucasian	IGAP	54162	All	AD	AD	synonymous_variant
chr3	46408373	rs6808835	1.59E-13	CCRL2	G	G	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF CCL4 	Fluid biomarker	synonymous_variant
chr3	46408373	rs6808835	5.35E-10	CCRL2	G	G	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	ADNI	308	All	CSF CCL4 	Fluid biomarker	synonymous_variant
chr3	46408373	rs6808835	8.13E-09	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR = 0	CSF CCL4 	Fluid biomarker	synonymous_variant
chr3	46408581	rs6441977	0.000000113	CCRL2	G	G	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	ADNI	308	All	CSF CCL4 	Fluid biomarker	missense_variant
chr3	46408581	rs6441977	0.000000763	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR = 0	CSF CCL4 	Fluid biomarker	missense_variant
chr3	46408581	rs6441977	0.00000726	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Amyloid deposition strata	CSF CCL4 	Fluid biomarker	missense_variant
chr3	46408581	rs6441977	0.0000363	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR > 0	CSF CCL4 	Fluid biomarker	missense_variant
chr3	46408581	rs6441977	0.000113	CCRL2	G	G	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	Knight-ADRC	266	All	CSF CCL4 	Fluid biomarker	missense_variant
chr3	46408581	rs6441977	0.000201	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	No amyloid deposition strata	CSF CCL4 	Fluid biomarker	missense_variant
chr3	46408581	rs6441977	0.000668	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	Plasma CCL4 	Fluid biomarker	missense_variant
chr3	46408581	rs6441977	0.41	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF P-tau181p	Fluid biomarker	missense_variant
chr3	46408581	rs6441977	0.59	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF T-tau	Fluid biomarker	missense_variant
chr3	46408581	rs6441977	0.8	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF Ab1-42	Fluid biomarker	missense_variant
chr3	46408581	rs6441977	0.81	NA	NR	NR	0.006	1.00602	CCRL2	SNP-based	Disease risk	25340798	Caucasian	IGAP	54162	All	AD	AD	missense_variant
chr3	46408581	rs6441977	7.66E-11	CCRL2	G	G	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF CCL4 	Fluid biomarker	missense_variant
chr3	46411372	rs6762266	0.000000184	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Amyloid deposition strata	CSF CCL4 	Fluid biomarker	intron_variant
chr3	46411372	rs6762266	0.000000684	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	No amyloid deposition strata	CSF CCL4 	Fluid biomarker	intron_variant
chr3	46411372	rs6762266	0.00000888	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR > 0	CSF CCL4 	Fluid biomarker	intron_variant
chr3	46411372	rs6762266	0.0000407	CCRL2	C	C	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	ADNI	308	All	CSF CCL4 	Fluid biomarker	intron_variant
chr3	46411372	rs6762266	0.000159	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	Plasma CCL4 	Fluid biomarker	intron_variant
chr3	46411372	rs6762266	0.58	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr3	46411372	rs6762266	0.59	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF Ab1-42	Fluid biomarker	intron_variant
chr3	46411372	rs6762266	0.64	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF T-tau	Fluid biomarker	intron_variant
chr3	46411372	rs6762266	0.7	NA	NR	NR	0.009	1.00904	CCRL2	SNP-based	Disease risk	25340798	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr3	46411372	rs6762266	1.25E-08	NA	NR	NR	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	Subjects with CDR = 0	CSF CCL4 	Fluid biomarker	intron_variant
chr3	46411372	rs6762266	2.27E-13	CCRL2	C	C	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	"ADNI, Knight-ADRC"	574	All	CSF CCL4 	Fluid biomarker	intron_variant
chr3	46411372	rs6762266	5.35E-10	CCRL2	C	C	NR	NA	CCRL2	SNP-based	Endophenotype	25340798	Caucasian	Knight-ADRC	266	All	CSF CCL4 	Fluid biomarker	intron_variant
chr3	52550771	rs2251219	0.28	PBRM1	NR	NR	1.06	1.06	SMIM4	SNP-based	Cross phenotype 	22005930	Caucasian	"ADGC, GERAD, Cohort from UK"	6958	AD+P and control subjects	AD+Psychosis	ADRD	synonymous_variant
chr3	52550771	rs2251219	0.95	PBRM1	NR	NR	1	1	SMIM4	SNP-based	Cross phenotype 	22005930	Caucasian	"ADGC, GERAD"	2034	AD+P and AD-P subjects	AD+Psychosis	ADRD	synonymous_variant
chr3	54319213	rs7431992	1.99E-08	CACNA2D3	A	A	1.59	1.59	CACNA2D3	SNP-based	Disease risk	26339675	Caribbean Hispanic	"EFIGA, NOMAS, WHICAP "	4514	All	LOAD	AD	intron_variant
chr3	54319213	rs7431992	5.80E-09	CACNA2D3	A	A	1.61	1.61	CACNA2D3	SNP-based	Disease risk	26339675	Caribbean Hispanic	"EFIGA, NOMAS, WHICAP "	4514	All	LOAD	AD	intron_variant
chr3	56705895	rs6805910	0.00061	ARHGEF3	C	C	NR	NA	ARHGEF3	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr3	56705895	rs6805910	0.000693	ARHGEF3	C	C	NR	NA	ARHGEF3	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	High-density lipoprotein (HDL)	Non-ADRD	intergenic_region
chr3	56705895	rs6805910	0.718	ARHGEF3	C	C	1	1	ARHGEF3	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intergenic_region
chr3	57192122	rs184384746	1.24E-08	HESX1	T	T	5.69	NA	HESX1	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	intergenic_region
chr3	59905250	rs643629	0.00000998	NR	A	A	NR	NA	FHIT	SNP-based	Disease risk	21390209	Caucasian	"ADNI, GenADA, Pfizer"	3595	All	AD	AD	intron_variant
chr3	59907310	rs624225	0.00000512	NR	C	C	NR	NA	FHIT	SNP-based	Disease risk	21390209	Caucasian	"ADNI, GenADA, Pfizer"	3595	All	AD	AD	intron_variant
chr3	64941350	rs704454	0.0000026	ADAMTS9	NR	NR	NR	NA	ADAMTS9	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	2222	AD subjects	Age at onset	Other	intron_variant
chr3	64941350	rs704454	0.0000046	ADAMTS9	NR	NR	1.22	3.38719	ADAMTS9	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	844	AD subjects	Age at onset	Other	intron_variant
chr3	64941350	rs704454	0.0000155	ADAMTS9	NR	NR	NR	NA	ADAMTS9	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	2222	AD subjects	Age at onset	Other	intron_variant
chr3	64941350	rs704454	0.0832	ADAMTS9	NR	NR	0.5	1.64872	ADAMTS9	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	1190	AD subjects	Age at onset	Other	intron_variant
chr3	64941350	rs704454	0.154	ADAMTS9	NR	NR	2.94	18.9158	ADAMTS9	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADNI	188	AD subjects	Age at onset	Other	intron_variant
chr3	66855351	rs9862849	0.00000266	KBTBD8	C	C	0.6	0.6	KBTBD8	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	7289	Plan 2 (only males)	AD	AD	intergenic_region
chr3	67406609	rs62256378	0.000000015	NR	A	A	0.97	2.63794	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	NR	AD subjects with APOE-e4 non-carrier 	CSF Ab1-42	Fluid biomarker	intron_variant
chr3	67406609	rs62256378	0.0000003	NR	A	A	0.61	1.84043	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	363	AD subjects	CSF Ab1-42	Fluid biomarker	intron_variant
chr3	67406609	rs62256378	0.0000019	NR	A	A	0.61	1.84043	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	515	AD subjects	CSF Ab1-42	Fluid biomarker	intron_variant
chr3	67406609	rs62256378	0.000025	NR	A	A	2.13	8.41487	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	113	AD subjects	CSF Ab1-42	Fluid biomarker	intron_variant
chr3	67406609	rs62256378	0.00011	NR	A	A	0.94	2.55998	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	NR	AD subjects with APOE-e4 non-carrier 	CSF Ab1-42	Fluid biomarker	intron_variant
chr3	67406609	rs62256378	0.0006	NR	A	A	0.82	2.2705	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	167	AD subjects	CSF Ab1-42	Fluid biomarker	intron_variant
chr3	67406609	rs62256378	0.0015	NR	A	A	0.35	1.41907	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	NR	AD subjects with heterozygous APOE-e4 	CSF Ab1-42	Fluid biomarker	intron_variant
chr3	67406609	rs62256378	0.0031	NR	A	A	0.32	1.37713	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	878	AD subjects	MMSE Score	Cognitive	intron_variant
chr3	67406609	rs62256378	0.0048	NR	A	A	1.68	5.36556	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	NR	AD subjects with APOE-e4 non-carrier 	CSF Ab1-42	Fluid biomarker	intron_variant
chr3	67406609	rs62256378	0.0088	NR	A	A	0.96	2.6117	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	NR	AD subjects with APOE-e4 non-carrier 	CSF Ab1-42	Fluid biomarker	intron_variant
chr3	67406609	rs62256378	0.02	NR	A	A	0.61	1.84043	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	NR	AD subjects with APOE-e4 non-carrier 	MMSE Score	Cognitive	intron_variant
chr3	67406609	rs62256378	0.021	NR	A	A	0.32	1.37713	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	NR	AD subjects with APOE-e4 non-carrier 	MMSE Score	Cognitive	intron_variant
chr3	67406609	rs62256378	0.03	NR	A	A	0.32	1.37713	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	NR	AD subjects with heterozygous APOE-e4 	CSF Ab1-42	Fluid biomarker	intron_variant
chr3	67406609	rs62256378	0.04	NR	A	A	0.45	1.56831	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	NR	AD subjects with heterozygous APOE-e4 	CSF Ab1-42	Fluid biomarker	intron_variant
chr3	67406609	rs62256378	0.072	NR	A	A	0.31	1.36343	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	NR	AD subjects with heterozygous APOE-e4 	MMSE Score	Cognitive	intron_variant
chr3	67406609	rs62256378	0.08	NR	A	A	0.28	1.32313	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	515	AD subjects	MMSE Score	Cognitive	intron_variant
chr3	67406609	rs62256378	0.08	NR	A	A	0.57	1.76827	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	113	AD subjects	MMSE Score	Cognitive	intron_variant
chr3	67406609	rs62256378	0.09	NR	A	A	0.5	1.64872	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	ADNI	83	AD subjects	CSF Ab1-42	Fluid biomarker	intron_variant
chr3	67406609	rs62256378	0.11	NR	A	A	0.24	1.27125	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	ADNI	83	AD subjects	MMSE Score	Cognitive	intron_variant
chr3	67406609	rs62256378	0.14	NR	A	A	0.66	1.93479	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	ADNI	NR	AD subjects with APOE-e4 non-carrier 	CSF Ab1-42	Fluid biomarker	intron_variant
chr3	67406609	rs62256378	0.14	NR	A	A	1.23	3.42123	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	ADNI	NR	AD subjects with homozygous APOE-e4 	MMSE Score	Cognitive	intron_variant
chr3	67406609	rs62256378	0.141	NR	A	A	0.4	1.49182	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	NR	AD subjects with homozygous APOE-e4 	MMSE Score	Cognitive	intron_variant
chr3	67406609	rs62256378	0.15	NR	A	A	0.43	1.53726	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	ADNI	NR	AD subjects with heterozygous APOE-e4 	MMSE Score	Cognitive	intron_variant
chr3	67406609	rs62256378	0.15	NR	A	A	0.66	1.93479	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	167	AD subjects	MMSE Score	Cognitive	intron_variant
chr3	67406609	rs62256378	0.16	NR	A	A	1.07	2.91538	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	NR	AD subjects with heterozygous APOE-e4 	MMSE Score	Cognitive	intron_variant
chr3	67406609	rs62256378	0.23	NR	A	A	0.57	1.76827	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	NR	AD subjects with APOE-e4 non-carrier 	MMSE Score	Cognitive	intron_variant
chr3	67406609	rs62256378	0.25	NR	A	A	0.38	1.46228	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	NR	AD subjects with heterozygous APOE-e4 	MMSE Score	Cognitive	intron_variant
chr3	67406609	rs62256378	0.25	NR	A	A	1.38	3.9749	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	NR	AD subjects with homozygous APOE-e4 	MMSE Score	Cognitive	intron_variant
chr3	67406609	rs62256378	0.26	NR	A	A	0.29	1.33643	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	NR	AD subjects with homozygous APOE-e4 	MMSE Score	Cognitive	intron_variant
chr3	67406609	rs62256378	0.29	NR	A	A	0.18	1.19722	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	NR	AD subjects with heterozygous APOE-e4 	MMSE Score	Cognitive	intron_variant
chr3	67406609	rs62256378	0.33	NR	A	A	0.48	1.61607	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	ADNI	NR	AD subjects with heterozygous APOE-e4 	CSF Ab1-42	Fluid biomarker	intron_variant
chr3	67406609	rs62256378	0.39	NR	A	A	0.26	1.29693	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	NR	AD subjects with APOE-e4 non-carrier 	MMSE Score	Cognitive	intron_variant
chr3	67406609	rs62256378	0.44	NR	A	A	0.24	1.27125	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	NR	AD subjects with heterozygous APOE-e4 	CSF Ab1-42	Fluid biomarker	intron_variant
chr3	67406609	rs62256378	0.5	NR	A	A	0.01	1.01005	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	ADNI	NR	AD subjects with APOE-e4 non-carrier 	MMSE Score	Cognitive	intron_variant
chr3	67406609	rs62256378	0.71	NR	A	A	-0.13	0.878095	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	NR	AD subjects with homozygous APOE-e4 	CSF Ab1-42	Fluid biomarker	intron_variant
chr3	67406609	rs62256378	0.83	NR	A	A	-0.04	0.960789	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	NR	AD subjects with homozygous APOE-e4 	CSF Ab1-42	Fluid biomarker	intron_variant
chr3	67406609	rs62256378	0.9	NR	A	A	-0.1	0.904837	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	ADNI	NR	AD subjects with homozygous APOE-e4 	CSF Ab1-42	Fluid biomarker	intron_variant
chr3	67406609	rs62256378	0.96	NR	A	A	0.01	1.01005	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	NR	AD subjects with homozygous APOE-e4 	CSF Ab1-42	Fluid biomarker	intron_variant
chr3	67406609	rs62256378	1	NR	A	A	-0.36	0.697676	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	NR	AD subjects with homozygous APOE-e4 	MMSE Score	Cognitive	intron_variant
chr3	67406609	rs62256378	2.50E-12	NR	A	A	0.71	2.03399	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	878	AD subjects	CSF Ab1-42	Fluid biomarker	intron_variant
chr3	67406609	rs62256378	2.50E-12	NR	A	A	0.71	2.03399	SUCLG2	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	878	AD subjects	CSF Ab1-42	Fluid biomarker	intron_variant
chr3	85835000	rs13078807	0.236	NR	G	G	0.969	0.969	CADM2	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	intron_variant
chr3	85835000	rs13078807	0.675	NR	G	G	0.982	0.982	CADM2	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	intron_variant
chr3	85835000	rs13078807	0.912	NR	G	G	1.01	1.01	CADM2	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	intron_variant
chr3	85835000	rs13078807	0.953	NR	G	G	0	1	CADM2	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	intron_variant
chr3	104209719	rs74528420	0.00000442	MIR548AB	T	T	0.72	0.72	ALCAM	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	10870	HTN-P group	AD	AD	intergenic_region
chr3	104241993	rs28868104	0.000000351	MIR548AB	C	C	0.69	0.69	ALCAM	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	10870	HTN-P group	AD	AD	intergenic_region
chr3	104256947	rs4501143	0.00000123	MIR548AB	T	T	1.44	1.44	ALCAM	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	10870	HTN-P group	AD	AD	intergenic_region
chr3	107825799	rs2029773	0.00000812	LINC00635	NR	NR	NR	NA	BBX	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	818	All	Plasma Clusterin	Fluid biomarker	intergenic_region
chr3	113103475	rs9811423	0.00000418	RP11-572M11.4	NR	NR	1.28	1.28	NEPRO	SNP-based	Disease risk	22005930	Caucasian	"ADGC, GERAD, Cohort from UK"	7693	AD+P and control subjects	AD+Psychosis	ADRD	intron_variant
chr3	122066784	rs2681411	0.0000421	CD86	NR	NR	NR	NA	CD86	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	intron_variant
chr3	128617674	rs2811488	0.0000105	"FLJ40473, RPN1"	NR	NR	NR	NA	RPN1	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	downstream_gene_variant
chr3	132225793	rs11714139	0.000000125	ACPP	A	A	NR	NA	CPNE4	SNP-based	Cross phenotype 	27357282	Caucasian	ADNI	297	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intron_variant
chr3	132225793	rs11714139	0.000481	ACPP	A	A	NR	NA	CPNE4	SNP-based	Cross phenotype 	27357282	Caucasian	Knight-ADRC	246	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intron_variant
chr3	132225793	rs11714139	5.41E-10	ACPP	A	A	NR	NA	CPNE4	SNP-based	Cross phenotype 	27357282	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intron_variant
chr3	132226007	rs56226080	0.000000125	ACPP	C	C	NR	NA	CPNE4	SNP-based	Cross phenotype 	27357282	Caucasian	ADNI	297	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intron_variant
chr3	132226007	rs56226080	0.000481	ACPP	C	C	NR	NA	CPNE4	SNP-based	Cross phenotype 	27357282	Caucasian	Knight-ADRC	246	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intron_variant
chr3	132226007	rs56226080	5.41E-10	ACPP	C	C	NR	NA	CPNE4	SNP-based	Cross phenotype 	27357282	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intron_variant
chr3	132229196	rs73211958	0.000000125	ACPP	A	A	NR	NA	CPNE4	SNP-based	Cross phenotype 	27357282	Caucasian	ADNI	297	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intron_variant
chr3	132229196	rs73211958	0.000511	ACPP	A	A	NR	NA	CPNE4	SNP-based	Cross phenotype 	27357282	Caucasian	Knight-ADRC	246	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intron_variant
chr3	132229196	rs73211958	5.82E-10	ACPP	A	A	NR	NA	CPNE4	SNP-based	Cross phenotype 	27357282	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intron_variant
chr3	132288366	rs11706024	1.71E-12	ACPP	A	A	NR	NA	CPNE4	SNP-based	Cross phenotype 	27357282	Caucasian	ADNI	297	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	upstream_gene_variant
chr3	132288366	rs11706024	3.62E-08	ACPP	A	A	NR	NA	CPNE4	SNP-based	Cross phenotype 	27357282	Caucasian	Knight-ADRC	246	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	upstream_gene_variant
chr3	132288366	rs11706024	6.40E-19	ACPP	A	A	NR	NA	CPNE4	SNP-based	Cross phenotype 	27357282	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	upstream_gene_variant
chr3	132291037	rs16839055	0.0000249	ACPP	T	T	NR	NA	CPNE4	SNP-based	Cross phenotype 	27357282	Caucasian	ADNI	297	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intergenic_region
chr3	132291037	rs16839055	0.000252	ACPP	T	T	NR	NA	CPNE4	SNP-based	Cross phenotype 	27357282	Caucasian	Knight-ADRC	246	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intergenic_region
chr3	132291037	rs16839055	2.55E-08	ACPP	T	T	NR	NA	CPNE4	SNP-based	Cross phenotype 	27357282	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intergenic_region
chr3	132296965	rs2887519	1.71E-12	ACPP	A	A	NR	NA	CPNE4	SNP-based	Cross phenotype 	27357282	Caucasian	ADNI	297	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intergenic_region
chr3	132296965	rs2887519	3.62E-08	ACPP	A	A	NR	NA	CPNE4	SNP-based	Cross phenotype 	27357282	Caucasian	Knight-ADRC	246	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intergenic_region
chr3	132296965	rs2887519	6.40E-19	ACPP	A	A	NR	NA	CPNE4	SNP-based	Cross phenotype 	27357282	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intergenic_region
chr3	132305299	rs113143077	1.71E-12	ACPP	A	A	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	ADNI	297	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intergenic_region
chr3	132305299	rs113143077	3.62E-08	ACPP	A	A	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	Knight-ADRC	246	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intergenic_region
chr3	132305299	rs113143077	6.40E-19	ACPP	A	A	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intergenic_region
chr3	132313089	rs73213842	1.71E-12	ACPP	A	A	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	ADNI	297	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	upstream_gene_variant
chr3	132313089	rs73213842	3.62E-08	ACPP	A	A	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	Knight-ADRC	246	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	upstream_gene_variant
chr3	132313089	rs73213842	6.40E-19	ACPP	A	A	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	upstream_gene_variant
chr3	132314846	rs17344445	1.71E-12	ACPP	A	A	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	ADNI	297	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	upstream_gene_variant
chr3	132314846	rs17344445	3.62E-08	ACPP	A	A	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	Knight-ADRC	246	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	upstream_gene_variant
chr3	132314846	rs17344445	6.40E-19	ACPP	A	A	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	upstream_gene_variant
chr3	132315355	rs3844501	1.74E-20	ACPP	T	T	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	upstream_gene_variant
chr3	132315355	rs3844501	1.97E-13	ACPP	T	T	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	ADNI	297	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	upstream_gene_variant
chr3	132315355	rs3844501	7.97E-09	ACPP	T	T	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	Knight-ADRC	246	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	upstream_gene_variant
chr3	132315535	rs3762671	1.52E-19	ACPP	T	T	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	upstream_gene_variant
chr3	132315535	rs3762671	3.25E-08	ACPP	T	T	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	Knight-ADRC	246	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	upstream_gene_variant
chr3	132315535	rs3762671	3.82E-13	ACPP	T	T	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	ADNI	297	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	upstream_gene_variant
chr3	132317103	rs56030168	0.00000134	ACPP	G	G	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	Knight-ADRC	246	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	upstream_gene_variant
chr3	132317103	rs56030168	2.94E-11	ACPP	G	G	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	ADNI	297	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	upstream_gene_variant
chr3	132317103	rs56030168	4.65E-16	ACPP	G	G	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	upstream_gene_variant
chr3	132323221	rs56073503	1.71E-12	ACPP	A	A	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	ADNI	297	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intron_variant
chr3	132323221	rs56073503	3.62E-08	ACPP	A	A	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	Knight-ADRC	246	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intron_variant
chr3	132323221	rs56073503	6.40E-19	ACPP	A	A	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intron_variant
chr3	132323245	rs56158166	1.71E-12	ACPP	T	T	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	ADNI	297	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intron_variant
chr3	132323245	rs56158166	3.62E-08	ACPP	T	T	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	Knight-ADRC	246	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intron_variant
chr3	132323245	rs56158166	6.40E-19	ACPP	T	T	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intron_variant
chr3	132326151	rs11716607	1.71E-12	ACPP	G	G	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	ADNI	297	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intron_variant
chr3	132326151	rs11716607	3.62E-08	ACPP	G	G	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	Knight-ADRC	246	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intron_variant
chr3	132326151	rs11716607	6.40E-19	ACPP	G	G	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intron_variant
chr3	132343273	rs4257547	0.0000519	ACPP	G	G	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	ADNI	297	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intron_variant
chr3	132343273	rs4257547	0.000194	ACPP	G	G	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	Knight-ADRC	246	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intron_variant
chr3	132343273	rs4257547	3.87E-08	ACPP	G	G	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intron_variant
chr3	132347347	rs11928839	0.0000649	ACPP	A	A	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	ADNI	297	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intron_variant
chr3	132347347	rs11928839	0.00016	ACPP	A	A	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	Knight-ADRC	246	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intron_variant
chr3	132347347	rs11928839	3.93E-08	ACPP	A	A	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intron_variant
chr3	132347415	rs11917521	0.0000649	ACPP	C	C	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	ADNI	297	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intron_variant
chr3	132347415	rs11917521	0.00016	ACPP	C	C	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	Knight-ADRC	246	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intron_variant
chr3	132347415	rs11917521	3.93E-08	ACPP	C	C	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intron_variant
chr3	132356006	rs17182812	0.0000649	ACPP	T	T	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	ADNI	297	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intron_variant
chr3	132356006	rs17182812	0.000139	ACPP	T	T	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	Knight-ADRC	246	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intron_variant
chr3	132356006	rs17182812	3.43E-08	ACPP	T	T	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intron_variant
chr3	132356902	rs1042330	0.0000649	ACPP	A	A	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	ADNI	297	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	3_prime_UTR_variant
chr3	132356902	rs1042330	0.000139	ACPP	A	A	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	Knight-ADRC	246	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	3_prime_UTR_variant
chr3	132356902	rs1042330	3.43E-08	ACPP	A	A	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	3_prime_UTR_variant
chr3	132357707	rs14192	0.000048	ACPP	C	C	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	ADNI	297	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	3_prime_UTR_variant
chr3	132357707	rs14192	0.000139	ACPP	C	C	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	Knight-ADRC	246	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	3_prime_UTR_variant
chr3	132357707	rs14192	2.57E-08	ACPP	C	C	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	3_prime_UTR_variant
chr3	132357862	rs1804136	0.000048	ACPP	T	T	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	ADNI	297	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	3_prime_UTR_variant
chr3	132357862	rs1804136	0.000139	ACPP	T	T	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	Knight-ADRC	246	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	3_prime_UTR_variant
chr3	132357862	rs1804136	2.57E-08	ACPP	T	T	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	3_prime_UTR_variant
chr3	132379021	rs3889987	0.000000408	ACPP	T	T	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	Knight-ADRC	246	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intergenic_region
chr3	132379021	rs3889987	1.77E-18	ACPP	T	T	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	"ADNI, Knight-ADRC"	543	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intergenic_region
chr3	132379021	rs3889987	2.15E-13	ACPP	T	T	NR	NA	ACP3	SNP-based	Cross phenotype 	27357282	Caucasian	ADNI	297	All	CSF Prostatic Acid Phosphatase (PAP)  	Fluid biomarker	intergenic_region
chr3	133775510	rs1049296	0.242	TF	T	T	1.12	1.12	TF	SNP-based	Disease risk	20534741	Caucasian	"ADC, UM"	1610	All	AD	AD	missense_variant
chr3	137931894	rs16847609	0.00000023	"CLDN18, SOX14"	A	A	1.21	1.21	CLDN18	SNP-based	Disease risk	25778476	Caucasian	IGAP	34152	APOE-e4- subjects	AD	AD	intergenic_region
chr3	137931894	rs16847609	0.00000053	"CLDN18, SOX14"	A	A	1.19	1.19	CLDN18	SNP-based	Disease risk	25778476	Caucasian	"ADGC, IGAP"	36569	APOE-e4- subjects	AD	AD	intergenic_region
chr3	137931894	rs16847609	0.47	"CLDN18, SOX14"	A	A	1.09	1.09	CLDN18	SNP-based	Disease risk	25778476	Caucasian	ADGC	2417	APOE-e4- subjects	AD	AD	intergenic_region
chr3	139531807	rs893703	0.0000012	NR	G	G	0.89	2.43513	RBP1	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	363	AD subjects	CSF Ab1-42	Fluid biomarker	intron_variant
chr3	139531807	rs893703	0.0032	NR	G	G	0.25	1.28403	RBP1	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	878	AD subjects	CSF Ab1-42	Fluid biomarker	intron_variant
chr3	139536170	rs4407373	0.68	NR	T	T	-0.05	0.951229	RBP1	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	515	AD subjects	CSF Ab1-42	Fluid biomarker	intron_variant
chr3	139559716	rs4564921	0.00000612	NMNAT3	C	C	0.14	1.15027	NMNAT3	SNP-based	Endophenotype	23836404	Caucasian	ADGC	651	All	Neuritic plaque (NP)	Neuropathology	intron_variant
chr3	139804291	rs952797	0.000000028	"NMNAT3, CLSTN2"	NA	NA	NA	NA	NMNAT3	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	"Cognitive function (Memory - Learning (or working memory), Memory - Delayed recall, Memory - Recognition, Executive Function - Stroop Color Word test, Executive Function - Part B of the Trail making test (TMTB), Executive Function - Block test, Verbal Fluency - Semantic fluency, Verbal Fluency - Phonological fluency)"	Cognitive	intergenic_region
chr3	139804291	rs952797	0.0002	"NMNAT3, CLSTN2"	NA	NA	NA	NA	NMNAT3	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Block test	Cognitive	intergenic_region
chr3	139804291	rs952797	0.05	"NMNAT3, CLSTN2"	NA	NA	NA	NA	NMNAT3	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Stroop Color Word test	Cognitive	intergenic_region
chr3	139804291	rs952797	0.06	"NMNAT3, CLSTN2"	NA	NA	NA	NA	NMNAT3	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Learning (or working memory)	Cognitive	intergenic_region
chr3	139804291	rs952797	0.24	"NMNAT3, CLSTN2"	NA	NA	NA	NA	NMNAT3	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Verbal Fluency - Phonological fluency	Cognitive	intergenic_region
chr3	139804291	rs952797	0.47	"NMNAT3, CLSTN2"	NA	NA	NA	NA	NMNAT3	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Delayed recall	Cognitive	intergenic_region
chr3	139804291	rs952797	0.57	"NMNAT3, CLSTN2"	NA	NA	NA	NA	NMNAT3	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Memory - Recognition	Cognitive	intergenic_region
chr3	139804291	rs952797	0.82	"NMNAT3, CLSTN2"	NA	NA	NA	NA	NMNAT3	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Verbal Fluency - Semantic fluency	Cognitive	intergenic_region
chr3	139804291	rs952797	0.89	"NMNAT3, CLSTN2"	NA	NA	NA	NA	NMNAT3	SNP-based	Endophenotype	17564960	genetically isolated community in the southwestern area of The Netherlands	GRIP	197	All	Executive Function - Part B of the Trail making test (TMTB)	Cognitive	intergenic_region
chr3	153652877	rs11711889	0.00000695	NR	NR	NR	NR	NA	ARHGEF26	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr3	153652877	rs11711889	0.000165	NR	NR	NR	0.5	0.5	ARHGEF26	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr3	153652877	rs11711889	0.000175	NR	NR	NR	NR	NA	ARHGEF26	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intron_variant
chr3	153652877	rs11711889	0.00365	NR	NR	NR	0.49	0.49	ARHGEF26	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intron_variant
chr3	153652877	rs11711889	0.0225	NR	NR	NR	NR	NA	ARHGEF26	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intron_variant
chr3	153652877	rs11711889	0.0381	NR	NR	NR	NR	NA	ARHGEF26	SNP-based	Disease risk	21059989	Caucasian	ADGC	1390	Unrelated individuals	LOAD	AD	intron_variant
chr3	153652877	rs11711889	0.383	NR	NR	NR	0.52	0.52	ARHGEF26	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intron_variant
chr3	153652877	rs11711889	0.49535	NR	NR	NR	NR	NA	ARHGEF26	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intron_variant
chr3	153652877	rs11711889	NA	NR	NR	NR	NR	NA	ARHGEF26	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intron_variant
chr3	155317962	rs114816986	0.00000197	NR	A	A	NR	NA	STRIT1	SNP-based	Disease risk	24770881	Caucasian	ADGC	2239	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	intergenic_region
chr3	158324919	rs144747720	0.00288	RSRC1	NR	NR	NR	NA	RSRC1	SNP-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr3	158324919	rs144747720	0.8971	NA	NR	NR	NR	NA	RSRC1	Gene-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr3	158605927	rs7617983	0.112	MLF1	NR	NR	NR	NA	MLF1	SNP-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	3_prime_UTR_variant
chr3	158605927	rs7617983	0.51648	NA	NR	NR	NR	NA	MLF1	Gene-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	3_prime_UTR_variant
chr3	160234491	rs6441306	0.00000122	IFT80	NR	NR	NR	NA	AC079594.2	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intron_variant
chr3	165567101	rs12493397	0.0000039	NR	A	A	0.64	1.89648	BCHE	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	363	AD subjects	CSF Ab1-42	Fluid biomarker	intron_variant
chr3	165567101	rs12493397	0.0012	NR	A	A	-0.18	0.83527	BCHE	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	878	AD subjects	CSF Ab1-42	Fluid biomarker	intron_variant
chr3	165571636	rs2222464	0.76	NR	C	C	-0.02	0.980199	BCHE	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	515	AD subjects	CSF Ab1-42	Fluid biomarker	intron_variant
chr3	178442780	rs12492269	0.00000222	LINC01014	NR	NR	NR	NA	KCNMB2	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	818	All	Plasma Clusterin	Fluid biomarker	intron_variant
chr3	178796465	rs73183328	0.000082	KCNMB2	A	A	2.42	2.42	KCNMB2	SNP-based	Disease risk	28131462	Caucasian	ADGC	3251	Individual who died at age 60 or older (ADD Model)	Hippocampal sclerosis of aging	ADRD	intron_variant
chr3	178796465	rs73183328	0.00016	KCNMB2	NR	NR	2.4	2.4	KCNMB2	SNP-based	Disease risk	28131462	Caucasian	ADGC	3251	Individual who died at age 60 or older (DOM Model)	Hippocampal sclerosis of aging	ADRD	intron_variant
chr3	178806917	rs13091964	0.011	KCNMB2	T	T	1.84	1.84	KCNMB2	SNP-based	Disease risk	28131462	Caucasian	ADGC	3251	Individual who died at age 60 or older (REC Model)	Hippocampal sclerosis of aging	ADRD	intron_variant
chr3	185787999	rs4481184	3.20E-10	IGF2BP2	NR	NR	NR	NA	IGF2BP2	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr3	185795604	rs7651090	2.00E-11	IGF2BP2	NR	NR	NR	NA	IGF2BP2	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr3	186116710	rs9816226	0.283	NR	T	T	0.004	1.00401	DGKG	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	intron_variant
chr3	186116710	rs9816226	0.391	NR	T	T	1.041	1.041	DGKG	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	intron_variant
chr3	186116710	rs9816226	0.449	NR	T	T	1.041	1.041	DGKG	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	intron_variant
chr3	186618152	rs2070633	0.00406	AHSG	NR	NR	-181.75	1.16675e-79	AHSG	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	IMAS	59	All	Plasma Fetuin-A	Fluid biomarker	intron_variant
chr3	186618152	rs2070633	4.50E-31	AHSG	NR	NR	-0.06	0.941765	AHSG	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	ADNI	521	All	Plasma Fetuin-A	Fluid biomarker	intron_variant
chr3	190889174	rs1393060	0.03	GLIS1	NR	NR	0.02	1.0202	GMNC	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	1527	Male subjects	CSF T-tau	Fluid biomarker	intron_variant
chr3	190889174	rs1393060	0.047	GLIS1	NR	NR	0.14	1.15027	GMNC	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	704	Female AD subjects	Neuronal Neurofibrillary Tangles	Neuropathology	intron_variant
chr3	190889174	rs1393060	0.93	GLIS1	NR	NR	0.01	1.01005	GMNC	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	362	Male AD subjects	Neuronal Neurofibrillary Tangles	Neuropathology	intron_variant
chr3	190889174	rs1393060	4.57E-10	GLIS1	NR	NR	0.05	1.05127	GMNC	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	1509	Female subjects	CSF T-tau	Fluid biomarker	intron_variant
chr3	190939374	rs1316356	0.000000196	SNAR-I	NR	NR	NR	NA	GMNC	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intergenic_region
chr3	190939374	rs1316356	0.00000028	SNAR-I	NR	NR	NR	NA	GMNC	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intergenic_region
chr3	190939374	rs1316356	0.102	SNAR-I	NR	NR	NR	NA	GMNC	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF Ab1-42	Fluid biomarker	intergenic_region
chr3	190945768	rs35055419	0.00000148	GLIS1	NR	NR	0.04	1.04081	GMNC	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	1509	Female subjects	CSF P-tau181p	Fluid biomarker	intergenic_region
chr3	190945768	rs35055419	0.0002	GLIS1	NR	NR	0.03	1.03045	GMNC	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	1527	Male subjects	CSF P-tau181p	Fluid biomarker	intergenic_region
chr3	190945768	rs35055419	0.0003	GLIS1	NR	NR	0.03	1.03045	GMNC	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	1527	Male subjects	CSF T-tau	Fluid biomarker	intergenic_region
chr3	190945768	rs35055419	0.00314	GLIS1	C	C	0.04	1.04081	GMNC	SNP-based	Age at onset (AAO) / Survival	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	39855	AD subjects	Age at onset	Other	intergenic_region
chr3	190945768	rs35055419	0.00908	GLIS1	C	C	1.04	2.82922	GMNC	SNP-based	Disease risk	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	74046	All	AD risk	AD	intergenic_region
chr3	190945768	rs35055419	0.0971	GLIS1	C	C	0.007	1.00702	GMNC	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	3146	All	CSF Ab1-42	Fluid biomarker	intergenic_region
chr3	190945768	rs35055419	0.525	GLIS1	C	C	0.03	1.03045	GMNC	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	1530	All	AD Progression (based on CDR Score)	Cognitive	intergenic_region
chr3	190945768	rs35055419	2.57E-08	GLIS1	NR	NR	0.05	1.05127	GMNC	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	1509	Female subjects	CSF T-tau	Fluid biomarker	intergenic_region
chr3	190945768	rs35055419	3.07E-11	GLIS1	C	C	0.04	1.04081	GMNC	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	3146	All	CSF T-tau	Fluid biomarker	intergenic_region
chr3	190945768	rs35055419	3.07E-11	GLIS1	NR	NR	0.04	1.04081	GMNC	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	3036	All	CSF T-tau	Fluid biomarker	intergenic_region
chr3	190945768	rs35055419	7.62E-10	GLIS1	C	C	0.04	1.04081	GMNC	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	3146	All	CSF P-tau181p	Fluid biomarker	intergenic_region
chr3	190945768	rs35055419	7.62E-10	GLIS1	NR	NR	0.04	1.04081	GMNC	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	3036	All	CSF P-tau181p	Fluid biomarker	intergenic_region
chr3	190951729	rs9877502	0.000000168	SNAR-I	NR	NR	NR	NA	GMNC	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intergenic_region
chr3	190951729	rs9877502	0.000000247	NR	NR	NR	NR	NA	GMNC	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intergenic_region
chr3	190951729	rs9877502	0.00000046	NR	NR	NR	NR	NA	GMNC	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intergenic_region
chr3	190951729	rs9877502	0.000000562	NR	NR	NR	NR	NA	GMNC	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intergenic_region
chr3	190951729	rs9877502	0.000000724	NR	NR	NR	NR	NA	GMNC	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intergenic_region
chr3	190951729	rs9877502	0.0000464	NR	A	A	-0.014	0.986098	GMNC	SNP-based	Cognitive	23562540	NR	ROSMAP	1593	All	global cognitive decline	Cognitive	intergenic_region
chr3	190951729	rs9877502	0.000267	NR	A	A	0.081	1.08437	GMNC	SNP-based	Disease risk	23562540	Caucasian	ADGC	22771	All	AD	AD	intergenic_region
chr3	190951729	rs9877502	0.014	NR	A	A	0.055	1.05654	GMNC	SNP-based	Neuropathology	23562540	NR	ROSMAP	651	All	tangle counts	Neuropathology	intergenic_region
chr3	190951729	rs9877502	0.022	SNAR-I	NR	NR	NR	NA	GMNC	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF Ab1-42	Fluid biomarker	intergenic_region
chr3	190951729	rs9877502	4.39E-08	NR	NR	NR	NR	NA	GMNC	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intergenic_region
chr3	190951729	rs9877502	4.98E-09	SNAR-I	NR	NR	NR	NA	GMNC	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intergenic_region
chr3	190951729	rs9877502	7.77E-09	NR	NR	NR	NR	NA	GMNC	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intergenic_region
chr3	190953113	rs9811910	0.01	NR	C	C	0.08	1.08329	GMNC	SNP-based	Endophenotype	27694991	Caucasian	"CHARGE, ENIGMA"	2363	European	Intracranial Volume	Imaging	intergenic_region
chr3	190953113	rs9811910	0.02	NR	C	C	0.35	1.41907	GMNC	SNP-based	Endophenotype	27694991	African American	"CHARGE, ENIGMA"	938	African	Intracranial Volume	Imaging	intergenic_region
chr3	190953113	rs9811910	0.187	NR	C	C	-0.15	0.860708	GMNC	SNP-based	Endophenotype	27694991	Hispanic	"CHARGE, ENIGMA"	1605	Hispanic	Intracranial Volume	Imaging	intergenic_region
chr3	190953113	rs9811910	0.621	NR	C	C	0.1	1.10517	GMNC	SNP-based	Endophenotype	27694991	Asian	"CHARGE, ENIGMA"	955	Asian	Intracranial Volume	Imaging	intergenic_region
chr3	190953113	rs9811910	1.20E-09	NR	C	C	0.1	1.10517	GMNC	SNP-based	Endophenotype	27694991	Caucasian	"CHARGE, ENIGMA"	26577	European	Intracranial Volume	Imaging	intergenic_region
chr4	864544	rs11248051	0.000000035	GAK	T	T	NR	NA	GAK	SNP-based	Disease risk	25687773	Caucasian	IPDGC	17352	All	PD	ADRD	intron_variant
chr4	864544	rs11248051	0.19	GAK	T	T	NR	NA	GAK	SNP-based	Disease risk	25687773	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr4	1166078	rs111388896	0.00515	UVSSA	C	C	NR	NA	SPON2	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	upstream_gene_variant
chr4	1166078	rs111388896	2.27E-24	NR	C	C	NR	NA	SPON2	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	UVSSA (ENSG00000163945) expression	Expression	upstream_gene_variant
chr4	1297549	rs3817604	0.00041	CRIPAK	T	T	NR	NA	MAEA	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	7289	Plan 2 (only males)	AD	AD	intron_variant
chr4	1297549	rs3817604	1.14E-09	NR	T	T	NR	NA	MAEA	SNP-based	eQTL	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	7289	Plan 2 (only males)	CRIPAK expression in Hippocampus	Expression	intron_variant
chr4	1297549	rs3817604	5.77E-10	NR	T	T	NR	NA	MAEA	SNP-based	eQTL	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	7289	Plan 2 (only males)	SFN (ILMN_1806607) expression	Expression	intron_variant
chr4	2101369	rs1923775	0.00000561	POLN	T	T	1.6	1.6	POLN	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr4	5095813	rs17675640	0.00000189	STK32B	G	G	0.77	0.77	STK32B	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AD	AD	intron_variant
chr4	5096839	rs6838792	0.00000161	STK32B	C	C	0.77	0.77	STK32B	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AD	AD	intron_variant
chr4	5099404	rs895681	0.00000272	STK32B	T	T	0.78	0.78	STK32B	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AD	AD	intron_variant
chr4	6265274	rs4688982	0.0000014	"LOC285484, WFS1"	NR	NR	NR	NA	WFS1	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	upstream_gene_variant
chr4	6265360	rs4688983	0.0000053	WFS1	NR	NR	NR	NA	WFS1	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	upstream_gene_variant
chr4	6301627	rs734312	0.00000032	WFS1	NR	NR	NR	NA	WFS1	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	missense_variant
chr4	7283629	rs3846421	0.000117	SORCS2	NR	NR	NR	NA	SORCS2	SNP-based	Disease risk	19118814	Caucasian	"CAP, Reiman et al.(2007)"	NR	All	LOAD	AD	intron_variant
chr4	7283629	rs3846421	0.00313	SORCS2	NR	NR	NR	NA	SORCS2	SNP-based	Disease risk	19118814	Caucasian	CAP	458	All	LOAD	AD	intron_variant
chr4	7283629	rs3846421	0.0206	SORCS2	NR	NR	NR	NA	SORCS2	SNP-based	Disease risk	19118814	Caucasian	Reiman et al.(2007)	NR	All	LOAD	AD	intron_variant
chr4	7312316	rs11722747	0.0484	SORCS2	A	A	0.06	1.06184	SORCS2	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr4	7324472	rs4689707	0.0434	SORCS2	T	T	0.07	1.07251	SORCS2	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr4	7326689	rs3864203	0.0364	SORCS2	A	A	0.0554	1.05696	SORCS2	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr4	7327007	rs7665496	0.0118	SORCS2	T	T	0.1045	1.11016	SORCS2	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr4	7327338	rs7661158	0.0372	SORCS2	A	A	0.0497	1.05096	SORCS2	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr4	7327597	rs6840423	0.0172	SORCS2	T	T	0.08	1.08329	SORCS2	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr4	7327699	rs3864202	0.0351	SORCS2	A	A	0.049	1.05022	SORCS2	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr4	7328949	rs16840053	0.0136	SORCS2	A	A	0.08	1.08329	SORCS2	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr4	7351325	rs13110208	0.00944	SORCS2	T	T	0.0626	1.0646	SORCS2	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr4	7388715	rs4689720	0.0264	SORCS2	T	T	0.1178	1.12502	SORCS2	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr4	7415514	rs7684383	0.0384	SORCS2	T	T	0.1429	1.15361	SORCS2	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr4	7415905	rs4234804	0.0251	SORCS2	A	A	0.1509	1.16288	SORCS2	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr4	7417549	rs6837589	0.0336	SORCS2	T	T	0.0589	1.06067	SORCS2	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr4	7418457	rs13105690	0.0155	SORCS2	T	T	0.0599	1.06173	SORCS2	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr4	7419058	rs4292336	0.049	SORCS2	A	A	0.05	1.05127	SORCS2	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr4	7620620	rs17465564	0.0315	SORCS2	A	A	0.09	1.09417	SORCS2	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr4	7665759	rs2214459	0.0265	SORCS2	T	T	0.0519	1.05327	SORCS2	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr4	7732116	rs12233824	0.0488	SORCS2	A	A	0.04	1.04081	SORCS2	SNP-based	Disease risk	23673467	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr4	8377136	rs62286001	0.00549	ACOX3	C	C	NR	NA	ACOX3	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	intron_variant
chr4	8377136	rs62286001	7.84E-14	NR	C	C	NR	NA	ACOX3	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	ACOX3 (ENSG00000087008) expression	Expression	intron_variant
chr4	10048517	rs733175	0.00000497	SLC2A9	NR	NR	1.37	1.37	SLC2A9	SNP-based	Disease risk	22005930	Caucasian	"ADGC, GERAD, Cohort from UK"	7693	AD+P and control subjects	AD+Psychosis	ADRD	intron_variant
chr4	10060702	rs6834555	0.000000306	SLC2A9	NR	NR	1.4	1.4	SLC2A9	SNP-based	Disease risk	22005930	Caucasian	"ADGC, GERAD, Cohort from UK"	7693	AD+P and control subjects	AD+Psychosis	ADRD	intergenic_region
chr4	11023058	rs6448451	1.19E-08	CLNK	A	A	NR	NA	CLNK	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	intergenic_region
chr4	11024404	rs6448453	0.024	CLNK	A	A	NR	NA	CLNK	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ"	79145	All	AD	AD	intergenic_region
chr4	11024404	rs6448453	1.93E-09	CLNK	A	A	6	NA	CLNK	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ, UKBB"	455258	All	AD + AD-by-proxy	AD	intergenic_region
chr4	11628425	rs6448799	0.901	HS3ST1	T	T	0.994	0.994	HS3ST1	SNP-based	Disease risk	24495969	Caucasian	Cohort from Spain	4372	All	AD	AD	intron_variant
chr4	11709608	rs13113697	0.000000503	HS3ST1	T	T	1.07	1.07	HS3ST1	SNP-based	Disease risk	25862742	Caucasian	IGAP	74046	All	AD	AD	intron_variant
chr4	11709608	rs13113697	0.031	HS3ST1	T	T	1.07	1.07	HS3ST1	SNP-based	Disease risk	25862742	Caucasian	deCODE	67817	All	AD	AD	intron_variant
chr4	11709608	rs13113697	0.088	HS3ST1	T	T	1.13	1.13	HS3ST1	SNP-based	Disease risk	25862742	Caucasian	DemGene	2015	All	AD	AD	intron_variant
chr4	11709608	rs13113697	2.86E-08	HS3ST1	T	T	1.07	1.07	HS3ST1	SNP-based	Disease risk	25862742	Caucasian	"deCODE, DemGene, IGAP"	143878	All	AD	AD	intron_variant
chr4	11721611	rs7657553	0.051	HS3ST1	A	A	1.95	NA	HS3ST1	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ, UKBB"	455258	All	AD + AD-by-proxy	AD	intron_variant
chr4	11721611	rs7657553	0.79	HS3ST1	A	A	NR	NA	HS3ST1	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	intron_variant
chr4	11721611	rs7657553	2.16E-08	HS3ST1	A	A	NR	NA	HS3ST1	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ"	79145	All	AD	AD	intron_variant
chr4	15735725	rs4698412	0.031	BST1	G	G	NR	NA	BST1	SNP-based	Disease risk	25687773	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr4	15735725	rs4698412	2.03E-08	BST1	A	A	NR	NA	BST1	SNP-based	Disease risk	25687773	Caucasian	IPDGC	17352	All	PD	ADRD	intron_variant
chr4	20759888	rs6817475	0.00000038	KCNIP4	G	G	0.17	1.1853	KCNIP4	SNP-based	Endophenotype	23836404	Caucasian	ADGC	651	All	Neuritic plaque (NP)	Neuropathology	intron_variant
chr4	25248350	rs313561	0.5	NR	G	G	-0.06	0.941765	PI4K2B	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	515	AD subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr4	25261856	rs313541	0.0000028	NR	G	G	0.5	1.64872	PI4K2B	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	363	AD subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr4	25261856	rs313541	0.013	NR	G	G	0.16	1.17351	PI4K2B	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	878	AD subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr4	30466544	rs6856768	0.00000463	NR	NR	NR	0.85	0.85	PCDH7	SNP-based	Disease risk	22832961	Caucasian	ADGC	8292	All	LOAD	AD	intergenic_region
chr4	30466544	rs6856768	0.0000822	NR	NR	NR	NR	NA	PCDH7	SNP-based	Disease risk	22832961	Caucasian	ADGC	8292	All	LOAD	AD	intergenic_region
chr4	30466544	rs6856768	0.00305	NR	NR	NR	0.81	0.81	PCDH7	SNP-based	Disease risk	22832961	Caucasian	ADGC	2099	All	LOAD	AD	intergenic_region
chr4	30466544	rs6856768	0.00311	NR	NR	NR	0.82	0.82	PCDH7	SNP-based	Disease risk	22832961	Caucasian	ADGC	2229	All	LOAD	AD	intergenic_region
chr4	30466544	rs6856768	0.0819	NR	NR	NR	0.89	0.89	PCDH7	SNP-based	Disease risk	22832961	Caucasian	ADGC	2321	All	LOAD	AD	intergenic_region
chr4	30466544	rs6856768	0.12	NR	NR	NR	0.88	0.88	PCDH7	SNP-based	Disease risk	22832961	Caucasian	MIRAGE	1262	All	LOAD	AD	intergenic_region
chr4	30466544	rs6856768	0.855	NR	NR	NR	0.97	0.97	PCDH7	SNP-based	Disease risk	22832961	Caucasian	ADNI	381	All	LOAD	AD	intergenic_region
chr4	33078033	rs1448284	0.00000132	NR	C	C	9939.9	inf	PCDH7	SNP-based	Endophenotype	20197096	Caucasian	ADNI	742	All	Temporal Lobe Atrophy	Imaging	intergenic_region
chr4	33078033	rs1448284	0.00000196	NR	C	C	9939.9	inf	PCDH7	SNP-based	Endophenotype	20197096	Caucasian	ADNI	742	All	Temporal Lobe Atrophy	Imaging	intergenic_region
chr4	33201518	rs10517270	0.00000413	NR	NR	NR	NR	NA	PCDH7	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	2222	AD subjects	Age at onset	Other	intergenic_region
chr4	33201518	rs10517270	0.00000587	NR	NR	NR	NR	NA	PCDH7	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	2222	AD subjects	Age at onset	Other	intergenic_region
chr4	33201518	rs10517270	0.000267	NR	NR	NR	-3.31	0.0365162	PCDH7	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	1190	AD subjects	Age at onset	Other	intergenic_region
chr4	33201518	rs10517270	0.0113	NR	NR	NR	-3.95	0.0192547	PCDH7	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	844	AD subjects	Age at onset	Other	intergenic_region
chr4	33201518	rs10517270	0.0408	NR	NR	NR	-18.66	7.87164e-09	PCDH7	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADNI	188	AD subjects	Age at onset	Other	intergenic_region
chr4	42410670	rs12639920	0.0000485	ATP8A1	NR	NR	NR	NA	ATP8A1	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	3_prime_UTR_variant
chr4	45180510	rs10938397	0.117	NR	G	G	1.041	1.041	GNPDA2	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	intergenic_region
chr4	45180510	rs10938397	0.2	NR	G	G	1.062	1.062	GNPDA2	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	intergenic_region
chr4	45180510	rs10938397	0.363	NR	G	G	0	1	GNPDA2	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	intergenic_region
chr4	45180510	rs10938397	0.93	NR	G	G	1	1	GNPDA2	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	intergenic_region
chr4	47790280	rs59776273	0.000099	CORIN	NR	NR	NR	NA	CORIN	SNP-based	Cross phenotype 	28780673	Caucasian	GAME-ON	33832	All	Breast Cancer	Non-ADRD	intron_variant
chr4	47790280	rs59776273	0.00019	CORIN	NR	NR	NR	NA	CORIN	SNP-based	Cross phenotype 	28780673	Caucasian	"GAME-ON, IGAP"	116992	All	AD + Breast cancer + Lung Cancer	Non-ADRD	intron_variant
chr4	47790280	rs59776273	0.00044	CORIN	NR	NR	NR	NA	CORIN	SNP-based	Cross phenotype 	28780673	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr4	47790280	rs59776273	0.032	CORIN	NR	NR	NR	NA	CORIN	SNP-based	Cross phenotype 	28780673	Caucasian	GAME-ON	28998	All	Lung Cancer	Non-ADRD	intron_variant
chr4	48998833	rs6850199	0.000000318	FLJ21511	A	A	NR	NA	CWH43	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	MCI	CSF T-tau	Fluid biomarker	intron_variant
chr4	49027884	rs2768975	0.000000196	FLJ21511	G	G	NR	NA	CWH43	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	MCI	CSF T-tau	Fluid biomarker	intron_variant
chr4	55802265	rs753129	0.000000285	AC110611.1	NR	NR	0.66	0.66	EXOC1L	SNP-based	Disease risk	22005930	Caucasian	"ADGC, GERAD"	2034	AD+P and AD-P subjects	AD+Psychosis	ADRD	downstream_gene_variant
chr4	60905713	rs1455280	0.0001	Intergenic (as reported in paper)	G	G	NR	NA	ADGRL3	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intergenic_region
chr4	60905713	rs1455280	0.00027	NR	G	G	NR	NA	ADGRL3	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intergenic_region
chr4	60905713	rs1455280	0.0026	NR	G	G	NR	NA	ADGRL3	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intergenic_region
chr4	67684577	rs13114818	0.000628	UBA6	C	C	NR	NA	UBA6	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr4	67684577	rs13114818	0.000896	UBA6	C	C	NR	NA	UBA6	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Total cholesterol (TC)	Non-ADRD	intron_variant
chr4	67684577	rs13114818	0.00303	UBA6	C	C	1.05	1.05	UBA6	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intron_variant
chr4	67684577	rs13114818	0.0075	UBA6	C	C	1.05	1.05	UBA6	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intron_variant
chr4	67684577	rs13114818	0.408	UBA6	C	C	0.94	0.94	UBA6	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intron_variant
chr4	67684577	rs13114818	0.44	UBA6	C	C	1	1	UBA6	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr4	72095821	rs12510838	0.00024	NPFFR2	G	G	NR	NA	NPFFR2	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intron_variant
chr4	72095821	rs12510838	0.0008	NPFFR2	G	G	NR	NA	NPFFR2	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr4	72095821	rs12510838	0.0047	NPFFR2	G	G	NR	NA	NPFFR2	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr4	73455883	rs10020432	0.0000226	AFP	NR	NR	-0.07	0.932394	AFP	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	ADNI	521	All	Plasma AFP	Fluid biomarker	3_prime_UTR_variant
chr4	76031127	rs6852075	0.000402	ART3	G	G	NR	NA	ART3	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr4	76031127	rs6852075	0.000517	ART3	G	G	NR	NA	ART3	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Total triglycerides (TG)	Non-ADRD	intron_variant
chr4	76031127	rs6852075	0.0177	ART3	G	G	0.97	0.97	ART3	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intron_variant
chr4	76031127	rs6852075	0.0196	ART3	G	G	0.97	0.97	ART3	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intron_variant
chr4	76031127	rs6852075	0.623	ART3	G	G	0.98	0.98	ART3	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intron_variant
chr4	76166551	rs7664889	0.000175	SCARB2	NR	NR	NR	NA	SCARB2	SNP-based	Disease risk	27899424	Caucasian	IFGC	12928	All	Frontotemporal Dementia	ADRD	intron_variant
chr4	76166551	rs7664889	0.000175	SCARB2	T	T	0.73	0.73	SCARB2	SNP-based	Disease risk	27899424	Caucasian	IFGC	6462	All	Frontotemporal Dementia	ADRD	intron_variant
chr4	76166551	rs7664889	0.00318	SCARB2	T	T	0.83	0.83	SCARB2	SNP-based	Disease risk	27899424	Caucasian	IFGC	12928	All	Frontotemporal Dementia	ADRD	intron_variant
chr4	76166551	rs7664889	0.82	SCARB2	T	T	0.98	0.98	SCARB2	SNP-based	Disease risk	27899424	Caucasian	IFGC	6466	All	Frontotemporal Dementia	ADRD	intron_variant
chr4	76189212	rs6825004	0.42	SCARB2	NR	NR	0.92	0.92	SCARB2	SNP-based	Endophenotype	26993346	Caucasian	Cohort from Europe	10840	All	PCA (posterior cortical atrophy)	Imaging	intron_variant
chr4	85495401	rs111882035	2.74E-08	ARHGAP24	G	G	-0.93	0.394554	ARHGAP24	SNP-based	Endophenotype	29274321	Caucasian	ADNI	581	MCI	Logic memory delayed (LMdT) recall test	Cognitive	intron_variant
chr4	89720189	rs356220	0.014	SNCA	C	C	NR	NA	SNCA	SNP-based	Disease risk	25687773	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr4	89720189	rs356220	1.47E-25	SNCA	T	T	NR	NA	SNCA	SNP-based	Disease risk	25687773	Caucasian	IPDGC	17352	All	PD	ADRD	intron_variant
chr4	89754087	rs3857059	0.78	SNCA	A	A	NR	NA	SNCA	SNP-based	Disease risk	25687773	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr4	89754087	rs3857059	1.66E-14	SNCA	G	G	NR	NA	SNCA	SNP-based	Disease risk	25687773	Caucasian	IPDGC	17352	All	PD	ADRD	intron_variant
chr4	89808451	rs2197120	0.99	SNCA	G	G	NR	NA	SNCA	SNP-based	Disease risk	25687773	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr4	89808451	rs2197120	6.29E-10	SNCA	G	G	NR	NA	SNCA	SNP-based	Disease risk	25687773	Caucasian	IPDGC	17352	All	PD	ADRD	intron_variant
chr4	89843548	rs7687945	0.92	SNCA	NR	NR	1	1	SNCA	SNP-based	Endophenotype	26993346	Caucasian	Cohort from Europe	10840	All	PCA (posterior cortical atrophy)	Imaging	downstream_gene_variant
chr4	94421638	rs4699852	0.00004	NR	A	A	NR	NA	PDLIM5	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intergenic_region
chr4	94421638	rs4699852	0.0008	Intergenic (as reported in paper)	A	A	NR	NA	PDLIM5	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intergenic_region
chr4	94421638	rs4699852	0.0032	NR	A	A	NR	NA	PDLIM5	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intergenic_region
chr4	95238666	rs12643654	0.000000495	UNC5C	G	G	NR	NA	UNC5C	SNP-based	Endophenotype	20932310	Caucasian	ADNI	172	AD	CSF P-tau181p	Fluid biomarker	intron_variant
chr4	95815327	rs12510298	0.0000099	"PDHA2, UNC5C"	NR	NR	NR	NA	PDHA2	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intergenic_region
chr4	99326433	rs72681907	0.00000704	ADH1C	NR	NR	NR	NA	ADH1B	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intergenic_region
chr4	99344800	rs283411	0.00000507	ADH1C	NR	NR	NR	NA	ADH1B	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intron_variant
chr4	99350902	rs1662046	0.0000033	ADH1C	NR	NR	0.45	1.56831	ADH1B	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	673	All	CSF Clusterin	Fluid biomarker	intron_variant
chr4	99350902	rs1662046	0.0000868	ADH1C	NR	NR	0.55	1.73325	ADH1B	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	403	Subjects with APOE-e4-	CSF Clusterin	Fluid biomarker	intron_variant
chr4	99350902	rs1662046	0.00511	ADH1C	NR	NR	0.45	1.56831	ADH1B	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	270	Subjects with APOE-e4+	CSF Clusterin	Fluid biomarker	intron_variant
chr4	99359562	rs283404	0.00000686	ADH1C	NR	NR	NR	NA	ADH1B	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intergenic_region
chr4	99361608	rs166892	0.00000686	ADH1C	NR	NR	NR	NA	ADH1B	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intergenic_region
chr4	99362508	rs1229852	0.00000686	ADH1C	NR	NR	NR	NA	ADH1B	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intergenic_region
chr4	99366025	rs283422	0.00000686	ADH1C	NR	NR	NR	NA	ADH1B	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intergenic_region
chr4	99366839	rs283421	0.00000686	ADH1C	NR	NR	NR	NA	ADH1B	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intergenic_region
chr4	99367818	rs283420	0.00000686	ADH1C	NR	NR	NR	NA	ADH1B	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intergenic_region
chr4	99371030	rs283418	0.00000742	ADH1C	NR	NR	NR	NA	ADH1B	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intergenic_region
chr4	99383266	rs284780	0.00000836	ADH1C	NR	NR	NR	NA	ADH7	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intergenic_region
chr4	102267552	rs13107325	0.119	NR	T	T	1.073	1.073	SLC39A8	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	missense_variant
chr4	102267552	rs13107325	0.141	NR	T	T	1.139	1.139	SLC39A8	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	missense_variant
chr4	102267552	rs13107325	0.179	NR	T	T	1.094	1.094	SLC39A8	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	missense_variant
chr4	102267552	rs13107325	0.86	NR	T	T	0.001	1.001	SLC39A8	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	missense_variant
chr4	107052129	rs388575	0.000000015	NR	C	C	0.422	1.52501	DKK2	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	363	AD subjects	CSF Ab1-42	Fluid biomarker	intron_variant
chr4	107052129	rs388575	0.0014	NR	C	C	-0.18	0.83527	DKK2	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	878	AD subjects	CSF Ab1-42	Fluid biomarker	intron_variant
chr4	107052129	rs388575	0.5	NR	C	C	0.05	1.05127	DKK2	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	515	AD subjects	CSF Ab1-42	Fluid biomarker	intron_variant
chr4	114132729	rs6854583	0.0000646	NR	NR	NR	2.13	2.13	ARSJ	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	235	All women	LOAD	AD	intergenic_region
chr4	114132729	rs6854583	0.00211	NR	NR	NR	2.38	2.38	ARSJ	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	235	All women	LOAD	AD	intergenic_region
chr4	114132729	rs6854583	0.00234	NR	NR	NR	1.78	1.78	ARSJ	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	235	All women	LOAD	AD	intergenic_region
chr4	114132729	rs6854583	0.0301	NR	NR	NR	1.59	1.59	ARSJ	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	282	All women	LOAD	AD	intergenic_region
chr4	119140180	rs4277762	0.0000205	MYOZ2	NR	NR	1.2	1.2	MYOZ2	SNP-based	Disease risk	30979435	Caucasian	ADGC	6466	Age >=80 y	AD	AD	intron_variant
chr4	119140180	rs4277762	0.476	MYOZ2	NR	NR	0.98	0.98	MYOZ2	SNP-based	Disease risk	30979435	Caucasian	ADGC	14704	Age 60-79 y	AD	AD	intron_variant
chr4	124943164	rs10022344	0.0000544	"ANKRD50, FAT4"	NR	NR	NR	NA	ANKRD50	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr4	125852943	rs1911014	0.00000356	Intergenic (as reported in paper)	A	A	NR	NA	FAT4	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intergenic_region
chr4	125852943	rs1911014	0.0003	NR	A	A	NR	NA	FAT4	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intergenic_region
chr4	125852943	rs1911014	0.00037	NR	A	A	NR	NA	FAT4	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intergenic_region
chr4	126740230	rs62324179	0.00000365	NR	T	T	NR	NA	INTU	SNP-based	Disease risk	24770881	Caucasian	ADGC	2239	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	intergenic_region
chr4	137367736	rs1425967	0.0000125	NR	NR	NR	NR	NA	PCDH18	SNP-based	Disease risk	19118814	Caucasian	"CAP, Reiman et al.(2007)"	NR	All	LOAD	AD	intergenic_region
chr4	137367736	rs1425967	0.000039	NR	NR	NR	NR	NA	PCDH18	SNP-based	Disease risk	19118814	Caucasian	CAP	458	All	LOAD	AD	intergenic_region
chr4	137367736	rs1425967	0.0105	NR	NR	NR	NR	NA	PCDH18	SNP-based	Disease risk	19118814	Caucasian	Reiman et al.(2007)	NR	All	LOAD	AD	intergenic_region
chr4	137405718	rs4416533	0.0000113	NR	NR	NR	NR	NA	PCDH18	SNP-based	Disease risk	19118814	Caucasian	"CAP, Reiman et al.(2007)"	NR	All	LOAD	AD	intergenic_region
chr4	137405718	rs4416533	0.0000361	NR	NR	NR	NR	NA	PCDH18	SNP-based	Disease risk	19118814	Caucasian	CAP	458	All	LOAD	AD	intergenic_region
chr4	137405718	rs4416533	0.0101	NR	NR	NR	NR	NA	PCDH18	SNP-based	Disease risk	19118814	Caucasian	Reiman et al.(2007)	NR	All	LOAD	AD	intergenic_region
chr4	142704235	rs28670348	0.000181	INPP4B	G	G	NR	NA	INPP4B	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr4	142704235	rs28670348	0.00101	INPP4B	G	G	NR	NA	INPP4B	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	High-density lipoprotein (HDL)	Non-ADRD	intron_variant
chr4	142704235	rs28670348	0.00776	INPP4B	G	G	1.07	1.07	INPP4B	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intron_variant
chr4	142704235	rs28670348	0.011	INPP4B	G	G	1.06	1.06	INPP4B	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intron_variant
chr4	142704235	rs28670348	0.918	INPP4B	G	G	1	1	INPP4B	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr4	142704235	rs28670348	0.93	INPP4B	G	G	0.99	0.99	INPP4B	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intron_variant
chr4	147403157	rs13121109	0.0000064	EDNRA	NR	NR	NR	NA	EDNRA	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	818	All	Plasma Clusterin	Fluid biomarker	intergenic_region
chr4	154426241	rs1466662	0.000000495	DCHS2	NR	NR	NR	NA	DCHS2	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	2222	AD subjects	Age at onset	Other	intron_variant
chr4	154426241	rs1466662	0.00000235	DCHS2	NR	NR	NR	NA	DCHS2	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	2222	AD subjects	Age at onset	Other	intron_variant
chr4	154426241	rs1466662	0.000137	DCHS2	NR	NR	-1	0.367879	DCHS2	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	844	AD subjects	Age at onset	Other	intron_variant
chr4	154426241	rs1466662	0.00119	DCHS2	NR	NR	-0.96	0.382893	DCHS2	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	1190	AD subjects	Age at onset	Other	intron_variant
chr4	154426241	rs1466662	0.759	DCHS2	NR	NR	-0.58	0.559898	DCHS2	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADNI	188	AD subjects	Age at onset	Other	intron_variant
chr4	154733269	rs727153	0.00000337	NR	C	C	NR	NA	LRAT	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr4	154733269	rs727153	0.00002	NR	C	C	NR	NA	LRAT	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intron_variant
chr4	154733269	rs727153	0.0009	Intergenic (as reported in paper)	C	C	NR	NA	LRAT	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr4	154741179	rs12501328	0.0032	LRAT	G	G	1.32	1.32	LRAT	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr4	154741179	rs12501328	0.0266	LRAT	G	G	1.27	1.27	LRAT	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intron_variant
chr4	154745783	rs201825	0.000000612	LRAT	C	C	1.3	1.3	LRAT	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr4	154745783	rs201825	0.00000165	LRAT	C	C	1.34	1.34	LRAT	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intron_variant
chr4	154747558	rs201824	0.00066	LRAT	T	T	1.24	1.24	LRAT	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intron_variant
chr4	154747733	rs201823	0.0004	LRAT	G	G	1.21	1.21	LRAT	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr4	154747733	rs201823	0.00042	LRAT	G	G	1.24	1.24	LRAT	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intron_variant
chr4	154756163	rs156500	0.0946	LRAT	C	C	1.17	1.17	LRAT	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intron_variant
chr4	154757193	rs156501	0.0058	LRAT	A	A	1.2	1.2	LRAT	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr4	154757193	rs156501	0.0164	LRAT	A	A	1.2	1.2	LRAT	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intron_variant
chr4	154762064	rs149225	0.349	LRAT	C	C	1.06	1.06	LRAT	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intron_variant
chr4	165829942	rs72635116	0.00000529	TLL1	NR	NR	0.313	1.36752	TLL1	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	673	All	CSF Clusterin	Fluid biomarker	intergenic_region
chr4	165829942	rs72635116	0.0000232	TLL1	NR	NR	0.383	1.46668	TLL1	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	403	Subjects with APOE-e4-	CSF Clusterin	Fluid biomarker	intergenic_region
chr4	165829942	rs72635116	0.113	TLL1	NR	NR	0.169	1.18412	TLL1	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	270	Subjects with APOE-e4+	CSF Clusterin	Fluid biomarker	intergenic_region
chr4	173173789	rs62341097	0.000000006	GALNT7	A	A	-1.15	0.316637	GALNT7	SNP-based	Endophenotype	25188341	Caucasian	ADGC	4046	All	Neuritic Plaque	Neuropathology	intron_variant
chr4	180964752	rs13115400	0.2	GLIS1	NR	NR	0.01	1.01005	TENM3	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	1527	Male subjects	CSF Ab1-42	Fluid biomarker	intergenic_region
chr4	180964752	rs13115400	0.24	GLIS1	NR	NR	0.07	1.07251	TENM3	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	704	Female AD subjects	Amyloid Burden	Neuropathology	intergenic_region
chr4	180964752	rs13115400	0.79	GLIS1	NR	NR	0.02	1.0202	TENM3	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	362	Male AD subjects	Amyloid Burden	Neuropathology	intergenic_region
chr4	180964752	rs13115400	3.97E-08	GLIS1	NR	NR	0.03	1.03045	TENM3	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	1509	Female subjects	CSF Ab1-42	Fluid biomarker	intergenic_region
chr4	182196767	rs13115107	0.0001	Intergenic (as reported in paper)	G	G	NR	NA	TENM3	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr4	182196767	rs13115107	0.00032	NR	G	G	NR	NA	TENM3	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intron_variant
chr4	182196767	rs13115107	0.0005	NR	G	G	NR	NA	TENM3	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr4	189068835	rs1353581	0.0000048	LINC01060	G	G	0.65	0.65	FRG1	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	intergenic_region
chr5	458726	rs11134054	1.95E-62	EXOC3	NR	NR	-0.57	0.565525	EXOC3	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	EXOC3 expression in Cerebellar	Expression	intron_variant
chr5	458726	rs11134054	4.06E-75	EXOC3	NR	NR	-0.6	0.548812	EXOC3	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	EXOC3 expression in Temporal cortex	Expression	intron_variant
chr5	458726	rs11134054	4.77E-28	EXOC3	NR	NR	-0.59	0.554327	EXOC3	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	EXOC3 expression in Cerebellar	Expression	intron_variant
chr5	458726	rs11134054	6.43E-30	EXOC3	NR	NR	-0.54	0.582748	EXOC3	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	EXOC3 expression in Cerebellar	Expression	intron_variant
chr5	1282299	rs7725218	0.000072	TERT	NR	NR	NR	NA	TERT	SNP-based	Cross phenotype 	28780673	Caucasian	GAME-ON	28998	All	Lung Cancer	Non-ADRD	intron_variant
chr5	1282299	rs7725218	0.00081	TERT	NR	NR	NR	NA	TERT	SNP-based	Cross phenotype 	28780673	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr5	1282299	rs7725218	0.0028	TERT	NR	NR	NR	NA	TERT	SNP-based	Cross phenotype 	28780673	Caucasian	"GAME-ON, IGAP"	116992	All	AD + Breast cancer + Lung Cancer	Non-ADRD	intron_variant
chr5	1282299	rs7725218	0.92	TERT	NR	NR	NR	NA	TERT	SNP-based	Cross phenotype 	28780673	Caucasian	GAME-ON	33832	All	Breast Cancer	Non-ADRD	intron_variant
chr5	7478801	rs252546	0.00000779	NR	G	G	NR	NA	ADCY2	SNP-based	Disease risk	21390209	Caucasian	"ADNI, GenADA, Pfizer"	3595	All	AD	AD	intron_variant
chr5	7896398	rs3776455	1.38E-129	MTRR	NR	NR	1.23	3.42123	MTRR	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	MTRR expression in Temporal cortex	Expression	intron_variant
chr5	7896398	rs3776455	1.80E-64	MTRR	NR	NR	1.12	3.06485	MTRR	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	MTRR expression in Cerebellar	Expression	intron_variant
chr5	7896398	rs3776455	2.83E-127	MTRR	NR	NR	1.2	3.32012	MTRR	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	MTRR expression in Cerebellar	Expression	intron_variant
chr5	7896398	rs3776455	2.97E-58	MTRR	NR	NR	1.3	3.6693	MTRR	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	MTRR expression in Cerebellar	Expression	intron_variant
chr5	11107401	rs2905990	0.0000379	CTNND2	T	T	NR	NA	CTNND2	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr5	11107401	rs2905990	0.00009	CTNND2	T	T	NR	NA	CTNND2	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intron_variant
chr5	11107401	rs2905990	0.0014	CTNND2	T	T	NR	NA	CTNND2	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr5	11148581	rs757459	0.0311	CTNND2	NR	NR	NR	NA	CTNND2	SNP-based	Endophenotype	22245343	Caucasian	ADNI	757	All	MRI	Imaging	intron_variant
chr5	14042267	rs17228994	0.000036	Intergenic (as reported in paper)	C	C	NR	NA	DNAH5	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intergenic_region
chr5	14042267	rs17228994	0.0006	NR	C	C	NR	NA	DNAH5	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intergenic_region
chr5	14042267	rs17228994	0.0025	NR	C	C	NR	NA	DNAH5	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intergenic_region
chr5	15669858	rs75002042	4.70E-09	FBXL7	A	A	0.6	0.6	FBXL7	SNP-based	Disease risk	26339675	Caribbean Hispanic	"EFIGA, NOMAS, WHICAP "	4514	All	LOAD	AD	intron_variant
chr5	15669858	rs75002042	6.19E-09	FBXL7	A	A	0.61	0.61	FBXL7	SNP-based	Disease risk	26339675	Caribbean Hispanic	"EFIGA, NOMAS, WHICAP "	4514	All	LOAD	AD	intron_variant
chr5	29005878	rs71618613	0.00000033	SUCLG2P4	C	C	0.71	0.71	CDH9	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	94437	All	Clinically diagnosed LOAD	AD	downstream_gene_variant
chr5	29005878	rs71618613	0.0000098	SUCLG2P4	C	C	0.68	0.68	CDH9	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	63926	All	Clinically diagnosed LOAD	AD	downstream_gene_variant
chr5	29005878	rs71618613	0.0068	SUCLG2P4	C	C	0.76	0.76	CDH9	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	30511	All	Clinically diagnosed LOAD	AD	downstream_gene_variant
chr5	30178906	rs13178362	0.00000066	NR	C	C	0.75	0.75	CDH6	SNP-based	Disease risk	24755620	Caucasian	ADGC	4569	All	AD	AD	intergenic_region
chr5	35080043	rs6883056	0.0000848	PRLR	C	C	NR	NA	PRLR	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr5	35080043	rs6883056	0.0023	PRLR	C	C	NR	NA	PRLR	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Low-density lipoprotein (LDL)	Non-ADRD	intron_variant
chr5	35080043	rs6883056	0.471	PRLR	C	C	1	1	PRLR	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr5	53369400	rs35868327	0.00000026	FST	A	A	0.68	0.68	FST	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	94437	All	Clinically diagnosed LOAD	AD	intergenic_region
chr5	53369400	rs35868327	0.00000078	FST	A	A	0.69	0.69	FST	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	63926	All	Clinically diagnosed LOAD	AD	intergenic_region
chr5	53369400	rs35868327	0.12	FST	A	A	0.58	0.58	FST	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	30511	All	Clinically diagnosed LOAD	AD	intergenic_region
chr5	56560548	rs3843467	0.0000025	"MAP3K1, LOC441073"	NR	NR	NR	NA	MAP3K1	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr5	61654384	rs11738335	0.00000428	FLJ37543	NR	NR	NR	NA	ZSWIM6	SNP-based	Disease risk	22832961	Caucasian	ADGC	8292	All	LOAD	AD	intron_variant
chr5	61654384	rs11738335	0.00000466	FLJ37543	NR	NR	0.83	0.83	ZSWIM6	SNP-based	Disease risk	22832961	Caucasian	ADGC	8292	All	LOAD	AD	intron_variant
chr5	61654384	rs11738335	0.000572	FLJ37543	NR	NR	0.75	0.75	ZSWIM6	SNP-based	Disease risk	22832961	Caucasian	ADGC	2229	All	LOAD	AD	intron_variant
chr5	61654384	rs11738335	0.0173	FLJ37543	NR	NR	0.83	0.83	ZSWIM6	SNP-based	Disease risk	22832961	Caucasian	ADGC	2321	All	LOAD	AD	intron_variant
chr5	61654384	rs11738335	0.0562	FLJ37543	NR	NR	0.84	0.84	ZSWIM6	SNP-based	Disease risk	22832961	Caucasian	MIRAGE	1262	All	LOAD	AD	intron_variant
chr5	61654384	rs11738335	0.0683	FLJ37543	NR	NR	0.86	0.86	ZSWIM6	SNP-based	Disease risk	22832961	Caucasian	ADGC	2099	All	LOAD	AD	intron_variant
chr5	61654384	rs11738335	0.439	FLJ37543	NR	NR	1.19	1.19	ZSWIM6	SNP-based	Disease risk	22832961	Caucasian	ADNI	381	All	LOAD	AD	intron_variant
chr5	71950137	rs1217745	0.00000324	NR	T	T	NR	NA	MAP1B	SNP-based	Disease risk	21390209	Caucasian	"ADNI, GenADA, Pfizer"	3595	All	AD	AD	null
chr5	75596177	rs5744712	0.00135	POLK	C	C	NR	NA	POLK	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr5	75596177	rs5744712	0.967	POLK	C	C	1	1	POLK	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr5	75596177	rs5744712	1.29E-17	POLK	C	C	NR	NA	POLK	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Low-density lipoprotein (LDL)	Non-ADRD	intron_variant
chr5	75719417	rs2112347	0.108	NR	T	T	0.965	0.965	POC5	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	upstream_gene_variant
chr5	75719417	rs2112347	0.656	NR	T	T	0.97	0.97	POC5	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	upstream_gene_variant
chr5	75719417	rs2112347	0.675	NR	T	T	0	1	POC5	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	upstream_gene_variant
chr5	75719417	rs2112347	0.863	NR	T	T	1	1	POC5	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	upstream_gene_variant
chr5	77143425	rs6885904	0.0000011	"LOC728723, LOCI00129287"	NR	NR	NR	NA	AC008581.2	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr5	82030091	rs11741569	0.000996	ATG10	G	G	NR	NA	ATG10	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	17480	Plan 1 (males and females)	AD	AD	intron_variant
chr5	82030091	rs11741569	9.69E-27	NR	G	G	NR	NA	ATG10	SNP-based	eQTL	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	17480	Plan 1 (males and females)	ATG10 (ILMN_2206098) expression	Expression	intron_variant
chr5	82066661	rs11748868	1.39E-09	NR	C	C	NR	NA	ATG10	SNP-based	eQTL	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	ATG10 expression in Putamen basal ganglia	Expression	intron_variant
chr5	82066661	rs11748868	2.70E-09	NR	C	C	NR	NA	ATG10	SNP-based	eQTL	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	ATG10 expression in Nucleus accumbens	Expression	intron_variant
chr5	83564666	rs67827860	1.25E-14	NR	T	T	-0.61	0.543351	VCAN	SNP-based	Endophenotype	29752348	Caucasian	UKBB	8239	All	Fractional Anisotropy	Imaging	intron_variant
chr5	83565581	rs13164785	3.72E-18	NR	G	G	0.67	1.95424	VCAN	SNP-based	Endophenotype	29752348	Caucasian	UKBB	8239	All	Mean Diffusivity	Imaging	intron_variant
chr5	88197708	rs75451667	0.049	TMEM161B	NR	NR	1.51	1.51	TMEM161B	SNP-based	Cross phenotype 	30010129	Asian	Cohort from Han Chinse	475	All	AD	AD	missense_variant
chr5	88210806	rs115873146	0.0075	TMEM161B	NR	NR	NR	NA	TMEM161B	SNP-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr5	88210806	rs115873146	0.43157	NA	NR	NR	NR	NA	TMEM161B	Gene-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr5	88842914	rs11951031	0.0282	MEF2C	A	A	0.72	NA	MEF2C	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	intron_variant
chr5	88885292	rs3850651	0.00028	MEF2C	NR	NR	NR	NA	MEF2C	SNP-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr5	88885292	rs3850651	0.0119	NA	NR	NR	NR	NA	MEF2C	Gene-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr5	88919777	rs304132	0.00000917	"MEF2C, LOC729011"	NR	NR	NR	NA	MEF2C	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr5	88927603	rs190982	0.000000032	MEF2C	G	G	0.93	0.93	MEF2C	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD, Cohorts from Europe and USA"	74046	All	LOAD	AD	intron_variant
chr5	88927603	rs190982	0.0000025	MEF2C	G	G	0.92	0.92	MEF2C	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD"	54162	All	LOAD	AD	intron_variant
chr5	88927603	rs190982	0.0000028	MEF2C	G	G	0.94	0.94	MEF2C	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	82771	All	Clinically diagnosed LOAD	AD	intron_variant
chr5	88927603	rs190982	0.00028	MEF2C	G	G	0.95	0.95	MEF2C	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	63926	All	Clinically diagnosed LOAD	AD	intron_variant
chr5	88927603	rs190982	0.0011	MEF2C	G	G	0.81	0.81	MEF2C	SNP-based	Endophenotype	25188341	Caucasian	ADGC	4914	All	Clinico-pathologic AD dementia (No neuropathologist documentation)	Neuropathology	intron_variant
chr5	88927603	rs190982	0.0027	MEF2C	G	G	0.93	0.93	MEF2C	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	18845	All	Clinically diagnosed LOAD	AD	intron_variant
chr5	88927603	rs190982	0.0034	MEF2C	G	G	0.93	0.93	MEF2C	SNP-based	Disease risk	24162737	Caucasian	Cohorts from Europe and USA	19884	All	LOAD	AD	intron_variant
chr5	88927603	rs190982	0.00629	MEF2C	G	G	0.885	0.885	MEF2C	SNP-based	Disease risk	24495969	Caucasian	Cohort from Spain	4372	All	AD	AD	intron_variant
chr5	88927603	rs190982	0.0066	MEF2C	G	G	0.81	0.81	MEF2C	SNP-based	Endophenotype	25188341	Caucasian	ADGC	3702	All	Clinico-pathologic AD dementia (with neuropathologist documentation)	Neuropathology	intron_variant
chr5	88927603	rs190982	0.66	MEF2C	NR	NR	0.99	0.99	MEF2C	SNP-based	Endophenotype	26993346	Caucasian	Cohort from Europe	10840	All	PCA (posterior cortical atrophy)	Imaging	intron_variant
chr5	88927603	rs190982	NR	MEF2C	A	A	1.24	1.24	MEF2C	SNP-based	Disease risk	27849641	Caucasian	ADGC	589	All	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr5	88927603	rs190982	NR	ZCWPW1	A	A	1.03	1.03	MEF2C	SNP-based	Disease risk	27849641	Caucasian	ADGC	292	APOE-e4 carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr5	88927603	rs190982	NR	ZCWPW1	A	A	1.15	1.15	MEF2C	SNP-based	Disease risk	27849641	Caucasian	ADGC	297	APOE-e4 non-carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr5	96987845	rs9918162	0.8	LNPEP	T	T	0.96	0.96	LNPEP	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	7289	Plan 2 (only males)	AD	AD	intron_variant
chr5	107836568	rs12188460	0.000623	FBXL17	G	G	NR	NA	FBXL17	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr5	107836568	rs12188460	0.000849	FBXL17	G	G	NR	NA	FBXL17	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	High-density lipoprotein (HDL)	Non-ADRD	intergenic_region
chr5	107836568	rs12188460	0.00264	FBXL17	G	G	1.04	1.04	FBXL17	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intergenic_region
chr5	107836568	rs12188460	0.00485	FBXL17	G	G	1.04	1.04	FBXL17	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intergenic_region
chr5	107836568	rs12188460	0.25	FBXL17	G	G	1.06	1.06	FBXL17	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intergenic_region
chr5	107836568	rs12188460	0.458	FBXL17	G	G	1	1	FBXL17	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intergenic_region
chr5	121229828	rs919289	0.0000032	NR	NR	NR	NR	NA	PRR16	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intron_variant
chr5	121229828	rs919289	0.000075	NR	NR	NR	0.56	0.56	PRR16	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intron_variant
chr5	121229828	rs919289	0.000468	NR	NR	NR	NR	NA	PRR16	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr5	121229828	rs919289	0.0105	NR	NR	NR	0.71	0.71	PRR16	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr5	121229828	rs919289	0.09558	NR	NR	NR	NR	NA	PRR16	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intron_variant
chr5	121229828	rs919289	0.34351	NR	NR	NR	NR	NA	PRR16	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intron_variant
chr5	121229828	rs919289	0.744	NR	NR	NR	NR	NA	PRR16	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intron_variant
chr5	121229828	rs919289	0.791	NR	NR	NR	NR	NA	PRR16	SNP-based	Disease risk	21059989	Caucasian	ADGC	1390	Unrelated individuals	LOAD	AD	intron_variant
chr5	121229828	rs919289	1	NR	NR	NR	1.06	1.06	PRR16	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intron_variant
chr5	121233413	rs4895298	0.000002	NR	NR	NR	NR	NA	PRR16	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intron_variant
chr5	121233413	rs4895298	0.000052	NR	NR	NR	0.55	0.55	PRR16	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intron_variant
chr5	121233413	rs4895298	0.000477	NR	NR	NR	NR	NA	PRR16	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr5	121233413	rs4895298	0.0108	NR	NR	NR	0.71	0.71	PRR16	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr5	121233413	rs4895298	0.14639	NR	NR	NR	NR	NA	PRR16	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intron_variant
chr5	121233413	rs4895298	0.22174	NR	NR	NR	NR	NA	PRR16	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intron_variant
chr5	121233413	rs4895298	0.634	NR	NR	NR	NR	NA	PRR16	SNP-based	Disease risk	21059989	Caucasian	ADGC	1390	Unrelated individuals	LOAD	AD	intron_variant
chr5	121233413	rs4895298	0.655	NR	NR	NR	NR	NA	PRR16	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intron_variant
chr5	121233413	rs4895298	1	NR	NR	NR	1.08	1.08	PRR16	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intron_variant
chr5	121233616	rs2973413	0.00000535	NR	NR	NR	NR	NA	PRR16	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intron_variant
chr5	121233616	rs2973413	0.000114	NR	NR	NR	0.56	0.56	PRR16	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intron_variant
chr5	121233616	rs2973413	0.000571	NR	NR	NR	NR	NA	PRR16	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr5	121233616	rs2973413	0.0124	NR	NR	NR	0.71	0.71	PRR16	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr5	121233616	rs2973413	0.15152	NR	NR	NR	NR	NA	PRR16	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intron_variant
chr5	121233616	rs2973413	0.21149	NR	NR	NR	NR	NA	PRR16	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intron_variant
chr5	121233616	rs2973413	0.532	NR	NR	NR	NR	NA	PRR16	SNP-based	Disease risk	21059989	Caucasian	ADGC	1390	Unrelated individuals	LOAD	AD	intron_variant
chr5	121233616	rs2973413	0.917	NR	NR	NR	NR	NA	PRR16	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intron_variant
chr5	121233616	rs2973413	1	NR	NR	NR	1.11	1.11	PRR16	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intron_variant
chr5	121280612	rs73276571	0.0000018	NR	A	A	0.66	1.93479	FTMT	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	363	AD subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr5	121280612	rs73276571	0.024	NR	A	A	0.22	1.24608	FTMT	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	878	AD subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr5	121280612	rs73276571	0.13	NR	A	A	-0.2	0.818731	FTMT	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	515	AD subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr5	123821728	rs257016	0.00000406	AC008541.1	NR	NR	0.7	0.7	CSNK1G3	SNP-based	Disease risk	22005930	Caucasian	"ADGC, GERAD"	2034	AD+P and AD-P subjects	AD+Psychosis	ADRD	intergenic_region
chr5	123821728	rs257016	0.00000541	AC008541.1	NR	NR	0.71	0.71	CSNK1G3	SNP-based	Disease risk	22005930	Caucasian	"ADGC, GERAD"	2034	AD+P and AD-P subjects	AD+Psychosis	ADRD	intergenic_region
chr5	123844055	rs12514988	0.00000948	NR	T	T	NR	NA	CSNK1G3	SNP-based	Disease risk	24770881	Caucasian	ADGC	2239	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	intergenic_region
chr5	124996410	rs4836133	0.002	NR	A	A	1.15	1.15	ZNF608	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	intergenic_region
chr5	124996410	rs4836133	0.482	NR	A	A	1.03	1.03	ZNF608	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	intergenic_region
chr5	124996410	rs4836133	0.52	NR	A	A	0.002	1.002	ZNF608	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	intergenic_region
chr5	124996410	rs4836133	0.613	NR	A	A	1.01	1.01	ZNF608	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	intergenic_region
chr5	128327887	rs39938	0.00000393	FBN2	T	T	1.23	1.23	FBN2	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	15235	All	Small sub-cortical brain infarcts (SSBI)	Imaging	intron_variant
chr5	128327887	rs39938	0.0000143	FBN2	T	T	NR	NA	FBN2	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	15235	All	Small sub-cortical brain infarcts (SSBI)	Imaging	intron_variant
chr5	128327887	rs39938	0.000165	FBN2	NR	NR	1.1	1.1	FBN2	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	26929	All	Brain infarcts (BI)	Imaging	intron_variant
chr5	128327887	rs39938	0.00158	FBN2	NR	NR	1.1	1.1	FBN2	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	22097	All	Small sub-cortical brain infarcts (SSBI)	Imaging	intron_variant
chr5	128327887	rs39938	0.27	FBN2	NR	NR	1.09	1.09	FBN2	SNP-based	Endophenotype	30651383	Caucasian	ADGC	2940	All	Pathologically defined infarcts	Imaging	intron_variant
chr5	128327887	rs39938	0.61	FBN2	NR	NR	0.98	0.98	FBN2	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	6862	All	Brain infarcts (BI)	Imaging	intron_variant
chr5	128327887	rs39938	0.61	FBN2	NR	NR	1.01	1.01	FBN2	SNP-based	Endophenotype	30651383	Caucasian	"CHARGE, METASTROKE, SiGN"	137560	All	Ischemic stroke (IS)	Imaging	intron_variant
chr5	128327887	rs39938	0.88	FBN2	NR	NR	1.01	1.01	FBN2	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	6862	All	Small sub-cortical brain infarcts (SSBI)	Imaging	intron_variant
chr5	128327887	rs39938	0.9	FBN2	NR	NR	1	1	FBN2	SNP-based	Endophenotype	30651383	Caucasian	"METASTROKE, SiGN, YLSDR"	41039	All	Ischemic stroke due to small vessel disease (IS-SVD)	Imaging	intron_variant
chr5	128327887	rs39938	1.77E-08	FBN2	T	T	1.21	1.21	FBN2	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	20067	All	Brain infarcts (BI)	Imaging	intron_variant
chr5	128327887	rs39938	4.83E-08	FBN2	T	T	NR	NA	FBN2	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	20067	All	Brain infarcts (BI)	Imaging	intron_variant
chr5	131351444	rs382216	0.0000002	"ACSL6, CDC42SE2"	T	T	0.87	0.87	CDC42SE2	SNP-based	Disease risk	25778476	Caucasian	"ADGC, IGAP"	36569	APOE-e4- subjects	AD	AD	intron_variant
chr5	131351444	rs382216	0.0000065	"ACSL6, CDC42SE2"	T	T	0.88	0.88	CDC42SE2	SNP-based	Disease risk	25778476	Caucasian	IGAP	34152	APOE-e4- subjects	AD	AD	intron_variant
chr5	131351444	rs382216	0.002	"ACSL6, CDC42SE2"	T	T	0.78	0.78	CDC42SE2	SNP-based	Disease risk	25778476	Caucasian	ADGC	2417	APOE-e4- subjects	AD	AD	intron_variant
chr5	140289801	rs1347143	0.0000117	PFDN1	NR	NR	NR	NA	PFDN1	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr5	140327854	rs11168036	0.00000032	"HBEGF, PFDN1"	T	T	1.12	1.12	HBEGF	SNP-based	Disease risk	25778476	Caucasian	"ADGC, IGAP"	36569	APOE-e4- subjects	AD	AD	downstream_gene_variant
chr5	140327854	rs11168036	0.0000018	"HBEGF, PFDN1"	T	T	1.08	1.08	HBEGF	SNP-based	Disease risk	28183528	Multi-ethnic	ADGC	33269	All	AD	AD	downstream_gene_variant
chr5	140327854	rs11168036	0.0006	"HBEGF, PFDN1"	T	T	1.08	1.08	HBEGF	SNP-based	Disease risk	28183528	Caucasian	IGAP	26287	All	AD	AD	downstream_gene_variant
chr5	140327854	rs11168036	0.64	"HBEGF, PFDN1"	T	T	0.97	0.97	HBEGF	SNP-based	Disease risk	25778476	Caucasian	ADGC	2417	APOE-e4- subjects	AD	AD	downstream_gene_variant
chr5	140327854	rs11168036	7.10E-09	"HBEGF, PFDN1"	T	T	1.08	1.08	HBEGF	SNP-based	Disease risk	28183528	Multi-ethnic	"ADGC, IGAP"	59556	All	AD	AD	downstream_gene_variant
chr5	140327854	rs11168036	9.30E-09	"HBEGF, PFDN1"	T	T	1.14	1.14	HBEGF	SNP-based	Disease risk	25778476	Caucasian	IGAP	34152	APOE-e4- subjects	AD	AD	downstream_gene_variant
chr5	140334979	rs2074613	0.000000929	HBEGF	C	C	NR	NA	HBEGF	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr5	140334979	rs2074613	0.0000136	HBEGF	C	C	NR	NA	HBEGF	SNP-based	Cross phenotype 	30413934	Caucasian	GIANT	681275	All	Body-mass index (BMI)	Non-ADRD	intron_variant
chr5	140334979	rs2074613	0.157	HBEGF	C	C	1	1	HBEGF	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr5	142435923	rs4912851	0.0000232	SPRY4	G	G	NR	NA	SPRY4	SNP-based	Cross phenotype 	30413934	Caucasian	"GIANT, UKBB"	180423	All	Waist-to-hip ratio (WHR)	Non-ADRD	intron_variant
chr5	142435923	rs4912851	0.0000339	SPRY4	G	G	NR	NA	SPRY4	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr5	142435923	rs4912851	0.00358	SPRY4	G	G	1.04	1.04	SPRY4	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intron_variant
chr5	142435923	rs4912851	0.00707	SPRY4	G	G	1.04	1.04	SPRY4	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intron_variant
chr5	142435923	rs4912851	0.232	SPRY4	G	G	1.06	1.06	SPRY4	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intron_variant
chr5	142435923	rs4912851	0.938	SPRY4	G	G	1	1	SPRY4	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr5	154460912	rs6884266	0.00986	SAP30L	C	C	NR	NA	SAP30L	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	3_prime_UTR_variant
chr5	154460912	rs6884266	1.72E-71	NR	C	C	NR	NA	SAP30L	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	SAP30L (ILMN_1843932) expression	Expression	3_prime_UTR_variant
chr5	157762610	rs11738432	1.68E-33	THG1L	NR	NR	-0.81	0.444858	LSM11	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	THG1L expression in Cerebellar	Expression	downstream_gene_variant
chr5	157762610	rs11738432	2.45E-39	THG1L	NR	NR	-0.94	0.390628	LSM11	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	THG1L expression in Cerebellar	Expression	downstream_gene_variant
chr5	157762610	rs11738432	3.12E-97	THG1L	NR	NR	-1.09	0.336216	LSM11	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	THG1L expression in Temporal cortex	Expression	downstream_gene_variant
chr5	157762610	rs11738432	3.58E-78	THG1L	NR	NR	-0.86	0.423162	LSM11	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	THG1L expression in Cerebellar	Expression	downstream_gene_variant
chr5	160961636	rs2176298	0.00015	LOC285629	T	T	NR	NA	ATP10B	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr5	160961636	rs2176298	0.000456	LOC285629	T	T	NR	NA	ATP10B	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Total triglycerides (TG)	Non-ADRD	intergenic_region
chr5	160961636	rs2176298	0.0147	LOC285629	T	T	1.03	1.03	ATP10B	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intergenic_region
chr5	160961636	rs2176298	0.0307	LOC285629	T	T	1.03	1.03	ATP10B	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intergenic_region
chr5	160961636	rs2176298	0.186	LOC285629	T	T	1	1	ATP10B	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intergenic_region
chr5	160961636	rs2176298	0.452	LOC285629	T	T	0.96	0.96	ATP10B	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intergenic_region
chr5	168466703	rs12514426	0.000928	WWC1	NR	NR	NR	NA	WWC1	SNP-based	Disease risk	19118814	Caucasian	"CAP, Reiman et al.(2007)"	NR	All	LOAD	AD	intron_variant
chr5	168466703	rs12514426	0.00498	WWC1	NR	NR	NR	NA	WWC1	SNP-based	Disease risk	19118814	Caucasian	Reiman et al.(2007)	NR	All	LOAD	AD	intron_variant
chr5	168466703	rs12514426	0.0359	WWC1	NR	NR	NR	NA	WWC1	SNP-based	Disease risk	19118814	Caucasian	CAP	458	All	LOAD	AD	intron_variant
chr5	171439292	rs62383992	0.000912	FGF18	A	A	NR	NA	FGF18	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Total cholesterol (TC)	Non-ADRD	intron_variant
chr5	171439292	rs62383992	0.0013	FGF18	A	A	NR	NA	FGF18	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr5	171439292	rs62383992	0.15	FGF18	A	A	1	1	FGF18	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr5	174587111	rs145848414	0.000000069	NR	A	A	2.29	2.29	MSX2	SNP-based	Disease risk	23571587	African American	ADGC	5896	All	LOAD	AD	intergenic_region
chr5	178148265	rs3812071	0.0223	RMND5B	C	C	NR	NA	RMND5B	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	3_prime_UTR_variant
chr5	178148265	rs3812071	8.86E-14	NR	C	C	NR	NA	RMND5B	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	RMND5B (ILMN_1737847) expression	Expression	3_prime_UTR_variant
chr5	180394728	rs11249708	0.000015	GFPT2	NR	NR	NR	NA	GFPT2	SNP-based	Cross phenotype 	28780673	Caucasian	GAME-ON	28998	All	Lung Cancer	Non-ADRD	intergenic_region
chr5	180394728	rs11249708	0.00012	GFPT2	NR	NR	NR	NA	GFPT2	SNP-based	Cross phenotype 	28780673	Caucasian	"GAME-ON, IGAP"	116992	All	AD + Breast cancer + Lung Cancer	Non-ADRD	intergenic_region
chr5	180394728	rs11249708	0.0006	GFPT2	NR	NR	NR	NA	GFPT2	SNP-based	Cross phenotype 	28780673	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr5	180394728	rs11249708	0.13	GFPT2	NR	NR	NR	NA	GFPT2	SNP-based	Cross phenotype 	28780673	Caucasian	GAME-ON	33832	All	Breast Cancer	Non-ADRD	intergenic_region
chr6	2838014	rs316341	0.00462	GLIS1	G	G	0.04	1.04081	SERPINB1	SNP-based	Age at onset (AAO) / Survival	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	39855	AD subjects	Age at onset	Other	intron_variant
chr6	2838014	rs316341	0.009	GLIS1	NR	NR	0.02	1.0202	SERPINB1	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	1527	Male subjects	CSF Ab1-42	Fluid biomarker	intron_variant
chr6	2838014	rs316341	0.00919	GLIS1	G	G	0.02	1.0202	SERPINB1	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	3146	All	CSF T-tau	Fluid biomarker	intron_variant
chr6	2838014	rs316341	0.06	GLIS1	NR	NR	0.19	1.20925	SERPINB1	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	362	Male AD subjects	Amyloid Burden	Neuropathology	intron_variant
chr6	2838014	rs316341	0.152	GLIS1	G	G	1.03	2.80107	SERPINB1	SNP-based	Disease risk	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	74046	All	AD risk	AD	intron_variant
chr6	2838014	rs316341	0.22	GLIS1	G	G	0.01	1.01005	SERPINB1	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	3146	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr6	2838014	rs316341	0.277	GLIS1	G	G	0.05	1.05127	SERPINB1	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	1530	All	AD Progression (based on CDR Score)	Cognitive	intron_variant
chr6	2838014	rs316341	0.99	GLIS1	NR	NR	0.001	1.001	SERPINB1	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	704	Female AD subjects	Amyloid Burden	Neuropathology	intron_variant
chr6	2838014	rs316341	1.72E-08	GLIS1	NR	NR	0.025	1.02532	SERPINB1	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	3036	All	CSF Ab1-42	Fluid biomarker	intron_variant
chr6	2838014	rs316341	1.76E-08	GLIS1	G	G	0.025	1.02532	SERPINB1	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	3146	All	CSF Ab1-42	Fluid biomarker	intron_variant
chr6	2838014	rs316341	4.25E-08	GLIS1	NR	NR	0.03	1.03045	SERPINB1	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	1509	Female subjects	CSF Ab1-42	Fluid biomarker	intron_variant
chr6	3979517	rs9392025	0.00276	HLA-DRB1	A	A	0.83	NA	PRPF4B	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	upstream_gene_variant
chr6	7281421	rs1050226	0.0000027	"RREB1, SSR1"	NR	NR	NR	NA	SSR1	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	3_prime_UTR_variant
chr6	11334421	rs760678	0.852	NEDD9	C	C	0.99	0.99	NEDD9	SNP-based	Disease risk	20534741	Caucasian	"ADC, UM"	1610	All	AD	AD	intron_variant
chr6	19350484	rs62402815	0.000000429	LOC101928519	G	G	0.61	0.61	ID4	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AD	AD	downstream_gene_variant
chr6	19350484	rs62402815	0.0000018	LOC101928519	G	G	0.69	0.69	ID4	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	17480	Plan 1 (males and females)	AD	AD	downstream_gene_variant
chr6	20541966	rs10484634	0.00000097	CDKAL1	NR	NR	NR	NA	CDKAL1	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr6	20578621	rs13205786	0.0000012	CDKAL1	NR	NR	NR	NA	CDKAL1	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr6	20612985	rs13200415	0.00000078	CDKAL1	NR	NR	NR	NA	CDKAL1	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr6	20675064	rs1012635	0.0000004	CDKAL1	NR	NR	NR	NA	CDKAL1	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr6	20717173	rs10946403	9.00E-20	CDKAL1	NR	NR	NR	NA	CDKAL1	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr6	20731293	rs7741604	0.000000086	CDKAL1	NR	NR	NR	NA	CDKAL1	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr6	20762940	rs4712540	0.0000058	CDKAL1	NR	NR	NR	NA	CDKAL1	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr6	23378723	rs1925458	0.00000126	NRSN1	G	G	0.64	0.64	NRSN1	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	10870	HTN-P group	AD	AD	intergenic_region
chr6	26114144	rs198834	2.11E-61	HIST1H4C	NR	NR	-0.43	0.650509	H2BC4	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	HIST1H4C expression in Cerebellar	Expression	downstream_gene_variant
chr6	26114144	rs198834	3.35E-48	HIST1H4C	NR	NR	-0.52	0.594521	H2BC4	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	HIST1H4C expression in Temporal cortex	Expression	downstream_gene_variant
chr6	26114144	rs198834	3.92E-32	HIST1H4C	NR	NR	-0.44	0.644036	H2BC4	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	HIST1H4C expression in Cerebellar	Expression	downstream_gene_variant
chr6	26114144	rs198834	8.78E-24	HIST1H4C	NR	NR	-0.42	0.657047	H2BC4	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	HIST1H4C expression in Cerebellar	Expression	downstream_gene_variant
chr6	27123646	rs6913660	0.54	HIST1H2BJ	NR	NR	1.04	1.04	H2BC11	SNP-based	Cross phenotype 	22005930	Caucasian	"ADGC, GERAD, Cohort from UK"	6958	AD+P and control subjects	AD+Psychosis	ADRD	upstream_gene_variant
chr6	27123646	rs6913660	0.95	HIST1H2BJ	NR	NR	1.01	1.01	H2BC11	SNP-based	Cross phenotype 	22005930	Caucasian	"ADGC, GERAD"	2034	AD+P and AD-P subjects	AD+Psychosis	ADRD	upstream_gene_variant
chr6	27176104	rs13194053	0.5	MHC	NR	NR	0.96	0.96	H2AC12	SNP-based	Cross phenotype 	22005930	Caucasian	"ADGC, GERAD, Cohort from UK"	6958	AD+P and control subjects	AD+Psychosis	ADRD	intergenic_region
chr6	27281152	rs6932590	0.33	PRSS16	NR	NR	0.88	0.88	POM121L2	SNP-based	Cross phenotype 	22005930	Caucasian	"ADGC, GERAD"	2034	AD+P and AD-P subjects	AD+Psychosis	ADRD	downstream_gene_variant
chr6	27281152	rs6932590	0.58	PRSS16	NR	NR	0.97	0.97	POM121L2	SNP-based	Cross phenotype 	22005930	Caucasian	"ADGC, GERAD, Cohort from UK"	6958	AD+P and control subjects	AD+Psychosis	ADRD	downstream_gene_variant
chr6	28209714	rs988084	3.28E-09	"TOB2P1, ZNF192P1"	NR	NR	NR	NA	ZSCAN9	SNP-based	Cross phenotype 	27357110	Caucasian	"ADNI, Knight-ADRC"	587	NA	Plasma Prolactin	Fluid biomarker	intergenic_region
chr6	28209714	rs988084	7.01E-26	"TOB2P1, ZNF192P1"	NR	NR	NR	NA	ZSCAN9	SNP-based	Cross phenotype 	27357110	Caucasian	"ADNI, Knight-ADRC"	543	NA	CSF Prolactin	Fluid biomarker	intergenic_region
chr6	28209810	rs988083	3.28E-09	"TOB2P1, ZNF192P1"	NR	NR	NR	NA	ZSCAN9	SNP-based	Cross phenotype 	27357110	Caucasian	"ADNI, Knight-ADRC"	587	NA	Plasma Prolactin	Fluid biomarker	intergenic_region
chr6	28209810	rs988083	7.01E-26	"TOB2P1, ZNF192P1"	NR	NR	NR	NA	ZSCAN9	SNP-based	Cross phenotype 	27357110	Caucasian	"ADNI, Knight-ADRC"	543	NA	CSF Prolactin	Fluid biomarker	intergenic_region
chr6	28216108	rs1150701	1.18E-08	TOB2P1	NR	NR	NR	NA	ZSCAN9	SNP-based	Cross phenotype 	27357110	Caucasian	"ADNI, Knight-ADRC"	587	NA	Plasma Prolactin	Fluid biomarker	downstream_gene_variant
chr6	28216108	rs1150701	1.44E-26	TOB2P1	NR	NR	NR	NA	ZSCAN9	SNP-based	Cross phenotype 	27357110	Caucasian	"ADNI, Knight-ADRC"	543	NA	CSF Prolactin	Fluid biomarker	downstream_gene_variant
chr6	28216319	rs1150702	1.18E-08	TOB2P1	NR	NR	NR	NA	ZSCAN9	SNP-based	Cross phenotype 	27357110	Caucasian	"ADNI, Knight-ADRC"	587	NA	Plasma Prolactin	Fluid biomarker	downstream_gene_variant
chr6	28216319	rs1150702	1.44E-26	TOB2P1	NR	NR	NR	NA	ZSCAN9	SNP-based	Cross phenotype 	27357110	Caucasian	"ADNI, Knight-ADRC"	543	NA	CSF Prolactin	Fluid biomarker	downstream_gene_variant
chr6	28216482	rs1150703	3.28E-09	TOB2P1	NR	NR	NR	NA	ZSCAN9	SNP-based	Cross phenotype 	27357110	Caucasian	"ADNI, Knight-ADRC"	587	NA	Plasma Prolactin	Fluid biomarker	downstream_gene_variant
chr6	28216482	rs1150703	7.01E-26	TOB2P1	NR	NR	NR	NA	ZSCAN9	SNP-based	Cross phenotype 	27357110	Caucasian	"ADNI, Knight-ADRC"	543	NA	CSF Prolactin	Fluid biomarker	downstream_gene_variant
chr6	28225353	rs1233712	1.18E-08	ZSCAN9	NR	NR	NR	NA	ZSCAN9	SNP-based	Cross phenotype 	27357110	Caucasian	"ADNI, Knight-ADRC"	587	NA	Plasma Prolactin	Fluid biomarker	5_prime_UTR_variant
chr6	28225353	rs1233712	1.44E-26	ZSCAN9	NR	NR	NR	NA	ZSCAN9	SNP-based	Cross phenotype 	27357110	Caucasian	"ADNI, Knight-ADRC"	543	NA	CSF Prolactin	Fluid biomarker	5_prime_UTR_variant
chr6	28289600	rs13211507	0.79	PGBD1	NR	NR	0.94	0.94	PGBD1	SNP-based	Cross phenotype 	22005930	Caucasian	"ADGC, GERAD"	2034	AD+P and AD-P subjects	AD+Psychosis	ADRD	intron_variant
chr6	28289600	rs13211507	0.95	PGBD1	NR	NR	1.01	1.01	PGBD1	SNP-based	Cross phenotype 	22005930	Caucasian	"ADGC, GERAD, Cohort from UK"	6958	AD+P and control subjects	AD+Psychosis	ADRD	intron_variant
chr6	28296904	rs3800324	0.00032	PGBD1	NR	NR	1.43	1.43	PGBD1	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	3870	All	LOAD	AD	missense_variant
chr6	28296904	rs3800324	0.026	PGBD1	NR	NR	NR	NA	PGBD1	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	720	All	LOAD	AD	missense_variant
chr6	28296904	rs3800324	0.146	PGBD1	NR	NR	NR	NA	PGBD1	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	1146	All	LOAD	AD	missense_variant
chr6	28296904	rs3800324	0.159	PGBD1	A	A	1.3	1.3	PGBD1	SNP-based	Disease risk	20534741	Caucasian	"ADC, UM"	1610	All	AD	AD	missense_variant
chr6	28296904	rs3800324	0.204	PGBD1	NR	NR	NR	NA	PGBD1	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	776	All	LOAD	AD	missense_variant
chr6	28296904	rs3800324	0.317	PGBD1	NR	NR	NR	NA	PGBD1	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	658	All	LOAD	AD	missense_variant
chr6	28296904	rs3800324	0.502	PGBD1	NR	NR	NR	NA	PGBD1	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	570	All	LOAD	AD	missense_variant
chr6	28363475	rs213228	0.018	ZKSCAN3	NR	NR	NR	NA	ZKSCAN3	SNP-based	Endophenotype	22245343	Caucasian	ADNI	757	All	MRI	Imaging	intron_variant
chr6	28390543	rs1361385	0.0098	ZSCAN12	NR	NR	NR	NA	ZSCAN12	SNP-based	Endophenotype	22245343	Caucasian	ADNI	757	All	MRI	Imaging	intron_variant
chr6	29555869	rs444013	0.00079	UBD	NR	NR	1.11	1.11	OR2I1P	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	3870	All	LOAD	AD	3_prime_UTR_variant
chr6	29555869	rs444013	0.01	UBD	NR	NR	NR	NA	OR2I1P	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	776	All	LOAD	AD	3_prime_UTR_variant
chr6	29555869	rs444013	0.042	UBD	NR	NR	NR	NA	OR2I1P	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	720	All	LOAD	AD	3_prime_UTR_variant
chr6	29555869	rs444013	0.299	UBD	NR	NR	NR	NA	OR2I1P	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	570	All	LOAD	AD	3_prime_UTR_variant
chr6	29555869	rs444013	0.741	UBD	NR	NR	NR	NA	OR2I1P	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	658	All	LOAD	AD	3_prime_UTR_variant
chr6	29555869	rs444013	0.845	UBD	NR	NR	NR	NA	OR2I1P	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	1146	All	LOAD	AD	3_prime_UTR_variant
chr6	29854484	rs2975033	1.57E-78	HLA-H	NR	NR	1.45	4.26311	HLA-G	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	HLA-H expression in Cerebellar	Expression	upstream_gene_variant
chr6	29854484	rs2975033	3.61E-36	HLA-H	NR	NR	1.39	4.01485	HLA-G	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	HLA-H expression in Cerebellar	Expression	upstream_gene_variant
chr6	29854484	rs2975033	3.63E-36	HLA-H	NR	NR	1.53	4.61818	HLA-G	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	HLA-H expression in Cerebellar	Expression	upstream_gene_variant
chr6	30066107	rs3807031	0.0000116	PPP1R11	NR	NR	NR	NA	PPP1R11	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	upstream_gene_variant
chr6	30171922	rs929156	0.0000169	TRIM15	NR	NR	NR	NA	TRIM15	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	missense_variant
chr6	31114212	rs3130977	0.0349	C6orf15	NR	NR	NR	NA	PSORS1C1	SNP-based	Endophenotype	22245343	Caucasian	ADNI	757	All	MRI	Imaging	upstream_gene_variant
chr6	31146405	rs746647	0.0496	CCHCR1	NR	NR	NR	NA	CCHCR1	SNP-based	Endophenotype	22245343	Caucasian	ADNI	757	All	MRI	Imaging	intron_variant
chr6	31844261	rs9267576	0.000017	"C6orf48, NEU1"	NR	NR	NR	NA	NEU1	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	downstream_gene_variant
chr6	31871532	rs2242665	0.0254	SLC44A4	NR	NR	NR	NA	SLC44A4	SNP-based	Endophenotype	22245343	Caucasian	ADNI	757	All	MRI	Imaging	missense_variant
chr6	31876147	rs2736428	0.0246	SLC44A4	NR	NR	NR	NA	SLC44A4	SNP-based	Endophenotype	22245343	Caucasian	ADNI	757	All	MRI	Imaging	intron_variant
chr6	31893364	rs2844457	0.0116	EHMT2	NR	NR	NR	NA	EHMT2	SNP-based	Endophenotype	22245343	Caucasian	ADNI	757	All	MRI	Imaging	intron_variant
chr6	31926167	rs2734335	0.0445	C2	NR	NR	NR	NA	C2	SNP-based	Endophenotype	22245343	Caucasian	ADNI	757	All	MRI	Imaging	intron_variant
chr6	31949763	rs4151657	0.0307	CFB	NR	NR	NR	NA	AL645922.1	SNP-based	Endophenotype	22245343	Caucasian	ADNI	757	All	MRI	Imaging	intron_variant
chr6	31962664	rs592229	0.0078	SKIV2L	NR	NR	NR	NA	SKIV2L	SNP-based	Endophenotype	22245343	Caucasian	ADNI	757	All	MRI	Imaging	intron_variant
chr6	32053353	rs11969759	0.0000021	TNXB	C	C	0.62	0.62	TNXB	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AD	AD	intron_variant
chr6	32056618	rs10947230	0.00000233	TNXB	C	C	0.62	0.62	TNXB	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AD	AD	missense_variant
chr6	32062507	rs2239689	0.0088	TNXB	NR	NR	NR	NA	TNXB	SNP-based	Endophenotype	22245343	Caucasian	ADNI	757	All	MRI	Imaging	intron_variant
chr6	32078498	rs7774197	0.00000417	TNXB	A	A	0.63	0.63	TNXB	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AD	AD	intron_variant
chr6	32121077	rs2228628	0.0316	ATF6B	NR	NR	NR	NA	ATF6B	SNP-based	Endophenotype	22245343	Caucasian	ADNI	757	All	MRI	Imaging	synonymous_variant
chr6	32205216	rs3131296	0.15	NOTCH4	NR	NR	1.16	1.16	NOTCH4	SNP-based	Cross phenotype 	22005930	Caucasian	"ADGC, GERAD"	2034	AD+P and AD-P subjects	AD+Psychosis	ADRD	intron_variant
chr6	32205216	rs3131296	0.33	NOTCH4	NR	NR	1.07	1.07	NOTCH4	SNP-based	Cross phenotype 	22005930	Caucasian	"ADGC, GERAD, Cohort from UK"	6958	AD+P and control subjects	AD+Psychosis	ADRD	intron_variant
chr6	32323177	rs485774	0.0331	C6orf10	NR	NR	NR	NA	TSBP1	SNP-based	Endophenotype	22245343	Caucasian	ADNI	757	All	MRI	Imaging	intron_variant
chr6	32463370	rs9268877	0.000031	HLA-DRA	A	A	NR	NA	HLA-DRA	SNP-based	eQTL	27899424	Caucasian	UKBEC	101	All	HLA-DPA1 expression in Frontal cortex	Expression	intron_variant
chr6	32463370	rs9268877	1.04E-10	HLA-DRA	NR	NR	NR	NA	HLA-DRA	SNP-based	Disease risk	27899424	Caucasian	IFGC	12928	All	Frontotemporal Dementia	ADRD	intron_variant
chr6	32539133	rs116715716	0.0000225	HLA-DRB1	T	T	NR	NA	HLA-DRB5	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Total cholesterol (TC)	Non-ADRD	intergenic_region
chr6	32539133	rs116715716	0.0000787	HLA-DRB1	T	T	NR	NA	HLA-DRB5	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr6	32542705	rs115124923	3.98E-08	HLA-DRB5	NR	NR	0.17	NA	HLA-DRB5	SNP-based	Age at onset (AAO) / Survival	28323831	Caucasian	ADGC	15795	All	Age of AD onset	Other	intergenic_region
chr6	32582545	rs9269853	2.66E-08	HLA-DRB1	T	T	NR	NA	HLA-DRB1	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ"	79145	All	AD	AD	intron_variant
chr6	32602623	rs2516049	0.0000361	HLA-DRB5	NR	NR	NR	NA	HLA-DRB1	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr6	32602623	rs2516049	0.0000537	HLA-DRB5	T	T	NR	NA	HLA-DRB1	SNP-based	Cross phenotype 	27088644	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr6	32602623	rs2516049	6.03E-15	HLA-DRB5	T	T	NR	NA	HLA-DRB1	SNP-based	Cross phenotype 	27088644	Caucasian	Cohort of Immune-Mediated Diseases	7484	All	Psoriasis	Non-ADRD	intergenic_region
chr6	32607629	rs9271058	0.000000051	HLA-DRB1	A	A	1.1	1.1	HLA-DRB1	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	63926	All	Clinically diagnosed LOAD	AD	intergenic_region
chr6	32607629	rs9271058	0.000057	HLA-DRB1	A	A	1.11	1.11	HLA-DRB1	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	18845	All	Clinically diagnosed LOAD	AD	intergenic_region
chr6	32607629	rs9271058	1.40E-11	HLA-DRB1	A	A	1.1	1.1	HLA-DRB1	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	82771	All	Clinically diagnosed LOAD	AD	intergenic_region
chr6	32609720	rs536810	0.00000718	HLA-DRB5	T	T	NR	NA	HLA-DQA1	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr6	32609720	rs536810	0.000203	HLA-DRB5	T	T	0.99	0.99	HLA-DQA1	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intergenic_region
chr6	32609720	rs536810	0.153	HLA-DRB5	T	T	0.93	0.93	HLA-DQA1	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intergenic_region
chr6	32609720	rs536810	1.14E-08	HLA-DRB5	T	T	0.92	0.92	HLA-DQA1	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intergenic_region
chr6	32609720	rs536810	3.48E-08	HLA-DRB5	T	T	0.92	0.92	HLA-DQA1	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intergenic_region
chr6	32609720	rs536810	4.33E-14	HLA-DRB5	T	T	NR	NA	HLA-DQA1	SNP-based	Cross phenotype 	30413934	Caucasian	"GIANT, UKBB"	180423	All	Waist-to-hip ratio (WHR)	Non-ADRD	intergenic_region
chr6	32610753	rs9271192	0.000000016	"HLA-DRB1, HLA-DRB5"	C	C	1.11	1.11	HLA-DQA1	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD"	54162	All	LOAD	AD	intergenic_region
chr6	32610753	rs9271192	0.000042	"HLA-DRB1, HLA-DRB5"	C	C	1.12	1.12	HLA-DQA1	SNP-based	Disease risk	24162737	Caucasian	Cohorts from Europe and USA	19884	All	LOAD	AD	intergenic_region
chr6	32610753	rs9271192	0.000266	HLA-DRB5	NR	NR	1.11	1.11	HLA-DQA1	SNP-based	Disease risk	30448613	Caucasian	ADGC	15330	All	AD	AD	intergenic_region
chr6	32610753	rs9271192	0.34	"HLA-DRB, HLA-DRB5"	C	C	1.08	1.08	HLA-DQA1	SNP-based	Endophenotype	25188341	Caucasian	ADGC	3702	All	Clinico-pathologic AD dementia (with neuropathologist documentation)	Neuropathology	intergenic_region
chr6	32610753	rs9271192	0.59	"HLA-DRB, HLA-DRB5"	C	C	1.04	1.04	HLA-DQA1	SNP-based	Endophenotype	25188341	Caucasian	ADGC	4914	All	Clinico-pathologic AD dementia (No neuropathologist documentation)	Neuropathology	intergenic_region
chr6	32610753	rs9271192	2.90E-12	"HLA-DRB1, HLA-DRB5"	C	C	1.11	1.11	HLA-DQA1	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD, Cohorts from Europe and USA"	74046	All	LOAD	AD	intergenic_region
chr6	32610753	rs9271192	NR	"HLA-DRB1, HLA-DRB5"	C	C	1.01	1.01	HLA-DQA1	SNP-based	Disease risk	27849641	Caucasian	ADGC	589	All	Symptomatic AD (CDR global score >=0.5)	AD	intergenic_region
chr6	32610753	rs9271192	NR	ZCWPW1	C	C	0.93	0.93	HLA-DQA1	SNP-based	Disease risk	27849641	Caucasian	ADGC	292	APOE-e4 carriers	Symptomatic AD (CDR global score >=0.5)	AD	intergenic_region
chr6	32610753	rs9271192	NR	ZCWPW1	C	C	1.03	1.03	HLA-DQA1	SNP-based	Disease risk	27849641	Caucasian	ADGC	297	APOE-e4 non-carriers	Symptomatic AD (CDR global score >=0.5)	AD	intergenic_region
chr6	32615580	rs6931277	0.000000178	HLA-DRB1	T	T	NR	NA	HLA-DQA1	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	intergenic_region
chr6	32615580	rs6931277	8.41E-11	HLA-DRB1	T	T	-6.49	NA	HLA-DQA1	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ, UKBB"	455258	All	AD + AD-by-proxy	AD	intergenic_region
chr6	32638163	rs1318392492	0.132	HLA-DRB5	G	G	0.86	NA		SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	NA
chr6	32639364	rs9272561	0.000000723	HLA-DQA1	G	G	NR	NA	HLA-DQA1	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Total cholesterol (TC)	Non-ADRD	3_prime_UTR_variant
chr6	32639364	rs9272561	5.37E-09	HLA-DQA1	G	G	NR	NA	HLA-DQA1	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	3_prime_UTR_variant
chr6	32702056	rs115675626	0.000631	HLA-DQB1	NR	NR	-0.11	NA	HLA-DQB1	SNP-based	Age at onset (AAO) / Survival	28323831	Caucasian	ADGC	15795	All	Age of AD onset	Other	downstream_gene_variant
chr6	32715085	rs3892710	0.00000232	HLA-DQA2	T	T	-0.2	0.818731	HLA-DQA2	SNP-based	Endophenotype	23836404	Caucasian	ADGC	651	All	Neuritic plaque (NP)	Neuropathology	upstream_gene_variant
chr6	33857581	rs2104362	0.00000503	"LEMD2, MLN, MIR1275"	NR	NR	NR	NA	MLN	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	2222	AD subjects	Age at onset	Other	intergenic_region
chr6	33857581	rs2104362	0.00000691	"LEMD2, MLN, MIR1275"	NR	NR	NR	NA	MLN	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	2222	AD subjects	Age at onset	Other	intergenic_region
chr6	33857581	rs2104362	0.000836	"LEMD2, MLN, MIR1275"	NR	NR	0.9	2.4596	MLN	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	844	AD subjects	Age at onset	Other	intergenic_region
chr6	33857581	rs2104362	0.00587	"LEMD2, MLN, MIR1275"	NR	NR	0.84	2.31637	MLN	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	1190	AD subjects	Age at onset	Other	intergenic_region
chr6	33857581	rs2104362	0.0679	"LEMD2, MLN, MIR1275"	NR	NR	4.4	81.4509	MLN	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADNI	188	AD subjects	Age at onset	Other	intergenic_region
chr6	34335092	rs206936	0.318	NR	G	G	0.956	0.956	NUDT3	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	intron_variant
chr6	34335092	rs206936	0.365	NR	G	G	0.976	0.976	NUDT3	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	intron_variant
chr6	34335092	rs206936	0.756	NR	G	G	0	1	NUDT3	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	intron_variant
chr6	34335092	rs206936	0.83	NR	G	G	0.99	0.99	NUDT3	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	intron_variant
chr6	40833992	rs12664598	0.00000652	NR	G	G	NR	NA	UNC5CL	SNP-based	Disease risk	21390209	Caucasian	"ADNI, GenADA, Pfizer"	3595	All	AD	AD	intergenic_region
chr6	40842273	rs9369240	0.00000487	NR	G	G	NR	NA	UNC5CL	SNP-based	Disease risk	21390209	Caucasian	"ADNI, GenADA, Pfizer"	3595	All	AD	AD	intergenic_region
chr6	40974457	rs187370608	1.45E-16	TREM2	A	A	8.26	NA	UNC5CL	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	intergenic_region
chr6	41066261	rs114812713	0.0072	OARD1	C	C	1.23	1.23	OARD1	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	30511	All	Clinically diagnosed LOAD	AD	3_prime_UTR_variant
chr6	41066261	rs114812713	2.10E-13	OARD1	C	C	1.32	1.32	OARD1	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	94437	All	Clinically diagnosed LOAD	AD	3_prime_UTR_variant
chr6	41066261	rs114812713	4.50E-12	OARD1	C	C	1.35	1.35	OARD1	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	63926	All	Clinically diagnosed LOAD	AD	3_prime_UTR_variant
chr6	41158917	rs2234256	0.56	TREM2	G	G	0	0		SNP-based	Disease risk	23150934	Caucasian	"Cohorts from Europe, USA"	784	All	AD	AD	NA
chr6	41159805	rs2234255	0.36	TREM2	A	A	NA	NA		SNP-based	Disease risk	23150934	Caucasian	"Cohorts from Europe, USA"	785	All	AD	AD	NA
chr6	41159867	rs149622783	1	TREM2	T	T	1.8	1.8		SNP-based	Disease risk	23150934	Caucasian	"Cohorts from Europe, USA"	782	All	AD	AD	NA
chr6	41161362	rs147564421	0.5	TREM2	A	A	NA	NA		SNP-based	Disease risk	23150934	Caucasian	"Cohorts from Europe, USA"	2198	All	AD	AD	NA
chr6	41161367	rs2234253	0.72	TREM2	T	T	1.4	1.4		SNP-based	Disease risk	23150934	Caucasian	"Cohorts from Europe, USA"	2196	All	AD	AD	NA
chr6	41161395	rs142232675	0.02	TREM2	T	T	NA	NA		SNP-based	Disease risk	23150934	Caucasian	"Cohorts from Europe, USA"	2196	All	AD	AD	NA
chr6	41161457	rs201258663	0.5	TREM2	A	A	NA	NA		SNP-based	Disease risk	23150934	Caucasian	"Cohorts from Europe, USA"	2198	All	AD	AD	NA
chr6	41161469	rs143332484	0.000000366	TREM2	T	T	3.97	3.97	TREM2	SNP-based	Disease risk	28714976	Caucasian	"CHARGE, EADI, GERAD"	3968	All	AD	AD	missense_variant
chr6	41161469	rs143332484	0.00245	TREM2	T	T	1.55	1.55	TREM2	SNP-based	Disease risk	28714976	Caucasian	ADGC	15288	All	AD	AD	missense_variant
chr6	41161469	rs143332484	0.5	TREM2	T	T	0.8	0.8	TREM2	SNP-based	Disease risk	23150934	Caucasian	"Cohorts from Europe, USA"	2194	All	AD	AD	missense_variant
chr6	41161469	rs143332484	1.55E-14	TREM2	T	T	1.67	1.67	TREM2	SNP-based	Disease risk	28714976	Caucasian	"ADGC, CHARGE, EADI, GERAD"	53042	All	AD	AD	missense_variant
chr6	41161469	rs143332484	3.48E-09	TREM2	T	T	1.58	1.58	TREM2	SNP-based	Disease risk	28714976	Caucasian	"ADGC, CHARGE, EADI, GERAD"	33786	All	AD	AD	missense_variant
chr6	41161514	rs75932628	0.00000123	TREM2	T	T	2.58	2.58	TREM2	SNP-based	Disease risk	28714976	Caucasian	ADGC	14884	All	AD	AD	missense_variant
chr6	41161514	rs75932628	0.00000739	TREM2	NR	NR	4.66	4.66	TREM2	SNP-based	Disease risk	23150908	Caucasian	Cohort from Europe	4786	All	AD	AD	missense_variant
chr6	41161514	rs75932628	0.00015	TREM2	T	T	2.5	2.5	TREM2	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	18845	All	Clinically diagnosed LOAD	AD	missense_variant
chr6	41161514	rs75932628	0.00053	TREM2	NR	NR	0.19	1.20925	TREM2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC"	815	All	CSF T-tau	Fluid biomarker	missense_variant
chr6	41161514	rs75932628	0.00069	TREM2	NR	NR	0.19	1.20925	TREM2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC"	815	All	CSF T-tau	Fluid biomarker	missense_variant
chr6	41161514	rs75932628	0.0013	TREM2	NR	NR	0.18	1.19722	TREM2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC"	815	All	CSF T-tau	Fluid biomarker	missense_variant
chr6	41161514	rs75932628	0.002	TREM2	NR	NR	0.16	1.17351	TREM2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC"	815	All	CSF P-tau181p	Fluid biomarker	missense_variant
chr6	41161514	rs75932628	0.002	TREM2	NR	NR	2.83	2.83	TREM2	SNP-based	Disease risk	23150908	Caucasian	"ADGC, Cohort from Europe"	11764	All	AD	AD	missense_variant
chr6	41161514	rs75932628	0.0026	TREM2	NR	NR	0.16	1.17351	TREM2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC"	815	All	CSF P-tau181p	Fluid biomarker	missense_variant
chr6	41161514	rs75932628	0.0047	TREM2	NR	NR	0.15	1.16183	TREM2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC"	815	All	CSF P-tau181p	Fluid biomarker	missense_variant
chr6	41161514	rs75932628	0.04	TREM2	NR	NR	3.15	3.15	TREM2	SNP-based	Disease risk	23150908	Caucasian	Cohort from Europe	2408	All	AD	AD	missense_variant
chr6	41161514	rs75932628	0.07	TREM2	NR	NR	2.45	2.45	TREM2	SNP-based	Disease risk	23150908	Caucasian	Cohort from Europe	5894	All	AD	AD	missense_variant
chr6	41161514	rs75932628	0.14	TREM2	NR	NR	3.52	3.52	TREM2	SNP-based	Disease risk	23150908	Caucasian	Cohort from Europe	2661	All	AD	AD	missense_variant
chr6	41161514	rs75932628	0.37	TREM2	NR	NR	3.03	3.03	TREM2	SNP-based	Disease risk	23150908	Caucasian	ADGC	801	All	AD	AD	missense_variant
chr6	41161514	rs75932628	1.13E-08	TREM2	NR	NR	2.62	2.62	TREM2	SNP-based	Disease risk	23150908	Caucasian	Cohort from Europe	113600	All	AD	AD	missense_variant
chr6	41161514	rs75932628	2.70E-15	TREM2	T	T	2.08	2.08	TREM2	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	82771	All	Clinically diagnosed LOAD	AD	missense_variant
chr6	41161514	rs75932628	2.90E-12	TREM2	T	T	2.01	2.01	TREM2	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	63926	All	Clinically diagnosed LOAD	AD	missense_variant
chr6	41161514	rs75932628	3.02E-12	TREM2	T	T	2.46	2.46	TREM2	SNP-based	Disease risk	28714976	Caucasian	"ADGC, CHARGE, EADI, GERAD"	30018	All	AD	AD	missense_variant
chr6	41161514	rs75932628	3.42E-10	TREM2	NR	NR	2.92	2.92	TREM2	SNP-based	Disease risk	23150908	Caucasian	Cohort from Europe	12438	All	AD	AD	missense_variant
chr6	41161514	rs75932628	4.38E-08	TREM2	T	T	2.37	2.37	TREM2	SNP-based	Disease risk	28714976	Caucasian	"CHARGE, EADI, GERAD"	35831	All	AD	AD	missense_variant
chr6	41161514	rs75932628	5.38E-24	TREM2	T	T	2.46	2.46	TREM2	SNP-based	Disease risk	28714976	Caucasian	"ADGC, CHARGE, EADI, GERAD"	80733	All	AD	AD	missense_variant
chr6	41161514	rs75932628	<1.00E-03	TREM2	T	T	4.5	4.5	TREM2	SNP-based	Disease risk	23150934	Caucasian	"Cohorts from Europe, USA"	2196	All	AD	AD	missense_variant
chr6	41161557	rs104894002	0.25	TREM2	A	A	NA	NA		SNP-based	Disease risk	23150934	Caucasian	"Cohorts from Europe, USA"	2187	All	AD	AD	NA
chr6	41170311	rs12202176	0.484	TREM2	A	A	1.19	NA	TREM2	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	intergenic_region
chr6	41186912	rs9381040	0.845	TREML2	T	T	0.991	0.991	TREML2	SNP-based	Disease risk	24495969	Caucasian	Cohort from Spain	4372	All	AD	AD	downstream_gene_variant
chr6	41197050	rs6916710	0.0064	NR	NR	NR	-0.03	0.970446	TREML2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC"	815	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr6	41197050	rs6916710	0.007	NR	NR	NR	-0.03	0.970446	TREML2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC"	815	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr6	41197050	rs6916710	0.0082	NR	NR	NR	-0.03	0.970446	TREML2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC"	815	All	CSF T-tau	Fluid biomarker	intron_variant
chr6	41197050	rs6916710	0.0093	NR	NR	NR	-0.03	0.970446	TREML2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC"	815	All	CSF T-tau	Fluid biomarker	intron_variant
chr6	41197050	rs6916710	0.011	NR	NR	NR	-0.03	0.970446	TREML2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC"	815	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr6	41197050	rs6916710	0.015	NR	NR	NR	-0.03	0.970446	TREML2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC"	815	All	CSF T-tau	Fluid biomarker	intron_variant
chr6	41368363	rs6922617	0.000000349	NR	NR	NR	NR	NA	NCR2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intergenic_region
chr6	41368363	rs6922617	0.00000166	NR	NR	NR	NR	NA	NCR2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intergenic_region
chr6	41368363	rs6922617	0.00000234	NR	NR	NR	NR	NA	NCR2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intergenic_region
chr6	41368363	rs6922617	0.0000049	NR	NR	NR	-0.1	0.904837	NCR2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC"	815	All	CSF P-tau181p	Fluid biomarker	intergenic_region
chr6	41368363	rs6922617	0.0000061	NR	NR	NR	-0.1	0.904837	NCR2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC"	815	All	CSF P-tau181p	Fluid biomarker	intergenic_region
chr6	41368363	rs6922617	0.0000065	NR	NR	NR	-0.1	0.904837	NCR2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC"	815	All	CSF P-tau181p	Fluid biomarker	intergenic_region
chr6	41368363	rs6922617	0.0000255	NCR2	NR	NR	NR	NA	NCR2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intergenic_region
chr6	41368363	rs6922617	0.000032	NR	NR	NR	-0.1	0.904837	NCR2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC"	815	All	CSF T-tau	Fluid biomarker	intergenic_region
chr6	41368363	rs6922617	0.000041	NR	NR	NR	-0.1	0.904837	NCR2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC"	815	All	CSF T-tau	Fluid biomarker	intergenic_region
chr6	41368363	rs6922617	0.000046	NR	NR	NR	-0.1	0.904837	NCR2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC"	815	All	CSF T-tau	Fluid biomarker	intergenic_region
chr6	41368363	rs6922617	0.0000461	NR	NR	NR	NR	NA	NCR2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intergenic_region
chr6	41368363	rs6922617	0.000122	NR	NR	NR	NR	NA	NCR2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intergenic_region
chr6	41368363	rs6922617	0.000403	NR	NR	NR	NR	NA	NCR2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intergenic_region
chr6	41368363	rs6922617	0.00369	NCR2	NR	NR	NR	NA	NCR2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF Ab1-42	Fluid biomarker	intergenic_region
chr6	41368363	rs6922617	0.33	NR	A	A	0.007	1.00702	NCR2	SNP-based	Cognitive	23562540	NR	ROSMAP	1593	All	global cognitive decline	Cognitive	intergenic_region
chr6	41368363	rs6922617	0.547	NR	A	A	-0.029	0.971416	NCR2	SNP-based	Neuropathology	23562540	NR	ROSMAP	651	All	tangle counts	Neuropathology	intergenic_region
chr6	41368363	rs6922617	0.677	NR	A	A	-0.0174	0.982751	NCR2	SNP-based	Disease risk	23562540	Caucasian	ADGC	22771	All	AD	AD	intergenic_region
chr6	41368363	rs6922617	3.58E-08	NCR2	NR	NR	NR	NA	NCR2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intergenic_region
chr6	41372834	rs11966476	0.0000159	NCR2	NR	NR	NR	NA	NCR2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intergenic_region
chr6	41372834	rs11966476	0.00399	NCR2	NR	NR	NR	NA	NCR2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF Ab1-42	Fluid biomarker	intergenic_region
chr6	41372834	rs11966476	4.97E-08	NCR2	NR	NR	NR	NA	NCR2	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intergenic_region
chr6	42972935	rs2395943	1.61E-70	PEX6	NR	NR	-0.39	0.677057	PEX6	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	PEX6 expression in Cerebellar	Expression	intron_variant
chr6	42972935	rs2395943	3.13E-29	PEX6	NR	NR	-0.39	0.677057	PEX6	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	PEX6 expression in Cerebellar	Expression	intron_variant
chr6	42972935	rs2395943	4.40E-66	PEX6	NR	NR	-0.46	0.631284	PEX6	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	PEX6 expression in Temporal cortex	Expression	intron_variant
chr6	42972935	rs2395943	8.43E-36	PEX6	NR	NR	-0.4	0.67032	PEX6	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	PEX6 expression in Cerebellar	Expression	intron_variant
chr6	43560704	rs1096699	2.70E-50	MAD2L1BP	NR	NR	1.31	3.70617	POLR1C	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	MAD2L1BP expression in Cerebellar	Expression	intron_variant
chr6	43560704	rs1096699	2.90E-54	MAD2L1BP	NR	NR	1.22	3.38719	POLR1C	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	MAD2L1BP expression in Cerebellar	Expression	intron_variant
chr6	43560704	rs1096699	6.25E-111	MAD2L1BP	NR	NR	1.26	3.52542	POLR1C	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	MAD2L1BP expression in Cerebellar	Expression	intron_variant
chr6	46217747	rs4530856	0.0000127	RCAN2	NR	NR	NR	NA	RCAN2	SNP-based	Disease risk	20061627	Caucasian	ADGC	699	All	LOAD	AD	downstream_gene_variant
chr6	47430010	rs2184397	0.00000551	"CD2AP, TNFRSF21"	NR	NR	NR	NA	CD2AP	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr6	47463548	rs9473117	0.00000023	CD2AP	C	C	1.09	1.09	CD2AP	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	63926	All	Clinically diagnosed LOAD	AD	upstream_gene_variant
chr6	47463548	rs9473117	0.0001	CD2AP	C	C	1.11	1.11	CD2AP	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	18845	All	Clinically diagnosed LOAD	AD	upstream_gene_variant
chr6	47463548	rs9473117	1.20E-10	CD2AP	C	C	1.09	1.09	CD2AP	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	82771	All	Clinically diagnosed LOAD	AD	upstream_gene_variant
chr6	47464901	rs9381563	0.0000081	CD2AP	C	C	NR	NA	CD2AP	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	upstream_gene_variant
chr6	47464901	rs9381563	2.52E-10	CD2AP	C	C	6.33	NA	CD2AP	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ, UKBB"	455258	All	AD + AD-by-proxy	AD	upstream_gene_variant
chr6	47464901	rs9381563	5.35E-09	CD2AP	C	C	NR	NA	CD2AP	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ"	79145	All	AD	AD	upstream_gene_variant
chr6	47484534	rs9296559	0.0015	CD2AP	NR	NR	1.1	1.1	CD2AP	SNP-based	Disease risk	21460840	Caucasian	"EADI, GERAD"	13448	All	AD	AD	intron_variant
chr6	47485642	rs9349407	0.00000103	CD2AP	C	C	1.12	1.12	CD2AP	SNP-based	Disease risk	21460841	Caucasian	ADGC	22771	All	LOAD	AD	intron_variant
chr6	47485642	rs9349407	0.00000117	CD2AP	C	C	1.14	1.14	CD2AP	SNP-based	Disease risk	21460841	Caucasian	ADGC	15675	All	LOAD	AD	intron_variant
chr6	47485642	rs9349407	0.00000205	CD2AP	C	C	1.12	1.12	CD2AP	SNP-based	Disease risk	21460841	Caucasian	ADGC	22771	All	LOAD	AD	intron_variant
chr6	47485642	rs9349407	0.00000529	CD2AP	C	C	1.14	1.14	CD2AP	SNP-based	Disease risk	21460841	Caucasian	ADGC	15675	All	LOAD	AD	intron_variant
chr6	47485642	rs9349407	0.0008	CD2AP	NR	NR	1.11	1.11	CD2AP	SNP-based	Disease risk	21460840	Caucasian	"EADI, GERAD"	13448	All	AD	AD	intron_variant
chr6	47485642	rs9349407	0.002	CD2AP	NR	NR	1.09	1.09	CD2AP	SNP-based	Disease risk	21460841	Caucasian	"CHARGE, EADI, GERAD"	25818	All	LOAD	AD	intron_variant
chr6	47485642	rs9349407	0.029	NR	C	C	0.07	1.07251	CD2AP	SNP-based	Endophenotype	23836404	Caucasian	ADGC	725	All	Neuritic Plaque Pathologic Burden	Neuropathology	intron_variant
chr6	47485642	rs9349407	0.0738	CD2AP	C	C	1.08	1.08	CD2AP	SNP-based	Disease risk	21460841	Caucasian	ADGC	7096	All	LOAD	AD	intron_variant
chr6	47485642	rs9349407	0.118	CD2AP	C	C	1.07	1.07	CD2AP	SNP-based	Disease risk	21460841	Caucasian	ADGC	7096	All	LOAD	AD	intron_variant
chr6	47485642	rs9349407	0.273	CD2AP 	C	C	-0.14	0.869358	CD2AP	SNP-based	Age at onset (AAO) / Survival	25199842	Caucasian	ADGC	9162	LOAD subjects	Age of AD onset	Other	intron_variant
chr6	47485642	rs9349407	0.383	CD2AP	G	G	0.94	0.94	CD2AP	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	2024	All	LOAD	AD	intron_variant
chr6	47485642	rs9349407	0.765	CD2AP 	C	C	-0.03	0.970446	CD2AP	SNP-based	Age at onset (AAO) / Survival	25199842	Caucasian	ADGC	9162	LOAD subjects	Age of AD onset	Other	intron_variant
chr6	47485642	rs9349407	0.854	CD2AP	C	C	0.98	0.98	CD2AP	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr6	47485642	rs9349407	8.60E-09	CD2AP	NR	NR	1.11	1.11	CD2AP	SNP-based	Disease risk	21460840	Caucasian	"ADGC, GERAD"	NR	All	AD	AD	intron_variant
chr6	47485642	rs9349407	8.60E-09	CD2AP	NR	NR	1.11	1.11	CD2AP	SNP-based	Disease risk	21460841	Caucasian	"ADGC, CHARGE, EADI, GERAD"	48589	All	LOAD	AD	intron_variant
chr6	47520026	rs10948363	0.000000031	CD2AP	G	G	1.1	1.1	CD2AP	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD"	54162	All	LOAD	AD	intron_variant
chr6	47520026	rs10948363	0.0000164	CD2AP	NR	NR	0.343	1.40917	CD2AP	SNP-based	eQTL	30448613	Caucasian	UKBEC	49	All	AK9 (t2969159) expression in frontal cortex	Expression	intron_variant
chr6	47520026	rs10948363	0.00041	CD2AP	G	G	1.09	1.09	CD2AP	SNP-based	Disease risk	24162737	Caucasian	Cohorts from Europe and USA	19884	All	LOAD	AD	intron_variant
chr6	47520026	rs10948363	0.16	CD2AP 	G	G	1.1	1.1	CD2AP	SNP-based	Endophenotype	25188341	Caucasian	ADGC	4914	All	Clinico-pathologic AD dementia (No neuropathologist documentation)	Neuropathology	intron_variant
chr6	47520026	rs10948363	0.38	CD2AP 	G	G	1.08	1.08	CD2AP	SNP-based	Endophenotype	25188341	Caucasian	ADGC	3702	All	Clinico-pathologic AD dementia (with neuropathologist documentation)	Neuropathology	intron_variant
chr6	47520026	rs10948363	0.67	CD2AP	NR	NR	0.97	0.97	CD2AP	SNP-based	Endophenotype	26993346	Caucasian	Cohort from Europe	10840	All	PCA (posterior cortical atrophy)	Imaging	intron_variant
chr6	47520026	rs10948363	5.20E-11	CD2AP	G	G	1.1	1.1	CD2AP	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD, Cohorts from Europe and USA"	74046	All	LOAD	AD	intron_variant
chr6	47520026	rs10948363	NR	CD2AP	G	G	0.73	0.73	CD2AP	SNP-based	Disease risk	27849641	Caucasian	ADGC	589	All	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr6	47520026	rs10948363	NR	ZCWPW1	G	G	0.35	0.35	CD2AP	SNP-based	Disease risk	27849641	Caucasian	ADGC	292	APOE-e4 carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr6	47520026	rs10948363	NR	ZCWPW1	G	G	0.99	0.99	CD2AP	SNP-based	Disease risk	27849641	Caucasian	ADGC	297	APOE-e4 non-carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr6	47581893	rs3818866	0.23	CD2AP	C	C	1.09	NA	CD2AP	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	intron_variant
chr6	47710446	rs1109581	0.00251	GPR115	NR	NR	-0.07	NA	ADGRF4	SNP-based	Age at onset (AAO) / Survival	28323831	Caucasian	ADGC	15795	All	Age of AD onset	Other	intron_variant
chr6	50835337	rs987237	0.268	NR	G	G	0.95	0.95	TFAP2B	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	intron_variant
chr6	50835337	rs987237	0.542	NR	G	G	1.03	1.03	TFAP2B	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	intron_variant
chr6	50835337	rs987237	0.553	NR	G	G	0	1	TFAP2B	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	intron_variant
chr6	50835337	rs987237	0.679	NR	G	G	0.988	0.988	TFAP2B	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	intron_variant
chr6	52792754	rs4715326	1.18E-08	GSTA1	NR	NR	-0.14	0.869358	GSTA1	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	ADNI	521	All	Plasma GST-alpha	Fluid biomarker	intron_variant
chr6	53390978	rs12194027	0.000139	ELOVL5	C	C	NR	NA	ELOVL5	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr6	53390978	rs12194027	0.000153	ELOVL5	C	C	NR	NA	ELOVL5	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Total triglycerides (TG)	Non-ADRD	intergenic_region
chr6	53390978	rs12194027	0.147	ELOVL5	C	C	1	1	ELOVL5	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intergenic_region
chr6	56433924	rs12195424	0.00000287	DST	NR	NR	0.35	1.41907	DST	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	673	All	CSF Clusterin	Fluid biomarker	upstream_gene_variant
chr6	56433924	rs12195424	0.000407	DST	NR	NR	0.338	1.40214	DST	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	403	Subjects with APOE-e4-	CSF Clusterin	Fluid biomarker	upstream_gene_variant
chr6	56433924	rs12195424	0.00611	DST	NR	NR	0.336	1.39934	DST	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	270	Subjects with APOE-e4+	CSF Clusterin	Fluid biomarker	upstream_gene_variant
chr6	56439165	rs77121579	0.00000369	DST	NR	NR	0.384	1.46815	DST	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	673	All	CSF Clusterin	Fluid biomarker	intergenic_region
chr6	56439165	rs77121579	0.000269	DST	NR	NR	0.383	1.46668	DST	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	403	Subjects with APOE-e4-	CSF Clusterin	Fluid biomarker	intergenic_region
chr6	56439165	rs77121579	0.0168	DST	NR	NR	0.333	1.39515	DST	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	270	Subjects with APOE-e4+	CSF Clusterin	Fluid biomarker	intergenic_region
chr6	57434294	rs2191651	1.36E-53	PRIM2	NR	NR	-0.57	0.565525	PRIM2	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	PRIM2 expression in Temporal cortex	Expression	intron_variant
chr6	60650744	rs7774782	0.000183	PRIM2	C	C	NR	NA	PRIM2	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Total cholesterol (TC)	Non-ADRD	intergenic_region
chr6	60650744	rs7774782	0.000293	PRIM2	C	C	NR	NA	PRIM2	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr6	60650744	rs7774782	0.506	PRIM2	C	C	1	1	PRIM2	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intergenic_region
chr6	62352030	rs12527308	0.31	NR	T	T	0.09	1.09417	KHDRBS2	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	515	AD subjects	CSF Ab1-42	Fluid biomarker	intergenic_region
chr6	67011595	rs12203791	0.000000976	NR	T	T	NR	NA	EYS	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF Ab1-42	Fluid biomarker	intergenic_region
chr6	68905723	rs10485435	0.000000614	NR	T	T	NR	NA	ADGRB3	SNP-based	Disease risk	21390209	Caucasian	"ADNI, GenADA, Pfizer"	3595	All	AD	AD	intron_variant
chr6	69884522	rs2502562	0.00000157	NR	A	A	NR	NA	COL19A1	SNP-based	Disease risk	21390209	Caucasian	"ADNI, GenADA, Pfizer"	3595	All	AD	AD	intron_variant
chr6	71429869	rs1727638	0.000000971	NR	A	A	NR	NA	OGFRL1	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF Ab1-42	Fluid biomarker	intergenic_region
chr6	71647057	rs9446432	0.0000028	NR	NR	NR	1.28	1.28	RIMS1	SNP-based	Disease risk	19734902	Caucasian	Cohorts from Europe and USA	11789	All	AD	AD	intergenic_region
chr6	80806319	rs13213247	0.000024	NR	NR	NR	NR	NA	BCKDHB	SNP-based	Disease risk	19118814	Caucasian	"CAP, Reiman et al.(2007)"	NR	All	LOAD	AD	intergenic_region
chr6	80806319	rs13213247	0.0000473	NR	NR	NR	NR	NA	BCKDHB	SNP-based	Disease risk	19118814	Caucasian	CAP	458	All	LOAD	AD	intergenic_region
chr6	80806319	rs13213247	0.0159	NR	NR	NR	NR	NA	BCKDHB	SNP-based	Disease risk	19118814	Caucasian	Reiman et al.(2007)	NR	All	LOAD	AD	intergenic_region
chr6	95766423	rs4642480	0.00000365	NR	G	G	0.14	1.15027	MANEA	SNP-based	Endophenotype	23836404	Caucasian	ADGC	651	All	Neuritic plaque (NP)	Neuropathology	intergenic_region
chr6	104845257	rs79147057	0.0207	HACE1	NR	NR	NR	NA	HACE1	SNP-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr6	104845257	rs79147057	0.77323	NA	NR	NR	NR	NA	HACE1	Gene-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr6	105037928	rs10457125	0.0128	LIN28B	NR	NR	NR	NA	LIN28B	SNP-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr6	105037928	rs10457125	0.37962	NA	NR	NR	NR	NA	LIN28B	Gene-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr6	106125497	rs4946727	0.0000221	NR	NR	NR	0.27	0.27	ATG5	SNP-based	Disease risk	21098978	Arab	Cohort from Israeli	266	All	AD	AD	intergenic_region
chr6	106129111	rs7761791	0.0000209	NR	NR	NR	2.38	2.38	ATG5	SNP-based	Disease risk	21098978	Arab	Cohort from Israeli	266	All	AD	AD	intergenic_region
chr6	106129632	rs6903903	0.0000276	NR	NR	NR	0.41	0.41	ATG5	SNP-based	Disease risk	21098978	Arab	Cohort from Israeli	266	All	AD	AD	intergenic_region
chr6	108624167	rs2022464	0.0047	NR	A	A	-0.09	0.913931	FOXO3	SNP-based	Endophenotype	27694991	Caucasian	"CHARGE, ENIGMA"	2363	European	Intracranial Volume	Imaging	intron_variant
chr6	108624167	rs2022464	0.013	NR	A	A	-0.09	0.913931	FOXO3	SNP-based	Endophenotype	27694991	Hispanic	"CHARGE, ENIGMA"	1605	Hispanic	Intracranial Volume	Imaging	intron_variant
chr6	108624167	rs2022464	0.035	NR	A	A	-0.11	0.895834	FOXO3	SNP-based	Endophenotype	27694991	Asian	"CHARGE, ENIGMA"	955	Asian	Intracranial Volume	Imaging	intron_variant
chr6	108624167	rs2022464	0.233	NR	A	A	-0.06	0.941765	FOXO3	SNP-based	Endophenotype	27694991	African American	"CHARGE, ENIGMA"	938	African	Intracranial Volume	Imaging	intron_variant
chr6	108624167	rs2022464	3.70E-11	NR	A	A	-0.06	0.941765	FOXO3	SNP-based	Endophenotype	27694991	Caucasian	"CHARGE, ENIGMA"	26577	European	Intracranial Volume	Imaging	intron_variant
chr6	109706740	rs2025148	0.0000382	FIG4	NR	NR	2.47	2.47	FIG4	SNP-based	Disease risk	21098978	Arab	Cohort from Israeli	266	All	AD	AD	intron_variant
chr6	113138211	rs2502399	0.00000535	LOC102724704	NR	NR	NR	NA	MARCKS	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	818	All	Plasma Clusterin	Fluid biomarker	intergenic_region
chr6	126470949	rs11759026	0.123	NR	A	A	-0.07	0.932394	CENPW	SNP-based	Endophenotype	27694991	Asian	"CHARGE, ENIGMA"	955	Asian	Intracranial Volume	Imaging	intergenic_region
chr6	126470949	rs11759026	0.194	NR	A	A	-0.13	0.878095	CENPW	SNP-based	Endophenotype	27694991	African American	"CHARGE, ENIGMA"	938	African	Intracranial Volume	Imaging	intergenic_region
chr6	126470949	rs11759026	0.209	NR	A	A	-0.05	0.951229	CENPW	SNP-based	Endophenotype	27694991	Hispanic	"CHARGE, ENIGMA"	1605	Hispanic	Intracranial Volume	Imaging	intergenic_region
chr6	126470949	rs11759026	0.528	NR	A	A	-0.02	0.980199	CENPW	SNP-based	Endophenotype	27694991	Caucasian	"CHARGE, ENIGMA"	2363	European	Intracranial Volume	Imaging	intergenic_region
chr6	126470949	rs11759026	2.20E-20	NR	A	A	-0.1	0.904837	CENPW	SNP-based	Endophenotype	27694991	Caucasian	"CHARGE, ENIGMA"	26577	European	Intracranial Volume	Imaging	intergenic_region
chr6	130961070	rs6941712	0.000000683	EPB41L2	C	C	-235.78	3.99988e-103	EPB41L2	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	intron_variant
chr6	130961070	rs6941712	0.00000461	EPB41L2	NR	NR	-149.67	9.98033e-66	EPB41L2	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	intron_variant
chr6	130961070	rs6941712	0.11	EPB41L2	C	C	-72.28	4.06626e-32	EPB41L2	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr6	130961070	rs6941712	0.17	EPB41L2	C	C	NR	NA	EPB41L2	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr6	130977259	rs12530288	0.000000682	EPB41L2	T	T	-235.8	3.92068e-103	EPB41L2	SNP-based	Endophenotype	22903471	Caucasian	Cohort from Australia	639	All	Lentiform nucleus volume	Imaging	intron_variant
chr6	130977259	rs12530288	0.00000976	EPB41L2	NR	NR	-144.17	2.44211e-63	EPB41L2	SNP-based	Endophenotype	22903471	Caucasian	"ADNI, Cohort from Australia"	1345	All	Lentiform nucleus volume	Imaging	intron_variant
chr6	130977259	rs12530288	0.16	EPB41L2	T	T	-62.45	7.55631e-28	EPB41L2	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr6	130977259	rs12530288	0.23	EPB41L2	T	T	NR	NA	EPB41L2	SNP-based	Endophenotype	22903471	Caucasian	ADNI	706	All	Lentiform nucleus volume	Imaging	intron_variant
chr6	135756791	rs79846291	1.76E-08	"LINC00271, PDE7B"	T	T	1.85	6.35982	PDE7B	SNP-based	Endophenotype	29274321	Caucasian	ADNI	141	AD	Hippocampal volume (HPV)	Imaging	intergenic_region
chr6	137816414	rs679670	0.00000983	NR	G	G	0.74	0.74	TNFAIP3	SNP-based	Disease risk	20885792	Caucasian	"CAP, MSBB, NCRAD"	2035	All	LOAD	AD	intergenic_region
chr6	137816414	rs679670	0.016	NR	G	G	0.87	0.87	TNFAIP3	SNP-based	Disease risk	20885792	Caucasian	"ADGC, CAP, CHARGE"	4355	All	LOAD	AD	intergenic_region
chr6	137816414	rs679670	0.25	NR	G	G	1.11	1.11	TNFAIP3	SNP-based	Disease risk	20885792	Caucasian	"ADGC, CAP, CHARGE"	2979	All	LOAD	AD	intergenic_region
chr6	138486144	rs4896367	0.0000014	NR	C	C	0.49	1.63232	NHSL1	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	363	AD subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr6	138486144	rs4896367	0.011	NR	C	C	0.16	1.17351	NHSL1	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	878	AD subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr6	138486144	rs4896367	0.62	NR	C	C	-0.04	0.960789	NHSL1	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	515	AD subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr6	142062945	rs6907175	0.00047	LOC651924	NR	NR	1.16	1.16	NMBR	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	3870	All	LOAD	AD	intron_variant
chr6	142062945	rs6907175	0.017	LOC651924	NR	NR	NR	NA	NMBR	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	776	All	LOAD	AD	intron_variant
chr6	142062945	rs6907175	0.027	LOC651924	A	A	1.18	1.18	NMBR	SNP-based	Disease risk	20534741	Caucasian	"ADC, UM"	1610	All	AD	AD	intron_variant
chr6	142062945	rs6907175	0.042	LOC651924	NR	NR	NR	NA	NMBR	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	570	All	LOAD	AD	intron_variant
chr6	142062945	rs6907175	0.304	LOC651924	NR	NR	NR	NA	NMBR	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	720	All	LOAD	AD	intron_variant
chr6	142062945	rs6907175	0.957	LOC651924	NR	NR	NR	NA	NMBR	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	658	All	LOAD	AD	intron_variant
chr6	148102235	rs9390537	0.00000817	SASH1	NR	NR	NR	NA	SASH1	SNP-based	Disease risk	20061627	Caucasian	ADGC	699	All	LOAD	AD	intergenic_region
chr6	150713594	rs9371194	0.0000019	PLEKHG1	T	T	1.19	1.19	PLEKHG1	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	17544	All	Small sub-cortical brain infarcts (SSBI)	Imaging	intron_variant
chr6	150713594	rs9371194	0.0000363	PLEKHG1	T	T	NR	NA	PLEKHG1	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	17544	All	Small sub-cortical brain infarcts (SSBI)	Imaging	intron_variant
chr6	150713594	rs9371194	0.0000594	PLEKHG1	T	T	1.12	1.12	PLEKHG1	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	20949	All	Brain infarcts (BI)	Imaging	intron_variant
chr6	150713594	rs9371194	0.000428	PLEKHG1	T	T	NR	NA	PLEKHG1	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	20949	All	Brain infarcts (BI)	Imaging	intron_variant
chr6	150713594	rs9371194	0.02	PLEKHG1	NR	NR	0.93	0.93	PLEKHG1	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	6862	All	Small sub-cortical brain infarcts (SSBI)	Imaging	intron_variant
chr6	150713594	rs9371194	0.03	PLEKHG1	NR	NR	0.94	0.94	PLEKHG1	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	6862	All	Brain infarcts (BI)	Imaging	intron_variant
chr6	150713594	rs9371194	0.08	PLEKHG1	NR	NR	1.02	1.02	PLEKHG1	SNP-based	Endophenotype	30651383	Caucasian	"CHARGE, METASTROKE, SiGN"	137560	All	Ischemic stroke (IS)	Imaging	intron_variant
chr6	150713594	rs9371194	0.17	PLEKHG1	NR	NR	1.03	1.03	PLEKHG1	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	24406	All	Small sub-cortical brain infarcts (SSBI)	Imaging	intron_variant
chr6	150713594	rs9371194	0.2	PLEKHG1	NR	NR	1.03	1.03	PLEKHG1	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	27811	All	Brain infarcts (BI)	Imaging	intron_variant
chr6	150713594	rs9371194	0.72	PLEKHG1	NR	NR	0.98	0.98	PLEKHG1	SNP-based	Endophenotype	30651383	Caucasian	ADGC	2940	All	Pathologically defined infarcts	Imaging	intron_variant
chr6	150713594	rs9371194	0.75	PLEKHG1	NR	NR	1.01	1.01	PLEKHG1	SNP-based	Endophenotype	30651383	Caucasian	"METASTROKE, SiGN, YLSDR"	41039	All	Ischemic stroke due to small vessel disease (IS-SVD)	Imaging	intron_variant
chr6	150885942	rs11754661	0.000000047	MTHFD1L	A	A	2.03	2.03	MTHFD1L	SNP-based	Disease risk	20885792	Caucasian	"CAP, MSBB, NCRAD"	2035	All	LOAD	AD	intron_variant
chr6	150885942	rs11754661	0.0000201	MTHFD1L	NR	NR	NR	NA	MTHFD1L	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	intron_variant
chr6	150885942	rs11754661	0.00187	MTHFD1L	A	A	2.34	2.34	MTHFD1L	SNP-based	Disease risk	20885792	Caucasian	"ADGC, CAP, CHARGE"	2979	All	LOAD	AD	intron_variant
chr6	150885942	rs11754661	1.90E-10	MTHFD1L	A	A	2.1	2.1	MTHFD1L	SNP-based	Disease risk	20885792	Caucasian	"ADGC, CAP, CHARGE"	4355	All	LOAD	AD	intron_variant
chr6	151818907	rs3844508	0.04	DAPK1	C	C	0.81	0.81	ESR1	SNP-based	Age at onset (AAO) / Survival	17998437	Caucasian	Cohorts from Canada	1321	All	Age of AD onset	Other	intron_variant
chr6	151818907	rs3844508	0.04	ESR1	C	C	0.72	0.72	ESR1	SNP-based	Disease risk	17998437	Caucasian	Cohorts from Canada	1321	All	AD	AD	intron_variant
chr6	154432335	rs9397718	0.0000034	NR	C	C	0.4	1.49182	AL357075.4	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	363	AD subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr6	154432335	rs9397718	0.0014	NR	C	C	0.18	1.19722	AL357075.4	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	878	AD subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr6	154440150	rs6911312	0.9	NR	C	C	-0.01	0.99005	AL357075.4	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	515	AD subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr6	155254808	rs9397794	0.0000026	NR	A	A	0.45	1.56831	TIAM2	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	363	AD subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr6	155254808	rs9397794	0.003	NR	A	A	0.18	1.19722	TIAM2	SNP-based	Endophenotype	25027320	Caucasian	"ADNI, Cohorts from Europe"	878	AD subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr6	155254808	rs9397794	0.88	NR	A	A	-0.01	0.99005	TIAM2	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	515	AD subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr6	156178397	rs9384428	0.0000085	NR	NR	NR	1.14	1.14	ARID1B	SNP-based	Disease risk	19734902	Caucasian	Cohorts from Europe and USA	11789	All	AD	AD	intergenic_region
chr6	160295034	rs3103351	0.00000404	SLC22A2	G	G	NR	NA	SLC22A2	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Low-density lipoprotein (LDL)	Non-ADRD	intergenic_region
chr6	160295034	rs3103351	0.00178	SLC22A2	G	G	NR	NA	SLC22A2	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr6	160295034	rs3103351	0.0452	SLC22A2	G	G	1	1	SLC22A2	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intergenic_region
chr6	160608696	rs13202636	0.000000227	LPA	NR	NR	-0.22	0.802519	LPA	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	ADNI	521	All	Plasma Lpa	Fluid biomarker	intron_variant
chr6	164151004	rs4145454	0.00000103	NR	G	G	1.53	NA	QKI	SNP-based	Disease risk	21379329	Caucasian	ADGC	1642	APOE-e4e3	LOAD	AD	intergenic_region
chr6	168076176	rs75889566	0.00000182	FRMD1	T	T	0.65	0.65	FRMD1	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	10122	All	Small sub-cortical brain infarcts (SSBI)	Imaging	intron_variant
chr6	168076176	rs75889566	0.000044	FRMD1	T	T	NR	NA	FRMD1	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	10122	All	Small sub-cortical brain infarcts (SSBI)	Imaging	intron_variant
chr6	168076176	rs75889566	0.000771	FRMD1	T	T	0.82	0.82	FRMD1	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	15912	All	Brain infarcts (BI)	Imaging	intron_variant
chr6	168076176	rs75889566	0.00203	FRMD1	T	T	NR	NA	FRMD1	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	15912	All	Brain infarcts (BI)	Imaging	intron_variant
chr6	168076176	rs75889566	0.03	FRMD1	NR	NR	0.9	0.9	FRMD1	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	16984	All	Small sub-cortical brain infarcts (SSBI)	Imaging	intron_variant
chr6	168076176	rs75889566	0.19	FRMD1	NR	NR	0.95	0.95	FRMD1	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	22774	All	Brain infarcts (BI)	Imaging	intron_variant
chr6	168076176	rs75889566	0.23	FRMD1	NR	NR	1.06	1.06	FRMD1	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	6862	All	Brain infarcts (BI)	Imaging	intron_variant
chr6	168076176	rs75889566	0.52	FRMD1	NR	NR	0.97	0.97	FRMD1	SNP-based	Endophenotype	30651383	Caucasian	"METASTROKE, SiGN, YLSDR"	41039	All	Ischemic stroke due to small vessel disease (IS-SVD)	Imaging	intron_variant
chr6	168076176	rs75889566	0.61	FRMD1	NR	NR	1.03	1.03	FRMD1	SNP-based	Endophenotype	30651383	Multi-ethnic	CHARGE	6862	All	Small sub-cortical brain infarcts (SSBI)	Imaging	intron_variant
chr6	168076176	rs75889566	0.67	FRMD1	NR	NR	0.99	0.99	FRMD1	SNP-based	Endophenotype	30651383	Caucasian	"CHARGE, METASTROKE, SiGN"	137560	All	Ischemic stroke (IS)	Imaging	intron_variant
chr6	168076176	rs75889566	0.77	FRMD1	NR	NR	1.04	1.04	FRMD1	SNP-based	Endophenotype	30651383	Caucasian	ADGC	2940	All	Pathologically defined infarcts	Imaging	intron_variant
chr6	168182326	rs9455973	0.0000447	NR	NR	NR	NR	NA	FRMD1	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	intergenic_region
chr7	1512784	rs6942930	0.0000161	NR	NR	NR	NR	NA	INTS1	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	upstream_gene_variant
chr7	5852503	rs117856560	0.015	ZNF815	C	C	NR	NA	OCM	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	7289	Plan 2 (only males)	AD	AD	intron_variant
chr7	5852503	rs117856560	8.23E-49	NR	C	C	NR	NA	OCM	SNP-based	eQTL	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	7289	Plan 2 (only males)	ZNF815 (ILMN_1700307) expression in peripheral blood	Expression	intron_variant
chr7	6387310	rs702483	0.000311	RAC1	T	T	NR	NA	RAC1	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	High-density lipoprotein (HDL)	Non-ADRD	intron_variant
chr7	6387310	rs702483	0.000618	RAC1	T	T	NR	NA	RAC1	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr7	6387310	rs702483	0.0175	RAC1	T	T	0.97	0.97	RAC1	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intron_variant
chr7	6387310	rs702483	0.0317	RAC1	T	T	0.97	0.97	RAC1	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intron_variant
chr7	6387310	rs702483	0.105	RAC1	T	T	1	1	RAC1	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr7	6387310	rs702483	0.56	RAC1	T	T	1.03	1.03	RAC1	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intron_variant
chr7	10277135	rs10271466	0.00000598	NR	NR	NR	NR	NA	NDUFA4	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intergenic_region
chr7	10277135	rs10271466	0.000105	NR	NR	NR	NR	NA	NDUFA4	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intergenic_region
chr7	10277135	rs10271466	0.000129	NR	NR	NR	1.82	1.82	NDUFA4	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intergenic_region
chr7	10277135	rs10271466	0.00232	NR	NR	NR	1.52	1.52	NDUFA4	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intergenic_region
chr7	10277135	rs10271466	0.926	NR	NR	NR	NR	NA	NDUFA4	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intergenic_region
chr7	10277135	rs10271466	1	NR	NR	NR	1.02	1.02	NDUFA4	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intergenic_region
chr7	10277135	rs10271466	NA	NR	NR	NR	NR	NA	NDUFA4	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intergenic_region
chr7	10277135	rs10271466	NA	NR	NR	NR	NR	NA	NDUFA4	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intergenic_region
chr7	12219129	rs3823612	0.00036	TMEM106B	NR	NR	1.4	1.4	TMEM106B	SNP-based	Disease risk	28131462	Caucasian	ADGC	3251	Individual who died at age 60 or older (ADD Model)	Hippocampal sclerosis of aging	ADRD	intron_variant
chr7	12219129	rs3823612	0.0011	TMEM106B	G	G	1.53	1.53	TMEM106B	SNP-based	Disease risk	28131462	Caucasian	ADGC	3251	Individual who died at age 60 or older (REC Model)	Hippocampal sclerosis of aging	ADRD	intron_variant
chr7	12228211	rs13229988	0.0062	TMEM106B	A	A	1.67	1.67	TMEM106B	SNP-based	Disease risk	28131462	Caucasian	ADGC	3251	Individual who died at age 60 or older (DOM Model)	Hippocampal sclerosis of aging	ADRD	intron_variant
chr7	12244161	rs1990622	0.049	TMEM106B	C	C	1.22	1.22	TMEM106B	SNP-based	Disease risk	24770881	Caucasian	ADGC	2239	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	downstream_gene_variant
chr7	12244161	rs1990622	0.132	TMEM106B	C	C	1.19	1.19	TMEM106B	SNP-based	Disease risk	24770881	Caucasian	ADGC	1636	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	downstream_gene_variant
chr7	12244161	rs1990622	0.198	TMEM106B	C	C	1.43	1.43	TMEM106B	SNP-based	Disease risk	24770881	Caucasian	ADGC	427	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	downstream_gene_variant
chr7	12244161	rs1990622	0.528	TMEM106B	C	C	1.24	1.24	TMEM106B	SNP-based	Disease risk	24770881	Caucasian	ADGC	176	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	downstream_gene_variant
chr7	12244161	rs1990622	NR	ABCC9	A	A	1.16	1.16	TMEM106B	SNP-based	Disease risk	25470345	Caucasian	ADGC	2343	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	downstream_gene_variant
chr7	12244161	rs1990622	NR	ABCC9	A	A	1.18	1.18	TMEM106B	SNP-based	Disease risk	25470345	Caucasian	ADGC	2343	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	downstream_gene_variant
chr7	12244161	rs1990622	NR	ABCC9	A	A	1.24	1.24	TMEM106B	SNP-based	Disease risk	25470345	Caucasian	ADGC	2343	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	downstream_gene_variant
chr7	12244161	rs1990622	NR	ABCC9	A	A	1.86	1.86	TMEM106B	SNP-based	Disease risk	25470345	Caucasian	ADGC	612	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	downstream_gene_variant
chr7	12244161	rs1990622	NR	ABCC9	A	A	2.14	2.14	TMEM106B	SNP-based	Disease risk	25470345	Caucasian	ADGC	612	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	downstream_gene_variant
chr7	12244161	rs1990622	NR	ABCC9	A	A	2.7	2.7	TMEM106B	SNP-based	Disease risk	25470345	Caucasian	ADGC	612	All	Hippocampal sclerosis of aging (HS-Aging)	ADRD	downstream_gene_variant
chr7	14848793	rs1117750	0.00000802	DGKB	NR	NR	NR	NA	DGKB	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr7	14848793	rs1117750	0.000192	NR	NR	NR	7.87	7.87	DGKB	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr7	14848793	rs1117750	0.00131	DGKB	NR	NR	NR	NA	DGKB	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intron_variant
chr7	14848793	rs1117750	0.00286	DGKB	NR	NR	NR	NA	DGKB	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intron_variant
chr7	14848793	rs1117750	0.0279	NR	NR	NR	2.29	2.29	DGKB	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intron_variant
chr7	14848793	rs1117750	0.04563	DGKB	NR	NR	NR	NA	DGKB	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intron_variant
chr7	14848793	rs1117750	0.0575	NR	NR	NR	1.67	1.67	DGKB	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intron_variant
chr7	14848793	rs1117750	0.26433	DGKB	NR	NR	NR	NA	DGKB	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intron_variant
chr7	14848793	rs1117750	0.953	DGKB	NR	NR	NR	NA	DGKB	SNP-based	Disease risk	21059989	Caucasian	ADGC	1390	Unrelated individuals	LOAD	AD	intron_variant
chr7	16722846	rs34331204	0.001	NR	NR	NR	0.27	1.30996	BZW2	SNP-based	Endophenotype	31497858	Caucasian	ADGC	NR	Males	Executive function	Cognitive	upstream_gene_variant
chr7	16722846	rs34331204	0.014	NR	NR	NR	252.17	32812513659558208417555928632904064147678450779683213019144254492454938840143200706111188441476454794743775232	BZW2	SNP-based	Endophenotype	31497858	Caucasian	ADGC	NR	Males	Hippocampal volume	Imaging	upstream_gene_variant
chr7	16722846	rs34331204	0.052	NR	NR	NR	-0.09	0.913931	BZW2	SNP-based	Age at onset (AAO) / Survival	31497858	Caucasian	ADGC	NR	Males	Age of onset in ADGC	Other	upstream_gene_variant
chr7	16722846	rs34331204	0.14	NR	NR	NR	0.1	1.10517	BZW2	SNP-based	Endophenotype	31497858	Caucasian	ADGC	NR	Males	Episodic memory	Cognitive	upstream_gene_variant
chr7	16722846	rs34331204	0.27	NR	NR	NR	0.04	1.04081	BZW2	SNP-based	Age at onset (AAO) / Survival	31497858	Caucasian	ADGC	NR	Females	Age of onset in ADGC	Other	upstream_gene_variant
chr7	16722846	rs34331204	0.35	NR	NR	NR	0.08	1.08329	BZW2	SNP-based	Age at onset (AAO) / Survival	31497858	Caucasian	ADGC	NR	Females	Age of onset in CERAD	Other	upstream_gene_variant
chr7	16722846	rs34331204	0.47	NR	NR	NR	-0.01	0.99005	BZW2	SNP-based	Endophenotype	31497858	Caucasian	ADGC	NR	Females	CSF P-tau181p	Fluid biomarker	upstream_gene_variant
chr7	16722846	rs34331204	0.47	NR	NR	NR	0.08	1.08329	BZW2	SNP-based	Age at onset (AAO) / Survival	31497858	Caucasian	ADGC	NR	Males	Age of onset in CERAD	Other	upstream_gene_variant
chr7	16722846	rs34331204	0.58	NR	NR	NR	-0.01	0.99005	BZW2	SNP-based	Endophenotype	31497858	Caucasian	ADGC	NR	Females	CSF T-tau	Fluid biomarker	upstream_gene_variant
chr7	16722846	rs34331204	0.69	NR	NR	NR	0.01	1.01005	BZW2	SNP-based	Endophenotype	31497858	Caucasian	ADGC	NR	Males	CSF T-tau	Fluid biomarker	upstream_gene_variant
chr7	16722846	rs34331204	0.73	NR	NR	NR	0.04	1.04081	BZW2	SNP-based	Endophenotype	31497858	Caucasian	ADGC	NR	Females	Episodic memory	Cognitive	upstream_gene_variant
chr7	16722846	rs34331204	0.8	NR	NR	NR	-33.18	3.89143e-15	BZW2	SNP-based	Endophenotype	31497858	Caucasian	ADGC	NR	Females	Hippocampal volume	Imaging	upstream_gene_variant
chr7	16722846	rs34331204	0.88	NR	NR	NR	-0.02	0.980199	BZW2	SNP-based	Endophenotype	31497858	Caucasian	ADGC	NR	Females	Executive function	Cognitive	upstream_gene_variant
chr7	16722846	rs34331204	0.89	NR	NR	NR	0	1	BZW2	SNP-based	Endophenotype	31497858	Caucasian	ADGC	NR	Males	CSF P-tau181p	Fluid biomarker	upstream_gene_variant
chr7	18658708	rs79524815	0.000000011	HDAC9	NR	NR	NR	NA	HDAC9	SNP-based	Pleiotropy 	29458411	Caucasian	ADGC	3598	All	Neurofibrillary tangles (NFT)+Cerebral amyloid angiopathy (CAA)	Neuropathology	intron_variant
chr7	18658708	rs79524815	0.0000033	HDAC9	NR	NR	NR	NA	HDAC9	SNP-based	Pleiotropy 	29458411	Caucasian	ADGC	3598	All	Neuritic plaque (NP)+Cerebral amyloid angiopathy (CAA)	Neuropathology	intron_variant
chr7	18658708	rs79524815	0.0000091	HDAC9	NR	NR	1.16	3.18993	HDAC9	SNP-based	Pleiotropy 	29458411	Caucasian	ADGC	3598	All	Cerebral amyloid angiopathy (CAA)	Neuropathology	intron_variant
chr7	18658708	rs79524815	0.000023	HDAC9	NR	NR	0.79	2.2034	HDAC9	SNP-based	Pleiotropy 	29458411	Caucasian	ADGC	3598	All	Neurofibrillary tangles (NFT)	Neuropathology	intron_variant
chr7	18658708	rs79524815	0.00013	HDAC9	NR	NR	NR	NA	HDAC9	SNP-based	Pleiotropy 	29458411	Caucasian	ADGC	3598	All	Neuritic plaque (NP)+Neurofibrillary tangles (NFT)	Neuropathology	intron_variant
chr7	18658708	rs79524815	0.03	HDAC9	NR	NR	0.43	1.53726	HDAC9	SNP-based	Pleiotropy 	29458411	Caucasian	ADGC	3598	All	Neuritic plaque (NP)	Neuropathology	intron_variant
chr7	18658708	rs79524815	0.03	HDAC9	NR	NR	0.69	1.99372	HDAC9	SNP-based	Pleiotropy 	29458411	Caucasian	ADGC	3598	All	AD	AD	intron_variant
chr7	19161192	rs11766540	0.0000193	NR	NR	NR	2.27	2.27	FERD3L	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	235	All women	LOAD	AD	intergenic_region
chr7	19161192	rs11766540	0.000246	NR	NR	NR	2.14	2.14	FERD3L	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	235	All women	LOAD	AD	intergenic_region
chr7	19161192	rs11766540	0.013	NR	NR	NR	2.09	2.09	FERD3L	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	235	All women	LOAD	AD	intergenic_region
chr7	19161192	rs11766540	0.185	NR	NR	NR	1.38	1.38	FERD3L	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	282	All women	LOAD	AD	intergenic_region
chr7	22665007	rs57375391	0.00000158	LOC401312	NR	NR	0.497	1.64378	STEAP1B	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	673	All	CSF Clusterin	Fluid biomarker	intron_variant
chr7	22665007	rs57375391	0.000129	LOC401312	NR	NR	0.514	1.67197	STEAP1B	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	403	Subjects with APOE-e4-	CSF Clusterin	Fluid biomarker	intron_variant
chr7	22665007	rs57375391	0.00105	LOC401312	NR	NR	0.539	1.71429	STEAP1B	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	270	Subjects with APOE-e4+	CSF Clusterin	Fluid biomarker	intron_variant
chr7	22727026	rs1800795	0.000000074	IL6	NR	NR	0.38	1.46228	STEAP1B	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	403	Subjects with APOE-e4-	CSF Clusterin	Fluid biomarker	intron_variant
chr7	22727026	rs1800795	0.00000994	IL6	NR	NR	0.24	1.27125	STEAP1B	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	673	All	CSF Clusterin	Fluid biomarker	intron_variant
chr7	22727026	rs1800795	0.785	IL6	NR	NR	0.02	1.0202	STEAP1B	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	270	Subjects with APOE-e4+	CSF Clusterin	Fluid biomarker	intron_variant
chr7	23530965	rs1046135	0.00189	TRA2A	T	T	NR	NA	TRA2A	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	7289	Plan 2 (only males)	AD	AD	intron_variant
chr7	23530965	rs1046135	4.32E-115	NR	T	T	NR	NA	TRA2A	SNP-based	eQTL	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	7289	Plan 2 (only males)	TRA2A (ILMN_1731043) expression in peripheral blood	Expression	intron_variant
chr7	25679184	rs1859849	0.00058	NR	NR	NR	1.15	1.15	NPVF	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	3870	All	LOAD	AD	intron_variant
chr7	25679184	rs1859849	0.0047	NR	NR	NR	NR	NA	NPVF	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	776	All	LOAD	AD	intron_variant
chr7	25679184	rs1859849	0.031	NR	NR	NR	NR	NA	NPVF	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	658	All	LOAD	AD	intron_variant
chr7	25679184	rs1859849	0.168	NR	NR	NR	NR	NA	NPVF	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	720	All	LOAD	AD	intron_variant
chr7	25679184	rs1859849	0.575	NR	NR	NR	NR	NA	NPVF	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	1146	All	LOAD	AD	intron_variant
chr7	25679184	rs1859849	0.776	NR	NR	NR	NR	NA	NPVF	SNP-based	Disease risk	17317784	Caucasian	Cohorts from UK	570	All	LOAD	AD	intron_variant
chr7	28102567	rs10245867	0.00000022	JAZF1	NR	NR	NR	NA	JAZF1	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr7	28105182	rs1109484	0.000013	JAZF1	NR	NR	NR	NA	JAZF1	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr7	28156794	rs849135	3.40E-10	JAZF1	NR	NR	NR	NA	JAZF1	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr7	28184434	rs849336	4.80E-09	LOC100128081	NR	NR	NR	NA	JAZF1	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr7	28216621	rs498475	8.80E-09	LOC100128081	NR	NR	NR	NA	JAZF1	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr7	29030593	rs7313	1.06E-36	CPVL	NR	NR	-0.88	0.414783	CPVL	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	CPVL expression in Cerebellar	Expression	missense_variant
chr7	29030593	rs7313	1.55E-67	CPVL	NR	NR	-1.34	0.261846	CPVL	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	CPVL expression in Temporal cortex	Expression	missense_variant
chr7	29030593	rs7313	2.22E-86	CPVL	NR	NR	-0.96	0.382893	CPVL	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	CPVL expression in Cerebellar	Expression	missense_variant
chr7	29030593	rs7313	9.48E-44	CPVL	NR	NR	-1.01	0.364219	CPVL	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	CPVL expression in Cerebellar	Expression	missense_variant
chr7	29201829	rs121724	0.000000145	CHN2	G	G	NR	NA	AC004593.2	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	MCI	CSF P-tau181p	Fluid biomarker	intron_variant
chr7	31952112	rs73310519	0.00000886	PDE1C	NR	NR	NR	NA	PDE1C	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intron_variant
chr7	37580319	rs17265593	0.00025	BC043356	NR	NR	-0.23	NA	GPR141	SNP-based	Age at onset (AAO) / Survival	28323831	Caucasian	ADGC	15795	All	Age of AD onset	Other	intergenic_region
chr7	37650904	rs2597283	0.000000167	BC043356	C	C	0.93	0.93	GPR141	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intergenic_region
chr7	37650904	rs2597283	0.00000165	BC043356	C	C	0.94	0.94	GPR141	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intergenic_region
chr7	37650904	rs2597283	0.00002	BC043356	NR	NR	0.28	NA	GPR141	SNP-based	Age at onset (AAO) / Survival	28323831	Caucasian	ADGC	15795	All	Age of AD onset	Other	intergenic_region
chr7	37650904	rs2597283	0.000042	BC043356	C	C	NR	NA	GPR141	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr7	37650904	rs2597283	0.000346	BC043356	C	C	NR	NA	GPR141	SNP-based	Cross phenotype 	30413934	Caucasian	GIANT	681275	All	Body-mass index (BMI)	Non-ADRD	intergenic_region
chr7	37650904	rs2597283	0.0648	BC043356	C	C	1	1	GPR141	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intergenic_region
chr7	37650904	rs2597283	0.353	BC043356	C	C	1.05	1.05	GPR141	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intergenic_region
chr7	37801932	rs2718058	0.000013	NME8	G	G	0.93	0.93	GPR141	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD"	54162	All	LOAD	AD	intron_variant
chr7	37801932	rs2718058	0.000063	NME8	G	G	0.91	0.91	GPR141	SNP-based	Disease risk	24162737	Caucasian	Cohorts from Europe and USA	19884	All	LOAD	AD	intron_variant
chr7	37801932	rs2718058	0.0023	GPR141	NR	NR	NR	NA	GPR141	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GPR141 (2997812) expression in substantia nigra (SNIG)	Expression	intron_variant
chr7	37801932	rs2718058	0.0075	GPR141	NR	NR	NR	NA	GPR141	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GPR141 (2997812) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr7	37801932	rs2718058	0.0085	GPR141	NR	NR	NR	NA	GPR141	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GPR141 (2997791) expression in putamen (PUTM)	Expression	intron_variant
chr7	37801932	rs2718058	0.02	GPR141	NR	NR	NR	NA	GPR141	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GPR141 (2997791) expression in frontal cortex (FCTX)	Expression	intron_variant
chr7	37801932	rs2718058	0.05	GPR141	NR	NR	NR	NA	GPR141	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GPR141 (2997812) expression in hippocampus (HIPP)	Expression	intron_variant
chr7	37801932	rs2718058	0.11	GPR141	NR	NR	NR	NA	GPR141	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GPR141 (2997791) expression in temporal cortex (TCTX)	Expression	intron_variant
chr7	37801932	rs2718058	0.12	NME8	G	G	1.081	1.081	GPR141	SNP-based	Disease risk	24495969	Caucasian	Cohort from Spain	4372	All	AD	AD	intron_variant
chr7	37801932	rs2718058	0.17	NME8	NR	NR	1.12	1.12	GPR141	SNP-based	Endophenotype	26993346	Caucasian	Cohort from Europe	10840	All	PCA (posterior cortical atrophy)	Imaging	intron_variant
chr7	37801932	rs2718058	0.23	GPR141	NR	NR	NR	NA	GPR141	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GPR141 (2997791) expression in substantia nigra (SNIG)	Expression	intron_variant
chr7	37801932	rs2718058	0.29	GPR141	NR	NR	NR	NA	GPR141	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GPR141 (2997812) expression in putamen (PUTM)	Expression	intron_variant
chr7	37801932	rs2718058	0.3	GPR141	NR	NR	NR	NA	GPR141	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GPR141 (2997812) expression in thalamus (THAL)	Expression	intron_variant
chr7	37801932	rs2718058	0.33	GPR141	NR	NR	NR	NA	GPR141	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GPR141 (2997791) expression in medulla (MEDU)	Expression	intron_variant
chr7	37801932	rs2718058	0.35	GPR141	NR	NR	NR	NA	GPR141	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GPR141 (2997791) expression in hippocampus (HIPP)	Expression	intron_variant
chr7	37801932	rs2718058	0.39	GPR141	NR	NR	NR	NA	GPR141	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GPR141 (2997791) expression in occipital cortex (OCTX)	Expression	intron_variant
chr7	37801932	rs2718058	0.43	GPR141	NR	NR	NR	NA	GPR141	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GPR141 (2997812) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr7	37801932	rs2718058	0.47	NME8	G	G	0.95	0.95	GPR141	SNP-based	Endophenotype	25188341	Caucasian	ADGC	3702	All	Clinico-pathologic AD dementia (with neuropathologist documentation)	Neuropathology	intron_variant
chr7	37801932	rs2718058	0.51	GPR141	NR	NR	NR	NA	GPR141	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GPR141 (2997812) expression in temporal cortex (TCTX)	Expression	intron_variant
chr7	37801932	rs2718058	0.55	NME8	G	G	0.96	0.96	GPR141	SNP-based	Endophenotype	25188341	Caucasian	ADGC	4914	All	Clinico-pathologic AD dementia (No neuropathologist documentation)	Neuropathology	intron_variant
chr7	37801932	rs2718058	0.64	GPR141	NR	NR	NR	NA	GPR141	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GPR141 (2997791) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr7	37801932	rs2718058	0.65	GPR141	NR	NR	NR	NA	GPR141	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GPR141 (2997812) expression in occipital cortex (OCTX)	Expression	intron_variant
chr7	37801932	rs2718058	0.67	GPR141	NR	NR	NR	NA	GPR141	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GPR141 (2997791) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr7	37801932	rs2718058	0.8	GPR141	NR	NR	NR	NA	GPR141	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GPR141 (2997812) expression in frontal cortex (FCTX)	Expression	intron_variant
chr7	37801932	rs2718058	0.95	GPR141	NR	NR	NR	NA	GPR141	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GPR141 (2997791) expression in thalamus (THAL)	Expression	intron_variant
chr7	37801932	rs2718058	0.98	GPR141	NR	NR	NR	NA	GPR141	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GPR141 (2997812) expression in medulla (MEDU)	Expression	intron_variant
chr7	37801932	rs2718058	4.80E-09	NME8	G	G	0.93	0.93	GPR141	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD, Cohorts from Europe and USA"	74046	All	LOAD	AD	intron_variant
chr7	37801932	rs2718058	NR	NME8	A	A	0.77	0.77	GPR141	SNP-based	Disease risk	27849641	Caucasian	ADGC	589	All	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr7	37801932	rs2718058	NR	ZCWPW1	A	A	0.743	0.743	GPR141	SNP-based	Disease risk	27849641	Caucasian	ADGC	297	APOE-e4 non-carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr7	37801932	rs2718058	NR	ZCWPW1	A	A	0.89	0.89	GPR141	SNP-based	Disease risk	27849641	Caucasian	ADGC	292	APOE-e4 carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr7	37804661	rs4723711	0.00000028	NME8	T	T	0.94	0.94	GPR141	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	82771	All	Clinically diagnosed LOAD	AD	intron_variant
chr7	37804661	rs4723711	0.0001	NME8	T	T	0.91	0.91	GPR141	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	18845	All	Clinically diagnosed LOAD	AD	intron_variant
chr7	37804661	rs4723711	0.00027	NME8	T	T	0.95	0.95	GPR141	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	63926	All	Clinically diagnosed LOAD	AD	intron_variant
chr7	37861400	rs17171184	0.0257	NME8	G	G	0.84	NA	EPDR1	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	intron_variant
chr7	48193794	rs144495862	0.00000922	ABCA13	NR	NR	0.422	1.52501	ABCA13	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	673	All	CSF Clusterin	Fluid biomarker	intron_variant
chr7	48193794	rs144495862	0.00117	ABCA13	NR	NR	0.545	1.72461	ABCA13	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	270	Subjects with APOE-e4+	CSF Clusterin	Fluid biomarker	intron_variant
chr7	48193794	rs144495862	0.0028	ABCA13	NR	NR	0.363	1.43764	ABCA13	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	403	Subjects with APOE-e4-	CSF Clusterin	Fluid biomarker	intron_variant
chr7	51075908	rs1437490	0.0043	COBL	NR	NR	NR	NA	COBL	SNP-based	Endophenotype	22245343	Caucasian	ADNI	757	All	MRI	Imaging	intron_variant
chr7	51510325	rs112404845	0.000000128	COBL	T	T	0.46	1.58407	COBL	SNP-based	Disease risk	27770636	African American	ADGC	5609	All	LOAD liability score	AD	intergenic_region
chr7	51510325	rs112404845	0.00000087	COBL	T	T	3.59	3.59	COBL	SNP-based	Disease risk	27770636	African American	ADGC	5609	All	LOAD	AD	intergenic_region
chr7	51510325	rs112404845	0.00000122	COBL	T	T	3.28	3.28	COBL	SNP-based	Disease risk	27770636	African American	ADGC	5609	All	LOAD	AD	intergenic_region
chr7	51510325	rs112404845	3.82E-08	COBL	T	T	0.47	1.59999	COBL	SNP-based	Disease risk	27770636	African American	ADGC	5609	All	LOAD liability score	AD	intergenic_region
chr7	55124563	rs13244925	0.000000912	EGFR	NR	NR	0.25	1.28403	EGFR	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	ADNI	521	All	Plasma EGFR	Fluid biomarker	intron_variant
chr7	71417177	rs7798395	0.0000022	WBSCR17	C	C	NR	NA	GALNT17	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr7	71417177	rs7798395	0.0009	WBSCR17	C	C	NR	NA	GALNT17	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intron_variant
chr7	71417177	rs7798395	0.0011	WBSCR17	C	C	NR	NA	GALNT17	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr7	88777238	rs73705514	2.86E-09	ZNF804B	C	C	-0.84	0.431711	ZNF804B	SNP-based	Endophenotype	29274321	Caucasian	ADNI	581	MCI	Logic memory delayed (LMdT) recall test	Cognitive	intron_variant
chr7	90631335	rs17867001	0.0101	CDK14	G	G	NR	NA	CDK14	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	intron_variant
chr7	90631335	rs17867001	4.63E-17	NR	G	G	NR	NA	CDK14	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	CDK14 (ENSG00000223969) expression	Expression	intron_variant
chr7	91274325	rs9942607	0.00000939	FZD1	NR	NR	NR	NA	FZD1	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intergenic_region
chr7	91274344	rs9942608	0.00000939	FZD1	NR	NR	NR	NA	FZD1	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intergenic_region
chr7	91275623	rs10252817	0.00000939	FZD1	NR	NR	NR	NA	FZD1	SNP-based	Endophenotype	22821396	Caucasian	"ADNI, Knight-ADRC"	570	All	CSF APOE  	Fluid biomarker	intergenic_region
chr7	91957075	rs756647	0.0248	AKAP9	NR	NR	NR	NA	AKAP9	SNP-based	Endophenotype	22245343	Caucasian	ADNI	757	All	MRI	Imaging	intron_variant
chr7	92079771	rs144662445	0.0022	AKAP9	NR	NR	2.75	2.75	AKAP9	SNP-based	Disease risk	25172201	African American	ADGC	2906	All	AD	AD	missense_variant
chr7	92079771	rs144662445	0.014	AKAP9	NR	NR	NR	NA	AKAP9	SNP-based	Disease risk	25172201	African American	ADGC	816	All	AD	AD	missense_variant
chr7	92102796	rs149979685	0.0022	AKAP9	NR	NR	3.61	3.61	AKAP9	SNP-based	Disease risk	25172201	African American	ADGC	2906	All	AD	AD	missense_variant
chr7	92102796	rs149979685	0.037	AKAP9	NR	NR	NR	NA	AKAP9	SNP-based	Disease risk	25172201	African American	ADGC	816	All	AD	AD	missense_variant
chr7	92117413	rs2301559	0.0419	CYP51A1	NR	NR	NR	NA	CYP51A1	SNP-based	Endophenotype	22245343	Caucasian	ADNI	757	All	MRI	Imaging	intron_variant
chr7	95320351	rs2299261	0.03	PON1	G	G	1.33	1.33	PON1	SNP-based	Age at onset (AAO) / Survival	17998437	Caucasian	Cohorts from Canada	1388	All	Age of AD onset	Other	intron_variant
chr7	95320351	rs2299261	0.36	PON1	G	G	1.33	1.33	PON1	SNP-based	Disease risk	17998437	Caucasian	Cohorts from Canada	1388	All	AD	AD	intron_variant
chr7	99875063	rs35649099	0.203	OR2AE1	NR	NR	0.01422	1.01432	OR2AE1	SNP-based	Endophenotype	27933404	Caucasian	"ADNI, BIOCARD, Knight-ADRC, Lund University, MAYO, UPENN, UW "	2886	AD subjects	CSF Ab1-42	Fluid biomarker	downstream_gene_variant
chr7	100131167	rs35991721	0.000000262	MBLAC1	T	T	0.93	0.93	MBLAC1	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intron_variant
chr7	100131167	rs35991721	0.00000322	MBLAC1	T	T	NR	NA	MBLAC1	SNP-based	Cross phenotype 	30413934	Caucasian	CARDIoGRAMplusC4D	155197	All	Coronary artery disease (CAD)	Non-ADRD	intron_variant
chr7	100131167	rs35991721	0.0000577	MBLAC1	T	T	NR	NA	MBLAC1	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr7	100131167	rs35991721	0.000234	MBLAC1	T	T	0.99	0.99	MBLAC1	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr7	100131167	rs35991721	0.000717	MBLAC1	T	T	0.83	0.83	MBLAC1	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intron_variant
chr7	100131167	rs35991721	5.32E-09	MBLAC1	T	T	0.92	0.92	MBLAC1	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intron_variant
chr7	100176704	rs12705074	0.0384	GPC2	NR	NR	0.01702	1.01717	GPC2	SNP-based	Endophenotype	27933404	Caucasian	"ADNI, BIOCARD, Knight-ADRC, Lund University, MAYO, UPENN, UW "	2886	AD subjects	CSF Ab1-42	Fluid biomarker	intron_variant
chr7	100223178	rs150436753	0.122	MGC2463	NR	NR	0.02	1.0202	CASTOR3	SNP-based	Endophenotype	27933404	Caucasian	"ADNI, BIOCARD, Knight-ADRC, Lund University, MAYO, UPENN, UW "	2886	AD subjects	CSF Ab1-42	Fluid biomarker	intron_variant
chr7	100334426	rs7384878	2.38E-10	ZCWPW1	A	A	NR	NA	SPDYE3	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	intron_variant
chr7	100363571	rs6955367	2.13E-91	PILRB	NR	NR	1.08	2.94468	PILRB	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	PILRB expression in Cerebellar	Expression	intron_variant
chr7	100363571	rs6955367	3.89E-43	PILRB	NR	NR	0.99	2.69123	PILRB	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	PILRB expression in Cerebellar	Expression	intron_variant
chr7	100363571	rs6955367	4.56E-138	PILRB	NR	NR	1.56	4.75882	PILRB	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	PILRB expression in Temporal cortex	Expression	intron_variant
chr7	100363571	rs6955367	6.99E-47	PILRB	NR	NR	1.21	3.35348	PILRB	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	PILRB expression in Cerebellar	Expression	intron_variant
chr7	100373690	rs2405442	0.00212	ZCWPW1	NR	NR	0.92	0.92	PILRA	SNP-based	Disease risk	30448613	Caucasian	ADGC	15330	All	AD	AD	synonymous_variant
chr7	100374211	rs1859788	0.00562	ZCWPW1	NR	NR	0.93	0.93	PILRA	SNP-based	Disease risk	30448613	Caucasian	ADGC	15330	All	AD	AD	missense_variant
chr7	100374211	rs1859788	2.22E-15	ZCWPW1	A	A	-7.93	NA	PILRA	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ, UKBB"	455258	All	AD + AD-by-proxy	AD	missense_variant
chr7	100374211	rs1859788	6.05E-09	ZCWPW1	A	A	NR	NA	PILRA	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ"	79145	All	AD	AD	missense_variant
chr7	100380783	rs28714213	0.0171	PILRA	NR	NR	0.017	1.01715	PILRA	SNP-based	Endophenotype	27933404	Caucasian	"ADNI, BIOCARD, Knight-ADRC, Lund University, MAYO, UPENN, UW "	2886	AD subjects	CSF Ab1-42	Fluid biomarker	intron_variant
chr7	100406823	rs1476679	0.00000023	ZCWPW1	NR	NR	0.15	1.16183	ZCWPW1	SNP-based	eQTL	30448613	Caucasian	ADNI	763	All	ZKSCAN1 (11760665_at) expression in blood	Expression	intron_variant
chr7	100406823	rs1476679	0.0000074	ZCWPW1	C	C	0.92	0.92	ZCWPW1	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD"	54162	All	LOAD	AD	intron_variant
chr7	100406823	rs1476679	0.0000097	ZCWPW1	C	C	0.89	0.89	ZCWPW1	SNP-based	Disease risk	24162737	Caucasian	Cohorts from Europe and USA	19884	All	LOAD	AD	intron_variant
chr7	100406823	rs1476679	0.0000126	ZCWPW1	NR	NR	0.11	NA	ZCWPW1	SNP-based	Age at onset (AAO) / Survival	28323831	Caucasian	ADGC	15795	All	Age of AD onset	Other	intron_variant
chr7	100406823	rs1476679	0.0000607	ZCWPW1	NR	NR	0.09	1.09417	ZCWPW1	SNP-based	eQTL	30448613	Caucasian	ADNI	763	All	PVRIG (11730247_a_at) expression in blood	Expression	intron_variant
chr7	100406823	rs1476679	0.00035	GATS	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GATS (3063856) expression in medulla (MEDU)	Expression	intron_variant
chr7	100406823	rs1476679	0.00042	PILRB	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB (3015452) expression in putamen (PUTM)	Expression	intron_variant
chr7	100406823	rs1476679	0.00058	"PILRA, PILRB"	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB/PILRA (3015527) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr7	100406823	rs1476679	0.00059	PILRB	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB (3015452) expression in hippocampus (HIPP)	Expression	intron_variant
chr7	100406823	rs1476679	0.00064	"PILRA, PILRB"	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB/PILRA (3015527) expression in thalamus (THAL)	Expression	intron_variant
chr7	100406823	rs1476679	0.000655	ZCWPW1	C	C	0.846	0.846	ZCWPW1	SNP-based	Disease risk	24495969	Caucasian	Cohort from Spain	4372	All	AD	AD	intron_variant
chr7	100406823	rs1476679	0.00083	"PILRA, PILRB"	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB/PILRA (3015536) expression in frontal cortex (FCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.00095	PILRB	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB (3015452) expression in occipital cortex (OCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.0011	"PILRA, PILRB"	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB/PILRA (3015527) expression in putamen (PUTM)	Expression	intron_variant
chr7	100406823	rs1476679	0.0011	ZCWPW1	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	ZCWPW1 (3063971) expression in frontal cortex (FCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.0012	PILRB	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB (3015452) expression in temporal cortex (TCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.0013	ZCWPW1	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	ZCWPW1 (t3063968) expression in substantia nigra (SNIG)	Expression	intron_variant
chr7	100406823	rs1476679	0.00141	ZCWPW1	NR	NR	0.92	0.92	ZCWPW1	SNP-based	Disease risk	30448613	Caucasian	ADGC	15330	All	AD	AD	intron_variant
chr7	100406823	rs1476679	0.0016	PILRB	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB (3015452) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr7	100406823	rs1476679	0.0022	ZCWPW1	NR	NR	0.109	1.11516	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	"UM, NACC"	364	All	PILRB expression in Brain	Expression	intron_variant
chr7	100406823	rs1476679	0.0023	"PILRA, PILRB"	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB/PILRA (3015527) expression in frontal cortex (FCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.0031	"PILRA, PILRB"	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB/PILRA (3015527) expression in hippocampus (HIPP)	Expression	intron_variant
chr7	100406823	rs1476679	0.0031	PILRB	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB (3015442) expression in hippocampus (HIPP)	Expression	intron_variant
chr7	100406823	rs1476679	0.0056	PILRB	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB (3015452) expression in thalamus (THAL)	Expression	intron_variant
chr7	100406823	rs1476679	0.0099	"PILRA, PILRB"	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB/PILRA (3015527) expression in substantia nigra (SNIG)	Expression	intron_variant
chr7	100406823	rs1476679	0.0099	GATS	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GATS (3063856) expression in thalamus (THAL)	Expression	intron_variant
chr7	100406823	rs1476679	0.01	GATS	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GATS (3063857) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr7	100406823	rs1476679	0.01	PILRB	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB (3015452) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr7	100406823	rs1476679	0.018	ZCWPW1	C	C	0.86	0.86	ZCWPW1	SNP-based	Endophenotype	25188341	Caucasian	ADGC	4914	All	Clinico-pathologic AD dementia (No neuropathologist documentation)	Neuropathology	intron_variant
chr7	100406823	rs1476679	0.02	"PILRA, PILRB"	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB/PILRA (3015527) expression in occipital cortex (OCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.02	"PILRA, PILRB"	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB/PILRA (3015527) expression in temporal cortex (TCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.02	GATS	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GATS (3063857) expression in frontal cortex (FCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.023	PILRB	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB (3015442) expression in substantia nigra (SNIG)	Expression	intron_variant
chr7	100406823	rs1476679	0.03	GATS	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GATS (3063856) expression in temporal cortex (TCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.03	PILRB	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB (3015442) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr7	100406823	rs1476679	0.04	"PILRA, PILRB"	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB/PILRA (3015536) expression in temporal cortex (TCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.04	GATS	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GATS (3063856) expression in hippocampus (HIPP)	Expression	intron_variant
chr7	100406823	rs1476679	0.04	GATS	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GATS (3063856) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr7	100406823	rs1476679	0.04	PILRB	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB (3015452) expression in frontal cortex (FCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.043	PILRB	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB (3015442) expression in putamen (PUTM)	Expression	intron_variant
chr7	100406823	rs1476679	0.045	PILRB	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB (3015442) expression in thalamus (THAL)	Expression	intron_variant
chr7	100406823	rs1476679	0.05	"PILRA, PILRB"	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB/PILRA (3015536) expression in substantia nigra (SNIG)	Expression	intron_variant
chr7	100406823	rs1476679	0.06	GATS	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GATS (3063856) expression in putamen (PUTM)	Expression	intron_variant
chr7	100406823	rs1476679	0.06	ZCWPW1	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	ZCWPW1 (3063971) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr7	100406823	rs1476679	0.06	ZCWPW1	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	ZCWPW1 (3063971) expression in thalamus (THAL)	Expression	intron_variant
chr7	100406823	rs1476679	0.06	ZCWPW1	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	ZCWPW1 (t3063968) expression in frontal cortex (FCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.061	ZCWPW1	C	C	0.86	0.86	ZCWPW1	SNP-based	Endophenotype	25188341	Caucasian	ADGC	3702	All	Clinico-pathologic AD dementia (with neuropathologist documentation)	Neuropathology	intron_variant
chr7	100406823	rs1476679	0.07	PILRB	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB (3015452) expression in medulla (MEDU)	Expression	intron_variant
chr7	100406823	rs1476679	0.07	PILRB	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB (3015476) expression in temporal cortex (TCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.09	ZCWPW1	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	ZCWPW1 (3063971) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr7	100406823	rs1476679	0.094	PILRB	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB (3015442) expression in temporal cortex (TCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.1	"PILRA, PILRB"	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB/PILRA (3015527) expression in medulla (MEDU)	Expression	intron_variant
chr7	100406823	rs1476679	0.1	GATS	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GATS (3063857) expression in occipital cortex (OCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.12	"PILRA, PILRB"	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB/PILRA (3015527) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr7	100406823	rs1476679	0.12	"PILRA, PILRB"	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB/PILRA (3015536) expression in thalamus (THAL)	Expression	intron_variant
chr7	100406823	rs1476679	0.13	PILRB	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB (3015442) expression in frontal cortex (FCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.14	GATS	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GATS (3063856) expression in occipital cortex (OCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.16	"PILRA, PILRB"	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB/PILRA (3015536) expression in hippocampus (HIPP)	Expression	intron_variant
chr7	100406823	rs1476679	0.16	GATS	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GATS (3063857) expression in substantia nigra (SNIG)	Expression	intron_variant
chr7	100406823	rs1476679	0.16	PILRB	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB (3015442) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr7	100406823	rs1476679	0.2	GATS	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GATS (3063856) expression in frontal cortex (FCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.2	PILRB	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB (3015476) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr7	100406823	rs1476679	0.23	PILRA	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRA (3015543) expression in hippocampus (HIPP)	Expression	intron_variant
chr7	100406823	rs1476679	0.23	PILRA	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRA (3015544) expression in hippocampus (HIPP)	Expression	intron_variant
chr7	100406823	rs1476679	0.24	PILRA	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRA (3015543) expression in occipital cortex (OCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.24	PILRA	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRA (3015544) expression in occipital cortex (OCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.24	PILRB	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB (3015476) expression in medulla (MEDU)	Expression	intron_variant
chr7	100406823	rs1476679	0.28	PILRA	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRA (3015543) expression in medulla (MEDU)	Expression	intron_variant
chr7	100406823	rs1476679	0.28	PILRA	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRA (3015544) expression in medulla (MEDU)	Expression	intron_variant
chr7	100406823	rs1476679	0.29	PILRB	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB (3015476) expression in occipital cortex (OCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.29	ZCWPW1	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	ZCWPW1 (t3063968) expression in putamen (PUTM)	Expression	intron_variant
chr7	100406823	rs1476679	0.3	PILRB	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB (3015452) expression in substantia nigra (SNIG)	Expression	intron_variant
chr7	100406823	rs1476679	0.3	ZCWPW1	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	ZCWPW1 (3063971) expression in temporal cortex (TCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.32	"PILRA, PILRB"	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB/PILRA (3015536) expression in occipital cortex (OCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.33	ZCWPW1	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	ZCWPW1 (3063971) expression in putamen (PUTM)	Expression	intron_variant
chr7	100406823	rs1476679	0.33	ZCWPW1	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	ZCWPW1 (t3063968) expression in thalamus (THAL)	Expression	intron_variant
chr7	100406823	rs1476679	0.34	PILRB	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB (3015442) expression in occipital cortex (OCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.34	PILRB	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB (3015476) expression in hippocampus (HIPP)	Expression	intron_variant
chr7	100406823	rs1476679	0.36	PILRB	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB (3015442) expression in medulla (MEDU)	Expression	intron_variant
chr7	100406823	rs1476679	0.36	ZCWPW1	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	ZCWPW1 (3063971) expression in medulla (MEDU)	Expression	intron_variant
chr7	100406823	rs1476679	0.39	"PILRA, PILRB"	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB/PILRA (3015536) expression in putamen (PUTM)	Expression	intron_variant
chr7	100406823	rs1476679	0.43	GATS	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GATS (3063856) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr7	100406823	rs1476679	0.5	"PILRA, PILRB"	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB/PILRA (3015536) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr7	100406823	rs1476679	0.5	"PILRA, PILRB"	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB/PILRA (3015536) expression in medulla (MEDU)	Expression	intron_variant
chr7	100406823	rs1476679	0.52	GATS	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GATS (3063857) expression in medulla (MEDU)	Expression	intron_variant
chr7	100406823	rs1476679	0.55	GATS	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GATS (3063857) expression in temporal cortex (TCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.56	GATS	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GATS (3063857) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr7	100406823	rs1476679	0.58	GATS	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GATS (3063857) expression in putamen (PUTM)	Expression	intron_variant
chr7	100406823	rs1476679	0.59	PILRA	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRA (3015543) expression in temporal cortex (TCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.59	PILRA	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRA (3015544) expression in temporal cortex (TCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.65	PILRB	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB (3015476) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr7	100406823	rs1476679	0.66	ZCWPW1	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	ZCWPW1 (t3063968) expression in temporal cortex (TCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.67	ZCWPW1	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	ZCWPW1 (t3063968) expression in occipital cortex (OCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.68	PILRA	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRA (3015543) expression in thalamus (THAL)	Expression	intron_variant
chr7	100406823	rs1476679	0.68	PILRA	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRA (3015544) expression in thalamus (THAL)	Expression	intron_variant
chr7	100406823	rs1476679	0.7	ZCWPW1	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	ZCWPW1 (3063971) expression in occipital cortex (OCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.7	ZCWPW1	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	ZCWPW1 (t3063968) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr7	100406823	rs1476679	0.72	GATS	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GATS (3063857) expression in hippocampus (HIPP)	Expression	intron_variant
chr7	100406823	rs1476679	0.72	PILRB	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB (3015476) expression in thalamus (THAL)	Expression	intron_variant
chr7	100406823	rs1476679	0.73	GATS	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GATS (3063856) expression in substantia nigra (SNIG)	Expression	intron_variant
chr7	100406823	rs1476679	0.73	ZCWPW1	NR	NR	1.05	1.05	ZCWPW1	SNP-based	Endophenotype	26993346	Caucasian	Cohort from Europe	10840	All	PCA (posterior cortical atrophy)	Imaging	intron_variant
chr7	100406823	rs1476679	0.74	PILRA	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRA (3015543) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr7	100406823	rs1476679	0.74	PILRA	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRA (3015544) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr7	100406823	rs1476679	0.76	PILRB	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB (3015476) expression in substantia nigra (SNIG)	Expression	intron_variant
chr7	100406823	rs1476679	0.77	ZCWPW1	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	ZCWPW1 (3063971) expression in substantia nigra (SNIG)	Expression	intron_variant
chr7	100406823	rs1476679	0.78	PILRA	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRA (3015543) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr7	100406823	rs1476679	0.78	PILRA	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRA (3015543) expression in substantia nigra (SNIG)	Expression	intron_variant
chr7	100406823	rs1476679	0.78	PILRA	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRA (3015544) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr7	100406823	rs1476679	0.78	PILRA	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRA (3015544) expression in substantia nigra (SNIG)	Expression	intron_variant
chr7	100406823	rs1476679	0.82	ZCWPW1	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	ZCWPW1 (t3063968) expression in medulla (MEDU)	Expression	intron_variant
chr7	100406823	rs1476679	0.83	ZCWPW1	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	ZCWPW1 (t3063968) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr7	100406823	rs1476679	0.84	ZCWPW1	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	ZCWPW1 (3063971) expression in hippocampus (HIPP)	Expression	intron_variant
chr7	100406823	rs1476679	0.9	PILRA	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRA (3015543) expression in frontal cortex (FCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.9	PILRA	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRA (3015544) expression in frontal cortex (FCTX)	Expression	intron_variant
chr7	100406823	rs1476679	0.9	ZCWPW1	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	ZCWPW1 (t3063968) expression in hippocampus (HIPP)	Expression	intron_variant
chr7	100406823	rs1476679	0.91	"PILRA, PILRB"	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB/PILRA (3015536) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr7	100406823	rs1476679	0.91	GATS	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	GATS (3063857) expression in thalamus (THAL)	Expression	intron_variant
chr7	100406823	rs1476679	0.93	PILRB	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB (3015476) expression in putamen (PUTM)	Expression	intron_variant
chr7	100406823	rs1476679	0.94	PILRA	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRA (3015543) expression in putamen (PUTM)	Expression	intron_variant
chr7	100406823	rs1476679	0.94	PILRA	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRA (3015544) expression in putamen (PUTM)	Expression	intron_variant
chr7	100406823	rs1476679	0.94	PILRB	NR	NR	NR	NA	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	PILRB (3015476) expression in frontal cortex (FCTX)	Expression	intron_variant
chr7	100406823	rs1476679	1.53E-17	ZCWPW1	NR	NR	0.18	1.19722	ZCWPW1	SNP-based	eQTL	30448613	Caucasian	ADNI	763	All	GATS (11722909_a_at) expression in blood	Expression	intron_variant
chr7	100406823	rs1476679	1.58E-08	ZCWPW1	NR	NR	0.107	1.11293	ZCWPW1	SNP-based	eQTL	30448613	Caucasian	ADNI	763	All	PILRB (11730023 s at) expression in blood	Expression	intron_variant
chr7	100406823	rs1476679	3.53E-09	ZCWPW1	NR	NR	0.129	1.13769	ZCWPW1	SNP-based	eQTL	30448613	Caucasian	ADNI	763	All	TRIM4 (11736388_a_at) expression in blood	Expression	intron_variant
chr7	100406823	rs1476679	3.77E-08	ZCWPW1	NR	NR	0.128	1.13655	ZCWPW1	SNP-based	eQTL	30448613	Caucasian	ADNI	763	All	PILRB (11730022_a_at) expression in blood	Expression	intron_variant
chr7	100406823	rs1476679	4.15E-09	ZCWPW1	NR	NR	0.115	1.12187	ZCWPW1	SNP-based	eQTL	30448613	Caucasian	ADNI	763	All	PILRB (11743311_a_at) expression in blood	Expression	intron_variant
chr7	100406823	rs1476679	5.60E-10	ZCWPW1	C	C	0.91	0.91	ZCWPW1	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD, Cohorts from Europe and USA"	74046	All	LOAD	AD	intron_variant
chr7	100406823	rs1476679	NR	ZCWPW1	T	T	1.04	1.04	ZCWPW1	SNP-based	Disease risk	27849641	Caucasian	ADGC	297	APOE-e4 non-carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr7	100406823	rs1476679	NR	ZCWPW1	T	T	1.31	1.31	ZCWPW1	SNP-based	Disease risk	27849641	Caucasian	ADGC	589	All	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr7	100406823	rs1476679	NR	ZCWPW1	T	T	2.98	2.98	ZCWPW1	SNP-based	Disease risk	27849641	Caucasian	ADGC	292	APOE-e4 carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr7	100415834	rs5015756	0.0000326	PILRB	NR	NR	0.081	1.08437	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	"JHU, UM"	150	Healthy subjects	PILRB (ILMN_1723984) expression in Frontal Cortex	Expression	intron_variant
chr7	100415834	rs5015756	0.0000412	PILRB	NR	NR	0.058	1.05971	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	"JHU, UM"	150	Healthy subjects	PILRB (ILMN_1723984) expression in Temporal cortex	Expression	intron_variant
chr7	100415834	rs5015756	0.0000565	PILRB	NR	NR	0.068	1.07037	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	"JHU, UM"	150	Healthy subjects	PILRB (ILMN_1685534) expression in Frontal Cortex	Expression	intron_variant
chr7	100415834	rs5015756	0.0182	PILRB	NR	NR	0.104	1.1096	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	"JHU, UM"	150	Healthy subjects	PILRB (ILMN_1768754) expression in Temporal cortex	Expression	intron_variant
chr7	100415834	rs5015756	0.0257	PILRB	NR	NR	0.031	1.03149	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	"JHU, UM"	150	Healthy subjects	PILRB (ILMN_1663753) expression in Temporal cortex	Expression	intron_variant
chr7	100415834	rs5015756	0.0384	PILRB	NR	NR	0.046	1.04707	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	"JHU, UM"	150	Healthy subjects	PILRB (ILMN_1760345) expression in Frontal Cortex	Expression	intron_variant
chr7	100415834	rs5015756	0.0572	PILRB	NR	NR	0.027	1.02737	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	"JHU, UM"	150	Healthy subjects	PILRB (ILMN_1685534) expression in Temporal cortex	Expression	intron_variant
chr7	100415834	rs5015756	0.0732	PILRB	NR	NR	0.021	1.02122	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	"JHU, UM"	150	Healthy subjects	PILRB (ILMN_1663753) expression in Frontal Cortex	Expression	intron_variant
chr7	100415834	rs5015756	0.29	PILRB	NR	NR	0.038	1.03873	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	"JHU, UM"	150	Healthy subjects	PILRB (ILMN_1768754) expression in Frontal Cortex	Expression	intron_variant
chr7	100415834	rs5015756	0.338	ZCWPW1	A	A	1.06	NA	ZCWPW1	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	intron_variant
chr7	100415834	rs5015756	0.436	PILRB	NR	NR	0.01	1.01005	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	"JHU, UM"	150	Healthy subjects	PILRB (ILMN_1760345) expression in Temporal cortex	Expression	intron_variant
chr7	100415834	rs5015756	0.524	PILRB	NR	NR	0.008	1.00803	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	"JHU, UM"	150	Healthy subjects	PILRB (ILMN_1729915) expression in Temporal cortex	Expression	intron_variant
chr7	100415834	rs5015756	0.71	PILRB	NR	NR	-0.005	0.995012	ZCWPW1	SNP-based	eQTL	26919393	Caucasian	"JHU, UM"	150	Healthy subjects	PILRB (ILMN_1729915) expression in Frontal Cortex	Expression	intron_variant
chr7	100494172	rs12539172	0.0000021	NYAP1	T	T	0.89	0.89	NYAP1	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	18845	All	Clinically diagnosed LOAD	AD	3_prime_UTR_variant
chr7	100494172	rs12539172	0.000021	NYAP1	T	T	0.93	0.93	NYAP1	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	63926	All	Clinically diagnosed LOAD	AD	3_prime_UTR_variant
chr7	100494172	rs12539172	9.30E-10	NYAP1	T	T	0.92	0.92	NYAP1	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	82771	All	Clinically diagnosed LOAD	AD	3_prime_UTR_variant
chr7	100565492	rs78951820	0.0247	AGFG2	NR	NR	0.03433	1.03493	AGFG2	SNP-based	Endophenotype	27933404	Caucasian	"ADNI, BIOCARD, Knight-ADRC, Lund University, MAYO, UPENN, UW "	2886	AD subjects	CSF Ab1-42	Fluid biomarker	3_prime_UTR_variant
chr7	101103377	rs10953322	0.00000465	TRIM56	G	G	0.76	0.76	TRIM56	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	17480	Plan 1 (males and females)	AD	AD	intergenic_region
chr7	101161149	rs1048365	0.0000784	AP1S1	T	T	NR	NA	AP1S1	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	3_prime_UTR_variant
chr7	101161149	rs1048365	0.000222	AP1S1	T	T	NR	NA	AP1S1	SNP-based	Cross phenotype 	30413934	Caucasian	GIANT	681275	All	Body-mass index (BMI)	Non-ADRD	3_prime_UTR_variant
chr7	101161149	rs1048365	0.945	AP1S1	T	T	1	1	AP1S1	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	3_prime_UTR_variant
chr7	103958224	rs6943822	0.0783	RELN	NR	NR	NR	NA	RELN	SNP-based	Endophenotype	20452100	Caucasian	ADGC	311	Non-Demented autopsy subjects	High Braak vs Low Braak	Neuropathology	intron_variant
chr7	103958224	rs6943822	0.446	RELN	NR	NR	NR	NA	RELN	SNP-based	Endophenotype	20452100	Caucasian	ADGC	311	Non-Demented autopsy subjects	High Braak vs Low Braak	Neuropathology	intron_variant
chr7	103985430	rs4298437	0.0162	RELN	NR	NR	NR	NA	RELN	SNP-based	Endophenotype	20452100	Caucasian	ADGC	311	Non-Demented autopsy subjects	High Braak vs Low Braak	Neuropathology	intron_variant
chr7	103985430	rs4298437	0.0341	RELN	NR	NR	NR	NA	RELN	SNP-based	Endophenotype	20452100	Caucasian	ADGC	311	Non-Demented autopsy subjects	High Braak vs Low Braak	Neuropathology	intron_variant
chr7	108346641	rs10487849	1.36E-08	NRCAM	NR	NR	0.06	1.06184	NRCAM	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	ADNI	521	All	Plasma Nr-CAM	Fluid biomarker	intron_variant
chr7	122377758	rs1859351	0.00016	CADPS2	NR	NR	NR	NA	CADPS2	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr7	129028456	rs10239340	1.01E-86	IRF5	NR	NR	0.92	2.50929	TNPO3	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	IRF5 expression in Temporal cortex	Expression	intron_variant
chr7	129028456	rs10239340	2.59E-27	IRF5	NR	NR	0.81	2.24791	TNPO3	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	IRF5 expression in Cerebellar	Expression	intron_variant
chr7	129028456	rs10239340	3.32E-38	IRF5	NR	NR	0.82	2.2705	TNPO3	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	IRF5 expression in Cerebellar	Expression	intron_variant
chr7	129028456	rs10239340	6.73E-71	IRF5	NR	NR	0.81	2.24791	TNPO3	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	IRF5 expression in Cerebellar	Expression	intron_variant
chr7	130748625	rs4731702	0.0000002	KLF14	NR	NR	NR	NA	KLF14	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intergenic_region
chr7	130753455	rs13234407	0.00000029	KLF14	NR	NR	NR	NA	KLF14	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intergenic_region
chr7	131603231	rs12534221	0.000000904	NR	A	A	NR	NA	PODXL	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF Ab1-42	Fluid biomarker	intergenic_region
chr7	132352924	rs12539196	0.000028	PLXNA4	A	A	NR	NA	PLXNA4	SNP-based	Disease risk	25043464	Caucasian	"ADGC, CHARGE"	6704	All	AD	AD	intron_variant
chr7	132426164	rs277470	0.000000041	PLXNA4	C	C	NR	NA	PLXNA4	SNP-based	Disease risk	25043464	Caucasian	"ADGC, CHARGE"	6704	All	AD	AD	intron_variant
chr7	143402040	rs10808026	0.000000031	EPHA1	A	A	0.9	0.9	EPHA1	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	63926	All	Clinically diagnosed LOAD	AD	intron_variant
chr7	143402040	rs10808026	0.0011	EPHA1	A	A	0.91	0.91	EPHA1	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	18845	All	Clinically diagnosed LOAD	AD	intron_variant
chr7	143402040	rs10808026	1.30E-10	EPHA1	A	A	0.9	0.9	EPHA1	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	82771	All	Clinically diagnosed LOAD	AD	intron_variant
chr7	143410495	rs12703526	6.91E-08	"EPHA1, TAS2R62P"	NR	NR	NR	NA	EPHA1	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr7	143410783	rs11762262	0.034	EPHA1	T	T	1.27	1.27	EPHA1	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr7	143411065	rs7810606	0.00000101	EPHA1	T	T	NR	NA	EPHA1	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	intron_variant
chr7	143411065	rs7810606	3.59E-11	EPHA1	T	T	-6.62	NA	EPHA1	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ, UKBB"	455258	All	AD + AD-by-proxy	AD	intron_variant
chr7	143411748	rs11763230	2.58E-11	EPHA1	T	T	NR	NA	EPHA1	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ"	79145	All	AD	AD	intron_variant
chr7	143412046	rs11767557	0.000000049	EPHA1	C	C	0.87	0.87	EPHA1	SNP-based	Disease risk	21460841	Caucasian	ADGC	22771	All	LOAD	AD	intron_variant
chr7	143412046	rs11767557	0.000000243	EPHA1	C	C	0.87	0.87	EPHA1	SNP-based	Disease risk	21460841	Caucasian	ADGC	22771	All	LOAD	AD	intron_variant
chr7	143412046	rs11767557	0.00029	EPHA1	NR	NR	0.91	0.91	EPHA1	SNP-based	Disease risk	21460841	Caucasian	"CHARGE, EADI, GERAD"	25818	All	LOAD	AD	intron_variant
chr7	143412046	rs11767557	0.00034	EPHA1	NR	NR	0.9	0.9	EPHA1	SNP-based	Disease risk	21460840	Caucasian	"EADI, GERAD"	19218	All	AD	AD	intron_variant
chr7	143412046	rs11767557	0.133	EPHA1	C	C	0.93	0.93	EPHA1	SNP-based	Disease risk	21460841	Caucasian	ADGC	7096	All	LOAD	AD	intron_variant
chr7	143412046	rs11767557	0.169	EPHA1	C	C	0.94	0.94	EPHA1	SNP-based	Disease risk	21460841	Caucasian	ADGC	7096	All	LOAD	AD	intron_variant
chr7	143412046	rs11767557	0.39	EPHA1	NR	NR	0.92	0.92	EPHA1	SNP-based	Endophenotype	26993346	Caucasian	Cohort from Europe	10840	All	PCA (posterior cortical atrophy)	Imaging	intron_variant
chr7	143412046	rs11767557	0.555	NR	C	C	0.02	1.0202	EPHA1	SNP-based	Endophenotype	23836404	Caucasian	ADGC	725	All	Neuritic Plaque Pathologic Burden	Neuropathology	intron_variant
chr7	143412046	rs11767557	0.586	EPHA1	C	C	1.06	1.06	EPHA1	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr7	143412046	rs11767557	0.647	EPHA1	C	C	1.03	1.03	EPHA1	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	2024	All	LOAD	AD	intron_variant
chr7	143412046	rs11767557	0.659	EPHA1 	C	C	0.07	1.07251	EPHA1	SNP-based	Age at onset (AAO) / Survival	25199842	Caucasian	ADGC	9162	LOAD subjects	Age of AD onset	Other	intron_variant
chr7	143412046	rs11767557	0.83	EPHA1 	C	C	0.03	1.03045	EPHA1	SNP-based	Age at onset (AAO) / Survival	25199842	Caucasian	ADGC	9162	LOAD subjects	Age of AD onset	Other	intron_variant
chr7	143412046	rs11767557	3.06E-08	EPHA1	C	C	0.84	0.84	EPHA1	SNP-based	Disease risk	21460841	Caucasian	ADGC	15675	All	LOAD	AD	intron_variant
chr7	143412046	rs11767557	6.00E-10	EPHA1	NR	NR	0.9	0.9	EPHA1	SNP-based	Disease risk	21460840	Caucasian	"ADGC, GERAD"	NR	All	AD	AD	intron_variant
chr7	143412046	rs11767557	6.00E-10	EPHA1	NR	NR	0.9	0.9	EPHA1	SNP-based	Disease risk	21460841	Caucasian	"ADGC, CHARGE, EADI, GERAD"	48589	All	LOAD	AD	intron_variant
chr7	143412046	rs11767557	7.33E-08	EPHA1	C	C	0.85	0.85	EPHA1	SNP-based	Disease risk	21460841	Caucasian	ADGC	15675	All	LOAD	AD	intron_variant
chr7	143413669	rs11771145	0.0000017	EPHA1	A	A	0.91	0.91	EPHA1	SNP-based	Disease risk	20460622	Caucasian	"ADGC, CHARGE, EADI, GERAD"	34363	All	AD	AD	intron_variant
chr7	143413669	rs11771145	0.00000368	EPHA1	NR	NR	0.11	1.11628	EPHA1	SNP-based	eQTL	30448613	Caucasian	ADNI	763	All	LOC154761 (11755327 s at) expression in blood	Expression	intron_variant
chr7	143413669	rs11771145	0.000028	EPHA1	A	A	0.9	0.9	EPHA1	SNP-based	Disease risk	24162737	Caucasian	Cohorts from Europe and USA	19884	All	LOAD	AD	intron_variant
chr7	143413669	rs11771145	0.000214	EPHA1	A	A	0.87	0.87	EPHA1	SNP-based	Disease risk	20460622	Caucasian	"ADGC, CHARGE"	16675	All	AD	AD	intron_variant
chr7	143413669	rs11771145	0.073	EPHA1 	A	A	0.89	0.89	EPHA1	SNP-based	Endophenotype	25188341	Caucasian	ADGC	4914	All	Clinico-pathologic AD dementia (No neuropathologist documentation)	Neuropathology	intron_variant
chr7	143413669	rs11771145	0.091	EPHA1 	A	A	0.88	0.88	EPHA1	SNP-based	Endophenotype	25188341	Caucasian	ADGC	3702	All	Clinico-pathologic AD dementia (with neuropathologist documentation)	Neuropathology	intron_variant
chr7	143413669	rs11771145	1.10E-13	EPHA1	A	A	0.9	0.9	EPHA1	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD, Cohorts from Europe and USA"	74046	All	LOAD	AD	intron_variant
chr7	143413669	rs11771145	1.32E-08	EPHA1	A	A	0.86	0.86	EPHA1	SNP-based	Disease risk	20460622	Caucasian	"ADGC, CHARGE, EADI"	24035	All	AD	AD	intron_variant
chr7	143413669	rs11771145	8.80E-10	EPHA1	A	A	0.9	0.9	EPHA1	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD"	54162	All	LOAD	AD	intron_variant
chr7	143413669	rs11771145	NR	EPHA1	G	G	0.96	0.96	EPHA1	SNP-based	Disease risk	27849641	Caucasian	ADGC	589	All	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr7	143413669	rs11771145	NR	ZCWPW1	G	G	0.88	0.88	EPHA1	SNP-based	Disease risk	27849641	Caucasian	ADGC	297	APOE-e4 non-carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr7	143413669	rs11771145	NR	ZCWPW1	G	G	1.29	1.29	EPHA1	SNP-based	Disease risk	27849641	Caucasian	ADGC	292	APOE-e4 carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr7	143425364	rs10226151	5.91E-09	"EPHA1, TAS2R62P"	NR	NR	NR	NA	EPHA1	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr7	143425831	rs78571833	0.000158	AL833583	NR	NR	0.14	NA	EPHA1	SNP-based	Age at onset (AAO) / Survival	28323831	Caucasian	ADGC	15795	All	Age of AD onset	Other	intron_variant
chr7	143444382	rs4595035	0.0094	EPHA1	T	T	1.25	1.25	TAS2R60	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	synonymous_variant
chr7	146252937	rs114360492	2.10E-09	CNTNAP2	T	T	5.99	NA	CNTNAP2	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	intron_variant
chr7	146265094	rs802571	0.00000126	CNTNAP2	C	C	0.52	0.52	CNTNAP2	SNP-based	Disease risk	26049409	Asian	Cohort from Japan	13296	e4 noncarrier	LOAD	AD	intron_variant
chr7	146265094	rs802571	0.0000314	CNTNAP2	C	C	0.36	0.36	CNTNAP2	SNP-based	Disease risk	26049409	Asian	Cohort from Japan	6948	e4 noncarrier	LOAD	AD	intron_variant
chr7	146265094	rs802571	0.00208	CNTNAP2	C	C	0.61	0.61	CNTNAP2	SNP-based	Disease risk	26049409	Asian	Cohort from Japan	6348	e4 noncarrier	LOAD	AD	intron_variant
chr7	147200311	rs10273775	0.00000894	CNTNAP2	G	G	1.52	1.52	CNTNAP2	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr7	150521029	rs73726888	4.21E-09	GIMAP7	NR	NR	NR	NA	GIMAP7	SNP-based	Cross phenotype 	27357110	Caucasian	"ADNI, Knight-ADRC"	587	NA	Plasma Prolactin	Fluid biomarker	3_prime_UTR_variant
chr7	150521029	rs73726888	6.44E-24	GIMAP7	NR	NR	NR	NA	GIMAP7	SNP-based	Cross phenotype 	27357110	Caucasian	"ADNI, Knight-ADRC"	543	NA	CSF Prolactin	Fluid biomarker	3_prime_UTR_variant
chr8	4005589	rs17068510	0.00000796	CSMD1	NR	NR	0.29	1.33643	CSMD1	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	673	All	CSF Clusterin	Fluid biomarker	intron_variant
chr8	4005589	rs17068510	0.000341	CSMD1	NR	NR	0.33	1.39097	CSMD1	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	403	Subjects with APOE-e4-	CSF Clusterin	Fluid biomarker	intron_variant
chr8	4005589	rs17068510	0.0081	CSMD1	NR	NR	0.25	1.28403	CSMD1	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	270	Subjects with APOE-e4+	CSF Clusterin	Fluid biomarker	intron_variant
chr8	4543602	rs11786902	0.00000867	NR	NR	NR	NR	NA	CSMD1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intron_variant
chr8	4543602	rs11786902	0.000134	NR	NR	NR	NR	NA	CSMD1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr8	4543602	rs11786902	0.00019	NR	NR	NR	0.59	0.59	CSMD1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intron_variant
chr8	4543602	rs11786902	0.00311	NR	NR	NR	0.69	0.69	CSMD1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr8	4543602	rs11786902	0.09129	NR	NR	NR	NR	NA	CSMD1	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intron_variant
chr8	4543602	rs11786902	0.43359	NR	NR	NR	NR	NA	CSMD1	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intron_variant
chr8	4543602	rs11786902	0.6	NR	NR	NR	NR	NA	CSMD1	SNP-based	Disease risk	21059989	Caucasian	ADGC	1390	Unrelated individuals	LOAD	AD	intron_variant
chr8	4543602	rs11786902	0.977	NR	NR	NR	NR	NA	CSMD1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intron_variant
chr8	4543602	rs11786902	1	NR	NR	NR	1.01	1.01	CSMD1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intron_variant
chr8	9141509	rs3748140	0.000000305	PPP1R3B	NR	NR	2.43	2.43	PPP1R3B	SNP-based	Disease risk	22832961	Caucasian	ADGC	8292	All	LOAD	AD	missense_variant
chr8	9141509	rs3748140	0.00000493	PPP1R3B	NR	NR	NR	NA	PPP1R3B	SNP-based	Disease risk	22832961	Caucasian	ADGC	8292	All	LOAD	AD	missense_variant
chr8	9141509	rs3748140	0.000575	PPP1R3B	NR	NR	2.8	2.8	PPP1R3B	SNP-based	Disease risk	22832961	Caucasian	ADGC	2229	All	LOAD	AD	missense_variant
chr8	9141509	rs3748140	0.00657	PPP1R3B	NR	NR	3.47	3.47	PPP1R3B	SNP-based	Disease risk	22832961	Caucasian	ADGC	2099	All	LOAD	AD	missense_variant
chr8	9141509	rs3748140	0.0148	PPP1R3B	NR	NR	2.24	2.24	PPP1R3B	SNP-based	Disease risk	22832961	Caucasian	ADGC	2321	All	LOAD	AD	missense_variant
chr8	9141509	rs3748140	0.131	PPP1R3B	NR	NR	10.14	10.14	PPP1R3B	SNP-based	Disease risk	22832961	Caucasian	ADNI	381	All	LOAD	AD	missense_variant
chr8	9141509	rs3748140	0.182	PPP1R3B	NR	NR	1.62	1.62	PPP1R3B	SNP-based	Disease risk	22832961	Caucasian	MIRAGE	1262	All	LOAD	AD	missense_variant
chr8	9400343	rs117922969	0.000531	AK055863	T	T	NR	NA	TNKS	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Total cholesterol (TC)	Non-ADRD	intron_variant
chr8	9400343	rs117922969	0.00143	AK055863	T	T	NR	NA	TNKS	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr8	9400343	rs117922969	0.598	AK055863	T	T	1	1	TNKS	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr8	9933227	rs17150816	0.000016	"MSRA, TNKS"	NR	NR	NR	NA	MSRA	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	upstream_gene_variant
chr8	10477271	rs11782819	0.191	UNQ9391	NR	NR	NR	NA	PRSS51	SNP-based	Endophenotype	20452100	Caucasian	ADGC	311	Non-Demented autopsy subjects	High Braak vs Low Braak	Neuropathology	non_coding_transcript_exon_variant
chr8	10477271	rs11782819	0.428	UNQ9391	NR	NR	NR	NA	PRSS51	SNP-based	Endophenotype	20452100	Caucasian	ADGC	311	Non-Demented autopsy subjects	High Braak vs Low Braak	Neuropathology	non_coding_transcript_exon_variant
chr8	10784455	rs7014168	0.000139	SOX7	A	A	0.94	0.94	PINX1	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intron_variant
chr8	10784455	rs7014168	0.000357	SOX7	A	A	0.95	0.95	PINX1	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intron_variant
chr8	10784455	rs7014168	0.000401	SOX7	A	A	NR	NA	PINX1	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Low-density lipoprotein (LDL)	Non-ADRD	intron_variant
chr8	10784455	rs7014168	0.000428	SOX7	A	A	NR	NA	PINX1	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr8	10784455	rs7014168	0.0565	SOX7	A	A	1	1	PINX1	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr8	10784455	rs7014168	0.674	SOX7	A	A	1.02	1.02	PINX1	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intron_variant
chr8	17639052	rs4921790	4.58E-09	"PDGFRL, MTUS1"	C	C	0.61	1.84043	PDGFRL	SNP-based	Endophenotype	29274321	Caucasian	ADNI	268	Normal controls	Hippocampal volume (HPV)	Imaging	intron_variant
chr8	17727620	rs7842088	0.000000212	MTUS1	G	G	NR	NA	MTUS1	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	MCI	CSF P-tau181p	Fluid biomarker	intron_variant
chr8	20789812	rs55644114	2.54E-08	"GFRA2, LZTS1"	A	A	0.41	1.50682	LZTS1	SNP-based	Endophenotype	29274321	Caucasian	ADNI	730	All	CSF Ab1-42	Fluid biomarker	intergenic_region
chr8	26915994	rs1481650	0.555	ADRA1A	NR	NR	NR	NA	ADRA1A	SNP-based	Endophenotype	20452100	Caucasian	ADGC	311	Non-Demented autopsy subjects	High Braak vs Low Braak	Neuropathology	intergenic_region
chr8	27298435	rs77389621	0.0584	TRIM35	NR	NR	0.02716	1.02753	TRIM35	SNP-based	Endophenotype	27933404	Caucasian	"ADNI, BIOCARD, Knight-ADRC, Lund University, MAYO, UPENN, UW "	2886	AD subjects	CSF Ab1-42	Fluid biomarker	intron_variant
chr8	27313969	rs7833348	0.025	PTK2B	A	A	0.66	NA	PTK2B	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	intron_variant
chr8	27337604	rs28834970	0.00000231	PIK2B	NR	NR	0.07	1.07251	PTK2B	SNP-based	eQTL	30448613	Caucasian	ADNI	763	All	TRIM35 (11723344_at) expression in blood	Expression	intron_variant
chr8	27337604	rs28834970	0.0000043	PTK2B	C	C	1.11	1.11	PTK2B	SNP-based	Disease risk	24162737	Caucasian	Cohorts from Europe and USA	19884	All	LOAD	AD	intron_variant
chr8	27337604	rs28834970	0.046	PTK2B	C	C	1.13	1.13	PTK2B	SNP-based	Endophenotype	25188341	Caucasian	ADGC	4914	All	Clinico-pathologic AD dementia (No neuropathologist documentation)	Neuropathology	intron_variant
chr8	27337604	rs28834970	0.23	PTK2B	C	C	1.09	1.09	PTK2B	SNP-based	Endophenotype	25188341	Caucasian	ADGC	3702	All	Clinico-pathologic AD dementia (with neuropathologist documentation)	Neuropathology	intron_variant
chr8	27337604	rs28834970	0.27	PTK2B	NR	NR	1.1	1.1	PTK2B	SNP-based	Endophenotype	26993346	Caucasian	Cohort from Europe	10840	All	PCA (posterior cortical atrophy)	Imaging	intron_variant
chr8	27337604	rs28834970	0.571	PTK2B	C	C	0.975	0.975	PTK2B	SNP-based	Disease risk	24495969	Caucasian	Cohort from Spain	4372	All	AD	AD	intron_variant
chr8	27337604	rs28834970	1.18E-17	PIK2B	NR	NR	0.09	1.09417	PTK2B	SNP-based	eQTL	30448613	Caucasian	ADNI	763	All	PTK2B (11720982 s at) expression in blood	Expression	intron_variant
chr8	27337604	rs28834970	3.30E-09	PTK2B	C	C	1.1	1.1	PTK2B	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD"	54162	All	LOAD	AD	intron_variant
chr8	27337604	rs28834970	6.86E-18	PIK2B	NR	NR	0.11	1.11628	PTK2B	SNP-based	eQTL	30448613	Caucasian	ADNI	763	All	PTK2B (11720981_a_at) expression in blood	Expression	intron_variant
chr8	27337604	rs28834970	7.33E-12	PIK2B	NR	NR	0.09	1.09417	PTK2B	SNP-based	eQTL	30448613	Caucasian	ADNI	763	All	PTK2B (11720980_a_at) expression in blood	Expression	intron_variant
chr8	27337604	rs28834970	7.40E-14	PTK2B	C	C	1.1	1.1	PTK2B	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD, Cohorts from Europe and USA"	74046	All	LOAD	AD	intron_variant
chr8	27337604	rs28834970	NR	PTK2B	C	C	1.22	1.22	PTK2B	SNP-based	Disease risk	27849641	Caucasian	ADGC	589	All	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr8	27337604	rs28834970	NR	ZCWPW1	C	C	1.1	1.1	PTK2B	SNP-based	Disease risk	27849641	Caucasian	ADGC	297	APOE-e4 non-carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr8	27337604	rs28834970	NR	ZCWPW1	C	C	1.38	1.38	PTK2B	SNP-based	Disease risk	27849641	Caucasian	ADGC	292	APOE-e4 carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr8	27362470	rs73223431	0.000015	PTK2B	T	T	1.11	1.11	PTK2B	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	18845	All	Clinically diagnosed LOAD	AD	intron_variant
chr8	27362470	rs73223431	6.30E-14	PTK2B	T	T	1.1	1.1	PTK2B	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	82771	All	Clinically diagnosed LOAD	AD	intron_variant
chr8	27362470	rs73223431	8.30E-10	PTK2B	T	T	1.1	1.1	PTK2B	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	63926	All	Clinically diagnosed LOAD	AD	intron_variant
chr8	27373302	rs12679874	0.00000164	PTK2B	A	A	NR	NA	PTK2B	SNP-based	Cross phenotype 	27088644	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr8	27373302	rs12679874	0.0000631	PTK2B	NR	NR	-0.09	NA	PTK2B	SNP-based	Age at onset (AAO) / Survival	28323831	Caucasian	ADGC	15795	All	Age of AD onset	Other	intron_variant
chr8	27373302	rs12679874	0.000438	PTK2B	A	A	NR	NA	PTK2B	SNP-based	Cross phenotype 	27088644	Caucasian	Cohort of Immune-Mediated Diseases	51009	All	Crohn disease	Non-ADRD	intron_variant
chr8	27434232	rs12056620	0.0000756	PTK2B	T	T	NR	NA	PTK2B	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr8	27434232	rs12056620	0.000335	PTK2B	T	T	NR	NA	PTK2B	SNP-based	Cross phenotype 	30413934	Caucasian	GIANT	681275	All	Body-mass index (BMI)	Non-ADRD	intron_variant
chr8	27434232	rs12056620	0.00223	PTK2B	T	T	1.04	1.04	PTK2B	SNP-based	Disease risk	30413934	Caucasian	"ADGC, IGAP"	79471	All	AD	AD	intron_variant
chr8	27434232	rs12056620	0.00266	PTK2B	T	T	1.04	1.04	PTK2B	SNP-based	Disease risk	30413934	Caucasian	IGAP	74046	All	AD	AD	intron_variant
chr8	27434232	rs12056620	0.127	PTK2B	T	T	1	1	PTK2B	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr8	27434232	rs12056620	0.55	PTK2B	T	T	1.03	1.03	PTK2B	SNP-based	Disease risk	30413934	Caucasian	ADGC	5425	All	AD	AD	intron_variant
chr8	27472579	rs2741342	0.00126	CHRNA2	NR	NR	0.09	NA	CHRNA2	SNP-based	Age at onset (AAO) / Survival	28323831	Caucasian	ADGC	15795	All	Age of AD onset	Other	intron_variant
chr8	27545260	rs7341557	0.016	EPHX2	NR	NR	0.02	1.0202	EPHX2	SNP-based	Endophenotype	27933404	Caucasian	"ADNI, BIOCARD, Knight-ADRC, Lund University, MAYO, UPENN, UW "	2886	AD subjects	CSF Ab1-42	Fluid biomarker	3_prime_UTR_variant
chr8	27565223	rs17466060	0.0000043	EPHX2	NR	NR	NR	NA	EPHX2	SNP-based	Cross phenotype 	28780673	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr8	27565223	rs17466060	0.0005	EPHX2	NR	NR	NR	NA	EPHX2	SNP-based	Cross phenotype 	28780673	Caucasian	"GAME-ON, IGAP"	116992	All	AD + Breast cancer + Lung Cancer	Non-ADRD	intron_variant
chr8	27565223	rs17466060	0.00057	EPHX2	NR	NR	NR	NA	EPHX2	SNP-based	Cross phenotype 	28780673	Caucasian	GAME-ON	28998	All	Lung Cancer	Non-ADRD	intron_variant
chr8	27565223	rs17466060	0.017	EPHX2	NR	NR	NR	NA	EPHX2	SNP-based	Cross phenotype 	28780673	Caucasian	GAME-ON	33832	All	Breast Cancer	Non-ADRD	intron_variant
chr8	27571711	rs1316801	0.00000101	CLU	NR	NR	NR	NA	CLU	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr8	27572989	rs7831810	0.01	CLU	NR	NR	0.09	NA	CLU	SNP-based	Age at onset (AAO) / Survival	28323831	Caucasian	ADGC	15795	All	Age of AD onset	Other	intron_variant
chr8	27586760	rs881146	0.00213	CLU	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intron_variant
chr8	27586760	rs881146	0.0374	CLU	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr8	27586760	rs881146	0.0617	CLU	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr8	27586760	rs881146	0.676	CLU	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intron_variant
chr8	27589507	rs12680584	0.103	CLU	A	A	0.88	NA	CLU	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	downstream_gene_variant
chr8	27591212	rs7012010	0.0025	CLU	C	C	1.1	1.1	CLU	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	downstream_gene_variant
chr8	27591212	rs7012010	0.0081	CLU	C	C	1.1	1.1	CLU	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	downstream_gene_variant
chr8	27591212	rs7012010	0.043	CLU	NR	NR	1.1	1.1	CLU	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4- carrier	AD	AD	downstream_gene_variant
chr8	27591212	rs7012010	0.0469	CUGBP2	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21379329	Caucasian	ADGC	250	APOE-e3/e2+e2/e2	LOAD	AD	downstream_gene_variant
chr8	27591212	rs7012010	0.0614	CUGBP2	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	downstream_gene_variant
chr8	27591212	rs7012010	0.064	CLU	NR	NR	1.05	1.05	CLU	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4+ carrier	AD	AD	downstream_gene_variant
chr8	27591212	rs7012010	0.0785	CUGBP2	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	downstream_gene_variant
chr8	27591212	rs7012010	0.117	CUGBP2	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21379329	Caucasian	ADGC	2167	APOE-e4+	LOAD	AD	downstream_gene_variant
chr8	27591212	rs7012010	0.121	CUGBP2	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	downstream_gene_variant
chr8	27591212	rs7012010	0.279	CUGBP2	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21379329	Caucasian	ADGC	3839	All	LOAD	AD	downstream_gene_variant
chr8	27591212	rs7012010	0.372	CUGBP2	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21379329	Caucasian	ADGC	1642	APOE-e4/e3	LOAD	AD	downstream_gene_variant
chr8	27591212	rs7012010	0.378	CUGBP2	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21379329	Caucasian	ADGC	3461	Northwestern European ancestry	LOAD	AD	downstream_gene_variant
chr8	27591212	rs7012010	0.418	CUGBP2	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21379329	Caucasian	ADGC	1422	APOE-e3/e3	LOAD	AD	downstream_gene_variant
chr8	27591212	rs7012010	0.487	CUGBP2	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21379329	Caucasian	ADGC	3839	All	LOAD	AD	downstream_gene_variant
chr8	27591212	rs7012010	0.496	CUGBP2	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21379329	Caucasian	ADGC	3722	All	LOAD	AD	downstream_gene_variant
chr8	27591212	rs7012010	0.65	CUGBP2	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21379329	Caucasian	ADGC	3786	All	LOAD	AD	downstream_gene_variant
chr8	27591212	rs7012010	0.985	CUGBP2	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21379329	Caucasian	ADGC	1672	APOE-e4-	LOAD	AD	downstream_gene_variant
chr8	27591212	rs7012010	0.99	CUGBP2	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21379329	Caucasian	ADGC	408	APOE-e4/e4	LOAD	AD	downstream_gene_variant
chr8	27595505	rs17057441	0.0177	CLU	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	downstream_gene_variant
chr8	27595505	rs17057441	0.0452	CLU	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	downstream_gene_variant
chr8	27595505	rs17057441	0.078	CLU	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	downstream_gene_variant
chr8	27595505	rs17057441	0.677	CLU	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	downstream_gene_variant
chr8	27597925	rs3087554	0.71	CLU	C	C	0.98	0.98	CLU	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	3_prime_UTR_variant
chr8	27597925	rs3087554	0.88	CLU	NR	NR	1.01	1.01	CLU	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4- carrier	AD	AD	3_prime_UTR_variant
chr8	27597925	rs3087554	0.92	CLU	C	C	1	1	CLU	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	3_prime_UTR_variant
chr8	27597925	rs3087554	0.97	CLU	NR	NR	1	1	CLU	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4+ carrier	AD	AD	3_prime_UTR_variant
chr8	27598736	rs2279590	0.000001	CLU	NR	NR	0.83	0.83	CLU	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	7353	All	AD	AD	intron_variant
chr8	27598736	rs2279590	0.000019	CLU	NR	NR	0.81	0.81	CLU	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	4774	APOE-e4 carrier	AD	AD	intron_variant
chr8	27598736	rs2279590	0.00082	CLU	NR	NR	0.88	0.88	CLU	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	6900	All	AD	AD	intron_variant
chr8	27598736	rs2279590	0.00701	CLU	T	T	0.85	0.85	CLU	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	2024	All	LOAD	AD	intron_variant
chr8	27598736	rs2279590	0.013	CLU	NR	NR	0.87	0.87	CLU	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	2616	All	AD	AD	intron_variant
chr8	27598736	rs2279590	0.013	CLU	NR	NR	0.92	0.92	CLU	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	9424	APOE-e4 non-carrier	AD	AD	intron_variant
chr8	27598736	rs2279590	0.031	CLU	NR	NR	0.82	0.82	CLU	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	1576	All	AD	AD	intron_variant
chr8	27598736	rs2279590	0.034	CLU	T	T	1.41	1.41	CLU	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr8	27598736	rs2279590	0.036	"CLU,MIR6843"	NR	NR	0.01	1.01005	CLU	SNP-based	Endophenotype	30805717	Caucasian	MAGIC	51750	All	Fasting Insulin	Fluid biomarker	intron_variant
chr8	27598736	rs2279590	0.097	CLU	T	T	0.82	0.82	CLU	SNP-based	Disease risk	23565137	Asian	Cohort from Korea	1468	All	LOAD	AD	intron_variant
chr8	27598736	rs2279590	0.24	CLU	NR	NR	0.91	0.91	CLU	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	1544	All	AD	AD	intron_variant
chr8	27598736	rs2279590	0.35	CLU	NR	NR	0.92	0.92	CLU	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	1232	All	AD	AD	intron_variant
chr8	27598736	rs2279590	3.75E-17	"CLU,MIR6843"	NR	NR	-0.14	0.869358	CLU	SNP-based	Endophenotype	30805717	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr8	27598736	rs2279590	8.90E-09	CLU	NR	NR	0.86	0.86	CLU	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	14253	All	AD	AD	intron_variant
chr8	27603578	rs9331926	0.02	CLU	G	G	1.96	1.96	CLU	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr8	27604964	rs7982	0.0002	CLU	T	T	0.87	0.87	CLU	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	synonymous_variant
chr8	27604964	rs7982	0.000364	CLU	NR	NR	0.91	0.91	CLU	SNP-based	Disease risk	30448613	Caucasian	ADGC	15330	All	AD	AD	synonymous_variant
chr8	27604964	rs7982	0.0046	CLU	T	T	0.89	0.89	CLU	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	synonymous_variant
chr8	27604964	rs7982	0.0092	CLU	NR	NR	0.87	0.87	CLU	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4- carrier	AD	AD	synonymous_variant
chr8	27604964	rs7982	0.22	CLU	NR	NR	0.92	0.92	CLU	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4+ carrier	AD	AD	synonymous_variant
chr8	27607002	rs11136000	0.000000523	CLU	A	A	0.89	0.89	CLU	SNP-based	Disease risk	22722634	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr8	27607002	rs11136000	0.0000015	CLU	NR	NR	0.83	0.83	CLU	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	7282	All	AD	AD	intron_variant
chr8	27607002	rs11136000	0.000027	CLU	NR	NR	0.81	0.81	CLU	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	4760	APOE-e4 carrier	AD	AD	intron_variant
chr8	27607002	rs11136000	0.000498	CLU	T	T	0.89	0.89	CLU	SNP-based	Disease risk	20460622	Caucasian	"ADGC, CHARGE"	16675	All	AD	AD	intron_variant
chr8	27607002	rs11136000	0.0007	CLU	T	T	0.91	0.91	CLU	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	intron_variant
chr8	27607002	rs11136000	0.000781	CLU	A	A	0.17	1.1853	CLU	SNP-based	eQTL	22722634	Caucasian	MAYO	399	All subjects with Temporal Cortex data	CLU (ILMN_1667058) expression in Temporal cortex (TCX)	Expression	intron_variant
chr8	27607002	rs11136000	0.00088	CLU	NR	NR	0.88	0.88	CLU	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	6929	All	AD	AD	intron_variant
chr8	27607002	rs11136000	0.0019	CUGBP2	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	intron_variant
chr8	27607002	rs11136000	0.0029	CUGBP2	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	intron_variant
chr8	27607002	rs11136000	0.007	CLU	NR	NR	0.91	0.91	CLU	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	9392	APOE-e4 non-carrier	AD	AD	intron_variant
chr8	27607002	rs11136000	0.0083	CUGBP2	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21379329	Caucasian	ADGC	3839	All	LOAD	AD	intron_variant
chr8	27607002	rs11136000	0.0096	CLU	T	T	0.92	0.92	CLU	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	intron_variant
chr8	27607002	rs11136000	0.0096	CUGBP2	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21379329	Caucasian	ADGC	3461	Northwestern European ancestry	LOAD	AD	intron_variant
chr8	27607002	rs11136000	0.0108	CUGBP2	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21379329	Caucasian	ADGC	1877	Unrelated cases and controls subjects	LOAD	AD	intron_variant
chr8	27607002	rs11136000	0.0109	CLU	T	T	0.87	0.87	CLU	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	2024	All	LOAD	AD	intron_variant
chr8	27607002	rs11136000	0.015	CLU	NR	NR	0.91	0.91	CLU	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4- carrier	AD	AD	intron_variant
chr8	27607002	rs11136000	0.0159	CUGBP2	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21379329	Caucasian	ADGC	3839	All	LOAD	AD	intron_variant
chr8	27607002	rs11136000	0.017	CLU	NR	NR	0.91	0.91	CLU	SNP-based	Disease risk	19734902	Caucasian	Cohorts from Europe and USA	4363	All	AD	AD	intron_variant
chr8	27607002	rs11136000	0.022	CLU	NR	NR	0.8	0.8	CLU	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	1454	All	AD	AD	intron_variant
chr8	27607002	rs11136000	0.0227	CUGBP2	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21379329	Caucasian	ADGC	3722	All	LOAD	AD	intron_variant
chr8	27607002	rs11136000	0.028	CLU	NR	NR	0.88	0.88	CLU	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	2695	All	AD	AD	intron_variant
chr8	27607002	rs11136000	0.03	CLU	NR	NR	0.82	0.82	CLU	SNP-based	Disease risk	20460622	Caucasian	Cohort from Europe	2349	All	AD	AD	intron_variant
chr8	27607002	rs11136000	0.032	CUGBP2	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21379329	Caucasian	ADGC	2167	APOE-e4+	LOAD	AD	intron_variant
chr8	27607002	rs11136000	0.0361	CLU	T	T	0.79	0.79	CLU	SNP-based	Disease risk	23565137	Asian	Cohort from Korea	1468	All	LOAD	AD	intron_variant
chr8	27607002	rs11136000	0.04	CLU	T	T	0.86	0.86	CLU	SNP-based	Disease risk	20534741	Caucasian	"ADC, UM"	1610	All	AD	AD	intron_variant
chr8	27607002	rs11136000	0.068	CLU	A	A	0.87	0.87	CLU	SNP-based	Disease risk	21390209	Caucasian	ADGC	1525	All	AD	AD	intron_variant
chr8	27607002	rs11136000	0.088	CUGBP2	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21379329	Caucasian	ADGC	1642	APOE-e4/e3	LOAD	AD	intron_variant
chr8	27607002	rs11136000	0.0956	CUGBP2	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21379329	Caucasian	ADGC	1672	APOE-e4-	LOAD	AD	intron_variant
chr8	27607002	rs11136000	0.11	CLU	NR	NR	-0.018	0.982161	CLU	SNP-based	Endophenotype	20558387	Caucasian	ADNI	740	All	Amygdala volume	Imaging	intron_variant
chr8	27607002	rs11136000	0.122	CLU	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intron_variant
chr8	27607002	rs11136000	0.153	CLU	A	A	0.93	0.93	CLU	SNP-based	Disease risk	21390209	Caucasian	"ADNI, GenADA, Pfizer"	3595	All	AD	AD	intron_variant
chr8	27607002	rs11136000	0.17	CLU	NR	NR	0.93	0.93	CLU	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4+ carrier	AD	AD	intron_variant
chr8	27607002	rs11136000	0.171	CUGBP2	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21379329	Caucasian	ADGC	1422	APOE-e3/e3	LOAD	AD	intron_variant
chr8	27607002	rs11136000	0.24	CLU	NR	NR	0.91	0.91	CLU	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	1544	All	AD	AD	intron_variant
chr8	27607002	rs11136000	0.243	CUGBP2	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21379329	Caucasian	ADGC	250	APOE-e3/e2+e2/e2	LOAD	AD	intron_variant
chr8	27607002	rs11136000	0.27	CLU	NR	NR	0.91	0.91	CLU	SNP-based	Endophenotype	26993346	Caucasian	Cohort from Europe	10840	All	PCA (posterior cortical atrophy)	Imaging	intron_variant
chr8	27607002	rs11136000	0.31	CLU	NR	NR	-0.03	0.970446	CLU	SNP-based	Endophenotype	20558387	Caucasian	ADNI	740	All	White matter lesion volume	Imaging	intron_variant
chr8	27607002	rs11136000	0.31	CLU	NR	NR	0.92	0.92	CLU	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	1236	All	AD	AD	intron_variant
chr8	27607002	rs11136000	0.373	CLU	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr8	27607002	rs11136000	0.488	CUGBP2	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21379329	Caucasian	ADGC	3786	All	LOAD	AD	intron_variant
chr8	27607002	rs11136000	0.5	CLU	NR	NR	-0.011	0.98906	CLU	SNP-based	Endophenotype	20558387	Caucasian	ADNI	740	All	Temporal pole cortex thickness	Imaging	intron_variant
chr8	27607002	rs11136000	0.582	CLU	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intron_variant
chr8	27607002	rs11136000	0.65	CLU	NR	NR	-0.011	0.98906	CLU	SNP-based	Endophenotype	20558387	Caucasian	ADNI	740	All	Entorhinal cortex thickness	Imaging	intron_variant
chr8	27607002	rs11136000	0.66	CLU	NR	NR	0.007	1.00702	CLU	SNP-based	Endophenotype	20558387	Caucasian	ADNI	740	All	Parahippocampal gyrus cortex thickness	Imaging	intron_variant
chr8	27607002	rs11136000	0.75	CLU	NR	NR	0.97	0.97	CLU	SNP-based	Disease risk	20558387	Caucasian	ADNI	740	All	AD + MCI	AD	intron_variant
chr8	27607002	rs11136000	0.78	CLU	NR	NR	-0.019	0.981179	CLU	SNP-based	Endophenotype	20558387	Caucasian	ADNI	740	All	Hippocampal volume	Imaging	intron_variant
chr8	27607002	rs11136000	0.787	CLU	A	A	0.96	0.96	CLU	SNP-based	Disease risk	21390209	Caucasian	ADNI	496	All	AD	AD	intron_variant
chr8	27607002	rs11136000	0.806	CLU	A	A	0.98	0.98	CLU	SNP-based	Disease risk	21390209	Caucasian	GenADA	1574	All	AD	AD	intron_variant
chr8	27607002	rs11136000	0.951	CLU	T	T	1.01	1.01	CLU	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr8	27607002	rs11136000	0.962	CLU	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intron_variant
chr8	27607002	rs11136000	0.966	CLU	NR	NR	NR	NA	CLU	SNP-based	Endophenotype	21390209	Caucasian	"ADNI, leadC"	597	AD subjects	AD Progression	Cognitive	intron_variant
chr8	27607002	rs11136000	0.993	CUGBP2	NR	NR	NR	NA	CLU	SNP-based	Disease risk	21379329	Caucasian	ADGC	408	APOE-e4/e4	LOAD	AD	intron_variant
chr8	27607002	rs11136000	1.40E-09	CLU	NR	NR	0.84	0.84	CLU	SNP-based	Disease risk	19734902	Caucasian	Cohorts from Europe and USA	11789	All	AD	AD	intron_variant
chr8	27607002	rs11136000	1.49E-09	CLU	T	T	0.85	0.85	CLU	SNP-based	Disease risk	20460622	Caucasian	"ADGC, CHARGE, EADI"	24035	All	AD	AD	intron_variant
chr8	27607002	rs11136000	1.62E-16	CLU	T	T	0.85	0.85	CLU	SNP-based	Disease risk	20460622	Caucasian	"ADGC, CHARGE, EADI, GERAD"	34363	All	AD	AD	intron_variant
chr8	27607002	rs11136000	1.72E-16	CLU	NR	NR	NR	NA	CLU	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr8	27607002	rs11136000	7.50E-09	CLU	NR	NR	0.86	0.86	CLU	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	14211	All	AD	AD	intron_variant
chr8	27607002	rs11136000	8.50E-10	CLU	NR	NR	0.86	0.86	CLU	SNP-based	Disease risk	19734902	Caucasian	Cohorts from Europe and USA	19052	All	AD	AD	intron_variant
chr8	27607002	rs11136000	NS	CLU	A	A	0.03	1.03045	CLU	SNP-based	eQTL	22722634	Caucasian	MAYO	374	All subjects with Cerebellum data	CLU (ILMN_1667058) expression in Cerebellar tissue (CER)	Expression	intron_variant
chr8	27607412	rs4236673	2.61E-19	"CLU, PTK2B"	A	A	-8.98	NA	CLU	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ, UKBB"	455258	All	AD + AD-by-proxy	AD	intron_variant
chr8	27607412	rs4236673	6.36E-20	"CLU, PTK2B"	A	A	NR	NA	CLU	SNP-based	Disease risk	30617256	Caucasian	"ADSP, IGAP, PGC-ALZ"	79145	All	AD	AD	intron_variant
chr8	27608664	rs1532277	5.01E-09	CLU	NR	NR	0.21	NA	CLU	SNP-based	Age at onset (AAO) / Survival	28323831	Caucasian	ADGC	15795	All	Age of AD onset	Other	intron_variant
chr8	27608798	rs1532278	0.0000202	CLU	T	T	0.89	0.89	CLU	SNP-based	Disease risk	21460841	Caucasian	ADGC	15675	All	LOAD	AD	intron_variant
chr8	27608798	rs1532278	0.0000555	CLU	T	T	0.9	0.9	CLU	SNP-based	Disease risk	21460841	Caucasian	ADGC	15675	All	LOAD	AD	intron_variant
chr8	27608798	rs1532278	0.000256	CLU	T	T	0.87	0.87	CLU	SNP-based	Disease risk	21460841	Caucasian	ADGC	7096	All	LOAD	AD	intron_variant
chr8	27608798	rs1532278	0.000274	CLU	T	T	0.87	0.87	CLU	SNP-based	Disease risk	21460841	Caucasian	ADGC	7096	All	LOAD	AD	intron_variant
chr8	27608798	rs1532278	0.661	CLU 	T	T	0.05	1.05127	CLU	SNP-based	Age at onset (AAO) / Survival	25199842	Caucasian	ADGC	9162	LOAD subjects	Age of AD onset	Other	intron_variant
chr8	27608798	rs1532278	0.977	CLU 	T	T	0	1	CLU	SNP-based	Age at onset (AAO) / Survival	25199842	Caucasian	ADGC	9162	LOAD subjects	Age of AD onset	Other	intron_variant
chr8	27608798	rs1532278	0.992	NR	T	T	0	1	CLU	SNP-based	Endophenotype	23836404	Caucasian	ADGC	725	All	Neuritic Plaque Pathologic Burden	Neuropathology	intron_variant
chr8	27608798	rs1532278	1.87E-08	CLU	T	T	0.89	0.89	CLU	SNP-based	Disease risk	21460841	Caucasian	ADGC	22771	All	LOAD	AD	intron_variant
chr8	27608798	rs1532278	7.45E-09	CLU/PTK2B	A	A	NR	NA	CLU	SNP-based	Disease risk	30617256	Caucasian	UKBB	376113	All	AD-by-proxy	AD	intron_variant
chr8	27608798	rs1532278	8.34E-08	CLU	T	T	0.89	0.89	CLU	SNP-based	Disease risk	21460841	Caucasian	ADGC	22771	All	LOAD	AD	intron_variant
chr8	27610169	rs9331896	0.0000096	CLU	C	C	0.9	0.9	CLU	SNP-based	Disease risk	25778476	Caucasian	"ADGC, IGAP"	36569	APOE-e4- subjects	AD	AD	intron_variant
chr8	27610169	rs9331896	0.00015	CLU	NR	NR	NR	NA	CLU	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CLU (t3129065) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr8	27610169	rs9331896	0.00035	CLU	NR	NR	NR	NA	CLU	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CLU (3129079) expression in intra-locular white matter (WHMT)	Expression	intron_variant
chr8	27610169	rs9331896	0.00045	CLU	NR	NR	NR	NA	CLU	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CLU (t3129065) expression in temporal cortex (TCTX)	Expression	intron_variant
chr8	27610169	rs9331896	0.00069	CLU	NR	NR	NR	NA	CLU	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CLU (t3129065) expression in hippocampus (HIPP)	Expression	intron_variant
chr8	27610169	rs9331896	0.00077	CLU	NR	NR	NR	NA	CLU	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CLU (t3129065) expression in occipital cortex (OCTX)	Expression	intron_variant
chr8	27610169	rs9331896	0.00102	CLU	NR	NR	0.92	0.92	CLU	SNP-based	Disease risk	30448613	Caucasian	ADGC	15330	All	AD	AD	intron_variant
chr8	27610169	rs9331896	0.0012	CLU	NR	NR	NR	NA	CLU	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CLU (t3129065)  expression in frontal cortex (FCTX)	Expression	intron_variant
chr8	27610169	rs9331896	0.0013	CLU	NR	NR	NR	NA	CLU	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CLU (3129079) expression in temporal cortex (TCTX)	Expression	intron_variant
chr8	27610169	rs9331896	0.0015	CLU	NR	NR	NR	NA	CLU	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CLU (3129079) expression in hippocampus (HIPP)	Expression	intron_variant
chr8	27610169	rs9331896	0.0047	CLU 	C	C	0.84	0.84	CLU	SNP-based	Endophenotype	25188341	Caucasian	ADGC	4914	All	Clinico-pathologic AD dementia (No neuropathologist documentation)	Neuropathology	intron_variant
chr8	27610169	rs9331896	0.03	CLU	NR	NR	NR	NA	CLU	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CLU (t3129065) expression in substantia nigra (SNIG)	Expression	intron_variant
chr8	27610169	rs9331896	0.04	CLU	NR	NR	NR	NA	CLU	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CLU (3129079)  expression in frontal cortex (FCTX)	Expression	intron_variant
chr8	27610169	rs9331896	0.042	CLU 	C	C	0.85	0.85	CLU	SNP-based	Endophenotype	25188341	Caucasian	ADGC	3702	All	Clinico-pathologic AD dementia (with neuropathologist documentation)	Neuropathology	intron_variant
chr8	27610169	rs9331896	0.07	CLU	NR	NR	NR	NA	CLU	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CLU (3129079) expression in occipital cortex (OCTX)	Expression	intron_variant
chr8	27610169	rs9331896	0.08	CLU	NR	NR	NR	NA	CLU	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CLU (t3129065) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr8	27610169	rs9331896	0.14	CLU	NR	NR	NR	NA	CLU	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CLU (3129079) expression in substantia nigra (SNIG)	Expression	intron_variant
chr8	27610169	rs9331896	0.14	CLU	NR	NR	NR	NA	CLU	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CLU (t3129065) expression in thalamus (THAL)	Expression	intron_variant
chr8	27610169	rs9331896	0.27	CLU	NR	NR	NR	NA	CLU	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CLU (3129079) expression in putamen (PUTM)	Expression	intron_variant
chr8	27610169	rs9331896	0.5	CLU	NR	NR	NR	NA	CLU	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CLU (3129079) expression in medulla (MEDU)	Expression	intron_variant
chr8	27610169	rs9331896	0.62	CLU	NR	NR	NR	NA	CLU	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CLU (t3129065) expression in medulla (MEDU)	Expression	intron_variant
chr8	27610169	rs9331896	0.69	CLU	NR	NR	NR	NA	CLU	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CLU (3129079) expression in thalamus (THAL)	Expression	intron_variant
chr8	27610169	rs9331896	0.89	CLU	NR	NR	NR	NA	CLU	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CLU (3129079) expression in cerebellar cortex (CRBL)	Expression	intron_variant
chr8	27610169	rs9331896	0.94	CLU	NR	NR	NR	NA	CLU	SNP-based	eQTL	26919393	Caucasian	UKBEC	134	Healthy subjects	CLU (t3129065) expression in putamen (PUTM)	Expression	intron_variant
chr8	27610169	rs9331896	1.70E-09	CLU	C	C	0.87	0.87	CLU	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	18845	All	Clinically diagnosed LOAD	AD	intron_variant
chr8	27610169	rs9331896	2.80E-09	CLU	C	C	0.84	0.84	CLU	SNP-based	Disease risk	25778476	Caucasian	"ADGC, IGAP"	21345	APOE-e4+ subjects	AD	AD	intron_variant
chr8	27610169	rs9331896	2.80E-25	CLU	C	C	0.86	0.86	CLU	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD, Cohorts from Europe and USA"	74046	All	LOAD	AD	intron_variant
chr8	27610169	rs9331896	3.60E-16	CLU	C	C	0.88	0.88	CLU	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	63926	All	Clinically diagnosed LOAD	AD	intron_variant
chr8	27610169	rs9331896	4.50E-10	CLU	C	C	0.86	0.86	CLU	SNP-based	Disease risk	24162737	Caucasian	Cohorts from Europe and USA	19884	All	LOAD	AD	intron_variant
chr8	27610169	rs9331896	4.60E-24	CLU	C	C	0.88	0.88	CLU	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	82771	All	Clinically diagnosed LOAD	AD	intron_variant
chr8	27610169	rs9331896	9.60E-17	CLU	C	C	0.86	0.86	CLU	SNP-based	Disease risk	24162737	Caucasian	"ADGC, CHARGE, EADI, GERAD"	54162	All	LOAD	AD	intron_variant
chr8	27610169	rs9331896	NR	CLU	T	T	0.83	0.83	CLU	SNP-based	Disease risk	27849641	Caucasian	ADGC	589	All	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr8	27610169	rs9331896	NR	ZCWPW1	T	T	0.73	0.73	CLU	SNP-based	Disease risk	27849641	Caucasian	ADGC	297	APOE-e4 non-carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr8	27610169	rs9331896	NR	ZCWPW1	T	T	1.18	1.18	CLU	SNP-based	Disease risk	27849641	Caucasian	ADGC	292	APOE-e4 carriers	Symptomatic AD (CDR global score >=0.5)	AD	intron_variant
chr8	27611345	rs9331888	0.000000094	CLU	NR	NR	1.16	1.16	CLU	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	14395	All	AD	AD	5_prime_UTR_variant
chr8	27611345	rs9331888	0.00000794	CLU	NR	NR	0.16	NA	CLU	SNP-based	Age at onset (AAO) / Survival	28323831	Caucasian	ADGC	15795	All	Age of AD onset	Other	5_prime_UTR_variant
chr8	27611345	rs9331888	0.000018	CLU	NR	NR	1.19	1.19	CLU	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	7353	All	AD	AD	5_prime_UTR_variant
chr8	27611345	rs9331888	0.000078	CLU	NR	NR	1.21	1.21	CLU	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	4821	APOE-e4 carrier	AD	AD	5_prime_UTR_variant
chr8	27611345	rs9331888	0.0029	CLU	NR	NR	1.12	1.12	CLU	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	7042	All	AD	AD	5_prime_UTR_variant
chr8	27611345	rs9331888	0.0045	CLU	NR	NR	1.22	1.22	CLU	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	2715	All	AD	AD	5_prime_UTR_variant
chr8	27611345	rs9331888	0.018	CLU	NR	NR	1.09	1.09	CLU	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	9518	APOE-e4 non-carrier	AD	AD	5_prime_UTR_variant
chr8	27611345	rs9331888	0.0697	CLU	G	G	1.1	1.1	CLU	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	2024	All	LOAD	AD	5_prime_UTR_variant
chr8	27611345	rs9331888	0.12	CLU	NR	NR	1.16	1.16	CLU	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	1573	All	AD	AD	5_prime_UTR_variant
chr8	27611345	rs9331888	0.19	CLU	NR	NR	0.92	0.92	CLU	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4+ carrier	AD	AD	5_prime_UTR_variant
chr8	27611345	rs9331888	0.192	CLU	G	G	0.89	0.89	CLU	SNP-based	Disease risk	23565137	Asian	Cohort from Korea	1468	All	LOAD	AD	5_prime_UTR_variant
chr8	27611345	rs9331888	0.32	CLU	NR	NR	1.09	1.09	CLU	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	1224	All	AD	AD	5_prime_UTR_variant
chr8	27611345	rs9331888	0.48	CLU	NR	NR	1.06	1.06	CLU	SNP-based	Disease risk	19734903	Caucasian	Cohorts from Europe	1530	All	AD	AD	5_prime_UTR_variant
chr8	27611345	rs9331888	0.53	CLU	NR	NR	1.03	1.03	CLU	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	Subjects with APOE-e4- carrier	AD	AD	5_prime_UTR_variant
chr8	27611345	rs9331888	0.74	CLU	G	G	0.99	0.99	CLU	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	5_prime_UTR_variant
chr8	27611345	rs9331888	0.76	CLU	G	G	0.99	0.99	CLU	SNP-based	Disease risk	20697030	Caucasian	ADGC	12969	All	AD	AD	5_prime_UTR_variant
chr8	27611345	rs9331888	>9.90E-01	CLU	G	G	1	1	CLU	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	5_prime_UTR_variant
chr8	27622508	rs2582367	0.000000697	"CLU, SCARA3"	NR	NR	NR	NA	CLU	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr8	27630273	rs569214	0.00000198	CLU	A	A	0.24	1.27125	SCARA3	SNP-based	eQTL	22722634	Caucasian	MAYO	399	All subjects with Temporal Cortex data	CLU (ILMN_1667058) expression in Temporal cortex (TCX)	Expression	upstream_gene_variant
chr8	27630273	rs569214	0.0264	CLU	A	A	0.95	2.58571	SCARA3	SNP-based	Disease risk	22722634	Caucasian	ADGC	22771	All	AD	AD	upstream_gene_variant
chr8	27630273	rs569214	NS	CLU	A	A	-0.02	0.980199	SCARA3	SNP-based	eQTL	22722634	Caucasian	MAYO	374	All subjects with Cerebellum data	CLU (ILMN_1667058) expression in Cerebellar tissue (CER)	Expression	upstream_gene_variant
chr8	27637095	rs894019	0.000000009	CLU	A	A	0.28	1.32313	SCARA3	SNP-based	eQTL	22722634	Caucasian	MAYO	399	All subjects with Temporal Cortex data	CLU (ILMN_1667058) expression in Temporal cortex (TCX)	Expression	intron_variant
chr8	27637095	rs894019	NS	CLU	A	A	0.01	1.01005	SCARA3	SNP-based	eQTL	22722634	Caucasian	MAYO	374	All subjects with Cerebellum data	CLU (ILMN_1667058) expression in Cerebellar tissue (CER)	Expression	intron_variant
chr8	27637095	rs894019	NS	CLU	A	A	1	2.71828	SCARA3	SNP-based	Disease risk	22722634	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr8	27648239	rs2582369	0.0000202	CLU	A	A	0.23	1.2586	SCARA3	SNP-based	eQTL	22722634	Caucasian	MAYO	399	All subjects with Temporal Cortex data	CLU (ILMN_1667058) expression in Temporal cortex (TCX)	Expression	intron_variant
chr8	27648239	rs2582369	NS	CLU	A	A	0.07	1.07251	SCARA3	SNP-based	eQTL	22722634	Caucasian	MAYO	374	All subjects with Cerebellum data	CLU (ILMN_1667058) expression in Cerebellar tissue (CER)	Expression	intron_variant
chr8	27648239	rs2582369	NS	CLU	A	A	1.04	2.82922	SCARA3	SNP-based	Disease risk	22722634	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr8	27652913	rs570197	0.0000401	CLU	G	G	0.22	1.24608	SCARA3	SNP-based	eQTL	22722634	Caucasian	MAYO	399	All subjects with Temporal Cortex data	CLU (ILMN_1667058) expression in Temporal cortex (TCX)	Expression	intron_variant
chr8	27652913	rs570197	NS	CLU	G	G	0.06	1.06184	SCARA3	SNP-based	eQTL	22722634	Caucasian	MAYO	374	All subjects with Cerebellum data	CLU (ILMN_1667058) expression in Cerebellar tissue (CER)	Expression	intron_variant
chr8	27652913	rs570197	NS	CLU	G	G	0.97	2.63794	SCARA3	SNP-based	Disease risk	22722634	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr8	27663228	rs542876	0.00000213	CLU	A	A	0.21	1.23368	SCARA3	SNP-based	eQTL	22722634	Caucasian	MAYO	399	All subjects with Temporal Cortex data	CLU (ILMN_1667058) expression in Temporal cortex (TCX)	Expression	intron_variant
chr8	27663228	rs542876	NS	CLU	A	A	-0.01	0.99005	SCARA3	SNP-based	eQTL	22722634	Caucasian	MAYO	374	All subjects with Cerebellum data	CLU (ILMN_1667058) expression in Cerebellar tissue (CER)	Expression	intron_variant
chr8	27679399	rs473024	0.0000104	CLU	G	G	0.24	1.27125	SCARA3	SNP-based	eQTL	22722634	Caucasian	MAYO	399	All subjects with Temporal Cortex data	CLU (ILMN_1667058) expression in Temporal cortex (TCX)	Expression	upstream_gene_variant
chr8	27679399	rs473024	NS	CLU	G	G	0.06	1.06184	SCARA3	SNP-based	eQTL	22722634	Caucasian	MAYO	374	All subjects with Cerebellum data	CLU (ILMN_1667058) expression in Cerebellar tissue (CER)	Expression	upstream_gene_variant
chr8	27679399	rs473024	NS	CLU	G	G	1.04	2.82922	SCARA3	SNP-based	Disease risk	22722634	Caucasian	ADGC	22771	All	AD	AD	upstream_gene_variant
chr8	27699009	rs4545046	0.00000712	LOC646843	NR	NR	NR	NA	SCARA3	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	818	All	Plasma Clusterin	Fluid biomarker	upstream_gene_variant
chr8	29184936	rs7007878	0.00000653	KIF13B	A	A	3.83	NA	KIF13B	SNP-based	Disease risk	21379329	Caucasian	ADGC	110	Southeastern European ancestry	LOAD	AD	intron_variant
chr8	37181847	rs1157242	0.000007	NR	NR	NR	1.17	1.17	KCNU1	SNP-based	Disease risk	19734902	Caucasian	Cohorts from Europe and USA	11789	All	AD	AD	intergenic_region
chr8	51826590	rs16916856	0.0000078	PCMTD1	C	C	NR	NA	PCMTD1	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr8	51826590	rs16916856	0.00069	PCMTD1	C	C	NR	NA	PCMTD1	SNP-based	Disease risk	18823527	Caucasian	MRC	2321	All	LOAD	AD	intron_variant
chr8	51826590	rs16916856	0.0036	PCMTD1	C	C	NR	NA	PCMTD1	SNP-based	Disease risk	18823527	Caucasian	MRC	3721	All	LOAD	AD	intron_variant
chr8	69517842	rs12548348	6.29E-11	SULF1	NR	NR	NR	NA	SULF1	SNP-based	Endophenotype	27357110	Caucasian	"ADNI, Knight-ADRC"	587	NA	Plasma Prolactin	Fluid biomarker	intron_variant
chr8	69517842	rs12548348	9.84E-26	SULF1	NR	NR	NR	NA	SULF1	SNP-based	Cross phenotype 	27357110	Caucasian	"ADNI, Knight-ADRC"	543	NA	CSF Prolactin	Fluid biomarker	intron_variant
chr8	77365237	rs4637816	0.00000931	LOC102724874	NR	NR	NR	NA	PEX2	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	818	All	Plasma Clusterin	Fluid biomarker	intergenic_region
chr8	80177631	rs7814569	0.00000118	"TPD52, ZBTB10"	A	A	0.51	NA	TPD52	SNP-based	Disease risk	21379329	Caucasian	ADGC	1422	APOE-e3e3	LOAD	AD	intron_variant
chr8	90639859	rs10102274	0.00000227	TMEM64	NR	NR	0.85	2.33965	TMEM64	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	673	All	CSF Clusterin	Fluid biomarker	intron_variant
chr8	90639859	rs10102274	0.0000754	TMEM64	NR	NR	1.05	2.85765	TMEM64	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	403	Subjects with APOE-e4-	CSF Clusterin	Fluid biomarker	intron_variant
chr8	90639859	rs10102274	0.0066	TMEM64	NR	NR	0.67	1.95424	TMEM64	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	270	Subjects with APOE-e4+	CSF Clusterin	Fluid biomarker	intron_variant
chr8	94841480	rs11996455	0.00009	INTS8	NR	NR	NR	NA	INTS8	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr8	94948283	rs896854	0.0000052	TP53INP1	NR	NR	NR	NA	NDUFAF6	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr8	94948283	rs896854	0.00416	TP53INP1	NR	NR	NR	NA	NDUFAF6	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr8	94951776	rs524678	0.082	TP53INP1	A	A	1.24	NA	NDUFAF6	SNP-based	Age at onset (AAO) / Survival	25649651	Caucasian	ADGC	983	AD subjects	AD Survival	Other	intron_variant
chr8	94959693	rs2011566	0.000278	C80RF38	G	G	NR	NA	NDUFAF6	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr8	94959693	rs2011566	0.000383	C80RF38	G	G	NR	NA	NDUFAF6	SNP-based	Cross phenotype 	30413934	Caucasian	CARDIoGRAMplusC4D	155197	All	Coronary artery disease (CAD)	Non-ADRD	intron_variant
chr8	94959693	rs2011566	0.00335	C80RF38	G	G	1	1	NDUFAF6	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr8	94964023	rs4735340	0.000000092	NDUFAF6	A	A	0.94	0.94	NDUFAF6	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	94437	All	Clinically diagnosed LOAD	AD	intron_variant
chr8	94964023	rs4735340	0.00000034	NDUFAF6	A	A	0.94	0.94	NDUFAF6	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	82771	All	Clinically diagnosed LOAD	AD	intron_variant
chr8	94964023	rs4735340	0.097	NDUFAF6	A	A	0.92	0.92	NDUFAF6	SNP-based	Disease risk	30820047	Non-Hispanic Caucasian	"ADGC, CHARGE, EADI, GERAD"	11666	All	Clinically diagnosed LOAD	AD	intron_variant
chr8	94968480	rs6982393	0.000039	"C8orf38, TP53INP1"	NR	NR	NR	NA	NDUFAF6	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr8	94968480	rs6982393	0.000311	"C8orf38, TP53INP1"	NR	NR	NR	NA	NDUFAF6	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr8	94988691	rs4734295	0.000068	"C8orf38, TP53INP1"	NR	NR	NR	NA	NDUFAF6	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr8	94988691	rs4734295	0.00014	"C8orf38, TP53INP1"	NR	NR	NR	NA	NDUFAF6	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr8	95038329	rs7812465	0.00021	C8orf38	NR	NR	NR	NA	NDUFAF6	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr8	95038329	rs7812465	0.000333	C8orf38	NR	NR	NR	NA	NDUFAF6	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr8	95041772	rs7818382	0.941	NDUFAF6	T	T	1.003	1.003	NDUFAF6	SNP-based	Disease risk	24495969	Caucasian	Cohort from Spain	4372	All	AD	AD	intron_variant
chr8	95448461	rs3133780	0.00018	"C8orf37, LOC643228"	NR	NR	NR	NA	C8orf37	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intron_variant
chr8	97351848	rs16895579	0.0000089	TSPYL5	A	A	NR	NA	TSPYL5	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intergenic_region
chr8	97351848	rs16895579	0.0000577	TSPYL5	A	A	NR	NA	TSPYL5	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Low-density lipoprotein (LDL)	Non-ADRD	intergenic_region
chr8	97351848	rs16895579	0.108	TSPYL5	A	A	1	1	TSPYL5	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intergenic_region
chr8	100670549	rs1693575	0.00000324	SNX31	NR	NR	0.36	1.43333	SNX31	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	673	All	CSF Clusterin	Fluid biomarker	intergenic_region
chr8	100670549	rs1693575	0.000463	SNX31	NR	NR	0.44	1.55271	SNX31	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	270	Subjects with APOE-e4+	CSF Clusterin	Fluid biomarker	intergenic_region
chr8	100670549	rs1693575	0.00148	SNX31	NR	NR	0.33	1.39097	SNX31	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	403	Subjects with APOE-e4-	CSF Clusterin	Fluid biomarker	intergenic_region
chr8	107074450	rs1461992	0.0000336	NR	NR	NR	0.49	0.49	ANGPT1	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	282	All women	LOAD	AD	intergenic_region
chr8	107074450	rs1461992	0.000675	NR	NR	NR	0.56	0.56	ANGPT1	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	282	All women	LOAD	AD	intergenic_region
chr8	107074450	rs1461992	0.00311	NR	NR	NR	0.51	0.51	ANGPT1	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	282	All women	LOAD	AD	intergenic_region
chr8	107074450	rs1461992	0.179	NR	NR	NR	0.69	0.69	ANGPT1	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	235	All women	LOAD	AD	intergenic_region
chr8	108601865	rs2928826	0.000000577	NR	T	T	NR	NA	TMEM74	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF T-tau	Fluid biomarker	intron_variant
chr8	108617674	rs2935776	0.000000553	NR	C	C	NR	NA	TMEM74	SNP-based	Endophenotype	20932310	Caucasian	ADNI	109	Normal controls	CSF T-tau	Fluid biomarker	intron_variant
chr8	115667320	rs13277568	0.00117	TRPS1	G	G	NR	NA	TRPS1	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Total cholesterol (TC)	Non-ADRD	intron_variant
chr8	115667320	rs13277568	0.00119	TRPS1	G	G	NR	NA	TRPS1	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr8	115667320	rs13277568	0.261	TRPS1	G	G	1	1	TRPS1	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr8	117173494	rs11558471	8.70E-10	SLC30A8	NR	NR	NR	NA	SLC30A8	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	3_prime_UTR_variant
chr8	117525450	rs10111328	0.000379	MED30	T	T	NR	NA	MED30	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	7289	Plan 2 (only males)	AD	AD	intron_variant
chr8	117525450	rs10111328	1.67E-20	NR	T	T	NR	NA	MED30	SNP-based	eQTL	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	7289	Plan 2 (only males)	MED30 (ILMN_1671603) expression in peripheral blood	Expression	intron_variant
chr8	121897448	rs956225	0.00000871	NR	G	G	0.3	0.3	HAS2	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	intron_variant
chr8	122973468	rs3802266	1.93E-95	ZHX2	NR	NR	-1.94	0.143704	ZHX2	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	ZHX2 expression in Cerebellar	Expression	3_prime_UTR_variant
chr8	122973468	rs3802266	2.97E-101	ZHX2	NR	NR	-2.35	0.0953692	ZHX2	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	ZHX2 expression in Temporal cortex	Expression	3_prime_UTR_variant
chr8	122973468	rs3802266	3.63E-38	ZHX2	NR	NR	-1.89	0.151072	ZHX2	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	ZHX2 expression in Cerebellar	Expression	3_prime_UTR_variant
chr8	122973468	rs3802266	9.47E-51	ZHX2	NR	NR	-1.99	0.136695	ZHX2	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	ZHX2 expression in Cerebellar	Expression	3_prime_UTR_variant
chr8	124272118	rs4457311	0.336	LOC442396	NR	NR	NR	NA	TMEM65	SNP-based	Endophenotype	20452100	Caucasian	ADGC	311	Non-Demented autopsy subjects	High Braak vs Low Braak	Neuropathology	intron_variant
chr8	124300419	rs10956170	0.912	TMEM65	NR	NR	NR	NA	TMEM65	SNP-based	Endophenotype	20452100	Caucasian	ADGC	311	Non-Demented autopsy subjects	High Braak vs Low Braak	Neuropathology	upstream_gene_variant
chr8	130734543	rs726411	0.000245	ADCY8	G	G	0.62	0.62	ADCY8	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	7289	Plan 2 (only males)	AD	AD	intergenic_region
chr8	132399360	rs2673604	0.0000026	KCNQ3	A	A	NR	NA	KCNQ3	SNP-based	Disease risk	21379329	Caucasian	ADGC	3839	All	LOAD	AD	intron_variant
chr8	143203248	rs4075205	0.0000366	NP_835466.1	NR	NR	NR	NA	GPIHBP1	SNP-based	Disease risk	20061627	Caucasian	ADGC	699	All	LOAD	AD	intergenic_region
chr8	143538865	rs3750208	0.00000728	ZC3H3	A	A	0.37	0.37	ZC3H3	SNP-based	Disease risk	22159054	African American	ADGC	1009	All	LOAD	AD	missense_variant
chr9	1521204	rs9886784	0.000312	NR	A	A	3.23	3.23	SMARCA2	SNP-based	Disease risk	17998437	Caucasian	Cohorts from Canada	1410	All	AD	AD	intergenic_region
chr9	1521204	rs9886784	0.0429	NR	A	A	2.9	2.9	SMARCA2	SNP-based	Disease risk	17998437	Caucasian	MRC	639	All	AD	AD	intergenic_region
chr9	2742771	rs2034764	0.00000382	"KCNV2, VLDLR"	NR	NR	NR	NA	PUM3	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	2222	AD subjects	Age at onset	Other	intron_variant
chr9	2742771	rs2034764	0.00000434	"KCNV2, VLDLR"	NR	NR	NR	NA	PUM3	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	2222	AD subjects	Age at onset	Other	intron_variant
chr9	2742771	rs2034764	0.00111	"KCNV2, VLDLR"	NR	NR	0.88	2.4109	PUM3	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	1190	AD subjects	Age at onset	Other	intron_variant
chr9	2742771	rs2034764	0.00162	"KCNV2, VLDLR"	NR	NR	0.76	2.13828	PUM3	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADGC	844	AD subjects	Age at onset	Other	intron_variant
chr9	2742771	rs2034764	0.236	"KCNV2, VLDLR"	NR	NR	2.52	12.4286	PUM3	SNP-based	Age at onset (AAO) / Survival	22005931	Caucasian	ADNI	188	AD subjects	Age at onset	Other	intron_variant
chr9	2828765	rs2173904	0.019	KIAA0020	NR	NR	1.45	1.45	PUM3	SNP-based	Cross phenotype 	30010129	Asian	Cohort from Han Chinse	475	All	AD	AD	missense_variant
chr9	2833267	rs10217194	0.00709	KIAA0020	NR	NR	NR	NA	PUM3	SNP-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr9	2833267	rs10217194	0.05889	NA	NR	NR	NR	NA	PUM3	Gene-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr9	3388125	rs62526377	0.00487	RFX3	NR	NR	NR	NA	RFX3	SNP-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr9	3388125	rs62526377	0.16583	NA	NR	NR	NR	NA	RFX3	Gene-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr9	3927704	rs622536	0.000000045	GLIS3	NR	NR	NR	NA	GLIS3	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr9	3927704	rs622536	0.000000668	GLIS3	NR	NR	NR	NA	GLIS3	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr9	3927704	rs622536	0.029	GLIS3	NR	NR	NR	NA	GLIS3	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF Ab1-42	Fluid biomarker	intron_variant
chr9	3927841	rs623295	0.000000045	GLIS3	NR	NR	NR	NA	GLIS3	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr9	3927841	rs623295	0.000000668	GLIS3	NR	NR	NR	NA	GLIS3	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr9	3927841	rs623295	0.00466	GLIS3	NR	NR	NR	NA	GLIS3	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF Ab1-42	Fluid biomarker	intron_variant
chr9	3928115	rs624290	0.000000045	GLIS3	NR	NR	NR	NA	GLIS3	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr9	3928115	rs624290	0.000000668	GLIS3	NR	NR	NR	NA	GLIS3	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr9	3928115	rs624290	0.00466	GLIS3	NR	NR	NR	NA	GLIS3	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF Ab1-42	Fluid biomarker	intron_variant
chr9	3929424	rs514716	0.00000002	NR	NR	NR	NR	NA	GLIS3	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr9	3929424	rs514716	0.00000023	NR	NR	NR	NR	NA	GLIS3	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr9	3929424	rs514716	0.000000414	NR	NR	NR	NR	NA	GLIS3	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr9	3929424	rs514716	0.000000743	NR	NR	NR	NR	NA	GLIS3	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr9	3929424	rs514716	0.00000136	GLIS1	C	C	0.044	1.04498	GLIS3	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	3146	All	CSF T-tau	Fluid biomarker	intron_variant
chr9	3929424	rs514716	0.0000345	GLIS1	NR	NR	0.05	1.05127	GLIS3	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	1509	Female subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr9	3929424	rs514716	0.0004	GLIS1	NR	NR	0.04	1.04081	GLIS3	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	1527	Male subjects	CSF P-tau181p	Fluid biomarker	intron_variant
chr9	3929424	rs514716	0.0145	GLIS1	C	C	0.045	1.04603	GLIS3	SNP-based	Age at onset (AAO) / Survival	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	39855	AD subjects	Age at onset	Other	intron_variant
chr9	3929424	rs514716	0.026	GLIS3	NR	NR	NR	NA	GLIS3	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF Ab1-42	Fluid biomarker	intron_variant
chr9	3929424	rs514716	0.0505	GLIS1	C	C	0.95	2.58571	GLIS3	SNP-based	Disease risk	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	74046	All	AD risk	AD	intron_variant
chr9	3929424	rs514716	0.294	GLIS1	C	C	0.01	1.01005	GLIS3	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	3146	All	CSF Ab1-42	Fluid biomarker	intron_variant
chr9	3929424	rs514716	0.36	NR	G	G	-0.036	0.96464	GLIS3	SNP-based	Neuropathology	23562540	NR	ROSMAP	651	All	tangle counts	Neuropathology	intron_variant
chr9	3929424	rs514716	0.479	NR	G	G	0.004	1.00401	GLIS3	SNP-based	Cognitive	23562540	NR	ROSMAP	1593	All	global cognitive decline	Cognitive	intron_variant
chr9	3929424	rs514716	0.518	NR	G	G	-0.022	0.97824	GLIS3	SNP-based	Disease risk	23562540	Caucasian	ADGC	22771	All	AD	AD	intron_variant
chr9	3929424	rs514716	0.666	GLIS1	C	C	0.029	1.02942	GLIS3	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	1530	All	AD Progression (based on CDR Score)	Cognitive	intron_variant
chr9	3929424	rs514716	1.07E-08	GLIS3	NR	NR	NR	NA	GLIS3	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr9	3929424	rs514716	1.38E-08	NR	NR	NR	NR	NA	GLIS3	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF T-tau	Fluid biomarker	intron_variant
chr9	3929424	rs514716	2.94E-08	GLIS1	C	C	0.049	1.05022	GLIS3	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	3146	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr9	3929424	rs514716	2.94E-08	GLIS1	NR	NR	0.05	1.05127	GLIS3	SNP-based	Endophenotype	28247064	Caucasian	"ADNI, BIOCARD, HB, Knight-ADRC, MAYO, SWEDEN, UPENN, UW"	3036	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr9	3929424	rs514716	3.22E-09	GLIS3	NR	NR	NR	NA	GLIS3	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr9	3929424	rs514716	3.76E-08	NR	NR	NR	NR	NA	GLIS3	SNP-based	Endophenotype	23562540	Caucasian	"ADNI, Knight-ADRC, UPENN, UW"	1269	All	CSF P-tau181p	Fluid biomarker	intron_variant
chr9	6248035	rs11792633	0.928	IL33	T	T	0.99	0.99	IL33	SNP-based	Disease risk	20534741	Caucasian	"ADC, UM"	1610	All	AD	AD	intron_variant
chr9	8095638	rs6477258	0.00000719	NR	NR	NR	NR	NA	DMAC1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intergenic_region
chr9	8095638	rs6477258	0.000173	NR	NR	NR	1.51	1.51	DMAC1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intergenic_region
chr9	8095638	rs6477258	0.00114	NR	NR	NR	NR	NA	DMAC1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intergenic_region
chr9	8095638	rs6477258	0.0025	NR	NR	NR	NR	NA	DMAC1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intergenic_region
chr9	8095638	rs6477258	0.0255	NR	NR	NR	1.74	1.74	DMAC1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intergenic_region
chr9	8095638	rs6477258	0.051	NR	NR	NR	1.4	1.4	DMAC1	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intergenic_region
chr9	8095638	rs6477258	NA	NR	NR	NR	NR	NA	DMAC1	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intergenic_region
chr9	8095638	rs6477258	NA	NR	NR	NR	NR	NA	DMAC1	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intergenic_region
chr9	8125410	rs10758939	0.00000475	NR	NR	NR	NR	NA	PTPRD	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intergenic_region
chr9	8125410	rs10758939	0.000124	NR	NR	NR	0.67	0.67	PTPRD	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	1093	All	LOAD	AD	intergenic_region
chr9	8125410	rs10758939	0.000478	NR	NR	NR	NR	NA	PTPRD	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intergenic_region
chr9	8125410	rs10758939	0.00421	NR	NR	NR	NR	NA	PTPRD	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intergenic_region
chr9	8125410	rs10758939	0.00976	NR	NR	NR	0.69	0.69	PTPRD	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	894	APOE-e4-	LOAD	AD	intergenic_region
chr9	8125410	rs10758939	0.0877	NR	NR	NR	0.64	0.64	PTPRD	SNP-based	Disease risk	21059989	Caribbean Hispanic	"EFIGA, WHICAP"	199	APOE-e4+	LOAD	AD	intergenic_region
chr9	8125410	rs10758939	0.25155	NR	NR	NR	NR	NA	PTPRD	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intergenic_region
chr9	8125410	rs10758939	0.3656	NR	NR	NR	NR	NA	PTPRD	SNP-based	Disease risk	21059989	Caucasian	ADGC	2449	Family-based individuals	LOAD	AD	intergenic_region
chr9	8125410	rs10758939	0.689	NR	NR	NR	NR	NA	PTPRD	SNP-based	Disease risk	21059989	Caucasian	ADGC	1390	Unrelated individuals	LOAD	AD	intergenic_region
chr9	10395255	rs11793419	0.00000533	PTPRD	NR	NR	NR	NA	PTPRD	SNP-based	Endophenotype	26545630	Caucasian	"ADNI, Knight-ADRC"	818	All	Plasma Clusterin	Fluid biomarker	intron_variant
chr9	16161235	rs4961664	0.00000444	C9orf92	T	T	0.81	0.81	C9orf92	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	17480	Plan 1 (males and females)	AD	AD	intergenic_region
chr9	16231987	rs9407730	0.00000361	NR	G	G	-0.21	0.810584	C9orf92	SNP-based	Endophenotype	23836404	Caucasian	ADGC	651	All	Neuritic plaque (NP)	Neuropathology	intron_variant
chr9	20145990	rs2039461	0.0000348	NR	NR	NR	NR	NA	MLLT3	SNP-based	Disease risk	19118814	Caucasian	CAP	988	All	LOAD	AD	intergenic_region
chr9	27543283	rs3849942	0.0048	C9orf72	NR	NR	NR	NA	C9orf72	SNP-based	Cross phenotype 	29630712	Caucasian	UKBEC	NR	All	MOBKL2B expression in brain	Expression	downstream_gene_variant
chr9	27543283	rs3849942	6.29E-19	C9orf72	NR	NR	NR	NA	C9orf72	SNP-based	Cross phenotype 	29630712	Caucasian	"ALS group, IGAP, FTGC, AFTD, PSP Genetics Consortium, IPDGC"	36052	All	AD	AD	downstream_gene_variant
chr9	27572636	rs2282240	0.000249	C9orf72	T	T	NR	NA	C9orf72	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AD	AD	intron_variant
chr9	27572636	rs2282240	1.18E-90	NR	T	T	NR	NA	C9orf72	SNP-based	eQTL	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	C9orf72 (ILMN_1741881) expression	Expression	intron_variant
chr9	27595997	rs13302855	0.00000404	C9orf72	NR	NR	NR	NA	C9orf72	SNP-based	Cross phenotype 	29630712	Caucasian	"ALS group, IGAP, FTGC, AFTD, PSP Genetics Consortium, IPDGC"	36052	All	AD	AD	intergenic_region
chr9	27595997	rs13302855	0.013	C9orf72	NR	NR	NR	NA	C9orf72	SNP-based	Cross phenotype 	29630712	Caucasian	UKBEC	NR	All	LRRC19 expression in brain	Expression	intergenic_region
chr9	28414341	rs10968576	0.253	NR	G	G	1.03	1.03	LINGO2	SNP-based	Cross phenotype 	26079416	Caucasian	ADGC	19692	All	AD	AD	intron_variant
chr9	28414341	rs10968576	0.731	NR	G	G	0	1	LINGO2	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Memory function (PMID:22992720; Documentation of Cognitive Functioning Measures in the Health and Retirement Study)	Cognitive	intron_variant
chr9	28414341	rs10968576	0.817	NR	G	G	1.01	1.01	LINGO2	SNP-based	Cross phenotype 	26079416	Caucasian	GERAD	10454	All	AD	AD	intron_variant
chr9	28414341	rs10968576	0.921	NR	G	G	1	1	LINGO2	SNP-based	Cross phenotype 	26079416	Caucasian	HRS	8403	All	Dementia probability score (PMID:22992720)	AD	intron_variant
chr9	28753984	rs10968750	0.00000197	LINGO2	T	T	2.63	2.63	LINGO2	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	intergenic_region
chr9	31546474	rs4576506	0.00000104	RP11-291J9.2	NR	NR	1.66	1.66	ACO1	SNP-based	Disease risk	22005930	Caucasian	"ADGC, GERAD, Cohort from UK"	7693	AD+P and control subjects	AD+Psychosis	ADRD	intergenic_region
chr9	35722285	rs2295797	0.00124	TPM2	C	C	NR	NA	TLN1	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	intron_variant
chr9	35722285	rs2295797	3.22E-144	NR	C	C	NR	NA	TLN1	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	TPM2 (ILMN_1757604) expression	Expression	intron_variant
chr9	35722285	rs2295797	6.45E-181	NR	C	C	NR	NA	TLN1	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	TPM2 (ILMN_1789196) expression	Expression	intron_variant
chr9	35960467	rs12378268	0.00000543	OR2S2	NR	NR	1.14	1.14	OR2S2	SNP-based	Disease risk	30979435	Caucasian	ADGC	14185	Age 60-79 y	AD	AD	upstream_gene_variant
chr9	35960467	rs12378268	0.363	OR2S2	NR	NR	1.04	1.04	OR2S2	SNP-based	Disease risk	30979435	Caucasian	ADGC	6339	Age >=80 y	AD	AD	upstream_gene_variant
chr9	36972798	rs138898773	0.008	PAX5	NR	NR	NR	NA	PAX5	SNP-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr9	36972798	rs138898773	0.4016	NA	NR	NR	NR	NA	PAX5	Gene-based	Cross phenotype 	30010129	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr9	37036250	rs2282079	0.00000381	PAX5	G	G	0.6	0.6	PAX5	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	17480	Plan 1 (males and females)	AD	AD	upstream_gene_variant
chr9	38189530	rs894520	0.936	NR	NR	NR	NR	NA	SHB	SNP-based	Endophenotype	20452100	Caucasian	ADGC	311	Non-Demented autopsy subjects	High Braak vs Low Braak	Neuropathology	upstream_gene_variant
chr9	71684384	rs7858861	0.0141	TMEM2	G	G	NR	NA	CEMIP2	SNP-based	Disease risk	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	AD	AD	3_prime_UTR_variant
chr9	71684384	rs7858861	1.78E-15	NR	G	G	NR	NA	CEMIP2	SNP-based	eQTL	31055733	Caucasian	"ADGC, CHS, CHARGE, HRS"	4806	HTN-N group	TMEM2 (ILMN_1784661) expression	Expression	3_prime_UTR_variant
chr9	75999104	rs11144711	0.000565	PCSK5	G	G	NR	NA	PCSK5	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr9	75999104	rs11144711	0.00249	PCSK5	G	G	NR	NA	PCSK5	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Low-density lipoprotein (LDL)	Non-ADRD	intron_variant
chr9	75999104	rs11144711	0.855	PCSK5	G	G	1	1	PCSK5	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr9	79282450	rs17198915	0.0000036	"CHCHD9, KRT18P24"	NR	NR	NR	NA	TLE4	SNP-based	Cross phenotype 	28870582	Caucasian	DIAGRAM	69033	All	Type 2 diabetes (T2D)	Non-ADRD	intergenic_region
chr9	83599234	rs12339683	0.000311	IDNK	T	T	NR	NA	IDNK	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Low-density lipoprotein (LDL)	Non-ADRD	upstream_gene_variant
chr9	83599234	rs12339683	0.00131	IDNK	T	T	NR	NA	IDNK	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	upstream_gene_variant
chr9	83599234	rs12339683	0.00306	IDNK	T	T	1.01	1.01	IDNK	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	upstream_gene_variant
chr9	86078545	rs7019241	0.000292	GOLPH2	T	T	0.54	0.54	GOLM1	SNP-based	Disease risk	17998437	Caucasian	Cohorts from Canada	1214	All	AD	AD	intron_variant
chr9	86078545	rs7019241	0.00982	GOLPH2	T	T	0.51	0.51	GOLM1	SNP-based	Disease risk	17998437	Caucasian	MRC	538	All	AD	AD	intron_variant
chr9	86085145	rs10868366	0.000243	GOLPH2	T	T	0.55	0.55	GOLM1	SNP-based	Disease risk	17998437	Caucasian	Cohorts from Canada	1380	All	AD	AD	intron_variant
chr9	86085145	rs10868366	0.00122	GOLPH2	T	T	0.46	0.46	GOLM1	SNP-based	Disease risk	17998437	Caucasian	MRC	641	All	AD	AD	intron_variant
chr9	87110354	rs7856774	0.0000549	NR	NR	NR	3.52	3.52	GAS1	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	235	All women	LOAD	AD	intergenic_region
chr9	87110354	rs7856774	0.0000559	NR	NR	NR	2.15	2.15	GAS1	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	235	All women	LOAD	AD	intergenic_region
chr9	87110354	rs7856774	0.0002	NR	NR	NR	2.13	2.13	GAS1	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	235	All women	LOAD	AD	intergenic_region
chr9	87110354	rs7856774	0.00832	NR	NR	NR	1.88	1.88	GAS1	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	282	All women	LOAD	AD	intergenic_region
chr9	87530200	rs12378187	0.02	DAPK1	G	G	0.79	0.79	DAPK1	SNP-based	Age at onset (AAO) / Survival	17998437	Caucasian	Cohorts from Canada	1341	All	Age of AD onset	Other	intron_variant
chr9	87530200	rs12378187	0.29	DAPK1	G	G	0.86	0.86	DAPK1	SNP-based	Disease risk	17998437	Caucasian	Cohorts from Canada	1341	All	AD	AD	intron_variant
chr9	87578076	rs4878104	0.334	DAPK1	T	T	1.08	1.08	DAPK1	SNP-based	Disease risk	20534741	Caucasian	"ADC, UM"	1610	All	AD	AD	intron_variant
chr9	90726252	rs1172922	0.00000456	SYK	A	A	1.41	1.41	SYK	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	10191	Plan 3 (only females)	AD	AD	intergenic_region
chr9	103261938	rs16922670	0.00000722	RP11-341A22.2	NR	NR	1.63	1.63	CYLC2	SNP-based	Disease risk	22005930	Caucasian	"ADGC, GERAD"	2034	AD+P and AD-P subjects	AD+Psychosis	ADRD	intron_variant
chr9	104868152	rs10991386	0.000000619	ABCA1	G	G	NR	NA	ABCA1	SNP-based	Cross phenotype 	30413934	Caucasian	ENGAGE	62166	All	Total cholesterol (TC)	Non-ADRD	intron_variant
chr9	104868152	rs10991386	0.0000854	ABCA1	G	G	NR	NA	ABCA1	SNP-based	Cross phenotype 	30413934	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chr9	104868152	rs10991386	0.0233	ABCA1	G	G	1	1	ABCA1	SNP-based	Disease risk	30413934	Caucasian	UKBB	376113	All	AD	AD	intron_variant
chr9	109849099	rs913360	0.000000183	PALM2	G	G	1.56	1.56	PALM2AKAP2	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	2024	All	LOAD	AD	intron_variant
chr9	109849099	rs913360	0.0000066	PALM2	G	G	1.29	1.29	PALM2AKAP2	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	3894	All	LOAD	AD	intron_variant
chr9	109849099	rs913360	0.16	PALM2	G	G	1.11	1.11	PALM2AKAP2	SNP-based	Disease risk	23565137	Asian	Cohort from Japan	1870	All	LOAD	AD	intron_variant
chr9	118689608	rs1360806	0.0000401	DBC1	NR	NR	NR	NA	BRINP1	SNP-based	Disease risk	20061627	Caucasian	ADGC	699	All	LOAD	AD	intron_variant
chr9	118708097	rs10984186	0.000000423	CDK5RAP2	NR	NR	1.43	1.43	BRINP1	SNP-based	Disease risk	29360470	Caucasian	Cohort from Quebec Founder Population	1943	All	AD	AD	upstream_gene_variant
chr9	118708097	rs10984186	0.013	CDK5RAP2	NR	NR	NR	NA	BRINP1	SNP-based	Endophenotype	29360470	Caucasian	ADNI	541	All	Hippocampal volume	Neuropathology	upstream_gene_variant
chr9	118708097	rs10984186	0.016	CDK5RAP2	NR	NR	NR	NA	BRINP1	SNP-based	Endophenotype	29360470	Caucasian	Cohort from Quebec Founder Population	141	All	Neurofibrillary tangle (NFT) density	Neuropathology	upstream_gene_variant
chr9	118708097	rs10984186	0.0462	CDK5RAP2	NR	NR	1.35	1.35	BRINP1	SNP-based	Disease risk	29360470	Caucasian	ADNI	535	All	AD	AD	upstream_gene_variant
chr9	118708097	rs10984186	0.225	CDK5RAP2	NR	NR	NR	NA	BRINP1	SNP-based	Disease risk	29360470	Caucasian	IGAP	54162	All	AD	AD	upstream_gene_variant
chr9	122388609	rs12551233	0.000000479	PTGS1	G	G	-0.32	0.726149	PTGS1	SNP-based	Endophenotype	23836404	Caucasian	ADGC	651	All	Neuritic plaque (NP)	Neuropathology	intron_variant
chr9	126594025	rs144621483	0.000000043	NR	T	T	-1.77	0.170333	LMX1B	SNP-based	Endophenotype	25188341	Caucasian	ADGC	4046	All	Neuritic Plaque	Neuropathology	intron_variant
chr9	130135914	rs2240913	1.23E-63	GPR107	NR	NR	0.66	1.93479	GPR107	SNP-based	eQTL	22685416	Caucasian	MAYO	374	All	GPR107 expression in Cerebellar	Expression	3_prime_UTR_variant
chr9	130135914	rs2240913	1.66E-30	GPR107	NR	NR	0.69	1.99372	GPR107	SNP-based	eQTL	22685416	Caucasian	MAYO	197	AD	GPR107 expression in Cerebellar	Expression	3_prime_UTR_variant
chr9	130135914	rs2240913	1.84E-28	GPR107	NR	NR	0.62	1.85893	GPR107	SNP-based	eQTL	22685416	Caucasian	MAYO	177	Non-AD	GPR107 expression in Cerebellar	Expression	3_prime_UTR_variant
chr9	130135914	rs2240913	5.66E-77	GPR107	NR	NR	0.95	2.58571	GPR107	SNP-based	eQTL	22685416	Caucasian	MAYO	399	All	GPR107 expression in Temporal cortex	Expression	3_prime_UTR_variant
chr9	131513059	rs7865761	0.04	POMT1	G	G	1.53	1.53	POMT1	SNP-based	Disease risk	17998437	Caucasian	Cohorts from Canada	1368	All	AD	AD	intron_variant
chr9	131513059	rs7865761	0.78	POMT1	G	G	1.03	1.03	POMT1	SNP-based	Age at onset (AAO) / Survival	17998437	Caucasian	Cohorts from Canada	1368	All	Age of AD onset	Other	intron_variant
chr9	133038965	rs689266	0.000015	GTF3C5	NR	NR	NR	NA	GTF3C5	SNP-based	Cross phenotype 	28870582	Caucasian	IGAP	54162	All	AD	AD	intron_variant
chrX	9835504	rs2405940	0.0003	SHROOM2	NR	NR	NR	NA	SHROOM2	SNP-based	Endophenotype	22245343	Caucasian	ADNI	757	All	MRI	Imaging	intron_variant
chrX	43732253	rs5905859	0.000019	MAOA	NR	NR	2.27	2.27	MAOA	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	235	All women	LOAD	AD	intron_variant
chrX	43732253	rs5905859	0.059	MAOA	NR	NR	1.44	1.44	MAOA	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	235	All women	LOAD	AD	intron_variant
chrX	43732253	rs5905859	0.152	NR	NR	NR	1.45	1.45	MAOA	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	235	All women	LOAD	AD	intron_variant
chrX	43732253	rs5905859	0.376	NR	NR	NR	1.21	1.21	MAOA	SNP-based	Disease risk	22785395	Caucasian	Cohort fro Polish	282	All women	LOAD	AD	intron_variant
chrX	46465158	rs7876304	0.0009	ZNF673	NR	NR	NR	NA	KRBOX4	SNP-based	Endophenotype	22245343	Caucasian	ADNI	757	All	MRI	Imaging	intron_variant
chrX	46607340	rs1883255	0.0015	SLC9A7	NR	NR	NR	NA	SLC9A7	SNP-based	Endophenotype	22245343	Caucasian	ADNI	757	All	MRI	Imaging	intron_variant
chrX	74448994	rs479640	0.0038	SLC16A2	NR	NR	NR	NA	SLC16A2	SNP-based	Endophenotype	22245343	Caucasian	ADNI	757	All	MRI	Imaging	intron_variant
chrX	87181248	rs5969117	0.00000142	KLHL4	C	C	1.49	1.49	KLHL4	SNP-based	Disease risk	30636644	Caucasian	"ADGC, CHS, CHARGE, HRS"	7289	Plan 2 (only males)	AD	AD	intergenic_region
chrX	92138738	rs5984894	0.0000002	PCDH11X	NR	NR	1.75	1.75	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	4740	"Female Homozygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.00000022	PCDH11X	NR	NR	1.3	1.3	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	4740	80+ years old subjects	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.0000048	PCDH11X	NR	NR	NR	NA	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	2716	All	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.000015	PCDH11X	NR	NR	1.39	1.39	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	2024	60-80 years old subjects	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.000057	PCDH11X	NR	NR	NR	NA	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	2024	All	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.0001	PCDH11X	NR	NR	NR	NA	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	890	All	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.0002	PCDH11X	NR	NR	1.7	1.7	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	2716	"Female Homozygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.0002	PCDH11X	NR	NR	1.92	1.92	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	2024	"Female Homozygotes, 60-80 years old subjects"	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.001	PCDH11X	NR	NR	1.45	1.45	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	890	80+ years old subjects	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.001	PCDH11X	NR	NR	2.28	2.28	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	890	"Female Homozygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.002	PCDH11X	NR	NR	1.23	1.23	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	2716	80+ years old subjects	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.006	PCDH11X	NR	NR	1.4	1.4	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	673	60-80 years old subjects	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.01	PCDH11X	NR	NR	1.26	1.26	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	4740	"Female Heterozygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.01	PCDH11X	NR	NR	1.35	1.35	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	904	60-80 years old subjects	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.01	PCDH11X	NR	NR	1.96	1.96	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	673	"Female Homozygotes, 60-80 years old subjects"	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.02	PCDH11X	NR	NR	1.43	1.43	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	2024	"Female Heterozygotes, 60-80 years old subjects"	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.02	PCDH11X	NR	NR	1.44	1.44	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	447	60-80 years old subjects	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.02	PCDH11X	NR	NR	2.02	2.02	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	904	"Female Homozygotes, 60-80 years old subjects"	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.03	PCDH11X	NR	NR	1.66	1.66	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	673	"Female Heterozygotes, 60-80 years old subjects"	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.03	PCDH11X	NR	NR	NR	NA	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	447	All	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.04	PCDH11X	NR	NR	1.33	1.33	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	2024	"Male Hemizygotes, 60-80 years old subjects"	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.04	PCDH11X	NR	NR	NR	NA	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	904	All	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.05	PCDH11X	NR	NR	NR	NA	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	434	All	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.06	PCDH11X	NR	NR	1.71	1.71	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	906	"Female Homozygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.07	PCDH11X	NR	NR	1.18	1.18	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	4740	"Male Hemizygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.09	PCDH11X	NR	NR	2	2	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	447	"Female Homozygotes, 60-80 years old subjects"	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.09	PCDH11X	NR	NR	NR	NA	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	673	All	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.1	PCDH11X	NR	NR	1.23	1.23	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	906	80+ years old subjects	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.1	PCDH11X	NR	NR	1.58	1.58	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	486	"Female Heterozygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.15	PCDH11X	NR	NR	1.19	1.19	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	2716	"Female Heterozygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.16	PCDH11X	NR	NR	1.46	1.46	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	904	"Female Heterozygotes, 60-80 years old subjects"	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.19	PCDH11X	NR	NR	1.4	1.4	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	447	"Male Hemizygotes, 60-80 years old subjects"	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.22	PCDH11X	NR	NR	1.55	1.55	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	447	"Female Heterozygotes, 60-80 years old subjects"	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.31	PCDH11X	NR	NR	1.28	1.28	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	673	"Male Hemizygotes, 60-80 years old subjects"	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.35	PCDH11X	NR	NR	NR	NA	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	906	All	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.38	PCDH11X	NR	NR	1.33	1.33	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	486	"Female Homozygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.43	PCDH11X	NR	NR	1.2	1.2	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	904	"Male Hemizygotes, 60-80 years old subjects"	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.47	PCDH11X	NR	NR	0.76	0.76	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	434	"Female Heterozygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.47	PCDH11X	NR	NR	1.19	1.19	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	906	"Female Heterozygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.48	PCDH11X	NR	NR	1.19	1.19	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	890	"Male Hemizygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.5	PCDH11X	NR	NR	1.1	1.1	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	486	80+ years old subjects	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.6	PCDH11X	NR	NR	NR	NA	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	486	All	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.74	PCDH11X	NR	NR	1.04	1.04	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	2716	"Male Hemizygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.83	PCDH11X	NR	NR	0.96	0.96	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	434	80+ years old subjects	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.86	PCDH11X	NR	NR	0.95	0.95	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	906	"Male Hemizygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.86	PCDH11X	NR	NR	1.04	1.04	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	890	"Female Heterozygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.89	PCDH11X	NR	NR	0.96	0.96	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	486	"Male Hemizygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.94	PCDH11X	NR	NR	0.97	0.97	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	434	"Male Hemizygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92138738	rs5984894	0.95	PCDH11X	NR	NR	0.97	0.97	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	434	"Female Homozygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92138738	rs5984894	3.90E-12	PCDH11X	NR	NR	NR	NA	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	4740	All	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.00000016	NR	NR	NR	1.29	1.29	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	5010	All	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.0000039	NR	NR	NR	NR	NA	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	2716	All	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.000032	NR	NR	NR	NR	NA	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	2024	All	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.0001	NR	NR	NR	1.72	1.72	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	4740	"Female Homozygotes, 60+ years old subjects"	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.0002	NR	NR	NR	1.68	1.68	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	2716	"Female Homozygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.0002	NR	NR	NR	1.85	1.85	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	2024	"Female Homozygotes, 60-80 years old subjects"	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.00025	NR	NR	NR	NR	NA	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	890	All	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.002	NR	NR	NR	2.16	2.16	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	890	"Female Homozygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.009	NR	NR	NR	2.01	2.01	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	673	"Female Homozygotes, 60-80 years old subjects"	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.01	NR	NR	NR	NR	NA	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	447	All	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.02	NR	NR	NR	2.48	2.48	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	447	"Female Homozygotes, 60-80 years old subjects"	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.03	NR	NR	NR	1.22	1.22	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	4740	"Female Heterozygotes, 60+ years old subjects"	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.04	NR	NR	NR	1.3	1.3	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	2024	"Male Hemizygotes, 60-80 years old subjects"	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.05	NR	NR	NR	1.32	1.32	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	2024	"Female Heterozygotes, 60-80 years old subjects"	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.06	NR	NR	NR	1.69	1.69	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	906	"Female Homozygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.06	NR	NR	NR	NR	NA	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	904	All	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.07	NR	NR	NR	1.61	1.61	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	904	"Female Homozygotes, 60-80 years old subjects"	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.07	NR	NR	NR	NR	NA	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	434	All	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.08	NR	NR	NR	1.17	1.17	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	4740	"Male Hemizygotes, 60+ years old subjects"	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.08	NR	NR	NR	NR	NA	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	673	All	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.09	NR	NR	NR	1.48	1.48	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	673	"Female Heterozygotes, 60-80 years old subjects"	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.09	NR	NR	NR	1.6	1.6	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	486	"Female Heterozygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.11	NR	NR	NR	1.71	1.71	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	447	"Female Heterozygotes, 60-80 years old subjects"	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.16	NR	NR	NR	1.39	1.39	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	447	"Male Hemizygotes, 60-80 years old subjects"	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.17	NR	NR	NR	1.17	1.17	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	2716	"Female Heterozygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.29	NR	NR	NR	1.41	1.41	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	486	"Female Homozygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.33	NR	NR	NR	1.27	1.27	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	673	"Male Hemizygotes, 60-80 years old subjects"	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.34	NR	NR	NR	1.22	1.22	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	904	"Male Hemizygotes, 60-80 years old subjects"	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.35	NR	NR	NR	NR	NA	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	906	All	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.47	NR	NR	NR	1.19	1.19	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	906	"Female Heterozygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.49	NR	NR	NR	1.17	1.17	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	904	"Female Heterozygotes, 60-80 years old subjects"	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.54	NR	NR	NR	NR	NA	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	486	All	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.55	NR	NR	NR	0.8	0.8	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	434	"Female Heterozygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.55	NR	NR	NR	1.15	1.15	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	890	"Male Hemizygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.69	NR	NR	NR	1.05	1.05	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	2716	"Male Hemizygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.86	NR	NR	NR	1.06	1.06	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	434	"Male Hemizygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.88	NR	NR	NR	0.96	0.96	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	486	"Male Hemizygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.91	NR	NR	NR	0.97	0.97	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	906	"Male Hemizygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.94	NR	NR	NR	1.03	1.03	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	434	"Female Homozygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92147221	rs2573905	0.95	NR	NR	NR	1.01	1.01	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	890	"Female Heterozygotes, 80+ years old subjects"	LOAD	AD	intron_variant
chrX	92147221	rs2573905	5.40E-13	NR	NR	NR	NR	NA	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	4740	All	LOAD	AD	intron_variant
chrX	92176386	rs5941047	0.00008	NR	NR	NR	1.21	1.21	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	5037	All	LOAD	AD	intron_variant
chrX	92184068	rs4568761	0.001	NR	NR	NR	1.17	1.17	PCDH11X	SNP-based	Disease risk	19136949	Caucasian	ADGC	5028	All	LOAD	AD	intron_variant
chrX	106034370	rs1804495	1.24E-12	SERPINA7	NR	NR	-0.11	0.895834	SERPINA7	SNP-based	Endophenotype	23894628	Non-Hispanic Caucasian	ADNI	521	All	Plasma TBG	Fluid biomarker	missense_variant
chrX	119393914	rs217969	0.5	NR	T	T	0.04	1.04081	SLC25A43	SNP-based	Endophenotype	25027320	Caucasian	Cohorts from Europe	515	AD subjects	CSF P-tau181p	Fluid biomarker	upstream_gene_variant
